data_2lbc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lbc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.414 HG12 ' HD1' ' A' ' 25' ' ' TYR . 4.3 mp . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 107.244 -1.391 . . . . 6.09 107.244 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.87 101.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.622 -1.172 . . . . 4.6 110.981 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' ' 21' ' ' ARG . 39.8 mt-10 -70.46 -2.12 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.372 -0.831 . . . . 5.13 111.008 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 1.2 m -57.62 -37.87 74.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.36 -0.608 . . . . 4.51 109.36 170.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -64.5 -49.03 72.93 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.701 -0.681 . . . . 3.46 111.372 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.5 p -66.59 -42.03 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 120.812 -0.355 . . . . 3.39 111.042 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 47.0 mtt -62.86 -34.83 78.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.266 -0.425 . . . . 5.53 111.145 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 5' ' ' SER . 51.0 mt-30 -59.14 -47.44 85.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.751 -0.38 . . . . 5.92 110.615 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.96 ' HB3' HD11 ' A' ' 17' ' ' LEU . 15.9 mt -60.31 -47.79 84.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.572 0.701 . . . . 3.9 109.989 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.17 -50.61 71.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.571 -1.195 . . . . 4.46 111.915 -174.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -69.53 1.27 4.2 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.528 0.566 . . . . 6.27 112.528 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 22.4 ptp -130.07 10.01 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.028 -0.269 . . . . 5.61 111.7 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.16 -94.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.528 -1.32 . . . . 4.85 113.611 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.629 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.8 m-85 -130.44 159.15 72.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.322 . . . . 5.55 110.129 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -69.66 80.79 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.984 2.456 . . . . 4.57 110.945 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.96 HD11 ' HB3' ' A' ' 10' ' ' LEU . 90.4 mt -81.67 66.72 7.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.7 -0.682 . . . . 3.76 111.849 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.74 -22.56 24.47 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.57 0.7 . . . . 5.48 110.125 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -58.9 -33.25 70.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.453 -0.794 . . . . 3.8 110.042 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.717 ' HG ' HD13 ' A' ' 10' ' ' LEU . 44.3 t -73.16 -39.37 65.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.606 -0.725 . . . . 3.27 109.855 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.427 ' HE ' ' CD ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -50.02 -56.18 11.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.666 0.746 . . . . 6.55 109.803 177.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.784 ' HZ1' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -71.69 -25.38 62.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.337 -0.847 . . . . 5.22 110.539 178.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . . . -68.34 -43.24 77.91 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 116.396 -0.365 . . . . 4.34 110.976 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 20' ' ' CYS . 88.5 t -60.1 -43.09 92.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.965 0.412 . . . . 4.58 109.978 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.414 ' HD1' HG12 ' A' ' 2' ' ' ILE . 80.1 t80 -65.84 -39.1 90.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.039 -0.528 . . . . 7.65 110.864 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -71.62 -43.64 65.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 7.32 111.824 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -61.88 -27.64 68.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.107 0.48 . . . . 5.71 110.908 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.78 38.6 6.89 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 6.04 112.357 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 58.94 75.42 0.4 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.243 0.544 . . . . 5.27 110.077 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.464 ' HB3' HG23 ' A' ' 34' ' ' VAL . 26.3 mmt -112.88 -0.6 14.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.167 -0.47 . . . . 6.57 110.803 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.87 159.27 23.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.774 -0.727 . . . . 4.23 112.184 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.34 88.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 3.88 111.299 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 4.0 mp0 -58.35 -39.35 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.9 -0.591 . . . . 5.59 111.024 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 30' ' ' MET . 75.1 t -71.54 -41.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 5.29 111.202 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.1 63.32 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 3.68 110.74 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' HD1' HD23 ' A' ' 10' ' ' LEU . 70.6 t80 -56.2 -43.09 78.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.99 -0.744 . . . . 5.05 108.99 170.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.505 ' HA ' HG13 ' A' ' 40' ' ' ILE . 26.2 t-20 -66.3 -37.84 86.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.857 . . . . 6.25 110.617 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.46 ' HE3' HD13 ' A' ' 39' ' ' ILE . 51.3 t90 -61.22 -35.52 77.44 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.433 0.635 . . . . 6.43 109.802 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.705 HG12 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -76.58 -43.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 3.69 111.696 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 37' ' ' ASN . 2.8 pp -70.33 -23.3 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.385 -0.526 . . . . 5.32 111.446 -174.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.29 -31.63 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 5.79 110.401 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -96.06 10.84 36.22 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.16 0.43 . . . . 5.81 112.16 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.3 ptt? . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 120.894 0.378 . . . . 6.2 111.051 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.7 0.286 . . . . 7.7 110.478 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.64 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 89.1 Cg_exo -49.85 167.05 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.732 2.954 . . . . 5.41 112.928 171.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.626 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 34.2 Cg_endo -61.47 112.45 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.481 2.121 . . . . 7.74 111.353 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.86 ' HA ' HG23 ' A' ' 82' ' ' VAL . 11.3 pt-20 -57.21 -27.59 62.13 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.882 -0.599 . . . . 10.13 110.63 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 5.8 tt0 -59.14 -51.99 67.64 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.21 0.528 . . . . 11.78 109.741 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.861 HD11 ' HB2' ' A' ' 106' ' ' LEU . 80.4 mt -75.77 -42.37 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.671 -0.695 . . . . 8.98 112.024 -175.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.86 HG23 ' HA ' ' A' ' 79' ' ' GLU . 12.0 m -56.01 -38.45 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.594 -0.891 . . . . 7.8 108.594 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.603 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -60.31 -50.09 75.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.561 -1.2 . . . . 11.19 110.649 175.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 81' ' ' ILE . 23.2 mt -59.24 -42.22 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.965 -0.562 . . . . 11.59 110.613 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.588 HG21 ' HD2' ' A' ' 90' ' ' PHE . 84.9 mt -65.5 -46.01 91.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.833 -0.622 . . . . 8.01 111.467 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.569 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -71.31 -20.48 62.19 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.073 -0.651 . . . . 10.38 110.837 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -76.79 -21.13 55.58 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.412 . . . . 12.35 110.416 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 mmt -71.5 -22.45 61.79 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.464 0.65 . . . . 10.6 109.813 173.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.77 -3.3 8.04 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.196 -0.911 . . . . 10.36 111.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.588 ' HD2' HG21 ' A' ' 85' ' ' ILE . 31.9 m-85 -87.06 -179.07 6.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.792 0.33 . . . . 8.89 110.478 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 26.5 tt0 -90.58 141.54 28.67 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.589 -0.523 . . . . 10.6 109.589 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.455 ' O ' HD12 ' A' ' 96' ' ' ILE . 11.7 ttm180 -56.48 -52.65 63.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.948 0.404 . . . . 12.6 110.354 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.78 -34.37 74.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.61 . . . . 9.25 110.938 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.2 tt0 -66.29 -39.2 89.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.57 -0.741 . . . . 7.2 109.359 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -62.32 -41.65 98.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.27 -0.877 . . . . 5.69 110.219 173.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.64 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.52 -52.09 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.872 -0.604 . . . . 6.87 110.419 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.542 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 59.6 tt0 -54.13 -47.94 71.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 8.99 110.742 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.89 -53.21 60.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.193 -0.912 . . . . 5.41 110.593 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.718 HD21 ' HB1' ' A' ' 109' ' ' ALA . 73.6 mt -61.48 -30.73 70.79 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.593 -0.276 . . . . 5.86 111.36 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -56.49 -48.18 77.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 8.38 109.802 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.31 68.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.929 -1.032 . . . . 8.88 111.624 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.653 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 23.6 p -81.59 -7.41 59.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.354 0.502 . . . . 8.79 112.354 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 65.18 63.27 0.67 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.601 0.715 . . . . 10.09 110.133 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.4 p-10 49.66 28.93 2.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.003 -1.453 . . . . 7.86 112.533 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -89.03 110.49 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.096 -0.705 . . . . 11.16 109.096 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.861 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.4 tt -56.31 -61.2 2.57 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.071 -0.968 . . . . 10.38 112.132 -175.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.404 ' N ' HD22 ' A' ' 106' ' ' LEU . 16.7 mm-40 -56.04 -46.89 78.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.378 -0.828 . . . . 11.82 111.115 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.653 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.3 ttm180 -66.36 -28.62 68.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.573 -0.285 . . . . 12.99 110.748 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.718 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.74 -50.66 68.2 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.332 -0.618 . . . . 6.65 109.332 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.91 -39.0 83.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.183 -0.917 . . . . 8.11 109.635 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.81 -51.1 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 9.04 109.826 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -64.11 -42.67 96.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.507 -1.224 . . . . 9.43 110.862 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 109' ' ' ALA . 47.6 mt -70.71 -40.66 77.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.361 -0.836 . . . . 5.25 111.584 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 7.33 111.802 -174.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.132 0.491 . . . . 6.09 109.876 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.92 82.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 4.6 110.364 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 8' ' ' MET . 43.8 mt-10 -72.63 -10.82 60.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.739 -0.664 . . . . 5.13 111.99 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.621 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 25.1 p -65.33 -32.6 74.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.732 -0.84 . . . . 4.51 108.732 175.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.71 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 43.6 m -59.87 -53.4 58.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.194 -0.912 . . . . 3.46 111.472 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -63.21 -37.84 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.734 -0.387 . . . . 3.39 110.435 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 64.3 mtt -62.69 -28.25 69.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 5.53 111.396 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 5' ' ' SER . 27.1 mt-30 -65.33 -46.74 79.06 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.91 -0.316 . . . . 5.92 110.478 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.686 HD13 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.21 -40.45 86.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.783 0.801 . . . . 3.9 109.375 176.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.47 -47.41 84.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.141 -1.391 . . . . 4.46 112.548 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.68 -27.87 69.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.267 0.469 . . . . 6.27 112.267 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 ptm -99.35 2.0 44.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.625 0.25 . . . . 5.61 111.268 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.96 -116.16 0.35 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.406 -0.902 . . . . 4.85 112.851 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.1 m-85 -101.65 154.32 37.35 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 5.55 110.719 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -71.47 85.65 0.88 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.785 2.323 . . . . 4.57 111.468 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.479 HD13 HD11 ' A' ' 39' ' ' ILE . 2.6 mm? -78.46 68.67 4.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 3.76 112.089 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.413 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 12.9 tt0 -55.53 -25.38 37.16 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.912 -0.492 . . . . 5.48 110.918 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.436 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -57.7 -31.95 66.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 3.8 109.801 174.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.686 ' SG ' HD13 ' A' ' 10' ' ' LEU . 28.0 t -73.68 -39.88 64.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.481 -0.781 . . . . 3.27 109.769 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -53.27 -53.37 51.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.085 0.469 . . . . 6.55 110.709 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 18' ' ' GLU . 8.7 ptpt -72.17 -22.83 61.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.226 -0.443 . . . . 5.22 110.721 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.28 76.66 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.237 -0.438 . . . . 4.34 110.75 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 20' ' ' CYS . 73.4 t -58.5 -42.17 83.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 4.58 110.159 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.11 -38.6 82.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.663 -0.415 . . . . 7.65 110.366 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.59 -37.64 82.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.388 -0.369 . . . . 7.32 111.427 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.5 p -71.55 -17.7 62.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 5.71 111.406 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.95 23.48 20.24 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.876 -0.678 . . . . 6.04 111.481 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.19 58.88 1.36 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.6 0.714 . . . . 5.27 110.263 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.407 ' HB3' HG21 ' A' ' 34' ' ' VAL . 87.4 mmm -88.23 -11.78 45.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.491 -0.777 . . . . 6.57 111.757 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.44 -173.67 17.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 4.23 113.298 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -58.84 -55.57 33.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.659 0.615 . . . . 3.88 112.659 -174.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.75 -44.78 92.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 5.59 112.149 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 30' ' ' MET . 86.9 t -65.25 -42.42 93.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.741 0.305 . . . . 5.29 111.096 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.16 50.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.596 -0.441 . . . . 3.68 111.172 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.54 ' O ' HG22 ' A' ' 39' ' ' ILE . 86.3 t80 -61.43 -40.63 95.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.978 -0.749 . . . . 5.05 108.978 171.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.529 ' O ' HG13 ' A' ' 40' ' ' ILE . 92.0 m-20 -60.69 -45.37 94.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.784 -0.644 . . . . 6.25 110.218 174.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 42.9 t90 -60.84 -41.33 95.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.067 0.46 . . . . 6.43 110.114 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 36' ' ' PHE . 3.9 tp -73.07 -36.23 50.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.125 -0.489 . . . . 3.69 111.487 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.0 -21.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.108 0.48 . . . . 5.32 110.804 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 37' ' ' ASN . 95.3 t -74.88 -42.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.116 -0.493 . . . . 5.79 110.508 171.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -100.54 16.5 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.992 0.367 . . . . 5.81 111.992 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.426 ' HE1' ' HB2' ' A' ' 43' ' ' MET . 5.0 ppp? . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 121.154 0.502 . . . . 6.2 111.059 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 7.1 tt0 . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 109.522 -0.548 . . . . 7.7 109.522 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.606 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 86.8 Cg_exo -53.24 160.76 4.31 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.626 2.884 . . . . 5.41 113.579 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.652 ' HD2' HD11 ' A' ' 99' ' ' LEU . 46.5 Cg_endo -66.39 112.96 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.943 2.429 . . . . 7.74 111.157 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.834 ' HA ' HG23 ' A' ' 82' ' ' VAL . 5.5 pt-20 -56.15 -27.35 53.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.67 -0.696 . . . . 10.13 111.079 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 4.7 tt0 -58.56 -53.07 62.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.195 0.521 . . . . 11.78 110.093 172.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.906 HD11 ' HB2' ' A' ' 106' ' ' LEU . 74.6 mt -74.66 -40.98 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.737 -0.665 . . . . 8.98 111.799 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.834 HG23 ' HA ' ' A' ' 79' ' ' GLU . 16.1 m -56.47 -37.85 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.719 -0.845 . . . . 7.8 108.719 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.57 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.3 -48.63 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.613 -1.176 . . . . 11.19 110.557 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.2 mt -60.63 -43.36 94.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 11.59 110.8 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 95' ' ' ALA . 87.7 mt -63.53 -45.31 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.951 -0.568 . . . . 8.01 111.57 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.596 HG21 ' O ' ' A' ' 82' ' ' VAL . 2.1 t -72.5 -20.54 61.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.313 -0.555 . . . . 10.38 110.945 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.1 m -79.92 -16.95 54.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.798 0.333 . . . . 12.35 110.517 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.4 mmm -74.65 -25.29 59.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.302 0.572 . . . . 10.6 109.932 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.63 -2.27 4.89 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.977 -1.01 . . . . 10.36 111.762 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.566 ' HD2' HG21 ' A' ' 85' ' ' ILE . 30.7 m-85 -94.39 -173.8 3.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.666 0.27 . . . . 8.89 110.55 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 7.3 tt0 -101.03 145.54 28.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.66 -0.496 . . . . 10.6 109.66 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.586 ' HG3' HG21 ' A' ' 82' ' ' VAL . 18.5 ttm180 -58.11 -52.21 66.48 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.045 0.45 . . . . 12.6 110.61 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.422 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 48.3 t30 -58.41 -37.36 75.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.617 -0.719 . . . . 9.25 110.766 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 5.9 tt0 -65.71 -38.3 88.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.629 -0.714 . . . . 7.2 109.748 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.577 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -64.09 -37.96 89.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.215 -0.902 . . . . 5.69 110.755 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.606 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER -58.61 -53.92 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 116.446 -0.343 . . . . 6.87 110.855 177.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 7.8 tt0 -57.4 -44.36 84.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.232 0.539 . . . . 8.99 110.866 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.56 ' O ' HG22 ' A' ' 102' ' ' THR . . . -59.32 -52.52 65.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.041 -0.981 . . . . 5.41 110.355 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.741 HD21 ' HB1' ' A' ' 109' ' ' ALA . 79.6 mt -61.69 -34.16 75.27 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.548 -0.296 . . . . 5.86 111.659 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 96' ' ' ILE . 59.1 mtp180 -58.47 -41.24 84.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.299 0.571 . . . . 8.38 110.643 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.4 -38.11 60.1 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.195 -0.911 . . . . 8.88 111.385 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 32.9 p -87.56 1.31 53.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.707 0.632 . . . . 8.79 112.707 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.19 65.21 1.23 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.67 -0.695 . . . . 10.09 110.575 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.5 p-10 50.01 28.33 2.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.13 -1.395 . . . . 7.86 112.562 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -90.12 109.69 20.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.257 -0.646 . . . . 11.16 109.257 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.906 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.2 tt -52.44 -59.96 3.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.945 -1.025 . . . . 10.38 111.771 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -54.24 -52.44 61.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.706 -1.134 . . . . 11.82 111.794 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.705 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 17.7 ttm180 -66.47 -27.48 67.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.511 . . . . 12.99 110.96 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.741 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.63 -51.37 67.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.398 -0.593 . . . . 6.65 109.398 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.2 mt -59.82 -38.6 82.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.267 -0.879 . . . . 8.11 109.763 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 8.3 t70 -54.76 -51.15 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.869 -1.06 . . . . 9.04 110.155 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.36 -48.1 79.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.326 -1.306 . . . . 9.43 110.395 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 109' ' ' ALA . 41.1 mt -62.09 -41.16 90.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.231 -0.895 . . . . 5.25 110.974 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.6 t80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 7.33 111.106 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.452 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 86.3 mt . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 108.823 -0.806 . . . . 6.09 108.823 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.15 81.15 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.138 0.495 . . . . 4.6 111.34 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HA ' HG12 ' A' ' 7' ' ' VAL . 35.8 mt-10 -70.83 -7.94 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.012 -0.54 . . . . 5.13 110.591 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.555 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 13.2 m -57.43 -34.83 69.34 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.27 -0.641 . . . . 4.51 109.27 170.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.499 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 3.3 m -66.13 -51.79 54.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.442 -0.799 . . . . 3.46 111.202 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -64.14 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 3.39 110.902 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 77.3 mtp -63.04 -32.66 74.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 5.53 111.052 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' A' ' 13' ' ' MET . 14.9 mm100 -59.37 -48.82 80.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.061 -0.256 . . . . 5.92 110.454 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.597 HD11 HG23 ' A' ' 39' ' ' ILE . 18.5 mt -64.63 -45.29 87.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.506 0.67 . . . . 3.9 110.184 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.79 -50.31 71.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.708 -1.133 . . . . 4.46 112.489 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.451 . . . . 6.27 111.565 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.615 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 24.2 ptt? -104.82 22.48 15.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.111 -0.495 . . . . 5.61 111.629 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.45 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.126 -1.035 . . . . 4.85 112.851 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 29.2 p90 -158.83 164.93 19.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.676 -0.861 . . . . 5.55 108.676 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.617 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 88.7 Cg_endo -71.52 83.94 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.562 2.175 . . . . 4.57 113.562 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.611 ' HG ' HG12 ' A' ' 39' ' ' ILE . 3.1 mm? -75.15 64.87 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.074 -0.25 . . . . 3.76 111.641 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.75 -19.38 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 121.387 -0.821 . . . . 5.48 109.681 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -57.82 -32.7 67.84 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.577 -0.738 . . . . 3.8 110.029 170.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.559 ' O ' HG22 ' A' ' 24' ' ' VAL . 35.1 t -72.09 -42.99 65.52 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.768 -1.105 . . . . 3.27 109.646 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -54.15 -46.67 72.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.161 0.505 . . . . 6.55 110.178 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 42.6 mtmt -70.52 -26.01 63.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 5.22 110.744 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB1' ' HD1' ' A' ' 38' ' ' TRP . . . -74.16 -44.89 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 4.34 110.928 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 20' ' ' CYS . 92.1 t -53.6 -47.68 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 4.58 109.954 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -56.08 -45.77 79.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.486 -0.779 . . . . 7.65 110.783 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -66.03 -40.3 90.92 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.405 -0.361 . . . . 7.32 111.593 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 p -67.47 -11.75 58.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.353 . . . . 5.71 111.51 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.62 26.18 47.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.921 -0.657 . . . . 6.04 111.722 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 76.7 m-20 60.84 60.57 1.84 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.181 0.515 . . . . 5.27 110.342 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.1 mmt -86.28 -34.25 20.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 6.57 112.152 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 170.4 17.74 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.929 -1.129 . . . . 4.23 112.795 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HA ' ' CB ' ' A' ' 6' ' ' SER . . . -62.62 -58.37 7.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.207 0.447 . . . . 3.88 112.207 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.58 -31.13 67.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.367 -0.379 . . . . 5.59 111.065 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.72 -45.28 92.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.068 -0.515 . . . . 5.29 110.662 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -27.02 50.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.92 -0.312 . . . . 3.68 111.258 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.543 ' O ' HG22 ' A' ' 39' ' ' ILE . 66.6 t80 -56.6 -43.92 80.61 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.875 -0.787 . . . . 5.05 108.875 169.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.573 ' O ' HG13 ' A' ' 40' ' ' ILE . 41.6 t-20 -63.06 -43.74 97.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.066 -0.97 . . . . 6.25 110.28 177.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.636 ' HD1' ' HB1' ' A' ' 23' ' ' ALA . 13.1 t-105 -65.49 -30.24 70.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.809 -0.357 . . . . 6.43 111.029 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.613 HD11 ' HB1' ' A' ' 19' ' ' ALA . 3.1 tp -76.21 -37.65 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.997 -0.281 . . . . 3.69 110.912 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.49 -21.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.444 0.64 . . . . 5.32 110.378 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 37' ' ' ASN . 72.4 t -74.22 -51.01 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.594 -0.73 . . . . 5.79 109.997 169.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -85.42 14.38 5.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.193 0.442 . . . . 5.81 112.193 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 23.2 ptt? . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.358 -0.608 . . . . 6.2 109.358 169.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 C--O 1.235 0.335 0 CA-C-O 120.511 0.196 . . . . 7.7 110.719 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.594 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 88.4 Cg_exo -51.03 165.04 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.524 2.816 . . . . 5.41 112.823 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 41.9 Cg_endo -63.53 112.54 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.474 2.116 . . . . 7.74 110.999 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.822 ' HA ' HG23 ' A' ' 82' ' ' VAL . 13.5 pt-20 -55.84 -30.72 61.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.899 -0.592 . . . . 10.13 110.295 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.73 -51.48 67.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.562 -0.744 . . . . 11.78 110.139 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.858 HD11 ' HB2' ' A' ' 106' ' ' LEU . 75.1 mt -76.24 -42.7 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.924 -0.58 . . . . 8.98 111.98 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.822 HG23 ' HA ' ' A' ' 79' ' ' GLU . 12.6 m -55.76 -37.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.507 -0.923 . . . . 7.8 108.507 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.591 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -62.24 -47.01 86.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.681 -1.145 . . . . 11.19 110.927 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.6 mt -60.58 -41.98 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.225 0.536 . . . . 11.59 110.501 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.659 HG21 ' HD2' ' A' ' 90' ' ' PHE . 89.6 mt -65.5 -47.4 86.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.703 -0.681 . . . . 8.01 111.527 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.579 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -70.19 -21.99 62.98 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.172 -0.611 . . . . 10.38 110.536 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 t -75.44 -19.95 59.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.976 0.417 . . . . 12.35 110.046 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.2 mmt -75.78 -24.55 56.0 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.323 0.582 . . . . 10.6 110.396 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.67 9.03 4.1 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.392 -0.822 . . . . 10.36 111.8 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.659 ' HD2' HG21 ' A' ' 85' ' ' ILE . 28.6 m-85 -101.05 -175.36 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.859 -0.423 . . . . 8.89 109.859 177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 51.5 tt0 -100.23 145.31 28.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.659 -0.497 . . . . 10.6 109.659 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.603 ' HG3' HG21 ' A' ' 82' ' ' VAL . 18.2 ttm180 -56.43 -52.29 65.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 12.6 110.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.455 ' HB3' ' NE2' ' A' ' 91' ' ' GLN . 28.3 t-20 -59.46 -35.96 75.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.792 -0.64 . . . . 9.25 111.085 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 7.7 tt0 -66.14 -38.65 88.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.699 . . . . 7.2 109.664 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.613 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -64.22 -39.51 94.13 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.231 -0.895 . . . . 5.69 110.412 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.594 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -59.26 -52.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.191 -0.459 . . . . 6.87 110.729 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 34.1 tt0 -56.61 -43.97 80.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.881 -0.6 . . . . 8.99 110.961 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.35 -53.89 52.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.409 -0.814 . . . . 5.41 110.846 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.788 HD21 ' HB1' ' A' ' 109' ' ' ALA . 84.3 mt -60.02 -34.2 73.04 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 111.474 0.176 . . . . 5.86 111.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.44 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.2 mtt180 -55.39 -46.47 76.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.528 0.68 . . . . 8.38 110.304 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.89 -42.48 69.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.125 -0.943 . . . . 8.88 111.422 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.3 p -82.93 -1.35 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.564 0.579 . . . . 8.79 112.564 -174.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m120 63.81 60.03 1.09 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.049 -0.523 . . . . 10.09 110.362 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.598 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 3.3 p-10 48.63 34.42 5.03 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.351 1.06 . . . . 7.86 111.933 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -93.24 111.29 22.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.79 -0.818 . . . . 11.16 108.79 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.858 ' HB2' HD11 ' A' ' 81' ' ' ILE . 7.8 tt -56.24 -59.35 5.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.464 -0.789 . . . . 10.38 111.516 -175.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -55.98 -50.06 71.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.711 -1.131 . . . . 11.82 111.344 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.692 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -66.03 -29.09 69.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.547 -0.751 . . . . 12.99 111.281 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.788 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.24 -50.13 72.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.308 -0.627 . . . . 6.65 109.308 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -61.31 -36.74 80.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.163 -0.926 . . . . 8.11 109.904 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.14 -52.88 63.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.263 -0.88 . . . . 9.04 109.627 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 63.8 t90 -60.59 -45.24 94.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.126 -1.397 . . . . 9.43 110.498 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 109' ' ' ALA . 53.0 mt -67.71 -34.25 66.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.058 -0.974 . . . . 5.25 110.901 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.9 t80 . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.382 0.61 . . . . 7.33 110.165 177.548 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.45 -0.574 . . . . 6.09 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -75.0 76.94 2.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.435 0.636 . . . . 4.6 109.642 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.536 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.5 mt-10 -72.34 -10.48 59.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.809 -0.632 . . . . 5.13 112.022 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 54.3 p -62.05 -38.01 87.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.371 0.605 . . . . 4.51 109.489 176.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.697 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 50.3 m -60.67 -52.27 65.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.097 -0.956 . . . . 3.46 111.594 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 4' ' ' GLU . 7.4 p -64.34 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.561 -0.456 . . . . 3.39 110.907 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 67.1 mtt -59.7 -31.88 70.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.519 -0.31 . . . . 5.53 111.22 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.585 ' O ' ' HG2' ' A' ' 13' ' ' MET . 15.3 mm100 -60.9 -56.88 15.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.593 -0.276 . . . . 5.92 110.48 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.697 HD13 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.9 -28.73 67.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.565 -0.454 . . . . 3.9 111.387 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.32 86.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.429 . . . . 4.46 110.996 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -79.45 -42.18 25.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 6.27 111.439 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.585 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 26.2 ptt? -92.14 32.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.782 0.325 . . . . 5.61 111.251 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.09 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.403 -0.903 . . . . 4.85 112.347 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.599 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 12.4 p90 -166.53 162.15 11.74 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.092 -0.707 . . . . 5.55 109.092 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.599 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 22.8 Cg_endo -55.1 91.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.687 2.924 . . . . 4.57 112.99 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 10' ' ' LEU . 70.4 mt -96.81 57.32 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.891 -0.595 . . . . 3.76 111.745 -175.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -55.67 -23.89 30.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.161 0.505 . . . . 5.48 110.718 174.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . . . -57.75 -36.95 72.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.925 -0.58 . . . . 3.8 110.001 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.697 ' SG ' HD13 ' A' ' 10' ' ' LEU . 20.2 t -73.81 -31.75 63.4 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.421 -0.809 . . . . 3.27 110.449 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.38 -48.72 71.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.48 -0.933 . . . . 6.55 108.48 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 18.8 mttm -66.09 -42.32 89.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.026 . . . . 5.22 109.976 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . . . -60.37 -40.81 92.16 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.643 -0.708 . . . . 4.34 111.918 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG22 ' HG ' ' A' ' 20' ' ' CYS . 39.9 t -59.08 -45.76 92.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.153 -0.314 . . . . 4.58 110.153 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.46 -41.83 99.05 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.454 -0.498 . . . . 7.65 110.223 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.15 -41.59 85.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.82 -0.627 . . . . 7.32 112.085 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -65.46 -23.36 66.9 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.057 0.456 . . . . 5.71 110.835 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.37 29.65 8.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.6 -0.727 . . . . 6.04 111.73 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 59.39 49.44 8.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.217 0.532 . . . . 5.27 110.297 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.4 mmm -82.42 3.78 26.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 6.57 112.192 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.32 171.45 23.08 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.567 -0.825 . . . . 4.23 112.444 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.697 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -67.68 -45.22 75.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.665 -0.267 . . . . 3.88 111.679 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.97 -31.36 70.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.481 -0.327 . . . . 5.59 111.663 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.07 -44.65 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 5.29 110.56 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.0 60.72 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.613 -0.435 . . . . 3.68 110.49 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 39' ' ' ILE . 83.9 t80 -56.35 -42.55 77.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.958 -0.756 . . . . 5.05 108.958 171.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.405 ' O ' HG13 ' A' ' 40' ' ' ILE . 11.1 m120 -61.75 -45.96 91.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 6.25 110.612 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -59.44 -43.03 93.22 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.532 0.682 . . . . 6.43 109.842 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.533 HG23 HD11 ' A' ' 10' ' ' LEU . 3.0 tp -74.77 -36.3 39.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.486 -0.779 . . . . 3.69 111.861 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.42 ' O ' ' HG3' ' A' ' 43' ' ' MET . 2.8 pp -71.47 -21.34 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 5.32 111.54 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.59 -36.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.54 . . . . 5.79 110.19 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -99.52 7.6 45.21 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.416 0.524 . . . . 5.81 112.416 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 4.8 ppp? . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.211 0.529 . . . . 6.2 111.001 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.141 -0.318 . . . . 7.7 110.141 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.628 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 76.7 Cg_exo -55.09 163.93 3.99 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.249 2.633 . . . . 5.41 112.044 171.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.656 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 36.6 Cg_endo -63.51 113.18 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.598 2.199 . . . . 7.74 111.464 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.875 ' HA ' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -58.16 -23.28 54.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.952 -0.567 . . . . 10.13 111.16 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 8.7 tt0 -61.61 -52.57 63.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.128 -0.487 . . . . 11.78 109.879 171.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.893 HD11 ' HB2' ' A' ' 106' ' ' LEU . 73.5 mt -75.18 -41.55 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.617 -0.72 . . . . 8.98 111.944 -175.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.875 HG23 ' HA ' ' A' ' 79' ' ' GLU . 13.7 m -56.56 -38.02 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.604 -0.887 . . . . 7.8 108.604 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.612 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -60.49 -49.88 75.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.903 -1.044 . . . . 11.19 110.576 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.0 mt -59.69 -43.07 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 11.59 110.808 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.597 HG21 ' HD2' ' A' ' 90' ' ' PHE . 90.5 mt -63.96 -47.76 89.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.92 -0.582 . . . . 8.01 111.84 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.559 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -70.08 -23.69 63.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.013 -0.675 . . . . 10.38 110.51 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.5 m -69.75 -31.2 69.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.701 0.286 . . . . 12.35 110.24 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 93.4 mmm -62.78 -29.07 70.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.206 0.526 . . . . 10.6 110.679 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.2 4.2 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.364 -0.835 . . . . 10.36 112.005 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.597 ' HD2' HG21 ' A' ' 85' ' ' ILE . 29.7 m-85 -91.5 -173.85 3.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.207 -0.294 . . . . 8.89 110.207 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 8.4 tt0 -101.49 147.16 26.7 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.699 -0.482 . . . . 10.6 109.699 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.469 ' HG3' HG21 ' A' ' 82' ' ' VAL . 20.7 ttm180 -57.74 -52.7 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 12.6 110.763 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -58.64 -36.74 74.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.776 -0.647 . . . . 9.25 110.786 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.8 tt0 -65.82 -38.94 90.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.546 -0.752 . . . . 7.2 109.63 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -63.88 -40.77 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.272 -0.876 . . . . 5.69 110.519 174.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.628 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -58.5 -52.2 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 116.002 -0.545 . . . . 6.87 110.656 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.615 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 27.3 tt0 -56.55 -44.78 81.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.046 -0.524 . . . . 8.99 111.08 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.95 -53.39 58.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.457 -0.792 . . . . 5.41 110.659 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.801 HD21 ' HB1' ' A' ' 109' ' ' ALA . 76.1 mt -61.65 -32.28 72.44 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.609 -0.269 . . . . 5.86 111.392 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.615 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 88.7 mtt180 -54.86 -46.7 74.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.601 . . . . 8.38 109.752 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.69 62.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.928 -1.033 . . . . 8.88 111.903 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 27.8 p -85.2 1.04 49.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.627 0.603 . . . . 8.79 112.627 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.73 45.68 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.972 -0.558 . . . . 10.09 110.242 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 0.7 OUTLIER 69.93 16.56 7.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 7.86 111.072 176.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.519 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.4 t-20 -80.43 111.07 16.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.482 -0.562 . . . . 11.16 109.482 176.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.893 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.4 tt -55.02 -60.28 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.287 -0.87 . . . . 10.38 111.536 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 -52.74 52.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.681 -1.145 . . . . 11.82 110.913 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 12.2 ttm180 -65.14 -28.48 69.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.429 -0.805 . . . . 12.99 111.354 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.801 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.04 -50.56 70.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.394 -0.595 . . . . 6.65 109.394 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.8 mt -59.75 -39.07 83.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 8.11 109.717 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.57 -50.06 73.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.007 -0.997 . . . . 9.04 109.956 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.57 -46.83 86.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.621 -1.172 . . . . 9.43 110.408 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 109' ' ' ALA . 46.2 mt -63.61 -35.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.201 -0.908 . . . . 5.25 110.926 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 80.9 t80 . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 7.33 110.108 177.471 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mt . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 110.35 -0.241 . . . . 6.09 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.96 94.43 1.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 4.6 110.208 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.0 mt-10 -72.49 -2.33 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.95 -0.568 . . . . 5.13 112.136 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 4.4 m -59.99 -41.98 93.25 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.582 -0.525 . . . . 4.51 109.582 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.571 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 20.8 p -61.98 -52.11 65.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 3.46 111.832 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.6 p -62.02 -39.74 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 120.852 -0.339 . . . . 3.39 110.996 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.477 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 49.4 mtm -65.18 -26.75 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.449 -0.342 . . . . 5.53 111.445 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 5' ' ' SER . 76.6 mt-30 -69.09 -37.68 78.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.7 -0.4 . . . . 5.92 110.266 175.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.738 ' HB3' HD12 ' A' ' 17' ' ' LEU . 13.6 mt -68.89 -40.5 79.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.079 0.942 . . . . 3.9 109.133 172.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.8 -41.73 99.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.507 -1.224 . . . . 4.46 111.675 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 8' ' ' MET . 71.0 mm-40 -62.31 -29.93 70.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.606 0.595 . . . . 6.27 112.606 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 10' ' ' LEU . 22.0 ptp -81.84 -4.46 56.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.441 -0.504 . . . . 5.61 110.156 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.17 48.73 1.41 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.711 -0.677 . . . . 4.85 113.462 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 73.0 m-85 -143.12 125.37 8.7 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.859 0.361 . . . . 5.55 110.583 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.45 66.71 5.49 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.468 2.779 . . . . 4.57 111.762 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.738 HD12 ' HB3' ' A' ' 10' ' ' LEU . 80.9 mt -94.2 57.66 2.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.649 0.737 . . . . 3.76 111.875 -172.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 13.9 tt0 -56.57 -22.32 32.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.179 0.514 . . . . 5.48 109.896 168.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -29.35 65.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.649 -0.705 . . . . 3.8 109.659 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.57 ' O ' HG22 ' A' ' 24' ' ' VAL . 37.7 t -72.19 -44.61 62.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.758 . . . . 3.27 108.955 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.448 ' NH2' ' HG3' ' A' ' 18' ' ' GLU . 12.2 ttp180 -51.84 -42.33 62.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.878 -0.601 . . . . 6.55 110.232 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 42.8 mttt -71.47 -39.42 70.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.613 -0.721 . . . . 5.22 110.435 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.57 99.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.601 -0.727 . . . . 4.34 111.268 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 20' ' ' CYS . 88.6 t -59.15 -46.21 92.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.166 -0.47 . . . . 4.58 110.432 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -54.47 -48.2 72.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.256 -0.429 . . . . 7.65 110.921 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.96 -39.62 87.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.194 -0.457 . . . . 7.32 111.611 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 p -68.32 -15.08 63.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.081 0.467 . . . . 5.71 110.979 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.71 29.27 43.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.352 -0.699 . . . . 6.04 111.352 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.3 t30 60.67 73.91 0.47 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.349 0.595 . . . . 5.27 110.626 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.522 ' HB3' HG23 ' A' ' 34' ' ' VAL . 19.2 mmt -102.31 18.8 20.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.771 -0.65 . . . . 6.57 110.863 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.24 -178.65 50.71 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.574 -0.739 . . . . 4.23 113.059 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.4 -37.38 77.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.785 0.291 . . . . 3.88 111.785 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -54.62 -56.55 17.88 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.618 0.723 . . . . 5.59 110.395 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 30' ' ' MET . 92.9 t -65.42 -40.38 88.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.05 -0.977 . . . . 5.29 111.803 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.44 -35.1 58.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.313 0.486 . . . . 3.68 112.313 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.5 t80 -58.75 -41.91 87.61 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.879 -0.785 . . . . 5.05 108.879 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.529 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.2 m-80 -69.28 -38.43 78.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.671 -0.695 . . . . 6.25 110.862 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.5 -37.23 86.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.803 -0.443 . . . . 6.43 109.803 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.6 HG23 HD11 ' A' ' 10' ' ' LEU . 4.7 tp -72.57 -39.01 60.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.058 -0.519 . . . . 3.69 111.176 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -70.15 -21.67 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.371 0.605 . . . . 5.32 110.786 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 37' ' ' ASN . 70.6 t -74.45 -44.85 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.892 -0.595 . . . . 5.79 110.644 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -99.42 12.22 36.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.95 0.405 . . . . 5.81 111.223 -173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.452 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 27.1 ptt? . . . . . 0 N--CA 1.468 0.472 0 CA-C-N 116.318 -0.401 . . . . 6.2 111.785 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 120.606 0.241 . . . . 7.7 110.523 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.627 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 73.0 Cg_exo -54.15 167.34 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.497 2.798 . . . . 5.41 112.592 172.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.633 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.5 Cg_endo -63.33 112.11 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.35 2.033 . . . . 7.74 111.185 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.757 ' HA ' HG23 ' A' ' 82' ' ' VAL . 9.6 pt-20 -57.0 -26.69 60.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 10.13 110.855 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 6.2 tt0 -58.99 -51.25 70.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.945 -0.571 . . . . 11.78 110.46 173.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.878 HD11 ' HB2' ' A' ' 106' ' ' LEU . 70.1 mt -76.19 -41.43 37.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.921 -0.582 . . . . 8.98 111.642 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 79' ' ' GLU . 11.3 m -55.55 -37.88 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.519 -0.919 . . . . 7.8 108.519 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -62.27 -48.54 79.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.637 -1.165 . . . . 11.19 110.871 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.3 mt -59.53 -42.16 87.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 11.59 110.624 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.601 HD13 ' HB3' ' A' ' 95' ' ' ALA . 87.1 mt -65.0 -44.9 95.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 8.01 111.434 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.581 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -73.48 -21.18 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.189 -0.604 . . . . 10.38 110.786 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.9 m -72.72 -26.55 61.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.063 0.458 . . . . 12.35 110.124 171.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.1 mmt -68.57 -26.9 65.62 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.963 -0.562 . . . . 10.6 110.462 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 -6.05 5.08 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.407 -0.815 . . . . 10.36 111.63 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.595 ' HD2' HG21 ' A' ' 85' ' ' ILE . 29.8 m-85 -87.7 -172.29 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.068 -0.345 . . . . 8.89 110.068 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 33.9 tt0 -103.63 146.92 27.86 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.931 -0.396 . . . . 10.6 109.931 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.586 ' HG3' HG21 ' A' ' 82' ' ' VAL . 16.0 ttm180 -57.0 -53.13 61.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.111 0.482 . . . . 12.6 110.19 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -59.07 -39.41 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 9.25 111.046 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 4.0 tt0 -63.91 -37.02 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.392 0.615 . . . . 7.2 109.758 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.601 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -64.99 -38.43 90.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.179 -0.919 . . . . 5.69 110.711 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.627 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -59.93 -52.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.053 -0.522 . . . . 6.87 110.636 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.476 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 60.5 tt0 -54.93 -46.03 74.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.769 -0.65 . . . . 8.99 110.855 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.89 -53.61 55.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.235 -0.893 . . . . 5.41 110.78 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.738 HD21 ' HB1' ' A' ' 109' ' ' ALA . 74.8 mt -61.38 -31.59 71.5 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.689 -0.232 . . . . 5.86 111.327 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.5 mtt180 -55.7 -50.29 70.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.393 0.616 . . . . 8.38 110.004 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.26 74.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.729 -1.123 . . . . 8.88 111.551 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 28.4 p -83.17 -5.7 59.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.694 0.627 . . . . 8.79 112.694 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 t30 64.78 65.72 0.61 Allowed 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.645 -0.707 . . . . 10.09 109.813 -175.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.544 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.4 p30 48.92 22.81 0.61 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.221 1.008 . . . . 7.86 112.428 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -81.68 109.45 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.726 -0.472 . . . . 11.16 109.726 173.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.878 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.0 tt -56.59 -59.84 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.176 0.922 . . . . 10.38 111.282 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.45 -48.3 71.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.9 -1.045 . . . . 11.82 111.268 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.1 ttm180 -69.5 -28.8 66.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 12.99 110.799 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.738 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.56 -51.24 68.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.219 -0.66 . . . . 6.65 109.219 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.4 mt -58.1 -40.12 80.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.845 -1.07 . . . . 8.11 109.605 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.33 -50.75 70.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.388 -0.824 . . . . 9.04 110.443 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -62.91 -44.44 96.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.491 -1.231 . . . . 9.43 110.375 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.557 HD12 HG23 ' A' ' 85' ' ' ILE . 51.5 mt -65.71 -45.16 92.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.009 -0.996 . . . . 5.25 111.251 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.2 t80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 7.33 110.976 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mt . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 108.141 -1.059 . . . . 6.09 108.141 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.7 88.11 0.35 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.377 0.608 . . . . 4.6 110.891 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.472 ' HA ' HG12 ' A' ' 7' ' ' VAL . 51.8 mt-10 -71.11 -8.18 51.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.282 -0.872 . . . . 5.13 110.59 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.631 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 18.8 m -57.7 -37.63 73.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.303 -0.628 . . . . 4.51 109.303 169.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 7.4 m -59.66 -51.85 68.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.794 -0.639 . . . . 3.46 110.937 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 21' ' ' ARG . 4.4 p -67.45 -38.87 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 120.636 -0.426 . . . . 3.39 110.74 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 78.6 mtp -62.93 -27.01 69.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 5.53 111.324 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 5' ' ' SER . 29.3 mt-30 -62.65 -53.4 55.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.811 -0.44 . . . . 5.92 109.811 171.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.909 HD11 HG23 ' A' ' 39' ' ' ILE . 11.7 mt -58.51 -45.27 89.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.725 0.774 . . . . 3.9 109.653 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.8 -29.32 70.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.343 -1.299 . . . . 4.46 111.64 -175.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.14 -51.71 6.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.699 -0.682 . . . . 6.27 111.872 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.5 ptp -101.28 25.0 8.73 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 111.993 0.368 . . . . 5.61 111.993 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.94 -92.44 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.947 -1.12 . . . . 4.85 113.022 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 62.4 m-85 -136.95 151.09 71.54 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.892 -0.41 . . . . 5.55 109.892 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.56 74.44 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.802 2.335 . . . . 4.57 111.451 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 10' ' ' LEU . 89.6 mt -89.45 62.6 6.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.772 -0.649 . . . . 3.76 112.175 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.543 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 7.6 tt0 -55.75 -24.54 35.86 Favored 'General case' 0 N--CA 1.458 -0.042 0 CA-C-O 120.939 0.399 . . . . 5.48 110.565 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -57.44 -31.17 65.65 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.124 -0.489 . . . . 3.8 110.255 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 10' ' ' LEU . 37.6 t -73.5 -42.98 61.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.425 -0.807 . . . . 3.27 109.658 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.598 ' HB2' HG13 ' A' ' 7' ' ' VAL . 24.5 ttt180 -52.02 -50.23 61.81 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.606 0.717 . . . . 6.55 110.082 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.543 ' HE2' ' O ' ' A' ' 18' ' ' GLU . 25.8 mtmt -72.09 -23.5 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.085 -0.962 . . . . 5.22 110.623 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.06 64.88 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.823 -0.626 . . . . 4.34 111.221 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 20' ' ' CYS . 97.7 t -58.97 -47.15 90.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.89 0.376 . . . . 4.58 110.11 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -58.64 -36.16 73.67 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.889 -0.596 . . . . 7.65 110.762 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.01 -45.78 39.52 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.506 -0.315 . . . . 7.32 111.674 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.406 ' HG1' ' HA ' ' A' ' 24' ' ' VAL . 21.4 p -62.21 -24.68 67.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.964 0.411 . . . . 5.71 111.162 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.14 29.41 20.13 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.803 -0.635 . . . . 6.04 112.039 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.7 t30 63.39 64.62 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.179 0.514 . . . . 5.27 110.497 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 34' ' ' VAL . 87.2 mmm -91.77 -11.22 37.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.117 -0.492 . . . . 6.57 110.742 178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.23 162.05 11.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.791 -0.719 . . . . 4.23 112.387 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -55.77 -46.07 78.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.942 0.497 . . . . 3.88 111.54 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.22 -41.46 99.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 5.59 111.431 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 30' ' ' MET . 98.8 t -62.58 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.475 -0.329 . . . . 5.29 111.256 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -28.89 54.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.629 -0.429 . . . . 3.68 111.24 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.614 ' O ' HG22 ' A' ' 39' ' ' ILE . 54.0 t80 -58.15 -43.24 87.25 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.043 -0.725 . . . . 5.05 109.043 170.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' HG13 ' A' ' 40' ' ' ILE . 13.6 m120 -67.72 -40.65 84.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 6.25 110.952 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -59.86 -38.34 81.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.386 0.612 . . . . 6.43 109.932 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.909 HG23 HD11 ' A' ' 10' ' ' LEU . 4.3 tp -74.57 -37.57 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.862 -0.608 . . . . 3.69 111.699 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.8 pp -70.34 -23.35 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.406 -0.517 . . . . 5.32 110.899 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.9 t -79.43 -34.84 16.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 5.79 110.725 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -98.96 5.29 47.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.15 0.426 . . . . 5.81 112.15 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.587 0.232 . . . . 6.2 111.316 -177.934 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.956 -0.387 . . . . 7.7 109.956 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.615 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 58.7 Cg_exo -55.87 161.54 8.18 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.878 2.386 . . . . 5.41 112.264 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.655 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.0 Cg_endo -62.66 112.62 1.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 7.74 111.246 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.785 ' HA ' HG23 ' A' ' 82' ' ' VAL . 1.6 pm0 -57.11 -25.73 59.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.731 -0.668 . . . . 10.13 111.528 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 7.0 tt0 -60.15 -50.94 71.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.014 0.435 . . . . 11.78 109.839 172.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.886 HD11 ' HB2' ' A' ' 106' ' ' LEU . 71.2 mt -75.38 -42.17 43.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 8.98 111.737 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.785 HG23 ' HA ' ' A' ' 79' ' ' GLU . 11.2 m -56.12 -38.18 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.426 -0.953 . . . . 7.8 108.426 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.574 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.04 -48.96 79.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.802 -1.09 . . . . 11.19 110.674 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.0 mt -59.39 -41.65 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 11.59 110.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.604 HG21 ' HD2' ' A' ' 90' ' ' PHE . 87.2 mt -66.0 -45.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.904 -0.589 . . . . 8.01 111.479 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.558 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.84 -21.16 61.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.333 -0.547 . . . . 10.38 110.75 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -74.39 -26.99 60.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 12.35 110.166 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 95.1 mmm -66.74 -26.48 67.01 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.398 0.618 . . . . 10.6 110.233 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.51 -10.77 4.65 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.415 -0.811 . . . . 10.36 111.714 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.604 ' HD2' HG21 ' A' ' 85' ' ' ILE . 33.4 m-85 -83.02 -175.0 5.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.717 0.294 . . . . 8.89 110.323 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.564 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 51.1 tt0 -100.72 147.61 25.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.791 -0.448 . . . . 10.6 109.791 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.549 ' HG3' HG21 ' A' ' 82' ' ' VAL . 7.9 ttm180 -55.72 -54.3 46.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.857 0.361 . . . . 12.6 110.503 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.423 ' HB3' ' NE2' ' A' ' 91' ' ' GLN . 55.7 t30 -58.46 -37.07 74.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.862 -0.608 . . . . 9.25 111.207 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.564 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.2 tt0 -65.49 -38.55 90.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 7.2 109.653 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -64.26 -37.88 89.07 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.25 -0.886 . . . . 5.69 110.625 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.615 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -60.9 -52.88 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.316 -0.402 . . . . 6.87 111.174 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.529 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 8.0 tt0 -56.09 -44.21 78.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.202 0.525 . . . . 8.99 110.713 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.31 -54.03 51.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.369 -0.832 . . . . 5.41 110.595 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.786 HD21 ' HB1' ' A' ' 109' ' ' ALA . 78.1 mt -61.18 -33.88 74.15 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.707 -0.224 . . . . 5.86 111.486 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.529 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 92.1 mtt180 -54.9 -46.83 74.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.484 0.659 . . . . 8.38 110.112 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.34 -38.05 68.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.87 -1.059 . . . . 8.88 111.467 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.698 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 23.7 p -85.6 1.5 48.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.81 0.67 . . . . 8.79 112.81 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m120 61.98 46.77 6.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.472 . . . . 10.09 111.123 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 9.4 m120 66.73 24.07 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.363 -0.835 . . . . 7.86 111.144 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 14.8 t-20 -86.46 113.9 22.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.892 -0.781 . . . . 11.16 108.892 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.886 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.1 tt -57.6 -59.05 5.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.904 -1.044 . . . . 10.38 111.268 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.61 -46.1 81.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.419 -1.264 . . . . 11.82 111.732 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.698 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.9 ttm180 -68.83 -28.83 67.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.445 -0.343 . . . . 12.99 110.625 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.786 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.64 -50.58 68.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.226 -0.657 . . . . 6.65 109.226 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.29 -38.31 83.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.43 -0.804 . . . . 8.11 109.739 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 7.7 t70 -54.73 -51.61 65.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.033 -0.985 . . . . 9.04 110.107 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -63.87 -46.61 84.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.116 -1.402 . . . . 9.43 110.679 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 95' ' ' ALA . 46.5 mt -64.57 -37.72 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.236 -0.893 . . . . 5.25 111.228 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.313 0.577 . . . . 7.33 110.432 179.233 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.556 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 78.3 mt . . . . . 0 N--CA 1.447 -0.599 0 CA-C-O 120.742 0.306 . . . . 6.09 111.15 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.68 82.25 1.56 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.299 0.571 . . . . 4.6 109.927 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.484 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.4 mt-10 -71.65 -3.11 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.647 -0.706 . . . . 5.13 111.107 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -56.71 -40.85 76.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 4.51 110.265 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.895 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 12.1 p -65.67 -52.47 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.736 -0.666 . . . . 3.46 111.751 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 21' ' ' ARG . 7.3 p -64.02 -38.73 83.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.913 -0.315 . . . . 3.39 111.274 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.454 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 64.7 mtt -62.5 -34.89 77.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.729 -0.214 . . . . 5.53 110.719 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 13' ' ' MET . 40.0 mt-30 -60.78 -40.25 91.91 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.79 -0.364 . . . . 5.92 110.76 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.717 ' HB3' HD13 ' A' ' 17' ' ' LEU . 11.2 mt -67.78 -49.0 64.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.878 0.847 . . . . 3.9 109.884 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.26 -50.55 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.99 -1.459 . . . . 4.46 113.111 -170.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 8' ' ' MET . 56.1 mm-40 -66.35 -24.1 66.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.164 0.431 . . . . 6.27 112.164 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 25.8 ptm -99.97 -3.85 31.36 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.652 -0.419 . . . . 5.61 111.79 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.6 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.674 -1.251 . . . . 4.85 113.588 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 33.0 m-85 -115.35 142.04 28.11 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 122.96 -0.141 . . . . 5.55 110.65 -172.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 76.73 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.983 2.455 . . . . 4.57 111.601 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.717 HD13 ' HB3' ' A' ' 10' ' ' LEU . 97.7 mt -79.8 66.76 5.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.49 -0.777 . . . . 3.76 111.846 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 21' ' ' ARG . 3.9 tt0 -56.68 -18.37 12.05 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.92 0.39 . . . . 5.48 110.892 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -57.51 -35.79 70.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.511 . . . . 3.8 109.83 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.614 ' O ' HG22 ' A' ' 24' ' ' VAL . 14.1 t -73.27 -41.98 63.02 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.335 -0.848 . . . . 3.27 109.287 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HB2' HG21 ' A' ' 7' ' ' VAL . 25.2 ttt180 -52.01 -53.29 43.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.366 -0.834 . . . . 6.55 110.7 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.719 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -71.55 -23.85 61.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 5.22 110.612 178.079 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB1' ' CD1' ' A' ' 38' ' ' TRP . . . -69.69 -42.3 74.3 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.981 -0.554 . . . . 4.34 110.771 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 20' ' ' CYS . 86.1 t -55.43 -45.63 78.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.279 -0.418 . . . . 4.58 110.025 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -59.44 -49.91 75.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.02 -0.536 . . . . 7.65 110.499 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.76 -39.37 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.223 -0.444 . . . . 7.32 112.08 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.6 p -70.13 -15.1 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.101 0.477 . . . . 5.71 111.318 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.08 28.27 34.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.831 -0.7 . . . . 6.04 111.485 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 61.8 m-80 60.68 65.56 1.02 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.256 0.55 . . . . 5.27 110.816 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 91.4 mmm -95.94 34.59 1.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.797 -0.638 . . . . 6.57 111.225 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.14 -179.53 45.23 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.072 -0.585 . . . . 4.23 113.58 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.895 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.17 -39.23 78.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.288 . . . . 3.88 111.579 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -58.41 -52.72 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 5.59 111.663 -175.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.3 t -67.32 -38.1 80.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.256 -0.429 . . . . 5.29 111.798 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -32.24 55.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.465 -0.494 . . . . 3.68 111.739 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' HG22 ' A' ' 39' ' ' ILE . 75.7 t80 -61.64 -39.7 92.25 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.459 -0.941 . . . . 5.05 108.459 170.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.726 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.8 t30 -64.59 -39.08 93.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.421 -0.809 . . . . 6.25 110.792 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.412 ' CD1' ' HB1' ' A' ' 23' ' ' ALA . 24.2 t-105 -67.86 -30.81 70.28 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.565 -0.454 . . . . 6.43 110.363 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 36' ' ' PHE . 4.3 tp -77.45 -32.61 18.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 120.805 -0.358 . . . . 3.69 111.47 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.3 pp -68.36 -26.55 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.111 -0.636 . . . . 5.32 109.776 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 37' ' ' ASN . 96.2 t -70.43 -36.88 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.579 -0.737 . . . . 5.79 110.231 170.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -102.22 20.77 16.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.192 -0.458 . . . . 5.81 111.909 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 6.2 110.871 174.473 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 109.399 -0.593 . . . . 7.7 109.399 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.612 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.5 Cg_exo -53.96 162.54 3.83 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 123.096 2.53 . . . . 5.41 112.412 175.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.638 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_endo -63.74 112.12 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.444 2.096 . . . . 7.74 111.089 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.766 ' HA ' HG23 ' A' ' 82' ' ' VAL . 11.7 pt-20 -56.42 -25.39 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.516 0.51 . . . . 10.13 110.556 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 2.3 tp10 -57.93 -55.0 40.58 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.486 -0.779 . . . . 11.78 110.163 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.877 HD11 ' HB2' ' A' ' 106' ' ' LEU . 82.6 mt -75.41 -40.64 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.774 -0.648 . . . . 8.98 112.094 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.766 HG23 ' HA ' ' A' ' 79' ' ' GLU . 9.0 m -56.32 -37.81 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 108.357 -0.979 . . . . 7.8 108.357 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.569 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -60.79 -48.83 80.03 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.885 -1.052 . . . . 11.19 110.599 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.8 mt -60.22 -43.54 93.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 11.59 110.827 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.591 HD13 ' HB3' ' A' ' 95' ' ' ALA . 86.4 mt -64.05 -45.52 96.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.034 -0.53 . . . . 8.01 111.708 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -72.13 -21.46 61.47 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.876 -0.729 . . . . 10.38 110.786 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.3 m -75.55 -22.04 57.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.041 0.448 . . . . 12.35 110.315 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.3 mmm -70.86 -26.63 63.34 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.275 0.56 . . . . 10.6 109.89 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.54 6.39 4.69 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.405 -0.816 . . . . 10.36 112.08 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.534 ' HD2' HG21 ' A' ' 85' ' ' ILE . 34.5 m-85 -99.24 -175.95 3.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.147 -0.316 . . . . 8.89 110.147 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.861 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 91.9 mt-30 -86.84 153.89 21.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.283 -0.266 . . . . 10.6 110.283 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.495 ' HG3' HG21 ' A' ' 82' ' ' VAL . 14.2 ttm180 -65.45 -51.41 60.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.141 -0.688 . . . . 12.6 109.141 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.41 -39.65 88.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 9.25 110.886 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.861 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 8.3 tt0 -64.41 -36.64 84.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.139 0.495 . . . . 7.2 109.689 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.591 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -65.17 -40.23 94.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.458 -0.792 . . . . 5.69 110.466 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.46 -52.1 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.285 -0.416 . . . . 6.87 110.529 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.538 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 49.8 tt0 -58.24 -44.6 88.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.825 -0.625 . . . . 8.99 110.973 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.1 61.84 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.54 -0.755 . . . . 5.41 110.441 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.757 HD21 ' HB1' ' A' ' 109' ' ' ALA . 74.1 mt -60.64 -33.1 72.29 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 111.631 0.234 . . . . 5.86 111.631 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.538 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 73.2 mtt180 -55.29 -48.45 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.563 0.697 . . . . 8.38 110.21 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.76 -40.64 72.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.859 -1.064 . . . . 8.88 111.298 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 24.7 p -82.81 -0.04 46.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.547 0.573 . . . . 8.79 112.547 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.8 m120 58.82 63.22 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 10.09 110.161 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.1 p-10 49.14 32.85 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.498 1.119 . . . . 7.86 112.722 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -93.78 113.87 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.033 -0.728 . . . . 11.16 109.033 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.877 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.2 tt -56.97 -60.6 3.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.99 -1.005 . . . . 10.38 111.594 -175.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -57.41 -45.84 84.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.365 -0.834 . . . . 11.82 111.667 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.718 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 34.5 ttm180 -67.46 -28.8 68.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.416 -0.356 . . . . 12.99 110.754 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.757 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.32 -51.33 66.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.449 -0.574 . . . . 6.65 109.449 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -59.01 -39.4 81.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.384 -0.825 . . . . 8.11 109.428 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.34 -46.21 83.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.029 -0.987 . . . . 9.04 110.461 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -67.8 -46.58 71.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.846 -1.07 . . . . 9.43 110.396 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 109' ' ' ALA . 46.5 mt -60.78 -39.68 82.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 5.25 110.354 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.847 -0.615 . . . . 7.33 110.805 177.532 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 25' ' ' TYR . 4.2 mp . . . . . 0 C--O 1.233 0.222 0 N-CA-C 109.731 -0.47 . . . . 6.09 109.731 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -63.58 97.6 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.224 0.535 . . . . 4.6 110.529 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.573 ' HA ' HG12 ' A' ' 7' ' ' VAL . 9.9 mt-10 -71.04 -5.41 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 5.13 111.9 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.3 t -55.94 -34.28 65.51 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.999 -0.741 . . . . 4.51 108.999 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.4 m -65.24 -52.76 52.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.671 -0.695 . . . . 3.46 111.049 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -69.03 -41.34 81.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.755 0.312 . . . . 3.39 111.308 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.633 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 57.7 mtt -59.54 -35.05 73.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.355 -0.384 . . . . 5.53 110.787 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -62.89 -42.52 99.8 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.029 0.206 . . . . 5.92 111.122 174.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.726 ' HB3' HD13 ' A' ' 17' ' ' LEU . 14.4 mt -63.26 -44.64 94.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.502 0.668 . . . . 3.9 109.685 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.1 -32.74 74.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.893 -1.049 . . . . 4.46 111.094 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 8' ' ' MET . 60.9 mm-40 -59.93 -31.18 69.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 6.27 110.281 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mtp -92.91 8.56 39.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.847 -0.615 . . . . 5.61 111.737 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.7 -102.74 0.23 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.798 -1.192 . . . . 4.85 114.228 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 93.5 m-85 -83.19 145.67 49.5 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 112.017 0.376 . . . . 5.55 112.017 -169.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.25 86.09 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.02 2.48 . . . . 4.57 110.98 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.752 HD12 HG12 ' A' ' 39' ' ' ILE . 92.2 mt -80.9 70.95 7.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.801 -0.636 . . . . 3.76 112.483 -170.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -24.37 38.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.256 0.551 . . . . 5.48 110.781 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -58.7 -30.97 67.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 3.8 110.022 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.59 ' SG ' HD13 ' A' ' 10' ' ' LEU . 36.9 t -73.18 -43.51 61.29 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.402 -0.817 . . . . 3.27 109.643 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -49.73 -57.0 8.14 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.681 -0.69 . . . . 6.55 109.836 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 14.8 ptpt -66.24 -32.82 74.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.69 -0.686 . . . . 5.22 110.673 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.02 95.15 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.382 -0.372 . . . . 4.34 111.145 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 20' ' ' CYS . 79.1 t -57.01 -43.57 81.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.398 . . . . 4.58 110.172 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.529 ' HB2' HG12 ' A' ' 2' ' ' ILE . 54.4 t80 -67.93 -42.68 80.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.776 -0.77 . . . . 7.65 110.684 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.23 -40.31 97.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 7.32 111.744 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.7 p -65.8 -23.16 66.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.163 0.506 . . . . 5.71 110.79 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.52 26.83 8.39 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.768 -0.651 . . . . 6.04 111.566 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.5 t30 61.88 62.24 1.28 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.345 0.593 . . . . 5.27 109.68 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 97.2 mmm -101.57 21.65 13.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.867 -0.606 . . . . 6.57 112.103 -172.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.41 177.15 48.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.306 -0.95 . . . . 4.23 113.108 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.65 -44.26 70.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.758 0.281 . . . . 3.88 111.758 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.11 -43.5 91.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 5.59 111.847 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.8 t -68.87 -39.75 80.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.406 -0.361 . . . . 5.29 111.177 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.3 55.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.841 -0.343 . . . . 3.68 111.563 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.602 ' O ' HG22 ' A' ' 39' ' ' ILE . 78.3 t80 -58.08 -43.58 87.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.729 -0.841 . . . . 5.05 108.729 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.591 ' O ' HG13 ' A' ' 40' ' ' ILE . 47.4 t30 -64.06 -43.14 96.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.376 -0.829 . . . . 6.25 110.368 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -63.81 -33.93 76.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 6.43 110.719 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.752 HG12 HD12 ' A' ' 17' ' ' LEU . 6.4 tp -76.09 -38.74 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 3.69 111.218 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -70.05 -21.91 24.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.187 0.518 . . . . 5.32 110.504 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 37' ' ' ASN . 92.8 t -76.32 -48.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.819 -0.628 . . . . 5.79 110.241 170.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -83.3 2.64 35.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.098 -0.501 . . . . 5.81 111.349 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.435 ' HE1' ' HB2' ' A' ' 43' ' ' MET . 4.6 ppp? . . . . . 0 C--N 1.326 -0.447 0 N-CA-C 111.931 0.345 . . . . 6.2 111.931 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 . . . . . 0 N--CA 1.442 -0.827 0 CA-C-O 121.439 0.637 . . . . 7.7 111.452 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.694 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.7 Cg_exo -58.58 166.38 6.45 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.891 3.06 . . . . 5.41 112.879 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.638 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 44.6 Cg_endo -66.66 111.88 2.26 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.686 2.257 . . . . 7.74 111.143 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.692 ' HA ' HG23 ' A' ' 82' ' ' VAL . 10.6 pt-20 -52.25 -30.11 26.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 10.13 111.237 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -58.66 -51.35 70.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.854 -0.612 . . . . 11.78 110.339 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.884 HD11 ' HB2' ' A' ' 106' ' ' LEU . 69.4 mt -75.13 -40.83 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.686 -0.688 . . . . 8.98 111.452 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' ' 79' ' ' GLU . 5.2 m -56.18 -38.29 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.626 -0.879 . . . . 7.8 108.626 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.542 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.07 -49.4 77.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.822 -1.081 . . . . 11.19 110.775 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.56 -40.11 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 11.59 110.729 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 95' ' ' ALA . 85.3 mt -67.33 -46.74 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.874 -0.603 . . . . 8.01 111.64 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.544 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.99 -21.13 63.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.175 -0.61 . . . . 10.38 110.638 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -75.35 -25.47 57.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 12.35 110.619 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 21.9 mmt -69.15 -26.51 64.91 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.168 -0.469 . . . . 10.6 110.242 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.88 -2.83 4.87 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.714 -0.676 . . . . 10.36 111.817 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.585 ' HD2' HG21 ' A' ' 85' ' ' ILE . 35.2 m-85 -93.08 -173.98 3.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 8.89 110.468 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 4.7 tt0 -99.31 147.88 24.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.278 -0.419 . . . . 10.6 110.371 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.5 ttm180 -57.11 -54.65 44.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 12.6 110.731 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.97 -36.19 78.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.266 0.555 . . . . 9.25 110.915 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.7 tt0 -64.45 -38.81 92.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.725 . . . . 7.2 109.569 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.587 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -64.15 -40.34 95.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.278 -0.874 . . . . 5.69 110.703 173.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.694 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -59.64 -52.48 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.994 -0.548 . . . . 6.87 110.857 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.544 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.5 tt0 -52.97 -47.32 68.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.483 0.659 . . . . 8.99 110.709 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.65 -54.05 50.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.013 -0.994 . . . . 5.41 110.74 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 109' ' ' ALA . 68.1 mt -62.15 -30.99 71.43 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 111.54 0.2 . . . . 5.86 111.54 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 86.7 mtt180 -55.31 -46.97 76.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.365 0.602 . . . . 8.38 109.508 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.87 57.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.936 -1.029 . . . . 8.88 112.035 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.816 HG22 ' HA ' ' A' ' 109' ' ' ALA . 29.2 p -83.19 -2.71 56.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.077 0.399 . . . . 8.79 112.077 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.96 41.44 2.08 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.06 0.85 . . . . 10.09 110.364 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 0.7 OUTLIER 72.23 18.7 4.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.456 -0.793 . . . . 7.86 110.962 178.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -82.6 115.68 21.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.524 -0.547 . . . . 11.16 109.524 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.884 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.3 tt -58.16 -60.53 3.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.081 -0.963 . . . . 10.38 111.722 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.408 ' N ' HD22 ' A' ' 106' ' ' LEU . 51.1 mm-40 -53.68 -51.95 61.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.318 -0.856 . . . . 11.82 111.71 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.655 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.0 ttm180 -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.196 -0.456 . . . . 12.99 110.868 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.816 ' HA ' HG22 ' A' ' 102' ' ' THR . . . -63.55 -50.61 68.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.302 -0.629 . . . . 6.65 109.302 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.21 -38.28 79.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.07 -0.968 . . . . 8.11 109.434 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.95 -51.82 67.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.037 -0.983 . . . . 9.04 110.3 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.27 -47.51 84.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.278 -1.328 . . . . 9.43 110.663 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 109' ' ' ALA . 47.9 mt -61.06 -41.9 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.12 -0.945 . . . . 5.25 110.804 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.4 t80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 7.33 110.546 179.733 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.43 HG23 ' HG3' ' A' ' 4' ' ' GLU . 54.7 mt . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.95 0.405 . . . . 6.09 111.343 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -83.33 82.64 8.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.238 0.542 . . . . 4.6 110.239 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HG3' HG23 ' A' ' 2' ' ' ILE . 36.1 mt-10 -71.64 -2.76 18.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 5.13 111.281 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.625 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 26.6 t -60.89 -35.91 77.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.717 -0.845 . . . . 4.51 108.717 168.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.425 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 6.7 m -58.48 -49.9 75.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.943 -0.571 . . . . 3.46 111.141 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 17' ' ' LEU . 2.7 p -64.26 -41.06 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.806 0.336 . . . . 3.39 110.832 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 81.1 mtp -63.71 -29.84 71.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.148 -0.478 . . . . 5.53 111.378 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.625 ' HG2' ' O ' ' A' ' 5' ' ' SER . 81.4 mm-40 -64.38 -44.44 91.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.996 -0.281 . . . . 5.92 110.504 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 20' ' ' CYS . 18.8 mt -68.09 -40.36 82.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.402 0.62 . . . . 3.9 109.756 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.64 -50.81 71.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.716 -1.129 . . . . 4.46 111.901 -175.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.99 -19.26 63.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.234 -0.439 . . . . 6.27 112.064 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptm -99.32 -4.6 31.38 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.57 -0.452 . . . . 5.61 111.321 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -98.4 0.12 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.189 -1.005 . . . . 4.85 113.206 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 99.0 m-85 -118.81 157.9 48.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.485 0.183 . . . . 5.55 111.047 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.65 82.46 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.594 2.196 . . . . 4.57 112.138 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' O ' HG22 ' A' ' 7' ' ' VAL . 4.4 mm? -73.86 69.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 3.76 111.618 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 5.6 tt0 -56.73 -24.14 47.56 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.277 -0.89 . . . . 5.48 109.981 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -29.68 66.33 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.062 -0.517 . . . . 3.8 109.856 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.662 ' HA ' HD11 ' A' ' 39' ' ' ILE . 49.9 t -69.37 -44.81 70.78 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.303 -0.629 . . . . 3.27 109.303 174.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.61 -49.76 67.12 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.013 -0.54 . . . . 6.55 109.911 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 26.5 mttm -62.16 -40.63 96.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.66 -0.7 . . . . 5.22 110.147 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.2 -43.19 92.38 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.364 -0.835 . . . . 4.34 111.714 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 20' ' ' CYS . 76.3 t -56.17 -47.18 81.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.743 0.306 . . . . 4.58 110.313 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.76 -36.7 83.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 7.65 110.492 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.1 -45.7 69.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 7.32 111.221 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -62.29 -27.14 68.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.194 0.521 . . . . 5.71 111.04 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.75 28.04 6.11 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.674 -0.694 . . . . 6.04 111.558 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 59.27 51.24 7.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.123 0.487 . . . . 5.27 109.923 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.439 ' HB3' HG21 ' A' ' 34' ' ' VAL . 80.9 mtp -81.39 -35.25 31.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 6.57 112.106 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.61 169.71 16.87 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.022 -1.085 . . . . 4.23 113.279 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.575 0.35 . . . . 3.88 111.706 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -67.66 -40.16 84.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 5.59 110.12 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 30' ' ' MET . 85.2 t -64.31 -41.49 92.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 5.29 110.782 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -32.89 58.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.441 -0.345 . . . . 3.68 111.109 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -55.24 -44.41 75.46 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.156 -0.683 . . . . 5.05 109.156 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.682 ' O ' HG13 ' A' ' 40' ' ' ILE . 8.2 t30 -67.92 -35.78 79.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.519 -0.764 . . . . 6.25 110.609 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -65.46 -32.85 74.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.094 0.473 . . . . 6.43 109.872 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 20' ' ' CYS . 1.4 mp -77.06 -37.76 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.864 -0.607 . . . . 3.69 112.099 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.4 pp -63.57 -30.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.637 0.732 . . . . 5.32 109.91 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 37' ' ' ASN . 60.2 t -69.57 -51.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.142 -0.935 . . . . 5.79 110.484 170.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -85.28 13.43 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.669 0.618 . . . . 5.81 112.669 -174.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.1 ptt? . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 6.2 111.07 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 110.147 -0.316 . . . . 7.7 110.147 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.605 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.3 Cg_exo -56.25 164.9 4.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.177 2.585 . . . . 5.41 112.115 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.617 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 39.8 Cg_endo -63.15 114.0 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.487 2.125 . . . . 7.74 111.186 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.776 ' HA ' HG23 ' A' ' 82' ' ' VAL . 15.1 pt-20 -58.2 -28.18 64.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 10.13 110.529 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.34 -51.34 69.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.073 -0.512 . . . . 11.78 109.92 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.87 HD11 ' HB2' ' A' ' 106' ' ' LEU . 73.7 mt -76.59 -41.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 115.844 -0.616 . . . . 8.98 111.76 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.776 HG23 ' HA ' ' A' ' 79' ' ' GLU . 10.9 m -55.49 -38.27 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.549 -0.908 . . . . 7.8 108.549 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.38 -49.07 78.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.782 -1.099 . . . . 11.19 110.715 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.1 mt -59.54 -42.29 87.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 11.59 110.423 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 95' ' ' ALA . 86.1 mt -64.83 -47.26 89.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.665 -0.698 . . . . 8.01 111.368 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.572 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -69.67 -21.2 63.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.98 -0.688 . . . . 10.38 110.874 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.1 m -76.52 -21.9 55.13 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.933 0.396 . . . . 12.35 110.645 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 94.2 mmm -71.33 -24.56 62.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.391 0.615 . . . . 10.6 110.167 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.93 0.48 5.59 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.108 -0.951 . . . . 10.36 111.529 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.585 ' HD2' HG21 ' A' ' 85' ' ' ILE . 34.3 m-85 -94.02 -173.67 3.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.827 0.346 . . . . 8.89 110.428 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.702 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.4 tt0 -100.08 146.47 26.74 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.85 -0.426 . . . . 10.6 109.85 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.574 ' HG3' HG21 ' A' ' 82' ' ' VAL . 5.7 ttm180 -58.13 -53.62 56.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.119 0.485 . . . . 12.6 110.196 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -58.93 -37.45 76.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 9.25 111.145 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.702 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.8 tt0 -64.08 -40.43 96.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.65 -0.705 . . . . 7.2 109.586 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.61 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -62.76 -38.51 90.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.02 -0.991 . . . . 5.69 110.735 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mp -60.88 -52.72 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 116.267 -0.424 . . . . 6.87 110.849 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.2 tt0 -55.36 -44.58 76.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 8.99 110.811 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.433 ' O ' HG22 ' A' ' 102' ' ' THR . . . -60.08 -53.47 57.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.249 -0.887 . . . . 5.41 110.835 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.712 HD21 ' HB1' ' A' ' 109' ' ' ALA . 69.7 mt -62.59 -29.83 70.89 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.62 -0.264 . . . . 5.86 111.547 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -57.23 -50.83 71.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.424 0.63 . . . . 8.38 110.311 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.98 84.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.921 -1.036 . . . . 8.88 111.319 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 29.4 p -82.02 -7.35 59.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.684 0.624 . . . . 8.79 112.684 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.26 67.86 0.76 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.671 0.748 . . . . 10.09 110.289 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.517 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 8.5 p30 52.26 21.1 1.54 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.844 -1.526 . . . . 7.86 112.889 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -82.33 110.35 17.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.495 -0.557 . . . . 11.16 109.495 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.87 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.2 tt -57.05 -60.74 3.14 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.973 -1.012 . . . . 10.38 111.732 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -56.78 -45.66 82.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.325 -0.852 . . . . 11.82 111.428 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.662 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 29.1 ttm180 -67.21 -28.45 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.397 -0.365 . . . . 12.99 111.003 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.712 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.84 -50.65 68.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.252 -0.647 . . . . 6.65 109.252 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.9 mt -59.82 -37.34 78.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.218 -0.901 . . . . 8.11 109.637 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 10.8 t70 -54.18 -53.52 52.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.187 0.994 . . . . 9.04 110.004 172.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -61.36 -45.75 93.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.893 -1.503 . . . . 9.43 110.594 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.571 HD12 HG23 ' A' ' 85' ' ' ILE . 41.7 mt -66.98 -39.18 82.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.075 -0.966 . . . . 5.25 111.105 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.2 t80 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 7.33 110.624 -179.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.492 HG22 ' CG1' ' A' ' 24' ' ' VAL . 42.9 mt . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 109.898 -0.408 . . . . 6.09 109.898 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.76 84.33 0.65 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.379 0.609 . . . . 4.6 110.16 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HA ' HG12 ' A' ' 7' ' ' VAL . 41.3 mt-10 -70.33 -5.5 28.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.424 -0.807 . . . . 5.13 110.063 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 4.3 m -57.86 -37.11 73.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.483 -0.78 . . . . 4.51 109.288 169.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.458 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.1 m -64.22 -52.48 58.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.817 -0.629 . . . . 3.46 111.236 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.599 HG13 ' HG2' ' A' ' 21' ' ' ARG . 4.8 p -64.61 -39.33 85.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.399 -0.364 . . . . 3.39 111.168 -177.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 23.7 mmt -66.46 -31.57 72.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.447 -0.342 . . . . 5.53 111.336 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 5' ' ' SER . 15.2 mm-40 -62.84 -39.3 93.95 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.253 -0.277 . . . . 5.92 110.253 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.685 HD11 HG23 ' A' ' 39' ' ' ILE . 16.4 mt -70.86 -43.96 67.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.754 0.787 . . . . 3.9 109.833 173.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.61 -42.98 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.363 -1.29 . . . . 4.46 112.066 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.19 -9.85 54.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 6.27 112.198 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -72.14 -23.38 61.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 5.61 110.321 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.62 48.16 0.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.841 -0.695 . . . . 4.85 113.023 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 60.0 t80 179.29 134.88 0.25 Allowed Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.49 . . . . 5.55 109.678 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.44 88.98 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.017 2.478 . . . . 4.57 112.241 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.72 57.66 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.317 -0.553 . . . . 3.76 110.829 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -56.34 -23.33 36.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.969 0.414 . . . . 5.48 111.009 174.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.678 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -59.81 -31.96 70.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.067 0.46 . . . . 3.8 110.281 172.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 23' ' ' ALA . 37.9 t -73.81 -39.06 64.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.274 -0.875 . . . . 3.27 109.869 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.599 ' HG2' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -50.16 -52.13 37.87 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.73 0.776 . . . . 6.55 109.074 173.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 32.4 mttt -63.89 -44.72 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.551 -1.204 . . . . 5.22 110.218 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . . . -56.57 -46.49 80.74 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.786 -0.643 . . . . 4.34 111.914 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 20' ' ' CYS . 98.5 t -59.37 -44.15 91.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 4.58 109.935 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.41 -43.48 98.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.964 -0.562 . . . . 7.65 110.973 175.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -69.41 -39.05 78.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.204 0.446 . . . . 7.32 112.204 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.4 p -67.3 -15.24 63.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.97 0.414 . . . . 5.71 111.268 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.7 23.12 47.73 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.652 -0.979 . . . . 6.04 110.652 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.98 72.56 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.633 -0.783 . . . . 5.27 110.496 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.466 ' HB3' HG22 ' A' ' 34' ' ' VAL . 92.0 mmm -94.03 9.65 36.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.301 -0.863 . . . . 6.57 111.407 -177.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 172.26 36.75 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.474 -0.87 . . . . 4.23 112.874 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -57.87 -50.3 73.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.058 0.543 . . . . 3.88 112.355 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -53.97 -43.49 69.97 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.218 0.451 . . . . 5.59 112.218 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 30' ' ' MET . 92.1 t -72.96 -40.63 59.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 5.29 111.076 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.48 -30.79 60.01 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.417 -0.513 . . . . 3.68 111.661 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.56 ' O ' HG22 ' A' ' 39' ' ' ILE . 76.3 t80 -59.84 -42.64 94.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.621 -0.881 . . . . 5.05 108.621 171.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.543 ' O ' HG13 ' A' ' 40' ' ' ILE . 27.2 t-20 -67.56 -39.67 84.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.583 -0.735 . . . . 6.25 110.244 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -63.36 -31.96 73.26 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.016 0.436 . . . . 6.43 110.184 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 10' ' ' LEU . 2.4 tp -76.79 -39.79 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.218 -0.446 . . . . 3.69 110.896 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.53 -16.19 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.387 0.613 . . . . 5.32 110.966 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 37' ' ' ASN . 75.1 t -79.17 -38.61 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.513 -0.767 . . . . 5.79 110.148 168.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -87.79 4.73 43.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.047 0.388 . . . . 5.81 112.047 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.57 0.224 . . . . 6.2 111.414 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.438 -1.039 0 N-CA-C 108.918 -0.771 . . . . 7.7 108.918 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.596 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 82.2 Cg_exo -51.47 162.27 1.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.953 2.435 . . . . 5.41 111.682 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.67 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 31.7 Cg_endo -60.94 110.37 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.512 2.141 . . . . 7.74 111.232 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.728 ' HA ' HG23 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -56.47 -26.86 55.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 10.13 111.389 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 5.2 tt0 -59.38 -51.56 69.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.263 -0.426 . . . . 11.78 110.069 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.918 HD11 ' HB2' ' A' ' 106' ' ' LEU . 73.5 mt -74.64 -42.2 48.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.101 -0.5 . . . . 8.98 111.981 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.728 HG23 ' HA ' ' A' ' 79' ' ' GLU . 8.4 m -56.02 -38.14 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.422 -0.955 . . . . 7.8 108.422 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.573 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.43 -48.74 79.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.753 -1.112 . . . . 11.19 110.758 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.42 -41.79 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.299 -0.41 . . . . 11.59 110.512 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.628 HG21 ' HD2' ' A' ' 90' ' ' PHE . 85.3 mt -65.29 -47.5 86.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.973 -0.558 . . . . 8.01 111.793 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.53 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.3 t -69.61 -21.67 63.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.316 -0.553 . . . . 10.38 110.966 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.0 m -71.49 -31.88 67.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.795 0.331 . . . . 12.35 110.44 171.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 98.3 mmm -64.94 -22.86 67.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.868 -0.605 . . . . 10.6 110.449 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.85 4.18 6.18 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.426 -0.806 . . . . 10.36 112.068 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.628 ' HD2' HG21 ' A' ' 85' ' ' ILE . 33.7 m-85 -96.32 -174.55 3.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.343 -0.243 . . . . 8.89 110.343 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -96.02 148.31 22.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.567 -0.531 . . . . 10.6 109.567 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.489 ' O ' HD12 ' A' ' 96' ' ' ILE . 12.5 ttm180 -58.8 -52.45 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.194 0.521 . . . . 12.6 110.069 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -61.6 -35.84 78.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 9.25 111.213 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -65.9 -38.44 88.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.524 -0.762 . . . . 7.2 109.554 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.606 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.181 -0.918 . . . . 5.69 110.501 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.596 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.95 -52.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 CA-C-N 116.342 -0.39 . . . . 6.87 110.914 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.7 tt0 -57.95 -43.68 86.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.151 -0.477 . . . . 8.99 110.989 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.528 ' O ' HG22 ' A' ' 102' ' ' THR . . . -60.45 -50.4 73.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.668 -0.697 . . . . 5.41 110.844 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.806 HD21 ' HB1' ' A' ' 109' ' ' ALA . 79.0 mt -63.08 -35.53 80.57 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.741 -0.208 . . . . 5.86 111.314 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.9 mtt180 -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.517 0.675 . . . . 8.38 110.277 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.93 72.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.736 -1.12 . . . . 8.88 111.6 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.689 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 63.0 p -86.69 2.66 47.79 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.116 0.784 . . . . 8.79 113.116 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 64.07 45.88 3.95 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.139 0.575 . . . . 10.09 111.395 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.575 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 77.2 m-20 68.08 21.12 8.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.405 -0.816 . . . . 7.86 111.509 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -82.89 104.5 13.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.604 -0.517 . . . . 11.16 109.604 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.918 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.5 tt -47.7 -61.17 2.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.065 -0.971 . . . . 10.38 111.886 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -56.64 -46.54 80.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.102 -0.953 . . . . 11.82 111.919 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.689 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.0 ttm180 -69.0 -28.97 67.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 12.99 110.537 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.806 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -61.4 -51.35 69.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.384 -0.599 . . . . 6.65 109.384 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.7 mt -59.26 -41.84 89.76 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.284 -0.871 . . . . 8.11 109.52 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.67 -49.52 70.42 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.599 0.714 . . . . 9.04 110.363 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -61.55 -48.56 80.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.442 -1.254 . . . . 9.43 110.253 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 109' ' ' ALA . 44.0 mt -63.46 -40.38 88.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.296 -0.866 . . . . 5.25 110.596 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.465 0.298 0 C-N-CA 123.118 0.567 . . . . 7.33 111.165 175.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.519 HD11 ' HD1' ' A' ' 25' ' ' TYR . 1.9 mp . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 110.032 -0.358 . . . . 6.09 110.032 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.407 ' N ' HG11 ' A' ' 24' ' ' VAL . 21.9 m-20 -70.01 81.7 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 4.6 110.346 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.555 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.5 mt-10 -71.18 -11.82 61.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.059 -0.519 . . . . 5.13 111.0 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 9' ' ' GLN . 6.9 t -60.46 -28.4 68.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.018 -0.734 . . . . 4.51 109.018 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.654 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 1.9 m -69.34 -50.69 44.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.907 -0.588 . . . . 3.46 110.896 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 4' ' ' GLU . 2.1 p -63.36 -45.89 96.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.448 -0.501 . . . . 3.39 110.805 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.533 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 55.3 mtm -68.97 -26.64 65.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.056 -0.52 . . . . 5.53 111.848 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.654 ' HG2' ' O ' ' A' ' 6' ' ' SER . 4.4 pt20 -69.03 -34.66 75.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.454 -0.498 . . . . 5.92 109.82 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 6' ' ' SER . 20.4 mt -68.63 -43.42 76.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.613 0.721 . . . . 3.9 109.083 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.56 -37.43 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.629 -1.169 . . . . 4.46 111.503 -176.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 8' ' ' MET . 52.4 mt-10 -65.95 -23.72 66.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.386 0.513 . . . . 6.27 112.386 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 ptp -117.11 -3.86 11.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.296 0.48 . . . . 5.61 112.296 -173.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.25 -101.35 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.935 -1.126 . . . . 4.85 113.643 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.523 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 95.9 m-85 -124.67 165.47 24.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.056 -0.35 . . . . 5.55 110.056 -172.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 71.5 Cg_endo -72.09 82.92 1.24 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.473 2.115 . . . . 4.57 111.62 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 3.4 mm? -75.94 66.5 2.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 3.76 111.805 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -25.73 54.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.617 0.722 . . . . 5.48 109.481 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -31.26 68.08 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.235 -0.893 . . . . 3.8 110.39 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 18.2 t -73.26 -37.71 66.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.422 -0.808 . . . . 3.27 109.706 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.31 -52.58 35.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.852 0.834 . . . . 6.55 108.94 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -70.4 -34.15 72.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.785 -1.098 . . . . 5.22 111.385 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . . . -61.6 -44.31 97.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.385 . . . . 4.34 111.599 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' CG1' HG22 ' A' ' 2' ' ' ILE . 94.1 t -64.69 -40.8 90.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 4.58 110.384 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.519 ' HD1' HD11 ' A' ' 2' ' ' ILE . 91.3 t80 -62.32 -41.21 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 7.65 110.422 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -68.95 -43.82 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 7.32 111.296 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.442 ' HG1' ' HA ' ' A' ' 24' ' ' VAL . 24.8 p -67.09 -17.17 64.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 5.71 111.359 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.85 49.61 5.59 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.707 -0.679 . . . . 6.04 111.907 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.07 45.41 4.57 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.532 0.733 . . . . 5.27 111.885 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.483 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.2 mmt -65.18 -63.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.544 -0.753 . . . . 6.57 111.223 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.87 166.72 38.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.728 -0.749 . . . . 4.23 111.693 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.645 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -65.31 -46.12 81.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.245 0.545 . . . . 3.88 110.982 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -76.13 -27.67 57.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.585 -0.734 . . . . 5.59 110.253 -177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 30' ' ' MET . 99.1 t -58.27 -44.28 87.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.855 0.36 . . . . 5.29 110.481 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.64 -31.76 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 3.68 110.759 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -51.71 -46.2 63.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.304 -0.628 . . . . 5.05 109.304 170.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.52 -47.41 86.29 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.59 -0.732 . . . . 6.25 110.754 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.736 ' HE3' HD13 ' A' ' 39' ' ' ILE . 50.4 t90 -57.2 -36.88 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 6.43 110.237 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.736 HD13 ' HE3' ' A' ' 38' ' ' TRP . 1.2 mp -75.1 -46.64 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.642 -0.708 . . . . 3.69 112.082 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.41 -19.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.394 0.616 . . . . 5.32 111.003 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -80.03 -41.8 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.694 . . . . 5.79 110.807 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -102.89 20.69 16.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.307 0.484 . . . . 5.81 112.307 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 C--N 1.32 -0.678 0 CA-C-O 121.412 0.625 . . . . 6.2 109.579 171.332 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.235 0.307 0 N-CA-C 109.827 -0.434 . . . . 7.7 109.827 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.1 Cg_exo -53.88 164.53 2.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.95 2.433 . . . . 5.41 112.217 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.651 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 37.8 Cg_endo -63.54 111.16 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.651 2.234 . . . . 7.74 110.73 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.844 ' HA ' HG23 ' A' ' 82' ' ' VAL . 11.0 pt-20 -58.55 -26.15 63.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.814 -0.63 . . . . 10.13 110.781 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 4.4 tt0 -60.36 -50.2 74.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.183 0.516 . . . . 11.78 109.869 172.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.909 HD11 ' HB2' ' A' ' 106' ' ' LEU . 71.0 mt -74.72 -42.66 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.655 . . . . 8.98 111.769 -175.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.844 HG23 ' HA ' ' A' ' 79' ' ' GLU . 14.2 m -55.76 -37.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.475 -0.935 . . . . 7.8 108.475 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.592 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -62.24 -48.74 78.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.653 -1.158 . . . . 11.19 110.897 175.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.6 mt -59.38 -42.88 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 11.59 110.326 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.664 HG21 ' HD2' ' A' ' 90' ' ' PHE . 88.9 mt -63.74 -47.44 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.812 -0.631 . . . . 8.01 111.356 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -71.15 -21.39 62.19 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.298 -0.561 . . . . 10.38 110.763 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -75.9 -22.21 56.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.04 0.448 . . . . 12.35 110.371 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.621 ' HE2' ' HA ' ' A' ' 88' ' ' MET . 29.5 mmt -72.75 -25.41 61.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.201 0.524 . . . . 10.6 110.072 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 4.55 3.96 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.539 -0.755 . . . . 10.36 112.069 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.664 ' HD2' HG21 ' A' ' 85' ' ' ILE . 28.0 m-85 -98.16 -177.51 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.766 0.317 . . . . 8.89 110.342 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 8.6 tt0 -94.45 142.34 27.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.561 -0.533 . . . . 10.6 109.561 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.461 ' HG3' HG21 ' A' ' 82' ' ' VAL . 18.0 ttm180 -57.89 -51.86 67.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.851 0.358 . . . . 12.6 111.241 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.59 -35.08 73.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 9.25 110.485 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.6 tt0 -66.63 -39.27 88.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.418 -0.81 . . . . 7.2 109.562 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.611 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -63.12 -40.55 97.93 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.285 -0.87 . . . . 5.69 110.498 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.58 -52.43 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.163 -0.471 . . . . 6.87 110.438 176.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.7 tt0 -56.74 -45.94 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 8.99 111.103 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 102' ' ' THR . . . -59.91 -51.07 71.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.474 -0.785 . . . . 5.41 110.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.748 HD21 ' HB1' ' A' ' 109' ' ' ALA . 82.2 mt -61.54 -35.62 78.27 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.641 -0.254 . . . . 5.86 111.609 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 90.8 mtt180 -54.03 -46.59 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.525 0.678 . . . . 8.38 110.153 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.64 67.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.764 -1.107 . . . . 8.88 111.615 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.5 p -86.19 3.98 40.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.871 0.693 . . . . 8.79 112.871 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 64.72 46.8 2.96 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.997 -0.547 . . . . 10.09 110.514 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.596 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 82.4 m-20 67.15 16.58 10.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.388 -0.824 . . . . 7.86 111.437 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -78.53 110.28 13.48 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.412 -0.588 . . . . 11.16 109.412 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.909 ' HB2' HD11 ' A' ' 81' ' ' ILE . 7.7 tt -55.33 -59.09 5.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.237 -0.892 . . . . 10.38 111.316 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.403 ' N ' HD22 ' A' ' 106' ' ' LEU . 16.6 mm-40 -53.35 -49.99 65.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.631 -1.168 . . . . 11.82 111.671 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.693 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 32.1 ttm180 -69.7 -28.76 66.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.443 -0.344 . . . . 12.99 111.017 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.748 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.02 -51.32 68.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.032 -0.729 . . . . 6.65 109.032 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 114' ' ' PHE . 23.6 mt -59.16 -40.78 86.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.85 -1.068 . . . . 8.11 109.902 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.59 -50.43 71.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 9.04 110.178 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -60.68 -44.67 96.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.854 -1.066 . . . . 9.43 110.472 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 109' ' ' ALA . 52.7 mt -70.45 -39.91 76.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.991 -1.004 . . . . 5.25 111.065 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 7.33 111.196 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.504 HG12 HD22 ' A' ' 29' ' ' ASN . 82.2 mt . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 121.154 0.502 . . . . 6.09 110.592 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.2 85.89 1.9 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.449 -0.796 . . . . 4.6 110.716 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.508 ' HA ' HG12 ' A' ' 7' ' ' VAL . 38.3 mt-10 -72.7 -4.73 33.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.125 -0.489 . . . . 5.13 112.158 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -67.83 -31.55 71.47 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.965 -0.754 . . . . 4.51 108.965 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.737 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 16.9 m -64.89 -46.4 81.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 3.46 110.899 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.1 p -68.94 -40.91 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.144 -0.622 . . . . 3.39 110.53 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 71.0 mtp -63.96 -30.91 71.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.441 . . . . 5.53 111.576 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.737 ' HG2' ' O ' ' A' ' 6' ' ' SER . 10.4 pt20 -68.46 -38.77 81.4 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.435 -0.506 . . . . 5.92 109.672 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.801 ' HB3' HD11 ' A' ' 17' ' ' LEU . 16.4 mt -66.78 -43.74 83.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.648 0.737 . . . . 3.9 109.556 173.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.6 -33.93 74.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.347 -1.297 . . . . 4.46 112.202 -173.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.3 -36.16 27.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.98 -0.554 . . . . 6.27 111.183 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 18.2 ptp -90.55 0.71 57.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 5.61 112.292 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.67 -92.32 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.747 -1.216 . . . . 4.85 113.763 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 96.7 m-85 -136.52 162.4 56.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.439 -0.208 . . . . 5.55 110.439 -172.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 64.3 Cg_endo -68.05 77.24 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.154 2.569 . . . . 4.57 111.66 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 10' ' ' LEU . 95.0 mt -85.16 63.84 8.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.967 -0.56 . . . . 3.76 112.428 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -55.96 -19.39 12.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.168 0.508 . . . . 5.48 110.057 169.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.543 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -57.68 -33.1 68.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.542 -0.754 . . . . 3.8 109.407 171.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.557 ' O ' HG22 ' A' ' 24' ' ' VAL . 34.9 t -70.61 -46.34 63.55 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 115.027 -0.988 . . . . 3.27 109.525 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -53.18 -51.45 62.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.933 0.397 . . . . 6.55 111.044 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -70.91 -23.52 62.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 5.22 110.542 179.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -40.76 64.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.381 -0.372 . . . . 4.34 110.785 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 20' ' ' CYS . 77.2 t -56.65 -42.6 76.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 4.58 110.22 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -65.12 -43.04 93.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 7.65 110.514 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.4 -41.17 85.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 7.32 111.78 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.4 p -65.3 -22.34 66.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 5.71 111.436 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.83 25.02 13.85 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.847 -0.692 . . . . 6.04 111.601 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.504 HD22 HG12 ' A' ' 2' ' ' ILE . 11.7 m120 60.72 47.21 8.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.333 0.587 . . . . 5.27 110.397 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.2 mmt -76.28 -23.33 54.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 6.57 112.483 -172.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.15 176.37 14.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.17 -1.014 . . . . 4.23 112.95 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -63.95 -58.96 5.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.559 0.344 . . . . 3.88 111.69 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -55.13 -35.14 64.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.49 . . . . 5.59 111.387 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.82 -46.64 84.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.052 -0.522 . . . . 5.29 111.184 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.36 -30.78 53.96 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.949 -0.3 . . . . 3.68 111.109 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 39' ' ' ILE . 65.8 t80 -58.48 -44.43 89.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.964 -0.754 . . . . 5.05 108.964 171.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.422 ' O ' HG13 ' A' ' 40' ' ' ILE . 7.4 t30 -63.73 -37.08 86.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.59 -0.732 . . . . 6.25 110.659 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -67.07 -33.85 76.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 6.43 110.418 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.717 HG23 HD11 ' A' ' 10' ' ' LEU . 3.2 tp -77.13 -38.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.466 -0.334 . . . . 3.69 111.171 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 43' ' ' MET . 2.7 pp -71.1 -28.0 31.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.715 -0.394 . . . . 5.32 110.918 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.9 -25.94 12.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.854 -0.338 . . . . 5.79 110.493 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -100.0 10.41 41.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.128 0.418 . . . . 5.81 112.128 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 14.1 ptp . . . . . 0 N--CA 1.465 0.313 0 CA-C-O 120.979 0.418 . . . . 6.2 110.149 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 109.762 -0.458 . . . . 7.7 109.762 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 83.7 Cg_exo -51.02 162.9 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.472 2.781 . . . . 5.41 112.822 176.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.657 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.0 Cg_endo -62.7 112.15 1.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.597 2.198 . . . . 7.74 111.526 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.741 ' HA ' HG23 ' A' ' 82' ' ' VAL . 10.9 pt-20 -58.97 -27.33 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.225 -0.898 . . . . 10.13 112.106 -174.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.584 ' HG2' ' N ' ' A' ' 81' ' ' ILE . 11.2 pm0 -70.21 -42.82 71.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.589 -0.893 . . . . 11.78 108.589 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' A' ' 106' ' ' LEU . 63.5 mt -70.82 -46.39 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.726 -1.125 . . . . 8.98 111.755 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.741 HG23 ' HA ' ' A' ' 79' ' ' GLU . 14.3 m -55.52 -38.0 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.54 -0.911 . . . . 7.8 108.54 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.561 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -62.36 -47.21 85.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.442 -1.254 . . . . 11.19 111.272 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 81' ' ' ILE . 18.8 mt -60.0 -42.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 11.59 110.238 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.622 HD13 ' HB3' ' A' ' 95' ' ' ALA . 86.2 mt -65.16 -45.86 92.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 8.01 111.286 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.593 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.62 -21.23 61.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.367 -0.533 . . . . 10.38 110.799 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.6 t -74.28 -28.87 61.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.6 -0.518 . . . . 12.35 109.6 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.6 mmm -66.06 -27.61 68.22 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.315 0.578 . . . . 10.6 110.159 175.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.14 -5.22 4.63 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.548 -0.751 . . . . 10.36 112.14 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 86' ' ' THR . 31.5 m-85 -87.93 -175.45 5.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.722 0.296 . . . . 8.89 110.236 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 8.7 tt0 -98.02 145.35 26.6 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.839 -0.43 . . . . 10.6 109.839 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.532 ' HG3' HG21 ' A' ' 82' ' ' VAL . 7.0 ttm180 -55.73 -51.27 67.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.126 0.489 . . . . 12.6 110.431 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.47 -38.38 80.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.781 . . . . 9.25 111.027 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.537 ' HG3' ' CD1' ' A' ' 113' ' ' ILE . 4.3 tp-100 -59.94 -46.92 87.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.852 0.834 . . . . 7.2 109.35 174.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.622 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -58.38 -40.78 83.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.457 -1.247 . . . . 5.69 110.854 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.57 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.81 -52.11 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.034 -0.53 . . . . 6.87 110.617 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.552 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 58.8 tt0 -56.97 -47.01 81.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.794 -0.639 . . . . 8.99 110.866 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.529 ' O ' HG22 ' A' ' 102' ' ' THR . . . -59.75 -50.67 72.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.236 -0.893 . . . . 5.41 110.973 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.651 HD21 ' HB1' ' A' ' 109' ' ' ALA . 72.7 mt -61.8 -33.51 74.25 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.45 -0.341 . . . . 5.86 111.376 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 95.0 mtt180 -55.93 -47.2 77.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.405 0.621 . . . . 8.38 110.169 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.94 71.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.107 -0.951 . . . . 8.88 111.401 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.0 p -85.77 -0.68 55.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.849 0.685 . . . . 8.79 112.849 -174.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.459 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER 66.76 48.18 1.41 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.15 0.58 . . . . 10.09 111.238 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.553 ' ND2' ' HD3' ' A' ' 78' ' ' PRO . 4.9 m-20 69.76 12.63 8.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.339 -0.846 . . . . 7.86 111.467 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -77.43 109.51 11.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.139 -0.689 . . . . 11.16 109.139 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.835 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.3 tt -56.46 -60.37 3.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.102 -0.954 . . . . 10.38 111.519 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.23 -45.68 72.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.979 -1.009 . . . . 11.82 111.542 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.709 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.4 ttm180 -70.92 -28.37 64.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.244 -0.434 . . . . 12.99 111.075 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.651 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.41 -51.32 68.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.382 -0.599 . . . . 6.65 109.382 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.1 mt -57.85 -38.6 75.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.374 -0.83 . . . . 8.11 109.662 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.56 -51.41 69.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.979 -1.01 . . . . 9.04 110.246 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -63.32 -45.58 90.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.759 -1.109 . . . . 9.43 110.177 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 109' ' ' ALA . 54.9 mt -62.54 -34.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.13 -0.941 . . . . 5.25 110.414 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 7.33 111.098 177.879 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.7 mt . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 121.268 0.556 . . . . 6.09 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.28 91.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.527 -0.76 . . . . 4.6 111.174 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.557 ' HG2' ' HG2' ' A' ' 21' ' ' ARG . 49.1 mt-10 -72.27 -5.71 37.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.875 -0.602 . . . . 5.13 111.579 176.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 2.0 m -59.11 -38.48 79.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.341 0.591 . . . . 4.51 109.565 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 24.1 m -64.63 -50.16 68.19 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.564 -0.744 . . . . 3.46 111.504 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -65.8 -41.81 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 120.849 -0.341 . . . . 3.39 111.153 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 88.3 mtp -61.21 -30.04 70.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.375 -0.375 . . . . 5.53 111.102 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 5' ' ' SER . 46.1 mt-30 -69.59 -34.67 74.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.69 -0.232 . . . . 5.92 111.053 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.798 HD11 HG23 ' A' ' 39' ' ' ILE . 14.3 mt -66.88 -47.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.838 0.827 . . . . 3.9 109.179 171.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.31 -45.83 91.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.022 -1.445 . . . . 4.46 112.403 -169.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 13' ' ' MET . 6.8 pt-20 -58.24 -36.26 72.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.301 0.572 . . . . 6.27 111.437 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.428 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 25.5 ptt? -99.36 7.47 45.52 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.401 -0.818 . . . . 5.61 112.063 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.29 103.21 0.2 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.624 -1.274 . . . . 4.85 114.521 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 78.6 m-85 71.66 138.27 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 113.47 0.915 . . . . 5.55 113.47 168.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.05 82.8 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.188 2.592 . . . . 4.57 111.364 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.573 HD13 HG12 ' A' ' 39' ' ' ILE . 85.7 mt -80.46 61.32 4.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.163 0.431 . . . . 3.76 112.163 -173.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -20.89 17.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.101 0.476 . . . . 5.48 110.626 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.719 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -58.55 -35.32 72.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.455 0.645 . . . . 3.8 109.909 171.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.683 ' SG ' HD13 ' A' ' 10' ' ' LEU . 33.5 t -73.92 -36.17 64.67 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.383 -0.826 . . . . 3.27 109.894 175.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.557 ' HG2' ' HG2' ' A' ' 4' ' ' GLU . 1.3 tmm_? -57.09 -48.34 78.83 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.378 0.609 . . . . 6.55 109.477 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.593 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -74.43 -25.42 59.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.998 -0.546 . . . . 5.22 110.325 176.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.716 ' HA ' ' HD2' ' A' ' 26' ' ' PHE . . . -66.65 -38.52 87.06 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.11 0.481 . . . . 4.34 110.609 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' HG1' ' A' ' 27' ' ' THR . 71.8 t -59.8 -37.77 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.833 -0.621 . . . . 4.58 109.865 173.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.48 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 89.9 t80 -60.81 -41.36 95.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.17 -0.468 . . . . 7.65 110.54 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.716 ' HD2' ' HA ' ' A' ' 23' ' ' ALA . 53.6 m-85 -64.8 -46.25 82.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.617 0.246 . . . . 7.32 111.286 176.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.597 ' HG1' ' HA ' ' A' ' 24' ' ' VAL . 33.7 p -70.62 -11.81 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 5.71 111.685 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.74 38.84 41.58 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 6.04 111.427 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.408 ' HA ' HG12 ' A' ' 24' ' ' VAL . 2.2 p-10 43.81 47.9 6.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.908 0.883 . . . . 5.27 111.966 -176.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.4 mtt -63.92 -64.48 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.498 -0.774 . . . . 6.57 110.66 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.84 179.99 45.78 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.815 -0.629 . . . . 4.23 111.665 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -65.22 -33.82 76.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.656 0.243 . . . . 3.88 111.656 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -53.74 -63.24 1.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.008 0.432 . . . . 5.59 111.837 -176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.23 -30.62 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 112.234 0.457 . . . . 5.29 112.234 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.85 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.667 -0.413 . . . . 3.68 111.988 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.585 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.7 t80 -58.72 -44.62 90.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.011 -0.737 . . . . 5.05 109.011 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -65.36 -34.64 78.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 6.25 111.031 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -66.23 -36.39 82.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.133 0.492 . . . . 6.43 110.506 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.798 HG23 HD11 ' A' ' 10' ' ' LEU . 7.0 tp -76.98 -41.56 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.236 -0.438 . . . . 3.69 111.38 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.05 -26.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.864 0.364 . . . . 5.32 111.003 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 p -80.66 -31.82 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.864 -0.334 . . . . 5.79 110.783 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -100.44 14.59 30.68 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 122.051 -0.406 . . . . 5.81 111.892 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.431 ' HE1' ' HB2' ' A' ' 43' ' ' MET . 4.8 ppp? . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 120.928 0.394 . . . . 6.2 111.399 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.664 0.269 . . . . 7.7 110.535 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.643 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 48.3 Cg_exo -61.87 164.48 16.34 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.062 2.508 . . . . 5.41 112.047 171.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.616 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 50.0 Cg_endo -66.37 112.92 2.48 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.95 2.433 . . . . 7.74 111.256 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.635 ' HA ' HG23 ' A' ' 82' ' ' VAL . 10.2 pt-20 -55.93 -29.56 60.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 10.13 110.77 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -56.89 -51.0 70.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.265 0.555 . . . . 11.78 110.29 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.944 HD11 ' HB2' ' A' ' 106' ' ' LEU . 71.8 mt -75.67 -41.4 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.75 -0.659 . . . . 8.98 111.8 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 79' ' ' GLU . 5.5 m -56.06 -38.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.601 -0.889 . . . . 7.8 108.601 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.521 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -62.11 -45.78 91.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.815 -1.084 . . . . 11.19 110.699 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.9 mt -62.5 -41.73 93.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 11.59 110.871 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.604 HD13 ' HB3' ' A' ' 95' ' ' ALA . 80.4 mt -65.97 -46.76 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.916 -0.584 . . . . 8.01 111.66 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.73 -21.2 63.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.042 -0.663 . . . . 10.38 110.518 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.5 t -73.03 -32.22 64.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.741 -0.466 . . . . 12.35 109.741 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.0 mmt -64.25 -26.26 68.42 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.214 0.531 . . . . 10.6 110.489 176.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.64 6.21 4.7 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.71 . . . . 10.36 112.01 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.566 ' HD2' HG21 ' A' ' 85' ' ' ILE . 32.2 m-85 -99.07 -174.01 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.68 0.276 . . . . 8.89 110.297 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.779 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 34.2 mt-30 -91.05 149.55 21.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.47 -0.332 . . . . 10.6 110.468 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.489 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.4 ttm180 -61.99 -51.16 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.427 -0.583 . . . . 12.6 109.427 173.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.472 -0.785 . . . . 9.25 110.879 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.779 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 1.0 OUTLIER -63.6 -37.45 87.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.264 0.554 . . . . 7.2 109.728 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.604 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -63.72 -41.39 98.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.427 -0.806 . . . . 5.69 110.451 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.643 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.79 -52.15 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.127 -0.488 . . . . 6.87 110.277 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.603 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.6 tt0 -53.86 -47.11 71.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.837 -0.62 . . . . 8.99 111.162 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.478 ' O ' HG22 ' A' ' 102' ' ' THR . . . -60.17 -52.09 66.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.01 -0.995 . . . . 5.41 110.91 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.735 HD21 ' HB1' ' A' ' 109' ' ' ALA . 75.2 mt -62.93 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.438 -0.346 . . . . 5.86 111.542 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.603 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.8 mtt180 -54.64 -46.17 73.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.787 0.804 . . . . 8.38 109.66 175.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.69 -44.74 55.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.53 -1.213 . . . . 8.88 111.382 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 64.3 p -81.41 0.06 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.917 0.71 . . . . 8.79 112.917 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 61.58 62.94 1.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 10.09 110.257 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.562 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.5 p30 53.09 23.42 3.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.662 1.185 . . . . 7.86 112.662 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.525 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.1 t-20 -87.44 108.78 19.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.386 -0.598 . . . . 11.16 109.386 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.944 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.7 tt -53.94 -61.27 2.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.915 -1.039 . . . . 10.38 112.042 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.02 -45.79 75.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.811 -1.086 . . . . 11.82 111.655 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.705 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 9.0 ttm180 -69.66 -28.69 66.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.053 -0.521 . . . . 12.99 110.845 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.735 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.37 -50.92 68.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.103 -0.703 . . . . 6.65 109.103 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.58 -39.1 79.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.404 -0.816 . . . . 8.11 109.668 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 11.0 t70 -54.17 -54.54 38.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.982 -1.008 . . . . 9.04 109.942 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -62.68 -39.7 94.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.058 -1.428 . . . . 9.43 110.781 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 95' ' ' ALA . 53.7 mt -71.37 -36.05 59.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.36 -0.836 . . . . 5.25 111.27 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.48 0.657 . . . . 7.33 109.996 176.651 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.525 HG22 ' CG1' ' A' ' 24' ' ' VAL . 52.8 mt . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 109.253 -0.647 . . . . 6.09 109.253 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.532 ' H ' HG11 ' A' ' 24' ' ' VAL . 10.0 m-20 -69.83 72.53 0.39 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.293 0.568 . . . . 4.6 109.605 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.556 ' HA ' HG12 ' A' ' 7' ' ' VAL . 43.7 mt-10 -71.14 -4.14 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.709 -0.678 . . . . 5.13 111.142 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.548 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 14.5 m -63.22 -30.96 72.0 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.251 -0.648 . . . . 4.51 109.251 169.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.682 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 48.2 t -66.96 -52.68 39.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.673 -0.694 . . . . 3.46 110.943 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 4' ' ' GLU . 5.1 p -63.67 -37.67 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.318 -0.401 . . . . 3.39 110.583 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 20.9 mmt -65.27 -29.0 69.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.0 -0.545 . . . . 5.53 111.516 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 5' ' ' SER . 71.3 mt-30 -66.37 -40.87 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.735 -0.386 . . . . 5.92 110.534 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.626 ' HB3' HD11 ' A' ' 17' ' ' LEU . 18.4 mt -68.67 -39.37 80.66 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.862 0.839 . . . . 3.9 109.533 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.88 -34.46 76.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.363 -1.29 . . . . 4.46 111.8 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 8' ' ' MET . 49.3 mt-10 -67.54 -18.91 65.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.34 . . . . 6.27 111.145 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.7 mtp -83.17 -1.16 52.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.168 0.508 . . . . 5.61 109.832 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.1 45.68 5.57 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.445 -0.798 . . . . 4.85 113.066 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -144.17 125.77 8.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.857 0.361 . . . . 5.55 110.64 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.59 66.12 4.69 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.354 2.703 . . . . 4.57 111.687 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.626 HD11 ' HB3' ' A' ' 10' ' ' LEU . 61.9 mt -89.65 64.6 6.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.691 0.758 . . . . 3.76 111.695 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -55.54 -21.81 18.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.02 -0.536 . . . . 5.48 109.714 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.771 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -57.92 -30.65 66.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.52 -0.764 . . . . 3.8 109.901 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.574 ' HB2' HD12 ' A' ' 10' ' ' LEU . 17.5 t -72.16 -44.71 62.66 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.506 -0.77 . . . . 3.27 109.037 174.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -48.82 72.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.43 -0.804 . . . . 6.55 110.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 10.9 ptpt -75.76 -23.29 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.981 -0.288 . . . . 5.22 110.734 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.9 93.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.328 0.585 . . . . 4.34 110.067 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.532 HG11 ' H ' ' A' ' 3' ' ' ASP . 77.1 t -58.58 -40.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 4.58 110.009 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 87.3 t80 -60.73 -49.95 75.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.685 -0.689 . . . . 7.65 110.57 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -61.81 -43.36 99.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.646 -0.252 . . . . 7.32 111.597 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.415 ' HG1' ' HA ' ' A' ' 24' ' ' VAL . 37.4 p -66.82 -27.74 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.125 0.488 . . . . 5.71 111.094 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.77 36.29 6.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.791 -0.64 . . . . 6.04 112.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.29 64.48 1.35 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.947 0.403 . . . . 5.27 110.139 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.7 mmt -97.71 -32.72 11.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.044 -0.525 . . . . 6.57 111.922 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 171.12 18.59 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 119.72 -1.229 . . . . 4.23 113.035 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.682 ' HA ' ' HB2' ' A' ' 6' ' ' SER . . . -67.14 -54.52 20.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.229 0.455 . . . . 3.88 112.229 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 36' ' ' PHE . 45.3 mt-10 -68.56 -24.23 64.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.837 0.351 . . . . 5.59 110.804 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.38 -46.67 89.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 5.29 110.318 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.4 ' HB3' ' OG ' ' A' ' 6' ' ' SER . . . -78.45 -27.38 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.49 -0.323 . . . . 3.68 111.09 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 39' ' ' ILE . 81.1 t80 -57.89 -44.25 86.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.036 -0.727 . . . . 5.05 109.036 169.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.521 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.6 t30 -62.94 -40.86 98.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.462 -0.79 . . . . 6.25 110.285 175.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -65.16 -33.57 76.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.895 -0.593 . . . . 6.43 110.626 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.771 HD11 ' HB1' ' A' ' 19' ' ' ALA . 3.9 tp -75.69 -37.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 3.69 111.111 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.1 -30.15 39.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.86 -0.336 . . . . 5.32 111.004 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.37 -21.47 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.796 -0.361 . . . . 5.79 110.76 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -101.8 1.32 37.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.902 0.382 . . . . 5.81 111.09 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.7 ptt? . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 112.56 0.578 . . . . 6.2 112.56 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 109.545 -0.539 . . . . 7.7 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.569 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.0 Cg_exo -54.06 166.8 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.683 2.256 . . . . 5.41 111.666 170.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.649 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.8 Cg_endo -64.38 109.42 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.175 1.917 . . . . 7.74 110.407 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.686 ' HA ' HG23 ' A' ' 82' ' ' VAL . 13.1 pt-20 -58.13 -23.56 55.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.461 0.476 . . . . 10.13 110.274 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 3.6 tt0 -59.31 -53.04 62.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.616 -0.72 . . . . 11.78 110.108 171.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.906 HD11 ' HB2' ' A' ' 106' ' ' LEU . 73.1 mt -73.67 -42.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.74 -0.664 . . . . 8.98 111.648 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 79' ' ' GLU . 5.8 m -55.14 -37.98 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.556 -0.905 . . . . 7.8 108.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.535 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.67 -47.97 82.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 11.19 111.055 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.8 mt -60.2 -41.33 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.863 -0.608 . . . . 11.59 110.309 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.611 HG21 ' HD2' ' A' ' 90' ' ' PHE . 85.8 mt -67.0 -45.16 87.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.747 -0.66 . . . . 8.01 111.657 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.571 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.14 -20.67 62.28 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.081 -0.648 . . . . 10.38 110.726 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.2 t -75.23 -27.14 59.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.121 0.486 . . . . 12.35 109.829 172.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.765 ' HE2' ' HA ' ' A' ' 88' ' ' MET . 23.8 mmt -68.37 -23.05 64.63 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 10.6 110.703 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.09 -5.24 5.68 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.518 -0.765 . . . . 10.36 111.635 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.611 ' HD2' HG21 ' A' ' 85' ' ' ILE . 29.3 m-85 -90.8 -176.24 4.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.32 . . . . 8.89 110.614 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.653 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.8 tt0 -98.01 147.07 24.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.823 -0.436 . . . . 10.6 109.823 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.58 ' HG3' HG21 ' A' ' 82' ' ' VAL . 10.2 ttm180 -56.66 -54.78 42.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 12.6 110.51 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.442 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 8.8 t30 -58.45 -36.74 74.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.853 -0.612 . . . . 9.25 111.016 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.653 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.0 tt0 -64.69 -38.39 90.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 7.2 109.626 176.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.599 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -66.06 -39.17 89.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.127 -0.942 . . . . 5.69 110.693 175.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -59.41 -52.49 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 116.212 -0.449 . . . . 6.87 111.039 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.485 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 57.5 tt0 -58.91 -41.62 87.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.052 -0.522 . . . . 8.99 110.862 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 102' ' ' THR . . . -59.98 -53.35 58.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.346 -0.843 . . . . 5.41 110.417 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.725 HD21 ' HB1' ' A' ' 109' ' ' ALA . 79.9 mt -61.46 -34.77 75.99 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.39 -0.368 . . . . 5.86 111.526 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 93.3 mtt180 -55.88 -46.35 78.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.544 0.688 . . . . 8.38 110.371 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.3 70.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.958 -1.019 . . . . 8.88 111.061 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.73 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 31.2 p -84.36 0.18 50.28 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.991 0.737 . . . . 8.79 112.991 -175.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.4 m120 60.87 61.88 1.57 Allowed 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.021 0.528 . . . . 10.09 110.458 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.587 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 10.1 p30 51.67 25.5 2.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.589 1.156 . . . . 7.86 112.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 13.1 t-20 -86.1 109.62 18.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.946 -0.761 . . . . 11.16 108.946 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.906 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.4 tt -54.75 -59.73 4.32 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.094 -0.957 . . . . 10.38 111.436 -176.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.24 -48.38 74.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.637 -1.165 . . . . 11.82 111.737 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.73 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -67.98 -28.71 67.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.407 -0.36 . . . . 12.99 110.92 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.725 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.22 -50.41 71.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.353 -0.61 . . . . 6.65 109.353 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.34 -39.22 86.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.266 -0.879 . . . . 8.11 109.665 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.93 -49.97 70.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.81 -1.086 . . . . 9.04 110.124 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -63.1 -49.85 72.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.375 -1.284 . . . . 9.43 110.489 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 95' ' ' ALA . 44.2 mt -62.16 -32.33 54.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.931 -1.031 . . . . 5.25 111.394 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 121.182 0.515 . . . . 7.33 110.997 178.78 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.529 HG22 ' CG1' ' A' ' 24' ' ' VAL . 78.1 mt . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 120.441 0.162 . . . . 6.09 110.923 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.34 74.74 1.87 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.174 0.512 . . . . 4.6 110.706 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HA ' HG12 ' A' ' 7' ' ' VAL . 46.0 mt-10 -71.67 -5.45 33.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.401 0.62 . . . . 5.13 110.147 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 15.2 m -61.78 -34.28 75.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.612 -0.722 . . . . 4.51 109.301 167.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 34.9 t -59.78 -51.93 67.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 3.46 110.716 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.8 p -66.58 -40.7 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.229 -0.441 . . . . 3.39 111.113 -177.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.6 mtp -63.45 -31.62 72.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.281 -0.418 . . . . 5.53 111.26 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.66 ' O ' ' HG2' ' A' ' 13' ' ' MET . 13.9 mm100 -60.28 -53.95 51.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 110.037 -0.357 . . . . 5.92 110.037 173.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.669 HD11 HG23 ' A' ' 39' ' ' ILE . 10.7 mt -57.2 -43.22 82.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.153 0.501 . . . . 3.9 109.841 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.88 -50.0 73.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.655 -1.157 . . . . 4.46 111.784 -172.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -60.17 -28.54 68.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.357 -0.383 . . . . 6.27 111.518 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.66 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 17.3 ptt? -112.91 31.1 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.891 0.33 . . . . 5.61 111.891 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.72 96.84 0.55 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.849 -1.167 . . . . 4.85 114.173 173.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 m-85 73.89 133.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 113.225 0.824 . . . . 5.55 113.225 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.31 83.77 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.93 2.42 . . . . 4.57 111.353 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 10' ' ' LEU . 95.4 mt -82.33 66.98 8.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.781 -0.645 . . . . 3.76 112.137 -173.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 3.7 tt0 -56.38 -19.76 16.28 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.892 0.377 . . . . 5.48 111.001 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.676 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -58.64 -32.34 68.96 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.929 0.395 . . . . 3.8 109.983 172.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.554 ' O ' HG22 ' A' ' 24' ' ' VAL . 49.5 t -72.02 -43.58 64.77 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.465 -0.789 . . . . 3.27 109.177 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 29.7 ttt180 -52.36 -52.75 51.72 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.868 -1.06 . . . . 6.55 110.049 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.728 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -72.71 -25.07 61.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.655 . . . . 5.22 110.834 177.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.46 78.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.62 0.248 . . . . 4.34 110.648 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 20' ' ' CYS . 93.4 t -56.83 -45.93 83.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.672 -0.492 . . . . 4.58 109.672 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -62.03 -46.47 89.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.506 -0.478 . . . . 7.65 110.713 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -64.25 -36.25 83.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 7.32 112.003 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.7 p -68.8 -21.05 64.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.205 0.526 . . . . 5.71 110.583 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.55 27.71 12.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.606 -0.725 . . . . 6.04 111.559 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 64.04 53.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.299 0.571 . . . . 5.27 110.327 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.505 ' HB3' HG23 ' A' ' 34' ' ' VAL . 20.4 mmt -82.08 -14.65 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 6.57 111.86 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.02 173.02 13.39 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.438 -0.887 . . . . 4.23 112.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 6' ' ' SER . . . -68.02 -48.04 66.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.34 . . . . 3.88 111.053 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.97 -49.11 69.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.068 -0.515 . . . . 5.59 111.22 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 30' ' ' MET . 95.9 t -60.46 -38.71 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 5.29 111.343 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.17 54.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.079 -0.248 . . . . 3.68 111.662 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.671 ' O ' HG22 ' A' ' 39' ' ' ILE . 59.2 t80 -56.94 -44.78 82.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.904 -0.776 . . . . 5.05 108.904 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.492 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.4 m-20 -65.79 -39.95 91.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.395 -0.821 . . . . 6.25 110.536 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -64.36 -34.77 78.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 6.43 110.468 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.676 HD11 ' HB1' ' A' ' 19' ' ' ALA . 7.2 tp -75.42 -40.73 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.201 -0.454 . . . . 3.69 111.475 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -69.71 -23.81 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.163 0.506 . . . . 5.32 110.606 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.92 -42.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 5.79 110.824 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -101.12 19.21 17.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.391 0.515 . . . . 5.81 112.391 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.4 ptm . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.2 0.524 . . . . 6.2 110.416 172.592 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 108.531 -0.914 . . . . 7.7 108.531 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 71.9 Cg_exo -52.67 159.2 5.07 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.756 2.304 . . . . 5.41 112.709 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.698 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 43.3 Cg_endo -65.29 113.28 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.874 2.383 . . . . 7.74 110.959 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.763 ' HA ' HG23 ' A' ' 82' ' ' VAL . 13.0 pt-20 -57.43 -28.8 63.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.955 -0.566 . . . . 10.13 110.309 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.62 -50.57 72.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.908 -0.587 . . . . 11.78 109.924 174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 106' ' ' LEU . 68.7 mt -76.27 -42.72 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.845 -0.616 . . . . 8.98 112.036 -176.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.763 HG23 ' HA ' ' A' ' 79' ' ' GLU . 10.0 m -55.35 -38.28 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.463 -0.94 . . . . 7.8 108.463 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.572 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -60.35 -49.66 76.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.822 -1.081 . . . . 11.19 110.57 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.3 mt -59.78 -42.14 87.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.459 . . . . 11.59 110.737 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.641 HG21 ' HD2' ' A' ' 90' ' ' PHE . 85.6 mt -64.63 -47.0 90.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.076 -0.511 . . . . 8.01 111.424 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.556 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.03 -21.18 61.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.152 -0.619 . . . . 10.38 110.809 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -77.01 -17.66 58.68 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.809 0.338 . . . . 12.35 110.449 172.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 97.1 mmm -75.28 -25.45 57.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.286 0.565 . . . . 10.6 109.503 173.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.69 -1.77 5.2 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.252 -0.885 . . . . 10.36 112.012 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.641 ' HD2' HG21 ' A' ' 85' ' ' ILE . 32.0 m-85 -92.21 -174.09 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.748 0.309 . . . . 8.89 110.692 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.728 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 6.7 tt0 -97.18 143.28 28.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.916 -0.401 . . . . 10.6 109.916 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' O ' HD12 ' A' ' 96' ' ' ILE . 5.2 ttm180 -55.9 -54.85 39.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.981 0.42 . . . . 12.6 110.29 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.543 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 54.1 t30 -59.63 -35.82 75.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.641 . . . . 9.25 111.031 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.728 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.5 tt0 -64.96 -39.82 94.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.638 . . . . 7.2 109.533 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.601 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -62.83 -39.17 93.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.935 -1.03 . . . . 5.69 110.408 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.577 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER -59.45 -52.9 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 116.322 -0.399 . . . . 6.87 110.805 176.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 7.5 tt0 -56.35 -44.62 80.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.221 0.534 . . . . 8.99 110.82 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.455 ' O ' HG22 ' A' ' 102' ' ' THR . . . -60.04 -53.29 59.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.304 -0.862 . . . . 5.41 110.729 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.754 HD21 ' HB1' ' A' ' 109' ' ' ALA . 77.1 mt -62.01 -32.88 73.41 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 111.779 0.289 . . . . 5.86 111.779 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.528 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 75.3 mtp180 -57.37 -43.73 83.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.436 0.636 . . . . 8.38 110.262 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.1 60.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.19 -0.914 . . . . 8.88 111.077 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 33.7 p -84.47 -0.72 53.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.19 0.811 . . . . 8.79 113.19 -174.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 62.03 63.45 1.09 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.577 0.548 . . . . 10.09 110.621 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.8 p-10 50.04 27.64 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.221 1.008 . . . . 7.86 111.967 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 43.6 t-20 -88.96 107.32 18.96 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.827 -0.805 . . . . 11.16 108.827 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.917 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.0 tt -53.78 -60.34 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.093 -0.958 . . . . 10.38 111.393 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.432 ' N ' HD22 ' A' ' 106' ' ' LEU . 37.5 mm-40 -54.45 -49.66 69.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.86 -1.064 . . . . 11.82 111.926 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.713 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 26.3 ttm180 -66.9 -28.51 68.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.452 -0.34 . . . . 12.99 110.793 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.96 -51.28 67.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.679 -0.489 . . . . 6.65 109.679 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.4 mt -59.88 -39.21 84.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.461 -0.79 . . . . 8.11 109.52 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.81 -50.36 68.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.866 -1.061 . . . . 9.04 109.877 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -63.32 -49.06 75.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.333 -1.303 . . . . 9.43 110.482 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 109' ' ' ALA . 46.3 mt -62.61 -37.08 78.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.944 -1.025 . . . . 5.25 111.23 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 7.33 110.663 179.828 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 2' ' ' ILE . 4.0 m-20 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 108.702 -0.851 . . . . 7.16 108.702 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.414 HG12 ' HD1' ' A' ' 25' ' ' TYR . 4.3 mp -95.96 75.14 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 107.244 -1.391 . . . . 6.09 107.244 166.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.87 101.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.622 -1.172 . . . . 4.6 110.981 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.427 ' CD ' ' HE ' ' A' ' 21' ' ' ARG . 39.8 mt-10 -70.46 -2.12 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.372 -0.831 . . . . 5.13 111.008 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 1.2 m -57.62 -37.87 74.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.36 -0.608 . . . . 4.51 109.36 170.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -64.5 -49.03 72.93 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.701 -0.681 . . . . 3.46 111.372 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.5 p -66.59 -42.03 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 120.812 -0.355 . . . . 3.39 111.042 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 47.0 mtt -62.86 -34.83 78.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.266 -0.425 . . . . 5.53 111.145 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 5' ' ' SER . 51.0 mt-30 -59.14 -47.44 85.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.751 -0.38 . . . . 5.92 110.615 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.96 ' HB3' HD11 ' A' ' 17' ' ' LEU . 15.9 mt -60.31 -47.79 84.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.572 0.701 . . . . 3.9 109.989 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.629 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.17 -50.61 71.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.571 -1.195 . . . . 4.46 111.915 -174.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -69.53 1.27 4.2 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.528 0.566 . . . . 6.27 112.528 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 22.4 ptp -130.07 10.01 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.028 -0.269 . . . . 5.61 111.7 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.16 -94.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.528 -1.32 . . . . 4.85 113.611 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.629 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.8 m-85 -130.44 159.15 72.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.322 . . . . 5.55 110.129 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 53' ' ' THR . 59.7 Cg_endo -69.66 80.79 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.984 2.456 . . . . 4.57 110.945 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.96 HD11 ' HB3' ' A' ' 10' ' ' LEU . 90.4 mt -81.67 66.72 7.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.7 -0.682 . . . . 3.76 111.849 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.74 -22.56 24.47 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.57 0.7 . . . . 5.48 110.125 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.475 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -58.9 -33.25 70.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.453 -0.794 . . . . 3.8 110.042 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.717 ' HG ' HD13 ' A' ' 10' ' ' LEU . 44.3 t -73.16 -39.37 65.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.606 -0.725 . . . . 3.27 109.855 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.427 ' HE ' ' CD ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -50.02 -56.18 11.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.666 0.746 . . . . 6.55 109.803 177.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.784 ' HZ1' ' HB3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -71.69 -25.38 62.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.337 -0.847 . . . . 5.22 110.539 178.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . . . -68.34 -43.24 77.91 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 116.396 -0.365 . . . . 4.34 110.976 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 20' ' ' CYS . 88.5 t -60.1 -43.09 92.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.965 0.412 . . . . 4.58 109.978 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.414 ' HD1' HG12 ' A' ' 2' ' ' ILE . 80.1 t80 -65.84 -39.1 90.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.039 -0.528 . . . . 7.65 110.864 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -71.62 -43.64 65.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 7.32 111.824 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -61.88 -27.64 68.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.107 0.48 . . . . 5.71 110.908 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.78 38.6 6.89 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 6.04 112.357 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 58.94 75.42 0.4 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.243 0.544 . . . . 5.27 110.077 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.464 ' HB3' HG23 ' A' ' 34' ' ' VAL . 26.3 mmt -112.88 -0.6 14.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.167 -0.47 . . . . 6.57 110.803 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.87 159.27 23.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.774 -0.727 . . . . 4.23 112.184 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.34 88.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 3.88 111.299 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 4.0 mp0 -58.35 -39.35 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.9 -0.591 . . . . 5.59 111.024 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.464 HG23 ' HB3' ' A' ' 30' ' ' MET . 75.1 t -71.54 -41.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 5.29 111.202 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.1 63.32 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 3.68 110.74 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' HD1' HD23 ' A' ' 10' ' ' LEU . 70.6 t80 -56.2 -43.09 78.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.99 -0.744 . . . . 5.05 108.99 170.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' HA ' HG13 ' A' ' 40' ' ' ILE . 26.2 t-20 -66.3 -37.84 86.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.857 . . . . 6.25 110.617 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.46 ' HE3' HD13 ' A' ' 39' ' ' ILE . 51.3 t90 -61.22 -35.52 77.44 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.433 0.635 . . . . 6.43 109.802 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.705 HG12 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -76.58 -43.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 3.69 111.696 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 37' ' ' ASN . 2.8 pp -70.33 -23.3 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.385 -0.526 . . . . 5.32 111.446 -174.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.29 -31.63 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 5.79 110.401 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -96.06 10.84 36.22 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.16 0.43 . . . . 5.81 112.16 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.41 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.3 ptt? -61.18 -21.42 63.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.894 0.378 . . . . 6.2 111.051 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -62.43 -29.98 70.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.694 -0.685 . . . . 6.34 110.644 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.21 132.25 90.07 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.818 -0.628 . . . . 5.62 110.376 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.58 -49.12 0.62 Allowed 'Trans proline' 0 CA--C 1.527 0.133 0 C-N-CA 122.937 2.425 . . . . 6.66 113.509 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -115.58 24.56 11.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.3 0.572 . . . . 6.09 111.372 -167.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.55 ' HE2' HG13 ' A' ' 39' ' ' ILE . 1.6 p90 -71.2 -17.79 62.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.722 0.773 . . . . 6.7 109.747 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.542 ' CB ' HD23 ' A' ' 17' ' ' LEU . . . -156.18 127.75 7.23 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.531 -1.213 . . . . 4.6 108.334 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -41.76 105.1 0.38 Allowed Pre-proline 0 C--N 1.323 -0.583 0 O-C-N 124.729 1.268 . . . . 5.96 112.007 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.8 17.11 1.71 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.011 2.474 . . . . 6.2 113.106 -174.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -128.64 32.98 4.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.765 -0.652 . . . . 8.57 109.784 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.551 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 9.2 m -145.03 96.5 2.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.39 -0.823 . . . . 7.68 110.08 -177.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 23.3 ptm -87.87 107.36 15.4 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.821 0.343 . . . . 7.67 111.057 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 53' ' ' THR . 7.0 Cg_exo -76.92 -28.84 5.8 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.358 2.705 . . . . 6.06 112.918 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.96 86.64 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.549 -1.31 . . . . 7.03 113.673 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -172.33 75.23 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.38 0.609 . . . . 9.21 109.49 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.69 -105.3 2.92 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.789 -0.72 . . . . 7.29 112.162 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.79 -70.52 2.26 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.994 -0.622 . . . . 7.34 112.238 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.13 -24.88 54.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.076 0.465 . . . . 8.32 110.761 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.56 -54.36 7.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.894 -0.593 . . . . 6.99 110.675 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 m -91.01 101.03 13.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.987 -0.551 . . . . 7.25 110.896 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.77 -61.26 0.43 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 6.54 110.308 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.43 -169.87 29.0 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.757 -0.735 . . . . 7.09 112.321 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.01 95.82 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.428 . . . . 7.55 110.252 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.8 p -85.12 75.93 10.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.515 0.674 . . . . 7.6 111.289 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 p -112.12 -13.89 11.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.811 -0.631 . . . . 8.44 110.86 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -105.76 9.14 33.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.864 0.364 . . . . 8.67 111.306 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.67 -134.61 38.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.003 -0.618 . . . . 7.01 111.917 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.2 13.86 24.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.602 0.201 . . . . 6.47 111.313 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.8 t 65.37 102.86 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.859 -0.609 . . . . 7.96 111.562 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.92 69.7 1.32 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.82 -0.705 . . . . 6.58 111.723 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.55 103.57 3.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.584 0.23 . . . . 7.68 111.456 -174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.417 ' OD2' ' HB2' ' A' ' 76' ' ' GLN . 5.4 t70 70.2 162.35 0.23 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.485 -0.779 . . . . 6.55 111.017 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.4 28.0 7.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.667 -0.697 . . . . 8.05 110.853 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.417 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 9.0 tt0 -77.68 140.92 63.98 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.626 -0.715 . . . . 7.7 110.478 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.64 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 89.1 Cg_exo -49.85 167.05 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.732 2.954 . . . . 5.41 112.928 171.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.626 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 34.2 Cg_endo -61.47 112.45 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.481 2.121 . . . . 7.74 111.353 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.86 ' HA ' HG23 ' A' ' 82' ' ' VAL . 11.3 pt-20 -57.21 -27.59 62.13 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.882 -0.599 . . . . 10.13 110.63 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 5.8 tt0 -59.14 -51.99 67.64 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.21 0.528 . . . . 11.78 109.741 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.861 HD11 ' HB2' ' A' ' 106' ' ' LEU . 80.4 mt -75.77 -42.37 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.671 -0.695 . . . . 8.98 112.024 -175.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.86 HG23 ' HA ' ' A' ' 79' ' ' GLU . 12.0 m -56.01 -38.45 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.594 -0.891 . . . . 7.8 108.594 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.603 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -60.31 -50.09 75.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.561 -1.2 . . . . 11.19 110.649 175.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 81' ' ' ILE . 23.2 mt -59.24 -42.22 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.965 -0.562 . . . . 11.59 110.613 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.588 HG21 ' HD2' ' A' ' 90' ' ' PHE . 84.9 mt -65.5 -46.01 91.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.833 -0.622 . . . . 8.01 111.467 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.569 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -71.31 -20.48 62.19 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.073 -0.651 . . . . 10.38 110.837 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -76.79 -21.13 55.58 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.412 . . . . 12.35 110.416 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 mmt -71.5 -22.45 61.79 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.464 0.65 . . . . 10.6 109.813 173.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.77 -3.3 8.04 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.196 -0.911 . . . . 10.36 111.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.588 ' HD2' HG21 ' A' ' 85' ' ' ILE . 31.9 m-85 -87.06 -179.07 6.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.792 0.33 . . . . 8.89 110.478 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 26.5 tt0 -90.58 141.54 28.67 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.589 -0.523 . . . . 10.6 109.589 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.455 ' O ' HD12 ' A' ' 96' ' ' ILE . 11.7 ttm180 -56.48 -52.65 63.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.948 0.404 . . . . 12.6 110.354 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.78 -34.37 74.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.61 . . . . 9.25 110.938 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.708 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.2 tt0 -66.29 -39.2 89.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.57 -0.741 . . . . 7.2 109.359 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.586 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -62.32 -41.65 98.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.27 -0.877 . . . . 5.69 110.219 173.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.64 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.52 -52.09 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.872 -0.604 . . . . 6.87 110.419 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.542 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 59.6 tt0 -54.13 -47.94 71.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 8.99 110.742 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.89 -53.21 60.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.193 -0.912 . . . . 5.41 110.593 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.718 HD21 ' HB1' ' A' ' 109' ' ' ALA . 73.6 mt -61.48 -30.73 70.79 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.593 -0.276 . . . . 5.86 111.36 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.542 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -56.49 -48.18 77.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 8.38 109.802 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.31 68.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.929 -1.032 . . . . 8.88 111.624 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.653 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 23.6 p -81.59 -7.41 59.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.354 0.502 . . . . 8.79 112.354 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 65.18 63.27 0.67 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.601 0.715 . . . . 10.09 110.133 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.4 p-10 49.66 28.93 2.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.003 -1.453 . . . . 7.86 112.533 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -89.03 110.49 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.096 -0.705 . . . . 11.16 109.096 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.861 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.4 tt -56.31 -61.2 2.57 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.071 -0.968 . . . . 10.38 112.132 -175.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.404 ' N ' HD22 ' A' ' 106' ' ' LEU . 16.7 mm-40 -56.04 -46.89 78.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.378 -0.828 . . . . 11.82 111.115 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.653 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.3 ttm180 -66.36 -28.62 68.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.573 -0.285 . . . . 12.99 110.748 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.718 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.74 -50.66 68.2 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.332 -0.618 . . . . 6.65 109.332 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.91 -39.0 83.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.183 -0.917 . . . . 8.11 109.635 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.81 -51.1 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 9.04 109.826 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -64.11 -42.67 96.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.507 -1.224 . . . . 9.43 110.862 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 109' ' ' ALA . 47.6 mt -70.71 -40.66 77.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.361 -0.836 . . . . 5.25 111.584 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.84 -31.98 70.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 7.33 111.802 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 p -77.88 4.37 12.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.547 0.689 . . . . 8.38 111.197 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -122.92 78.51 50.17 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 114.949 -1.023 . . . . 10.19 109.81 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.3 -70.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.431 2.754 . . . . 8.57 111.721 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 6.5 pt-20 -168.9 -57.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.021 -0.99 . . . . 11.42 109.925 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.432 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 30.8 t80 -127.92 27.24 5.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.244 0.545 . . . . 16.4 109.995 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 60.75 99.46 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.305 -0.861 . . . . 11.84 111.53 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -92.31 173.24 7.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.554 -0.748 . . . . 12.26 111.981 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -134.64 13.93 3.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.9 -1.045 . . . . 15.51 108.997 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 t -88.8 32.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.141 -0.936 . . . . 16.06 110.666 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.95 -69.77 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.906 -0.588 . . . . 17.4 110.368 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.3 t80 51.87 71.19 0.47 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.384 0.612 . . . . 19.63 110.885 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.212 -0.899 . . . . 20.33 109.946 179.396 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.079 -0.341 . . . . 7.16 110.079 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mt 62.34 86.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 123.563 0.539 . . . . 6.09 109.876 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.92 82.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 4.6 110.364 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 8' ' ' MET . 43.8 mt-10 -72.63 -10.82 60.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.739 -0.664 . . . . 5.13 111.99 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.621 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 25.1 p -65.33 -32.6 74.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.732 -0.84 . . . . 4.51 108.732 175.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.71 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 43.6 m -59.87 -53.4 58.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.194 -0.912 . . . . 3.46 111.472 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -63.21 -37.84 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.734 -0.387 . . . . 3.39 110.435 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 64.3 mtt -62.69 -28.25 69.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 5.53 111.396 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 5' ' ' SER . 27.1 mt-30 -65.33 -46.74 79.06 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.91 -0.316 . . . . 5.92 110.478 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.686 HD13 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.21 -40.45 86.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.783 0.801 . . . . 3.9 109.375 176.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.47 -47.41 84.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.141 -1.391 . . . . 4.46 112.548 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.68 -27.87 69.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.267 0.469 . . . . 6.27 112.267 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 ptm -99.35 2.0 44.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.625 0.25 . . . . 5.61 111.268 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.96 -116.16 0.35 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.406 -0.902 . . . . 4.85 112.851 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.1 m-85 -101.65 154.32 37.35 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 5.55 110.719 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.845 ' HG3' ' HB3' ' A' ' 52' ' ' LEU . 61.9 Cg_endo -71.47 85.65 0.88 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.785 2.323 . . . . 4.57 111.468 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.536 HD12 ' HB1' ' A' ' 49' ' ' ALA . 2.6 mm? -78.46 68.67 4.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 3.76 112.089 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.413 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 12.9 tt0 -55.53 -25.38 37.16 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.912 -0.492 . . . . 5.48 110.918 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.436 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -57.7 -31.95 66.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 3.8 109.801 174.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.686 ' SG ' HD13 ' A' ' 10' ' ' LEU . 28.0 t -73.68 -39.88 64.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.481 -0.781 . . . . 3.27 109.769 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -53.27 -53.37 51.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.085 0.469 . . . . 6.55 110.709 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 18' ' ' GLU . 8.7 ptpt -72.17 -22.83 61.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.226 -0.443 . . . . 5.22 110.721 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.28 76.66 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.237 -0.438 . . . . 4.34 110.75 174.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 20' ' ' CYS . 73.4 t -58.5 -42.17 83.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 4.58 110.159 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.11 -38.6 82.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.663 -0.415 . . . . 7.65 110.366 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.59 -37.64 82.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.388 -0.369 . . . . 7.32 111.427 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.5 p -71.55 -17.7 62.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 5.71 111.406 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.95 23.48 20.24 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.876 -0.678 . . . . 6.04 111.481 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.19 58.88 1.36 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.6 0.714 . . . . 5.27 110.263 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.407 ' HB3' HG21 ' A' ' 34' ' ' VAL . 87.4 mmm -88.23 -11.78 45.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.491 -0.777 . . . . 6.57 111.757 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.44 -173.67 17.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 4.23 113.298 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.71 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -58.84 -55.57 33.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.659 0.615 . . . . 3.88 112.659 -174.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.75 -44.78 92.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 5.59 112.149 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 30' ' ' MET . 86.9 t -65.25 -42.42 93.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.741 0.305 . . . . 5.29 111.096 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.16 50.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.596 -0.441 . . . . 3.68 111.172 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.54 ' O ' HG22 ' A' ' 39' ' ' ILE . 86.3 t80 -61.43 -40.63 95.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.978 -0.749 . . . . 5.05 108.978 171.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.529 ' O ' HG13 ' A' ' 40' ' ' ILE . 92.0 m-20 -60.69 -45.37 94.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.784 -0.644 . . . . 6.25 110.218 174.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 42.9 t90 -60.84 -41.33 95.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.067 0.46 . . . . 6.43 110.114 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 36' ' ' PHE . 3.9 tp -73.07 -36.23 50.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.125 -0.489 . . . . 3.69 111.487 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.0 -21.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.108 0.48 . . . . 5.32 110.804 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 37' ' ' ASN . 95.3 t -74.88 -42.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.116 -0.493 . . . . 5.79 110.508 171.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -100.54 16.5 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.992 0.367 . . . . 5.81 111.992 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.426 ' HE1' ' HB2' ' A' ' 43' ' ' MET . 5.0 ppp? -61.15 -21.35 63.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.154 0.502 . . . . 6.2 111.059 178.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.15 -21.56 65.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.577 -0.738 . . . . 6.34 112.261 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HB3' ' CD1' ' A' ' 48' ' ' PHE . 18.7 mt-10 -85.99 111.52 38.78 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.31 0.576 . . . . 5.62 110.876 -174.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -65.05 -52.19 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.721 2.947 . . . . 6.66 113.717 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -98.45 -6.14 31.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.803 -0.635 . . . . 6.09 111.307 -168.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 45' ' ' GLU . 17.0 m-85 -69.57 -11.24 60.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.424 . . . . 6.7 111.07 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.536 ' HB1' HD12 ' A' ' 17' ' ' LEU . . . -84.42 -120.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.467 -0.568 . . . . 4.6 109.467 171.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.496 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 21.3 mt-10 -137.5 143.58 41.54 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 110.07 -0.344 . . . . 5.96 110.07 172.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -71.45 69.53 2.65 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.749 2.299 . . . . 6.2 111.204 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.845 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 56.8 tp -138.37 108.57 6.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.368 -0.833 . . . . 8.57 110.307 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 m -43.57 120.33 1.93 Allowed 'General case' 0 C--O 1.236 0.392 0 O-C-N 124.025 0.828 . . . . 7.68 110.83 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.461 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 19.1 ptm -60.56 136.38 92.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.935 -0.575 . . . . 7.67 111.738 -172.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 7.2 Cg_exo -73.05 132.83 18.73 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.922 2.415 . . . . 6.06 111.189 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.85 89.1 1.42 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.867 -0.682 . . . . 7.03 112.046 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -66.81 100.43 0.71 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.963 -0.384 . . . . 9.21 109.963 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.39 36.94 4.97 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.862 -0.685 . . . . 7.29 111.539 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.38 31.94 2.88 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.252 -0.499 . . . . 7.34 112.913 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.8 -33.76 17.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.212 0.529 . . . . 8.32 109.87 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.4 83.13 6.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.782 -0.645 . . . . 6.99 110.372 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 p -64.89 -39.42 93.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.839 -0.619 . . . . 7.25 111.209 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.54 33.08 5.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.275 -0.421 . . . . 6.54 110.753 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.01 -129.76 29.71 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.935 -0.575 . . . . 7.09 112.618 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.23 -26.91 28.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 7.55 110.631 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m 64.88 33.06 10.33 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 114.714 -1.13 . . . . 7.6 112.018 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.87 94.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.829 0.823 . . . . 8.44 111.313 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -91.23 138.5 31.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.786 -0.643 . . . . 8.67 109.615 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.41 169.63 22.7 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.713 -0.756 . . . . 7.01 111.935 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.86 -14.45 44.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.671 0.272 . . . . 6.47 110.378 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 m 70.23 -65.79 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.117 -0.947 . . . . 7.96 111.546 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -145.58 126.48 2.57 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.103 -0.57 . . . . 6.58 111.677 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.584 ' N ' HD21 ' A' ' 73' ' ' LEU . 4.1 mm? -96.51 6.77 48.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.289 0.566 . . . . 7.68 110.025 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -99.99 97.19 8.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.362 -0.836 . . . . 6.55 110.185 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -157.62 122.84 4.5 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.155 -0.683 . . . . 8.05 109.155 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 7.1 tt0 -79.85 136.08 55.06 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 109.522 -0.548 . . . . 7.7 109.522 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.606 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 86.8 Cg_exo -53.24 160.76 4.31 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.626 2.884 . . . . 5.41 113.579 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.652 ' HD2' HD11 ' A' ' 99' ' ' LEU . 46.5 Cg_endo -66.39 112.96 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.943 2.429 . . . . 7.74 111.157 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.834 ' HA ' HG23 ' A' ' 82' ' ' VAL . 5.5 pt-20 -56.15 -27.35 53.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.67 -0.696 . . . . 10.13 111.079 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 4.7 tt0 -58.56 -53.07 62.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.195 0.521 . . . . 11.78 110.093 172.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.906 HD11 ' HB2' ' A' ' 106' ' ' LEU . 74.6 mt -74.66 -40.98 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.737 -0.665 . . . . 8.98 111.799 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.834 HG23 ' HA ' ' A' ' 79' ' ' GLU . 16.1 m -56.47 -37.85 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.719 -0.845 . . . . 7.8 108.719 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.57 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.3 -48.63 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.613 -1.176 . . . . 11.19 110.557 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.2 mt -60.63 -43.36 94.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 11.59 110.8 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 95' ' ' ALA . 87.7 mt -63.53 -45.31 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.951 -0.568 . . . . 8.01 111.57 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.596 HG21 ' O ' ' A' ' 82' ' ' VAL . 2.1 t -72.5 -20.54 61.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.313 -0.555 . . . . 10.38 110.945 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.1 m -79.92 -16.95 54.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.798 0.333 . . . . 12.35 110.517 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.4 mmm -74.65 -25.29 59.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.302 0.572 . . . . 10.6 109.932 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.63 -2.27 4.89 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.977 -1.01 . . . . 10.36 111.762 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.566 ' HD2' HG21 ' A' ' 85' ' ' ILE . 30.7 m-85 -94.39 -173.8 3.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.666 0.27 . . . . 8.89 110.55 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 7.3 tt0 -101.03 145.54 28.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.66 -0.496 . . . . 10.6 109.66 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.586 ' HG3' HG21 ' A' ' 82' ' ' VAL . 18.5 ttm180 -58.11 -52.21 66.48 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.045 0.45 . . . . 12.6 110.61 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.422 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 48.3 t30 -58.41 -37.36 75.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.617 -0.719 . . . . 9.25 110.766 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 5.9 tt0 -65.71 -38.3 88.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.629 -0.714 . . . . 7.2 109.748 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.577 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -64.09 -37.96 89.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.215 -0.902 . . . . 5.69 110.755 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.606 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER -58.61 -53.92 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 116.446 -0.343 . . . . 6.87 110.855 177.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 7.8 tt0 -57.4 -44.36 84.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.232 0.539 . . . . 8.99 110.866 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.56 ' O ' HG22 ' A' ' 102' ' ' THR . . . -59.32 -52.52 65.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.041 -0.981 . . . . 5.41 110.355 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.741 HD21 ' HB1' ' A' ' 109' ' ' ALA . 79.6 mt -61.69 -34.16 75.27 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.548 -0.296 . . . . 5.86 111.659 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 96' ' ' ILE . 59.1 mtp180 -58.47 -41.24 84.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.299 0.571 . . . . 8.38 110.643 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.4 -38.11 60.1 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.195 -0.911 . . . . 8.88 111.385 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 32.9 p -87.56 1.31 53.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.707 0.632 . . . . 8.79 112.707 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.19 65.21 1.23 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.67 -0.695 . . . . 10.09 110.575 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.5 p-10 50.01 28.33 2.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.13 -1.395 . . . . 7.86 112.562 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -90.12 109.69 20.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.257 -0.646 . . . . 11.16 109.257 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.906 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.2 tt -52.44 -59.96 3.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.945 -1.025 . . . . 10.38 111.771 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -54.24 -52.44 61.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.706 -1.134 . . . . 11.82 111.794 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.705 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 17.7 ttm180 -66.47 -27.48 67.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.511 . . . . 12.99 110.96 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.741 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.63 -51.37 67.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.398 -0.593 . . . . 6.65 109.398 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.2 mt -59.82 -38.6 82.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.267 -0.879 . . . . 8.11 109.763 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 8.3 t70 -54.76 -51.15 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.869 -1.06 . . . . 9.04 110.155 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.36 -48.1 79.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.326 -1.306 . . . . 9.43 110.395 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 109' ' ' ALA . 41.1 mt -62.09 -41.16 90.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.231 -0.895 . . . . 5.25 110.974 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.73 -26.55 68.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 7.33 111.106 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 m -75.37 -1.27 23.05 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 8.38 110.725 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 117' ' ' PRO . 92.8 m-70 -139.58 74.79 33.14 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.468 -0.938 . . . . 10.19 108.468 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 116' ' ' HIS . 1.9 Cg_endo -38.38 -61.75 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.833 1 C-N-CA 125.913 4.409 . . . . 8.57 114.361 -177.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 9.7 pt-20 -166.89 -51.0 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.331 -0.85 . . . . 11.42 108.915 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.467 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 37.2 t80 -140.68 37.43 1.82 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.624 -1.171 . . . . 16.4 108.001 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.401 ' HA ' ' HG2' ' A' ' 117' ' ' PRO . 29.1 mm-40 68.27 -178.96 0.22 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.398 -1.274 . . . . 11.84 110.032 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.35 164.25 16.61 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.898 -0.321 . . . . 12.26 111.587 -172.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.4 t70 73.3 132.62 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.257 -0.883 . . . . 15.51 113.113 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.7 t -159.32 137.31 10.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.758 -1.11 . . . . 16.06 108.053 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -150.15 150.05 31.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.059 0.457 . . . . 17.4 110.905 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -131.31 38.05 3.66 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.374 -0.83 . . . . 19.63 109.219 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 56.6 t . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.438 -0.801 . . . . 20.33 110.158 -175.168 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.714 -0.476 . . . . 7.16 109.714 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.452 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 86.3 mt -71.26 116.63 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.823 -0.806 . . . . 6.09 108.823 175.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.15 81.15 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.138 0.495 . . . . 4.6 111.34 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HA ' HG12 ' A' ' 7' ' ' VAL . 35.8 mt-10 -70.83 -7.94 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.012 -0.54 . . . . 5.13 110.591 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.555 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 13.2 m -57.43 -34.83 69.34 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.27 -0.641 . . . . 4.51 109.27 170.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.499 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 3.3 m -66.13 -51.79 54.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.442 -0.799 . . . . 3.46 111.202 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -64.14 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 3.39 110.902 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 77.3 mtp -63.04 -32.66 74.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 5.53 111.052 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.615 ' O ' ' HG2' ' A' ' 13' ' ' MET . 14.9 mm100 -59.37 -48.82 80.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.061 -0.256 . . . . 5.92 110.454 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.597 HD11 HG23 ' A' ' 39' ' ' ILE . 18.5 mt -64.63 -45.29 87.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.506 0.67 . . . . 3.9 110.184 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.79 -50.31 71.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.708 -1.133 . . . . 4.46 112.489 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 57' ' ' TYR . 8.5 pt-20 -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.451 . . . . 6.27 111.565 -172.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.615 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 24.2 ptt? -104.82 22.48 15.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.111 -0.495 . . . . 5.61 111.629 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.45 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.126 -1.035 . . . . 4.85 112.851 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 29.2 p90 -158.83 164.93 19.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.676 -0.861 . . . . 5.55 108.676 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.617 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 88.7 Cg_endo -71.52 83.94 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.562 2.175 . . . . 4.57 113.562 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.611 ' HG ' HG12 ' A' ' 39' ' ' ILE . 3.1 mm? -75.15 64.87 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.074 -0.25 . . . . 3.76 111.641 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.75 -19.38 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 121.387 -0.821 . . . . 5.48 109.681 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -57.82 -32.7 67.84 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.577 -0.738 . . . . 3.8 110.029 170.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.559 ' O ' HG22 ' A' ' 24' ' ' VAL . 35.1 t -72.09 -42.99 65.52 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.768 -1.105 . . . . 3.27 109.646 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -54.15 -46.67 72.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.161 0.505 . . . . 6.55 110.178 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 42.6 mtmt -70.52 -26.01 63.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 5.22 110.744 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB1' ' HD1' ' A' ' 38' ' ' TRP . . . -74.16 -44.89 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 4.34 110.928 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 20' ' ' CYS . 92.1 t -53.6 -47.68 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 4.58 109.954 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -56.08 -45.77 79.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.486 -0.779 . . . . 7.65 110.783 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -66.03 -40.3 90.92 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.405 -0.361 . . . . 7.32 111.593 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.8 p -67.47 -11.75 58.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.353 . . . . 5.71 111.51 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.62 26.18 47.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.921 -0.657 . . . . 6.04 111.722 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 76.7 m-20 60.84 60.57 1.84 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.181 0.515 . . . . 5.27 110.342 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.1 mmt -86.28 -34.25 20.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 6.57 112.152 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 170.4 17.74 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.929 -1.129 . . . . 4.23 112.795 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HA ' ' CB ' ' A' ' 6' ' ' SER . . . -62.62 -58.37 7.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.207 0.447 . . . . 3.88 112.207 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.58 -31.13 67.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.367 -0.379 . . . . 5.59 111.065 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.72 -45.28 92.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.068 -0.515 . . . . 5.29 110.662 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -27.02 50.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.92 -0.312 . . . . 3.68 111.258 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.543 ' O ' HG22 ' A' ' 39' ' ' ILE . 66.6 t80 -56.6 -43.92 80.61 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.875 -0.787 . . . . 5.05 108.875 169.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.573 ' O ' HG13 ' A' ' 40' ' ' ILE . 41.6 t-20 -63.06 -43.74 97.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.066 -0.97 . . . . 6.25 110.28 177.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.636 ' HD1' ' HB1' ' A' ' 23' ' ' ALA . 13.1 t-105 -65.49 -30.24 70.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.809 -0.357 . . . . 6.43 111.029 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.613 HD11 ' HB1' ' A' ' 19' ' ' ALA . 3.1 tp -76.21 -37.65 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.997 -0.281 . . . . 3.69 110.912 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.49 -21.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.444 0.64 . . . . 5.32 110.378 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 37' ' ' ASN . 72.4 t -74.22 -51.01 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.594 -0.73 . . . . 5.79 109.997 169.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.504 ' HA ' ' HG2' ' A' ' 44' ' ' GLU . 2.0 m-70 -85.42 14.38 5.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.193 0.442 . . . . 5.81 112.193 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 23.2 ptt? -62.85 -20.29 64.95 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.358 -0.608 . . . . 6.2 109.358 169.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.553 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 9.6 pt-20 -49.36 -30.51 7.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.288 -0.869 . . . . 6.34 110.712 172.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.553 ' HG2' ' HG3' ' A' ' 44' ' ' GLU . 1.3 pt-20 -115.35 84.27 11.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 5.62 110.089 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 10.8 Cg_endo -55.09 -45.48 40.37 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 123.897 3.064 . . . . 6.66 113.219 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -93.47 20.22 7.51 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.414 -1.266 . . . . 6.09 110.537 -168.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.511 ' HD2' ' HB3' ' A' ' 19' ' ' ALA . 25.4 t80 -76.36 -10.24 59.25 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.841 0.829 . . . . 6.7 108.882 172.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 16' ' ' PRO . . . -116.06 101.47 8.77 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.65 -1.159 . . . . 4.6 109.038 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 2.2 mp0 -47.08 108.17 0.83 Allowed Pre-proline 0 C--N 1.321 -0.656 0 O-C-N 123.936 0.772 . . . . 5.96 111.43 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 3.7 Cg_exo -80.38 57.61 6.6 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.379 2.719 . . . . 6.2 112.605 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.98 31.56 2.36 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.096 -0.502 . . . . 8.57 110.86 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.554 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 6.7 m -159.22 107.0 1.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.368 -0.378 . . . . 7.68 110.203 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.9 ttm -88.6 102.44 3.91 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 110.253 -0.277 . . . . 7.67 110.253 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 53' ' ' THR . 6.1 Cg_exo -80.69 123.39 4.74 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.215 2.61 . . . . 6.06 112.273 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.94 65.34 3.75 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.734 -0.746 . . . . 7.03 111.847 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.5 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 40.3 p90 -74.2 135.57 42.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.955 0.407 . . . . 9.21 110.52 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.47 -155.06 20.93 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.189 -0.764 . . . . 7.29 111.189 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.63 -126.5 7.49 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.556 -0.831 . . . . 7.34 111.706 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 67.51 -72.19 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.297 0.639 . . . . 8.32 111.338 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.48 -62.5 1.23 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.528 -0.305 . . . . 6.99 110.478 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.3 m 50.06 55.38 9.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.423 0.63 . . . . 7.25 110.467 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 66' ' ' SER . . . -101.23 81.29 2.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.509 -0.769 . . . . 6.54 111.644 -174.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.31 -20.04 79.16 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.797 -0.921 . . . . 7.09 110.797 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.771 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -171.76 -48.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.178 -1.045 . . . . 7.55 108.178 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 18.9 m -106.5 169.83 8.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.738 -1.119 . . . . 7.6 108.736 170.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.4 m -89.86 135.95 24.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.621 0.248 . . . . 8.44 110.804 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.0 t80 58.15 60.29 2.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.641 -0.709 . . . . 8.67 110.669 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.84 -147.14 18.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.594 -0.812 . . . . 7.01 112.792 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.39 34.17 4.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.28 0.562 . . . . 6.47 110.419 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.5 m -64.3 113.65 3.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.615 -0.72 . . . . 7.96 110.922 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.01 29.23 9.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 6.58 112.491 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -86.03 50.46 1.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.153 0.501 . . . . 7.68 111.242 -178.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.06 157.17 32.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.935 -0.575 . . . . 6.55 109.514 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -117.14 15.57 14.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.374 0.607 . . . . 8.05 110.379 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -62.78 143.56 96.86 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.778 -1.101 . . . . 7.7 110.719 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.594 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 88.4 Cg_exo -51.03 165.04 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.524 2.816 . . . . 5.41 112.823 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.625 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 41.9 Cg_endo -63.53 112.54 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.474 2.116 . . . . 7.74 110.999 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.822 ' HA ' HG23 ' A' ' 82' ' ' VAL . 13.5 pt-20 -55.84 -30.72 61.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.899 -0.592 . . . . 10.13 110.295 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.73 -51.48 67.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.562 -0.744 . . . . 11.78 110.139 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.858 HD11 ' HB2' ' A' ' 106' ' ' LEU . 75.1 mt -76.24 -42.7 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.924 -0.58 . . . . 8.98 111.98 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.822 HG23 ' HA ' ' A' ' 79' ' ' GLU . 12.6 m -55.76 -37.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.507 -0.923 . . . . 7.8 108.507 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.591 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -62.24 -47.01 86.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.681 -1.145 . . . . 11.19 110.927 175.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.63 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.6 mt -60.58 -41.98 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.225 0.536 . . . . 11.59 110.501 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.659 HG21 ' HD2' ' A' ' 90' ' ' PHE . 89.6 mt -65.5 -47.4 86.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.703 -0.681 . . . . 8.01 111.527 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.579 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -70.19 -21.99 62.98 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.172 -0.611 . . . . 10.38 110.536 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 t -75.44 -19.95 59.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.976 0.417 . . . . 12.35 110.046 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.2 mmt -75.78 -24.55 56.0 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.323 0.582 . . . . 10.6 110.396 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.67 9.03 4.1 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.392 -0.822 . . . . 10.36 111.8 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.659 ' HD2' HG21 ' A' ' 85' ' ' ILE . 28.6 m-85 -101.05 -175.36 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.859 -0.423 . . . . 8.89 109.859 177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 51.5 tt0 -100.23 145.31 28.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.659 -0.497 . . . . 10.6 109.659 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.603 ' HG3' HG21 ' A' ' 82' ' ' VAL . 18.2 ttm180 -56.43 -52.29 65.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 12.6 110.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.455 ' HB3' ' NE2' ' A' ' 91' ' ' GLN . 28.3 t-20 -59.46 -35.96 75.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.792 -0.64 . . . . 9.25 111.085 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 7.7 tt0 -66.14 -38.65 88.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.699 . . . . 7.2 109.664 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.613 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -64.22 -39.51 94.13 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.231 -0.895 . . . . 5.69 110.412 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.594 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -59.26 -52.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.191 -0.459 . . . . 6.87 110.729 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 34.1 tt0 -56.61 -43.97 80.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.881 -0.6 . . . . 8.99 110.961 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.35 -53.89 52.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.409 -0.814 . . . . 5.41 110.846 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.788 HD21 ' HB1' ' A' ' 109' ' ' ALA . 84.3 mt -60.02 -34.2 73.04 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 111.474 0.176 . . . . 5.86 111.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.44 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.2 mtt180 -55.39 -46.47 76.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.528 0.68 . . . . 8.38 110.304 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.89 -42.48 69.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.125 -0.943 . . . . 8.88 111.422 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.3 p -82.93 -1.35 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.564 0.579 . . . . 8.79 112.564 -174.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m120 63.81 60.03 1.09 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.049 -0.523 . . . . 10.09 110.362 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.598 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 3.3 p-10 48.63 34.42 5.03 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.351 1.06 . . . . 7.86 111.933 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -93.24 111.29 22.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.79 -0.818 . . . . 11.16 108.79 174.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.858 ' HB2' HD11 ' A' ' 81' ' ' ILE . 7.8 tt -56.24 -59.35 5.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.464 -0.789 . . . . 10.38 111.516 -175.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -55.98 -50.06 71.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.711 -1.131 . . . . 11.82 111.344 -177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.692 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -66.03 -29.09 69.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.547 -0.751 . . . . 12.99 111.281 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.788 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.24 -50.13 72.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.308 -0.627 . . . . 6.65 109.308 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -61.31 -36.74 80.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.163 -0.926 . . . . 8.11 109.904 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -57.14 -52.88 63.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.263 -0.88 . . . . 9.04 109.627 173.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 63.8 t90 -60.59 -45.24 94.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.126 -1.397 . . . . 9.43 110.498 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 109' ' ' ALA . 53.0 mt -67.71 -34.25 66.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.058 -0.974 . . . . 5.25 110.901 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -67.9 -30.37 69.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.382 0.61 . . . . 7.33 110.165 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.3 m -80.35 7.12 10.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.788 -0.642 . . . . 8.38 110.324 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -120.53 80.32 30.53 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.563 -0.744 . . . . 10.19 110.056 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.79 -60.85 0.68 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.915 2.41 . . . . 8.57 110.954 172.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -177.67 -39.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.496 -1.229 . . . . 11.42 110.251 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -131.93 2.48 4.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.638 0.732 . . . . 16.4 110.992 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 48.71 61.52 3.04 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.411 -1.268 . . . . 11.84 111.534 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -101.6 -178.49 3.74 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.957 -1.474 . . . . 12.26 109.135 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 t70 54.36 72.4 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.743 0.652 . . . . 15.51 110.384 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.2 p -66.91 105.89 1.75 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.954 -0.566 . . . . 16.06 111.366 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -47.15 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.271 0.841 . . . . 17.4 113.271 -170.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -126.27 9.34 7.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.611 0.243 . . . . 19.63 111.461 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.839 -0.6 . . . . 20.33 110.489 179.902 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.173 0.511 . . . . 7.16 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt -114.94 133.17 61.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 6.09 109.45 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -75.0 76.94 2.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.435 0.636 . . . . 4.6 109.642 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.536 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.5 mt-10 -72.34 -10.48 59.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.809 -0.632 . . . . 5.13 112.022 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 54.3 p -62.05 -38.01 87.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.371 0.605 . . . . 4.51 109.489 176.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.697 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 50.3 m -60.67 -52.27 65.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.097 -0.956 . . . . 3.46 111.594 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 4' ' ' GLU . 7.4 p -64.34 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.561 -0.456 . . . . 3.39 110.907 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 67.1 mtt -59.7 -31.88 70.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.519 -0.31 . . . . 5.53 111.22 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.585 ' O ' ' HG2' ' A' ' 13' ' ' MET . 15.3 mm100 -60.9 -56.88 15.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.593 -0.276 . . . . 5.92 110.48 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.697 HD13 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.9 -28.73 67.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.565 -0.454 . . . . 3.9 111.387 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.32 86.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.429 . . . . 4.46 110.996 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -79.45 -42.18 25.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 6.27 111.439 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.585 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 26.2 ptt? -92.14 32.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.782 0.325 . . . . 5.61 111.251 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.607 ' O ' ' HD2' ' A' ' 55' ' ' PRO . . . -172.09 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.403 -0.903 . . . . 4.85 112.347 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.599 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 12.4 p90 -166.53 162.15 11.74 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.092 -0.707 . . . . 5.55 109.092 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.599 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 22.8 Cg_endo -55.1 91.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.687 2.924 . . . . 4.57 112.99 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 10' ' ' LEU . 70.4 mt -96.81 57.32 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.891 -0.595 . . . . 3.76 111.745 -175.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -55.67 -23.89 30.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.161 0.505 . . . . 5.48 110.718 174.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.45 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . . . -57.75 -36.95 72.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.925 -0.58 . . . . 3.8 110.001 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.697 ' SG ' HD13 ' A' ' 10' ' ' LEU . 20.2 t -73.81 -31.75 63.4 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.421 -0.809 . . . . 3.27 110.449 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.38 -48.72 71.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.48 -0.933 . . . . 6.55 108.48 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 18.8 mttm -66.09 -42.32 89.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.026 . . . . 5.22 109.976 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.557 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . . . -60.37 -40.81 92.16 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.643 -0.708 . . . . 4.34 111.918 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG22 ' HG ' ' A' ' 20' ' ' CYS . 39.9 t -59.08 -45.76 92.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.153 -0.314 . . . . 4.58 110.153 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.46 -41.83 99.05 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.454 -0.498 . . . . 7.65 110.223 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.15 -41.59 85.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.82 -0.627 . . . . 7.32 112.085 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -65.46 -23.36 66.9 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.057 0.456 . . . . 5.71 110.835 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.37 29.65 8.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.6 -0.727 . . . . 6.04 111.73 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 59.39 49.44 8.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.217 0.532 . . . . 5.27 110.297 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.4 mmm -82.42 3.78 26.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 6.57 112.192 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.32 171.45 23.08 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.567 -0.825 . . . . 4.23 112.444 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.697 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -67.68 -45.22 75.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.665 -0.267 . . . . 3.88 111.679 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.97 -31.36 70.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.481 -0.327 . . . . 5.59 111.663 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.07 -44.65 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 5.29 110.56 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.0 60.72 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.613 -0.435 . . . . 3.68 110.49 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 39' ' ' ILE . 83.9 t80 -56.35 -42.55 77.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.958 -0.756 . . . . 5.05 108.958 171.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.405 ' O ' HG13 ' A' ' 40' ' ' ILE . 11.1 m120 -61.75 -45.96 91.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 6.25 110.612 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -59.44 -43.03 93.22 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.532 0.682 . . . . 6.43 109.842 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.533 HG23 HD11 ' A' ' 10' ' ' LEU . 3.0 tp -74.77 -36.3 39.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.486 -0.779 . . . . 3.69 111.861 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.42 ' O ' ' HG3' ' A' ' 43' ' ' MET . 2.8 pp -71.47 -21.34 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 5.32 111.54 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.59 -36.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.54 . . . . 5.79 110.19 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -99.52 7.6 45.21 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.416 0.524 . . . . 5.81 112.416 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 4.8 ppp? -76.76 -22.38 53.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.211 0.529 . . . . 6.2 111.001 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.11 -21.74 64.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.254 -0.885 . . . . 6.34 111.035 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.811 ' HG3' ' HB2' ' A' ' 48' ' ' PHE . 3.9 pt-20 -90.05 119.75 69.3 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.541 0.686 . . . . 5.62 109.407 172.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.45 -47.26 22.68 Favored 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 124.149 3.232 . . . . 6.66 114.947 -165.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -105.19 24.52 11.92 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.146 0.974 . . . . 6.09 110.713 -167.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.811 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 35.5 t80 -76.75 -25.71 53.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.444 -0.798 . . . . 6.7 110.493 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.591 ' HB1' HD22 ' A' ' 17' ' ' LEU . . . -93.21 -123.82 0.09 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.15 -0.477 . . . . 4.6 110.858 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 42.1 mt-10 -129.79 134.97 26.79 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.393 -0.595 . . . . 5.96 109.393 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 5.6 Cg_exo -78.71 65.99 8.65 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.944 2.429 . . . . 6.2 111.769 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' HG ' HG21 ' A' ' 53' ' ' THR . 51.2 tp -141.02 105.39 4.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.049 -0.523 . . . . 8.57 110.758 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.529 HG21 ' HG ' ' A' ' 52' ' ' LEU . 6.3 t 37.01 72.83 0.1 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.398 1.061 . . . . 7.68 113.229 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.452 ' HG3' ' HB2' ' A' ' 15' ' ' PHE . 4.2 mpp? -86.07 107.45 13.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 7.67 110.254 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.607 ' HD2' ' O ' ' A' ' 14' ' ' GLY . 6.1 Cg_exo -79.36 -54.9 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.146 2.564 . . . . 6.06 112.941 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.54 -179.66 19.47 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.29 -0.724 . . . . 7.03 111.29 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -109.92 -34.47 6.42 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.196 0.498 . . . . 9.21 112.217 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.89 -142.2 9.21 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.61 -1.281 . . . . 7.29 113.514 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.87 41.52 0.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.29 -0.724 . . . . 7.34 111.29 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.37 -164.53 1.3 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.451 0.167 . . . . 8.32 111.442 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.47 52.57 1.79 Allowed 'General case' 0 C--O 1.231 0.101 0 O-C-N 123.807 0.692 . . . . 6.99 111.546 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.1 t -94.54 119.09 32.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.788 -0.642 . . . . 7.25 110.214 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.13 140.54 48.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.248 -0.433 . . . . 6.54 110.307 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.4 95.71 0.4 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.547 -0.835 . . . . 7.09 112.879 -176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.63 152.57 22.3 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.543 -0.539 . . . . 7.55 109.543 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.547 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 11.3 t -161.31 -159.2 0.63 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.934 -0.306 . . . . 7.6 110.839 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.34 -23.16 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.208 0.448 . . . . 8.44 112.208 -175.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 66' ' ' SER . 21.5 p90 -78.58 64.02 3.52 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.67 0.748 . . . . 8.67 111.958 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.03 -13.35 69.24 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.698 -0.683 . . . . 7.01 111.851 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.771 ' HB2' HD22 ' A' ' 73' ' ' LEU . . . -120.97 154.29 36.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.228 -0.286 . . . . 6.47 110.228 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 p -80.95 57.67 3.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.159 0.504 . . . . 7.96 111.593 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.17 -56.3 4.85 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.033 -0.603 . . . . 6.58 112.345 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.771 HD22 ' HB2' ' A' ' 70' ' ' ALA . 1.8 mm? 65.5 32.53 9.37 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.858 0.463 . . . . 7.68 111.37 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -126.05 134.56 51.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.041 -0.725 . . . . 6.55 109.041 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -133.32 22.72 4.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.428 0.632 . . . . 8.05 110.272 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -93.78 135.84 24.54 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.315 -0.857 . . . . 7.7 110.141 -177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.628 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 76.7 Cg_exo -55.09 163.93 3.99 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.249 2.633 . . . . 5.41 112.044 171.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.656 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 36.6 Cg_endo -63.51 113.18 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.598 2.199 . . . . 7.74 111.464 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.875 ' HA ' HG23 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -58.16 -23.28 54.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.952 -0.567 . . . . 10.13 111.16 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 8.7 tt0 -61.61 -52.57 63.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.128 -0.487 . . . . 11.78 109.879 171.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.893 HD11 ' HB2' ' A' ' 106' ' ' LEU . 73.5 mt -75.18 -41.55 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.617 -0.72 . . . . 8.98 111.944 -175.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.875 HG23 ' HA ' ' A' ' 79' ' ' GLU . 13.7 m -56.56 -38.02 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.604 -0.887 . . . . 7.8 108.604 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.612 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -60.49 -49.88 75.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.903 -1.044 . . . . 11.19 110.576 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.0 mt -59.69 -43.07 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 11.59 110.808 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.597 HG21 ' HD2' ' A' ' 90' ' ' PHE . 90.5 mt -63.96 -47.76 89.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.92 -0.582 . . . . 8.01 111.84 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.559 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -70.08 -23.69 63.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.013 -0.675 . . . . 10.38 110.51 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.5 m -69.75 -31.2 69.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.701 0.286 . . . . 12.35 110.24 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 93.4 mmm -62.78 -29.07 70.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.206 0.526 . . . . 10.6 110.679 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.2 4.2 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.364 -0.835 . . . . 10.36 112.005 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.597 ' HD2' HG21 ' A' ' 85' ' ' ILE . 29.7 m-85 -91.5 -173.85 3.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.207 -0.294 . . . . 8.89 110.207 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 8.4 tt0 -101.49 147.16 26.7 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.699 -0.482 . . . . 10.6 109.699 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.469 ' HG3' HG21 ' A' ' 82' ' ' VAL . 20.7 ttm180 -57.74 -52.7 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 12.6 110.763 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -58.64 -36.74 74.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.776 -0.647 . . . . 9.25 110.786 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.8 tt0 -65.82 -38.94 90.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.546 -0.752 . . . . 7.2 109.63 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -63.88 -40.77 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.272 -0.876 . . . . 5.69 110.519 174.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.628 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -58.5 -52.2 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 116.002 -0.545 . . . . 6.87 110.656 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.615 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 27.3 tt0 -56.55 -44.78 81.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.046 -0.524 . . . . 8.99 111.08 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.95 -53.39 58.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.457 -0.792 . . . . 5.41 110.659 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.801 HD21 ' HB1' ' A' ' 109' ' ' ALA . 76.1 mt -61.65 -32.28 72.44 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.609 -0.269 . . . . 5.86 111.392 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.615 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 88.7 mtt180 -54.86 -46.7 74.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.601 . . . . 8.38 109.752 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.69 62.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.928 -1.033 . . . . 8.88 111.903 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 27.8 p -85.2 1.04 49.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.627 0.603 . . . . 8.79 112.627 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.73 45.68 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.972 -0.558 . . . . 10.09 110.242 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 0.7 OUTLIER 69.93 16.56 7.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 7.86 111.072 176.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.519 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.4 t-20 -80.43 111.07 16.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.482 -0.562 . . . . 11.16 109.482 176.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.893 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.4 tt -55.02 -60.28 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.287 -0.87 . . . . 10.38 111.536 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 -52.74 52.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.681 -1.145 . . . . 11.82 110.913 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 12.2 ttm180 -65.14 -28.48 69.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.429 -0.805 . . . . 12.99 111.354 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.801 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.04 -50.56 70.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.394 -0.595 . . . . 6.65 109.394 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.8 mt -59.75 -39.07 83.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 8.11 109.717 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.57 -50.06 73.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.007 -0.997 . . . . 9.04 109.956 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.57 -46.83 86.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.621 -1.172 . . . . 9.43 110.408 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 109' ' ' ALA . 46.2 mt -63.61 -35.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.201 -0.908 . . . . 5.25 110.926 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -68.01 -25.15 65.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 7.33 110.108 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.8 t -83.13 -2.47 55.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.454 0.645 . . . . 8.38 109.71 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -131.82 71.42 80.57 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.319 -0.855 . . . . 10.19 110.057 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -47.21 -51.47 9.39 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.995 3.13 . . . . 8.57 112.515 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.677 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 5.9 pt-20 -169.81 -60.94 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.761 -1.109 . . . . 11.42 108.932 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.677 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 29.2 t80 -152.56 28.46 0.55 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.858 -1.065 . . . . 16.4 108.387 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 65.1 -154.45 0.28 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.048 -0.978 . . . . 11.84 110.329 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.86 -167.94 0.54 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.715 0.293 . . . . 12.26 110.583 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.79 101.49 0.82 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.124 0.488 . . . . 15.51 110.447 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.3 m -88.58 160.26 17.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.558 -0.746 . . . . 16.06 110.483 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.29 1.68 35.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 17.4 111.312 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -82.53 90.44 6.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.971 -0.559 . . . . 19.63 110.26 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.805 -0.634 . . . . 20.33 110.294 179.535 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 1.5 p-10 . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.484 0.183 . . . . 7.16 111.344 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mt -129.55 99.83 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 O-C-N 122.28 -0.262 . . . . 6.09 110.35 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.96 94.43 1.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 4.6 110.208 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.521 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.0 mt-10 -72.49 -2.33 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.95 -0.568 . . . . 5.13 112.136 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 4.4 m -59.99 -41.98 93.25 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.582 -0.525 . . . . 4.51 109.582 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.571 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 20.8 p -61.98 -52.11 65.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 3.46 111.832 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.6 p -62.02 -39.74 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 120.852 -0.339 . . . . 3.39 110.996 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.477 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 49.4 mtm -65.18 -26.75 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.449 -0.342 . . . . 5.53 111.445 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 5' ' ' SER . 76.6 mt-30 -69.09 -37.68 78.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.7 -0.4 . . . . 5.92 110.266 175.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.738 ' HB3' HD12 ' A' ' 17' ' ' LEU . 13.6 mt -68.89 -40.5 79.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.079 0.942 . . . . 3.9 109.133 172.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.8 -41.73 99.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.507 -1.224 . . . . 4.46 111.675 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 8' ' ' MET . 71.0 mm-40 -62.31 -29.93 70.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.606 0.595 . . . . 6.27 112.606 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 10' ' ' LEU . 22.0 ptp -81.84 -4.46 56.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.441 -0.504 . . . . 5.61 110.156 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.17 48.73 1.41 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.711 -0.677 . . . . 4.85 113.462 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 73.0 m-85 -143.12 125.37 8.7 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.859 0.361 . . . . 5.55 110.583 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.813 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 89.6 Cg_endo -74.45 66.71 5.49 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.468 2.779 . . . . 4.57 111.762 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.738 HD12 ' HB3' ' A' ' 10' ' ' LEU . 80.9 mt -94.2 57.66 2.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.649 0.737 . . . . 3.76 111.875 -172.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 13.9 tt0 -56.57 -22.32 32.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.179 0.514 . . . . 5.48 109.896 168.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . . . -57.91 -29.35 65.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.649 -0.705 . . . . 3.8 109.659 172.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.57 ' O ' HG22 ' A' ' 24' ' ' VAL . 37.7 t -72.19 -44.61 62.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.758 . . . . 3.27 108.955 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.448 ' NH2' ' HG3' ' A' ' 18' ' ' GLU . 12.2 ttp180 -51.84 -42.33 62.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.878 -0.601 . . . . 6.55 110.232 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 42.8 mttt -71.47 -39.42 70.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.613 -0.721 . . . . 5.22 110.435 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.57 99.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.601 -0.727 . . . . 4.34 111.268 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 20' ' ' CYS . 88.6 t -59.15 -46.21 92.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.166 -0.47 . . . . 4.58 110.432 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -54.47 -48.2 72.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.256 -0.429 . . . . 7.65 110.921 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.96 -39.62 87.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.194 -0.457 . . . . 7.32 111.611 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 p -68.32 -15.08 63.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.081 0.467 . . . . 5.71 110.979 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.71 29.27 43.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.352 -0.699 . . . . 6.04 111.352 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 1' ' ' ASP . 51.3 t30 60.67 73.91 0.47 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.349 0.595 . . . . 5.27 110.626 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.522 ' HB3' HG23 ' A' ' 34' ' ' VAL . 19.2 mmt -102.31 18.8 20.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.771 -0.65 . . . . 6.57 110.863 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.24 -178.65 50.71 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.574 -0.739 . . . . 4.23 113.059 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.571 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.4 -37.38 77.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.785 0.291 . . . . 3.88 111.785 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -54.62 -56.55 17.88 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.618 0.723 . . . . 5.59 110.395 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 30' ' ' MET . 92.9 t -65.42 -40.38 88.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.05 -0.977 . . . . 5.29 111.803 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.44 -35.1 58.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.313 0.486 . . . . 3.68 112.313 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.537 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.5 t80 -58.75 -41.91 87.61 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.879 -0.785 . . . . 5.05 108.879 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.529 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.2 m-80 -69.28 -38.43 78.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.671 -0.695 . . . . 6.25 110.862 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.5 -37.23 86.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.803 -0.443 . . . . 6.43 109.803 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.6 HG23 HD11 ' A' ' 10' ' ' LEU . 4.7 tp -72.57 -39.01 60.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.058 -0.519 . . . . 3.69 111.176 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -70.15 -21.67 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.371 0.605 . . . . 5.32 110.786 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 37' ' ' ASN . 70.6 t -74.45 -44.85 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.892 -0.595 . . . . 5.79 110.644 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -99.42 12.22 36.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.95 0.405 . . . . 5.81 111.223 -173.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.452 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 27.1 ptt? -72.31 -20.9 61.42 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.318 -0.401 . . . . 6.2 111.785 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.63 2.56 3.12 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.854 0.359 . . . . 6.34 111.33 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.612 ' HB3' ' CD1' ' A' ' 48' ' ' PHE . 16.3 mm-40 -93.06 97.73 1.96 Allowed Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 108.548 -0.908 . . . . 5.62 108.548 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.41 -44.53 32.31 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.071 2.514 . . . . 6.66 113.219 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -115.05 13.03 16.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.816 0.817 . . . . 6.09 110.992 -169.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.612 ' CD1' ' HB3' ' A' ' 45' ' ' GLU . 22.7 m-85 -85.4 -11.54 54.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.987 -0.552 . . . . 6.7 111.113 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.49 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . . . -81.87 -92.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.123 -0.489 . . . . 4.6 110.1 176.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.813 ' HB2' ' HB2' ' A' ' 16' ' ' PRO . 47.4 mt-10 -138.0 157.62 72.73 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.3 -1.0 . . . . 5.96 108.3 174.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.48 116.7 2.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.367 2.045 . . . . 6.2 110.851 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 52' ' ' LEU . 4.0 mm? -44.97 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.168 0.803 . . . . 8.57 113.168 -168.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -144.03 61.69 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.263 -0.881 . . . . 7.68 108.92 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.448 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 24.5 ptt? -73.76 129.33 85.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 7.67 110.727 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 2.7 Cg_endo -81.93 -8.29 12.15 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.953 2.435 . . . . 6.06 112.251 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.01 -161.92 51.72 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.785 -0.643 . . . . 7.03 111.591 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -114.53 18.66 16.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.796 0.808 . . . . 9.21 109.381 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.39 91.58 0.8 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.342 -0.845 . . . . 7.29 111.069 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.69 142.43 15.96 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.71 -0.757 . . . . 7.34 112.507 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 65.39 -178.48 0.18 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.231 0.612 . . . . 8.32 111.997 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.11 148.29 18.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.611 -0.722 . . . . 6.99 109.951 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p -76.16 111.58 11.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.13 0.49 . . . . 7.25 110.987 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.61 160.77 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.701 -0.681 . . . . 6.54 110.078 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.64 103.77 0.27 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.536 -0.84 . . . . 7.09 112.703 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.99 -163.71 1.08 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.248 -0.279 . . . . 7.55 110.248 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.0 m -63.51 111.62 2.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.042 0.449 . . . . 7.6 110.941 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.437 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 15.5 m -102.7 48.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.143 -0.481 . . . . 8.44 110.972 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 92.6 t80 74.19 143.99 0.07 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.111 -0.949 . . . . 8.67 110.978 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.79 163.71 33.29 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.948 -0.644 . . . . 7.01 111.604 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.42 113.42 20.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.652 0.263 . . . . 6.47 110.669 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -83.02 45.31 1.0 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.289 -0.414 . . . . 7.96 111.481 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.34 79.39 0.18 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.755 -0.736 . . . . 6.58 112.204 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -90.47 11.88 20.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.98 0.419 . . . . 7.68 110.734 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -86.98 120.13 27.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.639 . . . . 6.55 110.876 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -133.92 36.65 3.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.488 -0.778 . . . . 8.05 109.098 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -118.72 136.21 24.07 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 115.539 -0.755 . . . . 7.7 110.523 -176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.627 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 73.0 Cg_exo -54.15 167.34 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.497 2.798 . . . . 5.41 112.592 172.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.633 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.5 Cg_endo -63.33 112.11 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.35 2.033 . . . . 7.74 111.185 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.757 ' HA ' HG23 ' A' ' 82' ' ' VAL . 9.6 pt-20 -57.0 -26.69 60.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 10.13 110.855 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 6.2 tt0 -58.99 -51.25 70.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.945 -0.571 . . . . 11.78 110.46 173.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.878 HD11 ' HB2' ' A' ' 106' ' ' LEU . 70.1 mt -76.19 -41.43 37.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.921 -0.582 . . . . 8.98 111.642 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.757 HG23 ' HA ' ' A' ' 79' ' ' GLU . 11.3 m -55.55 -37.88 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.519 -0.919 . . . . 7.8 108.519 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -62.27 -48.54 79.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.637 -1.165 . . . . 11.19 110.871 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.3 mt -59.53 -42.16 87.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 11.59 110.624 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.601 HD13 ' HB3' ' A' ' 95' ' ' ALA . 87.1 mt -65.0 -44.9 95.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 8.01 111.434 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.581 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -73.48 -21.18 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.189 -0.604 . . . . 10.38 110.786 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.9 m -72.72 -26.55 61.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.063 0.458 . . . . 12.35 110.124 171.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.1 mmt -68.57 -26.9 65.62 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.963 -0.562 . . . . 10.6 110.462 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 -6.05 5.08 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.407 -0.815 . . . . 10.36 111.63 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.595 ' HD2' HG21 ' A' ' 85' ' ' ILE . 29.8 m-85 -87.7 -172.29 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.068 -0.345 . . . . 8.89 110.068 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 33.9 tt0 -103.63 146.92 27.86 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.931 -0.396 . . . . 10.6 109.931 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.586 ' HG3' HG21 ' A' ' 82' ' ' VAL . 16.0 ttm180 -57.0 -53.13 61.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.111 0.482 . . . . 12.6 110.19 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -59.07 -39.41 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 9.25 111.046 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 4.0 tt0 -63.91 -37.02 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.392 0.615 . . . . 7.2 109.758 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.601 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -64.99 -38.43 90.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.179 -0.919 . . . . 5.69 110.711 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.627 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -59.93 -52.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.053 -0.522 . . . . 6.87 110.636 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.476 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 60.5 tt0 -54.93 -46.03 74.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.769 -0.65 . . . . 8.99 110.855 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.89 -53.61 55.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.235 -0.893 . . . . 5.41 110.78 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.738 HD21 ' HB1' ' A' ' 109' ' ' ALA . 74.8 mt -61.38 -31.59 71.5 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.689 -0.232 . . . . 5.86 111.327 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.5 mtt180 -55.7 -50.29 70.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.393 0.616 . . . . 8.38 110.004 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.26 74.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.729 -1.123 . . . . 8.88 111.551 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 28.4 p -83.17 -5.7 59.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.694 0.627 . . . . 8.79 112.694 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 t30 64.78 65.72 0.61 Allowed 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.645 -0.707 . . . . 10.09 109.813 -175.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.544 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.4 p30 48.92 22.81 0.61 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.221 1.008 . . . . 7.86 112.428 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -81.68 109.45 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.726 -0.472 . . . . 11.16 109.726 173.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.878 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.0 tt -56.59 -59.84 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.176 0.922 . . . . 10.38 111.282 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.45 -48.3 71.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.9 -1.045 . . . . 11.82 111.268 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.1 ttm180 -69.5 -28.8 66.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 12.99 110.799 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.738 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.56 -51.24 68.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.219 -0.66 . . . . 6.65 109.219 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.4 mt -58.1 -40.12 80.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.845 -1.07 . . . . 8.11 109.605 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.33 -50.75 70.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.388 -0.824 . . . . 9.04 110.443 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -62.91 -44.44 96.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.491 -1.231 . . . . 9.43 110.375 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.557 HD12 HG23 ' A' ' 85' ' ' ILE . 51.5 mt -65.71 -45.16 92.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.009 -0.996 . . . . 5.25 111.251 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -59.02 -26.1 64.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 7.33 110.976 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.0 m -73.55 3.15 6.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.538 -0.756 . . . . 8.38 111.101 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 117' ' ' PRO . 96.1 m-70 -128.0 74.62 78.9 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.819 -0.808 . . . . 10.19 108.819 166.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.445 ' HD2' ' OE1' ' A' ' 120' ' ' GLU . 3.7 Cg_endo -38.65 -72.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 125.176 3.917 . . . . 8.57 113.526 -170.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -159.78 -42.31 0.05 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.311 -0.859 . . . . 11.42 110.103 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -136.13 14.2 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.565 -0.454 . . . . 16.4 111.771 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.445 ' OE1' ' HD2' ' A' ' 117' ' ' PRO . 6.0 mm-40 60.73 100.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.38 -0.827 . . . . 11.84 111.645 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.94 155.07 20.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.181 0.515 . . . . 12.26 111.825 -173.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -147.87 125.29 11.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.671 -0.863 . . . . 15.51 108.671 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.6 t -83.15 -59.54 2.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.096 -0.502 . . . . 16.06 110.68 -174.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.6 t70 54.36 76.24 0.25 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.471 0.653 . . . . 17.4 110.403 -177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -104.79 125.83 51.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.769 -0.651 . . . . 19.63 110.844 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 50.5 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.587 -0.72 . . . . 20.33 109.914 177.558 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.638 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 7.3 m-20 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.293 0.568 . . . . 7.16 109.643 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mt -137.67 82.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 108.141 -1.059 . . . . 6.09 108.141 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.7 88.11 0.35 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.377 0.608 . . . . 4.6 110.891 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.472 ' HA ' HG12 ' A' ' 7' ' ' VAL . 51.8 mt-10 -71.11 -8.18 51.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.282 -0.872 . . . . 5.13 110.59 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.631 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 18.8 m -57.7 -37.63 73.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.303 -0.628 . . . . 4.51 109.303 169.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 7.4 m -59.66 -51.85 68.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.794 -0.639 . . . . 3.46 110.937 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 21' ' ' ARG . 4.4 p -67.45 -38.87 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 120.636 -0.426 . . . . 3.39 110.74 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 78.6 mtp -62.93 -27.01 69.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 5.53 111.324 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 5' ' ' SER . 29.3 mt-30 -62.65 -53.4 55.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.811 -0.44 . . . . 5.92 109.811 171.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.909 HD11 HG23 ' A' ' 39' ' ' ILE . 11.7 mt -58.51 -45.27 89.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.725 0.774 . . . . 3.9 109.653 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.8 -29.32 70.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.343 -1.299 . . . . 4.46 111.64 -175.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.14 -51.71 6.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.699 -0.682 . . . . 6.27 111.872 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.5 ptp -101.28 25.0 8.73 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 111.993 0.368 . . . . 5.61 111.993 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.94 -92.44 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.947 -1.12 . . . . 4.85 113.022 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 62.4 m-85 -136.95 151.09 71.54 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.892 -0.41 . . . . 5.55 109.892 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.56 74.44 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.802 2.335 . . . . 4.57 111.451 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 10' ' ' LEU . 89.6 mt -89.45 62.6 6.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.772 -0.649 . . . . 3.76 112.175 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.543 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 7.6 tt0 -55.75 -24.54 35.86 Favored 'General case' 0 N--CA 1.458 -0.042 0 CA-C-O 120.939 0.399 . . . . 5.48 110.565 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.514 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -57.44 -31.17 65.65 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.124 -0.489 . . . . 3.8 110.255 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 10' ' ' LEU . 37.6 t -73.5 -42.98 61.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.425 -0.807 . . . . 3.27 109.658 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.598 ' HB2' HG13 ' A' ' 7' ' ' VAL . 24.5 ttt180 -52.02 -50.23 61.81 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.606 0.717 . . . . 6.55 110.082 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.543 ' HE2' ' O ' ' A' ' 18' ' ' GLU . 25.8 mtmt -72.09 -23.5 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.085 -0.962 . . . . 5.22 110.623 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.06 64.88 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.823 -0.626 . . . . 4.34 111.221 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 20' ' ' CYS . 97.7 t -58.97 -47.15 90.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.89 0.376 . . . . 4.58 110.11 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -58.64 -36.16 73.67 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.889 -0.596 . . . . 7.65 110.762 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.01 -45.78 39.52 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.506 -0.315 . . . . 7.32 111.674 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.406 ' HG1' ' HA ' ' A' ' 24' ' ' VAL . 21.4 p -62.21 -24.68 67.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.964 0.411 . . . . 5.71 111.162 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.14 29.41 20.13 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.803 -0.635 . . . . 6.04 112.039 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.638 ' HB2' ' O ' ' A' ' 1' ' ' ASP . 66.7 t30 63.39 64.62 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.179 0.514 . . . . 5.27 110.497 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 34' ' ' VAL . 87.2 mmm -91.77 -11.22 37.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.117 -0.492 . . . . 6.57 110.742 178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.23 162.05 11.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.791 -0.719 . . . . 4.23 112.387 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -55.77 -46.07 78.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.942 0.497 . . . . 3.88 111.54 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.22 -41.46 99.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 5.59 111.431 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 30' ' ' MET . 98.8 t -62.58 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.475 -0.329 . . . . 5.29 111.256 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -28.89 54.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.629 -0.429 . . . . 3.68 111.24 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.614 ' O ' HG22 ' A' ' 39' ' ' ILE . 54.0 t80 -58.15 -43.24 87.25 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.043 -0.725 . . . . 5.05 109.043 170.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.52 ' O ' HG13 ' A' ' 40' ' ' ILE . 13.6 m120 -67.72 -40.65 84.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 6.25 110.952 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -59.86 -38.34 81.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.386 0.612 . . . . 6.43 109.932 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.909 HG23 HD11 ' A' ' 10' ' ' LEU . 4.3 tp -74.57 -37.57 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.862 -0.608 . . . . 3.69 111.699 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.8 pp -70.34 -23.35 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.406 -0.517 . . . . 5.32 110.899 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.9 t -79.43 -34.84 16.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 5.79 110.725 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -98.96 5.29 47.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.15 0.426 . . . . 5.81 112.15 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -69.91 -20.66 63.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.587 0.232 . . . . 6.2 111.316 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -56.19 -18.12 9.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.845 -0.616 . . . . 6.34 111.908 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 65.3 mm-40 -84.34 109.11 17.19 Favored Pre-proline 0 N--CA 1.454 -0.249 0 CA-C-N 116.439 -0.346 . . . . 5.62 110.072 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 11.4 Cg_endo -56.36 -43.95 50.84 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 123.914 3.076 . . . . 6.66 113.196 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -97.66 -3.51 39.22 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.967 -1.015 . . . . 6.09 111.325 -167.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 45' ' ' GLU . 3.4 m-85 -80.27 -14.5 58.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.03 0.443 . . . . 6.7 110.385 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.43 80.67 2.25 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.645 -0.872 . . . . 4.6 108.645 167.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.19 133.48 80.87 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 114.431 -1.259 . . . . 5.96 111.67 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.55 76.53 1.44 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.231 2.621 . . . . 6.2 112.941 -174.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.1 tp -122.65 106.37 10.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 8.57 109.948 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 p 53.91 81.72 0.09 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.337 0.655 . . . . 7.68 112.132 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.503 ' HE3' ' CD1' ' A' ' 15' ' ' PHE . 15.5 tpt -77.27 108.82 7.62 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.558 -0.746 . . . . 7.67 110.973 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -98.62 -163.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.75 2.967 . . . . 6.06 113.076 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.15 -44.62 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.768 -0.651 . . . . 7.03 112.153 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 13' ' ' MET . 62.9 t80 54.94 81.8 0.1 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.358 0.599 . . . . 9.21 111.077 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.09 104.37 1.07 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.582 -0.818 . . . . 7.29 111.904 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -131.43 46.57 1.06 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.953 -0.641 . . . . 7.34 112.184 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 71.46 135.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.676 0.75 . . . . 8.32 112.27 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.94 -37.95 10.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.578 -0.737 . . . . 6.99 109.723 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.1 137.19 32.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.574 -0.739 . . . . 7.25 110.118 175.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.32 10.15 41.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.946 0.403 . . . . 6.54 111.585 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.18 132.66 2.59 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.58 -0.819 . . . . 7.09 112.668 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.35 125.82 37.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.593 0.235 . . . . 7.55 110.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.1 m -148.7 141.55 24.67 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.792 -0.447 . . . . 7.6 109.792 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.5 136.36 56.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.911 0.386 . . . . 8.44 110.636 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -119.51 162.75 18.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.102 -0.499 . . . . 8.67 110.11 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.0 82.28 0.39 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 7.01 112.557 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.85 134.97 37.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.425 0.155 . . . . 6.47 110.73 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.2 m -72.18 82.51 1.0 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.584 0.707 . . . . 7.96 110.333 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.39 -44.3 0.45 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.332 -1.107 . . . . 6.58 110.332 -174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.13 -49.14 11.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.315 -0.995 . . . . 7.68 108.315 171.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.24 120.64 32.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.837 -1.074 . . . . 6.55 109.367 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -124.35 28.79 6.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.854 0.835 . . . . 8.05 109.609 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -72.53 136.07 81.12 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.816 -1.084 . . . . 7.7 109.956 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.615 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 58.7 Cg_exo -55.87 161.54 8.18 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.878 2.386 . . . . 5.41 112.264 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.655 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.0 Cg_endo -62.66 112.62 1.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 7.74 111.246 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.785 ' HA ' HG23 ' A' ' 82' ' ' VAL . 1.6 pm0 -57.11 -25.73 59.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.731 -0.668 . . . . 10.13 111.528 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 7.0 tt0 -60.15 -50.94 71.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.014 0.435 . . . . 11.78 109.839 172.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.886 HD11 ' HB2' ' A' ' 106' ' ' LEU . 71.2 mt -75.38 -42.17 43.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 8.98 111.737 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.785 HG23 ' HA ' ' A' ' 79' ' ' GLU . 11.2 m -56.12 -38.18 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.426 -0.953 . . . . 7.8 108.426 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.574 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.04 -48.96 79.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.802 -1.09 . . . . 11.19 110.674 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.0 mt -59.39 -41.65 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 11.59 110.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.604 HG21 ' HD2' ' A' ' 90' ' ' PHE . 87.2 mt -66.0 -45.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.904 -0.589 . . . . 8.01 111.479 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.558 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.84 -21.16 61.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.333 -0.547 . . . . 10.38 110.75 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -74.39 -26.99 60.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 12.35 110.166 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 95.1 mmm -66.74 -26.48 67.01 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.398 0.618 . . . . 10.6 110.233 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.51 -10.77 4.65 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.415 -0.811 . . . . 10.36 111.714 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.604 ' HD2' HG21 ' A' ' 85' ' ' ILE . 33.4 m-85 -83.02 -175.0 5.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.717 0.294 . . . . 8.89 110.323 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.564 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 51.1 tt0 -100.72 147.61 25.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.791 -0.448 . . . . 10.6 109.791 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.549 ' HG3' HG21 ' A' ' 82' ' ' VAL . 7.9 ttm180 -55.72 -54.3 46.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.857 0.361 . . . . 12.6 110.503 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.423 ' HB3' ' NE2' ' A' ' 91' ' ' GLN . 55.7 t30 -58.46 -37.07 74.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.862 -0.608 . . . . 9.25 111.207 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.564 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.2 tt0 -65.49 -38.55 90.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 7.2 109.653 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -64.26 -37.88 89.07 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.25 -0.886 . . . . 5.69 110.625 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.615 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -60.9 -52.88 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.316 -0.402 . . . . 6.87 111.174 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.529 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 8.0 tt0 -56.09 -44.21 78.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.202 0.525 . . . . 8.99 110.713 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.31 -54.03 51.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.369 -0.832 . . . . 5.41 110.595 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.786 HD21 ' HB1' ' A' ' 109' ' ' ALA . 78.1 mt -61.18 -33.88 74.15 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.707 -0.224 . . . . 5.86 111.486 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.529 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 92.1 mtt180 -54.9 -46.83 74.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.484 0.659 . . . . 8.38 110.112 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.34 -38.05 68.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.87 -1.059 . . . . 8.88 111.467 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.698 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 23.7 p -85.6 1.5 48.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.81 0.67 . . . . 8.79 112.81 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m120 61.98 46.77 6.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.472 . . . . 10.09 111.123 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 9.4 m120 66.73 24.07 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.363 -0.835 . . . . 7.86 111.144 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 14.8 t-20 -86.46 113.9 22.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.892 -0.781 . . . . 11.16 108.892 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.886 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.1 tt -57.6 -59.05 5.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.904 -1.044 . . . . 10.38 111.268 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.61 -46.1 81.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.419 -1.264 . . . . 11.82 111.732 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.698 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.9 ttm180 -68.83 -28.83 67.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.445 -0.343 . . . . 12.99 110.625 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.786 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.64 -50.58 68.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.226 -0.657 . . . . 6.65 109.226 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.29 -38.31 83.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.43 -0.804 . . . . 8.11 109.739 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 7.7 t70 -54.73 -51.61 65.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.033 -0.985 . . . . 9.04 110.107 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -63.87 -46.61 84.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.116 -1.402 . . . . 9.43 110.679 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.525 HD13 ' HA ' ' A' ' 95' ' ' ALA . 46.5 mt -64.57 -37.72 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.236 -0.893 . . . . 5.25 111.228 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.86 -26.42 67.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.313 0.577 . . . . 7.33 110.432 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.5 m -76.9 -2.51 33.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.319 -0.855 . . . . 8.38 109.963 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -135.72 67.11 64.69 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.573 -0.899 . . . . 10.19 108.573 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -38.44 -68.5 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 1 C-N-CA 125.303 4.002 . . . . 8.57 113.858 -169.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.795 ' HG3' ' HD1' ' A' ' 119' ' ' PHE . 7.2 pt-20 -167.85 -39.79 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.779 -1.1 . . . . 11.42 109.119 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.795 ' HD1' ' HG3' ' A' ' 118' ' ' GLU . 29.4 p90 -127.39 17.4 7.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.614 -0.721 . . . . 16.4 110.838 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 119' ' ' PHE . 10.7 mm-40 71.19 157.13 0.17 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.748 0.655 . . . . 11.84 111.761 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 44.0 -168.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.487 1.115 . . . . 12.26 113.245 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -142.37 131.93 23.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.917 -0.583 . . . . 15.51 109.504 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.3 m -121.38 -74.68 0.61 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.37 -0.377 . . . . 16.06 110.625 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -135.42 111.45 9.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 17.4 111.042 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -134.69 95.86 3.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 19.63 109.867 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.402 -0.809 . . . . 20.33 110.001 179.737 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 121.075 0.464 . . . . 7.16 110.616 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.556 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 78.3 mt -69.14 121.75 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.449 -0.796 . . . . 6.09 111.15 -175.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.68 82.25 1.56 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.299 0.571 . . . . 4.6 109.927 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.484 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.4 mt-10 -71.65 -3.11 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.647 -0.706 . . . . 5.13 111.107 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -56.71 -40.85 76.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 4.51 110.265 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.895 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 12.1 p -65.67 -52.47 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.736 -0.666 . . . . 3.46 111.751 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 21' ' ' ARG . 7.3 p -64.02 -38.73 83.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.913 -0.315 . . . . 3.39 111.274 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.454 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 64.7 mtt -62.5 -34.89 77.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.729 -0.214 . . . . 5.53 110.719 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 13' ' ' MET . 40.0 mt-30 -60.78 -40.25 91.91 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.79 -0.364 . . . . 5.92 110.76 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.717 ' HB3' HD13 ' A' ' 17' ' ' LEU . 11.2 mt -67.78 -49.0 64.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.878 0.847 . . . . 3.9 109.884 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.26 -50.55 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.99 -1.459 . . . . 4.46 113.111 -170.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 8' ' ' MET . 56.1 mm-40 -66.35 -24.1 66.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.164 0.431 . . . . 6.27 112.164 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 25.8 ptm -99.97 -3.85 31.36 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.652 -0.419 . . . . 5.61 111.79 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.6 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.674 -1.251 . . . . 4.85 113.588 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 33.0 m-85 -115.35 142.04 28.11 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 122.96 -0.141 . . . . 5.55 110.65 -172.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 76.73 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.983 2.455 . . . . 4.57 111.601 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.717 HD13 ' HB3' ' A' ' 10' ' ' LEU . 97.7 mt -79.8 66.76 5.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.49 -0.777 . . . . 3.76 111.846 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 21' ' ' ARG . 3.9 tt0 -56.68 -18.37 12.05 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.92 0.39 . . . . 5.48 110.892 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.65 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . . . -57.51 -35.79 70.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.511 . . . . 3.8 109.83 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.614 ' O ' HG22 ' A' ' 24' ' ' VAL . 14.1 t -73.27 -41.98 63.02 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.335 -0.848 . . . . 3.27 109.287 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HB2' HG21 ' A' ' 7' ' ' VAL . 25.2 ttt180 -52.01 -53.29 43.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.366 -0.834 . . . . 6.55 110.7 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.719 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -71.55 -23.85 61.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 5.22 110.612 178.079 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB1' ' CD1' ' A' ' 38' ' ' TRP . . . -69.69 -42.3 74.3 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.981 -0.554 . . . . 4.34 110.771 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 20' ' ' CYS . 86.1 t -55.43 -45.63 78.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.279 -0.418 . . . . 4.58 110.025 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -59.44 -49.91 75.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.02 -0.536 . . . . 7.65 110.499 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.76 -39.37 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.223 -0.444 . . . . 7.32 112.08 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.6 p -70.13 -15.1 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.101 0.477 . . . . 5.71 111.318 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.08 28.27 34.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.831 -0.7 . . . . 6.04 111.485 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 61.8 m-80 60.68 65.56 1.02 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.256 0.55 . . . . 5.27 110.816 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 91.4 mmm -95.94 34.59 1.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.797 -0.638 . . . . 6.57 111.225 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.14 -179.53 45.23 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.072 -0.585 . . . . 4.23 113.58 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.895 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.17 -39.23 78.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.288 . . . . 3.88 111.579 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -58.41 -52.72 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 5.59 111.663 -175.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.3 t -67.32 -38.1 80.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.256 -0.429 . . . . 5.29 111.798 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -32.24 55.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.465 -0.494 . . . . 3.68 111.739 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.594 ' O ' HG22 ' A' ' 39' ' ' ILE . 75.7 t80 -61.64 -39.7 92.25 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.459 -0.941 . . . . 5.05 108.459 170.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.726 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.8 t30 -64.59 -39.08 93.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.421 -0.809 . . . . 6.25 110.792 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.412 ' CD1' ' HB1' ' A' ' 23' ' ' ALA . 24.2 t-105 -67.86 -30.81 70.28 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.565 -0.454 . . . . 6.43 110.363 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 36' ' ' PHE . 4.3 tp -77.45 -32.61 18.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 120.805 -0.358 . . . . 3.69 111.47 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.3 pp -68.36 -26.55 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.111 -0.636 . . . . 5.32 109.776 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 37' ' ' ASN . 96.2 t -70.43 -36.88 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.579 -0.737 . . . . 5.79 110.231 170.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.437 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 39.7 m-70 -102.22 20.77 16.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.192 -0.458 . . . . 5.81 111.909 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -59.22 -22.31 60.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 6.2 110.871 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.37 14.95 1.76 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.592 -0.731 . . . . 6.34 111.911 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.719 ' HB3' ' HB2' ' A' ' 48' ' ' PHE . 4.5 mm-40 -107.65 93.81 10.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.526 -0.176 . . . . 5.62 110.526 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -59.18 -52.0 5.67 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.874 2.383 . . . . 6.66 112.258 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -86.72 -14.45 42.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.08 -1.418 . . . . 6.09 112.039 -168.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.719 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 23.7 m-85 -75.02 -9.49 58.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.164 0.507 . . . . 6.7 110.651 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' HB1' HD22 ' A' ' 17' ' ' LEU . . . -101.37 101.13 11.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.036 -1.098 . . . . 4.6 108.036 171.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -39.64 105.71 0.37 Allowed Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.495 1.122 . . . . 5.96 112.638 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.04 68.49 8.26 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.505 2.803 . . . . 6.2 112.322 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 tp -134.5 105.12 6.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.561 -0.745 . . . . 8.57 109.772 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.0 m 66.58 84.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 7.68 110.455 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 93.9 mmm -70.47 113.44 18.26 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.534 . . . . 7.67 109.878 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 74.5 Cg_endo -96.33 -168.3 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.227 2.618 . . . . 6.06 113.199 -173.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.75 166.62 39.78 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.97 -0.852 . . . . 7.03 110.97 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -82.42 133.0 35.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.065 0.433 . . . . 9.21 109.846 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.53 16.84 8.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.835 -0.698 . . . . 7.29 111.508 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.5 86.98 0.92 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.575 -0.61 . . . . 7.34 111.575 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.63 79.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.684 0.278 . . . . 8.32 111.375 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.95 -31.3 1.02 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.368 -0.378 . . . . 6.99 111.511 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.5 t -100.64 112.62 25.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.884 0.373 . . . . 7.25 110.88 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.45 -36.08 11.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.36 -0.607 . . . . 6.54 109.36 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.99 34.7 0.53 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.314 -0.857 . . . . 7.09 111.625 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.4 26.96 2.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.046 0.45 . . . . 7.55 111.268 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 p -89.43 -12.75 39.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.199 0.524 . . . . 7.6 110.407 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -89.33 86.51 2.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.883 -0.599 . . . . 8.44 110.778 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -137.85 115.23 11.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.237 0.541 . . . . 8.67 110.121 173.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.71 116.26 5.31 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.747 -0.661 . . . . 7.01 112.71 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.32 139.88 58.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.14 0.495 . . . . 6.47 110.4 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 m -66.52 -21.36 66.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.451 -0.795 . . . . 7.96 111.444 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.06 95.03 0.14 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.09 -0.576 . . . . 6.58 111.861 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.42 86.4 5.25 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.848 -0.797 . . . . 7.68 108.848 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.8 t70 58.7 80.51 0.18 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.577 0.704 . . . . 6.55 110.154 -173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -130.75 72.97 1.51 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.342 -0.845 . . . . 8.05 108.811 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -83.97 135.71 42.11 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.828 -0.624 . . . . 7.7 109.399 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.612 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.5 Cg_exo -53.96 162.54 3.83 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 123.096 2.53 . . . . 5.41 112.412 175.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.638 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_endo -63.74 112.12 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.444 2.096 . . . . 7.74 111.089 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.766 ' HA ' HG23 ' A' ' 82' ' ' VAL . 11.7 pt-20 -56.42 -25.39 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.516 0.51 . . . . 10.13 110.556 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 2.3 tp10 -57.93 -55.0 40.58 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.486 -0.779 . . . . 11.78 110.163 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.877 HD11 ' HB2' ' A' ' 106' ' ' LEU . 82.6 mt -75.41 -40.64 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.774 -0.648 . . . . 8.98 112.094 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.766 HG23 ' HA ' ' A' ' 79' ' ' GLU . 9.0 m -56.32 -37.81 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 108.357 -0.979 . . . . 7.8 108.357 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.569 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -60.79 -48.83 80.03 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.885 -1.052 . . . . 11.19 110.599 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.8 mt -60.22 -43.54 93.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 11.59 110.827 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.591 HD13 ' HB3' ' A' ' 95' ' ' ALA . 86.4 mt -64.05 -45.52 96.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.034 -0.53 . . . . 8.01 111.708 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -72.13 -21.46 61.47 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.876 -0.729 . . . . 10.38 110.786 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.3 m -75.55 -22.04 57.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.041 0.448 . . . . 12.35 110.315 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.452 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.3 mmm -70.86 -26.63 63.34 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.275 0.56 . . . . 10.6 109.89 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.54 6.39 4.69 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.405 -0.816 . . . . 10.36 112.08 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.534 ' HD2' HG21 ' A' ' 85' ' ' ILE . 34.5 m-85 -99.24 -175.95 3.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.147 -0.316 . . . . 8.89 110.147 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.861 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 91.9 mt-30 -86.84 153.89 21.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.283 -0.266 . . . . 10.6 110.283 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.495 ' HG3' HG21 ' A' ' 82' ' ' VAL . 14.2 ttm180 -65.45 -51.41 60.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.141 -0.688 . . . . 12.6 109.141 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.41 -39.65 88.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 9.25 110.886 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.861 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 8.3 tt0 -64.41 -36.64 84.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.139 0.495 . . . . 7.2 109.689 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.591 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -65.17 -40.23 94.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.458 -0.792 . . . . 5.69 110.466 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.46 -52.1 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.285 -0.416 . . . . 6.87 110.529 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.538 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 49.8 tt0 -58.24 -44.6 88.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.825 -0.625 . . . . 8.99 110.973 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.1 61.84 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.54 -0.755 . . . . 5.41 110.441 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.757 HD21 ' HB1' ' A' ' 109' ' ' ALA . 74.1 mt -60.64 -33.1 72.29 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 111.631 0.234 . . . . 5.86 111.631 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.538 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 73.2 mtt180 -55.29 -48.45 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.563 0.697 . . . . 8.38 110.21 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.76 -40.64 72.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.859 -1.064 . . . . 8.88 111.298 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 24.7 p -82.81 -0.04 46.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.547 0.573 . . . . 8.79 112.547 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.8 m120 58.82 63.22 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 10.09 110.161 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.1 p-10 49.14 32.85 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.498 1.119 . . . . 7.86 112.722 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -93.78 113.87 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.033 -0.728 . . . . 11.16 109.033 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.877 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.2 tt -56.97 -60.6 3.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.99 -1.005 . . . . 10.38 111.594 -175.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -57.41 -45.84 84.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.365 -0.834 . . . . 11.82 111.667 -178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.718 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 34.5 ttm180 -67.46 -28.8 68.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.416 -0.356 . . . . 12.99 110.754 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.757 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.32 -51.33 66.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.449 -0.574 . . . . 6.65 109.449 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -59.01 -39.4 81.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.384 -0.825 . . . . 8.11 109.428 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.34 -46.21 83.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.029 -0.987 . . . . 9.04 110.461 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -67.8 -46.58 71.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.846 -1.07 . . . . 9.43 110.396 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 109' ' ' ALA . 46.5 mt -60.78 -39.68 82.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 5.25 110.354 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -70.18 -22.79 62.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.847 -0.615 . . . . 7.33 110.805 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.5 t -78.14 -5.94 53.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.112 -0.495 . . . . 8.38 110.045 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -140.95 71.96 28.47 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 10.19 110.812 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.499 ' HG2' ' HA ' ' A' ' 120' ' ' GLU . 8.3 Cg_endo -50.88 -62.84 0.34 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 123.674 2.916 . . . . 8.57 111.573 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.552 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 7.9 pt-20 -155.47 -54.51 0.09 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.601 -1.181 . . . . 11.42 109.327 173.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.552 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 36.4 t80 -133.87 13.37 4.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.379 -0.828 . . . . 16.4 109.097 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' HA ' ' HG2' ' A' ' 117' ' ' PRO . 38.1 mt-10 65.2 176.75 0.2 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 114.841 -1.072 . . . . 11.84 111.321 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -120.53 133.22 55.42 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.513 -0.551 . . . . 12.26 109.513 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -145.46 -53.18 0.27 Allowed 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.231 -0.588 . . . . 15.51 111.278 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 p 42.89 55.87 4.22 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.463 0.649 . . . . 16.06 110.62 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -85.03 136.98 33.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.363 -0.835 . . . . 17.4 111.232 -174.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 t80 70.32 78.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.242 0.964 . . . . 19.63 110.765 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.252 1.185 0 CA-C-N 115.566 -0.743 . . . . 20.33 109.399 176.658 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.808 -0.812 . . . . 7.16 108.808 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 25' ' ' TYR . 4.2 mp 45.41 74.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.731 -0.47 . . . . 6.09 109.731 -169.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -63.58 97.6 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.224 0.535 . . . . 4.6 110.529 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.573 ' HA ' HG12 ' A' ' 7' ' ' VAL . 9.9 mt-10 -71.04 -5.41 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 5.13 111.9 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.3 t -55.94 -34.28 65.51 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.999 -0.741 . . . . 4.51 108.999 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.4 m -65.24 -52.76 52.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.671 -0.695 . . . . 3.46 111.049 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -69.03 -41.34 81.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.755 0.312 . . . . 3.39 111.308 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.633 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 57.7 mtt -59.54 -35.05 73.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.355 -0.384 . . . . 5.53 110.787 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -62.89 -42.52 99.8 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.029 0.206 . . . . 5.92 111.122 174.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.726 ' HB3' HD13 ' A' ' 17' ' ' LEU . 14.4 mt -63.26 -44.64 94.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.502 0.668 . . . . 3.9 109.685 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.1 -32.74 74.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.893 -1.049 . . . . 4.46 111.094 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 8' ' ' MET . 60.9 mm-40 -59.93 -31.18 69.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 6.27 110.281 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mtp -92.91 8.56 39.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.847 -0.615 . . . . 5.61 111.737 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.7 -102.74 0.23 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.798 -1.192 . . . . 4.85 114.228 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 93.5 m-85 -83.19 145.67 49.5 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 112.017 0.376 . . . . 5.55 112.017 -169.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.25 86.09 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.02 2.48 . . . . 4.57 110.98 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.752 HD12 HG12 ' A' ' 39' ' ' ILE . 92.2 mt -80.9 70.95 7.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.801 -0.636 . . . . 3.76 112.483 -170.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -24.37 38.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.256 0.551 . . . . 5.48 110.781 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -58.7 -30.97 67.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 3.8 110.022 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.59 ' SG ' HD13 ' A' ' 10' ' ' LEU . 36.9 t -73.18 -43.51 61.29 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.402 -0.817 . . . . 3.27 109.643 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -49.73 -57.0 8.14 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.681 -0.69 . . . . 6.55 109.836 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 14.8 ptpt -66.24 -32.82 74.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.69 -0.686 . . . . 5.22 110.673 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.02 95.15 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.382 -0.372 . . . . 4.34 111.145 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 20' ' ' CYS . 79.1 t -57.01 -43.57 81.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.398 . . . . 4.58 110.172 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' HB2' HG12 ' A' ' 2' ' ' ILE . 54.4 t80 -67.93 -42.68 80.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.776 -0.77 . . . . 7.65 110.684 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.23 -40.31 97.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 7.32 111.744 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.7 p -65.8 -23.16 66.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.163 0.506 . . . . 5.71 110.79 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.52 26.83 8.39 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.768 -0.651 . . . . 6.04 111.566 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.5 t30 61.88 62.24 1.28 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.345 0.593 . . . . 5.27 109.68 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 97.2 mmm -101.57 21.65 13.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.867 -0.606 . . . . 6.57 112.103 -172.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.41 177.15 48.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.306 -0.95 . . . . 4.23 113.108 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.65 -44.26 70.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.758 0.281 . . . . 3.88 111.758 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.11 -43.5 91.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 5.59 111.847 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.8 t -68.87 -39.75 80.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.406 -0.361 . . . . 5.29 111.177 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.3 55.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.841 -0.343 . . . . 3.68 111.563 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.602 ' O ' HG22 ' A' ' 39' ' ' ILE . 78.3 t80 -58.08 -43.58 87.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.729 -0.841 . . . . 5.05 108.729 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.591 ' O ' HG13 ' A' ' 40' ' ' ILE . 47.4 t30 -64.06 -43.14 96.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.376 -0.829 . . . . 6.25 110.368 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -63.81 -33.93 76.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 6.43 110.719 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.752 HG12 HD12 ' A' ' 17' ' ' LEU . 6.4 tp -76.09 -38.74 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 3.69 111.218 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -70.05 -21.91 24.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.187 0.518 . . . . 5.32 110.504 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 37' ' ' ASN . 92.8 t -76.32 -48.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.819 -0.628 . . . . 5.79 110.241 170.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -83.3 2.64 35.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.098 -0.501 . . . . 5.81 111.349 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.435 ' HE1' ' HB2' ' A' ' 43' ' ' MET . 4.6 ppp? -68.95 -21.8 64.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.931 0.345 . . . . 6.2 111.931 -176.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.6 -11.4 58.05 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.042 0.386 . . . . 6.34 112.042 -175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.758 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 31.3 mm-40 -67.8 142.42 95.68 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.973 0.416 . . . . 5.62 110.31 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.82 -41.98 27.35 Favored 'Trans proline' 0 N--CA 1.47 0.133 0 C-N-CA 123.303 2.669 . . . . 6.66 112.675 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -116.15 27.24 9.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.719 0.771 . . . . 6.09 110.564 -171.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.758 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.8 p90 -56.77 -28.54 61.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.695 -0.684 . . . . 6.7 111.86 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.22 113.56 4.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.784 -0.45 . . . . 4.6 109.784 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 43.5 mt-10 -57.01 118.29 22.99 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 5.96 110.279 175.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 7.9 Cg_exo -72.38 73.31 2.77 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.106 2.537 . . . . 6.2 113.015 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 23.6 tp -81.23 82.07 7.22 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.15 -0.685 . . . . 8.57 109.15 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.438 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 88.1 m 70.39 99.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.572 -0.74 . . . . 7.68 110.371 -172.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.25 109.68 25.18 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.813 -0.63 . . . . 7.67 110.738 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 53' ' ' THR . 3.5 Cg_exo -82.23 138.82 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.158 2.572 . . . . 6.06 112.16 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.6 90.25 1.61 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.971 -0.633 . . . . 7.03 111.822 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -79.46 66.96 5.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.499 0.666 . . . . 9.21 110.054 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.5 -60.84 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.41 -0.814 . . . . 7.29 111.415 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.6 -172.16 31.73 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.762 -0.733 . . . . 7.34 112.582 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.37 -65.73 0.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.537 -0.172 . . . . 8.32 110.537 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.92 54.65 8.74 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 123.699 0.624 . . . . 6.99 111.375 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 p -92.96 146.74 23.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.055 -0.521 . . . . 7.25 110.573 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.85 141.46 20.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 6.54 110.561 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.69 124.94 1.71 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.605 -0.598 . . . . 7.09 111.605 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 62.89 43.36 6.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.406 0.622 . . . . 7.55 110.488 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 t -89.33 159.39 17.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.414 -0.812 . . . . 7.6 110.178 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 t 60.5 68.24 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 121.651 0.739 . . . . 8.44 110.431 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -73.07 141.51 47.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.566 -0.743 . . . . 8.67 110.423 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.41 91.47 0.85 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.757 -0.735 . . . . 7.01 112.651 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.25 87.1 7.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.028 0.442 . . . . 6.47 110.107 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -83.93 -39.4 19.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.937 -0.574 . . . . 7.96 110.544 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.35 85.32 0.38 Allowed Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.543 -0.837 . . . . 6.58 112.325 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.476 ' N ' HD21 ' A' ' 73' ' ' LEU . 4.5 mm? -63.83 -61.34 2.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.726 -0.472 . . . . 7.68 109.726 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.2 t70 176.14 147.97 0.1 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.596 -0.729 . . . . 6.55 109.869 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -91.15 74.41 6.26 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.204 -1.406 . . . . 8.05 107.204 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.87 129.86 94.59 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 115.103 -0.953 . . . . 7.7 111.452 -168.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.694 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.7 Cg_exo -58.58 166.38 6.45 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.891 3.06 . . . . 5.41 112.879 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.638 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 44.6 Cg_endo -66.66 111.88 2.26 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.686 2.257 . . . . 7.74 111.143 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.692 ' HA ' HG23 ' A' ' 82' ' ' VAL . 10.6 pt-20 -52.25 -30.11 26.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 10.13 111.237 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -58.66 -51.35 70.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.854 -0.612 . . . . 11.78 110.339 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.884 HD11 ' HB2' ' A' ' 106' ' ' LEU . 69.4 mt -75.13 -40.83 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.686 -0.688 . . . . 8.98 111.452 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' ' 79' ' ' GLU . 5.2 m -56.18 -38.29 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.626 -0.879 . . . . 7.8 108.626 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.542 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.07 -49.4 77.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.822 -1.081 . . . . 11.19 110.775 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.56 -40.11 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 11.59 110.729 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 95' ' ' ALA . 85.3 mt -67.33 -46.74 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.874 -0.603 . . . . 8.01 111.64 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.544 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.99 -21.13 63.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.175 -0.61 . . . . 10.38 110.638 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -75.35 -25.47 57.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 12.35 110.619 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 21.9 mmt -69.15 -26.51 64.91 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.168 -0.469 . . . . 10.6 110.242 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.88 -2.83 4.87 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.714 -0.676 . . . . 10.36 111.817 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.585 ' HD2' HG21 ' A' ' 85' ' ' ILE . 35.2 m-85 -93.08 -173.98 3.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 8.89 110.468 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 4.7 tt0 -99.31 147.88 24.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.278 -0.419 . . . . 10.6 110.371 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.5 ttm180 -57.11 -54.65 44.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 12.6 110.731 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.97 -36.19 78.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.266 0.555 . . . . 9.25 110.915 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.557 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.7 tt0 -64.45 -38.81 92.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.725 . . . . 7.2 109.569 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.587 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -64.15 -40.34 95.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.278 -0.874 . . . . 5.69 110.703 173.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.694 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -59.64 -52.48 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.994 -0.548 . . . . 6.87 110.857 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.544 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.5 tt0 -52.97 -47.32 68.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.483 0.659 . . . . 8.99 110.709 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.65 -54.05 50.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.013 -0.994 . . . . 5.41 110.74 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.783 HD21 ' HB1' ' A' ' 109' ' ' ALA . 68.1 mt -62.15 -30.99 71.43 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 111.54 0.2 . . . . 5.86 111.54 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 86.7 mtt180 -55.31 -46.97 76.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.365 0.602 . . . . 8.38 109.508 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.87 57.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.936 -1.029 . . . . 8.88 112.035 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.816 HG22 ' HA ' ' A' ' 109' ' ' ALA . 29.2 p -83.19 -2.71 56.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.077 0.399 . . . . 8.79 112.077 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.96 41.44 2.08 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.06 0.85 . . . . 10.09 110.364 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 0.7 OUTLIER 72.23 18.7 4.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.456 -0.793 . . . . 7.86 110.962 178.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -82.6 115.68 21.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.524 -0.547 . . . . 11.16 109.524 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.884 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.3 tt -58.16 -60.53 3.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.081 -0.963 . . . . 10.38 111.722 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.408 ' N ' HD22 ' A' ' 106' ' ' LEU . 51.1 mm-40 -53.68 -51.95 61.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.318 -0.856 . . . . 11.82 111.71 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.655 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.0 ttm180 -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.196 -0.456 . . . . 12.99 110.868 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.816 ' HA ' HG22 ' A' ' 102' ' ' THR . . . -63.55 -50.61 68.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.302 -0.629 . . . . 6.65 109.302 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.21 -38.28 79.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.07 -0.968 . . . . 8.11 109.434 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.95 -51.82 67.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.037 -0.983 . . . . 9.04 110.3 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.27 -47.51 84.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.278 -1.328 . . . . 9.43 110.663 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 109' ' ' ALA . 47.9 mt -61.06 -41.9 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.12 -0.945 . . . . 5.25 110.804 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -67.52 -30.3 69.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 7.33 110.546 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.1 m -85.44 0.68 51.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.684 -0.689 . . . . 8.38 110.656 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -142.39 72.41 21.34 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.927 -0.579 . . . . 10.19 110.932 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.698 ' HD2' ' HG3' ' A' ' 120' ' ' GLU . 6.2 Cg_endo -48.43 -40.4 36.45 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.736 2.957 . . . . 8.57 111.87 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.508 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 8.6 pt-20 -178.26 -53.58 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.748 -1.114 . . . . 11.42 108.873 175.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.508 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 36.3 t80 -146.97 12.58 1.1 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.372 -0.831 . . . . 16.4 109.6 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.698 ' HG3' ' HD2' ' A' ' 117' ' ' PRO . 3.4 mp0 56.92 -161.16 0.21 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.427 -1.26 . . . . 11.84 111.137 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 2.0 pm0 -81.33 156.35 25.55 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.375 -0.53 . . . . 12.26 110.08 174.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.51 106.93 18.61 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.819 -0.628 . . . . 15.51 110.43 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.7 p -65.87 158.78 27.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.225 -0.898 . . . . 16.06 111.682 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.88 120.03 11.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.968 -0.56 . . . . 17.4 110.635 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -89.3 -12.83 39.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.041 0.448 . . . . 19.63 109.872 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.417 -0.802 . . . . 20.33 110.016 177.79 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.225 -0.287 . . . . 7.16 110.225 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.43 HG23 ' HG3' ' A' ' 4' ' ' GLU . 54.7 mt -59.46 113.93 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 123.358 0.411 . . . . 6.09 111.343 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -83.33 82.64 8.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.238 0.542 . . . . 4.6 110.239 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HG3' HG23 ' A' ' 2' ' ' ILE . 36.1 mt-10 -71.64 -2.76 18.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 5.13 111.281 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.625 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 26.6 t -60.89 -35.91 77.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.717 -0.845 . . . . 4.51 108.717 168.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.425 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 6.7 m -58.48 -49.9 75.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.943 -0.571 . . . . 3.46 111.141 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 17' ' ' LEU . 2.7 p -64.26 -41.06 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.806 0.336 . . . . 3.39 110.832 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 81.1 mtp -63.71 -29.84 71.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.148 -0.478 . . . . 5.53 111.378 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.625 ' HG2' ' O ' ' A' ' 5' ' ' SER . 81.4 mm-40 -64.38 -44.44 91.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.996 -0.281 . . . . 5.92 110.504 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 20' ' ' CYS . 18.8 mt -68.09 -40.36 82.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.402 0.62 . . . . 3.9 109.756 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.64 -50.81 71.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.716 -1.129 . . . . 4.46 111.901 -175.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.99 -19.26 63.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.234 -0.439 . . . . 6.27 112.064 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptm -99.32 -4.6 31.38 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.57 -0.452 . . . . 5.61 111.321 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -98.4 0.12 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.189 -1.005 . . . . 4.85 113.206 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.631 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 99.0 m-85 -118.81 157.9 48.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.485 0.183 . . . . 5.55 111.047 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.65 82.46 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.594 2.196 . . . . 4.57 112.138 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' O ' HG22 ' A' ' 7' ' ' VAL . 4.4 mm? -73.86 69.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 3.76 111.618 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 5.6 tt0 -56.73 -24.14 47.56 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.277 -0.89 . . . . 5.48 109.981 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -29.68 66.33 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.062 -0.517 . . . . 3.8 109.856 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.662 ' HA ' HD11 ' A' ' 39' ' ' ILE . 49.9 t -69.37 -44.81 70.78 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.303 -0.629 . . . . 3.27 109.303 174.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.61 -49.76 67.12 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.013 -0.54 . . . . 6.55 109.911 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 26.5 mttm -62.16 -40.63 96.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.66 -0.7 . . . . 5.22 110.147 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.2 -43.19 92.38 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.364 -0.835 . . . . 4.34 111.714 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 20' ' ' CYS . 76.3 t -56.17 -47.18 81.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.743 0.306 . . . . 4.58 110.313 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.76 -36.7 83.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 7.65 110.492 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.1 -45.7 69.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 7.32 111.221 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -62.29 -27.14 68.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.194 0.521 . . . . 5.71 111.04 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.75 28.04 6.11 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.674 -0.694 . . . . 6.04 111.558 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 59.27 51.24 7.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.123 0.487 . . . . 5.27 109.923 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.439 ' HB3' HG21 ' A' ' 34' ' ' VAL . 80.9 mtp -81.39 -35.25 31.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 6.57 112.106 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.61 169.71 16.87 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.022 -1.085 . . . . 4.23 113.279 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.575 0.35 . . . . 3.88 111.706 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -67.66 -40.16 84.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 5.59 110.12 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 30' ' ' MET . 85.2 t -64.31 -41.49 92.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 5.29 110.782 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -32.89 58.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.441 -0.345 . . . . 3.68 111.109 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -55.24 -44.41 75.46 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.156 -0.683 . . . . 5.05 109.156 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.682 ' O ' HG13 ' A' ' 40' ' ' ILE . 8.2 t30 -67.92 -35.78 79.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.519 -0.764 . . . . 6.25 110.609 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -65.46 -32.85 74.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.094 0.473 . . . . 6.43 109.872 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 20' ' ' CYS . 1.4 mp -77.06 -37.76 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.864 -0.607 . . . . 3.69 112.099 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.4 pp -63.57 -30.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.637 0.732 . . . . 5.32 109.91 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 37' ' ' ASN . 60.2 t -69.57 -51.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.142 -0.935 . . . . 5.79 110.484 170.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -85.28 13.43 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.669 0.618 . . . . 5.81 112.669 -174.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.1 ptt? -68.3 -22.1 64.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 6.2 111.07 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -84.47 8.44 16.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 6.34 111.334 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.755 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 13.6 mm-40 -76.73 138.25 66.41 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.131 -0.486 . . . . 5.62 110.096 174.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.98 -34.99 99.36 Favored 'Trans proline' 0 CA--C 1.522 -0.124 0 C-N-CA 122.926 2.417 . . . . 6.66 112.129 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -115.81 24.49 11.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.766 -1.106 . . . . 6.09 110.389 -171.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.755 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 3.3 p90 -60.02 -38.17 81.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.201 0.524 . . . . 6.7 111.349 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.23 97.71 4.35 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.657 -0.498 . . . . 4.6 109.657 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.519 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 47.8 mt-10 -60.01 126.03 82.48 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.572 -0.74 . . . . 5.96 110.634 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 8.2 Cg_exo -72.59 64.64 3.81 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.489 2.793 . . . . 6.2 113.251 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.85 109.24 11.42 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.801 -0.814 . . . . 8.57 108.801 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.7 p 58.07 71.13 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.06 0.85 . . . . 7.68 111.082 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 65.0 mtm -87.29 119.37 70.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.27 -0.877 . . . . 7.67 110.451 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.459 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 22.5 Cg_exo -67.83 -55.07 0.29 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.205 2.604 . . . . 6.06 112.31 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.74 61.93 5.75 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 111.23 -0.748 . . . . 7.03 111.23 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -77.97 123.05 26.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.218 0.532 . . . . 9.21 111.797 -171.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.43 147.05 13.43 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.702 -0.959 . . . . 7.29 110.702 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.65 20.04 6.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.55 -0.834 . . . . 7.34 112.347 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 59.17 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.334 0.654 . . . . 8.32 111.716 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.15 121.97 7.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.437 -0.347 . . . . 6.99 110.297 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.3 m -85.4 66.05 9.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.311 0.577 . . . . 7.25 109.691 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.62 97.28 6.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.658 -0.701 . . . . 6.54 111.334 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.31 121.91 6.26 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.879 -0.677 . . . . 7.09 111.594 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.38 151.49 30.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.767 0.317 . . . . 7.55 110.644 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.5 m -95.2 119.82 34.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.09 -0.504 . . . . 7.6 109.868 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.89 -10.27 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.058 -0.519 . . . . 8.44 112.18 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -117.29 140.06 50.04 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.186 -0.302 . . . . 8.67 110.186 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.65 -123.76 1.6 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.017 -0.611 . . . . 7.01 112.257 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.27 130.31 43.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.783 0.325 . . . . 6.47 110.856 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.9 p -83.4 33.07 0.45 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 7.96 111.737 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.77 -74.36 0.29 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.08 -0.581 . . . . 6.58 111.876 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 59.05 44.43 16.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.114 0.483 . . . . 7.68 110.807 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -147.47 111.12 4.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.784 -0.644 . . . . 6.55 109.726 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -160.58 65.78 0.32 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.66 0.743 . . . . 8.05 110.335 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -125.15 140.18 35.43 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.735 -0.666 . . . . 7.7 110.147 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.605 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.3 Cg_exo -56.25 164.9 4.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.177 2.585 . . . . 5.41 112.115 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.617 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 39.8 Cg_endo -63.15 114.0 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.487 2.125 . . . . 7.74 111.186 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.776 ' HA ' HG23 ' A' ' 82' ' ' VAL . 15.1 pt-20 -58.2 -28.18 64.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 10.13 110.529 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.34 -51.34 69.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.073 -0.512 . . . . 11.78 109.92 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.87 HD11 ' HB2' ' A' ' 106' ' ' LEU . 73.7 mt -76.59 -41.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 115.844 -0.616 . . . . 8.98 111.76 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.776 HG23 ' HA ' ' A' ' 79' ' ' GLU . 10.9 m -55.49 -38.27 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.549 -0.908 . . . . 7.8 108.549 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.38 -49.07 78.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.782 -1.099 . . . . 11.19 110.715 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.1 mt -59.54 -42.29 87.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 11.59 110.423 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.61 HD13 ' HB3' ' A' ' 95' ' ' ALA . 86.1 mt -64.83 -47.26 89.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.665 -0.698 . . . . 8.01 111.368 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.572 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -69.67 -21.2 63.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.98 -0.688 . . . . 10.38 110.874 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.1 m -76.52 -21.9 55.13 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.933 0.396 . . . . 12.35 110.645 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 94.2 mmm -71.33 -24.56 62.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.391 0.615 . . . . 10.6 110.167 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.93 0.48 5.59 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.108 -0.951 . . . . 10.36 111.529 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.585 ' HD2' HG21 ' A' ' 85' ' ' ILE . 34.3 m-85 -94.02 -173.67 3.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.827 0.346 . . . . 8.89 110.428 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.702 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.4 tt0 -100.08 146.47 26.74 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.85 -0.426 . . . . 10.6 109.85 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.574 ' HG3' HG21 ' A' ' 82' ' ' VAL . 5.7 ttm180 -58.13 -53.62 56.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.119 0.485 . . . . 12.6 110.196 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -58.93 -37.45 76.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 9.25 111.145 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.702 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.8 tt0 -64.08 -40.43 96.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.65 -0.705 . . . . 7.2 109.586 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.61 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -62.76 -38.51 90.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.02 -0.991 . . . . 5.69 110.735 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mp -60.88 -52.72 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 116.267 -0.424 . . . . 6.87 110.849 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.2 tt0 -55.36 -44.58 76.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 8.99 110.811 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.433 ' O ' HG22 ' A' ' 102' ' ' THR . . . -60.08 -53.47 57.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.249 -0.887 . . . . 5.41 110.835 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.712 HD21 ' HB1' ' A' ' 109' ' ' ALA . 69.7 mt -62.59 -29.83 70.89 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.62 -0.264 . . . . 5.86 111.547 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -57.23 -50.83 71.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.424 0.63 . . . . 8.38 110.311 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.98 84.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.921 -1.036 . . . . 8.88 111.319 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 29.4 p -82.02 -7.35 59.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.684 0.624 . . . . 8.79 112.684 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.26 67.86 0.76 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.671 0.748 . . . . 10.09 110.289 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.517 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 8.5 p30 52.26 21.1 1.54 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.844 -1.526 . . . . 7.86 112.889 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -82.33 110.35 17.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.495 -0.557 . . . . 11.16 109.495 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.87 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.2 tt -57.05 -60.74 3.14 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.973 -1.012 . . . . 10.38 111.732 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -56.78 -45.66 82.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.325 -0.852 . . . . 11.82 111.428 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.662 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 29.1 ttm180 -67.21 -28.45 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.397 -0.365 . . . . 12.99 111.003 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.712 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.84 -50.65 68.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.252 -0.647 . . . . 6.65 109.252 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.9 mt -59.82 -37.34 78.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.218 -0.901 . . . . 8.11 109.637 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 10.8 t70 -54.18 -53.52 52.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.187 0.994 . . . . 9.04 110.004 172.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -61.36 -45.75 93.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.893 -1.503 . . . . 9.43 110.594 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.571 HD12 HG23 ' A' ' 85' ' ' ILE . 41.7 mt -66.98 -39.18 82.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.075 -0.966 . . . . 5.25 111.105 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.509 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 40.2 t80 -67.37 -20.7 65.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 7.33 110.624 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.7 t -67.15 -14.31 62.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.364 0.602 . . . . 8.38 109.814 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -125.49 67.35 57.27 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.167 -0.679 . . . . 10.19 109.167 171.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 114' ' ' PHE . 1.2 Cg_endo -39.17 -66.17 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 125.272 3.981 . . . . 8.57 114.445 -170.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 117' ' ' PRO . 3.5 pt-20 -167.39 -42.55 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.89 -1.05 . . . . 11.42 108.989 -173.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -146.53 30.37 1.01 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.742 -1.117 . . . . 16.4 108.422 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 64.27 -162.75 0.27 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.839 -1.073 . . . . 11.84 109.528 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.91 116.8 26.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.322 0.582 . . . . 12.26 110.581 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -135.23 109.74 8.5 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.52 -0.763 . . . . 15.51 109.574 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -58.25 117.76 4.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.607 -0.724 . . . . 16.06 111.072 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -92.92 97.36 10.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.284 0.564 . . . . 17.4 109.641 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -79.07 96.49 5.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.84 -0.618 . . . . 19.63 110.543 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.666 -0.683 . . . . 20.33 109.625 177.464 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.703 0.763 . . . . 7.16 109.777 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.492 HG22 ' CG1' ' A' ' 24' ' ' VAL . 42.9 mt -129.48 112.4 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-N 115.025 -0.989 . . . . 6.09 109.898 -175.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.76 84.33 0.65 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.379 0.609 . . . . 4.6 110.16 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' HA ' HG12 ' A' ' 7' ' ' VAL . 41.3 mt-10 -70.33 -5.5 28.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.424 -0.807 . . . . 5.13 110.063 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 4.3 m -57.86 -37.11 73.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.483 -0.78 . . . . 4.51 109.288 169.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.458 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.1 m -64.22 -52.48 58.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.817 -0.629 . . . . 3.46 111.236 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.599 HG13 ' HG2' ' A' ' 21' ' ' ARG . 4.8 p -64.61 -39.33 85.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.399 -0.364 . . . . 3.39 111.168 -177.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 23.7 mmt -66.46 -31.57 72.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.447 -0.342 . . . . 5.53 111.336 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 5' ' ' SER . 15.2 mm-40 -62.84 -39.3 93.95 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.253 -0.277 . . . . 5.92 110.253 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.685 HD11 HG23 ' A' ' 39' ' ' ILE . 16.4 mt -70.86 -43.96 67.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.754 0.787 . . . . 3.9 109.833 173.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.61 -42.98 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.363 -1.29 . . . . 4.46 112.066 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.19 -9.85 54.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 6.27 112.198 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -72.14 -23.38 61.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 5.61 110.321 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.62 48.16 0.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.841 -0.695 . . . . 4.85 113.023 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 60.0 t80 179.29 134.88 0.25 Allowed Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.49 . . . . 5.55 109.678 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 89.2 Cg_endo -75.44 88.98 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.017 2.478 . . . . 4.57 112.241 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.72 57.66 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.317 -0.553 . . . . 3.76 110.829 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -56.34 -23.33 36.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.969 0.414 . . . . 5.48 111.009 174.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.678 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -59.81 -31.96 70.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.067 0.46 . . . . 3.8 110.281 172.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 23' ' ' ALA . 37.9 t -73.81 -39.06 64.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.274 -0.875 . . . . 3.27 109.869 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.599 ' HG2' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -50.16 -52.13 37.87 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.73 0.776 . . . . 6.55 109.074 173.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 32.4 mttt -63.89 -44.72 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.551 -1.204 . . . . 5.22 110.218 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.509 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . . . -56.57 -46.49 80.74 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.786 -0.643 . . . . 4.34 111.914 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 20' ' ' CYS . 98.5 t -59.37 -44.15 91.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 4.58 109.935 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.41 -43.48 98.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.964 -0.562 . . . . 7.65 110.973 175.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -69.41 -39.05 78.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.204 0.446 . . . . 7.32 112.204 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.4 p -67.3 -15.24 63.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.97 0.414 . . . . 5.71 111.268 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.7 23.12 47.73 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.652 -0.979 . . . . 6.04 110.652 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.98 72.56 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.633 -0.783 . . . . 5.27 110.496 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.466 ' HB3' HG22 ' A' ' 34' ' ' VAL . 92.0 mmm -94.03 9.65 36.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.301 -0.863 . . . . 6.57 111.407 -177.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 172.26 36.75 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.474 -0.87 . . . . 4.23 112.874 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -57.87 -50.3 73.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.058 0.543 . . . . 3.88 112.355 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -53.97 -43.49 69.97 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.218 0.451 . . . . 5.59 112.218 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 30' ' ' MET . 92.1 t -72.96 -40.63 59.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 5.29 111.076 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.48 -30.79 60.01 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.417 -0.513 . . . . 3.68 111.661 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.56 ' O ' HG22 ' A' ' 39' ' ' ILE . 76.3 t80 -59.84 -42.64 94.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.621 -0.881 . . . . 5.05 108.621 171.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.543 ' O ' HG13 ' A' ' 40' ' ' ILE . 27.2 t-20 -67.56 -39.67 84.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.583 -0.735 . . . . 6.25 110.244 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -63.36 -31.96 73.26 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.016 0.436 . . . . 6.43 110.184 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 10' ' ' LEU . 2.4 tp -76.79 -39.79 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.218 -0.446 . . . . 3.69 110.896 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.53 -16.19 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.387 0.613 . . . . 5.32 110.966 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 37' ' ' ASN . 75.1 t -79.17 -38.61 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.513 -0.767 . . . . 5.79 110.148 168.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -87.79 4.73 43.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.047 0.388 . . . . 5.81 112.047 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -23.24 65.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.57 0.224 . . . . 6.2 111.414 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -95.22 13.98 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.057 0.456 . . . . 6.34 111.299 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.566 ' CB ' ' HB3' ' A' ' 48' ' ' PHE . 10.6 mm-40 -92.57 131.03 35.12 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.899 -0.592 . . . . 5.62 110.321 175.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.69 -40.51 9.85 Favored 'Trans proline' 0 CA--C 1.527 0.125 0 C-N-CA 122.979 2.453 . . . . 6.66 113.16 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -116.91 25.4 10.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.69 0.757 . . . . 6.09 111.386 -169.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.566 ' HB3' ' CB ' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -70.28 -36.82 74.64 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.659 -0.65 . . . . 6.7 111.6 -176.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.94 114.12 5.86 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.804 0.335 . . . . 4.6 110.321 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' C ' ' H ' ' A' ' 52' ' ' LEU . 48.0 mt-10 -60.65 125.91 83.79 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.637 -0.71 . . . . 5.96 110.06 174.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -73.01 38.52 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.103 2.535 . . . . 6.2 112.06 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 50' ' ' GLU . 37.1 tp -77.28 106.64 9.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.464 -0.789 . . . . 8.57 110.034 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 m 62.64 63.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.583 0.706 . . . . 7.68 110.149 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.476 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 ppp? -84.42 124.0 74.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.679 -0.691 . . . . 7.67 109.854 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.16 -174.31 2.07 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.583 2.189 . . . . 6.06 112.712 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.41 122.9 1.79 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.942 -0.647 . . . . 7.03 111.92 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -115.09 123.4 48.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.884 0.373 . . . . 9.21 110.737 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.92 166.24 32.4 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.06 -0.591 . . . . 7.29 111.664 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.9 3.56 81.03 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.791 -0.718 . . . . 7.34 111.454 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.61 160.55 29.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.758 0.313 . . . . 8.32 110.308 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.06 159.19 15.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.992 -0.549 . . . . 6.99 110.705 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.6 p -103.57 94.15 5.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 7.25 110.635 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.53 134.84 36.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 6.54 110.54 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.25 -100.11 0.88 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.801 -0.714 . . . . 7.09 112.215 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 57.74 77.48 0.28 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.145 0.498 . . . . 7.55 110.937 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.8 m -75.76 -43.42 46.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.825 -0.625 . . . . 7.6 111.124 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.77 151.78 12.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.911 -0.586 . . . . 8.44 111.748 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -120.19 148.23 43.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.956 -0.757 . . . . 8.67 108.956 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.87 77.36 0.34 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.169 -1.015 . . . . 7.01 113.148 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.14 -76.93 0.22 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.578 -0.527 . . . . 6.47 109.578 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m 60.08 -84.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.76 0.652 . . . . 7.96 112.76 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.97 88.94 0.97 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.009 -0.615 . . . . 6.58 112.281 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.19 99.97 9.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.788 0.328 . . . . 7.68 110.436 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.35 141.85 35.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.169 -0.469 . . . . 6.55 110.035 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -146.6 134.97 21.88 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.159 -0.682 . . . . 8.05 109.159 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -101.53 134.5 20.2 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 108.918 -0.771 . . . . 7.7 108.918 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.596 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 82.2 Cg_exo -51.47 162.27 1.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.953 2.435 . . . . 5.41 111.682 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.67 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 31.7 Cg_endo -60.94 110.37 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.512 2.141 . . . . 7.74 111.232 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.728 ' HA ' HG23 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -56.47 -26.86 55.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 10.13 111.389 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 5.2 tt0 -59.38 -51.56 69.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.263 -0.426 . . . . 11.78 110.069 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.918 HD11 ' HB2' ' A' ' 106' ' ' LEU . 73.5 mt -74.64 -42.2 48.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.101 -0.5 . . . . 8.98 111.981 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.728 HG23 ' HA ' ' A' ' 79' ' ' GLU . 8.4 m -56.02 -38.14 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.422 -0.955 . . . . 7.8 108.422 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.573 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.43 -48.74 79.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.753 -1.112 . . . . 11.19 110.758 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.42 -41.79 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.299 -0.41 . . . . 11.59 110.512 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.628 HG21 ' HD2' ' A' ' 90' ' ' PHE . 85.3 mt -65.29 -47.5 86.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.973 -0.558 . . . . 8.01 111.793 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.53 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.3 t -69.61 -21.67 63.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.316 -0.553 . . . . 10.38 110.966 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.0 m -71.49 -31.88 67.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.795 0.331 . . . . 12.35 110.44 171.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 98.3 mmm -64.94 -22.86 67.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.868 -0.605 . . . . 10.6 110.449 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.85 4.18 6.18 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.426 -0.806 . . . . 10.36 112.068 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.628 ' HD2' HG21 ' A' ' 85' ' ' ILE . 33.7 m-85 -96.32 -174.55 3.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.343 -0.243 . . . . 8.89 110.343 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -96.02 148.31 22.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.567 -0.531 . . . . 10.6 109.567 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.489 ' O ' HD12 ' A' ' 96' ' ' ILE . 12.5 ttm180 -58.8 -52.45 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.194 0.521 . . . . 12.6 110.069 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -61.6 -35.84 78.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 9.25 111.213 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -65.9 -38.44 88.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.524 -0.762 . . . . 7.2 109.554 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.606 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.181 -0.918 . . . . 5.69 110.501 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.596 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.95 -52.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 CA-C-N 116.342 -0.39 . . . . 6.87 110.914 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.7 tt0 -57.95 -43.68 86.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.151 -0.477 . . . . 8.99 110.989 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.528 ' O ' HG22 ' A' ' 102' ' ' THR . . . -60.45 -50.4 73.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.668 -0.697 . . . . 5.41 110.844 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.806 HD21 ' HB1' ' A' ' 109' ' ' ALA . 79.0 mt -63.08 -35.53 80.57 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.741 -0.208 . . . . 5.86 111.314 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.9 mtt180 -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.517 0.675 . . . . 8.38 110.277 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.93 72.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.736 -1.12 . . . . 8.88 111.6 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.689 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 63.0 p -86.69 2.66 47.79 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.116 0.784 . . . . 8.79 113.116 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 64.07 45.88 3.95 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.139 0.575 . . . . 10.09 111.395 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.575 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 77.2 m-20 68.08 21.12 8.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.405 -0.816 . . . . 7.86 111.509 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -82.89 104.5 13.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.604 -0.517 . . . . 11.16 109.604 175.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.918 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.5 tt -47.7 -61.17 2.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.065 -0.971 . . . . 10.38 111.886 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -56.64 -46.54 80.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.102 -0.953 . . . . 11.82 111.919 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.689 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.0 ttm180 -69.0 -28.97 67.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 12.99 110.537 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.806 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -61.4 -51.35 69.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.384 -0.599 . . . . 6.65 109.384 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.7 mt -59.26 -41.84 89.76 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.284 -0.871 . . . . 8.11 109.52 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.67 -49.52 70.42 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.599 0.714 . . . . 9.04 110.363 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -61.55 -48.56 80.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.442 -1.254 . . . . 9.43 110.253 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 109' ' ' ALA . 44.0 mt -63.46 -40.38 88.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.296 -0.866 . . . . 5.25 110.596 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -61.93 -34.58 76.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.118 0.567 . . . . 7.33 111.165 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 m -82.47 11.97 5.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.313 -0.858 . . . . 8.38 110.741 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.568 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 82.0 t60 -132.7 71.95 78.02 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.276 -0.874 . . . . 10.19 109.565 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -49.52 -63.31 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 124.046 3.164 . . . . 8.57 112.503 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -179.22 -53.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.736 -1.12 . . . . 11.42 110.016 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -113.93 6.63 16.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.531 . . . . 16.4 110.543 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.568 ' OE1' ' HA ' ' A' ' 116' ' ' HIS . 5.5 mm-40 56.92 -167.35 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.897 -1.047 . . . . 11.84 111.794 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.52 156.73 42.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 12.26 110.196 170.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 125' ' ' PHE . 7.5 p-10 -119.87 38.59 3.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.445 0.641 . . . . 15.51 110.611 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.8 p -73.43 -20.12 60.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.627 -0.715 . . . . 16.06 110.842 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -160.74 138.63 9.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.75 -0.659 . . . . 17.4 110.429 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 122' ' ' ASP . 88.6 m-85 -117.03 -4.55 11.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.155 -0.475 . . . . 19.63 110.593 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.441 -0.79 . . . . 20.33 110.735 -176.417 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.076 0.465 . . . . 7.16 110.26 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.519 HD11 ' HD1' ' A' ' 25' ' ' TYR . 1.9 mp -66.03 121.86 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 115.725 -0.671 . . . . 6.09 110.032 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.407 ' N ' HG11 ' A' ' 24' ' ' VAL . 21.9 m-20 -70.01 81.7 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 4.6 110.346 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.555 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.5 mt-10 -71.18 -11.82 61.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.059 -0.519 . . . . 5.13 111.0 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 9' ' ' GLN . 6.9 t -60.46 -28.4 68.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.018 -0.734 . . . . 4.51 109.018 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.654 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 1.9 m -69.34 -50.69 44.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.907 -0.588 . . . . 3.46 110.896 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 4' ' ' GLU . 2.1 p -63.36 -45.89 96.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.448 -0.501 . . . . 3.39 110.805 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.533 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 55.3 mtm -68.97 -26.64 65.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.056 -0.52 . . . . 5.53 111.848 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.654 ' HG2' ' O ' ' A' ' 6' ' ' SER . 4.4 pt20 -69.03 -34.66 75.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.454 -0.498 . . . . 5.92 109.82 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 6' ' ' SER . 20.4 mt -68.63 -43.42 76.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.613 0.721 . . . . 3.9 109.083 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.56 -37.43 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.629 -1.169 . . . . 4.46 111.503 -176.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 8' ' ' MET . 52.4 mt-10 -65.95 -23.72 66.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.386 0.513 . . . . 6.27 112.386 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 ptp -117.11 -3.86 11.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.296 0.48 . . . . 5.61 112.296 -173.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.25 -101.35 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.935 -1.126 . . . . 4.85 113.643 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.523 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 95.9 m-85 -124.67 165.47 24.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.056 -0.35 . . . . 5.55 110.056 -172.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 71.5 Cg_endo -72.09 82.92 1.24 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.473 2.115 . . . . 4.57 111.62 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 3.4 mm? -75.94 66.5 2.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 3.76 111.805 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -25.73 54.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.617 0.722 . . . . 5.48 109.481 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -31.26 68.08 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.235 -0.893 . . . . 3.8 110.39 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 18.2 t -73.26 -37.71 66.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.422 -0.808 . . . . 3.27 109.706 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.31 -52.58 35.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.852 0.834 . . . . 6.55 108.94 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -70.4 -34.15 72.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.785 -1.098 . . . . 5.22 111.385 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . . . -61.6 -44.31 97.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.385 . . . . 4.34 111.599 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' CG1' HG22 ' A' ' 2' ' ' ILE . 94.1 t -64.69 -40.8 90.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 4.58 110.384 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.519 ' HD1' HD11 ' A' ' 2' ' ' ILE . 91.3 t80 -62.32 -41.21 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 7.65 110.422 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -68.95 -43.82 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 7.32 111.296 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.442 ' HG1' ' HA ' ' A' ' 24' ' ' VAL . 24.8 p -67.09 -17.17 64.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 5.71 111.359 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.85 49.61 5.59 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.707 -0.679 . . . . 6.04 111.907 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.07 45.41 4.57 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.532 0.733 . . . . 5.27 111.885 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.483 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.2 mmt -65.18 -63.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.544 -0.753 . . . . 6.57 111.223 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.87 166.72 38.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.728 -0.749 . . . . 4.23 111.693 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.645 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -65.31 -46.12 81.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.245 0.545 . . . . 3.88 110.982 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -76.13 -27.67 57.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.585 -0.734 . . . . 5.59 110.253 -177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 30' ' ' MET . 99.1 t -58.27 -44.28 87.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.855 0.36 . . . . 5.29 110.481 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.64 -31.76 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 3.68 110.759 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -51.71 -46.2 63.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.304 -0.628 . . . . 5.05 109.304 170.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.52 -47.41 86.29 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.59 -0.732 . . . . 6.25 110.754 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.736 ' HE3' HD13 ' A' ' 39' ' ' ILE . 50.4 t90 -57.2 -36.88 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 6.43 110.237 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.736 HD13 ' HE3' ' A' ' 38' ' ' TRP . 1.2 mp -75.1 -46.64 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.642 -0.708 . . . . 3.69 112.082 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.41 -19.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.394 0.616 . . . . 5.32 111.003 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -80.03 -41.8 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.694 . . . . 5.79 110.807 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.458 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 88.2 m-70 -102.89 20.69 16.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.307 0.484 . . . . 5.81 112.307 -175.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -67.2 -21.28 65.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.412 0.625 . . . . 6.2 109.579 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.03 6.19 9.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.144 -0.934 . . . . 6.34 111.969 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.865 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 66.8 mm-40 -82.42 136.26 46.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.176 -0.676 . . . . 5.62 109.176 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.56 -41.96 13.76 Favored 'Trans proline' 0 N--CA 1.471 0.164 0 C-N-CA 123.112 2.541 . . . . 6.66 113.473 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -116.83 25.34 10.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.628 0.728 . . . . 6.09 110.602 -170.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.865 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 4.3 p90 -59.11 -35.74 73.96 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.644 -0.707 . . . . 6.7 112.063 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.2 117.12 4.12 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.193 -0.669 . . . . 4.6 109.193 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 35.6 mt-10 -62.36 114.12 10.87 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.907 -0.588 . . . . 5.96 110.099 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 19.1 Cg_endo -90.51 62.3 1.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.356 2.704 . . . . 6.2 113.369 -171.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.8 tp -124.07 36.42 4.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.767 0.794 . . . . 8.57 109.346 175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.1 t -169.3 50.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.016 -0.993 . . . . 7.68 109.924 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.6 ttp -76.97 118.61 73.05 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.519 -0.764 . . . . 7.67 110.65 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' HD3' ' HD3' ' A' ' 16' ' ' PRO . 94.3 Cg_endo -86.49 166.97 9.0 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.852 2.368 . . . . 6.06 112.181 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.27 115.82 4.29 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.499 -0.64 . . . . 7.03 111.499 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -68.58 141.37 55.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.041 0.448 . . . . 9.21 111.28 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.65 71.33 2.98 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.748 -0.66 . . . . 7.29 112.591 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.09 68.38 0.25 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.385 -0.686 . . . . 7.34 111.385 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.56 -60.91 1.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.787 0.327 . . . . 8.32 110.971 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.84 147.45 40.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.145 -0.48 . . . . 6.99 110.257 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.9 p -89.22 117.8 28.45 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.893 0.378 . . . . 7.25 111.071 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.44 70.17 0.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.012 -0.54 . . . . 6.54 110.064 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.09 -37.61 0.38 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.905 -0.664 . . . . 7.09 111.99 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.38 120.96 42.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.859 -0.423 . . . . 7.55 109.859 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 m -79.8 87.27 5.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.234 -0.439 . . . . 7.6 110.224 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.8 -59.66 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.94 -0.573 . . . . 8.44 109.639 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.6 t80 52.63 83.15 0.06 Allowed 'General case' 0 N--CA 1.463 0.218 0 O-C-N 124.039 0.837 . . . . 8.67 110.474 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.95 80.41 1.09 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.811 -0.709 . . . . 7.01 113.09 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.61 58.14 4.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.16 0.505 . . . . 6.47 110.398 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -70.02 -33.08 71.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.839 -0.619 . . . . 7.96 110.363 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.17 -65.64 0.52 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.074 -0.584 . . . . 6.58 111.856 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.442 ' HB3' ' H ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER 56.87 -95.05 0.05 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.048 0.539 . . . . 7.68 111.123 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.442 ' H ' ' HB3' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -143.88 159.17 43.02 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 120.786 0.327 . . . . 6.55 110.175 -179.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -140.54 34.04 1.84 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.746 0.784 . . . . 8.05 109.509 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -74.31 142.55 78.59 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.319 -0.855 . . . . 7.7 109.827 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.1 Cg_exo -53.88 164.53 2.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.95 2.433 . . . . 5.41 112.217 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.651 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 37.8 Cg_endo -63.54 111.16 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.651 2.234 . . . . 7.74 110.73 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.844 ' HA ' HG23 ' A' ' 82' ' ' VAL . 11.0 pt-20 -58.55 -26.15 63.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.814 -0.63 . . . . 10.13 110.781 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 4.4 tt0 -60.36 -50.2 74.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.183 0.516 . . . . 11.78 109.869 172.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.909 HD11 ' HB2' ' A' ' 106' ' ' LEU . 71.0 mt -74.72 -42.66 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.655 . . . . 8.98 111.769 -175.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.844 HG23 ' HA ' ' A' ' 79' ' ' GLU . 14.2 m -55.76 -37.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.475 -0.935 . . . . 7.8 108.475 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.592 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -62.24 -48.74 78.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.653 -1.158 . . . . 11.19 110.897 175.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.6 mt -59.38 -42.88 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 11.59 110.326 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.664 HG21 ' HD2' ' A' ' 90' ' ' PHE . 88.9 mt -63.74 -47.44 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.812 -0.631 . . . . 8.01 111.356 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -71.15 -21.39 62.19 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.298 -0.561 . . . . 10.38 110.763 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -75.9 -22.21 56.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.04 0.448 . . . . 12.35 110.371 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.621 ' HE2' ' HA ' ' A' ' 88' ' ' MET . 29.5 mmt -72.75 -25.41 61.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.201 0.524 . . . . 10.6 110.072 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 4.55 3.96 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.539 -0.755 . . . . 10.36 112.069 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.664 ' HD2' HG21 ' A' ' 85' ' ' ILE . 28.0 m-85 -98.16 -177.51 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.766 0.317 . . . . 8.89 110.342 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 8.6 tt0 -94.45 142.34 27.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.561 -0.533 . . . . 10.6 109.561 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.461 ' HG3' HG21 ' A' ' 82' ' ' VAL . 18.0 ttm180 -57.89 -51.86 67.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.851 0.358 . . . . 12.6 111.241 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.59 -35.08 73.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 9.25 110.485 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.6 tt0 -66.63 -39.27 88.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.418 -0.81 . . . . 7.2 109.562 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.611 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -63.12 -40.55 97.93 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.285 -0.87 . . . . 5.69 110.498 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.58 -52.43 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.163 -0.471 . . . . 6.87 110.438 176.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.463 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.7 tt0 -56.74 -45.94 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 8.99 111.103 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 102' ' ' THR . . . -59.91 -51.07 71.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.474 -0.785 . . . . 5.41 110.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.748 HD21 ' HB1' ' A' ' 109' ' ' ALA . 82.2 mt -61.54 -35.62 78.27 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.641 -0.254 . . . . 5.86 111.609 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 90.8 mtt180 -54.03 -46.59 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.525 0.678 . . . . 8.38 110.153 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.64 67.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.764 -1.107 . . . . 8.88 111.615 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.5 p -86.19 3.98 40.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.871 0.693 . . . . 8.79 112.871 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 64.72 46.8 2.96 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.997 -0.547 . . . . 10.09 110.514 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.596 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 82.4 m-20 67.15 16.58 10.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.388 -0.824 . . . . 7.86 111.437 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -78.53 110.28 13.48 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.412 -0.588 . . . . 11.16 109.412 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.909 ' HB2' HD11 ' A' ' 81' ' ' ILE . 7.7 tt -55.33 -59.09 5.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.237 -0.892 . . . . 10.38 111.316 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.403 ' N ' HD22 ' A' ' 106' ' ' LEU . 16.6 mm-40 -53.35 -49.99 65.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.631 -1.168 . . . . 11.82 111.671 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.693 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 32.1 ttm180 -69.7 -28.76 66.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.443 -0.344 . . . . 12.99 111.017 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.748 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.02 -51.32 68.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.032 -0.729 . . . . 6.65 109.032 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 114' ' ' PHE . 23.6 mt -59.16 -40.78 86.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.85 -1.068 . . . . 8.11 109.902 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.59 -50.43 71.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 9.04 110.178 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -60.68 -44.67 96.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.854 -1.066 . . . . 9.43 110.472 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 109' ' ' ALA . 52.7 mt -70.45 -39.91 76.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.991 -1.004 . . . . 5.25 111.065 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -64.95 -28.33 69.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 7.33 111.196 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.8 t -83.38 5.84 22.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.859 -0.61 . . . . 8.38 110.044 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.561 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 52.3 m-70 -136.4 78.61 44.35 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.388 -0.824 . . . . 10.19 110.502 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -47.88 -70.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.858 3.039 . . . . 8.57 112.118 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.6 -51.48 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.942 -1.026 . . . . 11.42 109.484 172.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -117.73 9.76 13.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 16.4 110.609 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.561 ' OE2' ' HA ' ' A' ' 116' ' ' HIS . 12.5 mm-40 61.42 -170.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.646 -0.706 . . . . 11.84 110.387 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -92.41 143.12 26.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.295 -0.632 . . . . 12.26 109.295 169.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -109.83 151.94 26.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.489 -0.323 . . . . 15.51 110.4 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 p -50.18 117.18 2.21 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.031 0.832 . . . . 16.06 112.235 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.7 148.54 22.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.913 -0.585 . . . . 17.4 110.21 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -103.69 124.34 48.68 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.658 -0.701 . . . . 19.63 110.009 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.247 0.934 0 CA-C-N 116.294 -0.412 . . . . 20.33 110.921 -178.833 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.885 0.374 . . . . 7.16 110.713 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.504 HG12 HD22 ' A' ' 29' ' ' ASN . 82.2 mt -78.93 109.97 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.154 0.502 . . . . 6.09 110.592 -177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.2 85.89 1.9 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.449 -0.796 . . . . 4.6 110.716 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.508 ' HA ' HG12 ' A' ' 7' ' ' VAL . 38.3 mt-10 -72.7 -4.73 33.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.125 -0.489 . . . . 5.13 112.158 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -67.83 -31.55 71.47 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.965 -0.754 . . . . 4.51 108.965 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.737 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 16.9 m -64.89 -46.4 81.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 3.46 110.899 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.1 p -68.94 -40.91 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.144 -0.622 . . . . 3.39 110.53 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 71.0 mtp -63.96 -30.91 71.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.441 . . . . 5.53 111.576 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.737 ' HG2' ' O ' ' A' ' 6' ' ' SER . 10.4 pt20 -68.46 -38.77 81.4 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.435 -0.506 . . . . 5.92 109.672 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.801 ' HB3' HD11 ' A' ' 17' ' ' LEU . 16.4 mt -66.78 -43.74 83.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.648 0.737 . . . . 3.9 109.556 173.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.6 -33.93 74.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.347 -1.297 . . . . 4.46 112.202 -173.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.3 -36.16 27.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.98 -0.554 . . . . 6.27 111.183 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 18.2 ptp -90.55 0.71 57.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 5.61 112.292 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.67 -92.32 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.747 -1.216 . . . . 4.85 113.763 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.669 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 96.7 m-85 -136.52 162.4 56.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.439 -0.208 . . . . 5.55 110.439 -172.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 64.3 Cg_endo -68.05 77.24 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.154 2.569 . . . . 4.57 111.66 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 10' ' ' LEU . 95.0 mt -85.16 63.84 8.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.967 -0.56 . . . . 3.76 112.428 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -55.96 -19.39 12.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.168 0.508 . . . . 5.48 110.057 169.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HB3' ' CD2' ' A' ' 48' ' ' PHE . . . -57.68 -33.1 68.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.542 -0.754 . . . . 3.8 109.407 171.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.557 ' O ' HG22 ' A' ' 24' ' ' VAL . 34.9 t -70.61 -46.34 63.55 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 115.027 -0.988 . . . . 3.27 109.525 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -53.18 -51.45 62.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.933 0.397 . . . . 6.55 111.044 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -70.91 -23.52 62.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 5.22 110.542 179.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -40.76 64.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.381 -0.372 . . . . 4.34 110.785 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 20' ' ' CYS . 77.2 t -56.65 -42.6 76.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 4.58 110.22 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -65.12 -43.04 93.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 7.65 110.514 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.4 -41.17 85.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 7.32 111.78 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.4 p -65.3 -22.34 66.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 5.71 111.436 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.83 25.02 13.85 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.847 -0.692 . . . . 6.04 111.601 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.504 HD22 HG12 ' A' ' 2' ' ' ILE . 11.7 m120 60.72 47.21 8.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.333 0.587 . . . . 5.27 110.397 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.2 mmt -76.28 -23.33 54.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 6.57 112.483 -172.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.15 176.37 14.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.17 -1.014 . . . . 4.23 112.95 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -63.95 -58.96 5.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.559 0.344 . . . . 3.88 111.69 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -55.13 -35.14 64.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.49 . . . . 5.59 111.387 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.82 -46.64 84.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.052 -0.522 . . . . 5.29 111.184 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.36 -30.78 53.96 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.949 -0.3 . . . . 3.68 111.109 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 39' ' ' ILE . 65.8 t80 -58.48 -44.43 89.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.964 -0.754 . . . . 5.05 108.964 171.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.422 ' O ' HG13 ' A' ' 40' ' ' ILE . 7.4 t30 -63.73 -37.08 86.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.59 -0.732 . . . . 6.25 110.659 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -67.07 -33.85 76.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 6.43 110.418 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.717 HG23 HD11 ' A' ' 10' ' ' LEU . 3.2 tp -77.13 -38.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.466 -0.334 . . . . 3.69 111.171 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 43' ' ' MET . 2.7 pp -71.1 -28.0 31.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.715 -0.394 . . . . 5.32 110.918 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.9 -25.94 12.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.854 -0.338 . . . . 5.79 110.493 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -100.0 10.41 41.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.128 0.418 . . . . 5.81 112.128 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 14.1 ptp -62.4 -20.85 64.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.979 0.418 . . . . 6.2 110.149 174.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.29 -16.5 5.59 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.702 -0.681 . . . . 6.34 110.988 173.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.553 ' CB ' ' HB2' ' A' ' 48' ' ' PHE . 65.4 mm-40 -108.55 88.08 4.83 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.072 -0.513 . . . . 5.62 109.726 172.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 10.0 Cg_endo -53.5 -45.43 41.14 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.387 2.724 . . . . 6.66 111.972 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.18 23.77 7.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.989 -1.46 . . . . 6.09 110.378 -170.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.616 ' CD2' ' HB3' ' A' ' 19' ' ' ALA . 6.9 t80 -77.36 -14.59 59.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.416 0.627 . . . . 6.7 109.399 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.33 -129.34 0.3 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.634 -0.712 . . . . 4.6 109.174 174.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.85 159.84 28.43 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.134 -0.691 . . . . 5.96 109.134 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -34.77 142.04 0.08 OUTLIER 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.856 3.038 . . . . 6.2 113.078 172.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.16 67.25 3.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.825 -0.625 . . . . 8.57 112.26 -169.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.5 p -99.51 132.03 45.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.088 -0.505 . . . . 7.68 109.832 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 20.9 ptp -86.06 115.84 63.42 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 121.018 0.437 . . . . 7.67 110.446 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.93 19.07 1.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.862 2.375 . . . . 6.06 112.909 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.91 81.45 0.37 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.094 -0.574 . . . . 7.03 112.241 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -78.69 24.48 0.29 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.06 0.393 . . . . 9.21 112.06 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 171.09 70.54 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.898 -0.668 . . . . 7.29 112.072 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.83 -153.8 34.96 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.69 -0.767 . . . . 7.34 112.569 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.38 -166.15 1.28 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.82 0.343 . . . . 8.32 110.79 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.81 29.5 5.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.996 0.369 . . . . 6.99 111.996 -173.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.7 t 61.13 59.05 2.08 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.913 -0.585 . . . . 7.25 111.758 172.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.6 125.34 29.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 6.54 110.545 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.81 140.04 9.82 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.033 -0.604 . . . . 7.09 112.014 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.29 112.53 17.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.716 0.293 . . . . 7.55 110.762 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -83.29 92.64 7.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.197 0.522 . . . . 7.6 110.62 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.17 125.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.907 -0.588 . . . . 8.44 109.932 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -84.28 -29.83 26.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.871 0.367 . . . . 8.67 110.874 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.04 -63.6 3.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.895 -0.669 . . . . 7.01 112.877 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 56.52 36.14 27.11 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.316 0.579 . . . . 6.47 109.867 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 m -56.17 125.81 23.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.859 -1.064 . . . . 7.96 112.197 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.06 -57.23 4.81 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.733 -0.667 . . . . 6.58 112.844 174.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 55.32 63.25 2.15 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.05 -0.722 . . . . 7.68 109.05 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.2 121.72 11.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.899 -1.046 . . . . 6.55 111.583 -174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -108.19 30.5 6.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.178 -0.919 . . . . 8.05 108.667 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -73.32 142.1 81.33 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-N 114.431 -1.259 . . . . 7.7 109.762 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 83.7 Cg_exo -51.02 162.9 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.472 2.781 . . . . 5.41 112.822 176.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.657 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.0 Cg_endo -62.7 112.15 1.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.597 2.198 . . . . 7.74 111.526 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.741 ' HA ' HG23 ' A' ' 82' ' ' VAL . 10.9 pt-20 -58.97 -27.33 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.225 -0.898 . . . . 10.13 112.106 -174.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.584 ' HG2' ' N ' ' A' ' 81' ' ' ILE . 11.2 pm0 -70.21 -42.82 71.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.589 -0.893 . . . . 11.78 108.589 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' A' ' 106' ' ' LEU . 63.5 mt -70.82 -46.39 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.726 -1.125 . . . . 8.98 111.755 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.741 HG23 ' HA ' ' A' ' 79' ' ' GLU . 14.3 m -55.52 -38.0 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.54 -0.911 . . . . 7.8 108.54 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.561 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -62.36 -47.21 85.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.442 -1.254 . . . . 11.19 111.272 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 81' ' ' ILE . 18.8 mt -60.0 -42.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 11.59 110.238 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.622 HD13 ' HB3' ' A' ' 95' ' ' ALA . 86.2 mt -65.16 -45.86 92.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 8.01 111.286 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.593 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.62 -21.23 61.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.367 -0.533 . . . . 10.38 110.799 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.6 t -74.28 -28.87 61.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.6 -0.518 . . . . 12.35 109.6 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.6 mmm -66.06 -27.61 68.22 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.315 0.578 . . . . 10.6 110.159 175.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.14 -5.22 4.63 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.548 -0.751 . . . . 10.36 112.14 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 86' ' ' THR . 31.5 m-85 -87.93 -175.45 5.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.722 0.296 . . . . 8.89 110.236 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 8.7 tt0 -98.02 145.35 26.6 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.839 -0.43 . . . . 10.6 109.839 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.532 ' HG3' HG21 ' A' ' 82' ' ' VAL . 7.0 ttm180 -55.73 -51.27 67.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.126 0.489 . . . . 12.6 110.431 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.47 -38.38 80.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.781 . . . . 9.25 111.027 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.537 ' HG3' ' CD1' ' A' ' 113' ' ' ILE . 4.3 tp-100 -59.94 -46.92 87.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.852 0.834 . . . . 7.2 109.35 174.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.622 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -58.38 -40.78 83.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.457 -1.247 . . . . 5.69 110.854 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.57 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.81 -52.11 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.034 -0.53 . . . . 6.87 110.617 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.552 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 58.8 tt0 -56.97 -47.01 81.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.794 -0.639 . . . . 8.99 110.866 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.529 ' O ' HG22 ' A' ' 102' ' ' THR . . . -59.75 -50.67 72.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.236 -0.893 . . . . 5.41 110.973 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.651 HD21 ' HB1' ' A' ' 109' ' ' ALA . 72.7 mt -61.8 -33.51 74.25 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.45 -0.341 . . . . 5.86 111.376 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 95.0 mtt180 -55.93 -47.2 77.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.405 0.621 . . . . 8.38 110.169 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.94 71.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.107 -0.951 . . . . 8.88 111.401 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.0 p -85.77 -0.68 55.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.849 0.685 . . . . 8.79 112.849 -174.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.459 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER 66.76 48.18 1.41 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.15 0.58 . . . . 10.09 111.238 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.553 ' ND2' ' HD3' ' A' ' 78' ' ' PRO . 4.9 m-20 69.76 12.63 8.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.339 -0.846 . . . . 7.86 111.467 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -77.43 109.51 11.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.139 -0.689 . . . . 11.16 109.139 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.835 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.3 tt -56.46 -60.37 3.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.102 -0.954 . . . . 10.38 111.519 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.23 -45.68 72.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.979 -1.009 . . . . 11.82 111.542 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.709 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.4 ttm180 -70.92 -28.37 64.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.244 -0.434 . . . . 12.99 111.075 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.651 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.41 -51.32 68.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.382 -0.599 . . . . 6.65 109.382 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.1 mt -57.85 -38.6 75.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.374 -0.83 . . . . 8.11 109.662 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.56 -51.41 69.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.979 -1.01 . . . . 9.04 110.246 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -63.32 -45.58 90.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.759 -1.109 . . . . 9.43 110.177 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 109' ' ' ALA . 54.9 mt -62.54 -34.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.13 -0.941 . . . . 5.25 110.414 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -69.39 -31.19 69.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 7.33 111.098 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.5 t -75.49 -0.19 19.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.412 0.625 . . . . 8.38 110.176 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -140.55 72.22 30.82 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.2 -0.909 . . . . 10.19 108.578 169.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -27.07 -65.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.952 1 C-N-CA 126.222 4.614 . . . . 8.57 114.474 -171.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -158.59 -41.87 0.06 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.834 -1.075 . . . . 11.42 108.427 173.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -151.23 46.89 0.83 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.106 -0.952 . . . . 16.4 109.633 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 64.34 -159.83 0.29 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.071 -0.968 . . . . 11.84 110.827 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.23 -172.89 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.578 0.228 . . . . 12.26 110.702 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.0 70.77 0.56 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.032 0.832 . . . . 15.51 110.878 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.2 p -125.13 145.28 50.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.251 -0.886 . . . . 16.06 109.908 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -91.3 25.42 2.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.309 0.576 . . . . 17.4 111.0 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.52 79.8 1.25 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.764 -0.653 . . . . 19.63 109.756 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.36 -0.829 . . . . 20.33 110.637 -178.645 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 110.056 -0.35 . . . . 7.16 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.7 mt 57.38 88.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 123.714 0.634 . . . . 6.09 110.414 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.28 91.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.527 -0.76 . . . . 4.6 111.174 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.557 ' HG2' ' HG2' ' A' ' 21' ' ' ARG . 49.1 mt-10 -72.27 -5.71 37.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.875 -0.602 . . . . 5.13 111.579 176.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 2.0 m -59.11 -38.48 79.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.341 0.591 . . . . 4.51 109.565 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 24.1 m -64.63 -50.16 68.19 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.564 -0.744 . . . . 3.46 111.504 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -65.8 -41.81 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 120.849 -0.341 . . . . 3.39 111.153 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 88.3 mtp -61.21 -30.04 70.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.375 -0.375 . . . . 5.53 111.102 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 5' ' ' SER . 46.1 mt-30 -69.59 -34.67 74.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.69 -0.232 . . . . 5.92 111.053 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.798 HD11 HG23 ' A' ' 39' ' ' ILE . 14.3 mt -66.88 -47.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.838 0.827 . . . . 3.9 109.179 171.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.31 -45.83 91.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.022 -1.445 . . . . 4.46 112.403 -169.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 13' ' ' MET . 6.8 pt-20 -58.24 -36.26 72.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.301 0.572 . . . . 6.27 111.437 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.428 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 25.5 ptt? -99.36 7.47 45.52 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.401 -0.818 . . . . 5.61 112.063 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.29 103.21 0.2 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.624 -1.274 . . . . 4.85 114.521 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.651 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 78.6 m-85 71.66 138.27 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 113.47 0.915 . . . . 5.55 113.47 168.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.05 82.8 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.188 2.592 . . . . 4.57 111.364 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.573 HD13 HG12 ' A' ' 39' ' ' ILE . 85.7 mt -80.46 61.32 4.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.163 0.431 . . . . 3.76 112.163 -173.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -20.89 17.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.101 0.476 . . . . 5.48 110.626 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.719 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -58.55 -35.32 72.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.455 0.645 . . . . 3.8 109.909 171.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.683 ' SG ' HD13 ' A' ' 10' ' ' LEU . 33.5 t -73.92 -36.17 64.67 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.383 -0.826 . . . . 3.27 109.894 175.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.557 ' HG2' ' HG2' ' A' ' 4' ' ' GLU . 1.3 tmm_? -57.09 -48.34 78.83 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.378 0.609 . . . . 6.55 109.477 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.593 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -74.43 -25.42 59.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.998 -0.546 . . . . 5.22 110.325 176.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.716 ' HA ' ' HD2' ' A' ' 26' ' ' PHE . . . -66.65 -38.52 87.06 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.11 0.481 . . . . 4.34 110.609 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' HG1' ' A' ' 27' ' ' THR . 71.8 t -59.8 -37.77 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.833 -0.621 . . . . 4.58 109.865 173.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.48 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 89.9 t80 -60.81 -41.36 95.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.17 -0.468 . . . . 7.65 110.54 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.716 ' HD2' ' HA ' ' A' ' 23' ' ' ALA . 53.6 m-85 -64.8 -46.25 82.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.617 0.246 . . . . 7.32 111.286 176.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.597 ' HG1' ' HA ' ' A' ' 24' ' ' VAL . 33.7 p -70.62 -11.81 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 5.71 111.685 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.74 38.84 41.58 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 6.04 111.427 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.408 ' HA ' HG12 ' A' ' 24' ' ' VAL . 2.2 p-10 43.81 47.9 6.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.908 0.883 . . . . 5.27 111.966 -176.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.4 mtt -63.92 -64.48 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.498 -0.774 . . . . 6.57 110.66 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.84 179.99 45.78 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.815 -0.629 . . . . 4.23 111.665 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -65.22 -33.82 76.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.656 0.243 . . . . 3.88 111.656 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -53.74 -63.24 1.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.008 0.432 . . . . 5.59 111.837 -176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.23 -30.62 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 112.234 0.457 . . . . 5.29 112.234 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.85 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.667 -0.413 . . . . 3.68 111.988 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.585 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.7 t80 -58.72 -44.62 90.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.011 -0.737 . . . . 5.05 109.011 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -65.36 -34.64 78.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 6.25 111.031 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -66.23 -36.39 82.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.133 0.492 . . . . 6.43 110.506 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.798 HG23 HD11 ' A' ' 10' ' ' LEU . 7.0 tp -76.98 -41.56 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.236 -0.438 . . . . 3.69 111.38 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.05 -26.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.864 0.364 . . . . 5.32 111.003 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 p -80.66 -31.82 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.864 -0.334 . . . . 5.79 110.783 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -100.44 14.59 30.68 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 122.051 -0.406 . . . . 5.81 111.892 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.431 ' HE1' ' HB2' ' A' ' 43' ' ' MET . 4.8 ppp? -64.08 -22.57 66.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.928 0.394 . . . . 6.2 111.399 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.0 -3.84 41.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.07 0.396 . . . . 6.34 112.07 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.818 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 21.9 mm-40 -66.01 123.28 84.64 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.97 -0.381 . . . . 5.62 109.97 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -58.98 -36.34 96.98 Favored 'Trans proline' 0 N--CA 1.472 0.244 0 C-N-CA 123.1 2.533 . . . . 6.66 112.141 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -115.98 26.88 9.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.791 -1.095 . . . . 6.09 110.245 -171.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.818 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.5 p90 -60.33 -43.85 96.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.778 -0.646 . . . . 6.7 111.468 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.547 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -158.97 162.27 36.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.312 -0.996 . . . . 4.6 108.312 -175.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -100.81 90.54 1.55 Allowed Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 114.975 -1.011 . . . . 5.96 109.303 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 49' ' ' ALA . 97.1 Cg_endo -84.76 48.7 2.44 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.895 2.397 . . . . 6.2 112.809 -171.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -87.23 33.21 0.68 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.536 -0.756 . . . . 8.57 110.626 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.468 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 85.8 m -158.2 94.52 1.3 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.853 -0.612 . . . . 7.68 110.047 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 79.4 mtp -88.09 103.94 5.97 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.235 -0.438 . . . . 7.67 109.905 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.49 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 8.0 Cg_exo -72.65 -60.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.024 2.483 . . . . 6.06 112.691 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.33 -176.05 20.55 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.959 -0.639 . . . . 7.03 112.541 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -165.11 173.73 11.11 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.797 -0.446 . . . . 9.21 109.797 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.67 -136.34 7.55 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.581 -0.819 . . . . 7.29 112.544 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.72 -133.68 3.72 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.312 -0.47 . . . . 7.34 111.983 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -134.0 -44.75 0.79 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.216 -0.29 . . . . 8.32 110.216 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 49.94 53.24 13.14 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.639 0.587 . . . . 6.99 111.86 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.572 ' HB3' ' HB1' ' A' ' 65' ' ' ALA . 52.4 m 62.58 63.69 0.99 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.619 -0.719 . . . . 7.25 111.163 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.2 -42.41 31.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.138 0.494 . . . . 6.54 110.049 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.43 46.73 1.79 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.63 -0.795 . . . . 7.09 111.7 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.572 ' HB1' ' HB3' ' A' ' 62' ' ' SER . . . -97.82 23.88 7.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 7.55 111.499 -175.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.1 m -151.33 139.69 20.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.12 0.486 . . . . 7.6 110.875 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.7 t -110.01 103.33 15.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.611 -0.722 . . . . 8.44 109.212 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -121.75 102.43 8.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.951 0.405 . . . . 8.67 110.502 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.57 18.57 5.15 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.877 -0.889 . . . . 7.01 110.877 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 73' ' ' LEU . . . -85.73 75.93 10.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.316 -0.442 . . . . 6.47 111.403 -175.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 p -66.82 -42.57 85.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.361 0.601 . . . . 7.96 110.042 175.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -143.81 78.15 0.27 Allowed Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.596 -1.002 . . . . 6.58 110.596 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.677 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 6.0 tt -74.24 -53.92 8.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.004 0.431 . . . . 7.68 110.513 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -98.35 119.39 36.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.073 -0.512 . . . . 6.55 110.235 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -130.17 33.85 4.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.448 0.642 . . . . 8.05 109.741 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -85.42 141.21 36.56 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.375 -0.83 . . . . 7.7 110.535 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.643 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 48.3 Cg_exo -61.87 164.48 16.34 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.062 2.508 . . . . 5.41 112.047 171.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.616 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 50.0 Cg_endo -66.37 112.92 2.48 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.95 2.433 . . . . 7.74 111.256 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.635 ' HA ' HG23 ' A' ' 82' ' ' VAL . 10.2 pt-20 -55.93 -29.56 60.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 10.13 110.77 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -56.89 -51.0 70.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.265 0.555 . . . . 11.78 110.29 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.944 HD11 ' HB2' ' A' ' 106' ' ' LEU . 71.8 mt -75.67 -41.4 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.75 -0.659 . . . . 8.98 111.8 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 79' ' ' GLU . 5.5 m -56.06 -38.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.601 -0.889 . . . . 7.8 108.601 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.521 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -62.11 -45.78 91.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.815 -1.084 . . . . 11.19 110.699 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.636 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.9 mt -62.5 -41.73 93.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 11.59 110.871 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.604 HD13 ' HB3' ' A' ' 95' ' ' ALA . 80.4 mt -65.97 -46.76 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.916 -0.584 . . . . 8.01 111.66 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.73 -21.2 63.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.042 -0.663 . . . . 10.38 110.518 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.5 t -73.03 -32.22 64.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.741 -0.466 . . . . 12.35 109.741 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.0 mmt -64.25 -26.26 68.42 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.214 0.531 . . . . 10.6 110.489 176.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.64 6.21 4.7 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.71 . . . . 10.36 112.01 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.566 ' HD2' HG21 ' A' ' 85' ' ' ILE . 32.2 m-85 -99.07 -174.01 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.68 0.276 . . . . 8.89 110.297 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.779 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 34.2 mt-30 -91.05 149.55 21.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.47 -0.332 . . . . 10.6 110.468 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.489 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.4 ttm180 -61.99 -51.16 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.427 -0.583 . . . . 12.6 109.427 173.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.472 -0.785 . . . . 9.25 110.879 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.779 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 1.0 OUTLIER -63.6 -37.45 87.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.264 0.554 . . . . 7.2 109.728 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.604 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -63.72 -41.39 98.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.427 -0.806 . . . . 5.69 110.451 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.643 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.79 -52.15 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.127 -0.488 . . . . 6.87 110.277 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.603 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.6 tt0 -53.86 -47.11 71.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.837 -0.62 . . . . 8.99 111.162 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.478 ' O ' HG22 ' A' ' 102' ' ' THR . . . -60.17 -52.09 66.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.01 -0.995 . . . . 5.41 110.91 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.735 HD21 ' HB1' ' A' ' 109' ' ' ALA . 75.2 mt -62.93 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.438 -0.346 . . . . 5.86 111.542 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.603 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.8 mtt180 -54.64 -46.17 73.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.787 0.804 . . . . 8.38 109.66 175.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.69 -44.74 55.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.53 -1.213 . . . . 8.88 111.382 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 64.3 p -81.41 0.06 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.917 0.71 . . . . 8.79 112.917 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 61.58 62.94 1.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 10.09 110.257 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.562 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.5 p30 53.09 23.42 3.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.662 1.185 . . . . 7.86 112.662 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.525 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.1 t-20 -87.44 108.78 19.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.386 -0.598 . . . . 11.16 109.386 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.944 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.7 tt -53.94 -61.27 2.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.915 -1.039 . . . . 10.38 112.042 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.02 -45.79 75.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.811 -1.086 . . . . 11.82 111.655 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.705 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 9.0 ttm180 -69.66 -28.69 66.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.053 -0.521 . . . . 12.99 110.845 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.735 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -63.37 -50.92 68.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.103 -0.703 . . . . 6.65 109.103 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.58 -39.1 79.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.404 -0.816 . . . . 8.11 109.668 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 11.0 t70 -54.17 -54.54 38.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.982 -1.008 . . . . 9.04 109.942 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -62.68 -39.7 94.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.058 -1.428 . . . . 9.43 110.781 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 95' ' ' ALA . 53.7 mt -71.37 -36.05 59.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.36 -0.836 . . . . 5.25 111.27 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -64.85 -33.39 75.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.48 0.657 . . . . 7.33 109.996 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.3 t -84.01 11.03 8.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.195 -0.911 . . . . 8.38 110.287 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -135.06 70.34 69.89 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.541 -0.754 . . . . 10.19 109.744 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.469 ' HD2' ' OE2' ' A' ' 120' ' ' GLU . 9.6 Cg_endo -49.29 -66.78 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 124.438 3.426 . . . . 8.57 113.431 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -171.1 -42.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.545 -0.752 . . . . 11.42 110.461 -176.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -147.89 16.29 1.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.232 0.539 . . . . 16.4 109.921 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.469 ' OE2' ' HD2' ' A' ' 117' ' ' PRO . 46.6 mm-40 63.73 118.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.208 -0.905 . . . . 11.84 111.869 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.92 123.42 32.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.402 0.62 . . . . 12.26 110.865 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -137.43 -50.59 0.62 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.88 -0.6 . . . . 15.51 110.398 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.6 t -119.46 56.25 0.93 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.416 0.627 . . . . 16.06 109.987 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -111.54 -43.83 3.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.845 -0.616 . . . . 17.4 110.002 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -78.64 -38.53 39.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.857 -0.611 . . . . 19.63 109.364 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.421 -0.809 . . . . 20.33 110.591 179.577 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 121.277 0.561 . . . . 7.16 109.877 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.525 HG22 ' CG1' ' A' ' 24' ' ' VAL . 52.8 mt -138.82 135.3 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 115.47 -0.786 . . . . 6.09 109.253 178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.532 ' H ' HG11 ' A' ' 24' ' ' VAL . 10.0 m-20 -69.83 72.53 0.39 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.293 0.568 . . . . 4.6 109.605 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.556 ' HA ' HG12 ' A' ' 7' ' ' VAL . 43.7 mt-10 -71.14 -4.14 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.709 -0.678 . . . . 5.13 111.142 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.548 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 14.5 m -63.22 -30.96 72.0 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.251 -0.648 . . . . 4.51 109.251 169.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.682 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 48.2 t -66.96 -52.68 39.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.673 -0.694 . . . . 3.46 110.943 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 4' ' ' GLU . 5.1 p -63.67 -37.67 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.318 -0.401 . . . . 3.39 110.583 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.547 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 20.9 mmt -65.27 -29.0 69.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.0 -0.545 . . . . 5.53 111.516 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 5' ' ' SER . 71.3 mt-30 -66.37 -40.87 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.735 -0.386 . . . . 5.92 110.534 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.626 ' HB3' HD11 ' A' ' 17' ' ' LEU . 18.4 mt -68.67 -39.37 80.66 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.862 0.839 . . . . 3.9 109.533 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.88 -34.46 76.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.363 -1.29 . . . . 4.46 111.8 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 8' ' ' MET . 49.3 mt-10 -67.54 -18.91 65.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.34 . . . . 6.27 111.145 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.7 mtp -83.17 -1.16 52.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.168 0.508 . . . . 5.61 109.832 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.1 45.68 5.57 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.445 -0.798 . . . . 4.85 113.066 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -144.17 125.77 8.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.857 0.361 . . . . 5.55 110.64 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.59 66.12 4.69 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.354 2.703 . . . . 4.57 111.687 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.626 HD11 ' HB3' ' A' ' 10' ' ' LEU . 61.9 mt -89.65 64.6 6.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.691 0.758 . . . . 3.76 111.695 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -55.54 -21.81 18.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.02 -0.536 . . . . 5.48 109.714 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.771 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -57.92 -30.65 66.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.52 -0.764 . . . . 3.8 109.901 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.574 ' HB2' HD12 ' A' ' 10' ' ' LEU . 17.5 t -72.16 -44.71 62.66 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.506 -0.77 . . . . 3.27 109.037 174.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -48.82 72.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.43 -0.804 . . . . 6.55 110.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 10.9 ptpt -75.76 -23.29 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.981 -0.288 . . . . 5.22 110.734 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.9 93.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.328 0.585 . . . . 4.34 110.067 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.532 HG11 ' H ' ' A' ' 3' ' ' ASP . 77.1 t -58.58 -40.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 4.58 110.009 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 87.3 t80 -60.73 -49.95 75.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.685 -0.689 . . . . 7.65 110.57 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -61.81 -43.36 99.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.646 -0.252 . . . . 7.32 111.597 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.415 ' HG1' ' HA ' ' A' ' 24' ' ' VAL . 37.4 p -66.82 -27.74 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.125 0.488 . . . . 5.71 111.094 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.77 36.29 6.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.791 -0.64 . . . . 6.04 112.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.29 64.48 1.35 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.947 0.403 . . . . 5.27 110.139 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.7 mmt -97.71 -32.72 11.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.044 -0.525 . . . . 6.57 111.922 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 171.12 18.59 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 119.72 -1.229 . . . . 4.23 113.035 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.682 ' HA ' ' HB2' ' A' ' 6' ' ' SER . . . -67.14 -54.52 20.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.229 0.455 . . . . 3.88 112.229 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 36' ' ' PHE . 45.3 mt-10 -68.56 -24.23 64.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.837 0.351 . . . . 5.59 110.804 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.38 -46.67 89.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 5.29 110.318 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.4 ' HB3' ' OG ' ' A' ' 6' ' ' SER . . . -78.45 -27.38 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.49 -0.323 . . . . 3.68 111.09 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' O ' HG22 ' A' ' 39' ' ' ILE . 81.1 t80 -57.89 -44.25 86.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.036 -0.727 . . . . 5.05 109.036 169.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.521 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.6 t30 -62.94 -40.86 98.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.462 -0.79 . . . . 6.25 110.285 175.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -65.16 -33.57 76.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.895 -0.593 . . . . 6.43 110.626 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.771 HD11 ' HB1' ' A' ' 19' ' ' ALA . 3.9 tp -75.69 -37.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 3.69 111.111 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.1 -30.15 39.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.86 -0.336 . . . . 5.32 111.004 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.37 -21.47 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.796 -0.361 . . . . 5.79 110.76 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -101.8 1.32 37.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.902 0.382 . . . . 5.81 111.09 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.7 ptt? -62.87 -23.72 67.46 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.56 0.578 . . . . 6.2 112.56 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -71.04 -10.71 60.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.763 0.316 . . . . 6.34 111.78 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.799 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 6.6 mm-40 -77.42 127.4 82.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.437 -0.347 . . . . 5.62 110.666 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.22 -35.71 90.87 Favored 'Trans proline' 0 N--CA 1.473 0.306 0 C-N-CA 123.63 2.887 . . . . 6.66 113.014 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -115.7 25.64 10.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.113 -0.949 . . . . 6.09 110.392 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.799 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.0 p90 -63.3 -32.33 73.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.642 -0.708 . . . . 6.7 111.528 -176.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.52 -140.35 0.15 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.989 -0.745 . . . . 4.6 108.989 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -101.36 105.37 39.46 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.7 -0.482 . . . . 5.96 109.7 176.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.27 60.57 6.38 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 123.278 2.652 . . . . 6.2 112.129 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -128.98 96.3 4.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.628 -0.714 . . . . 8.57 110.227 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 53' ' ' THR . 9.9 t 36.24 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.403 1.081 . . . . 7.68 113.495 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 61.4 mtt -71.46 127.66 90.9 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.595 -0.729 . . . . 7.67 110.303 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.79 -64.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.546 2.831 . . . . 6.06 113.159 -176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.26 166.16 39.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.914 -0.66 . . . . 7.03 112.014 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -84.5 28.42 0.65 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.096 0.474 . . . . 9.21 111.672 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.09 73.37 2.29 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.977 -0.63 . . . . 7.29 111.884 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.39 170.72 25.42 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.777 -0.725 . . . . 7.34 112.02 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.94 139.3 48.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.868 0.366 . . . . 8.32 110.818 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.411 ' C ' ' HG ' ' A' ' 62' ' ' SER . . . -129.89 120.66 25.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 6.99 109.763 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 61' ' ' ALA . 26.2 p 47.02 58.23 4.98 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.681 0.613 . . . . 7.25 110.885 -175.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.42 83.2 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 6.54 110.849 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.79 -118.26 2.69 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.71 -0.677 . . . . 7.09 111.443 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.11 155.05 17.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.415 -0.587 . . . . 7.55 109.415 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 t -82.55 72.1 9.62 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.592 -0.521 . . . . 7.6 109.592 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.4 t -95.19 124.46 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.6 -0.727 . . . . 8.44 110.442 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -93.47 -179.52 5.07 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.02 -0.536 . . . . 8.67 110.152 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.45 -164.82 14.22 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.319 -0.943 . . . . 7.01 112.543 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.42 -70.17 0.79 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.074 -0.343 . . . . 6.47 110.074 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m 58.25 63.34 1.76 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.9 -0.591 . . . . 7.96 110.483 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.5 39.06 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.411 -0.813 . . . . 6.58 111.251 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.18 20.02 15.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.065 0.459 . . . . 7.68 110.943 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -142.34 149.26 39.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.101 -0.5 . . . . 6.55 109.961 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -169.5 177.34 4.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.143 -1.058 . . . . 8.05 108.143 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -141.91 140.16 19.36 Favored Pre-proline 0 N--CA 1.438 -1.043 0 N-CA-C 109.545 -0.539 . . . . 7.7 109.545 173.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.569 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.0 Cg_exo -54.06 166.8 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.683 2.256 . . . . 5.41 111.666 170.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.649 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.8 Cg_endo -64.38 109.42 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.175 1.917 . . . . 7.74 110.407 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.686 ' HA ' HG23 ' A' ' 82' ' ' VAL . 13.1 pt-20 -58.13 -23.56 55.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.461 0.476 . . . . 10.13 110.274 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 3.6 tt0 -59.31 -53.04 62.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.616 -0.72 . . . . 11.78 110.108 171.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.906 HD11 ' HB2' ' A' ' 106' ' ' LEU . 73.1 mt -73.67 -42.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.74 -0.664 . . . . 8.98 111.648 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 79' ' ' GLU . 5.8 m -55.14 -37.98 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.556 -0.905 . . . . 7.8 108.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.535 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -61.67 -47.97 82.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 11.19 111.055 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.8 mt -60.2 -41.33 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.863 -0.608 . . . . 11.59 110.309 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.611 HG21 ' HD2' ' A' ' 90' ' ' PHE . 85.8 mt -67.0 -45.16 87.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.747 -0.66 . . . . 8.01 111.657 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.571 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.14 -20.67 62.28 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.081 -0.648 . . . . 10.38 110.726 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.2 t -75.23 -27.14 59.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.121 0.486 . . . . 12.35 109.829 172.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.765 ' HE2' ' HA ' ' A' ' 88' ' ' MET . 23.8 mmt -68.37 -23.05 64.63 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 10.6 110.703 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.09 -5.24 5.68 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.518 -0.765 . . . . 10.36 111.635 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.611 ' HD2' HG21 ' A' ' 85' ' ' ILE . 29.3 m-85 -90.8 -176.24 4.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.32 . . . . 8.89 110.614 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.653 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.8 tt0 -98.01 147.07 24.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.823 -0.436 . . . . 10.6 109.823 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.58 ' HG3' HG21 ' A' ' 82' ' ' VAL . 10.2 ttm180 -56.66 -54.78 42.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 12.6 110.51 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.442 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 8.8 t30 -58.45 -36.74 74.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.853 -0.612 . . . . 9.25 111.016 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.653 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.0 tt0 -64.69 -38.39 90.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 7.2 109.626 176.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.599 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -66.06 -39.17 89.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.127 -0.942 . . . . 5.69 110.693 175.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -59.41 -52.49 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 116.212 -0.449 . . . . 6.87 111.039 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.485 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 57.5 tt0 -58.91 -41.62 87.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.052 -0.522 . . . . 8.99 110.862 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' O ' HG22 ' A' ' 102' ' ' THR . . . -59.98 -53.35 58.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.346 -0.843 . . . . 5.41 110.417 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.725 HD21 ' HB1' ' A' ' 109' ' ' ALA . 79.9 mt -61.46 -34.77 75.99 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.39 -0.368 . . . . 5.86 111.526 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 93.3 mtt180 -55.88 -46.35 78.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.544 0.688 . . . . 8.38 110.371 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.3 70.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.958 -1.019 . . . . 8.88 111.061 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.73 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 31.2 p -84.36 0.18 50.28 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.991 0.737 . . . . 8.79 112.991 -175.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.4 m120 60.87 61.88 1.57 Allowed 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.021 0.528 . . . . 10.09 110.458 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.587 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 10.1 p30 51.67 25.5 2.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.589 1.156 . . . . 7.86 112.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 13.1 t-20 -86.1 109.62 18.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.946 -0.761 . . . . 11.16 108.946 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.906 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.4 tt -54.75 -59.73 4.32 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.094 -0.957 . . . . 10.38 111.436 -176.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.24 -48.38 74.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.637 -1.165 . . . . 11.82 111.737 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.73 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -67.98 -28.71 67.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.407 -0.36 . . . . 12.99 110.92 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.725 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.22 -50.41 71.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.353 -0.61 . . . . 6.65 109.353 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.0 mt -60.34 -39.22 86.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.266 -0.879 . . . . 8.11 109.665 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.93 -49.97 70.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.81 -1.086 . . . . 9.04 110.124 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -63.1 -49.85 72.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.375 -1.284 . . . . 9.43 110.489 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 95' ' ' ALA . 44.2 mt -62.16 -32.33 54.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.931 -1.031 . . . . 5.25 111.394 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -61.95 -29.42 70.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.182 0.515 . . . . 7.33 110.997 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -82.99 -3.13 56.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.543 0.687 . . . . 8.38 109.841 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -141.82 62.68 15.02 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 10.19 110.246 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -36.5 -58.44 0.51 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 125.18 3.92 . . . . 8.57 113.308 -170.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 5.2 pt-20 -157.32 -57.06 0.08 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.866 -1.061 . . . . 11.42 108.835 173.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.46 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 33.1 t80 -158.76 12.29 0.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 16.4 110.562 176.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.08 -168.29 0.16 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.137 -0.483 . . . . 11.84 110.05 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -135.22 166.04 24.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.669 -0.493 . . . . 12.26 109.669 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.3 t70 51.75 76.13 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.07 0.857 . . . . 15.51 110.938 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.8 t -91.78 106.87 18.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.962 -0.563 . . . . 16.06 110.123 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -96.09 -28.78 14.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.013 -0.539 . . . . 17.4 110.436 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -88.64 -46.74 8.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.485 -0.325 . . . . 19.63 110.693 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 41.0 t . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.615 -0.707 . . . . 20.33 110.215 -178.109 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.079 0.466 . . . . 7.16 110.764 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.529 HG22 ' CG1' ' A' ' 24' ' ' VAL . 78.1 mt -98.27 130.32 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.646 -0.706 . . . . 6.09 110.923 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.34 74.74 1.87 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.174 0.512 . . . . 4.6 110.706 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HA ' HG12 ' A' ' 7' ' ' VAL . 46.0 mt-10 -71.67 -5.45 33.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.401 0.62 . . . . 5.13 110.147 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 15.2 m -61.78 -34.28 75.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.612 -0.722 . . . . 4.51 109.301 167.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 34.9 t -59.78 -51.93 67.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 3.46 110.716 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.8 p -66.58 -40.7 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.229 -0.441 . . . . 3.39 111.113 -177.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.6 mtp -63.45 -31.62 72.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.281 -0.418 . . . . 5.53 111.26 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.66 ' O ' ' HG2' ' A' ' 13' ' ' MET . 13.9 mm100 -60.28 -53.95 51.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 110.037 -0.357 . . . . 5.92 110.037 173.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.669 HD11 HG23 ' A' ' 39' ' ' ILE . 10.7 mt -57.2 -43.22 82.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.153 0.501 . . . . 3.9 109.841 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.88 -50.0 73.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.655 -1.157 . . . . 4.46 111.784 -172.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -60.17 -28.54 68.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.357 -0.383 . . . . 6.27 111.518 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.66 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 17.3 ptt? -112.91 31.1 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.891 0.33 . . . . 5.61 111.891 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.533 ' HA2' ' HE1' ' A' ' 54' ' ' MET . . . 134.72 96.84 0.55 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.849 -1.167 . . . . 4.85 114.173 173.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 m-85 73.89 133.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 113.225 0.824 . . . . 5.55 113.225 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.31 83.77 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.93 2.42 . . . . 4.57 111.353 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 10' ' ' LEU . 95.4 mt -82.33 66.98 8.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.781 -0.645 . . . . 3.76 112.137 -173.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 3.7 tt0 -56.38 -19.76 16.28 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.892 0.377 . . . . 5.48 111.001 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.676 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -58.64 -32.34 68.96 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.929 0.395 . . . . 3.8 109.983 172.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.554 ' O ' HG22 ' A' ' 24' ' ' VAL . 49.5 t -72.02 -43.58 64.77 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.465 -0.789 . . . . 3.27 109.177 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 29.7 ttt180 -52.36 -52.75 51.72 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.868 -1.06 . . . . 6.55 110.049 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.728 ' HZ2' ' HB3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -72.71 -25.07 61.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.655 . . . . 5.22 110.834 177.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.46 78.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.62 0.248 . . . . 4.34 110.648 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 20' ' ' CYS . 93.4 t -56.83 -45.93 83.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.672 -0.492 . . . . 4.58 109.672 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -62.03 -46.47 89.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.506 -0.478 . . . . 7.65 110.713 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -64.25 -36.25 83.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 7.32 112.003 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.7 p -68.8 -21.05 64.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.205 0.526 . . . . 5.71 110.583 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.55 27.71 12.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.606 -0.725 . . . . 6.04 111.559 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 64.04 53.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.299 0.571 . . . . 5.27 110.327 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.505 ' HB3' HG23 ' A' ' 34' ' ' VAL . 20.4 mmt -82.08 -14.65 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 6.57 111.86 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.02 173.02 13.39 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.438 -0.887 . . . . 4.23 112.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 6' ' ' SER . . . -68.02 -48.04 66.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.34 . . . . 3.88 111.053 -178.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.97 -49.11 69.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.068 -0.515 . . . . 5.59 111.22 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 30' ' ' MET . 95.9 t -60.46 -38.71 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 5.29 111.343 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.17 54.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.079 -0.248 . . . . 3.68 111.662 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.671 ' O ' HG22 ' A' ' 39' ' ' ILE . 59.2 t80 -56.94 -44.78 82.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.904 -0.776 . . . . 5.05 108.904 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.492 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.4 m-20 -65.79 -39.95 91.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.395 -0.821 . . . . 6.25 110.536 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -64.36 -34.77 78.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 6.43 110.468 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.676 HD11 ' HB1' ' A' ' 19' ' ' ALA . 7.2 tp -75.42 -40.73 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.201 -0.454 . . . . 3.69 111.475 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -69.71 -23.81 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.163 0.506 . . . . 5.32 110.606 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.2 t -78.92 -42.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 5.79 110.824 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -101.12 19.21 17.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.391 0.515 . . . . 5.81 112.391 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.4 ptm -63.27 -21.11 66.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.2 0.524 . . . . 6.2 110.416 172.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -66.23 -11.27 49.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.276 -0.874 . . . . 6.34 112.42 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 39.9 mm-40 -69.45 140.28 89.89 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.062 -0.347 . . . . 5.62 110.062 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.8 -49.16 5.66 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.965 2.443 . . . . 6.66 113.417 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -108.94 25.63 11.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.944 0.878 . . . . 6.09 110.361 -169.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.678 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 1.6 p90 -62.04 -25.81 67.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.399 -0.819 . . . . 6.7 112.08 -176.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.524 ' HB1' HD23 ' A' ' 17' ' ' LEU . . . -139.14 119.75 14.06 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.011 0.434 . . . . 4.6 110.285 -176.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 28.1 mt-10 -59.6 114.83 10.43 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.211 -0.904 . . . . 5.96 110.228 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 2.8 Cg_exo -75.8 71.92 5.32 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.083 2.522 . . . . 6.2 112.272 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.2 tp -127.73 67.72 1.32 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.886 -0.597 . . . . 8.57 110.685 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 m 66.12 113.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.736 -0.665 . . . . 7.68 112.044 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.533 ' HE1' ' HA2' ' A' ' 14' ' ' GLY . 17.1 ptm -86.38 129.43 53.4 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.235 -0.439 . . . . 7.67 110.538 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 13.2 Cg_exo -71.29 149.82 57.91 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.806 2.338 . . . . 6.06 111.539 175.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.88 115.02 2.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.027 -0.606 . . . . 7.03 111.991 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -70.21 128.17 35.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.668 0.27 . . . . 9.21 110.465 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.55 170.52 16.62 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.086 -0.578 . . . . 7.29 111.723 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.83 169.15 54.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.003 -0.618 . . . . 7.34 112.384 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.0 133.35 43.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.338 0.589 . . . . 8.32 111.327 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.64 27.22 3.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.573 -0.74 . . . . 6.99 110.648 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.8 t -125.55 144.09 50.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.017 -0.538 . . . . 7.25 110.263 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.61 87.64 6.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.105 -0.498 . . . . 6.54 109.76 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.5 -40.05 40.35 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.965 -0.636 . . . . 7.09 112.637 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.78 -56.21 0.83 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.906 -0.173 . . . . 7.55 111.256 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.2 t 54.68 50.67 15.37 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.198 0.523 . . . . 7.6 110.097 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.638 HG13 ' HD1' ' A' ' 68' ' ' PHE . 7.5 p -89.63 -32.0 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.969 -0.559 . . . . 8.44 110.008 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.638 ' HD1' HG13 ' A' ' 67' ' ' VAL . 9.8 m-85 -97.4 43.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.944 -0.571 . . . . 8.67 110.715 177.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.53 153.27 21.5 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.718 -0.674 . . . . 7.01 111.478 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.63 -30.02 15.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.798 0.333 . . . . 6.47 110.345 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.6 t 63.1 -86.84 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.307 -0.86 . . . . 7.96 111.424 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -129.18 10.68 6.19 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.946 -0.645 . . . . 6.58 111.786 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 73' ' ' LEU . 4.4 mm? 63.15 53.22 2.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.095 0.474 . . . . 7.68 111.288 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.57 76.05 7.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.592 0.71 . . . . 6.55 109.519 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -132.92 76.04 1.66 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.226 -0.897 . . . . 8.05 109.377 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -70.32 139.06 86.85 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.531 -0.914 . . . . 7.7 108.531 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.577 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 71.9 Cg_exo -52.67 159.2 5.07 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.756 2.304 . . . . 5.41 112.709 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.698 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 43.3 Cg_endo -65.29 113.28 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.874 2.383 . . . . 7.74 110.959 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.763 ' HA ' HG23 ' A' ' 82' ' ' VAL . 13.0 pt-20 -57.43 -28.8 63.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.955 -0.566 . . . . 10.13 110.309 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -57.62 -50.57 72.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.908 -0.587 . . . . 11.78 109.924 174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 106' ' ' LEU . 68.7 mt -76.27 -42.72 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.845 -0.616 . . . . 8.98 112.036 -176.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.763 HG23 ' HA ' ' A' ' 79' ' ' GLU . 10.0 m -55.35 -38.28 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.463 -0.94 . . . . 7.8 108.463 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.572 ' N ' HG22 ' A' ' 82' ' ' VAL . . . -60.35 -49.66 76.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.822 -1.081 . . . . 11.19 110.57 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.3 mt -59.78 -42.14 87.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.459 . . . . 11.59 110.737 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.641 HG21 ' HD2' ' A' ' 90' ' ' PHE . 85.6 mt -64.63 -47.0 90.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.076 -0.511 . . . . 8.01 111.424 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.556 HG21 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.03 -21.18 61.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.152 -0.619 . . . . 10.38 110.809 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -77.01 -17.66 58.68 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.809 0.338 . . . . 12.35 110.449 172.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 97.1 mmm -75.28 -25.45 57.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.286 0.565 . . . . 10.6 109.503 173.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.69 -1.77 5.2 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.252 -0.885 . . . . 10.36 112.012 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.641 ' HD2' HG21 ' A' ' 85' ' ' ILE . 32.0 m-85 -92.21 -174.09 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.748 0.309 . . . . 8.89 110.692 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.728 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 6.7 tt0 -97.18 143.28 28.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.916 -0.401 . . . . 10.6 109.916 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' O ' HD12 ' A' ' 96' ' ' ILE . 5.2 ttm180 -55.9 -54.85 39.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.981 0.42 . . . . 12.6 110.29 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.543 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 54.1 t30 -59.63 -35.82 75.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.641 . . . . 9.25 111.031 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.728 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.5 tt0 -64.96 -39.82 94.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.638 . . . . 7.2 109.533 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.601 ' HB3' HD13 ' A' ' 85' ' ' ILE . . . -62.83 -39.17 93.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.935 -1.03 . . . . 5.69 110.408 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.577 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER -59.45 -52.9 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 116.322 -0.399 . . . . 6.87 110.805 176.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.528 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 7.5 tt0 -56.35 -44.62 80.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.221 0.534 . . . . 8.99 110.82 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.455 ' O ' HG22 ' A' ' 102' ' ' THR . . . -60.04 -53.29 59.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.304 -0.862 . . . . 5.41 110.729 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.754 HD21 ' HB1' ' A' ' 109' ' ' ALA . 77.1 mt -62.01 -32.88 73.41 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 111.779 0.289 . . . . 5.86 111.779 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.528 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 75.3 mtp180 -57.37 -43.73 83.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.436 0.636 . . . . 8.38 110.262 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.1 60.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.19 -0.914 . . . . 8.88 111.077 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 33.7 p -84.47 -0.72 53.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.19 0.811 . . . . 8.79 113.19 -174.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 62.03 63.45 1.09 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.577 0.548 . . . . 10.09 110.621 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.555 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.8 p-10 50.04 27.64 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.221 1.008 . . . . 7.86 111.967 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 43.6 t-20 -88.96 107.32 18.96 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.827 -0.805 . . . . 11.16 108.827 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.917 ' HB2' HD11 ' A' ' 81' ' ' ILE . 8.0 tt -53.78 -60.34 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.093 -0.958 . . . . 10.38 111.393 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.432 ' N ' HD22 ' A' ' 106' ' ' LEU . 37.5 mm-40 -54.45 -49.66 69.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.86 -1.064 . . . . 11.82 111.926 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.713 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 26.3 ttm180 -66.9 -28.51 68.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.452 -0.34 . . . . 12.99 110.793 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB1' HD21 ' A' ' 99' ' ' LEU . . . -62.96 -51.28 67.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.679 -0.489 . . . . 6.65 109.679 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.4 mt -59.88 -39.21 84.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.461 -0.79 . . . . 8.11 109.52 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.81 -50.36 68.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.866 -1.061 . . . . 9.04 109.877 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -63.32 -49.06 75.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.333 -1.303 . . . . 9.43 110.482 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 109' ' ' ALA . 46.3 mt -62.61 -37.08 78.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.944 -1.025 . . . . 5.25 111.23 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.38 -24.15 67.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 7.33 110.663 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.8 m -86.33 7.65 24.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.91 -0.586 . . . . 8.38 111.0 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -138.91 74.88 36.83 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.037 -0.529 . . . . 10.19 110.05 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -45.23 -59.93 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.571 3.514 . . . . 8.57 112.778 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.695 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 4.3 pt-20 -163.98 -56.44 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.685 -1.143 . . . . 11.42 108.133 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.695 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 91.4 t80 -128.31 -43.45 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.364 -1.289 . . . . 16.4 109.429 173.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 138.36 175.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 126.245 2.215 . . . . 11.84 109.149 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.27 147.35 52.57 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.492 -0.558 . . . . 12.26 109.492 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.65 -66.71 0.36 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.538 0.57 . . . . 15.51 112.538 -171.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.7 m -74.08 -15.18 61.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.579 -0.737 . . . . 16.06 112.893 -165.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -85.97 -41.86 14.52 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.54 -0.464 . . . . 17.4 110.881 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -78.37 -34.62 48.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.22 -0.446 . . . . 19.63 110.341 178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.245 -0.883 . . . . 20.33 110.734 179.396 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.413 HG12 ' HD1' ' A' ' 25' ' ' TYR . 4.3 mp . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 107.244 -1.391 . . . . 5.69 107.244 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.87 101.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.622 -1.172 . . . . 4.6 110.981 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' CD ' ' HE ' ' A' ' 21' ' ' ARG . 39.8 mt-10 -70.46 -2.12 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.372 -0.831 . . . . 5.13 111.008 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 1.2 m -57.62 -37.87 74.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.36 -0.608 . . . . 4.17 109.36 170.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -64.5 -49.03 72.93 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.701 -0.681 . . . . 3.42 111.372 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -66.59 -42.03 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 120.812 -0.355 . . . . 3.24 111.042 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 47.0 mtt -62.86 -34.83 78.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.266 -0.425 . . . . 5.17 111.145 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 5' ' ' SER . 51.0 mt-30 -59.14 -47.44 85.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.751 -0.38 . . . . 5.38 110.615 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.979 ' HB3' HD12 ' A' ' 17' ' ' LEU . 15.9 mt -60.31 -47.79 84.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.572 0.701 . . . . 3.9 109.989 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.17 -50.61 71.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.571 -1.195 . . . . 4.46 111.915 -174.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -69.53 1.27 4.2 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.528 0.566 . . . . 6.27 112.528 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 22.4 ptp -130.07 10.01 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.028 -0.269 . . . . 5.2 111.7 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.16 -94.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.528 -1.32 . . . . 4.75 113.611 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.8 m-85 -130.44 159.15 72.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.322 . . . . 5.09 110.129 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -69.66 80.79 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.984 2.456 . . . . 4.25 110.945 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.979 HD12 ' HB3' ' A' ' 10' ' ' LEU . 90.4 mt -81.67 66.72 7.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.7 -0.682 . . . . 3.29 111.849 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.74 -22.56 24.47 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.57 0.7 . . . . 5.48 110.125 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB1' ' HZ3' ' A' ' 38' ' ' TRP . . . -58.9 -33.25 70.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.453 -0.794 . . . . 3.54 110.042 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.573 ' HB2' HD12 ' A' ' 10' ' ' LEU . 44.3 t -73.16 -39.37 65.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.606 -0.725 . . . . 3.27 109.855 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.455 ' HE ' ' CD ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -50.02 -56.18 11.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.666 0.746 . . . . 6.1 109.803 177.159 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.605 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -71.69 -25.38 62.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.337 -0.847 . . . . 4.77 110.539 178.459 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -68.34 -43.24 77.91 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 116.396 -0.365 . . . . 4.34 110.976 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 20' ' ' CYS . 88.5 t -60.1 -43.09 92.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.965 0.412 . . . . 4.58 109.978 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.413 ' HD1' HG12 ' A' ' 2' ' ' ILE . 80.1 t80 -65.84 -39.1 90.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.039 -0.528 . . . . 7.48 110.864 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -71.62 -43.64 65.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 6.84 111.824 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -61.88 -27.64 68.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.107 0.48 . . . . 5.71 110.908 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.78 38.6 6.89 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 5.75 112.357 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 58.94 75.42 0.4 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.243 0.544 . . . . 5.06 110.077 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.487 ' HB3' HG21 ' A' ' 34' ' ' VAL . 26.3 mmt -112.88 -0.6 14.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.167 -0.47 . . . . 6.28 110.803 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.87 159.27 23.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.774 -0.727 . . . . 4.17 112.184 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.34 88.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 3.73 111.299 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 4.0 mp0 -58.35 -39.35 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.9 -0.591 . . . . 5.46 111.024 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' A' ' 30' ' ' MET . 75.1 t -71.54 -41.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 4.88 111.202 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.1 63.32 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 3.68 110.74 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.477 ' HD1' HD22 ' A' ' 10' ' ' LEU . 70.6 t80 -56.2 -43.09 78.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.99 -0.744 . . . . 4.71 108.99 170.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.524 ' HA ' HG13 ' A' ' 40' ' ' ILE . 26.2 t-20 -66.3 -37.84 86.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.857 . . . . 5.69 110.617 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.467 ' HE3' HD12 ' A' ' 39' ' ' ILE . 51.3 t90 -61.22 -35.52 77.44 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.433 0.635 . . . . 5.87 109.802 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.741 HG12 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -76.58 -43.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 3.69 111.696 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 37' ' ' ASN . 2.8 pp -70.33 -23.3 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.385 -0.526 . . . . 5.04 111.446 -174.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.29 -31.63 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 5.37 110.401 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -96.06 10.84 36.22 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.16 0.43 . . . . 5.35 112.16 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.3 ptt? . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 120.894 0.378 . . . . 5.73 111.051 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.7 0.286 . . . . 7.14 110.478 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.628 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 89.1 Cg_exo -49.85 167.05 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.732 2.954 . . . . 5.41 112.928 171.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.669 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 34.2 Cg_endo -61.47 112.45 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.481 2.121 . . . . 7.14 111.353 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.773 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.3 pt-20 -57.21 -27.59 62.13 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.882 -0.599 . . . . 10.13 110.63 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.8 tt0 -59.14 -51.99 67.64 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.21 0.528 . . . . 11.78 109.741 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 84' ' ' ILE . 80.4 mt -75.77 -42.37 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.671 -0.695 . . . . 8.42 112.024 -175.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.773 HG22 ' HA ' ' A' ' 79' ' ' GLU . 12.0 m -56.01 -38.45 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.594 -0.891 . . . . 7.57 108.594 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.31 -50.09 75.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.561 -1.2 . . . . 10.39 110.649 175.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 81' ' ' ILE . 23.2 mt -59.24 -42.22 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.965 -0.562 . . . . 10.78 110.613 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.738 HD12 ' HB1' ' A' ' 95' ' ' ALA . 84.9 mt -65.5 -46.01 91.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.833 -0.622 . . . . 8.01 111.467 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -71.31 -20.48 62.19 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.073 -0.651 . . . . 10.38 110.837 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -76.79 -21.13 55.58 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.412 . . . . 12.35 110.416 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 mmt -71.5 -22.45 61.79 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.464 0.65 . . . . 10.33 109.813 173.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.77 -3.3 8.04 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.196 -0.911 . . . . 9.53 111.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.599 ' HB2' HG22 ' A' ' 85' ' ' ILE . 31.9 m-85 -87.06 -179.07 6.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.792 0.33 . . . . 8.89 110.478 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 34.6 tt0 -90.58 141.54 28.67 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.589 -0.523 . . . . 10.16 109.589 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 11.7 ttm180 -56.48 -52.65 63.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.948 0.404 . . . . 11.98 110.354 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.78 -34.37 74.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.61 . . . . 9.02 110.938 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.2 tt0 -66.29 -39.2 89.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.57 -0.741 . . . . 6.68 109.359 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.738 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.32 -41.65 98.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.27 -0.877 . . . . 5.22 110.219 173.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.628 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.52 -52.09 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.872 -0.604 . . . . 6.39 110.419 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.573 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 59.6 tt0 -54.13 -47.94 71.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 8.36 110.742 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.89 -53.21 60.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.193 -0.912 . . . . 5.41 110.593 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 109' ' ' ALA . 73.6 mt -61.48 -30.73 70.79 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.593 -0.276 . . . . 5.77 111.36 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.573 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -56.49 -48.18 77.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 7.71 109.802 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.31 68.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.929 -1.032 . . . . 8.88 111.624 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 98' ' ' ALA . 23.6 p -81.59 -7.41 59.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.354 0.502 . . . . 8.79 112.354 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.5 t30 65.18 63.27 0.67 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.601 0.715 . . . . 10.09 110.133 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.576 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.4 p-10 49.66 28.93 2.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.003 -1.453 . . . . 7.8 112.533 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -89.03 110.49 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.096 -0.705 . . . . 10.49 109.096 173.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.748 HD12 HG12 ' A' ' 81' ' ' ILE . 8.4 tt -56.31 -61.2 2.57 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.071 -0.968 . . . . 9.54 112.132 -175.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.431 ' N ' HD23 ' A' ' 106' ' ' LEU . 16.7 mm-40 -56.04 -46.89 78.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.378 -0.828 . . . . 11.82 111.115 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.639 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.3 ttm180 -66.36 -28.62 68.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.573 -0.285 . . . . 12.41 110.748 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.67 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.74 -50.66 68.2 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.332 -0.618 . . . . 6.3 109.332 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.54 HD23 HG23 ' A' ' 85' ' ' ILE . 18.3 mt -59.91 -39.0 83.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.183 -0.917 . . . . 7.78 109.635 175.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.81 -51.1 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 9.04 109.826 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -64.11 -42.67 96.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.507 -1.224 . . . . 8.69 110.862 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.665 HD13 ' HG2' ' A' ' 94' ' ' GLN . 47.6 mt -70.71 -40.66 77.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.361 -0.836 . . . . 5.25 111.584 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 6.92 111.802 -174.931 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.132 0.491 . . . . 5.69 109.876 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.92 82.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 4.6 110.364 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 8' ' ' MET . 43.8 mt-10 -72.63 -10.82 60.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.739 -0.664 . . . . 5.13 111.99 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.628 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 25.1 p -65.33 -32.6 74.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.732 -0.84 . . . . 4.17 108.732 175.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.689 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 43.6 m -59.87 -53.4 58.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.194 -0.912 . . . . 3.42 111.472 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -63.21 -37.84 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.734 -0.387 . . . . 3.24 110.435 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.486 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 64.3 mtt -62.69 -28.25 69.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 5.17 111.396 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 5' ' ' SER . 93.6 mt-30 -65.33 -46.74 79.06 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.91 -0.316 . . . . 5.38 110.478 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.695 HD11 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.21 -40.45 86.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.783 0.801 . . . . 3.9 109.375 176.13 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.47 -47.41 84.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.141 -1.391 . . . . 4.46 112.548 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.68 -27.87 69.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.267 0.469 . . . . 6.27 112.267 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 ptm -99.35 2.0 44.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.625 0.25 . . . . 5.2 111.268 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.96 -116.16 0.35 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.406 -0.902 . . . . 4.75 112.851 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.1 m-85 -101.65 154.32 37.35 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 5.09 110.719 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -71.47 85.65 0.88 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.785 2.323 . . . . 4.25 111.468 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 39' ' ' ILE . 2.6 mm? -78.46 68.67 4.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 3.29 112.089 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 12.9 tt0 -55.53 -25.38 37.16 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.912 -0.492 . . . . 5.48 110.918 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.7 -31.95 66.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 3.54 109.801 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.695 ' SG ' HD11 ' A' ' 10' ' ' LEU . 28.0 t -73.68 -39.88 64.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.481 -0.781 . . . . 3.27 109.769 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 18' ' ' GLU . 10.0 ttp180 -53.27 -53.37 51.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.085 0.469 . . . . 6.1 110.709 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 18' ' ' GLU . 8.7 ptpt -72.17 -22.83 61.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.226 -0.443 . . . . 4.77 110.721 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . . . -69.39 -41.28 76.66 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.237 -0.438 . . . . 4.34 110.75 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 20' ' ' CYS . 73.4 t -58.5 -42.17 83.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 4.58 110.159 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.11 -38.6 82.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.663 -0.415 . . . . 7.48 110.366 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.59 -37.64 82.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.388 -0.369 . . . . 6.84 111.427 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.5 p -71.55 -17.7 62.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 5.71 111.406 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.95 23.48 20.24 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.876 -0.678 . . . . 5.75 111.481 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.19 58.88 1.36 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.6 0.714 . . . . 5.06 110.263 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.429 ' HB3' HG21 ' A' ' 34' ' ' VAL . 87.4 mmm -88.23 -11.78 45.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.491 -0.777 . . . . 6.28 111.757 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.44 -173.67 17.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 4.17 113.298 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.689 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -58.84 -55.57 33.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.659 0.615 . . . . 3.73 112.659 -174.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.75 -44.78 92.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 5.46 112.149 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 30' ' ' MET . 86.9 t -65.25 -42.42 93.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.741 0.305 . . . . 4.88 111.096 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.16 50.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.596 -0.441 . . . . 3.68 111.172 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.519 ' O ' HG22 ' A' ' 39' ' ' ILE . 86.3 t80 -61.43 -40.63 95.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.978 -0.749 . . . . 4.71 108.978 171.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 40' ' ' ILE . 92.0 m-20 -60.69 -45.37 94.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.784 -0.644 . . . . 5.69 110.218 174.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 23' ' ' ALA . 42.9 t90 -60.84 -41.33 95.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.067 0.46 . . . . 5.87 110.114 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 36' ' ' PHE . 3.9 tp -73.07 -36.23 50.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.125 -0.489 . . . . 3.69 111.487 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.0 -21.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.108 0.48 . . . . 5.04 110.804 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 37' ' ' ASN . 95.3 t -74.88 -42.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.116 -0.493 . . . . 5.37 110.508 171.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -100.54 16.5 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.992 0.367 . . . . 5.35 111.992 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.0 ppp? . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 121.154 0.502 . . . . 5.73 111.059 178.019 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 50.3 tt0 . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 109.522 -0.548 . . . . 7.14 109.522 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.586 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 86.8 Cg_exo -53.24 160.76 4.31 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.626 2.884 . . . . 5.41 113.579 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.722 ' HD2' HD13 ' A' ' 99' ' ' LEU . 46.5 Cg_endo -66.39 112.96 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.943 2.429 . . . . 7.14 111.157 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 82' ' ' VAL . 5.5 pt-20 -56.15 -27.35 53.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.67 -0.696 . . . . 10.13 111.079 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.7 tt0 -58.56 -53.07 62.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.195 0.521 . . . . 11.78 110.093 172.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.782 ' HA ' HD12 ' A' ' 84' ' ' ILE . 74.6 mt -74.66 -40.98 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.737 -0.665 . . . . 8.42 111.799 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.752 ' O ' HG22 ' A' ' 86' ' ' THR . 16.1 m -56.47 -37.85 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.719 -0.845 . . . . 7.57 108.719 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.3 -48.63 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.613 -1.176 . . . . 10.39 110.557 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.782 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.2 mt -60.63 -43.36 94.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 10.78 110.8 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.755 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.7 mt -63.53 -45.31 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.951 -0.568 . . . . 8.01 111.57 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 82' ' ' VAL . 2.1 t -72.5 -20.54 61.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.313 -0.555 . . . . 10.38 110.945 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.1 m -79.92 -16.95 54.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.798 0.333 . . . . 12.35 110.517 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.4 mmm -74.65 -25.29 59.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.302 0.572 . . . . 10.33 109.932 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.63 -2.27 4.89 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.977 -1.01 . . . . 9.53 111.762 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.596 ' HB2' HG22 ' A' ' 85' ' ' ILE . 30.7 m-85 -94.39 -173.8 3.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.666 0.27 . . . . 8.89 110.55 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 7.3 tt0 -101.03 145.54 28.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.66 -0.496 . . . . 10.16 109.66 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.447 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.5 ttm180 -58.11 -52.21 66.48 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.045 0.45 . . . . 11.98 110.61 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 48.3 t30 -58.41 -37.36 75.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.617 -0.719 . . . . 9.02 110.766 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 5.9 tt0 -65.71 -38.3 88.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.629 -0.714 . . . . 6.68 109.748 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.755 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.09 -37.96 89.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.215 -0.902 . . . . 5.22 110.755 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.597 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -58.61 -53.92 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 116.446 -0.343 . . . . 6.39 110.855 177.238 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 53.5 tt0 -57.4 -44.36 84.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.232 0.539 . . . . 8.36 110.866 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.32 -52.52 65.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.041 -0.981 . . . . 5.41 110.355 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.722 HD13 ' HD2' ' A' ' 78' ' ' PRO . 79.6 mt -61.69 -34.16 75.27 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.548 -0.296 . . . . 5.77 111.659 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 96' ' ' ILE . 59.1 mtp180 -58.47 -41.24 84.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.299 0.571 . . . . 7.71 110.643 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.4 -38.11 60.1 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.195 -0.911 . . . . 8.88 111.385 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 32.9 p -87.56 1.31 53.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.707 0.632 . . . . 8.79 112.707 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.19 65.21 1.23 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.67 -0.695 . . . . 10.09 110.575 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.5 p-10 50.01 28.33 2.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.13 -1.395 . . . . 7.8 112.562 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.5 t-20 -90.12 109.69 20.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.257 -0.646 . . . . 10.49 109.257 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.737 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.2 tt -52.44 -59.96 3.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.945 -1.025 . . . . 9.54 111.771 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -54.24 -52.44 61.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.706 -1.134 . . . . 11.82 111.794 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 17.7 ttm180 -66.47 -27.48 67.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.511 . . . . 12.41 110.96 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.63 -51.37 67.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.398 -0.593 . . . . 6.3 109.398 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.482 HD23 HG23 ' A' ' 85' ' ' ILE . 18.2 mt -59.82 -38.6 82.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.267 -0.879 . . . . 7.78 109.763 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 8.3 t70 -54.76 -51.15 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.869 -1.06 . . . . 9.04 110.155 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.36 -48.1 79.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.326 -1.306 . . . . 8.69 110.395 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 95' ' ' ALA . 41.1 mt -62.09 -41.16 90.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.231 -0.895 . . . . 5.25 110.974 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.6 t80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 6.92 111.106 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.462 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 86.3 mt . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 108.823 -0.806 . . . . 5.69 108.823 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.15 81.15 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.138 0.495 . . . . 4.6 111.34 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.581 ' HA ' HG12 ' A' ' 7' ' ' VAL . 35.8 mt-10 -70.83 -7.94 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.012 -0.54 . . . . 5.13 110.591 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 13.2 m -57.43 -34.83 69.34 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.27 -0.641 . . . . 4.17 109.27 170.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 3.3 m -66.13 -51.79 54.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.442 -0.799 . . . . 3.42 111.202 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -64.14 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 3.24 110.902 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 77.3 mtp -63.04 -32.66 74.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 5.17 111.052 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.625 ' O ' ' HG2' ' A' ' 13' ' ' MET . 86.3 mm-40 -59.37 -48.82 80.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.061 -0.256 . . . . 5.38 110.454 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 39' ' ' ILE . 18.5 mt -64.63 -45.29 87.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.506 0.67 . . . . 3.9 110.184 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.79 -50.31 71.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.708 -1.133 . . . . 4.46 112.489 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.451 . . . . 6.27 111.565 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.625 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 24.2 ptt? -104.82 22.48 15.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.111 -0.495 . . . . 5.2 111.629 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.45 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.126 -1.035 . . . . 4.75 112.851 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 29.2 p90 -158.83 164.93 19.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.676 -0.861 . . . . 5.09 108.676 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 88.7 Cg_endo -71.52 83.94 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.562 2.175 . . . . 4.25 113.562 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.637 ' HG ' HG12 ' A' ' 39' ' ' ILE . 3.1 mm? -75.15 64.87 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.074 -0.25 . . . . 3.29 111.641 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.75 -19.38 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 121.387 -0.821 . . . . 5.48 109.681 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.594 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . . . -57.82 -32.7 67.84 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.577 -0.738 . . . . 3.54 110.029 170.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 35.1 t -72.09 -42.99 65.52 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.768 -1.105 . . . . 3.27 109.646 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -54.15 -46.67 72.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.161 0.505 . . . . 6.1 110.178 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 42.6 mtmt -70.52 -26.01 63.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 4.77 110.744 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.565 ' HB1' ' HD1' ' A' ' 38' ' ' TRP . . . -74.16 -44.89 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 4.34 110.928 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 20' ' ' CYS . 92.1 t -53.6 -47.68 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 4.58 109.954 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -56.08 -45.77 79.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.486 -0.779 . . . . 7.48 110.783 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -66.03 -40.3 90.92 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.405 -0.361 . . . . 6.84 111.593 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 30' ' ' MET . 74.8 p -67.47 -11.75 58.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.353 . . . . 5.71 111.51 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.62 26.18 47.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.921 -0.657 . . . . 5.75 111.722 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 76.7 m-20 60.84 60.57 1.84 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.181 0.515 . . . . 5.06 110.342 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 27' ' ' THR . 17.1 mmt -86.28 -34.25 20.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 6.28 112.152 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 170.4 17.74 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.929 -1.129 . . . . 4.17 112.795 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 6' ' ' SER . . . -62.62 -58.37 7.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.207 0.447 . . . . 3.73 112.207 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.58 -31.13 67.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.367 -0.379 . . . . 5.46 111.065 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.72 -45.28 92.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.068 -0.515 . . . . 4.88 110.662 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -27.02 50.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.92 -0.312 . . . . 3.68 111.258 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 66.6 t80 -56.6 -43.92 80.61 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.875 -0.787 . . . . 4.71 108.875 169.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.568 ' O ' HG13 ' A' ' 40' ' ' ILE . 41.6 t-20 -63.06 -43.74 97.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.066 -0.97 . . . . 5.69 110.28 177.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.565 ' HD1' ' HB1' ' A' ' 23' ' ' ALA . 13.1 t-105 -65.49 -30.24 70.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.809 -0.357 . . . . 5.87 111.029 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.637 HG12 ' HG ' ' A' ' 17' ' ' LEU . 3.1 tp -76.21 -37.65 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.997 -0.281 . . . . 3.69 110.912 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.49 -21.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.444 0.64 . . . . 5.04 110.378 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 37' ' ' ASN . 72.4 t -74.22 -51.01 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.594 -0.73 . . . . 5.37 109.997 169.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -85.42 14.38 5.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.193 0.442 . . . . 5.35 112.193 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 23.2 ptt? . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.358 -0.608 . . . . 5.73 109.358 169.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 . . . . . 0 C--O 1.235 0.335 0 CA-C-O 120.511 0.196 . . . . 7.14 110.719 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.573 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 88.4 Cg_exo -51.03 165.04 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.524 2.816 . . . . 5.41 112.823 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.669 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 41.9 Cg_endo -63.53 112.54 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.474 2.116 . . . . 7.14 110.999 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.753 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.5 pt-20 -55.84 -30.72 61.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.899 -0.592 . . . . 10.13 110.295 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.73 -51.48 67.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.562 -0.744 . . . . 11.78 110.139 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 75.1 mt -76.24 -42.7 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.924 -0.58 . . . . 8.42 111.98 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.779 ' O ' HG22 ' A' ' 86' ' ' THR . 12.6 m -55.76 -37.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.507 -0.923 . . . . 7.57 108.507 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.01 86.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.681 -1.145 . . . . 10.39 110.927 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.6 mt -60.58 -41.98 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.225 0.536 . . . . 10.78 110.501 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.75 HD12 ' HB1' ' A' ' 95' ' ' ALA . 89.6 mt -65.5 -47.4 86.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.703 -0.681 . . . . 8.01 111.527 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -70.19 -21.99 62.98 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.172 -0.611 . . . . 10.38 110.536 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 t -75.44 -19.95 59.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.976 0.417 . . . . 12.35 110.046 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.2 mmt -75.78 -24.55 56.0 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.323 0.582 . . . . 10.33 110.396 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.67 9.03 4.1 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.392 -0.822 . . . . 9.53 111.8 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.606 ' HB2' HG22 ' A' ' 85' ' ' ILE . 28.6 m-85 -101.05 -175.36 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.859 -0.423 . . . . 8.89 109.859 177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.587 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 7.2 tt0 -100.23 145.31 28.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.659 -0.497 . . . . 10.16 109.659 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.2 ttm180 -56.43 -52.29 65.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 11.98 110.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.46 -35.96 75.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.792 -0.64 . . . . 9.02 111.085 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.618 ' HG2' HD13 ' A' ' 113' ' ' ILE . 7.7 tt0 -66.14 -38.65 88.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.699 . . . . 6.68 109.664 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.75 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.22 -39.51 94.13 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.231 -0.895 . . . . 5.22 110.412 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.573 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -59.26 -52.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.191 -0.459 . . . . 6.39 110.729 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.452 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 34.1 tt0 -56.61 -43.97 80.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.881 -0.6 . . . . 8.36 110.961 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.35 -53.89 52.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.409 -0.814 . . . . 5.41 110.846 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.728 HD23 ' HB2' ' A' ' 109' ' ' ALA . 84.3 mt -60.02 -34.2 73.04 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 111.474 0.176 . . . . 5.77 111.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.2 mtt180 -55.39 -46.47 76.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.528 0.68 . . . . 7.71 110.304 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.89 -42.48 69.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.125 -0.943 . . . . 8.88 111.422 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.687 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.3 p -82.93 -1.35 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.564 0.579 . . . . 8.79 112.564 -174.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m120 63.81 60.03 1.09 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.049 -0.523 . . . . 10.09 110.362 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 3.3 p-10 48.63 34.42 5.03 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.351 1.06 . . . . 7.8 111.933 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.6 t-20 -93.24 111.29 22.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.79 -0.818 . . . . 10.49 108.79 174.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.7 HD12 HG12 ' A' ' 81' ' ' ILE . 7.8 tt -56.24 -59.35 5.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.464 -0.789 . . . . 9.54 111.516 -175.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.413 ' N ' HD23 ' A' ' 106' ' ' LEU . 4.3 mt-10 -55.98 -50.06 71.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.711 -1.131 . . . . 11.82 111.344 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.687 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -66.03 -29.09 69.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.547 -0.751 . . . . 12.41 111.281 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.728 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.24 -50.13 72.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.308 -0.627 . . . . 6.3 109.308 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 85' ' ' ILE . 18.5 mt -61.31 -36.74 80.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.163 -0.926 . . . . 7.78 109.904 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 8.4 t70 -57.14 -52.88 63.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.263 -0.88 . . . . 9.04 109.627 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 63.8 t90 -60.59 -45.24 94.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.126 -1.397 . . . . 8.69 110.498 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.625 HD11 ' HA ' ' A' ' 95' ' ' ALA . 53.0 mt -67.71 -34.25 66.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.058 -0.974 . . . . 5.25 110.901 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.9 t80 . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.382 0.61 . . . . 6.92 110.165 177.548 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.45 -0.574 . . . . 5.69 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -75.0 76.94 2.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.435 0.636 . . . . 4.6 109.642 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.519 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.5 mt-10 -72.34 -10.48 59.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.809 -0.632 . . . . 5.13 112.022 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 54.3 p -62.05 -38.01 87.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.371 0.605 . . . . 4.17 109.489 176.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.684 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 50.3 m -60.67 -52.27 65.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.097 -0.956 . . . . 3.42 111.594 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.57 HG23 ' HB3' ' A' ' 20' ' ' CYS . 7.4 p -64.34 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.561 -0.456 . . . . 3.24 110.907 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 67.1 mtt -59.7 -31.88 70.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.519 -0.31 . . . . 5.17 111.22 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.591 ' O ' ' HG2' ' A' ' 13' ' ' MET . 86.1 mm-40 -60.9 -56.88 15.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.593 -0.276 . . . . 5.38 110.48 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.81 HD11 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.9 -28.73 67.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.565 -0.454 . . . . 3.9 111.387 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.32 86.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.429 . . . . 4.46 110.996 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -79.45 -42.18 25.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 6.27 111.439 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.591 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 26.2 ptt? -92.14 32.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.782 0.325 . . . . 5.2 111.251 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.09 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.403 -0.903 . . . . 4.75 112.347 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.626 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 12.4 p90 -166.53 162.15 11.74 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.092 -0.707 . . . . 5.09 109.092 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 22.8 Cg_endo -55.1 91.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.687 2.924 . . . . 4.25 112.99 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.647 HD12 ' HB2' ' A' ' 10' ' ' LEU . 70.4 mt -96.81 57.32 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.891 -0.595 . . . . 3.29 111.745 -175.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -55.67 -23.89 30.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.161 0.505 . . . . 5.48 110.718 174.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.455 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . . . -57.75 -36.95 72.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.925 -0.58 . . . . 3.54 110.001 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.81 ' SG ' HD11 ' A' ' 10' ' ' LEU . 20.2 t -73.81 -31.75 63.4 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.421 -0.809 . . . . 3.27 110.449 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.38 -48.72 71.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.48 -0.933 . . . . 6.1 108.48 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 18.8 mttm -66.09 -42.32 89.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.026 . . . . 4.77 109.976 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -60.37 -40.81 92.16 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.643 -0.708 . . . . 4.34 111.918 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 20' ' ' CYS . 39.9 t -59.08 -45.76 92.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.153 -0.314 . . . . 4.58 110.153 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.46 -41.83 99.05 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.454 -0.498 . . . . 7.48 110.223 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.15 -41.59 85.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.82 -0.627 . . . . 6.84 112.085 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -65.46 -23.36 66.9 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.057 0.456 . . . . 5.71 110.835 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.37 29.65 8.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.6 -0.727 . . . . 5.75 111.73 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 59.39 49.44 8.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.217 0.532 . . . . 5.06 110.297 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.4 mmm -82.42 3.78 26.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 6.28 112.192 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.32 171.45 23.08 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.567 -0.825 . . . . 4.17 112.444 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.684 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -67.68 -45.22 75.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.665 -0.267 . . . . 3.73 111.679 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.97 -31.36 70.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.481 -0.327 . . . . 5.46 111.663 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.07 -44.65 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 4.88 110.56 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.0 60.72 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.613 -0.435 . . . . 3.68 110.49 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.454 ' O ' HG22 ' A' ' 39' ' ' ILE . 83.9 t80 -56.35 -42.55 77.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.958 -0.756 . . . . 4.71 108.958 171.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -61.75 -45.96 91.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 5.69 110.612 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -59.44 -43.03 93.22 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.532 0.682 . . . . 5.87 109.842 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 10' ' ' LEU . 3.0 tp -74.77 -36.3 39.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.486 -0.779 . . . . 3.69 111.861 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 43' ' ' MET . 2.8 pp -71.47 -21.34 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 5.04 111.54 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.59 -36.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.54 . . . . 5.37 110.19 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -99.52 7.6 45.21 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.416 0.524 . . . . 5.35 112.416 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 4.8 ppp? . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.211 0.529 . . . . 5.73 111.001 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.141 -0.318 . . . . 7.14 110.141 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.621 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 76.7 Cg_exo -55.09 163.93 3.99 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.249 2.633 . . . . 5.41 112.044 171.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.685 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 36.6 Cg_endo -63.51 113.18 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.598 2.199 . . . . 7.14 111.464 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -58.16 -23.28 54.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.952 -0.567 . . . . 10.13 111.16 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 8.7 tt0 -61.61 -52.57 63.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.128 -0.487 . . . . 11.78 109.879 171.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.5 mt -75.18 -41.55 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.617 -0.72 . . . . 8.42 111.944 -175.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.79 HG22 ' HA ' ' A' ' 79' ' ' GLU . 13.7 m -56.56 -38.02 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.604 -0.887 . . . . 7.57 108.604 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.49 -49.88 75.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.903 -1.044 . . . . 10.39 110.576 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.0 mt -59.69 -43.07 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 10.78 110.808 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.743 HD12 ' HB1' ' A' ' 95' ' ' ALA . 90.5 mt -63.96 -47.76 89.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.92 -0.582 . . . . 8.01 111.84 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -70.08 -23.69 63.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.013 -0.675 . . . . 10.38 110.51 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.5 m -69.75 -31.2 69.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.701 0.286 . . . . 12.35 110.24 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 93.4 mmm -62.78 -29.07 70.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.206 0.526 . . . . 10.33 110.679 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.2 4.2 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.364 -0.835 . . . . 9.53 112.005 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.57 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.7 m-85 -91.5 -173.85 3.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.207 -0.294 . . . . 8.89 110.207 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.594 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 58.1 tt0 -101.49 147.16 26.7 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.699 -0.482 . . . . 10.16 109.699 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' HD12 ' A' ' 96' ' ' ILE . 20.7 ttm180 -57.74 -52.7 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 11.98 110.763 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -58.64 -36.74 74.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.776 -0.647 . . . . 9.02 110.786 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.653 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.8 tt0 -65.82 -38.94 90.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.546 -0.752 . . . . 6.68 109.63 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.743 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.88 -40.77 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.272 -0.876 . . . . 5.22 110.519 174.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.621 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -58.5 -52.2 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 116.002 -0.545 . . . . 6.39 110.656 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.646 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 27.3 tt0 -56.55 -44.78 81.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.046 -0.524 . . . . 8.36 111.08 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.95 -53.39 58.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.457 -0.792 . . . . 5.41 110.659 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 109' ' ' ALA . 76.1 mt -61.65 -32.28 72.44 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.609 -0.269 . . . . 5.77 111.392 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.646 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 88.7 mtt180 -54.86 -46.7 74.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.601 . . . . 7.71 109.752 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.69 62.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.928 -1.033 . . . . 8.88 111.903 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 27.8 p -85.2 1.04 49.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.627 0.603 . . . . 8.79 112.627 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.73 45.68 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.972 -0.558 . . . . 10.09 110.242 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.655 ' ND2' ' HD3' ' A' ' 78' ' ' PRO . 2.8 m-20 69.93 16.56 7.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 7.8 111.072 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.4 t-20 -80.43 111.07 16.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.482 -0.562 . . . . 10.49 109.482 176.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.4 tt -55.02 -60.28 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.287 -0.87 . . . . 9.54 111.536 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 -52.74 52.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.681 -1.145 . . . . 11.82 110.913 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.692 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 12.2 ttm180 -65.14 -28.48 69.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.429 -0.805 . . . . 12.41 111.354 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.04 -50.56 70.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.394 -0.595 . . . . 6.3 109.394 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 85' ' ' ILE . 15.8 mt -59.75 -39.07 83.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 7.78 109.717 175.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.57 -50.06 73.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.007 -0.997 . . . . 9.04 109.956 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.57 -46.83 86.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.621 -1.172 . . . . 8.69 110.408 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.653 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.2 mt -63.61 -35.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.201 -0.908 . . . . 5.25 110.926 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 80.9 t80 . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 6.92 110.108 177.471 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mt . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 110.35 -0.241 . . . . 5.69 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.96 94.43 1.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 4.6 110.208 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.541 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.0 mt-10 -72.49 -2.33 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.95 -0.568 . . . . 5.13 112.136 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 4.4 m -59.99 -41.98 93.25 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.582 -0.525 . . . . 4.17 109.582 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 20.8 p -61.98 -52.11 65.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 3.42 111.832 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.6 p -62.02 -39.74 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 120.852 -0.339 . . . . 3.24 110.996 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.54 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 49.4 mtm -65.18 -26.75 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.449 -0.342 . . . . 5.17 111.445 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 5' ' ' SER . 76.6 mt-30 -69.09 -37.68 78.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.7 -0.4 . . . . 5.38 110.266 175.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.759 ' HB3' HD12 ' A' ' 17' ' ' LEU . 13.6 mt -68.89 -40.5 79.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.079 0.942 . . . . 3.9 109.133 172.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 8' ' ' MET . . . -62.8 -41.73 99.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.507 -1.224 . . . . 4.46 111.675 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 8' ' ' MET . 71.0 mm-40 -62.31 -29.93 70.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.606 0.595 . . . . 6.27 112.606 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.636 ' HG2' ' O ' ' A' ' 10' ' ' LEU . 22.0 ptp -81.84 -4.46 56.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.441 -0.504 . . . . 5.2 110.156 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.17 48.73 1.41 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.711 -0.677 . . . . 4.75 113.462 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 73.0 m-85 -143.12 125.37 8.7 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.859 0.361 . . . . 5.09 110.583 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.45 66.71 5.49 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.468 2.779 . . . . 4.25 111.762 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 10' ' ' LEU . 80.9 mt -94.2 57.66 2.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.649 0.737 . . . . 3.29 111.875 -172.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 13.9 tt0 -56.57 -22.32 32.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.179 0.514 . . . . 5.48 109.896 168.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -29.35 65.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.649 -0.705 . . . . 3.54 109.659 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.579 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.7 t -72.19 -44.61 62.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.758 . . . . 3.27 108.955 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.451 ' NH2' ' HG3' ' A' ' 18' ' ' GLU . 12.2 ttp180 -51.84 -42.33 62.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.878 -0.601 . . . . 6.1 110.232 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 42.8 mttt -71.47 -39.42 70.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.613 -0.721 . . . . 4.77 110.435 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.57 99.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.601 -0.727 . . . . 4.34 111.268 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 20' ' ' CYS . 88.6 t -59.15 -46.21 92.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.166 -0.47 . . . . 4.58 110.432 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -54.47 -48.2 72.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.256 -0.429 . . . . 7.48 110.921 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.96 -39.62 87.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.194 -0.457 . . . . 6.84 111.611 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 p -68.32 -15.08 63.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.081 0.467 . . . . 5.71 110.979 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.71 29.27 43.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.352 -0.699 . . . . 5.75 111.352 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.3 t30 60.67 73.91 0.47 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.349 0.595 . . . . 5.06 110.626 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.543 ' HB3' HG21 ' A' ' 34' ' ' VAL . 19.2 mmt -102.31 18.8 20.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.771 -0.65 . . . . 6.28 110.863 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.24 -178.65 50.71 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.574 -0.739 . . . . 4.17 113.059 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.4 -37.38 77.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.785 0.291 . . . . 3.73 111.785 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -54.62 -56.55 17.88 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.618 0.723 . . . . 5.46 110.395 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 30' ' ' MET . 92.9 t -65.42 -40.38 88.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.05 -0.977 . . . . 4.88 111.803 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.44 -35.1 58.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.313 0.486 . . . . 3.68 112.313 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.5 t80 -58.75 -41.91 87.61 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.879 -0.785 . . . . 4.71 108.879 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.528 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.2 m-80 -69.28 -38.43 78.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.671 -0.695 . . . . 5.69 110.862 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.5 -37.23 86.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.803 -0.443 . . . . 5.87 109.803 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.556 HG21 HD13 ' A' ' 10' ' ' LEU . 4.7 tp -72.57 -39.01 60.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.058 -0.519 . . . . 3.69 111.176 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -70.15 -21.67 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.371 0.605 . . . . 5.04 110.786 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 37' ' ' ASN . 70.6 t -74.45 -44.85 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.892 -0.595 . . . . 5.37 110.644 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -99.42 12.22 36.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.95 0.405 . . . . 5.35 111.223 -173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.453 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 27.1 ptt? . . . . . 0 N--CA 1.468 0.472 0 CA-C-N 116.318 -0.401 . . . . 5.73 111.785 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 120.606 0.241 . . . . 7.14 110.523 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.612 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 73.0 Cg_exo -54.15 167.34 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.497 2.798 . . . . 5.41 112.592 172.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.672 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.5 Cg_endo -63.33 112.11 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.35 2.033 . . . . 7.14 111.185 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.697 ' HA ' HG22 ' A' ' 82' ' ' VAL . 9.6 pt-20 -57.0 -26.69 60.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 10.13 110.855 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 6.2 tt0 -58.99 -51.25 70.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.945 -0.571 . . . . 11.78 110.46 173.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.798 ' HA ' HD12 ' A' ' 84' ' ' ILE . 70.1 mt -76.19 -41.43 37.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.921 -0.582 . . . . 8.42 111.642 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 86' ' ' THR . 11.3 m -55.55 -37.88 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.519 -0.919 . . . . 7.57 108.519 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.27 -48.54 79.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.637 -1.165 . . . . 10.39 110.871 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.3 mt -59.53 -42.16 87.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 10.78 110.624 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.729 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.1 mt -65.0 -44.9 95.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 8.01 111.434 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -73.48 -21.18 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.189 -0.604 . . . . 10.38 110.786 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.9 m -72.72 -26.55 61.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.063 0.458 . . . . 12.35 110.124 171.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.1 mmt -68.57 -26.9 65.62 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.963 -0.562 . . . . 10.33 110.462 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 -6.05 5.08 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.407 -0.815 . . . . 9.53 111.63 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.626 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.8 m-85 -87.7 -172.29 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.068 -0.345 . . . . 8.89 110.068 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 33.9 tt0 -103.63 146.92 27.86 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.931 -0.396 . . . . 10.16 109.931 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 16.0 ttm180 -57.0 -53.13 61.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.111 0.482 . . . . 11.98 110.19 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -59.07 -39.41 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 9.02 111.046 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 4.0 tt0 -63.91 -37.02 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.392 0.615 . . . . 6.68 109.758 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.729 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.99 -38.43 90.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.179 -0.919 . . . . 5.22 110.711 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -59.93 -52.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.053 -0.522 . . . . 6.39 110.636 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 60.5 tt0 -54.93 -46.03 74.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.769 -0.65 . . . . 8.36 110.855 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.89 -53.61 55.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.235 -0.893 . . . . 5.41 110.78 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.713 HD23 ' HB2' ' A' ' 109' ' ' ALA . 74.8 mt -61.38 -31.59 71.5 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.689 -0.232 . . . . 5.77 111.327 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.5 mtt180 -55.7 -50.29 70.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.393 0.616 . . . . 7.71 110.004 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.26 74.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.729 -1.123 . . . . 8.88 111.551 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 28.4 p -83.17 -5.7 59.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.694 0.627 . . . . 8.79 112.694 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 t30 64.78 65.72 0.61 Allowed 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.645 -0.707 . . . . 10.09 109.813 -175.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.551 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.4 p30 48.92 22.81 0.61 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.221 1.008 . . . . 7.8 112.428 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -81.68 109.45 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.726 -0.472 . . . . 10.49 109.726 173.2 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.0 tt -56.59 -59.84 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.176 0.922 . . . . 9.54 111.282 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.45 -48.3 71.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.9 -1.045 . . . . 11.82 111.268 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.693 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.1 ttm180 -69.5 -28.8 66.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 12.41 110.799 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.713 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.56 -51.24 68.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.219 -0.66 . . . . 6.3 109.219 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.625 HD23 HG23 ' A' ' 85' ' ' ILE . 21.4 mt -58.1 -40.12 80.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.845 -1.07 . . . . 7.78 109.605 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.33 -50.75 70.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.388 -0.824 . . . . 9.04 110.443 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -62.91 -44.44 96.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.491 -1.231 . . . . 8.69 110.375 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 95' ' ' ALA . 51.5 mt -65.71 -45.16 92.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.009 -0.996 . . . . 5.25 111.251 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.2 t80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 6.92 110.976 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mt . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 108.141 -1.059 . . . . 5.69 108.141 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.7 88.11 0.35 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.377 0.608 . . . . 4.6 110.891 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.481 ' HA ' HG12 ' A' ' 7' ' ' VAL . 51.8 mt-10 -71.11 -8.18 51.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.282 -0.872 . . . . 5.13 110.59 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.635 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 18.8 m -57.7 -37.63 73.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.303 -0.628 . . . . 4.17 109.303 169.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 7.4 m -59.66 -51.85 68.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.794 -0.639 . . . . 3.42 110.937 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.568 HG11 ' HB2' ' A' ' 21' ' ' ARG . 4.4 p -67.45 -38.87 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 120.636 -0.426 . . . . 3.24 110.74 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.472 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 78.6 mtp -62.93 -27.01 69.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 5.17 111.324 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG3' ' O ' ' A' ' 5' ' ' SER . 79.5 mt-30 -62.65 -53.4 55.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.811 -0.44 . . . . 5.38 109.811 171.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.841 HD13 HG21 ' A' ' 39' ' ' ILE . 11.7 mt -58.51 -45.27 89.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.725 0.774 . . . . 3.9 109.653 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.8 -29.32 70.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.343 -1.299 . . . . 4.46 111.64 -175.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.14 -51.71 6.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.699 -0.682 . . . . 6.27 111.872 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.5 ptp -101.28 25.0 8.73 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 111.993 0.368 . . . . 5.2 111.993 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.94 -92.44 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.947 -1.12 . . . . 4.75 113.022 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 62.4 m-85 -136.95 151.09 71.54 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.892 -0.41 . . . . 5.09 109.892 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.56 74.44 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.802 2.335 . . . . 4.25 111.451 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.815 HD12 ' HB3' ' A' ' 10' ' ' LEU . 89.6 mt -89.45 62.6 6.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.772 -0.649 . . . . 3.29 112.175 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.551 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 7.6 tt0 -55.75 -24.54 35.86 Favored 'General case' 0 N--CA 1.458 -0.042 0 CA-C-O 120.939 0.399 . . . . 5.48 110.565 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.44 -31.17 65.65 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.124 -0.489 . . . . 3.54 110.255 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.6 t -73.5 -42.98 61.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.425 -0.807 . . . . 3.27 109.658 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HB2' HG11 ' A' ' 7' ' ' VAL . 24.5 ttt180 -52.02 -50.23 61.81 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.606 0.717 . . . . 6.1 110.082 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HE2' ' O ' ' A' ' 18' ' ' GLU . 25.8 mtmt -72.09 -23.5 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.085 -0.962 . . . . 4.77 110.623 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -73.6 -39.06 64.88 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.823 -0.626 . . . . 4.34 111.221 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' CYS . 97.7 t -58.97 -47.15 90.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.89 0.376 . . . . 4.58 110.11 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -58.64 -36.16 73.67 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.889 -0.596 . . . . 7.48 110.762 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.01 -45.78 39.52 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.506 -0.315 . . . . 6.84 111.674 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.4 p -62.21 -24.68 67.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.964 0.411 . . . . 5.71 111.162 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.14 29.41 20.13 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.803 -0.635 . . . . 5.75 112.039 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.7 t30 63.39 64.62 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.179 0.514 . . . . 5.06 110.497 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.611 ' HB3' HG21 ' A' ' 34' ' ' VAL . 87.2 mmm -91.77 -11.22 37.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.117 -0.492 . . . . 6.28 110.742 178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.23 162.05 11.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.791 -0.719 . . . . 4.17 112.387 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -55.77 -46.07 78.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.942 0.497 . . . . 3.73 111.54 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.22 -41.46 99.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 5.46 111.431 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.611 HG21 ' HB3' ' A' ' 30' ' ' MET . 98.8 t -62.58 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.475 -0.329 . . . . 4.88 111.256 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -28.89 54.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.629 -0.429 . . . . 3.68 111.24 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.605 ' O ' HG22 ' A' ' 39' ' ' ILE . 54.0 t80 -58.15 -43.24 87.25 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.043 -0.725 . . . . 4.71 109.043 170.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 40' ' ' ILE . 94.2 m-20 -67.72 -40.65 84.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 5.69 110.952 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -59.86 -38.34 81.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.386 0.612 . . . . 5.87 109.932 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.841 HG21 HD13 ' A' ' 10' ' ' LEU . 4.3 tp -74.57 -37.57 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.862 -0.608 . . . . 3.69 111.699 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.8 pp -70.34 -23.35 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.406 -0.517 . . . . 5.04 110.899 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.9 t -79.43 -34.84 16.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 5.37 110.725 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -98.96 5.29 47.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.15 0.426 . . . . 5.35 112.15 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.587 0.232 . . . . 5.73 111.316 -177.934 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.956 -0.387 . . . . 7.14 109.956 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.605 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 58.7 Cg_exo -55.87 161.54 8.18 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.878 2.386 . . . . 5.41 112.264 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.695 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.0 Cg_endo -62.66 112.62 1.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 7.14 111.246 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.757 ' HA ' HG22 ' A' ' 82' ' ' VAL . 1.6 pm0 -57.11 -25.73 59.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.731 -0.668 . . . . 10.13 111.528 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 7.0 tt0 -60.15 -50.94 71.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.014 0.435 . . . . 11.78 109.839 172.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.796 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.2 mt -75.38 -42.17 43.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 8.42 111.737 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 86' ' ' THR . 11.2 m -56.12 -38.18 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.426 -0.953 . . . . 7.57 108.426 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.04 -48.96 79.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.802 -1.09 . . . . 10.39 110.674 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.0 mt -59.39 -41.65 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 10.78 110.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.742 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.2 mt -66.0 -45.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.904 -0.589 . . . . 8.01 111.479 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.84 -21.16 61.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.333 -0.547 . . . . 10.38 110.75 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -74.39 -26.99 60.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 12.35 110.166 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 95.1 mmm -66.74 -26.48 67.01 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.398 0.618 . . . . 10.33 110.233 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.51 -10.77 4.65 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.415 -0.811 . . . . 9.53 111.714 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.591 ' HB2' HG22 ' A' ' 85' ' ' ILE . 33.4 m-85 -83.02 -175.0 5.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.717 0.294 . . . . 8.89 110.323 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 51.1 tt0 -100.72 147.61 25.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.791 -0.448 . . . . 10.16 109.791 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.512 ' O ' HD12 ' A' ' 96' ' ' ILE . 7.9 ttm180 -55.72 -54.3 46.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.857 0.361 . . . . 11.98 110.503 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB3' ' NE2' ' A' ' 91' ' ' GLN . 55.7 t30 -58.46 -37.07 74.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.862 -0.608 . . . . 9.02 111.207 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.614 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.2 tt0 -65.49 -38.55 90.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 6.68 109.653 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.26 -37.88 89.07 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.25 -0.886 . . . . 5.22 110.625 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -60.9 -52.88 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.316 -0.402 . . . . 6.39 111.174 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.559 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 53.1 tt0 -56.09 -44.21 78.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.202 0.525 . . . . 8.36 110.713 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.31 -54.03 51.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.369 -0.832 . . . . 5.41 110.595 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.705 HD23 ' HB2' ' A' ' 109' ' ' ALA . 78.1 mt -61.18 -33.88 74.15 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.707 -0.224 . . . . 5.77 111.486 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.559 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 92.1 mtt180 -54.9 -46.83 74.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.484 0.659 . . . . 7.71 110.112 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.34 -38.05 68.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.87 -1.059 . . . . 8.88 111.467 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 23.7 p -85.6 1.5 48.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.81 0.67 . . . . 8.79 112.81 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m120 61.98 46.77 6.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.472 . . . . 10.09 111.123 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 48.8 m-20 66.73 24.07 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.363 -0.835 . . . . 7.8 111.144 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 14.8 t-20 -86.46 113.9 22.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.892 -0.781 . . . . 10.49 108.892 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.726 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.1 tt -57.6 -59.05 5.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.904 -1.044 . . . . 9.54 111.268 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.61 -46.1 81.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.419 -1.264 . . . . 11.82 111.732 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.692 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.9 ttm180 -68.83 -28.83 67.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.445 -0.343 . . . . 12.41 110.625 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.705 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.64 -50.58 68.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.226 -0.657 . . . . 6.3 109.226 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.525 HD23 HG23 ' A' ' 85' ' ' ILE . 18.2 mt -60.29 -38.31 83.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.43 -0.804 . . . . 7.78 109.739 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 7.7 t70 -54.73 -51.61 65.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.033 -0.985 . . . . 9.04 110.107 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -63.87 -46.61 84.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.116 -1.402 . . . . 8.69 110.679 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.682 HD11 ' HA ' ' A' ' 95' ' ' ALA . 46.5 mt -64.57 -37.72 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.236 -0.893 . . . . 5.25 111.228 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.313 0.577 . . . . 6.92 110.432 179.233 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.572 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 78.3 mt . . . . . 0 N--CA 1.447 -0.599 0 CA-C-O 120.742 0.306 . . . . 5.69 111.15 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.68 82.25 1.56 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.299 0.571 . . . . 4.6 109.927 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.4 mt-10 -71.65 -3.11 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.647 -0.706 . . . . 5.13 111.107 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -56.71 -40.85 76.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 4.17 110.265 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.915 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 12.1 p -65.67 -52.47 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.736 -0.666 . . . . 3.42 111.751 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 21' ' ' ARG . 7.3 p -64.02 -38.73 83.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.913 -0.315 . . . . 3.24 111.274 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 64.7 mtt -62.5 -34.89 77.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.729 -0.214 . . . . 5.17 110.719 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 13' ' ' MET . 40.0 mt-30 -60.78 -40.25 91.91 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.79 -0.364 . . . . 5.38 110.76 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.737 ' HB3' HD12 ' A' ' 17' ' ' LEU . 11.2 mt -67.78 -49.0 64.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.878 0.847 . . . . 3.9 109.884 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.26 -50.55 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.99 -1.459 . . . . 4.46 113.111 -170.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 8' ' ' MET . 56.1 mm-40 -66.35 -24.1 66.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.164 0.431 . . . . 6.27 112.164 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 25.8 ptm -99.97 -3.85 31.36 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.652 -0.419 . . . . 5.2 111.79 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.6 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.674 -1.251 . . . . 4.75 113.588 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 33.0 m-85 -115.35 142.04 28.11 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 122.96 -0.141 . . . . 5.09 110.65 -172.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 76.73 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.983 2.455 . . . . 4.25 111.601 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.737 HD12 ' HB3' ' A' ' 10' ' ' LEU . 97.7 mt -79.8 66.76 5.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.49 -0.777 . . . . 3.29 111.846 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 21' ' ' ARG . 3.9 tt0 -56.68 -18.37 12.05 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.92 0.39 . . . . 5.48 110.892 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.51 -35.79 70.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.511 . . . . 3.54 109.83 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.625 ' O ' HG23 ' A' ' 24' ' ' VAL . 14.1 t -73.27 -41.98 63.02 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.335 -0.848 . . . . 3.27 109.287 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' HB2' HG21 ' A' ' 7' ' ' VAL . 25.2 ttt180 -52.01 -53.29 43.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.366 -0.834 . . . . 6.1 110.7 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HZ3' ' HB3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -71.55 -23.85 61.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 4.77 110.612 178.079 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HB1' ' CD1' ' A' ' 38' ' ' TRP . . . -69.69 -42.3 74.3 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.981 -0.554 . . . . 4.34 110.771 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 20' ' ' CYS . 86.1 t -55.43 -45.63 78.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.279 -0.418 . . . . 4.58 110.025 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -59.44 -49.91 75.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.02 -0.536 . . . . 7.48 110.499 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.76 -39.37 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.223 -0.444 . . . . 6.84 112.08 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.6 p -70.13 -15.1 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.101 0.477 . . . . 5.71 111.318 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.08 28.27 34.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.831 -0.7 . . . . 5.75 111.485 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 61.8 m-80 60.68 65.56 1.02 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.256 0.55 . . . . 5.06 110.816 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.402 ' HB3' HG21 ' A' ' 34' ' ' VAL . 91.4 mmm -95.94 34.59 1.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.797 -0.638 . . . . 6.28 111.225 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.14 -179.53 45.23 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.072 -0.585 . . . . 4.17 113.58 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.17 -39.23 78.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.288 . . . . 3.73 111.579 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -58.41 -52.72 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 5.46 111.663 -175.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 30' ' ' MET . 69.3 t -67.32 -38.1 80.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.256 -0.429 . . . . 4.88 111.798 -175.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -32.24 55.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.465 -0.494 . . . . 3.68 111.739 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.621 ' O ' HG22 ' A' ' 39' ' ' ILE . 75.7 t80 -61.64 -39.7 92.25 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.459 -0.941 . . . . 4.71 108.459 170.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.731 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.8 t30 -64.59 -39.08 93.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.421 -0.809 . . . . 5.69 110.792 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.415 ' CD1' ' HB1' ' A' ' 23' ' ' ALA . 24.2 t-105 -67.86 -30.81 70.28 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.565 -0.454 . . . . 5.87 110.363 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 36' ' ' PHE . 4.3 tp -77.45 -32.61 18.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 120.805 -0.358 . . . . 3.69 111.47 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.3 pp -68.36 -26.55 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.111 -0.636 . . . . 5.04 109.776 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 37' ' ' ASN . 96.2 t -70.43 -36.88 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.579 -0.737 . . . . 5.37 110.231 170.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -102.22 20.77 16.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.192 -0.458 . . . . 5.35 111.909 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 5.73 110.871 174.473 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 109.399 -0.593 . . . . 7.14 109.399 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.593 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.5 Cg_exo -53.96 162.54 3.83 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 123.096 2.53 . . . . 5.41 112.412 175.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.672 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_endo -63.74 112.12 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.444 2.096 . . . . 7.14 111.089 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.7 pt-20 -56.42 -25.39 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.516 0.51 . . . . 10.13 110.556 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 2.3 tp10 -57.93 -55.0 40.58 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.486 -0.779 . . . . 11.78 110.163 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.796 ' HA ' HD12 ' A' ' 84' ' ' ILE . 82.6 mt -75.41 -40.64 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.774 -0.648 . . . . 8.42 112.094 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.765 ' O ' HG22 ' A' ' 86' ' ' THR . 9.0 m -56.32 -37.81 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 108.357 -0.979 . . . . 7.57 108.357 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.79 -48.83 80.03 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.885 -1.052 . . . . 10.39 110.599 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.8 mt -60.22 -43.54 93.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 10.78 110.827 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.72 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.4 mt -64.05 -45.52 96.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.034 -0.53 . . . . 8.01 111.708 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -72.13 -21.46 61.47 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.876 -0.729 . . . . 10.38 110.786 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.3 m -75.55 -22.04 57.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.041 0.448 . . . . 12.35 110.315 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.3 mmm -70.86 -26.63 63.34 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.275 0.56 . . . . 10.33 109.89 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.54 6.39 4.69 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.405 -0.816 . . . . 9.53 112.08 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 34.5 m-85 -99.24 -175.95 3.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.147 -0.316 . . . . 8.89 110.147 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.902 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 91.9 mt-30 -86.84 153.89 21.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.283 -0.266 . . . . 10.16 110.283 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 96' ' ' ILE . 14.2 ttm180 -65.45 -51.41 60.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.141 -0.688 . . . . 11.98 109.141 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.41 -39.65 88.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 9.02 110.886 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.902 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 6.5 tt0 -64.41 -36.64 84.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.139 0.495 . . . . 6.68 109.689 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.72 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -65.17 -40.23 94.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.458 -0.792 . . . . 5.22 110.466 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.593 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.46 -52.1 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.285 -0.416 . . . . 6.39 110.529 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.561 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 49.8 tt0 -58.24 -44.6 88.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.825 -0.625 . . . . 8.36 110.973 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.83 -53.1 61.84 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.54 -0.755 . . . . 5.41 110.441 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 109' ' ' ALA . 74.1 mt -60.64 -33.1 72.29 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 111.631 0.234 . . . . 5.77 111.631 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.561 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 73.2 mtt180 -55.29 -48.45 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.563 0.697 . . . . 7.71 110.21 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.76 -40.64 72.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.859 -1.064 . . . . 8.88 111.298 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 24.7 p -82.81 -0.04 46.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.547 0.573 . . . . 8.79 112.547 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 58.82 63.22 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 10.09 110.161 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.1 p-10 49.14 32.85 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.498 1.119 . . . . 7.8 112.722 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 16.2 t-20 -93.78 113.87 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.033 -0.728 . . . . 10.49 109.033 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.712 HD12 HG12 ' A' ' 81' ' ' ILE . 8.2 tt -56.97 -60.6 3.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.99 -1.005 . . . . 9.54 111.594 -175.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.409 ' N ' HD23 ' A' ' 106' ' ' LEU . 7.2 mm-40 -57.41 -45.84 84.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.365 -0.834 . . . . 11.82 111.667 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.709 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 34.5 ttm180 -67.46 -28.8 68.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.416 -0.356 . . . . 12.41 110.754 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.32 -51.33 66.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.449 -0.574 . . . . 6.3 109.449 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.532 HD23 HG23 ' A' ' 85' ' ' ILE . 17.8 mt -59.01 -39.4 81.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.384 -0.825 . . . . 7.78 109.428 174.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.34 -46.21 83.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.029 -0.987 . . . . 9.04 110.461 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -67.8 -46.58 71.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.846 -1.07 . . . . 8.69 110.396 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.586 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.5 mt -60.78 -39.68 82.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 5.25 110.354 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.847 -0.615 . . . . 6.92 110.805 177.532 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.553 HG12 ' HB2' ' A' ' 25' ' ' TYR . 4.2 mp . . . . . 0 C--O 1.233 0.222 0 N-CA-C 109.731 -0.47 . . . . 5.69 109.731 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -63.58 97.6 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.224 0.535 . . . . 4.6 110.529 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.602 ' HA ' HG12 ' A' ' 7' ' ' VAL . 9.9 mt-10 -71.04 -5.41 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 5.13 111.9 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.3 t -55.94 -34.28 65.51 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.999 -0.741 . . . . 4.17 108.999 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.4 m -65.24 -52.76 52.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.671 -0.695 . . . . 3.42 111.049 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -69.03 -41.34 81.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.755 0.312 . . . . 3.24 111.308 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.641 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 57.7 mtt -59.54 -35.05 73.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.355 -0.384 . . . . 5.17 110.787 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -62.89 -42.52 99.8 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.029 0.206 . . . . 5.38 111.122 174.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.747 ' HB3' HD12 ' A' ' 17' ' ' LEU . 14.4 mt -63.26 -44.64 94.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.502 0.668 . . . . 3.9 109.685 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.1 -32.74 74.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.893 -1.049 . . . . 4.46 111.094 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.641 ' HG2' ' O ' ' A' ' 8' ' ' MET . 60.9 mm-40 -59.93 -31.18 69.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 6.27 110.281 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mtp -92.91 8.56 39.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.847 -0.615 . . . . 5.2 111.737 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.7 -102.74 0.23 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.798 -1.192 . . . . 4.75 114.228 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 93.5 m-85 -83.19 145.67 49.5 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 112.017 0.376 . . . . 5.09 112.017 -169.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.25 86.09 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.02 2.48 . . . . 4.25 110.98 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.785 HD13 HG12 ' A' ' 39' ' ' ILE . 92.2 mt -80.9 70.95 7.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.801 -0.636 . . . . 3.29 112.483 -170.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -24.37 38.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.256 0.551 . . . . 5.48 110.781 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.7 -30.97 67.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 3.54 110.022 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.562 ' O ' HG23 ' A' ' 24' ' ' VAL . 36.9 t -73.18 -43.51 61.29 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.402 -0.817 . . . . 3.27 109.643 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -49.73 -57.0 8.14 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.681 -0.69 . . . . 6.1 109.836 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 14.8 ptpt -66.24 -32.82 74.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.69 -0.686 . . . . 4.77 110.673 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.02 95.15 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.382 -0.372 . . . . 4.34 111.145 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 20' ' ' CYS . 79.1 t -57.01 -43.57 81.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.398 . . . . 4.58 110.172 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.553 ' HB2' HG12 ' A' ' 2' ' ' ILE . 54.4 t80 -67.93 -42.68 80.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.776 -0.77 . . . . 7.48 110.684 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.23 -40.31 97.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 6.84 111.744 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.7 p -65.8 -23.16 66.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.163 0.506 . . . . 5.71 110.79 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.52 26.83 8.39 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.768 -0.651 . . . . 5.75 111.566 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.5 t30 61.88 62.24 1.28 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.345 0.593 . . . . 5.06 109.68 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 97.2 mmm -101.57 21.65 13.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.867 -0.606 . . . . 6.28 112.103 -172.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.41 177.15 48.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.306 -0.95 . . . . 4.17 113.108 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.65 -44.26 70.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.758 0.281 . . . . 3.73 111.758 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.11 -43.5 91.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 5.46 111.847 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.8 t -68.87 -39.75 80.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.406 -0.361 . . . . 4.88 111.177 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.3 55.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.841 -0.343 . . . . 3.68 111.563 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.599 ' O ' HG22 ' A' ' 39' ' ' ILE . 78.3 t80 -58.08 -43.58 87.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.729 -0.841 . . . . 4.71 108.729 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.592 ' O ' HG13 ' A' ' 40' ' ' ILE . 47.4 t30 -64.06 -43.14 96.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.376 -0.829 . . . . 5.69 110.368 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -63.81 -33.93 76.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 5.87 110.719 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.785 HG12 HD13 ' A' ' 17' ' ' LEU . 6.4 tp -76.09 -38.74 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 3.69 111.218 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -70.05 -21.91 24.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.187 0.518 . . . . 5.04 110.504 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 37' ' ' ASN . 92.8 t -76.32 -48.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.819 -0.628 . . . . 5.37 110.241 170.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -83.3 2.64 35.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.098 -0.501 . . . . 5.35 111.349 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.6 ppp? . . . . . 0 C--N 1.326 -0.447 0 N-CA-C 111.931 0.345 . . . . 5.73 111.931 -176.943 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 24.8 tt0 . . . . . 0 N--CA 1.442 -0.827 0 CA-C-O 121.439 0.637 . . . . 7.14 111.452 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.676 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.7 Cg_exo -58.58 166.38 6.45 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.891 3.06 . . . . 5.41 112.879 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.686 ' HD3' ' ND2' ' A' ' 104' ' ' ASN . 44.6 Cg_endo -66.66 111.88 2.26 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.686 2.257 . . . . 7.14 111.143 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.6 pt-20 -52.25 -30.11 26.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 10.13 111.237 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 6.2 tt0 -58.66 -51.35 70.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.854 -0.612 . . . . 11.78 110.339 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.754 ' HA ' HD12 ' A' ' 84' ' ' ILE . 69.4 mt -75.13 -40.83 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.686 -0.688 . . . . 8.42 111.452 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.771 ' O ' HG22 ' A' ' 86' ' ' THR . 5.2 m -56.18 -38.29 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.626 -0.879 . . . . 7.57 108.626 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.07 -49.4 77.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.822 -1.081 . . . . 10.39 110.775 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.56 -40.11 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 10.78 110.729 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.732 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.3 mt -67.33 -46.74 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.874 -0.603 . . . . 8.01 111.64 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.99 -21.13 63.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.175 -0.61 . . . . 10.38 110.638 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -75.35 -25.47 57.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 12.35 110.619 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 21.9 mmt -69.15 -26.51 64.91 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.168 -0.469 . . . . 10.33 110.242 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.88 -2.83 4.87 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.714 -0.676 . . . . 9.53 111.817 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 35.2 m-85 -93.08 -173.98 3.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 8.89 110.468 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.596 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 17.9 tt0 -99.31 147.88 24.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.278 -0.419 . . . . 10.16 110.371 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.5 ttm180 -57.11 -54.65 44.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 11.98 110.731 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.97 -36.19 78.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.266 0.555 . . . . 9.02 110.915 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.646 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.7 tt0 -64.45 -38.81 92.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.725 . . . . 6.68 109.569 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.732 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.15 -40.34 95.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.278 -0.874 . . . . 5.22 110.703 173.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.676 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -59.64 -52.48 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.994 -0.548 . . . . 6.39 110.857 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.577 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 49.9 tt0 -52.97 -47.32 68.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.483 0.659 . . . . 8.36 110.709 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.65 -54.05 50.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.013 -0.994 . . . . 5.41 110.74 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 109' ' ' ALA . 68.1 mt -62.15 -30.99 71.43 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 111.54 0.2 . . . . 5.77 111.54 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 86.7 mtt180 -55.31 -46.97 76.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.365 0.602 . . . . 7.71 109.508 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.87 57.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.936 -1.029 . . . . 8.88 112.035 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 98' ' ' ALA . 29.2 p -83.19 -2.71 56.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.077 0.399 . . . . 8.79 112.077 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 58.0 t30 67.96 41.44 2.08 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.06 0.85 . . . . 10.09 110.364 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.686 ' ND2' ' HD3' ' A' ' 78' ' ' PRO . 3.7 m-20 72.23 18.7 4.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.456 -0.793 . . . . 7.8 110.962 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 17.6 t-20 -82.6 115.68 21.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.524 -0.547 . . . . 10.49 109.524 174.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.3 tt -58.16 -60.53 3.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.081 -0.963 . . . . 9.54 111.722 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.403 ' N ' HD23 ' A' ' 106' ' ' LEU . 51.1 mm-40 -53.68 -51.95 61.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.318 -0.856 . . . . 11.82 111.71 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.645 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.0 ttm180 -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.196 -0.456 . . . . 12.41 110.868 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.55 -50.61 68.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.302 -0.629 . . . . 6.3 109.302 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.573 HD23 HG23 ' A' ' 85' ' ' ILE . 15.7 mt -59.21 -38.28 79.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.07 -0.968 . . . . 7.78 109.434 175.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 15.1 t70 -56.95 -51.82 67.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.037 -0.983 . . . . 9.04 110.3 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.27 -47.51 84.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.278 -1.328 . . . . 8.69 110.663 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.663 HD11 ' HA ' ' A' ' 95' ' ' ALA . 47.9 mt -61.06 -41.9 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.12 -0.945 . . . . 5.25 110.804 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.4 t80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 6.92 110.546 179.733 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.442 HG22 ' HG3' ' A' ' 4' ' ' GLU . 54.7 mt . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.95 0.405 . . . . 5.69 111.343 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -83.33 82.64 8.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.238 0.542 . . . . 4.6 110.239 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 2' ' ' ILE . 36.1 mt-10 -71.64 -2.76 18.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 5.13 111.281 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.635 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 26.6 t -60.89 -35.91 77.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.717 -0.845 . . . . 4.17 108.717 168.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 6.7 m -58.48 -49.9 75.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.943 -0.571 . . . . 3.42 111.141 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 17' ' ' LEU . 2.7 p -64.26 -41.06 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.806 0.336 . . . . 3.24 110.832 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 81.1 mtp -63.71 -29.84 71.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.148 -0.478 . . . . 5.17 111.378 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 5' ' ' SER . 81.4 mm-40 -64.38 -44.44 91.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.996 -0.281 . . . . 5.38 110.504 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 20' ' ' CYS . 18.8 mt -68.09 -40.36 82.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.402 0.62 . . . . 3.9 109.756 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.64 -50.81 71.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.716 -1.129 . . . . 4.46 111.901 -175.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.99 -19.26 63.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.234 -0.439 . . . . 6.27 112.064 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptm -99.32 -4.6 31.38 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.57 -0.452 . . . . 5.2 111.321 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -98.4 0.12 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.189 -1.005 . . . . 4.75 113.206 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 99.0 m-85 -118.81 157.9 48.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.485 0.183 . . . . 5.09 111.047 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.65 82.46 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.594 2.196 . . . . 4.25 112.138 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 7' ' ' VAL . 4.4 mm? -73.86 69.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 3.29 111.618 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 5.6 tt0 -56.73 -24.14 47.56 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.277 -0.89 . . . . 5.48 109.981 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -29.68 66.33 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.062 -0.517 . . . . 3.54 109.856 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.688 ' HA ' HD11 ' A' ' 39' ' ' ILE . 49.9 t -69.37 -44.81 70.78 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.303 -0.629 . . . . 3.27 109.303 174.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.61 -49.76 67.12 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.013 -0.54 . . . . 6.1 109.911 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 26.5 mttm -62.16 -40.63 96.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.66 -0.7 . . . . 4.77 110.147 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.2 -43.19 92.38 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.364 -0.835 . . . . 4.34 111.714 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' CYS . 76.3 t -56.17 -47.18 81.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.743 0.306 . . . . 4.58 110.313 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.76 -36.7 83.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 7.48 110.492 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.1 -45.7 69.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 6.84 111.221 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -62.29 -27.14 68.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.194 0.521 . . . . 5.71 111.04 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.75 28.04 6.11 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.674 -0.694 . . . . 5.75 111.558 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 59.27 51.24 7.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.123 0.487 . . . . 5.06 109.923 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.462 ' HB3' HG21 ' A' ' 34' ' ' VAL . 80.9 mtp -81.39 -35.25 31.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 6.28 112.106 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.61 169.71 16.87 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.022 -1.085 . . . . 4.17 113.279 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.575 0.35 . . . . 3.73 111.706 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -67.66 -40.16 84.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 5.46 110.12 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 30' ' ' MET . 85.2 t -64.31 -41.49 92.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 4.88 110.782 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -32.89 58.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.441 -0.345 . . . . 3.68 111.109 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 40' ' ' ILE . 78.8 t80 -55.24 -44.41 75.46 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.156 -0.683 . . . . 4.71 109.156 172.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.686 ' O ' HG13 ' A' ' 40' ' ' ILE . 8.2 t30 -67.92 -35.78 79.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.519 -0.764 . . . . 5.69 110.609 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -65.46 -32.85 74.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.094 0.473 . . . . 5.87 109.872 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.688 HD11 ' HA ' ' A' ' 20' ' ' CYS . 1.4 mp -77.06 -37.76 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.864 -0.607 . . . . 3.69 112.099 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.4 pp -63.57 -30.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.637 0.732 . . . . 5.04 109.91 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' ASN . 60.2 t -69.57 -51.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.142 -0.935 . . . . 5.37 110.484 170.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -85.28 13.43 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.669 0.618 . . . . 5.35 112.669 -174.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.1 ptt? . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 5.73 111.07 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 110.147 -0.316 . . . . 7.14 110.147 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.3 Cg_exo -56.25 164.9 4.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.177 2.585 . . . . 5.41 112.115 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.658 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 39.8 Cg_endo -63.15 114.0 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.487 2.125 . . . . 7.14 111.186 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.726 ' HA ' HG22 ' A' ' 82' ' ' VAL . 15.1 pt-20 -58.2 -28.18 64.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 10.13 110.529 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 3.1 tt0 -57.34 -51.34 69.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.073 -0.512 . . . . 11.78 109.92 173.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.7 mt -76.59 -41.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 115.844 -0.616 . . . . 8.42 111.76 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.771 ' O ' HG22 ' A' ' 86' ' ' THR . 10.9 m -55.49 -38.27 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.549 -0.908 . . . . 7.57 108.549 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.38 -49.07 78.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.782 -1.099 . . . . 10.39 110.715 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.1 mt -59.54 -42.29 87.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 10.78 110.423 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.702 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.1 mt -64.83 -47.26 89.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.665 -0.698 . . . . 8.01 111.368 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -69.67 -21.2 63.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.98 -0.688 . . . . 10.38 110.874 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.1 m -76.52 -21.9 55.13 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.933 0.396 . . . . 12.35 110.645 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 94.2 mmm -71.33 -24.56 62.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.391 0.615 . . . . 10.33 110.167 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.93 0.48 5.59 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.108 -0.951 . . . . 9.53 111.529 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 34.3 m-85 -94.02 -173.67 3.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.827 0.346 . . . . 8.89 110.428 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.4 tt0 -100.08 146.47 26.74 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.85 -0.426 . . . . 10.16 109.85 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.516 ' O ' HD12 ' A' ' 96' ' ' ILE . 5.7 ttm180 -58.13 -53.62 56.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.119 0.485 . . . . 11.98 110.196 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -58.93 -37.45 76.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 9.02 111.145 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.8 tt0 -64.08 -40.43 96.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.65 -0.705 . . . . 6.68 109.586 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.702 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.76 -38.51 90.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.02 -0.991 . . . . 5.22 110.735 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.578 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mp -60.88 -52.72 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 116.267 -0.424 . . . . 6.39 110.849 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 49.4 tt0 -55.36 -44.58 76.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 8.36 110.811 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.08 -53.47 57.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.249 -0.887 . . . . 5.41 110.835 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.674 HD23 ' HB2' ' A' ' 109' ' ' ALA . 69.7 mt -62.59 -29.83 70.89 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.62 -0.264 . . . . 5.77 111.547 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -57.23 -50.83 71.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.424 0.63 . . . . 7.71 110.311 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.98 84.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.921 -1.036 . . . . 8.88 111.319 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 29.4 p -82.02 -7.35 59.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.684 0.624 . . . . 8.79 112.684 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.26 67.86 0.76 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.671 0.748 . . . . 10.09 110.289 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 8.5 p30 52.26 21.1 1.54 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.844 -1.526 . . . . 7.8 112.889 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.414 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 17.6 m-80 -82.33 110.35 17.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.495 -0.557 . . . . 10.49 109.495 174.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.733 HD12 HG12 ' A' ' 81' ' ' ILE . 8.2 tt -57.05 -60.74 3.14 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.973 -1.012 . . . . 9.54 111.732 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.414 ' N ' HD23 ' A' ' 106' ' ' LEU . 5.9 mm-40 -56.78 -45.66 82.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.325 -0.852 . . . . 11.82 111.428 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.646 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 29.1 ttm180 -67.21 -28.45 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.397 -0.365 . . . . 12.41 111.003 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.674 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.84 -50.65 68.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.252 -0.647 . . . . 6.3 109.252 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 HG23 ' A' ' 85' ' ' ILE . 17.9 mt -59.82 -37.34 78.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.218 -0.901 . . . . 7.78 109.637 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 10.8 t70 -54.18 -53.52 52.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.187 0.994 . . . . 9.04 110.004 172.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -61.36 -45.75 93.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.893 -1.503 . . . . 8.69 110.594 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.671 HD11 ' HA ' ' A' ' 95' ' ' ALA . 41.7 mt -66.98 -39.18 82.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.075 -0.966 . . . . 5.25 111.105 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.2 t80 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 6.92 110.624 -179.783 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.407 HG23 ' CG1' ' A' ' 24' ' ' VAL . 42.9 mt . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 109.898 -0.408 . . . . 5.69 109.898 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.76 84.33 0.65 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.379 0.609 . . . . 4.6 110.16 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.601 ' HA ' HG12 ' A' ' 7' ' ' VAL . 41.3 mt-10 -70.33 -5.5 28.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.424 -0.807 . . . . 5.13 110.063 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.442 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 4.3 m -57.86 -37.11 73.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.483 -0.78 . . . . 4.17 109.288 169.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.1 m -64.22 -52.48 58.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.817 -0.629 . . . . 3.42 111.236 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.624 HG11 ' HG2' ' A' ' 21' ' ' ARG . 4.8 p -64.61 -39.33 85.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.399 -0.364 . . . . 3.24 111.168 -177.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.481 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 23.7 mmt -66.46 -31.57 72.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.447 -0.342 . . . . 5.17 111.336 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 5' ' ' SER . 15.2 mm-40 -62.84 -39.3 93.95 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.253 -0.277 . . . . 5.38 110.253 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 39' ' ' ILE . 16.4 mt -70.86 -43.96 67.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.754 0.787 . . . . 3.9 109.833 173.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.61 -42.98 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.363 -1.29 . . . . 4.46 112.066 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.19 -9.85 54.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 6.27 112.198 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -72.14 -23.38 61.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 5.2 110.321 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 15' ' ' PHE . . . 124.62 48.16 0.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.841 -0.695 . . . . 4.75 113.023 176.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 60.0 t80 179.29 134.88 0.25 Allowed Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.49 . . . . 5.09 109.678 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.44 88.98 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.017 2.478 . . . . 4.25 112.241 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.72 57.66 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.317 -0.553 . . . . 3.29 110.829 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -56.34 -23.33 36.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.969 0.414 . . . . 5.48 111.009 174.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.647 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -59.81 -31.96 70.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.067 0.46 . . . . 3.54 110.281 172.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.569 ' HB3' HG23 ' A' ' 7' ' ' VAL . 37.9 t -73.81 -39.06 64.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.274 -0.875 . . . . 3.27 109.869 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.624 ' HG2' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -50.16 -52.13 37.87 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.73 0.776 . . . . 6.1 109.074 173.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 32.4 mttt -63.89 -44.72 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.551 -1.204 . . . . 4.77 110.218 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -56.57 -46.49 80.74 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.786 -0.643 . . . . 4.34 111.914 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 20' ' ' CYS . 98.5 t -59.37 -44.15 91.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 4.58 109.935 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.41 -43.48 98.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.964 -0.562 . . . . 7.48 110.973 175.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -69.41 -39.05 78.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.204 0.446 . . . . 6.84 112.204 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.4 p -67.3 -15.24 63.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.97 0.414 . . . . 5.71 111.268 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.7 23.12 47.73 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.652 -0.979 . . . . 5.75 110.652 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.98 72.56 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.633 -0.783 . . . . 5.06 110.496 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 34' ' ' VAL . 92.0 mmm -94.03 9.65 36.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.301 -0.863 . . . . 6.28 111.407 -177.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 172.26 36.75 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.474 -0.87 . . . . 4.17 112.874 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -57.87 -50.3 73.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.058 0.543 . . . . 3.73 112.355 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -53.97 -43.49 69.97 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.218 0.451 . . . . 5.46 112.218 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 30' ' ' MET . 92.1 t -72.96 -40.63 59.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 4.88 111.076 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.48 -30.79 60.01 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.417 -0.513 . . . . 3.68 111.661 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.567 ' O ' HG22 ' A' ' 39' ' ' ILE . 76.3 t80 -59.84 -42.64 94.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.621 -0.881 . . . . 4.71 108.621 171.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.542 ' O ' HG13 ' A' ' 40' ' ' ILE . 27.2 t-20 -67.56 -39.67 84.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.583 -0.735 . . . . 5.69 110.244 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -63.36 -31.96 73.26 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.016 0.436 . . . . 5.87 110.184 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.647 HD11 ' HB3' ' A' ' 19' ' ' ALA . 2.4 tp -76.79 -39.79 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.218 -0.446 . . . . 3.69 110.896 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.53 -16.19 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.387 0.613 . . . . 5.04 110.966 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 37' ' ' ASN . 75.1 t -79.17 -38.61 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.513 -0.767 . . . . 5.37 110.148 168.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -87.79 4.73 43.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.047 0.388 . . . . 5.35 112.047 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.57 0.224 . . . . 5.73 111.414 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 N--CA 1.438 -1.039 0 N-CA-C 108.918 -0.771 . . . . 7.14 108.918 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 82.2 Cg_exo -51.47 162.27 1.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.953 2.435 . . . . 5.41 111.682 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.708 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 31.7 Cg_endo -60.94 110.37 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.512 2.141 . . . . 7.14 111.232 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -56.47 -26.86 55.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 10.13 111.389 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.2 tt0 -59.38 -51.56 69.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.263 -0.426 . . . . 11.78 110.069 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.783 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.5 mt -74.64 -42.2 48.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.101 -0.5 . . . . 8.42 111.981 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.76 ' O ' HG22 ' A' ' 86' ' ' THR . 8.4 m -56.02 -38.14 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.422 -0.955 . . . . 7.57 108.422 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.43 -48.74 79.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.753 -1.112 . . . . 10.39 110.758 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.783 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.42 -41.79 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.299 -0.41 . . . . 10.78 110.512 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.746 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.3 mt -65.29 -47.5 86.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.973 -0.558 . . . . 8.01 111.793 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.76 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.3 t -69.61 -21.67 63.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.316 -0.553 . . . . 10.38 110.966 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.0 m -71.49 -31.88 67.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.795 0.331 . . . . 12.35 110.44 171.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 98.3 mmm -64.94 -22.86 67.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.868 -0.605 . . . . 10.33 110.449 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.85 4.18 6.18 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.426 -0.806 . . . . 9.53 112.068 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.601 ' HB2' HG22 ' A' ' 85' ' ' ILE . 33.7 m-85 -96.32 -174.55 3.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.343 -0.243 . . . . 8.89 110.343 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -96.02 148.31 22.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.567 -0.531 . . . . 10.16 109.567 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.505 ' O ' HD12 ' A' ' 96' ' ' ILE . 12.5 ttm180 -58.8 -52.45 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.194 0.521 . . . . 11.98 110.069 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -61.6 -35.84 78.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 9.02 111.213 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.58 ' HG2' HD13 ' A' ' 113' ' ' ILE . 7.3 tt0 -65.9 -38.44 88.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.524 -0.762 . . . . 6.68 109.554 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.746 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.181 -0.918 . . . . 5.22 110.501 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.59 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.95 -52.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 CA-C-N 116.342 -0.39 . . . . 6.39 110.914 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.462 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.7 tt0 -57.95 -43.68 86.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.151 -0.477 . . . . 8.36 110.989 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.45 -50.4 73.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.668 -0.697 . . . . 5.41 110.844 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 109' ' ' ALA . 79.0 mt -63.08 -35.53 80.57 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.741 -0.208 . . . . 5.77 111.314 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.462 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.9 mtt180 -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.517 0.675 . . . . 7.71 110.277 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.93 72.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.736 -1.12 . . . . 8.88 111.6 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 63.0 p -86.69 2.66 47.79 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.116 0.784 . . . . 8.79 113.116 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 64.07 45.88 3.95 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.139 0.575 . . . . 10.09 111.395 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.579 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 77.2 m-20 68.08 21.12 8.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.405 -0.816 . . . . 7.8 111.509 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 4.5 m-20 -82.89 104.5 13.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.604 -0.517 . . . . 10.49 109.604 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.774 HD12 HG12 ' A' ' 81' ' ' ILE . 8.5 tt -47.7 -61.17 2.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.065 -0.971 . . . . 9.54 111.886 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.412 ' N ' HD23 ' A' ' 106' ' ' LEU . 6.4 mm-40 -56.64 -46.54 80.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.102 -0.953 . . . . 11.82 111.919 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.674 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.0 ttm180 -69.0 -28.97 67.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 12.41 110.537 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.746 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -61.4 -51.35 69.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.384 -0.599 . . . . 6.3 109.384 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.515 HD23 HG23 ' A' ' 85' ' ' ILE . 20.7 mt -59.26 -41.84 89.76 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.284 -0.871 . . . . 7.78 109.52 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.67 -49.52 70.42 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.599 0.714 . . . . 9.04 110.363 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -61.55 -48.56 80.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.442 -1.254 . . . . 8.69 110.253 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.58 HD13 ' HG2' ' A' ' 94' ' ' GLN . 44.0 mt -63.46 -40.38 88.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.296 -0.866 . . . . 5.25 110.596 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.465 0.298 0 C-N-CA 123.118 0.567 . . . . 6.92 111.165 175.947 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.613 HD11 ' HD1' ' A' ' 25' ' ' TYR . 1.9 mp . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 110.032 -0.358 . . . . 5.69 110.032 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.4 ' N ' HG11 ' A' ' 24' ' ' VAL . 21.9 m-20 -70.01 81.7 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 4.6 110.346 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.547 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.5 mt-10 -71.18 -11.82 61.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.059 -0.519 . . . . 5.13 111.0 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 9' ' ' GLN . 6.9 t -60.46 -28.4 68.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.018 -0.734 . . . . 4.17 109.018 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.66 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 1.9 m -69.34 -50.69 44.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.907 -0.588 . . . . 3.42 110.896 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 4' ' ' GLU . 2.1 p -63.36 -45.89 96.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.448 -0.501 . . . . 3.24 110.805 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.528 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 55.3 mtm -68.97 -26.64 65.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.056 -0.52 . . . . 5.17 111.848 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 6' ' ' SER . 4.4 pt20 -69.03 -34.66 75.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.454 -0.498 . . . . 5.38 109.82 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 6' ' ' SER . 20.4 mt -68.63 -43.42 76.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.613 0.721 . . . . 3.9 109.083 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.56 -37.43 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.629 -1.169 . . . . 4.46 111.503 -176.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 8' ' ' MET . 52.4 mt-10 -65.95 -23.72 66.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.386 0.513 . . . . 6.27 112.386 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 ptp -117.11 -3.86 11.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.296 0.48 . . . . 5.2 112.296 -173.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.25 -101.35 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.935 -1.126 . . . . 4.75 113.643 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.519 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 95.9 m-85 -124.67 165.47 24.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.056 -0.35 . . . . 5.09 110.056 -172.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 71.5 Cg_endo -72.09 82.92 1.24 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.473 2.115 . . . . 4.25 111.62 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 3.4 mm? -75.94 66.5 2.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 3.29 111.805 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -25.73 54.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.617 0.722 . . . . 5.48 109.481 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -31.26 68.08 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.235 -0.893 . . . . 3.54 110.39 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 18.2 t -73.26 -37.71 66.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.422 -0.808 . . . . 3.27 109.706 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.31 -52.58 35.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.852 0.834 . . . . 6.1 108.94 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -70.4 -34.15 72.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.785 -1.098 . . . . 4.77 111.385 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -61.6 -44.31 97.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.385 . . . . 4.34 111.599 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.492 ' CG1' HG23 ' A' ' 2' ' ' ILE . 94.1 t -64.69 -40.8 90.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 4.58 110.384 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.613 ' HD1' HD11 ' A' ' 2' ' ' ILE . 91.3 t80 -62.32 -41.21 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 7.48 110.422 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -68.95 -43.82 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 6.84 111.296 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.8 p -67.09 -17.17 64.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 5.71 111.359 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.85 49.61 5.59 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.707 -0.679 . . . . 5.75 111.907 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.07 45.41 4.57 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.532 0.733 . . . . 5.06 111.885 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.502 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.2 mmt -65.18 -63.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.544 -0.753 . . . . 6.28 111.223 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.87 166.72 38.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.728 -0.749 . . . . 4.17 111.693 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.647 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -65.31 -46.12 81.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.245 0.545 . . . . 3.73 110.982 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 36' ' ' PHE . 15.2 mm-40 -76.13 -27.67 57.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.585 -0.734 . . . . 5.46 110.253 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 30' ' ' MET . 99.1 t -58.27 -44.28 87.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.855 0.36 . . . . 4.88 110.481 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.64 -31.76 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 3.68 110.759 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 51.5 t80 -51.71 -46.2 63.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.304 -0.628 . . . . 4.71 109.304 170.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.52 -47.41 86.29 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.59 -0.732 . . . . 5.69 110.754 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.725 ' HE3' HD12 ' A' ' 39' ' ' ILE . 50.4 t90 -57.2 -36.88 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 5.87 110.237 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.725 HD12 ' HE3' ' A' ' 38' ' ' TRP . 1.2 mp -75.1 -46.64 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.642 -0.708 . . . . 3.69 112.082 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.41 -19.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.394 0.616 . . . . 5.04 111.003 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -80.03 -41.8 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.694 . . . . 5.37 110.807 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -102.89 20.69 16.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.307 0.484 . . . . 5.35 112.307 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 C--N 1.32 -0.678 0 CA-C-O 121.412 0.625 . . . . 5.73 109.579 171.332 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.235 0.307 0 N-CA-C 109.827 -0.434 . . . . 7.14 109.827 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.544 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.1 Cg_exo -53.88 164.53 2.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.95 2.433 . . . . 5.41 112.217 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.687 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 37.8 Cg_endo -63.54 111.16 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.651 2.234 . . . . 7.14 110.73 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.0 pt-20 -58.55 -26.15 63.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.814 -0.63 . . . . 10.13 110.781 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.4 tt0 -60.36 -50.2 74.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.183 0.516 . . . . 11.78 109.869 172.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.77 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.0 mt -74.72 -42.66 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.655 . . . . 8.42 111.769 -175.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.754 ' O ' HG22 ' A' ' 86' ' ' THR . 14.2 m -55.76 -37.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.475 -0.935 . . . . 7.57 108.475 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.24 -48.74 78.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.653 -1.158 . . . . 10.39 110.897 175.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.77 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.6 mt -59.38 -42.88 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 10.78 110.326 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.726 HD12 ' HB1' ' A' ' 95' ' ' ALA . 88.9 mt -63.74 -47.44 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.812 -0.631 . . . . 8.01 111.356 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -71.15 -21.39 62.19 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.298 -0.561 . . . . 10.38 110.763 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -75.9 -22.21 56.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.04 0.448 . . . . 12.35 110.371 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 29.5 mmt -72.75 -25.41 61.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.201 0.524 . . . . 10.33 110.072 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 4.55 3.96 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.539 -0.755 . . . . 9.53 112.069 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.599 ' HB2' HG22 ' A' ' 85' ' ' ILE . 28.0 m-85 -98.16 -177.51 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.766 0.317 . . . . 8.89 110.342 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.687 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 58.1 tt0 -94.45 142.34 27.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.561 -0.533 . . . . 10.16 109.561 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.0 ttm180 -57.89 -51.86 67.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.851 0.358 . . . . 11.98 111.241 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.59 -35.08 73.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 9.02 110.485 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.687 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.6 tt0 -66.63 -39.27 88.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.418 -0.81 . . . . 6.68 109.562 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.726 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.12 -40.55 97.93 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.285 -0.87 . . . . 5.22 110.498 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.596 HG13 HG11 ' A' ' 82' ' ' VAL . 1.1 mt -58.58 -52.43 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.163 -0.471 . . . . 6.39 110.438 176.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.7 tt0 -56.74 -45.94 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 8.36 111.103 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.91 -51.07 71.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.474 -0.785 . . . . 5.41 110.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 109' ' ' ALA . 82.2 mt -61.54 -35.62 78.27 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.641 -0.254 . . . . 5.77 111.609 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 90.8 mtt180 -54.03 -46.59 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.525 0.678 . . . . 7.71 110.153 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.64 67.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.764 -1.107 . . . . 8.88 111.615 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.697 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.5 p -86.19 3.98 40.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.871 0.693 . . . . 8.79 112.871 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.3 t30 64.72 46.8 2.96 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.997 -0.547 . . . . 10.09 110.514 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.609 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 82.4 m-20 67.15 16.58 10.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.388 -0.824 . . . . 7.8 111.437 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.9 t-20 -78.53 110.28 13.48 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.412 -0.588 . . . . 10.49 109.412 175.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.748 HD12 HG12 ' A' ' 81' ' ' ILE . 7.7 tt -55.33 -59.09 5.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.237 -0.892 . . . . 9.54 111.316 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.413 ' N ' HD23 ' A' ' 106' ' ' LEU . 16.6 mm-40 -53.35 -49.99 65.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.631 -1.168 . . . . 11.82 111.671 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.697 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 32.1 ttm180 -69.7 -28.76 66.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.443 -0.344 . . . . 12.41 111.017 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.699 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.02 -51.32 68.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.032 -0.729 . . . . 6.3 109.032 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.578 HD23 HG23 ' A' ' 85' ' ' ILE . 23.6 mt -59.16 -40.78 86.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.85 -1.068 . . . . 7.78 109.902 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.59 -50.43 71.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 9.04 110.178 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -60.68 -44.67 96.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.854 -1.066 . . . . 8.69 110.472 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.649 HD11 ' HA ' ' A' ' 95' ' ' ALA . 52.7 mt -70.45 -39.91 76.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.991 -1.004 . . . . 5.25 111.065 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 6.92 111.196 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.2 mt . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 121.154 0.502 . . . . 5.69 110.592 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.2 85.89 1.9 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.449 -0.796 . . . . 4.6 110.716 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.529 ' HA ' HG12 ' A' ' 7' ' ' VAL . 38.3 mt-10 -72.7 -4.73 33.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.125 -0.489 . . . . 5.13 112.158 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -67.83 -31.55 71.47 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.965 -0.754 . . . . 4.17 108.965 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.75 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 16.9 m -64.89 -46.4 81.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 3.42 110.899 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.1 p -68.94 -40.91 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.144 -0.622 . . . . 3.24 110.53 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 71.0 mtp -63.96 -30.91 71.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.441 . . . . 5.17 111.576 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.75 ' HG2' ' O ' ' A' ' 6' ' ' SER . 10.4 pt20 -68.46 -38.77 81.4 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.435 -0.506 . . . . 5.38 109.672 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.858 ' HB3' HD12 ' A' ' 17' ' ' LEU . 16.4 mt -66.78 -43.74 83.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.648 0.737 . . . . 3.9 109.556 173.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.678 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.6 -33.93 74.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.347 -1.297 . . . . 4.46 112.202 -173.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.3 -36.16 27.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.98 -0.554 . . . . 6.27 111.183 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 18.2 ptp -90.55 0.71 57.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 5.2 112.292 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.67 -92.32 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.747 -1.216 . . . . 4.75 113.763 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 96.7 m-85 -136.52 162.4 56.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.439 -0.208 . . . . 5.09 110.439 -172.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 64.3 Cg_endo -68.05 77.24 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.154 2.569 . . . . 4.25 111.66 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.858 HD12 ' HB3' ' A' ' 10' ' ' LEU . 95.0 mt -85.16 63.84 8.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.967 -0.56 . . . . 3.29 112.428 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -55.96 -19.39 12.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.168 0.508 . . . . 5.48 110.057 169.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.68 -33.1 68.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.542 -0.754 . . . . 3.54 109.407 171.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 34.9 t -70.61 -46.34 63.55 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 115.027 -0.988 . . . . 3.27 109.525 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -53.18 -51.45 62.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.933 0.397 . . . . 6.1 111.044 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.91 -23.52 62.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 4.77 110.542 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -40.76 64.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.381 -0.372 . . . . 4.34 110.785 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 20' ' ' CYS . 77.2 t -56.65 -42.6 76.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 4.58 110.22 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -65.12 -43.04 93.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 7.48 110.514 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.4 -41.17 85.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 6.84 111.78 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.4 p -65.3 -22.34 66.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 5.71 111.436 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.83 25.02 13.85 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.847 -0.692 . . . . 5.75 111.601 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 60.72 47.21 8.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.333 0.587 . . . . 5.06 110.397 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.502 ' HB2' HG11 ' A' ' 34' ' ' VAL . 22.2 mmt -76.28 -23.33 54.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 6.28 112.483 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.15 176.37 14.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.17 -1.014 . . . . 4.17 112.95 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -63.95 -58.96 5.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.559 0.344 . . . . 3.73 111.69 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -55.13 -35.14 64.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.49 . . . . 5.46 111.387 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' A' ' 30' ' ' MET . 59.6 t -66.82 -46.64 84.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.052 -0.522 . . . . 4.88 111.184 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.36 -30.78 53.96 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.949 -0.3 . . . . 3.68 111.109 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 39' ' ' ILE . 65.8 t80 -58.48 -44.43 89.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.964 -0.754 . . . . 4.71 108.964 171.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.42 ' O ' HG13 ' A' ' 40' ' ' ILE . 7.4 t30 -63.73 -37.08 86.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.59 -0.732 . . . . 5.69 110.659 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -67.07 -33.85 76.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 5.87 110.418 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.788 HG12 HD13 ' A' ' 17' ' ' LEU . 3.2 tp -77.13 -38.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.466 -0.334 . . . . 3.69 111.171 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 43' ' ' MET . 2.7 pp -71.1 -28.0 31.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.715 -0.394 . . . . 5.04 110.918 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.9 -25.94 12.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.854 -0.338 . . . . 5.37 110.493 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -100.0 10.41 41.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.128 0.418 . . . . 5.35 112.128 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 14.1 ptp . . . . . 0 N--CA 1.465 0.313 0 CA-C-O 120.979 0.418 . . . . 5.73 110.149 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 109.762 -0.458 . . . . 7.14 109.762 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.569 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 83.7 Cg_exo -51.02 162.9 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.472 2.781 . . . . 5.41 112.822 176.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.7 ' HD2' HD13 ' A' ' 99' ' ' LEU . 38.0 Cg_endo -62.7 112.15 1.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.597 2.198 . . . . 7.14 111.526 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.9 pt-20 -58.97 -27.33 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.225 -0.898 . . . . 10.13 112.106 -174.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.57 ' HG2' ' N ' ' A' ' 81' ' ' ILE . 11.2 pm0 -70.21 -42.82 71.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.589 -0.893 . . . . 11.78 108.589 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 63.5 mt -70.82 -46.39 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.726 -1.125 . . . . 8.42 111.755 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 86' ' ' THR . 14.3 m -55.52 -38.0 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.54 -0.911 . . . . 7.57 108.54 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.36 -47.21 85.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.442 -1.254 . . . . 10.39 111.272 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 18.8 mt -60.0 -42.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 10.78 110.238 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.771 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.2 mt -65.16 -45.86 92.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 8.01 111.286 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.62 -21.23 61.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.367 -0.533 . . . . 10.38 110.799 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.6 t -74.28 -28.87 61.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.6 -0.518 . . . . 12.35 109.6 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.563 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.6 mmm -66.06 -27.61 68.22 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.315 0.578 . . . . 10.33 110.159 175.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.14 -5.22 4.63 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.548 -0.751 . . . . 9.53 112.14 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.619 ' HB2' HG22 ' A' ' 85' ' ' ILE . 31.5 m-85 -87.93 -175.45 5.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.722 0.296 . . . . 8.89 110.236 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 55.5 tt0 -98.02 145.35 26.6 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.839 -0.43 . . . . 10.16 109.839 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 7.0 ttm180 -55.73 -51.27 67.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.126 0.489 . . . . 11.98 110.431 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.47 -38.38 80.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.781 . . . . 9.02 111.027 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.632 ' HG3' HD13 ' A' ' 113' ' ' ILE . 4.3 tp-100 -59.94 -46.92 87.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.852 0.834 . . . . 6.68 109.35 174.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.771 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -58.38 -40.78 83.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.457 -1.247 . . . . 5.22 110.854 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.81 -52.11 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.034 -0.53 . . . . 6.39 110.617 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.577 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 58.8 tt0 -56.97 -47.01 81.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.794 -0.639 . . . . 8.36 110.866 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.75 -50.67 72.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.236 -0.893 . . . . 5.41 110.973 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.7 HD13 ' HD2' ' A' ' 78' ' ' PRO . 72.7 mt -61.8 -33.51 74.25 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.45 -0.341 . . . . 5.77 111.376 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 95.0 mtt180 -55.93 -47.2 77.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.405 0.621 . . . . 7.71 110.169 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.94 71.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.107 -0.951 . . . . 8.88 111.401 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.0 p -85.77 -0.68 55.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.849 0.685 . . . . 8.79 112.849 -174.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 66.76 48.18 1.41 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.15 0.58 . . . . 10.09 111.238 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.568 ' ND2' ' HD3' ' A' ' 78' ' ' PRO . 4.9 m-20 69.76 12.63 8.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.339 -0.846 . . . . 7.8 111.467 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 12.3 t-20 -77.43 109.51 11.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.139 -0.689 . . . . 10.49 109.139 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 81' ' ' ILE . 8.3 tt -56.46 -60.37 3.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.102 -0.954 . . . . 9.54 111.519 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.23 -45.68 72.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.979 -1.009 . . . . 11.82 111.542 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.705 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.4 ttm180 -70.92 -28.37 64.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.244 -0.434 . . . . 12.41 111.075 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.627 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.41 -51.32 68.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.382 -0.599 . . . . 6.3 109.382 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.58 HD23 HG23 ' A' ' 85' ' ' ILE . 18.1 mt -57.85 -38.6 75.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.374 -0.83 . . . . 7.78 109.662 174.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.56 -51.41 69.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.979 -1.01 . . . . 9.04 110.246 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -63.32 -45.58 90.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.759 -1.109 . . . . 8.69 110.177 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.632 HD13 ' HG3' ' A' ' 94' ' ' GLN . 54.9 mt -62.54 -34.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.13 -0.941 . . . . 5.25 110.414 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 6.92 111.098 177.879 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.7 mt . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 121.268 0.556 . . . . 5.69 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.28 91.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.527 -0.76 . . . . 4.6 111.174 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 21' ' ' ARG . 49.1 mt-10 -72.27 -5.71 37.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.875 -0.602 . . . . 5.13 111.579 176.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 2.0 m -59.11 -38.48 79.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.341 0.591 . . . . 4.17 109.565 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 24.1 m -64.63 -50.16 68.19 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.564 -0.744 . . . . 3.42 111.504 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -65.8 -41.81 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 120.849 -0.341 . . . . 3.24 111.153 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 88.3 mtp -61.21 -30.04 70.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.375 -0.375 . . . . 5.17 111.102 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 5' ' ' SER . 46.1 mt-30 -69.59 -34.67 74.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.69 -0.232 . . . . 5.38 111.053 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.702 HD13 HG21 ' A' ' 39' ' ' ILE . 14.3 mt -66.88 -47.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.838 0.827 . . . . 3.9 109.179 171.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.31 -45.83 91.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.022 -1.445 . . . . 4.46 112.403 -169.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 13' ' ' MET . 6.8 pt-20 -58.24 -36.26 72.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.301 0.572 . . . . 6.27 111.437 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.445 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 25.5 ptt? -99.36 7.47 45.52 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.401 -0.818 . . . . 5.2 112.063 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.29 103.21 0.2 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.624 -1.274 . . . . 4.75 114.521 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 78.6 m-85 71.66 138.27 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 113.47 0.915 . . . . 5.09 113.47 168.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.05 82.8 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.188 2.592 . . . . 4.25 111.364 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.702 HD13 HG12 ' A' ' 39' ' ' ILE . 85.7 mt -80.46 61.32 4.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.163 0.431 . . . . 3.29 112.163 -173.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -20.89 17.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.101 0.476 . . . . 5.48 110.626 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.55 -35.32 72.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.455 0.645 . . . . 3.54 109.909 171.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 33.5 t -73.92 -36.17 64.67 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.383 -0.826 . . . . 3.27 109.894 175.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 4' ' ' GLU . 1.3 tmm_? -57.09 -48.34 78.83 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.378 0.609 . . . . 6.1 109.477 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -74.43 -25.42 59.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.998 -0.546 . . . . 4.77 110.325 176.326 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.729 ' HA ' ' HD2' ' A' ' 26' ' ' PHE . . . -66.65 -38.52 87.06 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.11 0.481 . . . . 4.34 110.609 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 20' ' ' CYS . 71.8 t -59.8 -37.77 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.833 -0.621 . . . . 4.58 109.865 173.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 89.9 t80 -60.81 -41.36 95.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.17 -0.468 . . . . 7.48 110.54 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.729 ' HD2' ' HA ' ' A' ' 23' ' ' ALA . 53.6 m-85 -64.8 -46.25 82.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.617 0.246 . . . . 6.84 111.286 176.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 24' ' ' VAL . 33.7 p -70.62 -11.81 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 5.71 111.685 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.74 38.84 41.58 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 5.75 111.427 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.415 ' HA ' HG13 ' A' ' 24' ' ' VAL . 2.2 p-10 43.81 47.9 6.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.908 0.883 . . . . 5.06 111.966 -176.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.4 mtt -63.92 -64.48 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.498 -0.774 . . . . 6.28 110.66 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.84 179.99 45.78 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.815 -0.629 . . . . 4.17 111.665 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -65.22 -33.82 76.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.656 0.243 . . . . 3.73 111.656 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -53.74 -63.24 1.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.008 0.432 . . . . 5.46 111.837 -176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.23 -30.62 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 112.234 0.457 . . . . 4.88 112.234 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.85 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.667 -0.413 . . . . 3.68 111.988 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.559 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.7 t80 -58.72 -44.62 90.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.011 -0.737 . . . . 4.71 109.011 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -65.36 -34.64 78.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 5.69 111.031 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -66.23 -36.39 82.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.133 0.492 . . . . 5.87 110.506 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 10' ' ' LEU . 7.0 tp -76.98 -41.56 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.236 -0.438 . . . . 3.69 111.38 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.05 -26.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.864 0.364 . . . . 5.04 111.003 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 p -80.66 -31.82 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.864 -0.334 . . . . 5.37 110.783 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -100.44 14.59 30.68 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 122.051 -0.406 . . . . 5.35 111.892 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.8 ppp? . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 120.928 0.394 . . . . 5.73 111.399 177.394 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.664 0.269 . . . . 7.14 110.535 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.647 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 48.3 Cg_exo -61.87 164.48 16.34 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.062 2.508 . . . . 5.41 112.047 171.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.653 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 50.0 Cg_endo -66.37 112.92 2.48 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.95 2.433 . . . . 7.14 111.256 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.2 pt-20 -55.93 -29.56 60.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 10.13 110.77 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.3 tt0 -56.89 -51.0 70.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.265 0.555 . . . . 11.78 110.29 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.8 mt -75.67 -41.4 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.75 -0.659 . . . . 8.42 111.8 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.774 ' O ' HG22 ' A' ' 86' ' ' THR . 5.5 m -56.06 -38.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.601 -0.889 . . . . 7.57 108.601 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.11 -45.78 91.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.815 -1.084 . . . . 10.39 110.699 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.9 mt -62.5 -41.73 93.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 10.78 110.871 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.724 HD12 ' HB1' ' A' ' 95' ' ' ALA . 80.4 mt -65.97 -46.76 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.916 -0.584 . . . . 8.01 111.66 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.73 -21.2 63.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.042 -0.663 . . . . 10.38 110.518 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.5 t -73.03 -32.22 64.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.741 -0.466 . . . . 12.35 109.741 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.0 mmt -64.25 -26.26 68.42 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.214 0.531 . . . . 10.33 110.489 176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.64 6.21 4.7 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.71 . . . . 9.53 112.01 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.644 ' HB2' HG22 ' A' ' 85' ' ' ILE . 32.2 m-85 -99.07 -174.01 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.68 0.276 . . . . 8.89 110.297 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.811 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 34.2 mt-30 -91.05 149.55 21.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.47 -0.332 . . . . 10.16 110.468 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.4 ttm180 -61.99 -51.16 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.427 -0.583 . . . . 11.98 109.427 173.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.472 -0.785 . . . . 9.02 110.879 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.811 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 1.0 OUTLIER -63.6 -37.45 87.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.264 0.554 . . . . 6.68 109.728 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.724 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.72 -41.39 98.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.427 -0.806 . . . . 5.22 110.451 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.647 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.79 -52.15 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.127 -0.488 . . . . 6.39 110.277 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.639 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.6 tt0 -53.86 -47.11 71.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.837 -0.62 . . . . 8.36 111.162 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HB2' ' CG1' ' A' ' 113' ' ' ILE . . . -60.17 -52.09 66.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.01 -0.995 . . . . 5.41 110.91 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 109' ' ' ALA . 75.2 mt -62.93 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.438 -0.346 . . . . 5.77 111.542 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.639 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.8 mtt180 -54.64 -46.17 73.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.787 0.804 . . . . 7.71 109.66 175.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.69 -44.74 55.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.53 -1.213 . . . . 8.88 111.382 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.698 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 64.3 p -81.41 0.06 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.917 0.71 . . . . 8.79 112.917 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 61.58 62.94 1.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 10.09 110.257 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.5 p30 53.09 23.42 3.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.662 1.185 . . . . 7.8 112.662 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.553 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.1 t-20 -87.44 108.78 19.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.386 -0.598 . . . . 10.49 109.386 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.779 HD12 HG12 ' A' ' 81' ' ' ILE . 8.7 tt -53.94 -61.27 2.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.915 -1.039 . . . . 9.54 112.042 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.02 -45.79 75.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.811 -1.086 . . . . 11.82 111.655 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.698 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 9.0 ttm180 -69.66 -28.69 66.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.053 -0.521 . . . . 12.41 110.845 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.688 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.37 -50.92 68.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.103 -0.703 . . . . 6.3 109.103 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 85' ' ' ILE . 21.7 mt -58.58 -39.1 79.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.404 -0.816 . . . . 7.78 109.668 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 11.0 t70 -54.17 -54.54 38.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.982 -1.008 . . . . 9.04 109.942 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -62.68 -39.7 94.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.058 -1.428 . . . . 8.69 110.781 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.68 HD11 ' HA ' ' A' ' 95' ' ' ALA . 53.7 mt -71.37 -36.05 59.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.36 -0.836 . . . . 5.25 111.27 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.48 0.657 . . . . 6.92 109.996 176.651 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.445 HG23 ' CG1' ' A' ' 24' ' ' VAL . 52.8 mt . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 109.253 -0.647 . . . . 5.69 109.253 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.557 ' H ' HG11 ' A' ' 24' ' ' VAL . 10.0 m-20 -69.83 72.53 0.39 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.293 0.568 . . . . 4.6 109.605 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.577 ' HA ' HG12 ' A' ' 7' ' ' VAL . 43.7 mt-10 -71.14 -4.14 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.709 -0.678 . . . . 5.13 111.142 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.552 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 14.5 m -63.22 -30.96 72.0 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.251 -0.648 . . . . 4.17 109.251 169.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.659 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 48.2 t -66.96 -52.68 39.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.673 -0.694 . . . . 3.42 110.943 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 4' ' ' GLU . 5.1 p -63.67 -37.67 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.318 -0.401 . . . . 3.24 110.583 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 20.9 mmt -65.27 -29.0 69.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.0 -0.545 . . . . 5.17 111.516 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 5' ' ' SER . 71.3 mt-30 -66.37 -40.87 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.735 -0.386 . . . . 5.38 110.534 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.698 ' HB3' HD12 ' A' ' 17' ' ' LEU . 18.4 mt -68.67 -39.37 80.66 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.862 0.839 . . . . 3.9 109.533 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 8' ' ' MET . . . -61.88 -34.46 76.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.363 -1.29 . . . . 4.46 111.8 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 8' ' ' MET . 49.3 mt-10 -67.54 -18.91 65.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.34 . . . . 6.27 111.145 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.7 mtp -83.17 -1.16 52.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.168 0.508 . . . . 5.2 109.832 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.1 45.68 5.57 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.445 -0.798 . . . . 4.75 113.066 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -144.17 125.77 8.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.857 0.361 . . . . 5.09 110.64 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.59 66.12 4.69 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.354 2.703 . . . . 4.25 111.687 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.698 HD12 ' HB3' ' A' ' 10' ' ' LEU . 61.9 mt -89.65 64.6 6.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.691 0.758 . . . . 3.29 111.695 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -55.54 -21.81 18.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.02 -0.536 . . . . 5.48 109.714 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.603 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.92 -30.65 66.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.52 -0.764 . . . . 3.54 109.901 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HB2' HD12 ' A' ' 10' ' ' LEU . 17.5 t -72.16 -44.71 62.66 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.506 -0.77 . . . . 3.27 109.037 174.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -48.82 72.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.43 -0.804 . . . . 6.1 110.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 10.9 ptpt -75.76 -23.29 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.981 -0.288 . . . . 4.77 110.734 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.9 93.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.328 0.585 . . . . 4.34 110.067 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.557 HG11 ' H ' ' A' ' 3' ' ' ASP . 77.1 t -58.58 -40.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 4.58 110.009 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 87.3 t80 -60.73 -49.95 75.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.685 -0.689 . . . . 7.48 110.57 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -61.81 -43.36 99.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.646 -0.252 . . . . 6.84 111.597 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -66.82 -27.74 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.125 0.488 . . . . 5.71 111.094 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.77 36.29 6.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.791 -0.64 . . . . 5.75 112.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 59.29 64.48 1.35 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.947 0.403 . . . . 5.06 110.139 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.7 mmt -97.71 -32.72 11.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.044 -0.525 . . . . 6.28 111.922 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 171.12 18.59 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 119.72 -1.229 . . . . 4.17 113.035 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.659 ' HA ' ' HB2' ' A' ' 6' ' ' SER . . . -67.14 -54.52 20.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.229 0.455 . . . . 3.73 112.229 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.532 ' HA ' ' HB3' ' A' ' 36' ' ' PHE . 45.3 mt-10 -68.56 -24.23 64.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.837 0.351 . . . . 5.46 110.804 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.38 -46.67 89.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 4.88 110.318 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB3' ' OG ' ' A' ' 6' ' ' SER . . . -78.45 -27.38 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.49 -0.323 . . . . 3.68 111.09 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 81.1 t80 -57.89 -44.25 86.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.036 -0.727 . . . . 4.71 109.036 169.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.518 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.6 t30 -62.94 -40.86 98.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.462 -0.79 . . . . 5.69 110.285 175.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -65.16 -33.57 76.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.895 -0.593 . . . . 5.87 110.626 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 19' ' ' ALA . 3.9 tp -75.69 -37.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 3.69 111.111 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.1 -30.15 39.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.86 -0.336 . . . . 5.04 111.004 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.37 -21.47 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.796 -0.361 . . . . 5.37 110.76 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -101.8 1.32 37.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.902 0.382 . . . . 5.35 111.09 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.7 ptt? . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 112.56 0.578 . . . . 5.73 112.56 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 109.545 -0.539 . . . . 7.14 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.0 Cg_exo -54.06 166.8 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.683 2.256 . . . . 5.41 111.666 170.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.689 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.8 Cg_endo -64.38 109.42 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.175 1.917 . . . . 7.14 110.407 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.675 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.1 pt-20 -58.13 -23.56 55.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.461 0.476 . . . . 10.13 110.274 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 3.6 tt0 -59.31 -53.04 62.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.616 -0.72 . . . . 11.78 110.108 171.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.1 mt -73.67 -42.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.74 -0.664 . . . . 8.42 111.648 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.781 ' O ' HG22 ' A' ' 86' ' ' THR . 5.8 m -55.14 -37.98 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.556 -0.905 . . . . 7.57 108.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.67 -47.97 82.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 10.39 111.055 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.8 mt -60.2 -41.33 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.863 -0.608 . . . . 10.78 110.309 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.734 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.8 mt -67.0 -45.16 87.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.747 -0.66 . . . . 8.01 111.657 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.14 -20.67 62.28 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.081 -0.648 . . . . 10.38 110.726 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.2 t -75.23 -27.14 59.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.121 0.486 . . . . 12.35 109.829 172.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 23.8 mmt -68.37 -23.05 64.63 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 10.33 110.703 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.09 -5.24 5.68 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.518 -0.765 . . . . 9.53 111.635 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.595 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.3 m-85 -90.8 -176.24 4.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.32 . . . . 8.89 110.614 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.8 tt0 -98.01 147.07 24.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.823 -0.436 . . . . 10.16 109.823 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.503 ' O ' HD12 ' A' ' 96' ' ' ILE . 10.2 ttm180 -56.66 -54.78 42.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 11.98 110.51 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.445 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 8.8 t30 -58.45 -36.74 74.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.853 -0.612 . . . . 9.02 111.016 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.0 tt0 -64.69 -38.39 90.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 6.68 109.626 176.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.734 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -66.06 -39.17 89.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.127 -0.942 . . . . 5.22 110.693 175.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.557 HG13 HG11 ' A' ' 82' ' ' VAL . 1.1 mp -59.41 -52.49 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 116.212 -0.449 . . . . 6.39 111.039 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 57.5 tt0 -58.91 -41.62 87.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.052 -0.522 . . . . 8.36 110.862 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.98 -53.35 58.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.346 -0.843 . . . . 5.41 110.417 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 109' ' ' ALA . 79.9 mt -61.46 -34.77 75.99 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.39 -0.368 . . . . 5.77 111.526 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 93.3 mtt180 -55.88 -46.35 78.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.544 0.688 . . . . 7.71 110.371 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.3 70.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.958 -1.019 . . . . 8.88 111.061 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.72 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 31.2 p -84.36 0.18 50.28 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.991 0.737 . . . . 8.79 112.991 -175.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 60.87 61.88 1.57 Allowed 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.021 0.528 . . . . 10.09 110.458 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.594 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 10.1 p30 51.67 25.5 2.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.589 1.156 . . . . 7.8 112.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 13.1 t-20 -86.1 109.62 18.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.946 -0.761 . . . . 10.49 108.946 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.724 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.4 tt -54.75 -59.73 4.32 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.094 -0.957 . . . . 9.54 111.436 -176.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.24 -48.38 74.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.637 -1.165 . . . . 11.82 111.737 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.72 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -67.98 -28.71 67.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.407 -0.36 . . . . 12.41 110.92 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.22 -50.41 71.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.353 -0.61 . . . . 6.3 109.353 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.508 HD23 HG23 ' A' ' 85' ' ' ILE . 17.0 mt -60.34 -39.22 86.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.266 -0.879 . . . . 7.78 109.665 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.93 -49.97 70.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.81 -1.086 . . . . 9.04 110.124 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -63.1 -49.85 72.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.375 -1.284 . . . . 8.69 110.489 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.694 HD11 ' HA ' ' A' ' 95' ' ' ALA . 44.2 mt -62.16 -32.33 54.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.931 -1.031 . . . . 5.25 111.394 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 121.182 0.515 . . . . 6.92 110.997 178.78 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.486 HG23 ' CG1' ' A' ' 24' ' ' VAL . 78.1 mt . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 120.441 0.162 . . . . 5.69 110.923 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.34 74.74 1.87 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.174 0.512 . . . . 4.6 110.706 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.412 ' HA ' HG12 ' A' ' 7' ' ' VAL . 46.0 mt-10 -71.67 -5.45 33.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.401 0.62 . . . . 5.13 110.147 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 15.2 m -61.78 -34.28 75.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.612 -0.722 . . . . 4.17 109.301 167.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -59.78 -51.93 67.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 3.42 110.716 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 17' ' ' LEU . 3.8 p -66.58 -40.7 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.229 -0.441 . . . . 3.24 111.113 -177.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.6 mtp -63.45 -31.62 72.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.281 -0.418 . . . . 5.17 111.26 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 13' ' ' MET . 13.9 mm100 -60.28 -53.95 51.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 110.037 -0.357 . . . . 5.38 110.037 173.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.634 ' HB3' HD12 ' A' ' 17' ' ' LEU . 10.7 mt -57.2 -43.22 82.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.153 0.501 . . . . 3.9 109.841 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.88 -50.0 73.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.655 -1.157 . . . . 4.46 111.784 -172.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -60.17 -28.54 68.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.357 -0.383 . . . . 6.27 111.518 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.68 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 17.3 ptt? -112.91 31.1 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.891 0.33 . . . . 5.2 111.891 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.72 96.84 0.55 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.849 -1.167 . . . . 4.75 114.173 173.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 m-85 73.89 133.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 113.225 0.824 . . . . 5.09 113.225 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.31 83.77 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.93 2.42 . . . . 4.25 111.353 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.634 HD12 ' HB3' ' A' ' 10' ' ' LEU . 95.4 mt -82.33 66.98 8.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.781 -0.645 . . . . 3.29 112.137 -173.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 3.7 tt0 -56.38 -19.76 16.28 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.892 0.377 . . . . 5.48 111.001 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.64 -32.34 68.96 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.929 0.395 . . . . 3.54 109.983 172.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 49.5 t -72.02 -43.58 64.77 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.465 -0.789 . . . . 3.27 109.177 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 29.7 ttt180 -52.36 -52.75 51.72 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.868 -1.06 . . . . 6.1 110.049 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -72.71 -25.07 61.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.655 . . . . 4.77 110.834 177.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.46 78.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.62 0.248 . . . . 4.34 110.648 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' CYS . 93.4 t -56.83 -45.93 83.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.672 -0.492 . . . . 4.58 109.672 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -62.03 -46.47 89.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.506 -0.478 . . . . 7.48 110.713 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -64.25 -36.25 83.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 6.84 112.003 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.7 p -68.8 -21.05 64.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.205 0.526 . . . . 5.71 110.583 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.55 27.71 12.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.606 -0.725 . . . . 5.75 111.559 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 64.04 53.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.299 0.571 . . . . 5.06 110.327 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.542 ' HB3' HG21 ' A' ' 34' ' ' VAL . 20.4 mmt -82.08 -14.65 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 6.28 111.86 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.02 173.02 13.39 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.438 -0.887 . . . . 4.17 112.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.04 66.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.34 . . . . 3.73 111.053 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.97 -49.11 69.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.068 -0.515 . . . . 5.46 111.22 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 30' ' ' MET . 95.9 t -60.46 -38.71 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 4.88 111.343 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.17 54.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.079 -0.248 . . . . 3.68 111.662 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.656 ' O ' HG22 ' A' ' 39' ' ' ILE . 59.2 t80 -56.94 -44.78 82.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.904 -0.776 . . . . 4.71 108.904 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.493 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.4 m-20 -65.79 -39.95 91.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.395 -0.821 . . . . 5.69 110.536 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -64.36 -34.77 78.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 5.87 110.468 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 36' ' ' PHE . 7.2 tp -75.42 -40.73 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.201 -0.454 . . . . 3.69 111.475 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -69.71 -23.81 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.163 0.506 . . . . 5.04 110.606 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 37' ' ' ASN . 85.2 t -78.92 -42.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 5.37 110.824 171.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -101.12 19.21 17.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.391 0.515 . . . . 5.35 112.391 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.4 ptm . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.2 0.524 . . . . 5.73 110.416 172.592 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 108.531 -0.914 . . . . 7.14 108.531 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 71.9 Cg_exo -52.67 159.2 5.07 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.756 2.304 . . . . 5.41 112.709 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.739 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 43.3 Cg_endo -65.29 113.28 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.874 2.383 . . . . 7.14 110.959 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.728 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.0 pt-20 -57.43 -28.8 63.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.955 -0.566 . . . . 10.13 110.309 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.3 tt0 -57.62 -50.57 72.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.908 -0.587 . . . . 11.78 109.924 174.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.766 ' HA ' HD12 ' A' ' 84' ' ' ILE . 68.7 mt -76.27 -42.72 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.845 -0.616 . . . . 8.42 112.036 -176.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 86' ' ' THR . 10.0 m -55.35 -38.28 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.463 -0.94 . . . . 7.57 108.463 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.35 -49.66 76.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.822 -1.081 . . . . 10.39 110.57 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.766 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.3 mt -59.78 -42.14 87.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.459 . . . . 10.78 110.737 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.771 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.6 mt -64.63 -47.0 90.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.076 -0.511 . . . . 8.01 111.424 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.03 -21.18 61.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.152 -0.619 . . . . 10.38 110.809 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -77.01 -17.66 58.68 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.809 0.338 . . . . 12.35 110.449 172.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 97.1 mmm -75.28 -25.45 57.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.286 0.565 . . . . 10.33 109.503 173.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.69 -1.77 5.2 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.252 -0.885 . . . . 9.53 112.012 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.624 ' HB2' HG22 ' A' ' 85' ' ' ILE . 32.0 m-85 -92.21 -174.09 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.748 0.309 . . . . 8.89 110.692 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.755 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 6.7 tt0 -97.18 143.28 28.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.916 -0.401 . . . . 10.16 109.916 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 96' ' ' ILE . 5.2 ttm180 -55.9 -54.85 39.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.981 0.42 . . . . 11.98 110.29 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.551 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 54.1 t30 -59.63 -35.82 75.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.641 . . . . 9.02 111.031 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.755 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.5 tt0 -64.96 -39.82 94.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.638 . . . . 6.68 109.533 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.771 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.83 -39.17 93.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.935 -1.03 . . . . 5.22 110.408 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER -59.45 -52.9 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 116.322 -0.399 . . . . 6.39 110.805 176.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.542 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 49.4 tt0 -56.35 -44.62 80.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.221 0.534 . . . . 8.36 110.82 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.04 -53.29 59.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.304 -0.862 . . . . 5.41 110.729 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.723 HD23 ' HB2' ' A' ' 109' ' ' ALA . 77.1 mt -62.01 -32.88 73.41 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 111.779 0.289 . . . . 5.77 111.779 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 75.3 mtp180 -57.37 -43.73 83.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.436 0.636 . . . . 7.71 110.262 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.1 60.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.19 -0.914 . . . . 8.88 111.077 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 33.7 p -84.47 -0.72 53.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.19 0.811 . . . . 8.79 113.19 -174.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 62.03 63.45 1.09 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.577 0.548 . . . . 10.09 110.621 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.8 p-10 50.04 27.64 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.221 1.008 . . . . 7.8 111.967 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 43.6 t-20 -88.96 107.32 18.96 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.827 -0.805 . . . . 10.49 108.827 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.737 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.0 tt -53.78 -60.34 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.093 -0.958 . . . . 9.54 111.393 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.422 ' N ' HD23 ' A' ' 106' ' ' LEU . 37.5 mm-40 -54.45 -49.66 69.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.86 -1.064 . . . . 11.82 111.926 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 26.3 ttm180 -66.9 -28.51 68.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.452 -0.34 . . . . 12.41 110.793 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.723 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.96 -51.28 67.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.679 -0.489 . . . . 6.3 109.679 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.577 HD23 HG23 ' A' ' 85' ' ' ILE . 16.4 mt -59.88 -39.21 84.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.461 -0.79 . . . . 7.78 109.52 175.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.81 -50.36 68.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.866 -1.061 . . . . 9.04 109.877 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -63.32 -49.06 75.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.333 -1.303 . . . . 8.69 110.482 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.647 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.3 mt -62.61 -37.08 78.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.944 -1.025 . . . . 5.25 111.23 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 6.92 110.663 179.828 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 108.702 -0.851 . . . . 7.16 108.702 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.413 HG12 ' HD1' ' A' ' 25' ' ' TYR . 4.3 mp -95.96 75.14 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 107.244 -1.391 . . . . 5.69 107.244 166.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.87 101.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.622 -1.172 . . . . 4.6 110.981 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' CD ' ' HE ' ' A' ' 21' ' ' ARG . 39.8 mt-10 -70.46 -2.12 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.372 -0.831 . . . . 5.13 111.008 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 1.2 m -57.62 -37.87 74.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.36 -0.608 . . . . 4.17 109.36 170.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -64.5 -49.03 72.93 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.701 -0.681 . . . . 3.42 111.372 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -66.59 -42.03 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 120.812 -0.355 . . . . 3.24 111.042 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 47.0 mtt -62.86 -34.83 78.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.266 -0.425 . . . . 5.17 111.145 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 5' ' ' SER . 51.0 mt-30 -59.14 -47.44 85.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.751 -0.38 . . . . 5.38 110.615 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.979 ' HB3' HD12 ' A' ' 17' ' ' LEU . 15.9 mt -60.31 -47.79 84.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.572 0.701 . . . . 3.9 109.989 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.17 -50.61 71.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.571 -1.195 . . . . 4.46 111.915 -174.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -69.53 1.27 4.2 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.528 0.566 . . . . 6.27 112.528 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 22.4 ptp -130.07 10.01 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.028 -0.269 . . . . 5.2 111.7 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.16 -94.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.528 -1.32 . . . . 4.75 113.611 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.8 m-85 -130.44 159.15 72.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.322 . . . . 5.09 110.129 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 53' ' ' THR . 59.7 Cg_endo -69.66 80.79 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.984 2.456 . . . . 4.25 110.945 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.979 HD12 ' HB3' ' A' ' 10' ' ' LEU . 90.4 mt -81.67 66.72 7.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.7 -0.682 . . . . 3.29 111.849 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.74 -22.56 24.47 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.57 0.7 . . . . 5.48 110.125 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB1' ' HZ3' ' A' ' 38' ' ' TRP . . . -58.9 -33.25 70.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.453 -0.794 . . . . 3.54 110.042 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.573 ' HB2' HD12 ' A' ' 10' ' ' LEU . 44.3 t -73.16 -39.37 65.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.606 -0.725 . . . . 3.27 109.855 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.455 ' HE ' ' CD ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -50.02 -56.18 11.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.666 0.746 . . . . 6.1 109.803 177.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.605 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -71.69 -25.38 62.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.337 -0.847 . . . . 4.77 110.539 178.459 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -68.34 -43.24 77.91 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 116.396 -0.365 . . . . 4.34 110.976 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 20' ' ' CYS . 88.5 t -60.1 -43.09 92.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.965 0.412 . . . . 4.58 109.978 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.413 ' HD1' HG12 ' A' ' 2' ' ' ILE . 80.1 t80 -65.84 -39.1 90.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.039 -0.528 . . . . 7.48 110.864 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -71.62 -43.64 65.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 6.84 111.824 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -61.88 -27.64 68.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.107 0.48 . . . . 5.71 110.908 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.78 38.6 6.89 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 5.75 112.357 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 58.94 75.42 0.4 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.243 0.544 . . . . 5.06 110.077 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.487 ' HB3' HG21 ' A' ' 34' ' ' VAL . 26.3 mmt -112.88 -0.6 14.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.167 -0.47 . . . . 6.28 110.803 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.87 159.27 23.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.774 -0.727 . . . . 4.17 112.184 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.34 88.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 3.73 111.299 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 4.0 mp0 -58.35 -39.35 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.9 -0.591 . . . . 5.46 111.024 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' A' ' 30' ' ' MET . 75.1 t -71.54 -41.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 4.88 111.202 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.1 63.32 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 3.68 110.74 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.477 ' HD1' HD22 ' A' ' 10' ' ' LEU . 70.6 t80 -56.2 -43.09 78.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.99 -0.744 . . . . 4.71 108.99 170.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.524 ' HA ' HG13 ' A' ' 40' ' ' ILE . 26.2 t-20 -66.3 -37.84 86.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.857 . . . . 5.69 110.617 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.467 ' HE3' HD12 ' A' ' 39' ' ' ILE . 51.3 t90 -61.22 -35.52 77.44 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.433 0.635 . . . . 5.87 109.802 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.741 HG12 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -76.58 -43.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 3.69 111.696 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 37' ' ' ASN . 2.8 pp -70.33 -23.3 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.385 -0.526 . . . . 5.04 111.446 -174.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.29 -31.63 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 5.37 110.401 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -96.06 10.84 36.22 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.16 0.43 . . . . 5.35 112.16 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.3 ptt? -61.18 -21.42 63.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.894 0.378 . . . . 5.73 111.051 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -62.43 -29.98 70.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.694 -0.685 . . . . 6.34 110.644 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.21 132.25 90.07 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.818 -0.628 . . . . 5.62 110.376 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.58 -49.12 0.62 Allowed 'Trans proline' 0 CA--C 1.527 0.133 0 C-N-CA 122.937 2.425 . . . . 6.22 113.509 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -115.58 24.56 11.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.3 0.572 . . . . 6.09 111.372 -167.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.556 ' HE2' HG13 ' A' ' 39' ' ' ILE . 1.6 p90 -71.2 -17.79 62.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.722 0.773 . . . . 5.89 109.747 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.552 ' CB ' HD23 ' A' ' 17' ' ' LEU . . . -156.18 127.75 7.23 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.531 -1.213 . . . . 4.6 108.334 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 50' ' ' GLU . 27.1 mt-10 -41.76 105.1 0.38 Allowed Pre-proline 0 C--N 1.323 -0.583 0 O-C-N 124.729 1.268 . . . . 5.96 112.007 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.8 17.11 1.71 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.011 2.474 . . . . 6.2 113.106 -174.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -128.64 32.98 4.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.765 -0.652 . . . . 8.24 109.784 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.546 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 9.2 m -145.03 96.5 2.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.39 -0.823 . . . . 7.27 110.08 -177.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 23.3 ptm -87.87 107.36 15.4 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.821 0.343 . . . . 7.41 111.057 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 53' ' ' THR . 7.0 Cg_exo -76.92 -28.84 5.8 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.358 2.705 . . . . 5.89 112.918 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.96 86.64 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.549 -1.31 . . . . 6.63 113.673 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -172.33 75.23 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.38 0.609 . . . . 9.15 109.49 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.69 -105.3 2.92 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.789 -0.72 . . . . 6.92 112.162 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.79 -70.52 2.26 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.994 -0.622 . . . . 7.34 112.238 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.13 -24.88 54.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.076 0.465 . . . . 7.8 110.761 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.56 -54.36 7.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.894 -0.593 . . . . 6.73 110.675 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 m -91.01 101.03 13.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.987 -0.551 . . . . 7.03 110.896 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.77 -61.26 0.43 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 6.23 110.308 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.43 -169.87 29.0 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.757 -0.735 . . . . 7.09 112.321 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.01 95.82 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.428 . . . . 7.1 110.252 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.8 p -85.12 75.93 10.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.515 0.674 . . . . 7.6 111.289 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 p -112.12 -13.89 11.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.811 -0.631 . . . . 8.01 110.86 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -105.76 9.14 33.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.864 0.364 . . . . 8.06 111.306 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.67 -134.61 38.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.003 -0.618 . . . . 6.62 111.917 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.509 ' H ' HD21 ' A' ' 73' ' ' LEU . . . -95.2 13.86 24.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.602 0.201 . . . . 6.12 111.313 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.8 t 65.37 102.86 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.859 -0.609 . . . . 7.65 111.562 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.92 69.7 1.32 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.82 -0.705 . . . . 6.25 111.723 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.509 HD21 ' H ' ' A' ' 70' ' ' ALA . 4.4 mm? -71.55 103.57 3.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.584 0.23 . . . . 7.29 111.456 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.435 ' OD2' ' HB2' ' A' ' 76' ' ' GLN . 5.4 t70 70.2 162.35 0.23 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.485 -0.779 . . . . 6.55 111.017 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.4 28.0 7.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.667 -0.697 . . . . 7.51 110.853 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.435 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 60.8 tt0 -77.68 140.92 63.98 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.626 -0.715 . . . . 7.14 110.478 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.628 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 89.1 Cg_exo -49.85 167.05 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.732 2.954 . . . . 5.41 112.928 171.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.669 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 34.2 Cg_endo -61.47 112.45 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.481 2.121 . . . . 7.14 111.353 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.773 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.3 pt-20 -57.21 -27.59 62.13 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.882 -0.599 . . . . 10.13 110.63 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.8 tt0 -59.14 -51.99 67.64 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.21 0.528 . . . . 11.78 109.741 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 84' ' ' ILE . 80.4 mt -75.77 -42.37 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.671 -0.695 . . . . 8.42 112.024 -175.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.773 HG22 ' HA ' ' A' ' 79' ' ' GLU . 12.0 m -56.01 -38.45 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.594 -0.891 . . . . 7.57 108.594 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.31 -50.09 75.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.561 -1.2 . . . . 10.39 110.649 175.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 81' ' ' ILE . 23.2 mt -59.24 -42.22 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.965 -0.562 . . . . 10.78 110.613 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.738 HD12 ' HB1' ' A' ' 95' ' ' ALA . 84.9 mt -65.5 -46.01 91.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.833 -0.622 . . . . 8.01 111.467 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -71.31 -20.48 62.19 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.073 -0.651 . . . . 10.38 110.837 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -76.79 -21.13 55.58 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.412 . . . . 12.35 110.416 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 mmt -71.5 -22.45 61.79 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.464 0.65 . . . . 10.33 109.813 173.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.77 -3.3 8.04 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.196 -0.911 . . . . 9.53 111.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.599 ' HB2' HG22 ' A' ' 85' ' ' ILE . 31.9 m-85 -87.06 -179.07 6.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.792 0.33 . . . . 8.89 110.478 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 34.6 tt0 -90.58 141.54 28.67 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.589 -0.523 . . . . 10.16 109.589 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 11.7 ttm180 -56.48 -52.65 63.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.948 0.404 . . . . 11.98 110.354 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.78 -34.37 74.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.61 . . . . 9.02 110.938 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.2 tt0 -66.29 -39.2 89.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.57 -0.741 . . . . 6.68 109.359 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.738 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.32 -41.65 98.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.27 -0.877 . . . . 5.22 110.219 173.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.628 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.52 -52.09 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.872 -0.604 . . . . 6.39 110.419 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.573 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 59.6 tt0 -54.13 -47.94 71.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 8.36 110.742 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.89 -53.21 60.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.193 -0.912 . . . . 5.41 110.593 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 109' ' ' ALA . 73.6 mt -61.48 -30.73 70.79 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.593 -0.276 . . . . 5.77 111.36 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.573 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -56.49 -48.18 77.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 7.71 109.802 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.31 68.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.929 -1.032 . . . . 8.88 111.624 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 98' ' ' ALA . 23.6 p -81.59 -7.41 59.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.354 0.502 . . . . 8.79 112.354 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.5 t30 65.18 63.27 0.67 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.601 0.715 . . . . 10.09 110.133 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.576 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.4 p-10 49.66 28.93 2.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.003 -1.453 . . . . 7.8 112.533 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -89.03 110.49 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.096 -0.705 . . . . 10.49 109.096 173.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.748 HD12 HG12 ' A' ' 81' ' ' ILE . 8.4 tt -56.31 -61.2 2.57 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.071 -0.968 . . . . 9.54 112.132 -175.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.431 ' N ' HD23 ' A' ' 106' ' ' LEU . 16.7 mm-40 -56.04 -46.89 78.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.378 -0.828 . . . . 11.82 111.115 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.639 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.3 ttm180 -66.36 -28.62 68.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.573 -0.285 . . . . 12.41 110.748 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.67 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.74 -50.66 68.2 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.332 -0.618 . . . . 6.3 109.332 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.54 HD23 HG23 ' A' ' 85' ' ' ILE . 18.3 mt -59.91 -39.0 83.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.183 -0.917 . . . . 7.78 109.635 175.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.81 -51.1 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 9.04 109.826 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -64.11 -42.67 96.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.507 -1.224 . . . . 8.69 110.862 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.665 HD13 ' HG2' ' A' ' 94' ' ' GLN . 47.6 mt -70.71 -40.66 77.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.361 -0.836 . . . . 5.25 111.584 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.84 -31.98 70.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 6.92 111.802 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 p -77.88 4.37 12.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.547 0.689 . . . . 8.33 111.197 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -122.92 78.51 50.17 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 114.949 -1.023 . . . . 9.41 109.81 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.3 -70.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.431 2.754 . . . . 7.92 111.721 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 6.5 pt-20 -168.9 -57.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.021 -0.99 . . . . 11.42 109.925 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.428 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 30.8 t80 -127.92 27.24 5.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.244 0.545 . . . . 15.58 109.995 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 60.75 99.46 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.305 -0.861 . . . . 11.4 111.53 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -92.31 173.24 7.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.554 -0.748 . . . . 12.26 111.981 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -134.64 13.93 3.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.9 -1.045 . . . . 15.51 108.997 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 t -88.8 32.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.141 -0.936 . . . . 16.06 110.666 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.95 -69.77 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.906 -0.588 . . . . 17.4 110.368 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.3 t80 51.87 71.19 0.47 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.384 0.612 . . . . 19.19 110.885 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.212 -0.899 . . . . 20.33 109.946 179.396 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.079 -0.341 . . . . 7.16 110.079 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mt 62.34 86.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 123.563 0.539 . . . . 5.69 109.876 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.92 82.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 4.6 110.364 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 8' ' ' MET . 43.8 mt-10 -72.63 -10.82 60.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.739 -0.664 . . . . 5.13 111.99 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.628 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 25.1 p -65.33 -32.6 74.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.732 -0.84 . . . . 4.17 108.732 175.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.689 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 43.6 m -59.87 -53.4 58.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.194 -0.912 . . . . 3.42 111.472 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -63.21 -37.84 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.734 -0.387 . . . . 3.24 110.435 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.486 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 64.3 mtt -62.69 -28.25 69.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 5.17 111.396 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 5' ' ' SER . 93.6 mt-30 -65.33 -46.74 79.06 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.91 -0.316 . . . . 5.38 110.478 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.695 HD11 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.21 -40.45 86.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.783 0.801 . . . . 3.9 109.375 176.13 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.47 -47.41 84.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.141 -1.391 . . . . 4.46 112.548 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.68 -27.87 69.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.267 0.469 . . . . 6.27 112.267 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 ptm -99.35 2.0 44.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.625 0.25 . . . . 5.2 111.268 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.96 -116.16 0.35 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.406 -0.902 . . . . 4.75 112.851 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.1 m-85 -101.65 154.32 37.35 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 5.09 110.719 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.872 ' HG3' ' HB3' ' A' ' 52' ' ' LEU . 61.9 Cg_endo -71.47 85.65 0.88 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.785 2.323 . . . . 4.25 111.468 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 39' ' ' ILE . 2.6 mm? -78.46 68.67 4.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 3.29 112.089 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 12.9 tt0 -55.53 -25.38 37.16 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.912 -0.492 . . . . 5.48 110.918 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.7 -31.95 66.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 3.54 109.801 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.695 ' SG ' HD11 ' A' ' 10' ' ' LEU . 28.0 t -73.68 -39.88 64.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.481 -0.781 . . . . 3.27 109.769 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 18' ' ' GLU . 10.0 ttp180 -53.27 -53.37 51.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.085 0.469 . . . . 6.1 110.709 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 18' ' ' GLU . 8.7 ptpt -72.17 -22.83 61.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.226 -0.443 . . . . 4.77 110.721 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . . . -69.39 -41.28 76.66 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.237 -0.438 . . . . 4.34 110.75 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 20' ' ' CYS . 73.4 t -58.5 -42.17 83.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 4.58 110.159 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.11 -38.6 82.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.663 -0.415 . . . . 7.48 110.366 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.59 -37.64 82.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.388 -0.369 . . . . 6.84 111.427 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.5 p -71.55 -17.7 62.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 5.71 111.406 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.95 23.48 20.24 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.876 -0.678 . . . . 5.75 111.481 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.19 58.88 1.36 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.6 0.714 . . . . 5.06 110.263 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.429 ' HB3' HG21 ' A' ' 34' ' ' VAL . 87.4 mmm -88.23 -11.78 45.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.491 -0.777 . . . . 6.28 111.757 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.44 -173.67 17.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 4.17 113.298 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.689 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -58.84 -55.57 33.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.659 0.615 . . . . 3.73 112.659 -174.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.75 -44.78 92.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 5.46 112.149 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 30' ' ' MET . 86.9 t -65.25 -42.42 93.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.741 0.305 . . . . 4.88 111.096 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.16 50.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.596 -0.441 . . . . 3.68 111.172 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.519 ' O ' HG22 ' A' ' 39' ' ' ILE . 86.3 t80 -61.43 -40.63 95.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.978 -0.749 . . . . 4.71 108.978 171.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 40' ' ' ILE . 92.0 m-20 -60.69 -45.37 94.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.784 -0.644 . . . . 5.69 110.218 174.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 23' ' ' ALA . 42.9 t90 -60.84 -41.33 95.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.067 0.46 . . . . 5.87 110.114 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 36' ' ' PHE . 3.9 tp -73.07 -36.23 50.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.125 -0.489 . . . . 3.69 111.487 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.0 -21.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.108 0.48 . . . . 5.04 110.804 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 37' ' ' ASN . 95.3 t -74.88 -42.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.116 -0.493 . . . . 5.37 110.508 171.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -100.54 16.5 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.992 0.367 . . . . 5.35 111.992 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -61.15 -21.35 63.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.154 0.502 . . . . 5.73 111.059 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.15 -21.56 65.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.577 -0.738 . . . . 6.34 112.261 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 48' ' ' PHE . 18.7 mt-10 -85.99 111.52 38.78 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.31 0.576 . . . . 5.62 110.876 -174.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 25.6 Cg_endo -65.05 -52.19 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.721 2.947 . . . . 6.22 113.717 -176.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -98.45 -6.14 31.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.803 -0.635 . . . . 6.09 111.307 -168.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 45' ' ' GLU . 17.0 m-85 -69.57 -11.24 60.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.424 . . . . 5.89 111.07 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -84.42 -120.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.467 -0.568 . . . . 4.6 109.467 171.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.52 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 21.3 mt-10 -137.5 143.58 41.54 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 110.07 -0.344 . . . . 5.96 110.07 172.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -71.45 69.53 2.65 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.749 2.299 . . . . 6.2 111.204 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.872 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 56.8 tp -138.37 108.57 6.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.368 -0.833 . . . . 8.24 110.307 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 m -43.57 120.33 1.93 Allowed 'General case' 0 C--O 1.236 0.392 0 O-C-N 124.025 0.828 . . . . 7.27 110.83 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.482 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 19.1 ptm -60.56 136.38 92.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.935 -0.575 . . . . 7.41 111.738 -172.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 7.2 Cg_exo -73.05 132.83 18.73 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.922 2.415 . . . . 5.89 111.189 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.85 89.1 1.42 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.867 -0.682 . . . . 6.63 112.046 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -66.81 100.43 0.71 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.963 -0.384 . . . . 9.15 109.963 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.39 36.94 4.97 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.862 -0.685 . . . . 6.92 111.539 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.38 31.94 2.88 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.252 -0.499 . . . . 7.34 112.913 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.8 -33.76 17.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.212 0.529 . . . . 7.8 109.87 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.4 83.13 6.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.782 -0.645 . . . . 6.73 110.372 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 p -64.89 -39.42 93.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.839 -0.619 . . . . 7.03 111.209 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.54 33.08 5.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.275 -0.421 . . . . 6.23 110.753 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.01 -129.76 29.71 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.935 -0.575 . . . . 7.09 112.618 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.23 -26.91 28.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 7.1 110.631 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m 64.88 33.06 10.33 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 114.714 -1.13 . . . . 7.6 112.018 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.87 94.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.829 0.823 . . . . 8.01 111.313 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -91.23 138.5 31.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.786 -0.643 . . . . 8.06 109.615 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.41 169.63 22.7 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.713 -0.756 . . . . 6.62 111.935 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.86 -14.45 44.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.671 0.272 . . . . 6.12 110.378 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 m 70.23 -65.79 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.117 -0.947 . . . . 7.65 111.546 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -145.58 126.48 2.57 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.103 -0.57 . . . . 6.25 111.677 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.51 6.77 48.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.289 0.566 . . . . 7.29 110.025 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -99.99 97.19 8.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.362 -0.836 . . . . 6.55 110.185 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -157.62 122.84 4.5 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.155 -0.683 . . . . 7.51 109.155 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 50.3 tt0 -79.85 136.08 55.06 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 109.522 -0.548 . . . . 7.14 109.522 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.586 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 86.8 Cg_exo -53.24 160.76 4.31 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.626 2.884 . . . . 5.41 113.579 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.722 ' HD2' HD13 ' A' ' 99' ' ' LEU . 46.5 Cg_endo -66.39 112.96 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.943 2.429 . . . . 7.14 111.157 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 82' ' ' VAL . 5.5 pt-20 -56.15 -27.35 53.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.67 -0.696 . . . . 10.13 111.079 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.7 tt0 -58.56 -53.07 62.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.195 0.521 . . . . 11.78 110.093 172.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.782 ' HA ' HD12 ' A' ' 84' ' ' ILE . 74.6 mt -74.66 -40.98 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.737 -0.665 . . . . 8.42 111.799 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.752 ' O ' HG22 ' A' ' 86' ' ' THR . 16.1 m -56.47 -37.85 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.719 -0.845 . . . . 7.57 108.719 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.3 -48.63 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.613 -1.176 . . . . 10.39 110.557 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.782 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.2 mt -60.63 -43.36 94.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 10.78 110.8 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.755 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.7 mt -63.53 -45.31 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.951 -0.568 . . . . 8.01 111.57 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 82' ' ' VAL . 2.1 t -72.5 -20.54 61.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.313 -0.555 . . . . 10.38 110.945 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.1 m -79.92 -16.95 54.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.798 0.333 . . . . 12.35 110.517 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.4 mmm -74.65 -25.29 59.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.302 0.572 . . . . 10.33 109.932 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.63 -2.27 4.89 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.977 -1.01 . . . . 9.53 111.762 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.596 ' HB2' HG22 ' A' ' 85' ' ' ILE . 30.7 m-85 -94.39 -173.8 3.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.666 0.27 . . . . 8.89 110.55 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 7.3 tt0 -101.03 145.54 28.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.66 -0.496 . . . . 10.16 109.66 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.447 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.5 ttm180 -58.11 -52.21 66.48 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.045 0.45 . . . . 11.98 110.61 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 48.3 t30 -58.41 -37.36 75.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.617 -0.719 . . . . 9.02 110.766 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 5.9 tt0 -65.71 -38.3 88.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.629 -0.714 . . . . 6.68 109.748 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.755 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.09 -37.96 89.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.215 -0.902 . . . . 5.22 110.755 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.597 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -58.61 -53.92 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 116.446 -0.343 . . . . 6.39 110.855 177.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 53.5 tt0 -57.4 -44.36 84.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.232 0.539 . . . . 8.36 110.866 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.32 -52.52 65.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.041 -0.981 . . . . 5.41 110.355 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.722 HD13 ' HD2' ' A' ' 78' ' ' PRO . 79.6 mt -61.69 -34.16 75.27 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.548 -0.296 . . . . 5.77 111.659 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 96' ' ' ILE . 59.1 mtp180 -58.47 -41.24 84.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.299 0.571 . . . . 7.71 110.643 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.4 -38.11 60.1 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.195 -0.911 . . . . 8.88 111.385 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 32.9 p -87.56 1.31 53.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.707 0.632 . . . . 8.79 112.707 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.19 65.21 1.23 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.67 -0.695 . . . . 10.09 110.575 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.5 p-10 50.01 28.33 2.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.13 -1.395 . . . . 7.8 112.562 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.5 t-20 -90.12 109.69 20.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.257 -0.646 . . . . 10.49 109.257 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.737 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.2 tt -52.44 -59.96 3.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.945 -1.025 . . . . 9.54 111.771 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -54.24 -52.44 61.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.706 -1.134 . . . . 11.82 111.794 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 17.7 ttm180 -66.47 -27.48 67.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.511 . . . . 12.41 110.96 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.63 -51.37 67.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.398 -0.593 . . . . 6.3 109.398 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.482 HD23 HG23 ' A' ' 85' ' ' ILE . 18.2 mt -59.82 -38.6 82.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.267 -0.879 . . . . 7.78 109.763 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 8.3 t70 -54.76 -51.15 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.869 -1.06 . . . . 9.04 110.155 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.36 -48.1 79.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.326 -1.306 . . . . 8.69 110.395 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 95' ' ' ALA . 41.1 mt -62.09 -41.16 90.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.231 -0.895 . . . . 5.25 110.974 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.73 -26.55 68.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 6.92 111.106 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 m -75.37 -1.27 23.05 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 8.33 110.725 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -139.58 74.79 33.14 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.468 -0.938 . . . . 9.41 108.468 173.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.416 ' HG2' ' CA ' ' A' ' 120' ' ' GLU . 1.9 Cg_endo -38.38 -61.75 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.833 1 C-N-CA 125.913 4.409 . . . . 7.92 114.361 -177.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 9.7 pt-20 -166.89 -51.0 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.331 -0.85 . . . . 11.42 108.915 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.462 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 37.2 t80 -140.68 37.43 1.82 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.624 -1.171 . . . . 15.58 108.001 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.416 ' CA ' ' HG2' ' A' ' 117' ' ' PRO . 29.1 mm-40 68.27 -178.96 0.22 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.398 -1.274 . . . . 11.4 110.032 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.35 164.25 16.61 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.898 -0.321 . . . . 12.26 111.587 -172.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.4 t70 73.3 132.62 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.257 -0.883 . . . . 15.51 113.113 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.7 t -159.32 137.31 10.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.758 -1.11 . . . . 16.06 108.053 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -150.15 150.05 31.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.059 0.457 . . . . 17.4 110.905 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -131.31 38.05 3.66 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.374 -0.83 . . . . 19.19 109.219 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 56.6 t . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.438 -0.801 . . . . 20.33 110.158 -175.168 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.714 -0.476 . . . . 7.16 109.714 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.462 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 86.3 mt -71.26 116.63 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.823 -0.806 . . . . 5.69 108.823 175.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.15 81.15 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.138 0.495 . . . . 4.6 111.34 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.581 ' HA ' HG12 ' A' ' 7' ' ' VAL . 35.8 mt-10 -70.83 -7.94 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.012 -0.54 . . . . 5.13 110.591 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 13.2 m -57.43 -34.83 69.34 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.27 -0.641 . . . . 4.17 109.27 170.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 3.3 m -66.13 -51.79 54.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.442 -0.799 . . . . 3.42 111.202 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -64.14 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 3.24 110.902 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 77.3 mtp -63.04 -32.66 74.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 5.17 111.052 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.625 ' O ' ' HG2' ' A' ' 13' ' ' MET . 86.3 mm-40 -59.37 -48.82 80.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.061 -0.256 . . . . 5.38 110.454 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 39' ' ' ILE . 18.5 mt -64.63 -45.29 87.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.506 0.67 . . . . 3.9 110.184 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.79 -50.31 71.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.708 -1.133 . . . . 4.46 112.489 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 57' ' ' TYR . 8.5 pt-20 -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.451 . . . . 6.27 111.565 -172.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.625 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 24.2 ptt? -104.82 22.48 15.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.111 -0.495 . . . . 5.2 111.629 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.45 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.126 -1.035 . . . . 4.75 112.851 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 29.2 p90 -158.83 164.93 19.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.676 -0.861 . . . . 5.09 108.676 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 88.7 Cg_endo -71.52 83.94 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.562 2.175 . . . . 4.25 113.562 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.637 ' HG ' HG12 ' A' ' 39' ' ' ILE . 3.1 mm? -75.15 64.87 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.074 -0.25 . . . . 3.29 111.641 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.75 -19.38 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 121.387 -0.821 . . . . 5.48 109.681 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.594 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . . . -57.82 -32.7 67.84 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.577 -0.738 . . . . 3.54 110.029 170.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 35.1 t -72.09 -42.99 65.52 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.768 -1.105 . . . . 3.27 109.646 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -54.15 -46.67 72.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.161 0.505 . . . . 6.1 110.178 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 42.6 mtmt -70.52 -26.01 63.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 4.77 110.744 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.565 ' HB1' ' HD1' ' A' ' 38' ' ' TRP . . . -74.16 -44.89 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 4.34 110.928 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 20' ' ' CYS . 92.1 t -53.6 -47.68 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 4.58 109.954 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -56.08 -45.77 79.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.486 -0.779 . . . . 7.48 110.783 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -66.03 -40.3 90.92 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.405 -0.361 . . . . 6.84 111.593 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 30' ' ' MET . 74.8 p -67.47 -11.75 58.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.353 . . . . 5.71 111.51 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.62 26.18 47.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.921 -0.657 . . . . 5.75 111.722 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 76.7 m-20 60.84 60.57 1.84 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.181 0.515 . . . . 5.06 110.342 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 27' ' ' THR . 17.1 mmt -86.28 -34.25 20.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 6.28 112.152 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 170.4 17.74 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.929 -1.129 . . . . 4.17 112.795 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 6' ' ' SER . . . -62.62 -58.37 7.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.207 0.447 . . . . 3.73 112.207 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.58 -31.13 67.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.367 -0.379 . . . . 5.46 111.065 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.72 -45.28 92.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.068 -0.515 . . . . 4.88 110.662 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -27.02 50.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.92 -0.312 . . . . 3.68 111.258 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 66.6 t80 -56.6 -43.92 80.61 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.875 -0.787 . . . . 4.71 108.875 169.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.568 ' O ' HG13 ' A' ' 40' ' ' ILE . 41.6 t-20 -63.06 -43.74 97.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.066 -0.97 . . . . 5.69 110.28 177.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.565 ' HD1' ' HB1' ' A' ' 23' ' ' ALA . 13.1 t-105 -65.49 -30.24 70.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.809 -0.357 . . . . 5.87 111.029 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.637 HG12 ' HG ' ' A' ' 17' ' ' LEU . 3.1 tp -76.21 -37.65 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.997 -0.281 . . . . 3.69 110.912 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.49 -21.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.444 0.64 . . . . 5.04 110.378 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 37' ' ' ASN . 72.4 t -74.22 -51.01 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.594 -0.73 . . . . 5.37 109.997 169.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 44' ' ' GLU . 2.0 m-70 -85.42 14.38 5.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.193 0.442 . . . . 5.35 112.193 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 23.2 ptt? -62.85 -20.29 64.95 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.358 -0.608 . . . . 5.73 109.358 169.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.581 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 9.6 pt-20 -49.36 -30.51 7.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.288 -0.869 . . . . 6.34 110.712 172.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.581 ' HG2' ' HG3' ' A' ' 44' ' ' GLU . 1.3 pt-20 -115.35 84.27 11.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 5.62 110.089 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 10.8 Cg_endo -55.09 -45.48 40.37 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 123.897 3.064 . . . . 6.22 113.219 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -93.47 20.22 7.51 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.414 -1.266 . . . . 6.09 110.537 -168.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -76.36 -10.24 59.25 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.841 0.829 . . . . 5.89 108.882 172.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 16' ' ' PRO . . . -116.06 101.47 8.77 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.65 -1.159 . . . . 4.6 109.038 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 2.2 mp0 -47.08 108.17 0.83 Allowed Pre-proline 0 C--N 1.321 -0.656 0 O-C-N 123.936 0.772 . . . . 5.96 111.43 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 3.7 Cg_exo -80.38 57.61 6.6 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.379 2.719 . . . . 6.2 112.605 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.98 31.56 2.36 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.096 -0.502 . . . . 8.24 110.86 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.54 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 6.7 m -159.22 107.0 1.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.368 -0.378 . . . . 7.27 110.203 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.9 ttm -88.6 102.44 3.91 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 110.253 -0.277 . . . . 7.41 110.253 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 53' ' ' THR . 6.1 Cg_exo -80.69 123.39 4.74 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.215 2.61 . . . . 5.89 112.273 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.94 65.34 3.75 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.734 -0.746 . . . . 6.63 111.847 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.512 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 40.3 p90 -74.2 135.57 42.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.955 0.407 . . . . 9.15 110.52 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.47 -155.06 20.93 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.189 -0.764 . . . . 6.92 111.189 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.63 -126.5 7.49 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.556 -0.831 . . . . 7.34 111.706 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 67.51 -72.19 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.297 0.639 . . . . 7.8 111.338 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.48 -62.5 1.23 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.528 -0.305 . . . . 6.73 110.478 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.3 m 50.06 55.38 9.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.423 0.63 . . . . 7.03 110.467 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 66' ' ' SER . . . -101.23 81.29 2.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.509 -0.769 . . . . 6.23 111.644 -174.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.31 -20.04 79.16 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.797 -0.921 . . . . 7.09 110.797 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.773 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -171.76 -48.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.178 -1.045 . . . . 7.1 108.178 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 18.9 m -106.5 169.83 8.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.738 -1.119 . . . . 7.6 108.736 170.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.4 m -89.86 135.95 24.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.621 0.248 . . . . 8.01 110.804 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.0 t80 58.15 60.29 2.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.641 -0.709 . . . . 8.06 110.669 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.84 -147.14 18.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.594 -0.812 . . . . 6.62 112.792 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.39 34.17 4.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.28 0.562 . . . . 6.12 110.419 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.5 m -64.3 113.65 3.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.615 -0.72 . . . . 7.65 110.922 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.01 29.23 9.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 6.25 112.491 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.773 HD21 ' HB3' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -86.03 50.46 1.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.153 0.501 . . . . 7.29 111.242 -178.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.06 157.17 32.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.935 -0.575 . . . . 6.55 109.514 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -117.14 15.57 14.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.374 0.607 . . . . 7.51 110.379 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -62.78 143.56 96.86 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.778 -1.101 . . . . 7.14 110.719 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.573 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 88.4 Cg_exo -51.03 165.04 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.524 2.816 . . . . 5.41 112.823 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.669 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 41.9 Cg_endo -63.53 112.54 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.474 2.116 . . . . 7.14 110.999 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.753 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.5 pt-20 -55.84 -30.72 61.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.899 -0.592 . . . . 10.13 110.295 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.73 -51.48 67.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.562 -0.744 . . . . 11.78 110.139 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 75.1 mt -76.24 -42.7 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.924 -0.58 . . . . 8.42 111.98 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.779 ' O ' HG22 ' A' ' 86' ' ' THR . 12.6 m -55.76 -37.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.507 -0.923 . . . . 7.57 108.507 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.01 86.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.681 -1.145 . . . . 10.39 110.927 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.6 mt -60.58 -41.98 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.225 0.536 . . . . 10.78 110.501 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.75 HD12 ' HB1' ' A' ' 95' ' ' ALA . 89.6 mt -65.5 -47.4 86.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.703 -0.681 . . . . 8.01 111.527 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -70.19 -21.99 62.98 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.172 -0.611 . . . . 10.38 110.536 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 t -75.44 -19.95 59.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.976 0.417 . . . . 12.35 110.046 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.2 mmt -75.78 -24.55 56.0 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.323 0.582 . . . . 10.33 110.396 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.67 9.03 4.1 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.392 -0.822 . . . . 9.53 111.8 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.606 ' HB2' HG22 ' A' ' 85' ' ' ILE . 28.6 m-85 -101.05 -175.36 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.859 -0.423 . . . . 8.89 109.859 177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.587 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 7.2 tt0 -100.23 145.31 28.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.659 -0.497 . . . . 10.16 109.659 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.2 ttm180 -56.43 -52.29 65.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 11.98 110.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.46 -35.96 75.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.792 -0.64 . . . . 9.02 111.085 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.618 ' HG2' HD13 ' A' ' 113' ' ' ILE . 7.7 tt0 -66.14 -38.65 88.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.699 . . . . 6.68 109.664 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.75 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.22 -39.51 94.13 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.231 -0.895 . . . . 5.22 110.412 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.573 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -59.26 -52.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.191 -0.459 . . . . 6.39 110.729 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.452 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 34.1 tt0 -56.61 -43.97 80.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.881 -0.6 . . . . 8.36 110.961 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.35 -53.89 52.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.409 -0.814 . . . . 5.41 110.846 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.728 HD23 ' HB2' ' A' ' 109' ' ' ALA . 84.3 mt -60.02 -34.2 73.04 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 111.474 0.176 . . . . 5.77 111.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.2 mtt180 -55.39 -46.47 76.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.528 0.68 . . . . 7.71 110.304 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.89 -42.48 69.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.125 -0.943 . . . . 8.88 111.422 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.687 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.3 p -82.93 -1.35 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.564 0.579 . . . . 8.79 112.564 -174.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m120 63.81 60.03 1.09 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.049 -0.523 . . . . 10.09 110.362 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 3.3 p-10 48.63 34.42 5.03 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.351 1.06 . . . . 7.8 111.933 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.6 t-20 -93.24 111.29 22.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.79 -0.818 . . . . 10.49 108.79 174.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.7 HD12 HG12 ' A' ' 81' ' ' ILE . 7.8 tt -56.24 -59.35 5.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.464 -0.789 . . . . 9.54 111.516 -175.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.413 ' N ' HD23 ' A' ' 106' ' ' LEU . 4.3 mt-10 -55.98 -50.06 71.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.711 -1.131 . . . . 11.82 111.344 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.687 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -66.03 -29.09 69.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.547 -0.751 . . . . 12.41 111.281 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.728 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.24 -50.13 72.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.308 -0.627 . . . . 6.3 109.308 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 85' ' ' ILE . 18.5 mt -61.31 -36.74 80.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.163 -0.926 . . . . 7.78 109.904 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 8.4 t70 -57.14 -52.88 63.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.263 -0.88 . . . . 9.04 109.627 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 63.8 t90 -60.59 -45.24 94.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.126 -1.397 . . . . 8.69 110.498 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.625 HD11 ' HA ' ' A' ' 95' ' ' ALA . 53.0 mt -67.71 -34.25 66.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.058 -0.974 . . . . 5.25 110.901 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -67.9 -30.37 69.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.382 0.61 . . . . 6.92 110.165 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.3 m -80.35 7.12 10.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.788 -0.642 . . . . 8.33 110.324 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -120.53 80.32 30.53 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.563 -0.744 . . . . 9.41 110.056 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.79 -60.85 0.68 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.915 2.41 . . . . 7.92 110.954 172.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -177.67 -39.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.496 -1.229 . . . . 11.42 110.251 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -131.93 2.48 4.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.638 0.732 . . . . 15.58 110.992 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 48.71 61.52 3.04 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.411 -1.268 . . . . 11.4 111.534 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -101.6 -178.49 3.74 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.957 -1.474 . . . . 12.26 109.135 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 t70 54.36 72.4 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.743 0.652 . . . . 15.51 110.384 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.2 p -66.91 105.89 1.75 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.954 -0.566 . . . . 16.06 111.366 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -47.15 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.271 0.841 . . . . 17.4 113.271 -170.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -126.27 9.34 7.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.611 0.243 . . . . 19.19 111.461 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.839 -0.6 . . . . 20.33 110.489 179.902 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.173 0.511 . . . . 7.16 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt -114.94 133.17 61.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 5.69 109.45 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -75.0 76.94 2.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.435 0.636 . . . . 4.6 109.642 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.519 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.5 mt-10 -72.34 -10.48 59.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.809 -0.632 . . . . 5.13 112.022 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 54.3 p -62.05 -38.01 87.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.371 0.605 . . . . 4.17 109.489 176.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.684 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 50.3 m -60.67 -52.27 65.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.097 -0.956 . . . . 3.42 111.594 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.57 HG23 ' HB3' ' A' ' 20' ' ' CYS . 7.4 p -64.34 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.561 -0.456 . . . . 3.24 110.907 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 67.1 mtt -59.7 -31.88 70.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.519 -0.31 . . . . 5.17 111.22 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.591 ' O ' ' HG2' ' A' ' 13' ' ' MET . 86.1 mm-40 -60.9 -56.88 15.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.593 -0.276 . . . . 5.38 110.48 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.81 HD11 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.9 -28.73 67.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.565 -0.454 . . . . 3.9 111.387 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.32 86.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.429 . . . . 4.46 110.996 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -79.45 -42.18 25.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 6.27 111.439 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.591 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 26.2 ptt? -92.14 32.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.782 0.325 . . . . 5.2 111.251 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.618 ' O ' ' HD2' ' A' ' 55' ' ' PRO . . . -172.09 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.403 -0.903 . . . . 4.75 112.347 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.626 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 12.4 p90 -166.53 162.15 11.74 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.092 -0.707 . . . . 5.09 109.092 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 22.8 Cg_endo -55.1 91.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.687 2.924 . . . . 4.25 112.99 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.647 HD12 ' HB2' ' A' ' 10' ' ' LEU . 70.4 mt -96.81 57.32 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.891 -0.595 . . . . 3.29 111.745 -175.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -55.67 -23.89 30.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.161 0.505 . . . . 5.48 110.718 174.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.455 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . . . -57.75 -36.95 72.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.925 -0.58 . . . . 3.54 110.001 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.81 ' SG ' HD11 ' A' ' 10' ' ' LEU . 20.2 t -73.81 -31.75 63.4 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.421 -0.809 . . . . 3.27 110.449 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.38 -48.72 71.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.48 -0.933 . . . . 6.1 108.48 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 18.8 mttm -66.09 -42.32 89.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.026 . . . . 4.77 109.976 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -60.37 -40.81 92.16 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.643 -0.708 . . . . 4.34 111.918 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 20' ' ' CYS . 39.9 t -59.08 -45.76 92.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.153 -0.314 . . . . 4.58 110.153 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.46 -41.83 99.05 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.454 -0.498 . . . . 7.48 110.223 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.15 -41.59 85.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.82 -0.627 . . . . 6.84 112.085 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -65.46 -23.36 66.9 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.057 0.456 . . . . 5.71 110.835 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.37 29.65 8.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.6 -0.727 . . . . 5.75 111.73 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 59.39 49.44 8.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.217 0.532 . . . . 5.06 110.297 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.4 mmm -82.42 3.78 26.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 6.28 112.192 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.32 171.45 23.08 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.567 -0.825 . . . . 4.17 112.444 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.684 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -67.68 -45.22 75.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.665 -0.267 . . . . 3.73 111.679 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.97 -31.36 70.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.481 -0.327 . . . . 5.46 111.663 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.07 -44.65 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 4.88 110.56 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.0 60.72 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.613 -0.435 . . . . 3.68 110.49 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.454 ' O ' HG22 ' A' ' 39' ' ' ILE . 83.9 t80 -56.35 -42.55 77.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.958 -0.756 . . . . 4.71 108.958 171.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -61.75 -45.96 91.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 5.69 110.612 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -59.44 -43.03 93.22 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.532 0.682 . . . . 5.87 109.842 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 10' ' ' LEU . 3.0 tp -74.77 -36.3 39.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.486 -0.779 . . . . 3.69 111.861 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 43' ' ' MET . 2.8 pp -71.47 -21.34 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 5.04 111.54 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.59 -36.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.54 . . . . 5.37 110.19 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -99.52 7.6 45.21 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.416 0.524 . . . . 5.35 112.416 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 4.8 ppp? -76.76 -22.38 53.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.211 0.529 . . . . 5.73 111.001 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.11 -21.74 64.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.254 -0.885 . . . . 6.34 111.035 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.827 ' HG3' ' HB2' ' A' ' 48' ' ' PHE . 3.9 pt-20 -90.05 119.75 69.3 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.541 0.686 . . . . 5.62 109.407 172.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.45 -47.26 22.68 Favored 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 124.149 3.232 . . . . 6.22 114.947 -165.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -105.19 24.52 11.92 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.146 0.974 . . . . 6.09 110.713 -167.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.827 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 35.5 t80 -76.75 -25.71 53.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.444 -0.798 . . . . 5.89 110.493 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 16' ' ' PRO . . . -93.21 -123.82 0.09 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.15 -0.477 . . . . 4.6 110.858 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 42.1 mt-10 -129.79 134.97 26.79 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.393 -0.595 . . . . 5.96 109.393 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 5.6 Cg_exo -78.71 65.99 8.65 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.944 2.429 . . . . 6.2 111.769 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.55 ' HG ' HG22 ' A' ' 53' ' ' THR . 51.2 tp -141.02 105.39 4.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.049 -0.523 . . . . 8.24 110.758 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.55 HG22 ' HG ' ' A' ' 52' ' ' LEU . 6.3 t 37.01 72.83 0.1 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.398 1.061 . . . . 7.27 113.229 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.477 ' HG3' ' HB2' ' A' ' 15' ' ' PHE . 4.2 mpp? -86.07 107.45 13.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 7.41 110.254 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 14' ' ' GLY . 6.1 Cg_exo -79.36 -54.9 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.146 2.564 . . . . 5.89 112.941 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.54 -179.66 19.47 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.29 -0.724 . . . . 6.63 111.29 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -109.92 -34.47 6.42 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.196 0.498 . . . . 9.15 112.217 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.89 -142.2 9.21 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.61 -1.281 . . . . 6.92 113.514 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.87 41.52 0.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.29 -0.724 . . . . 7.34 111.29 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.37 -164.53 1.3 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.451 0.167 . . . . 7.8 111.442 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.47 52.57 1.79 Allowed 'General case' 0 C--O 1.231 0.101 0 O-C-N 123.807 0.692 . . . . 6.73 111.546 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.1 t -94.54 119.09 32.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.788 -0.642 . . . . 7.03 110.214 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.13 140.54 48.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.248 -0.433 . . . . 6.23 110.307 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.4 95.71 0.4 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.547 -0.835 . . . . 7.09 112.879 -176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.63 152.57 22.3 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.543 -0.539 . . . . 7.1 109.543 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.562 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 11.3 t -161.31 -159.2 0.63 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.934 -0.306 . . . . 7.6 110.839 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.34 -23.16 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.208 0.448 . . . . 8.01 112.208 -175.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.562 ' CE2' ' HB3' ' A' ' 66' ' ' SER . 21.5 p90 -78.58 64.02 3.52 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.67 0.748 . . . . 8.06 111.958 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.03 -13.35 69.24 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.698 -0.683 . . . . 6.62 111.851 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.793 ' HB1' HD23 ' A' ' 73' ' ' LEU . . . -120.97 154.29 36.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.228 -0.286 . . . . 6.12 110.228 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 p -80.95 57.67 3.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.159 0.504 . . . . 7.65 111.593 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.17 -56.3 4.85 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.033 -0.603 . . . . 6.25 112.345 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.793 HD23 ' HB1' ' A' ' 70' ' ' ALA . 1.8 mm? 65.5 32.53 9.37 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.858 0.463 . . . . 7.29 111.37 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -126.05 134.56 51.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.041 -0.725 . . . . 6.55 109.041 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -133.32 22.72 4.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.428 0.632 . . . . 7.51 110.272 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -93.78 135.84 24.54 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.315 -0.857 . . . . 7.14 110.141 -177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.621 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 76.7 Cg_exo -55.09 163.93 3.99 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.249 2.633 . . . . 5.41 112.044 171.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.685 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 36.6 Cg_endo -63.51 113.18 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.598 2.199 . . . . 7.14 111.464 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -58.16 -23.28 54.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.952 -0.567 . . . . 10.13 111.16 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 8.7 tt0 -61.61 -52.57 63.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.128 -0.487 . . . . 11.78 109.879 171.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.5 mt -75.18 -41.55 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.617 -0.72 . . . . 8.42 111.944 -175.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.79 HG22 ' HA ' ' A' ' 79' ' ' GLU . 13.7 m -56.56 -38.02 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.604 -0.887 . . . . 7.57 108.604 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.49 -49.88 75.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.903 -1.044 . . . . 10.39 110.576 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.0 mt -59.69 -43.07 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 10.78 110.808 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.743 HD12 ' HB1' ' A' ' 95' ' ' ALA . 90.5 mt -63.96 -47.76 89.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.92 -0.582 . . . . 8.01 111.84 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -70.08 -23.69 63.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.013 -0.675 . . . . 10.38 110.51 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.5 m -69.75 -31.2 69.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.701 0.286 . . . . 12.35 110.24 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 93.4 mmm -62.78 -29.07 70.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.206 0.526 . . . . 10.33 110.679 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.2 4.2 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.364 -0.835 . . . . 9.53 112.005 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.57 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.7 m-85 -91.5 -173.85 3.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.207 -0.294 . . . . 8.89 110.207 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.594 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 58.1 tt0 -101.49 147.16 26.7 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.699 -0.482 . . . . 10.16 109.699 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' HD12 ' A' ' 96' ' ' ILE . 20.7 ttm180 -57.74 -52.7 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 11.98 110.763 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -58.64 -36.74 74.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.776 -0.647 . . . . 9.02 110.786 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.653 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.8 tt0 -65.82 -38.94 90.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.546 -0.752 . . . . 6.68 109.63 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.743 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.88 -40.77 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.272 -0.876 . . . . 5.22 110.519 174.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.621 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -58.5 -52.2 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 116.002 -0.545 . . . . 6.39 110.656 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.646 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 27.3 tt0 -56.55 -44.78 81.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.046 -0.524 . . . . 8.36 111.08 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.95 -53.39 58.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.457 -0.792 . . . . 5.41 110.659 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 109' ' ' ALA . 76.1 mt -61.65 -32.28 72.44 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.609 -0.269 . . . . 5.77 111.392 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.646 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 88.7 mtt180 -54.86 -46.7 74.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.601 . . . . 7.71 109.752 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.69 62.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.928 -1.033 . . . . 8.88 111.903 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 27.8 p -85.2 1.04 49.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.627 0.603 . . . . 8.79 112.627 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.73 45.68 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.972 -0.558 . . . . 10.09 110.242 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.655 ' ND2' ' HD3' ' A' ' 78' ' ' PRO . 2.8 m-20 69.93 16.56 7.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 7.8 111.072 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.4 t-20 -80.43 111.07 16.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.482 -0.562 . . . . 10.49 109.482 176.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.4 tt -55.02 -60.28 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.287 -0.87 . . . . 9.54 111.536 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 -52.74 52.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.681 -1.145 . . . . 11.82 110.913 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.692 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 12.2 ttm180 -65.14 -28.48 69.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.429 -0.805 . . . . 12.41 111.354 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.04 -50.56 70.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.394 -0.595 . . . . 6.3 109.394 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 85' ' ' ILE . 15.8 mt -59.75 -39.07 83.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 7.78 109.717 175.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.57 -50.06 73.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.007 -0.997 . . . . 9.04 109.956 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.57 -46.83 86.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.621 -1.172 . . . . 8.69 110.408 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.653 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.2 mt -63.61 -35.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.201 -0.908 . . . . 5.25 110.926 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -68.01 -25.15 65.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 6.92 110.108 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.8 t -83.13 -2.47 55.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.454 0.645 . . . . 8.33 109.71 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -131.82 71.42 80.57 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.319 -0.855 . . . . 9.41 110.057 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -47.21 -51.47 9.39 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.995 3.13 . . . . 7.92 112.515 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.674 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 5.9 pt-20 -169.81 -60.94 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.761 -1.109 . . . . 11.42 108.932 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.674 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 29.2 t80 -152.56 28.46 0.55 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.858 -1.065 . . . . 15.58 108.387 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 65.1 -154.45 0.28 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.048 -0.978 . . . . 11.4 110.329 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.86 -167.94 0.54 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.715 0.293 . . . . 12.26 110.583 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.79 101.49 0.82 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.124 0.488 . . . . 15.51 110.447 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.3 m -88.58 160.26 17.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.558 -0.746 . . . . 16.06 110.483 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.29 1.68 35.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 17.4 111.312 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -82.53 90.44 6.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.971 -0.559 . . . . 19.19 110.26 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.805 -0.634 . . . . 20.33 110.294 179.535 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 1.5 p-10 . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.484 0.183 . . . . 7.16 111.344 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mt -129.55 99.83 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 O-C-N 122.28 -0.262 . . . . 5.69 110.35 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.96 94.43 1.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 4.6 110.208 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.541 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.0 mt-10 -72.49 -2.33 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.95 -0.568 . . . . 5.13 112.136 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 4.4 m -59.99 -41.98 93.25 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.582 -0.525 . . . . 4.17 109.582 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 20.8 p -61.98 -52.11 65.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 3.42 111.832 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.6 p -62.02 -39.74 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 120.852 -0.339 . . . . 3.24 110.996 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.54 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 49.4 mtm -65.18 -26.75 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.449 -0.342 . . . . 5.17 111.445 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 5' ' ' SER . 76.6 mt-30 -69.09 -37.68 78.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.7 -0.4 . . . . 5.38 110.266 175.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.759 ' HB3' HD12 ' A' ' 17' ' ' LEU . 13.6 mt -68.89 -40.5 79.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.079 0.942 . . . . 3.9 109.133 172.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 8' ' ' MET . . . -62.8 -41.73 99.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.507 -1.224 . . . . 4.46 111.675 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 8' ' ' MET . 71.0 mm-40 -62.31 -29.93 70.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.606 0.595 . . . . 6.27 112.606 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.636 ' HG2' ' O ' ' A' ' 10' ' ' LEU . 22.0 ptp -81.84 -4.46 56.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.441 -0.504 . . . . 5.2 110.156 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.17 48.73 1.41 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.711 -0.677 . . . . 4.75 113.462 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 73.0 m-85 -143.12 125.37 8.7 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.859 0.361 . . . . 5.09 110.583 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.838 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 89.6 Cg_endo -74.45 66.71 5.49 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.468 2.779 . . . . 4.25 111.762 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 10' ' ' LEU . 80.9 mt -94.2 57.66 2.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.649 0.737 . . . . 3.29 111.875 -172.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 13.9 tt0 -56.57 -22.32 32.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.179 0.514 . . . . 5.48 109.896 168.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . . . -57.91 -29.35 65.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.649 -0.705 . . . . 3.54 109.659 172.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.579 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.7 t -72.19 -44.61 62.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.758 . . . . 3.27 108.955 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.451 ' NH2' ' HG3' ' A' ' 18' ' ' GLU . 12.2 ttp180 -51.84 -42.33 62.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.878 -0.601 . . . . 6.1 110.232 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 42.8 mttt -71.47 -39.42 70.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.613 -0.721 . . . . 4.77 110.435 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.57 99.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.601 -0.727 . . . . 4.34 111.268 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 20' ' ' CYS . 88.6 t -59.15 -46.21 92.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.166 -0.47 . . . . 4.58 110.432 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -54.47 -48.2 72.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.256 -0.429 . . . . 7.48 110.921 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.96 -39.62 87.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.194 -0.457 . . . . 6.84 111.611 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 p -68.32 -15.08 63.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.081 0.467 . . . . 5.71 110.979 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.71 29.27 43.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.352 -0.699 . . . . 5.75 111.352 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' ' 1' ' ' ASP . 51.3 t30 60.67 73.91 0.47 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.349 0.595 . . . . 5.06 110.626 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.543 ' HB3' HG21 ' A' ' 34' ' ' VAL . 19.2 mmt -102.31 18.8 20.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.771 -0.65 . . . . 6.28 110.863 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.24 -178.65 50.71 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.574 -0.739 . . . . 4.17 113.059 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.4 -37.38 77.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.785 0.291 . . . . 3.73 111.785 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -54.62 -56.55 17.88 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.618 0.723 . . . . 5.46 110.395 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 30' ' ' MET . 92.9 t -65.42 -40.38 88.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.05 -0.977 . . . . 4.88 111.803 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.44 -35.1 58.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.313 0.486 . . . . 3.68 112.313 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.5 t80 -58.75 -41.91 87.61 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.879 -0.785 . . . . 4.71 108.879 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.528 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.2 m-80 -69.28 -38.43 78.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.671 -0.695 . . . . 5.69 110.862 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.5 -37.23 86.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.803 -0.443 . . . . 5.87 109.803 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.556 HG21 HD13 ' A' ' 10' ' ' LEU . 4.7 tp -72.57 -39.01 60.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.058 -0.519 . . . . 3.69 111.176 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -70.15 -21.67 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.371 0.605 . . . . 5.04 110.786 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 37' ' ' ASN . 70.6 t -74.45 -44.85 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.892 -0.595 . . . . 5.37 110.644 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -99.42 12.22 36.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.95 0.405 . . . . 5.35 111.223 -173.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.453 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 27.1 ptt? -72.31 -20.9 61.42 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.318 -0.401 . . . . 5.73 111.785 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.63 2.56 3.12 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.854 0.359 . . . . 6.34 111.33 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.622 ' HB3' ' CD1' ' A' ' 48' ' ' PHE . 16.3 mm-40 -93.06 97.73 1.96 Allowed Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 108.548 -0.908 . . . . 5.62 108.548 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.41 -44.53 32.31 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.071 2.514 . . . . 6.22 113.219 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -115.05 13.03 16.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.816 0.817 . . . . 6.09 110.992 -169.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.622 ' CD1' ' HB3' ' A' ' 45' ' ' GLU . 22.7 m-85 -85.4 -11.54 54.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.987 -0.552 . . . . 5.89 111.113 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' A' ' 19' ' ' ALA . . . -81.87 -92.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.123 -0.489 . . . . 4.6 110.1 176.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.838 ' HB2' ' HB2' ' A' ' 16' ' ' PRO . 47.4 mt-10 -138.0 157.62 72.73 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.3 -1.0 . . . . 5.96 108.3 174.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.48 116.7 2.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.367 2.045 . . . . 6.2 110.851 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -44.97 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.168 0.803 . . . . 8.24 113.168 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -144.03 61.69 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.263 -0.881 . . . . 7.27 108.92 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.497 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 24.5 ptt? -73.76 129.33 85.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 7.41 110.727 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 2.7 Cg_endo -81.93 -8.29 12.15 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.953 2.435 . . . . 5.89 112.251 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.01 -161.92 51.72 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.785 -0.643 . . . . 6.63 111.591 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -114.53 18.66 16.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.796 0.808 . . . . 9.15 109.381 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.39 91.58 0.8 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.342 -0.845 . . . . 6.92 111.069 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.69 142.43 15.96 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.71 -0.757 . . . . 7.34 112.507 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 65.39 -178.48 0.18 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.231 0.612 . . . . 7.8 111.997 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.11 148.29 18.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.611 -0.722 . . . . 6.73 109.951 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p -76.16 111.58 11.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.13 0.49 . . . . 7.03 110.987 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.61 160.77 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.701 -0.681 . . . . 6.23 110.078 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.64 103.77 0.27 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.536 -0.84 . . . . 7.09 112.703 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.99 -163.71 1.08 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.248 -0.279 . . . . 7.1 110.248 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.0 m -63.51 111.62 2.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.042 0.449 . . . . 7.6 110.941 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 15.5 m -102.7 48.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.143 -0.481 . . . . 8.01 110.972 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 92.6 t80 74.19 143.99 0.07 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.111 -0.949 . . . . 8.06 110.978 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.79 163.71 33.29 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.948 -0.644 . . . . 6.62 111.604 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.42 113.42 20.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.652 0.263 . . . . 6.12 110.669 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -83.02 45.31 1.0 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.289 -0.414 . . . . 7.65 111.481 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.34 79.39 0.18 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.755 -0.736 . . . . 6.25 112.204 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -90.47 11.88 20.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.98 0.419 . . . . 7.29 110.734 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -86.98 120.13 27.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.639 . . . . 6.55 110.876 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -133.92 36.65 3.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.488 -0.778 . . . . 7.51 109.098 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -118.72 136.21 24.07 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 115.539 -0.755 . . . . 7.14 110.523 -176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.612 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 73.0 Cg_exo -54.15 167.34 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.497 2.798 . . . . 5.41 112.592 172.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.672 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.5 Cg_endo -63.33 112.11 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.35 2.033 . . . . 7.14 111.185 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.697 ' HA ' HG22 ' A' ' 82' ' ' VAL . 9.6 pt-20 -57.0 -26.69 60.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 10.13 110.855 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 6.2 tt0 -58.99 -51.25 70.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.945 -0.571 . . . . 11.78 110.46 173.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.798 ' HA ' HD12 ' A' ' 84' ' ' ILE . 70.1 mt -76.19 -41.43 37.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.921 -0.582 . . . . 8.42 111.642 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 86' ' ' THR . 11.3 m -55.55 -37.88 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.519 -0.919 . . . . 7.57 108.519 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.27 -48.54 79.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.637 -1.165 . . . . 10.39 110.871 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.3 mt -59.53 -42.16 87.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 10.78 110.624 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.729 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.1 mt -65.0 -44.9 95.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 8.01 111.434 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -73.48 -21.18 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.189 -0.604 . . . . 10.38 110.786 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.9 m -72.72 -26.55 61.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.063 0.458 . . . . 12.35 110.124 171.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.1 mmt -68.57 -26.9 65.62 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.963 -0.562 . . . . 10.33 110.462 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 -6.05 5.08 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.407 -0.815 . . . . 9.53 111.63 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.626 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.8 m-85 -87.7 -172.29 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.068 -0.345 . . . . 8.89 110.068 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 33.9 tt0 -103.63 146.92 27.86 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.931 -0.396 . . . . 10.16 109.931 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 16.0 ttm180 -57.0 -53.13 61.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.111 0.482 . . . . 11.98 110.19 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -59.07 -39.41 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 9.02 111.046 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 4.0 tt0 -63.91 -37.02 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.392 0.615 . . . . 6.68 109.758 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.729 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.99 -38.43 90.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.179 -0.919 . . . . 5.22 110.711 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -59.93 -52.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.053 -0.522 . . . . 6.39 110.636 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 60.5 tt0 -54.93 -46.03 74.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.769 -0.65 . . . . 8.36 110.855 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.89 -53.61 55.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.235 -0.893 . . . . 5.41 110.78 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.713 HD23 ' HB2' ' A' ' 109' ' ' ALA . 74.8 mt -61.38 -31.59 71.5 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.689 -0.232 . . . . 5.77 111.327 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.5 mtt180 -55.7 -50.29 70.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.393 0.616 . . . . 7.71 110.004 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.26 74.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.729 -1.123 . . . . 8.88 111.551 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 28.4 p -83.17 -5.7 59.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.694 0.627 . . . . 8.79 112.694 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 t30 64.78 65.72 0.61 Allowed 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.645 -0.707 . . . . 10.09 109.813 -175.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.551 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.4 p30 48.92 22.81 0.61 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.221 1.008 . . . . 7.8 112.428 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -81.68 109.45 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.726 -0.472 . . . . 10.49 109.726 173.2 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.0 tt -56.59 -59.84 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.176 0.922 . . . . 9.54 111.282 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.45 -48.3 71.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.9 -1.045 . . . . 11.82 111.268 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.693 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.1 ttm180 -69.5 -28.8 66.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 12.41 110.799 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.713 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.56 -51.24 68.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.219 -0.66 . . . . 6.3 109.219 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.625 HD23 HG23 ' A' ' 85' ' ' ILE . 21.4 mt -58.1 -40.12 80.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.845 -1.07 . . . . 7.78 109.605 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.33 -50.75 70.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.388 -0.824 . . . . 9.04 110.443 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -62.91 -44.44 96.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.491 -1.231 . . . . 8.69 110.375 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 95' ' ' ALA . 51.5 mt -65.71 -45.16 92.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.009 -0.996 . . . . 5.25 111.251 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -59.02 -26.1 64.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 6.92 110.976 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.0 m -73.55 3.15 6.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.538 -0.756 . . . . 8.33 111.101 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -128.0 74.62 78.9 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.819 -0.808 . . . . 9.41 108.819 166.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.438 ' HD2' ' OE1' ' A' ' 120' ' ' GLU . 3.7 Cg_endo -38.65 -72.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 125.176 3.917 . . . . 7.92 113.526 -170.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -159.78 -42.31 0.05 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.311 -0.859 . . . . 11.42 110.103 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -136.13 14.2 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.565 -0.454 . . . . 15.58 111.771 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.438 ' OE1' ' HD2' ' A' ' 117' ' ' PRO . 6.0 mm-40 60.73 100.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.38 -0.827 . . . . 11.4 111.645 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.94 155.07 20.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.181 0.515 . . . . 12.26 111.825 -173.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -147.87 125.29 11.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.671 -0.863 . . . . 15.51 108.671 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.6 t -83.15 -59.54 2.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.096 -0.502 . . . . 16.06 110.68 -174.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.6 t70 54.36 76.24 0.25 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.471 0.653 . . . . 17.4 110.403 -177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -104.79 125.83 51.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.769 -0.651 . . . . 19.19 110.844 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 50.5 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.587 -0.72 . . . . 20.33 109.914 177.558 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.64 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 7.3 m-20 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.293 0.568 . . . . 7.16 109.643 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mt -137.67 82.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 108.141 -1.059 . . . . 5.69 108.141 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.7 88.11 0.35 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.377 0.608 . . . . 4.6 110.891 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.481 ' HA ' HG12 ' A' ' 7' ' ' VAL . 51.8 mt-10 -71.11 -8.18 51.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.282 -0.872 . . . . 5.13 110.59 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.635 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 18.8 m -57.7 -37.63 73.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.303 -0.628 . . . . 4.17 109.303 169.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 7.4 m -59.66 -51.85 68.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.794 -0.639 . . . . 3.42 110.937 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.568 HG11 ' HB2' ' A' ' 21' ' ' ARG . 4.4 p -67.45 -38.87 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 120.636 -0.426 . . . . 3.24 110.74 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.472 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 78.6 mtp -62.93 -27.01 69.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 5.17 111.324 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG3' ' O ' ' A' ' 5' ' ' SER . 79.5 mt-30 -62.65 -53.4 55.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.811 -0.44 . . . . 5.38 109.811 171.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.841 HD13 HG21 ' A' ' 39' ' ' ILE . 11.7 mt -58.51 -45.27 89.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.725 0.774 . . . . 3.9 109.653 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.8 -29.32 70.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.343 -1.299 . . . . 4.46 111.64 -175.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.14 -51.71 6.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.699 -0.682 . . . . 6.27 111.872 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.5 ptp -101.28 25.0 8.73 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 111.993 0.368 . . . . 5.2 111.993 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.94 -92.44 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.947 -1.12 . . . . 4.75 113.022 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 62.4 m-85 -136.95 151.09 71.54 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.892 -0.41 . . . . 5.09 109.892 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.56 74.44 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.802 2.335 . . . . 4.25 111.451 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.815 HD12 ' HB3' ' A' ' 10' ' ' LEU . 89.6 mt -89.45 62.6 6.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.772 -0.649 . . . . 3.29 112.175 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.551 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 7.6 tt0 -55.75 -24.54 35.86 Favored 'General case' 0 N--CA 1.458 -0.042 0 CA-C-O 120.939 0.399 . . . . 5.48 110.565 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.44 -31.17 65.65 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.124 -0.489 . . . . 3.54 110.255 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.6 t -73.5 -42.98 61.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.425 -0.807 . . . . 3.27 109.658 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HB2' HG11 ' A' ' 7' ' ' VAL . 24.5 ttt180 -52.02 -50.23 61.81 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.606 0.717 . . . . 6.1 110.082 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HE2' ' O ' ' A' ' 18' ' ' GLU . 25.8 mtmt -72.09 -23.5 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.085 -0.962 . . . . 4.77 110.623 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -73.6 -39.06 64.88 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.823 -0.626 . . . . 4.34 111.221 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' CYS . 97.7 t -58.97 -47.15 90.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.89 0.376 . . . . 4.58 110.11 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -58.64 -36.16 73.67 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.889 -0.596 . . . . 7.48 110.762 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.01 -45.78 39.52 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.506 -0.315 . . . . 6.84 111.674 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.4 p -62.21 -24.68 67.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.964 0.411 . . . . 5.71 111.162 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.14 29.41 20.13 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.803 -0.635 . . . . 5.75 112.039 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.64 ' HB2' ' O ' ' A' ' 1' ' ' ASP . 66.7 t30 63.39 64.62 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.179 0.514 . . . . 5.06 110.497 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.611 ' HB3' HG21 ' A' ' 34' ' ' VAL . 87.2 mmm -91.77 -11.22 37.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.117 -0.492 . . . . 6.28 110.742 178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.23 162.05 11.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.791 -0.719 . . . . 4.17 112.387 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -55.77 -46.07 78.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.942 0.497 . . . . 3.73 111.54 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.22 -41.46 99.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 5.46 111.431 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.611 HG21 ' HB3' ' A' ' 30' ' ' MET . 98.8 t -62.58 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.475 -0.329 . . . . 4.88 111.256 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -28.89 54.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.629 -0.429 . . . . 3.68 111.24 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.605 ' O ' HG22 ' A' ' 39' ' ' ILE . 54.0 t80 -58.15 -43.24 87.25 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.043 -0.725 . . . . 4.71 109.043 170.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 40' ' ' ILE . 94.2 m-20 -67.72 -40.65 84.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 5.69 110.952 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -59.86 -38.34 81.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.386 0.612 . . . . 5.87 109.932 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.841 HG21 HD13 ' A' ' 10' ' ' LEU . 4.3 tp -74.57 -37.57 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.862 -0.608 . . . . 3.69 111.699 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.8 pp -70.34 -23.35 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.406 -0.517 . . . . 5.04 110.899 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.9 t -79.43 -34.84 16.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 5.37 110.725 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -98.96 5.29 47.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.15 0.426 . . . . 5.35 112.15 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -69.91 -20.66 63.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.587 0.232 . . . . 5.73 111.316 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -56.19 -18.12 9.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.845 -0.616 . . . . 6.34 111.908 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 65.3 mm-40 -84.34 109.11 17.19 Favored Pre-proline 0 N--CA 1.454 -0.249 0 CA-C-N 116.439 -0.346 . . . . 5.62 110.072 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 11.4 Cg_endo -56.36 -43.95 50.84 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 123.914 3.076 . . . . 6.22 113.196 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -97.66 -3.51 39.22 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.967 -1.015 . . . . 6.09 111.325 -167.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 45' ' ' GLU . 3.4 m-85 -80.27 -14.5 58.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.03 0.443 . . . . 5.89 110.385 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.43 80.67 2.25 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.645 -0.872 . . . . 4.6 108.645 167.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.19 133.48 80.87 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 114.431 -1.259 . . . . 5.96 111.67 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.55 76.53 1.44 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.231 2.621 . . . . 6.2 112.941 -174.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.1 tp -122.65 106.37 10.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 8.24 109.948 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 p 53.91 81.72 0.09 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.337 0.655 . . . . 7.27 112.132 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.5 tpt -77.27 108.82 7.62 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.558 -0.746 . . . . 7.41 110.973 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -98.62 -163.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.75 2.967 . . . . 5.89 113.076 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.15 -44.62 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.768 -0.651 . . . . 6.63 112.153 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' HB3' ' HA ' ' A' ' 13' ' ' MET . 62.9 t80 54.94 81.8 0.1 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.358 0.599 . . . . 9.15 111.077 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.09 104.37 1.07 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.582 -0.818 . . . . 6.92 111.904 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -131.43 46.57 1.06 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.953 -0.641 . . . . 7.34 112.184 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 71.46 135.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.676 0.75 . . . . 7.8 112.27 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.94 -37.95 10.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.578 -0.737 . . . . 6.73 109.723 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.1 137.19 32.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.574 -0.739 . . . . 7.03 110.118 175.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.32 10.15 41.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.946 0.403 . . . . 6.23 111.585 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.18 132.66 2.59 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.58 -0.819 . . . . 7.09 112.668 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.35 125.82 37.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.593 0.235 . . . . 7.1 110.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.1 m -148.7 141.55 24.67 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.792 -0.447 . . . . 7.6 109.792 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.5 136.36 56.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.911 0.386 . . . . 8.01 110.636 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -119.51 162.75 18.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.102 -0.499 . . . . 8.06 110.11 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.0 82.28 0.39 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 6.62 112.557 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.85 134.97 37.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.425 0.155 . . . . 6.12 110.73 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.2 m -72.18 82.51 1.0 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.584 0.707 . . . . 7.65 110.333 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.39 -44.3 0.45 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.332 -1.107 . . . . 6.25 110.332 -174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.13 -49.14 11.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.315 -0.995 . . . . 7.29 108.315 171.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.24 120.64 32.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.837 -1.074 . . . . 6.55 109.367 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -124.35 28.79 6.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.854 0.835 . . . . 7.51 109.609 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -72.53 136.07 81.12 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.816 -1.084 . . . . 7.14 109.956 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.605 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 58.7 Cg_exo -55.87 161.54 8.18 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.878 2.386 . . . . 5.41 112.264 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.695 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.0 Cg_endo -62.66 112.62 1.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 7.14 111.246 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.757 ' HA ' HG22 ' A' ' 82' ' ' VAL . 1.6 pm0 -57.11 -25.73 59.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.731 -0.668 . . . . 10.13 111.528 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 7.0 tt0 -60.15 -50.94 71.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.014 0.435 . . . . 11.78 109.839 172.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.796 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.2 mt -75.38 -42.17 43.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 8.42 111.737 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 86' ' ' THR . 11.2 m -56.12 -38.18 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.426 -0.953 . . . . 7.57 108.426 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.04 -48.96 79.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.802 -1.09 . . . . 10.39 110.674 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.0 mt -59.39 -41.65 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 10.78 110.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.742 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.2 mt -66.0 -45.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.904 -0.589 . . . . 8.01 111.479 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.84 -21.16 61.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.333 -0.547 . . . . 10.38 110.75 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -74.39 -26.99 60.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 12.35 110.166 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 95.1 mmm -66.74 -26.48 67.01 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.398 0.618 . . . . 10.33 110.233 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.51 -10.77 4.65 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.415 -0.811 . . . . 9.53 111.714 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.591 ' HB2' HG22 ' A' ' 85' ' ' ILE . 33.4 m-85 -83.02 -175.0 5.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.717 0.294 . . . . 8.89 110.323 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 51.1 tt0 -100.72 147.61 25.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.791 -0.448 . . . . 10.16 109.791 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.512 ' O ' HD12 ' A' ' 96' ' ' ILE . 7.9 ttm180 -55.72 -54.3 46.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.857 0.361 . . . . 11.98 110.503 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB3' ' NE2' ' A' ' 91' ' ' GLN . 55.7 t30 -58.46 -37.07 74.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.862 -0.608 . . . . 9.02 111.207 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.614 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.2 tt0 -65.49 -38.55 90.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 6.68 109.653 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.26 -37.88 89.07 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.25 -0.886 . . . . 5.22 110.625 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -60.9 -52.88 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.316 -0.402 . . . . 6.39 111.174 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.559 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 53.1 tt0 -56.09 -44.21 78.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.202 0.525 . . . . 8.36 110.713 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.31 -54.03 51.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.369 -0.832 . . . . 5.41 110.595 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.705 HD23 ' HB2' ' A' ' 109' ' ' ALA . 78.1 mt -61.18 -33.88 74.15 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.707 -0.224 . . . . 5.77 111.486 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.559 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 92.1 mtt180 -54.9 -46.83 74.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.484 0.659 . . . . 7.71 110.112 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.34 -38.05 68.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.87 -1.059 . . . . 8.88 111.467 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 23.7 p -85.6 1.5 48.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.81 0.67 . . . . 8.79 112.81 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m120 61.98 46.77 6.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.472 . . . . 10.09 111.123 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 48.8 m-20 66.73 24.07 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.363 -0.835 . . . . 7.8 111.144 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 14.8 t-20 -86.46 113.9 22.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.892 -0.781 . . . . 10.49 108.892 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.726 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.1 tt -57.6 -59.05 5.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.904 -1.044 . . . . 9.54 111.268 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.61 -46.1 81.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.419 -1.264 . . . . 11.82 111.732 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.692 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.9 ttm180 -68.83 -28.83 67.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.445 -0.343 . . . . 12.41 110.625 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.705 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.64 -50.58 68.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.226 -0.657 . . . . 6.3 109.226 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.525 HD23 HG23 ' A' ' 85' ' ' ILE . 18.2 mt -60.29 -38.31 83.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.43 -0.804 . . . . 7.78 109.739 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 7.7 t70 -54.73 -51.61 65.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.033 -0.985 . . . . 9.04 110.107 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -63.87 -46.61 84.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.116 -1.402 . . . . 8.69 110.679 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.682 HD11 ' HA ' ' A' ' 95' ' ' ALA . 46.5 mt -64.57 -37.72 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.236 -0.893 . . . . 5.25 111.228 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.86 -26.42 67.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.313 0.577 . . . . 6.92 110.432 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.5 m -76.9 -2.51 33.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.319 -0.855 . . . . 8.33 109.963 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -135.72 67.11 64.69 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.573 -0.899 . . . . 9.41 108.573 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -38.44 -68.5 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 1 C-N-CA 125.303 4.002 . . . . 7.92 113.858 -169.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.81 ' HG3' ' HD1' ' A' ' 119' ' ' PHE . 7.2 pt-20 -167.85 -39.79 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.779 -1.1 . . . . 11.42 109.119 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.81 ' HD1' ' HG3' ' A' ' 118' ' ' GLU . 29.4 p90 -127.39 17.4 7.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.614 -0.721 . . . . 15.58 110.838 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 119' ' ' PHE . 10.7 mm-40 71.19 157.13 0.17 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.748 0.655 . . . . 11.4 111.761 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 44.0 -168.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.487 1.115 . . . . 12.26 113.245 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -142.37 131.93 23.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.917 -0.583 . . . . 15.51 109.504 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.3 m -121.38 -74.68 0.61 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.37 -0.377 . . . . 16.06 110.625 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -135.42 111.45 9.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 17.4 111.042 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -134.69 95.86 3.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 19.19 109.867 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.402 -0.809 . . . . 20.33 110.001 179.737 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 121.075 0.464 . . . . 7.16 110.616 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.572 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 78.3 mt -69.14 121.75 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.449 -0.796 . . . . 5.69 111.15 -175.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.68 82.25 1.56 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.299 0.571 . . . . 4.6 109.927 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.4 mt-10 -71.65 -3.11 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.647 -0.706 . . . . 5.13 111.107 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -56.71 -40.85 76.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 4.17 110.265 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.915 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 12.1 p -65.67 -52.47 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.736 -0.666 . . . . 3.42 111.751 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 21' ' ' ARG . 7.3 p -64.02 -38.73 83.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.913 -0.315 . . . . 3.24 111.274 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 64.7 mtt -62.5 -34.89 77.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.729 -0.214 . . . . 5.17 110.719 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 13' ' ' MET . 40.0 mt-30 -60.78 -40.25 91.91 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.79 -0.364 . . . . 5.38 110.76 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.737 ' HB3' HD12 ' A' ' 17' ' ' LEU . 11.2 mt -67.78 -49.0 64.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.878 0.847 . . . . 3.9 109.884 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.26 -50.55 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.99 -1.459 . . . . 4.46 113.111 -170.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 8' ' ' MET . 56.1 mm-40 -66.35 -24.1 66.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.164 0.431 . . . . 6.27 112.164 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 25.8 ptm -99.97 -3.85 31.36 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.652 -0.419 . . . . 5.2 111.79 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.6 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.674 -1.251 . . . . 4.75 113.588 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 33.0 m-85 -115.35 142.04 28.11 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 122.96 -0.141 . . . . 5.09 110.65 -172.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 76.73 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.983 2.455 . . . . 4.25 111.601 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.737 HD12 ' HB3' ' A' ' 10' ' ' LEU . 97.7 mt -79.8 66.76 5.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.49 -0.777 . . . . 3.29 111.846 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 21' ' ' ARG . 3.9 tt0 -56.68 -18.37 12.05 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.92 0.39 . . . . 5.48 110.892 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.899 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . . . -57.51 -35.79 70.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.511 . . . . 3.54 109.83 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.625 ' O ' HG23 ' A' ' 24' ' ' VAL . 14.1 t -73.27 -41.98 63.02 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.335 -0.848 . . . . 3.27 109.287 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' HB2' HG21 ' A' ' 7' ' ' VAL . 25.2 ttt180 -52.01 -53.29 43.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.366 -0.834 . . . . 6.1 110.7 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HZ3' ' HB3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -71.55 -23.85 61.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 4.77 110.612 178.079 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HB1' ' CD1' ' A' ' 38' ' ' TRP . . . -69.69 -42.3 74.3 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.981 -0.554 . . . . 4.34 110.771 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 20' ' ' CYS . 86.1 t -55.43 -45.63 78.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.279 -0.418 . . . . 4.58 110.025 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -59.44 -49.91 75.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.02 -0.536 . . . . 7.48 110.499 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.76 -39.37 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.223 -0.444 . . . . 6.84 112.08 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.6 p -70.13 -15.1 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.101 0.477 . . . . 5.71 111.318 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.08 28.27 34.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.831 -0.7 . . . . 5.75 111.485 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 61.8 m-80 60.68 65.56 1.02 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.256 0.55 . . . . 5.06 110.816 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.402 ' HB3' HG21 ' A' ' 34' ' ' VAL . 91.4 mmm -95.94 34.59 1.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.797 -0.638 . . . . 6.28 111.225 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.14 -179.53 45.23 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.072 -0.585 . . . . 4.17 113.58 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.17 -39.23 78.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.288 . . . . 3.73 111.579 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -58.41 -52.72 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 5.46 111.663 -175.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 30' ' ' MET . 69.3 t -67.32 -38.1 80.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.256 -0.429 . . . . 4.88 111.798 -175.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -32.24 55.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.465 -0.494 . . . . 3.68 111.739 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.621 ' O ' HG22 ' A' ' 39' ' ' ILE . 75.7 t80 -61.64 -39.7 92.25 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.459 -0.941 . . . . 4.71 108.459 170.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.731 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.8 t30 -64.59 -39.08 93.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.421 -0.809 . . . . 5.69 110.792 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.415 ' CD1' ' HB1' ' A' ' 23' ' ' ALA . 24.2 t-105 -67.86 -30.81 70.28 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.565 -0.454 . . . . 5.87 110.363 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 36' ' ' PHE . 4.3 tp -77.45 -32.61 18.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 120.805 -0.358 . . . . 3.69 111.47 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.3 pp -68.36 -26.55 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.111 -0.636 . . . . 5.04 109.776 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 37' ' ' ASN . 96.2 t -70.43 -36.88 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.579 -0.737 . . . . 5.37 110.231 170.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.449 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 39.7 m-70 -102.22 20.77 16.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.192 -0.458 . . . . 5.35 111.909 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -59.22 -22.31 60.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 5.73 110.871 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.37 14.95 1.76 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.592 -0.731 . . . . 6.34 111.911 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.729 ' HB3' ' HB2' ' A' ' 48' ' ' PHE . 4.5 mm-40 -107.65 93.81 10.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.526 -0.176 . . . . 5.62 110.526 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 11.1 Cg_endo -59.18 -52.0 5.67 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.874 2.383 . . . . 6.22 112.258 174.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -86.72 -14.45 42.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.08 -1.418 . . . . 6.09 112.039 -168.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.899 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 23.7 m-85 -75.02 -9.49 58.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.164 0.507 . . . . 5.89 110.651 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -101.37 101.13 11.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.036 -1.098 . . . . 4.6 108.036 171.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 34.0 mm-40 -39.64 105.71 0.37 Allowed Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.495 1.122 . . . . 5.96 112.638 -176.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 5.9 Cg_exo -79.04 68.49 8.26 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.505 2.803 . . . . 6.2 112.322 -175.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 tp -134.5 105.12 6.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.561 -0.745 . . . . 8.24 109.772 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.0 m 66.58 84.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 7.27 110.455 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 93.9 mmm -70.47 113.44 18.26 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.534 . . . . 7.41 109.878 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 74.5 Cg_endo -96.33 -168.3 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.227 2.618 . . . . 5.89 113.199 -173.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.75 166.62 39.78 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.97 -0.852 . . . . 6.63 110.97 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -82.42 133.0 35.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.065 0.433 . . . . 9.15 109.846 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.53 16.84 8.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.835 -0.698 . . . . 6.92 111.508 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.5 86.98 0.92 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.575 -0.61 . . . . 7.34 111.575 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.63 79.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.684 0.278 . . . . 7.8 111.375 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.95 -31.3 1.02 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.368 -0.378 . . . . 6.73 111.511 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.5 t -100.64 112.62 25.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.884 0.373 . . . . 7.03 110.88 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.45 -36.08 11.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.36 -0.607 . . . . 6.23 109.36 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.99 34.7 0.53 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.314 -0.857 . . . . 7.09 111.625 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.4 26.96 2.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.046 0.45 . . . . 7.1 111.268 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 p -89.43 -12.75 39.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.199 0.524 . . . . 7.6 110.407 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -89.33 86.51 2.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.883 -0.599 . . . . 8.01 110.778 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -137.85 115.23 11.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.237 0.541 . . . . 8.06 110.121 173.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.71 116.26 5.31 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.747 -0.661 . . . . 6.62 112.71 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.32 139.88 58.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.14 0.495 . . . . 6.12 110.4 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 m -66.52 -21.36 66.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.451 -0.795 . . . . 7.65 111.444 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.06 95.03 0.14 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.09 -0.576 . . . . 6.25 111.861 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.42 86.4 5.25 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.848 -0.797 . . . . 7.29 108.848 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.8 t70 58.7 80.51 0.18 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.577 0.704 . . . . 6.55 110.154 -173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -130.75 72.97 1.51 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.342 -0.845 . . . . 7.51 108.811 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -83.97 135.71 42.11 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.828 -0.624 . . . . 7.14 109.399 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.593 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.5 Cg_exo -53.96 162.54 3.83 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 123.096 2.53 . . . . 5.41 112.412 175.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.672 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_endo -63.74 112.12 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.444 2.096 . . . . 7.14 111.089 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.7 pt-20 -56.42 -25.39 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.516 0.51 . . . . 10.13 110.556 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 2.3 tp10 -57.93 -55.0 40.58 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.486 -0.779 . . . . 11.78 110.163 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.796 ' HA ' HD12 ' A' ' 84' ' ' ILE . 82.6 mt -75.41 -40.64 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.774 -0.648 . . . . 8.42 112.094 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.765 ' O ' HG22 ' A' ' 86' ' ' THR . 9.0 m -56.32 -37.81 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 108.357 -0.979 . . . . 7.57 108.357 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.79 -48.83 80.03 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.885 -1.052 . . . . 10.39 110.599 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.8 mt -60.22 -43.54 93.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 10.78 110.827 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.72 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.4 mt -64.05 -45.52 96.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.034 -0.53 . . . . 8.01 111.708 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -72.13 -21.46 61.47 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.876 -0.729 . . . . 10.38 110.786 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.3 m -75.55 -22.04 57.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.041 0.448 . . . . 12.35 110.315 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.3 mmm -70.86 -26.63 63.34 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.275 0.56 . . . . 10.33 109.89 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.54 6.39 4.69 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.405 -0.816 . . . . 9.53 112.08 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 34.5 m-85 -99.24 -175.95 3.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.147 -0.316 . . . . 8.89 110.147 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.902 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 91.9 mt-30 -86.84 153.89 21.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.283 -0.266 . . . . 10.16 110.283 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 96' ' ' ILE . 14.2 ttm180 -65.45 -51.41 60.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.141 -0.688 . . . . 11.98 109.141 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.41 -39.65 88.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 9.02 110.886 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.902 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 6.5 tt0 -64.41 -36.64 84.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.139 0.495 . . . . 6.68 109.689 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.72 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -65.17 -40.23 94.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.458 -0.792 . . . . 5.22 110.466 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.593 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.46 -52.1 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.285 -0.416 . . . . 6.39 110.529 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.561 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 49.8 tt0 -58.24 -44.6 88.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.825 -0.625 . . . . 8.36 110.973 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.83 -53.1 61.84 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.54 -0.755 . . . . 5.41 110.441 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 109' ' ' ALA . 74.1 mt -60.64 -33.1 72.29 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 111.631 0.234 . . . . 5.77 111.631 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.561 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 73.2 mtt180 -55.29 -48.45 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.563 0.697 . . . . 7.71 110.21 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.76 -40.64 72.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.859 -1.064 . . . . 8.88 111.298 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 24.7 p -82.81 -0.04 46.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.547 0.573 . . . . 8.79 112.547 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 58.82 63.22 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 10.09 110.161 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.1 p-10 49.14 32.85 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.498 1.119 . . . . 7.8 112.722 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 16.2 t-20 -93.78 113.87 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.033 -0.728 . . . . 10.49 109.033 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.712 HD12 HG12 ' A' ' 81' ' ' ILE . 8.2 tt -56.97 -60.6 3.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.99 -1.005 . . . . 9.54 111.594 -175.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.409 ' N ' HD23 ' A' ' 106' ' ' LEU . 7.2 mm-40 -57.41 -45.84 84.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.365 -0.834 . . . . 11.82 111.667 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.709 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 34.5 ttm180 -67.46 -28.8 68.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.416 -0.356 . . . . 12.41 110.754 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.32 -51.33 66.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.449 -0.574 . . . . 6.3 109.449 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.532 HD23 HG23 ' A' ' 85' ' ' ILE . 17.8 mt -59.01 -39.4 81.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.384 -0.825 . . . . 7.78 109.428 174.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.34 -46.21 83.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.029 -0.987 . . . . 9.04 110.461 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -67.8 -46.58 71.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.846 -1.07 . . . . 8.69 110.396 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.586 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.5 mt -60.78 -39.68 82.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 5.25 110.354 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -70.18 -22.79 62.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.847 -0.615 . . . . 6.92 110.805 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.5 t -78.14 -5.94 53.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.112 -0.495 . . . . 8.33 110.045 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -140.95 71.96 28.47 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 9.41 110.812 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.528 ' HG2' ' HA ' ' A' ' 120' ' ' GLU . 8.3 Cg_endo -50.88 -62.84 0.34 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 123.674 2.916 . . . . 7.92 111.573 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.535 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 7.9 pt-20 -155.47 -54.51 0.09 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.601 -1.181 . . . . 11.42 109.327 173.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.535 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 36.4 t80 -133.87 13.37 4.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.379 -0.828 . . . . 15.58 109.097 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 117' ' ' PRO . 38.1 mt-10 65.2 176.75 0.2 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 114.841 -1.072 . . . . 11.4 111.321 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -120.53 133.22 55.42 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.513 -0.551 . . . . 12.26 109.513 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -145.46 -53.18 0.27 Allowed 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.231 -0.588 . . . . 15.51 111.278 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 p 42.89 55.87 4.22 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.463 0.649 . . . . 16.06 110.62 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -85.03 136.98 33.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.363 -0.835 . . . . 17.4 111.232 -174.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 t80 70.32 78.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.242 0.964 . . . . 19.19 110.765 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.252 1.185 0 CA-C-N 115.566 -0.743 . . . . 20.33 109.399 176.658 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.808 -0.812 . . . . 7.16 108.808 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.553 HG12 ' HB2' ' A' ' 25' ' ' TYR . 4.2 mp 45.41 74.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.731 -0.47 . . . . 5.69 109.731 -169.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -63.58 97.6 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.224 0.535 . . . . 4.6 110.529 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.602 ' HA ' HG12 ' A' ' 7' ' ' VAL . 9.9 mt-10 -71.04 -5.41 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 5.13 111.9 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.3 t -55.94 -34.28 65.51 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.999 -0.741 . . . . 4.17 108.999 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.4 m -65.24 -52.76 52.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.671 -0.695 . . . . 3.42 111.049 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -69.03 -41.34 81.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.755 0.312 . . . . 3.24 111.308 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.641 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 57.7 mtt -59.54 -35.05 73.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.355 -0.384 . . . . 5.17 110.787 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -62.89 -42.52 99.8 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.029 0.206 . . . . 5.38 111.122 174.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.747 ' HB3' HD12 ' A' ' 17' ' ' LEU . 14.4 mt -63.26 -44.64 94.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.502 0.668 . . . . 3.9 109.685 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.1 -32.74 74.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.893 -1.049 . . . . 4.46 111.094 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.641 ' HG2' ' O ' ' A' ' 8' ' ' MET . 60.9 mm-40 -59.93 -31.18 69.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 6.27 110.281 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mtp -92.91 8.56 39.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.847 -0.615 . . . . 5.2 111.737 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.7 -102.74 0.23 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.798 -1.192 . . . . 4.75 114.228 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 93.5 m-85 -83.19 145.67 49.5 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 112.017 0.376 . . . . 5.09 112.017 -169.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.25 86.09 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.02 2.48 . . . . 4.25 110.98 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.785 HD13 HG12 ' A' ' 39' ' ' ILE . 92.2 mt -80.9 70.95 7.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.801 -0.636 . . . . 3.29 112.483 -170.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -24.37 38.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.256 0.551 . . . . 5.48 110.781 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.7 -30.97 67.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 3.54 110.022 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.562 ' O ' HG23 ' A' ' 24' ' ' VAL . 36.9 t -73.18 -43.51 61.29 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.402 -0.817 . . . . 3.27 109.643 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -49.73 -57.0 8.14 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.681 -0.69 . . . . 6.1 109.836 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 14.8 ptpt -66.24 -32.82 74.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.69 -0.686 . . . . 4.77 110.673 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.02 95.15 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.382 -0.372 . . . . 4.34 111.145 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 20' ' ' CYS . 79.1 t -57.01 -43.57 81.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.398 . . . . 4.58 110.172 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.553 ' HB2' HG12 ' A' ' 2' ' ' ILE . 54.4 t80 -67.93 -42.68 80.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.776 -0.77 . . . . 7.48 110.684 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.23 -40.31 97.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 6.84 111.744 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.7 p -65.8 -23.16 66.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.163 0.506 . . . . 5.71 110.79 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.52 26.83 8.39 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.768 -0.651 . . . . 5.75 111.566 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.5 t30 61.88 62.24 1.28 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.345 0.593 . . . . 5.06 109.68 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 97.2 mmm -101.57 21.65 13.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.867 -0.606 . . . . 6.28 112.103 -172.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.41 177.15 48.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.306 -0.95 . . . . 4.17 113.108 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.65 -44.26 70.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.758 0.281 . . . . 3.73 111.758 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.11 -43.5 91.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 5.46 111.847 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.8 t -68.87 -39.75 80.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.406 -0.361 . . . . 4.88 111.177 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.3 55.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.841 -0.343 . . . . 3.68 111.563 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.599 ' O ' HG22 ' A' ' 39' ' ' ILE . 78.3 t80 -58.08 -43.58 87.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.729 -0.841 . . . . 4.71 108.729 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.592 ' O ' HG13 ' A' ' 40' ' ' ILE . 47.4 t30 -64.06 -43.14 96.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.376 -0.829 . . . . 5.69 110.368 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -63.81 -33.93 76.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 5.87 110.719 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.785 HG12 HD13 ' A' ' 17' ' ' LEU . 6.4 tp -76.09 -38.74 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 3.69 111.218 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -70.05 -21.91 24.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.187 0.518 . . . . 5.04 110.504 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 37' ' ' ASN . 92.8 t -76.32 -48.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.819 -0.628 . . . . 5.37 110.241 170.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -83.3 2.64 35.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.098 -0.501 . . . . 5.35 111.349 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -68.95 -21.8 64.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.931 0.345 . . . . 5.73 111.931 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.6 -11.4 58.05 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.042 0.386 . . . . 6.34 112.042 -175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.785 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 31.3 mm-40 -67.8 142.42 95.68 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.973 0.416 . . . . 5.62 110.31 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.82 -41.98 27.35 Favored 'Trans proline' 0 N--CA 1.47 0.133 0 C-N-CA 123.303 2.669 . . . . 6.22 112.675 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -116.15 27.24 9.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.719 0.771 . . . . 6.09 110.564 -171.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.785 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.8 p90 -56.77 -28.54 61.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.695 -0.684 . . . . 5.89 111.86 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.22 113.56 4.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.784 -0.45 . . . . 4.6 109.784 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 43.5 mt-10 -57.01 118.29 22.99 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 5.96 110.279 175.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 7.9 Cg_exo -72.38 73.31 2.77 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.106 2.537 . . . . 6.2 113.015 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.401 ' O ' ' HB ' ' A' ' 53' ' ' THR . 23.6 tp -81.23 82.07 7.22 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.15 -0.685 . . . . 8.24 109.15 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 88.1 m 70.39 99.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.572 -0.74 . . . . 7.27 110.371 -172.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.25 109.68 25.18 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.813 -0.63 . . . . 7.41 110.738 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 53' ' ' THR . 3.5 Cg_exo -82.23 138.82 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.158 2.572 . . . . 5.89 112.16 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.6 90.25 1.61 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.971 -0.633 . . . . 6.63 111.822 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -79.46 66.96 5.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.499 0.666 . . . . 9.15 110.054 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.5 -60.84 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.41 -0.814 . . . . 6.92 111.415 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.6 -172.16 31.73 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.762 -0.733 . . . . 7.34 112.582 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.37 -65.73 0.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.537 -0.172 . . . . 7.8 110.537 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.92 54.65 8.74 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 123.699 0.624 . . . . 6.73 111.375 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 p -92.96 146.74 23.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.055 -0.521 . . . . 7.03 110.573 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.85 141.46 20.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 6.23 110.561 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.69 124.94 1.71 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.605 -0.598 . . . . 7.09 111.605 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 62.89 43.36 6.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.406 0.622 . . . . 7.1 110.488 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 t -89.33 159.39 17.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.414 -0.812 . . . . 7.6 110.178 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 t 60.5 68.24 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 121.651 0.739 . . . . 8.01 110.431 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -73.07 141.51 47.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.566 -0.743 . . . . 8.06 110.423 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.41 91.47 0.85 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.757 -0.735 . . . . 6.62 112.651 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.25 87.1 7.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.028 0.442 . . . . 6.12 110.107 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -83.93 -39.4 19.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.937 -0.574 . . . . 7.65 110.544 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.35 85.32 0.38 Allowed Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.543 -0.837 . . . . 6.25 112.325 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.83 -61.34 2.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.726 -0.472 . . . . 7.29 109.726 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.2 t70 176.14 147.97 0.1 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.596 -0.729 . . . . 6.55 109.869 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -91.15 74.41 6.26 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.204 -1.406 . . . . 7.51 107.204 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 24.8 tt0 -64.87 129.86 94.59 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 115.103 -0.953 . . . . 7.14 111.452 -168.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.676 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.7 Cg_exo -58.58 166.38 6.45 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.891 3.06 . . . . 5.41 112.879 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.686 ' HD3' ' ND2' ' A' ' 104' ' ' ASN . 44.6 Cg_endo -66.66 111.88 2.26 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.686 2.257 . . . . 7.14 111.143 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.6 pt-20 -52.25 -30.11 26.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 10.13 111.237 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 6.2 tt0 -58.66 -51.35 70.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.854 -0.612 . . . . 11.78 110.339 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.754 ' HA ' HD12 ' A' ' 84' ' ' ILE . 69.4 mt -75.13 -40.83 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.686 -0.688 . . . . 8.42 111.452 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.771 ' O ' HG22 ' A' ' 86' ' ' THR . 5.2 m -56.18 -38.29 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.626 -0.879 . . . . 7.57 108.626 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.07 -49.4 77.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.822 -1.081 . . . . 10.39 110.775 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.56 -40.11 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 10.78 110.729 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.732 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.3 mt -67.33 -46.74 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.874 -0.603 . . . . 8.01 111.64 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.99 -21.13 63.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.175 -0.61 . . . . 10.38 110.638 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -75.35 -25.47 57.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 12.35 110.619 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 21.9 mmt -69.15 -26.51 64.91 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.168 -0.469 . . . . 10.33 110.242 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.88 -2.83 4.87 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.714 -0.676 . . . . 9.53 111.817 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 35.2 m-85 -93.08 -173.98 3.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 8.89 110.468 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.596 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 17.9 tt0 -99.31 147.88 24.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.278 -0.419 . . . . 10.16 110.371 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.5 ttm180 -57.11 -54.65 44.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 11.98 110.731 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.97 -36.19 78.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.266 0.555 . . . . 9.02 110.915 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.646 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.7 tt0 -64.45 -38.81 92.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.725 . . . . 6.68 109.569 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.732 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.15 -40.34 95.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.278 -0.874 . . . . 5.22 110.703 173.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.676 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -59.64 -52.48 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.994 -0.548 . . . . 6.39 110.857 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.577 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 49.9 tt0 -52.97 -47.32 68.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.483 0.659 . . . . 8.36 110.709 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.65 -54.05 50.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.013 -0.994 . . . . 5.41 110.74 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 109' ' ' ALA . 68.1 mt -62.15 -30.99 71.43 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 111.54 0.2 . . . . 5.77 111.54 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 86.7 mtt180 -55.31 -46.97 76.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.365 0.602 . . . . 7.71 109.508 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.87 57.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.936 -1.029 . . . . 8.88 112.035 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 98' ' ' ALA . 29.2 p -83.19 -2.71 56.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.077 0.399 . . . . 8.79 112.077 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 58.0 t30 67.96 41.44 2.08 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.06 0.85 . . . . 10.09 110.364 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.686 ' ND2' ' HD3' ' A' ' 78' ' ' PRO . 3.7 m-20 72.23 18.7 4.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.456 -0.793 . . . . 7.8 110.962 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 17.6 t-20 -82.6 115.68 21.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.524 -0.547 . . . . 10.49 109.524 174.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.3 tt -58.16 -60.53 3.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.081 -0.963 . . . . 9.54 111.722 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.403 ' N ' HD23 ' A' ' 106' ' ' LEU . 51.1 mm-40 -53.68 -51.95 61.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.318 -0.856 . . . . 11.82 111.71 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.645 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.0 ttm180 -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.196 -0.456 . . . . 12.41 110.868 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.55 -50.61 68.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.302 -0.629 . . . . 6.3 109.302 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.573 HD23 HG23 ' A' ' 85' ' ' ILE . 15.7 mt -59.21 -38.28 79.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.07 -0.968 . . . . 7.78 109.434 175.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 15.1 t70 -56.95 -51.82 67.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.037 -0.983 . . . . 9.04 110.3 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.27 -47.51 84.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.278 -1.328 . . . . 8.69 110.663 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.663 HD11 ' HA ' ' A' ' 95' ' ' ALA . 47.9 mt -61.06 -41.9 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.12 -0.945 . . . . 5.25 110.804 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -67.52 -30.3 69.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 6.92 110.546 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.1 m -85.44 0.68 51.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.684 -0.689 . . . . 8.33 110.656 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -142.39 72.41 21.34 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.927 -0.579 . . . . 9.41 110.932 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.72 ' HD2' ' HG3' ' A' ' 120' ' ' GLU . 6.2 Cg_endo -48.43 -40.4 36.45 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.736 2.957 . . . . 7.92 111.87 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.496 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 8.6 pt-20 -178.26 -53.58 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.748 -1.114 . . . . 11.42 108.873 175.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.496 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 36.3 t80 -146.97 12.58 1.1 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.372 -0.831 . . . . 15.58 109.6 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.72 ' HG3' ' HD2' ' A' ' 117' ' ' PRO . 3.4 mp0 56.92 -161.16 0.21 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.427 -1.26 . . . . 11.4 111.137 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 2.0 pm0 -81.33 156.35 25.55 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.375 -0.53 . . . . 12.26 110.08 174.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.51 106.93 18.61 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.819 -0.628 . . . . 15.51 110.43 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.7 p -65.87 158.78 27.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.225 -0.898 . . . . 16.06 111.682 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.88 120.03 11.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.968 -0.56 . . . . 17.4 110.635 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -89.3 -12.83 39.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.041 0.448 . . . . 19.19 109.872 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.417 -0.802 . . . . 20.33 110.016 177.79 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.225 -0.287 . . . . 7.16 110.225 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.442 HG22 ' HG3' ' A' ' 4' ' ' GLU . 54.7 mt -59.46 113.93 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 123.358 0.411 . . . . 5.69 111.343 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -83.33 82.64 8.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.238 0.542 . . . . 4.6 110.239 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 2' ' ' ILE . 36.1 mt-10 -71.64 -2.76 18.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 5.13 111.281 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.635 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 26.6 t -60.89 -35.91 77.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.717 -0.845 . . . . 4.17 108.717 168.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 6.7 m -58.48 -49.9 75.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.943 -0.571 . . . . 3.42 111.141 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 17' ' ' LEU . 2.7 p -64.26 -41.06 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.806 0.336 . . . . 3.24 110.832 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 81.1 mtp -63.71 -29.84 71.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.148 -0.478 . . . . 5.17 111.378 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 5' ' ' SER . 81.4 mm-40 -64.38 -44.44 91.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.996 -0.281 . . . . 5.38 110.504 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 20' ' ' CYS . 18.8 mt -68.09 -40.36 82.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.402 0.62 . . . . 3.9 109.756 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.64 -50.81 71.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.716 -1.129 . . . . 4.46 111.901 -175.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.99 -19.26 63.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.234 -0.439 . . . . 6.27 112.064 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptm -99.32 -4.6 31.38 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.57 -0.452 . . . . 5.2 111.321 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -98.4 0.12 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.189 -1.005 . . . . 4.75 113.206 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 99.0 m-85 -118.81 157.9 48.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.485 0.183 . . . . 5.09 111.047 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 56.0 Cg_endo -71.65 82.46 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.594 2.196 . . . . 4.25 112.138 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 7' ' ' VAL . 4.4 mm? -73.86 69.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 3.29 111.618 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 5.6 tt0 -56.73 -24.14 47.56 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.277 -0.89 . . . . 5.48 109.981 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -29.68 66.33 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.062 -0.517 . . . . 3.54 109.856 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.688 ' HA ' HD11 ' A' ' 39' ' ' ILE . 49.9 t -69.37 -44.81 70.78 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.303 -0.629 . . . . 3.27 109.303 174.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.61 -49.76 67.12 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.013 -0.54 . . . . 6.1 109.911 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 26.5 mttm -62.16 -40.63 96.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.66 -0.7 . . . . 4.77 110.147 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.2 -43.19 92.38 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.364 -0.835 . . . . 4.34 111.714 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' CYS . 76.3 t -56.17 -47.18 81.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.743 0.306 . . . . 4.58 110.313 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.76 -36.7 83.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 7.48 110.492 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.1 -45.7 69.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 6.84 111.221 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -62.29 -27.14 68.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.194 0.521 . . . . 5.71 111.04 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.75 28.04 6.11 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.674 -0.694 . . . . 5.75 111.558 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 59.27 51.24 7.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.123 0.487 . . . . 5.06 109.923 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.462 ' HB3' HG21 ' A' ' 34' ' ' VAL . 80.9 mtp -81.39 -35.25 31.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 6.28 112.106 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.61 169.71 16.87 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.022 -1.085 . . . . 4.17 113.279 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.575 0.35 . . . . 3.73 111.706 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -67.66 -40.16 84.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 5.46 110.12 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 30' ' ' MET . 85.2 t -64.31 -41.49 92.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 4.88 110.782 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -32.89 58.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.441 -0.345 . . . . 3.68 111.109 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 40' ' ' ILE . 78.8 t80 -55.24 -44.41 75.46 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.156 -0.683 . . . . 4.71 109.156 172.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.686 ' O ' HG13 ' A' ' 40' ' ' ILE . 8.2 t30 -67.92 -35.78 79.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.519 -0.764 . . . . 5.69 110.609 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -65.46 -32.85 74.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.094 0.473 . . . . 5.87 109.872 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.688 HD11 ' HA ' ' A' ' 20' ' ' CYS . 1.4 mp -77.06 -37.76 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.864 -0.607 . . . . 3.69 112.099 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.4 pp -63.57 -30.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.637 0.732 . . . . 5.04 109.91 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' ASN . 60.2 t -69.57 -51.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.142 -0.935 . . . . 5.37 110.484 170.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -85.28 13.43 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.669 0.618 . . . . 5.35 112.669 -174.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.1 ptt? -68.3 -22.1 64.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 5.73 111.07 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -84.47 8.44 16.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 6.34 111.334 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 13.6 mm-40 -76.73 138.25 66.41 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.131 -0.486 . . . . 5.62 110.096 174.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.98 -34.99 99.36 Favored 'Trans proline' 0 CA--C 1.522 -0.124 0 C-N-CA 122.926 2.417 . . . . 6.22 112.129 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -115.81 24.49 11.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.766 -1.106 . . . . 6.09 110.389 -171.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.786 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 3.3 p90 -60.02 -38.17 81.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.201 0.524 . . . . 5.89 111.349 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.23 97.71 4.35 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.657 -0.498 . . . . 4.6 109.657 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 47.8 mt-10 -60.01 126.03 82.48 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.572 -0.74 . . . . 5.96 110.634 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.528 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 8.2 Cg_exo -72.59 64.64 3.81 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.489 2.793 . . . . 6.2 113.251 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.85 109.24 11.42 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.801 -0.814 . . . . 8.24 108.801 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.7 p 58.07 71.13 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.06 0.85 . . . . 7.27 111.082 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 65.0 mtm -87.29 119.37 70.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.27 -0.877 . . . . 7.41 110.451 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 22.5 Cg_exo -67.83 -55.07 0.29 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.205 2.604 . . . . 5.89 112.31 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.74 61.93 5.75 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 111.23 -0.748 . . . . 6.63 111.23 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -77.97 123.05 26.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.218 0.532 . . . . 9.15 111.797 -171.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.43 147.05 13.43 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.702 -0.959 . . . . 6.92 110.702 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.65 20.04 6.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.55 -0.834 . . . . 7.34 112.347 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 59.17 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.334 0.654 . . . . 7.8 111.716 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.15 121.97 7.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.437 -0.347 . . . . 6.73 110.297 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.3 m -85.4 66.05 9.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.311 0.577 . . . . 7.03 109.691 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.62 97.28 6.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.658 -0.701 . . . . 6.23 111.334 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.31 121.91 6.26 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.879 -0.677 . . . . 7.09 111.594 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.38 151.49 30.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.767 0.317 . . . . 7.1 110.644 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.5 m -95.2 119.82 34.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.09 -0.504 . . . . 7.6 109.868 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.89 -10.27 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.058 -0.519 . . . . 8.01 112.18 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -117.29 140.06 50.04 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.186 -0.302 . . . . 8.06 110.186 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.65 -123.76 1.6 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.017 -0.611 . . . . 6.62 112.257 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB1' HD23 ' A' ' 73' ' ' LEU . . . -96.27 130.31 43.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.783 0.325 . . . . 6.12 110.856 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.9 p -83.4 33.07 0.45 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 7.65 111.737 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.77 -74.36 0.29 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.08 -0.581 . . . . 6.25 111.876 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.452 HD23 ' HB1' ' A' ' 70' ' ' ALA . 4.3 mm? 59.05 44.43 16.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.114 0.483 . . . . 7.29 110.807 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -147.47 111.12 4.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.784 -0.644 . . . . 6.55 109.726 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -160.58 65.78 0.32 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.66 0.743 . . . . 7.51 110.335 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -125.15 140.18 35.43 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.735 -0.666 . . . . 7.14 110.147 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.3 Cg_exo -56.25 164.9 4.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.177 2.585 . . . . 5.41 112.115 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.658 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 39.8 Cg_endo -63.15 114.0 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.487 2.125 . . . . 7.14 111.186 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.726 ' HA ' HG22 ' A' ' 82' ' ' VAL . 15.1 pt-20 -58.2 -28.18 64.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 10.13 110.529 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 3.1 tt0 -57.34 -51.34 69.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.073 -0.512 . . . . 11.78 109.92 173.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.7 mt -76.59 -41.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 115.844 -0.616 . . . . 8.42 111.76 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.771 ' O ' HG22 ' A' ' 86' ' ' THR . 10.9 m -55.49 -38.27 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.549 -0.908 . . . . 7.57 108.549 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.38 -49.07 78.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.782 -1.099 . . . . 10.39 110.715 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.1 mt -59.54 -42.29 87.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 10.78 110.423 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.702 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.1 mt -64.83 -47.26 89.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.665 -0.698 . . . . 8.01 111.368 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -69.67 -21.2 63.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.98 -0.688 . . . . 10.38 110.874 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.1 m -76.52 -21.9 55.13 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.933 0.396 . . . . 12.35 110.645 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 94.2 mmm -71.33 -24.56 62.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.391 0.615 . . . . 10.33 110.167 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.93 0.48 5.59 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.108 -0.951 . . . . 9.53 111.529 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 34.3 m-85 -94.02 -173.67 3.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.827 0.346 . . . . 8.89 110.428 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.4 tt0 -100.08 146.47 26.74 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.85 -0.426 . . . . 10.16 109.85 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.516 ' O ' HD12 ' A' ' 96' ' ' ILE . 5.7 ttm180 -58.13 -53.62 56.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.119 0.485 . . . . 11.98 110.196 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -58.93 -37.45 76.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 9.02 111.145 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.8 tt0 -64.08 -40.43 96.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.65 -0.705 . . . . 6.68 109.586 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.702 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.76 -38.51 90.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.02 -0.991 . . . . 5.22 110.735 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.578 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mp -60.88 -52.72 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 116.267 -0.424 . . . . 6.39 110.849 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 49.4 tt0 -55.36 -44.58 76.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 8.36 110.811 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.08 -53.47 57.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.249 -0.887 . . . . 5.41 110.835 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.674 HD23 ' HB2' ' A' ' 109' ' ' ALA . 69.7 mt -62.59 -29.83 70.89 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.62 -0.264 . . . . 5.77 111.547 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -57.23 -50.83 71.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.424 0.63 . . . . 7.71 110.311 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.98 84.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.921 -1.036 . . . . 8.88 111.319 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 29.4 p -82.02 -7.35 59.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.684 0.624 . . . . 8.79 112.684 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.26 67.86 0.76 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.671 0.748 . . . . 10.09 110.289 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 8.5 p30 52.26 21.1 1.54 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.844 -1.526 . . . . 7.8 112.889 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.414 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 17.6 m-80 -82.33 110.35 17.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.495 -0.557 . . . . 10.49 109.495 174.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.733 HD12 HG12 ' A' ' 81' ' ' ILE . 8.2 tt -57.05 -60.74 3.14 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.973 -1.012 . . . . 9.54 111.732 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.414 ' N ' HD23 ' A' ' 106' ' ' LEU . 5.9 mm-40 -56.78 -45.66 82.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.325 -0.852 . . . . 11.82 111.428 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.646 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 29.1 ttm180 -67.21 -28.45 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.397 -0.365 . . . . 12.41 111.003 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.674 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.84 -50.65 68.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.252 -0.647 . . . . 6.3 109.252 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 HG23 ' A' ' 85' ' ' ILE . 17.9 mt -59.82 -37.34 78.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.218 -0.901 . . . . 7.78 109.637 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 10.8 t70 -54.18 -53.52 52.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.187 0.994 . . . . 9.04 110.004 172.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -61.36 -45.75 93.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.893 -1.503 . . . . 8.69 110.594 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.671 HD11 ' HA ' ' A' ' 95' ' ' ALA . 41.7 mt -66.98 -39.18 82.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.075 -0.966 . . . . 5.25 111.105 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 40.2 t80 -67.37 -20.7 65.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 6.92 110.624 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.7 t -67.15 -14.31 62.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.364 0.602 . . . . 8.33 109.814 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -125.49 67.35 57.27 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.167 -0.679 . . . . 9.41 109.167 171.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 114' ' ' PHE . 1.2 Cg_endo -39.17 -66.17 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 125.272 3.981 . . . . 7.92 114.445 -170.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.475 ' HG2' ' HB2' ' A' ' 117' ' ' PRO . 3.5 pt-20 -167.39 -42.55 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.89 -1.05 . . . . 11.42 108.989 -173.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -146.53 30.37 1.01 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.742 -1.117 . . . . 15.58 108.422 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.417 ' CA ' ' HG2' ' A' ' 117' ' ' PRO . 57.8 mm-40 64.27 -162.75 0.27 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.839 -1.073 . . . . 11.4 109.528 -174.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 0.8 OUTLIER -87.91 116.8 26.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.322 0.582 . . . . 12.26 110.581 177.041 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -135.23 109.74 8.5 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.52 -0.763 . . . . 15.51 109.574 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -58.25 117.76 4.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.607 -0.724 . . . . 16.06 111.072 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -92.92 97.36 10.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.284 0.564 . . . . 17.4 109.641 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -79.07 96.49 5.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.84 -0.618 . . . . 19.19 110.543 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.666 -0.683 . . . . 20.33 109.625 177.464 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.703 0.763 . . . . 7.16 109.777 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.407 HG23 ' CG1' ' A' ' 24' ' ' VAL . 42.9 mt -129.48 112.4 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-N 115.025 -0.989 . . . . 5.69 109.898 -175.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.76 84.33 0.65 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.379 0.609 . . . . 4.6 110.16 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.601 ' HA ' HG12 ' A' ' 7' ' ' VAL . 41.3 mt-10 -70.33 -5.5 28.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.424 -0.807 . . . . 5.13 110.063 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.442 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 4.3 m -57.86 -37.11 73.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.483 -0.78 . . . . 4.17 109.288 169.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.1 m -64.22 -52.48 58.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.817 -0.629 . . . . 3.42 111.236 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.624 HG11 ' HG2' ' A' ' 21' ' ' ARG . 4.8 p -64.61 -39.33 85.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.399 -0.364 . . . . 3.24 111.168 -177.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.481 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 23.7 mmt -66.46 -31.57 72.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.447 -0.342 . . . . 5.17 111.336 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 5' ' ' SER . 15.2 mm-40 -62.84 -39.3 93.95 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.253 -0.277 . . . . 5.38 110.253 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 39' ' ' ILE . 16.4 mt -70.86 -43.96 67.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.754 0.787 . . . . 3.9 109.833 173.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.61 -42.98 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.363 -1.29 . . . . 4.46 112.066 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.19 -9.85 54.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 6.27 112.198 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -72.14 -23.38 61.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 5.2 110.321 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 15' ' ' PHE . . . 124.62 48.16 0.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.841 -0.695 . . . . 4.75 113.023 176.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 60.0 t80 179.29 134.88 0.25 Allowed Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.49 . . . . 5.09 109.678 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 89.2 Cg_endo -75.44 88.98 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.017 2.478 . . . . 4.25 112.241 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.72 57.66 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.317 -0.553 . . . . 3.29 110.829 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -56.34 -23.33 36.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.969 0.414 . . . . 5.48 111.009 174.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.647 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -59.81 -31.96 70.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.067 0.46 . . . . 3.54 110.281 172.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.569 ' HB3' HG23 ' A' ' 7' ' ' VAL . 37.9 t -73.81 -39.06 64.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.274 -0.875 . . . . 3.27 109.869 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.624 ' HG2' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -50.16 -52.13 37.87 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.73 0.776 . . . . 6.1 109.074 173.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 32.4 mttt -63.89 -44.72 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.551 -1.204 . . . . 4.77 110.218 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -56.57 -46.49 80.74 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.786 -0.643 . . . . 4.34 111.914 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 20' ' ' CYS . 98.5 t -59.37 -44.15 91.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 4.58 109.935 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.41 -43.48 98.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.964 -0.562 . . . . 7.48 110.973 175.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -69.41 -39.05 78.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.204 0.446 . . . . 6.84 112.204 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.4 p -67.3 -15.24 63.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.97 0.414 . . . . 5.71 111.268 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.7 23.12 47.73 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.652 -0.979 . . . . 5.75 110.652 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.98 72.56 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.633 -0.783 . . . . 5.06 110.496 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 34' ' ' VAL . 92.0 mmm -94.03 9.65 36.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.301 -0.863 . . . . 6.28 111.407 -177.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 172.26 36.75 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.474 -0.87 . . . . 4.17 112.874 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -57.87 -50.3 73.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.058 0.543 . . . . 3.73 112.355 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -53.97 -43.49 69.97 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.218 0.451 . . . . 5.46 112.218 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 30' ' ' MET . 92.1 t -72.96 -40.63 59.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 4.88 111.076 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.48 -30.79 60.01 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.417 -0.513 . . . . 3.68 111.661 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.567 ' O ' HG22 ' A' ' 39' ' ' ILE . 76.3 t80 -59.84 -42.64 94.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.621 -0.881 . . . . 4.71 108.621 171.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.542 ' O ' HG13 ' A' ' 40' ' ' ILE . 27.2 t-20 -67.56 -39.67 84.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.583 -0.735 . . . . 5.69 110.244 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -63.36 -31.96 73.26 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.016 0.436 . . . . 5.87 110.184 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.647 HD11 ' HB3' ' A' ' 19' ' ' ALA . 2.4 tp -76.79 -39.79 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.218 -0.446 . . . . 3.69 110.896 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.53 -16.19 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.387 0.613 . . . . 5.04 110.966 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 37' ' ' ASN . 75.1 t -79.17 -38.61 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.513 -0.767 . . . . 5.37 110.148 168.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -87.79 4.73 43.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.047 0.388 . . . . 5.35 112.047 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -23.24 65.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.57 0.224 . . . . 5.73 111.414 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -95.22 13.98 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.057 0.456 . . . . 6.34 111.299 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.571 ' CB ' ' HB3' ' A' ' 48' ' ' PHE . 10.6 mm-40 -92.57 131.03 35.12 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.899 -0.592 . . . . 5.62 110.321 175.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.69 -40.51 9.85 Favored 'Trans proline' 0 CA--C 1.527 0.125 0 C-N-CA 122.979 2.453 . . . . 6.22 113.16 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -116.91 25.4 10.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.69 0.757 . . . . 6.09 111.386 -169.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.571 ' HB3' ' CB ' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -70.28 -36.82 74.64 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.659 -0.65 . . . . 5.89 111.6 -176.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.94 114.12 5.86 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.804 0.335 . . . . 4.6 110.321 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 52' ' ' LEU . 48.0 mt-10 -60.65 125.91 83.79 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.637 -0.71 . . . . 5.96 110.06 174.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 9.8 Cg_exo -73.01 38.52 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.103 2.535 . . . . 6.2 112.06 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 50' ' ' GLU . 37.1 tp -77.28 106.64 9.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.464 -0.789 . . . . 8.24 110.034 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 m 62.64 63.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.583 0.706 . . . . 7.27 110.149 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.514 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 ppp? -84.42 124.0 74.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.679 -0.691 . . . . 7.41 109.854 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.16 -174.31 2.07 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.583 2.189 . . . . 5.89 112.712 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.41 122.9 1.79 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.942 -0.647 . . . . 6.63 111.92 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -115.09 123.4 48.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.884 0.373 . . . . 9.15 110.737 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.92 166.24 32.4 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.06 -0.591 . . . . 6.92 111.664 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.9 3.56 81.03 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.791 -0.718 . . . . 7.34 111.454 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.61 160.55 29.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.758 0.313 . . . . 7.8 110.308 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.06 159.19 15.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.992 -0.549 . . . . 6.73 110.705 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.6 p -103.57 94.15 5.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 7.03 110.635 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.53 134.84 36.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 6.23 110.54 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.25 -100.11 0.88 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.801 -0.714 . . . . 7.09 112.215 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 57.74 77.48 0.28 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.145 0.498 . . . . 7.1 110.937 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.8 m -75.76 -43.42 46.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.825 -0.625 . . . . 7.6 111.124 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.77 151.78 12.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.911 -0.586 . . . . 8.01 111.748 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -120.19 148.23 43.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.956 -0.757 . . . . 8.06 108.956 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.87 77.36 0.34 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.169 -1.015 . . . . 6.62 113.148 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.14 -76.93 0.22 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.578 -0.527 . . . . 6.12 109.578 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m 60.08 -84.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.76 0.652 . . . . 7.65 112.76 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.97 88.94 0.97 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.009 -0.615 . . . . 6.25 112.281 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.19 99.97 9.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.788 0.328 . . . . 7.29 110.436 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.35 141.85 35.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.169 -0.469 . . . . 6.55 110.035 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -146.6 134.97 21.88 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.159 -0.682 . . . . 7.51 109.159 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -101.53 134.5 20.2 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 108.918 -0.771 . . . . 7.14 108.918 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 82.2 Cg_exo -51.47 162.27 1.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.953 2.435 . . . . 5.41 111.682 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.708 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 31.7 Cg_endo -60.94 110.37 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.512 2.141 . . . . 7.14 111.232 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -56.47 -26.86 55.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 10.13 111.389 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.2 tt0 -59.38 -51.56 69.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.263 -0.426 . . . . 11.78 110.069 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.783 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.5 mt -74.64 -42.2 48.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.101 -0.5 . . . . 8.42 111.981 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.76 ' O ' HG22 ' A' ' 86' ' ' THR . 8.4 m -56.02 -38.14 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.422 -0.955 . . . . 7.57 108.422 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.43 -48.74 79.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.753 -1.112 . . . . 10.39 110.758 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.783 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.42 -41.79 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.299 -0.41 . . . . 10.78 110.512 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.746 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.3 mt -65.29 -47.5 86.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.973 -0.558 . . . . 8.01 111.793 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.76 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.3 t -69.61 -21.67 63.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.316 -0.553 . . . . 10.38 110.966 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.0 m -71.49 -31.88 67.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.795 0.331 . . . . 12.35 110.44 171.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 98.3 mmm -64.94 -22.86 67.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.868 -0.605 . . . . 10.33 110.449 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.85 4.18 6.18 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.426 -0.806 . . . . 9.53 112.068 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.601 ' HB2' HG22 ' A' ' 85' ' ' ILE . 33.7 m-85 -96.32 -174.55 3.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.343 -0.243 . . . . 8.89 110.343 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -96.02 148.31 22.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.567 -0.531 . . . . 10.16 109.567 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.505 ' O ' HD12 ' A' ' 96' ' ' ILE . 12.5 ttm180 -58.8 -52.45 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.194 0.521 . . . . 11.98 110.069 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -61.6 -35.84 78.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 9.02 111.213 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.58 ' HG2' HD13 ' A' ' 113' ' ' ILE . 7.3 tt0 -65.9 -38.44 88.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.524 -0.762 . . . . 6.68 109.554 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.746 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.181 -0.918 . . . . 5.22 110.501 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.59 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.95 -52.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 CA-C-N 116.342 -0.39 . . . . 6.39 110.914 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.462 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.7 tt0 -57.95 -43.68 86.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.151 -0.477 . . . . 8.36 110.989 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.45 -50.4 73.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.668 -0.697 . . . . 5.41 110.844 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 109' ' ' ALA . 79.0 mt -63.08 -35.53 80.57 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.741 -0.208 . . . . 5.77 111.314 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.462 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.9 mtt180 -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.517 0.675 . . . . 7.71 110.277 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.93 72.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.736 -1.12 . . . . 8.88 111.6 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 63.0 p -86.69 2.66 47.79 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.116 0.784 . . . . 8.79 113.116 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 64.07 45.88 3.95 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.139 0.575 . . . . 10.09 111.395 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.579 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 77.2 m-20 68.08 21.12 8.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.405 -0.816 . . . . 7.8 111.509 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 4.5 m-20 -82.89 104.5 13.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.604 -0.517 . . . . 10.49 109.604 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.774 HD12 HG12 ' A' ' 81' ' ' ILE . 8.5 tt -47.7 -61.17 2.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.065 -0.971 . . . . 9.54 111.886 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.412 ' N ' HD23 ' A' ' 106' ' ' LEU . 6.4 mm-40 -56.64 -46.54 80.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.102 -0.953 . . . . 11.82 111.919 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.674 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.0 ttm180 -69.0 -28.97 67.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 12.41 110.537 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.746 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -61.4 -51.35 69.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.384 -0.599 . . . . 6.3 109.384 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.515 HD23 HG23 ' A' ' 85' ' ' ILE . 20.7 mt -59.26 -41.84 89.76 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.284 -0.871 . . . . 7.78 109.52 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.67 -49.52 70.42 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.599 0.714 . . . . 9.04 110.363 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -61.55 -48.56 80.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.442 -1.254 . . . . 8.69 110.253 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.58 HD13 ' HG2' ' A' ' 94' ' ' GLN . 44.0 mt -63.46 -40.38 88.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.296 -0.866 . . . . 5.25 110.596 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -61.93 -34.58 76.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.118 0.567 . . . . 6.92 111.165 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 m -82.47 11.97 5.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.313 -0.858 . . . . 8.33 110.741 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.58 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 82.0 t60 -132.7 71.95 78.02 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.276 -0.874 . . . . 9.41 109.565 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -49.52 -63.31 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 124.046 3.164 . . . . 7.92 112.503 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -179.22 -53.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.736 -1.12 . . . . 11.42 110.016 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -113.93 6.63 16.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.531 . . . . 15.58 110.543 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.58 ' OE1' ' HA ' ' A' ' 116' ' ' HIS . 5.5 mm-40 56.92 -167.35 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.897 -1.047 . . . . 11.4 111.794 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.52 156.73 42.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 12.26 110.196 170.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 125' ' ' PHE . 7.5 p-10 -119.87 38.59 3.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.445 0.641 . . . . 15.51 110.611 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.8 p -73.43 -20.12 60.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.627 -0.715 . . . . 16.06 110.842 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -160.74 138.63 9.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.75 -0.659 . . . . 17.4 110.429 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 122' ' ' ASP . 88.6 m-85 -117.03 -4.55 11.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.155 -0.475 . . . . 19.19 110.593 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.441 -0.79 . . . . 20.33 110.735 -176.417 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.076 0.465 . . . . 7.16 110.26 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.613 HD11 ' HD1' ' A' ' 25' ' ' TYR . 1.9 mp -66.03 121.86 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 115.725 -0.671 . . . . 5.69 110.032 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.4 ' N ' HG11 ' A' ' 24' ' ' VAL . 21.9 m-20 -70.01 81.7 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 4.6 110.346 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.547 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.5 mt-10 -71.18 -11.82 61.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.059 -0.519 . . . . 5.13 111.0 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 9' ' ' GLN . 6.9 t -60.46 -28.4 68.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.018 -0.734 . . . . 4.17 109.018 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.66 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 1.9 m -69.34 -50.69 44.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.907 -0.588 . . . . 3.42 110.896 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 4' ' ' GLU . 2.1 p -63.36 -45.89 96.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.448 -0.501 . . . . 3.24 110.805 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.528 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 55.3 mtm -68.97 -26.64 65.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.056 -0.52 . . . . 5.17 111.848 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 6' ' ' SER . 4.4 pt20 -69.03 -34.66 75.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.454 -0.498 . . . . 5.38 109.82 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 6' ' ' SER . 20.4 mt -68.63 -43.42 76.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.613 0.721 . . . . 3.9 109.083 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.56 -37.43 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.629 -1.169 . . . . 4.46 111.503 -176.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 8' ' ' MET . 52.4 mt-10 -65.95 -23.72 66.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.386 0.513 . . . . 6.27 112.386 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 ptp -117.11 -3.86 11.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.296 0.48 . . . . 5.2 112.296 -173.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.25 -101.35 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.935 -1.126 . . . . 4.75 113.643 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.519 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 95.9 m-85 -124.67 165.47 24.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.056 -0.35 . . . . 5.09 110.056 -172.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 71.5 Cg_endo -72.09 82.92 1.24 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.473 2.115 . . . . 4.25 111.62 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 3.4 mm? -75.94 66.5 2.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 3.29 111.805 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -25.73 54.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.617 0.722 . . . . 5.48 109.481 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -31.26 68.08 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.235 -0.893 . . . . 3.54 110.39 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 18.2 t -73.26 -37.71 66.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.422 -0.808 . . . . 3.27 109.706 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.31 -52.58 35.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.852 0.834 . . . . 6.1 108.94 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -70.4 -34.15 72.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.785 -1.098 . . . . 4.77 111.385 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -61.6 -44.31 97.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.385 . . . . 4.34 111.599 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.492 ' CG1' HG23 ' A' ' 2' ' ' ILE . 94.1 t -64.69 -40.8 90.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 4.58 110.384 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.613 ' HD1' HD11 ' A' ' 2' ' ' ILE . 91.3 t80 -62.32 -41.21 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 7.48 110.422 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -68.95 -43.82 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 6.84 111.296 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.8 p -67.09 -17.17 64.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 5.71 111.359 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.85 49.61 5.59 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.707 -0.679 . . . . 5.75 111.907 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.07 45.41 4.57 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.532 0.733 . . . . 5.06 111.885 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.502 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.2 mmt -65.18 -63.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.544 -0.753 . . . . 6.28 111.223 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.87 166.72 38.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.728 -0.749 . . . . 4.17 111.693 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.647 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -65.31 -46.12 81.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.245 0.545 . . . . 3.73 110.982 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 36' ' ' PHE . 15.2 mm-40 -76.13 -27.67 57.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.585 -0.734 . . . . 5.46 110.253 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 30' ' ' MET . 99.1 t -58.27 -44.28 87.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.855 0.36 . . . . 4.88 110.481 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.64 -31.76 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 3.68 110.759 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 51.5 t80 -51.71 -46.2 63.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.304 -0.628 . . . . 4.71 109.304 170.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.52 -47.41 86.29 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.59 -0.732 . . . . 5.69 110.754 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.725 ' HE3' HD12 ' A' ' 39' ' ' ILE . 50.4 t90 -57.2 -36.88 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 5.87 110.237 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.725 HD12 ' HE3' ' A' ' 38' ' ' TRP . 1.2 mp -75.1 -46.64 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.642 -0.708 . . . . 3.69 112.082 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.41 -19.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.394 0.616 . . . . 5.04 111.003 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -80.03 -41.8 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.694 . . . . 5.37 110.807 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.473 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 88.2 m-70 -102.89 20.69 16.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.307 0.484 . . . . 5.35 112.307 -175.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -67.2 -21.28 65.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.412 0.625 . . . . 5.73 109.579 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.03 6.19 9.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.144 -0.934 . . . . 6.34 111.969 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 66.8 mm-40 -82.42 136.26 46.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.176 -0.676 . . . . 5.62 109.176 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.56 -41.96 13.76 Favored 'Trans proline' 0 N--CA 1.471 0.164 0 C-N-CA 123.112 2.541 . . . . 6.22 113.473 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -116.83 25.34 10.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.628 0.728 . . . . 6.09 110.602 -170.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.892 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 4.3 p90 -59.11 -35.74 73.96 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.644 -0.707 . . . . 5.89 112.063 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.2 117.12 4.12 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.193 -0.669 . . . . 4.6 109.193 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 35.6 mt-10 -62.36 114.12 10.87 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.907 -0.588 . . . . 5.96 110.099 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 19.1 Cg_endo -90.51 62.3 1.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.356 2.704 . . . . 6.2 113.369 -171.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.8 tp -124.07 36.42 4.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.767 0.794 . . . . 8.24 109.346 175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.1 t -169.3 50.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.016 -0.993 . . . . 7.27 109.924 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.6 ttp -76.97 118.61 73.05 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.519 -0.764 . . . . 7.41 110.65 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.471 ' HD3' ' HD3' ' A' ' 16' ' ' PRO . 94.3 Cg_endo -86.49 166.97 9.0 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.852 2.368 . . . . 5.89 112.181 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.27 115.82 4.29 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.499 -0.64 . . . . 6.63 111.499 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -68.58 141.37 55.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.041 0.448 . . . . 9.15 111.28 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.65 71.33 2.98 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.748 -0.66 . . . . 6.92 112.591 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.09 68.38 0.25 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.385 -0.686 . . . . 7.34 111.385 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.56 -60.91 1.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.787 0.327 . . . . 7.8 110.971 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.84 147.45 40.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.145 -0.48 . . . . 6.73 110.257 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.9 p -89.22 117.8 28.45 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.893 0.378 . . . . 7.03 111.071 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.44 70.17 0.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.012 -0.54 . . . . 6.23 110.064 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.09 -37.61 0.38 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.905 -0.664 . . . . 7.09 111.99 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.38 120.96 42.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.859 -0.423 . . . . 7.1 109.859 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 m -79.8 87.27 5.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.234 -0.439 . . . . 7.6 110.224 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.8 -59.66 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.94 -0.573 . . . . 8.01 109.639 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.6 t80 52.63 83.15 0.06 Allowed 'General case' 0 N--CA 1.463 0.218 0 O-C-N 124.039 0.837 . . . . 8.06 110.474 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.95 80.41 1.09 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.811 -0.709 . . . . 6.62 113.09 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.61 58.14 4.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.16 0.505 . . . . 6.12 110.398 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -70.02 -33.08 71.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.839 -0.619 . . . . 7.65 110.363 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.17 -65.64 0.52 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.074 -0.584 . . . . 6.25 111.856 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' HB3' ' H ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER 56.87 -95.05 0.05 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.048 0.539 . . . . 7.29 111.123 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.428 ' H ' ' HB3' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -143.88 159.17 43.02 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 120.786 0.327 . . . . 6.55 110.175 -179.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -140.54 34.04 1.84 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.746 0.784 . . . . 7.51 109.509 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -74.31 142.55 78.59 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.319 -0.855 . . . . 7.14 109.827 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.544 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.1 Cg_exo -53.88 164.53 2.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.95 2.433 . . . . 5.41 112.217 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.687 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 37.8 Cg_endo -63.54 111.16 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.651 2.234 . . . . 7.14 110.73 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.0 pt-20 -58.55 -26.15 63.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.814 -0.63 . . . . 10.13 110.781 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.4 tt0 -60.36 -50.2 74.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.183 0.516 . . . . 11.78 109.869 172.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.77 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.0 mt -74.72 -42.66 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.655 . . . . 8.42 111.769 -175.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.754 ' O ' HG22 ' A' ' 86' ' ' THR . 14.2 m -55.76 -37.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.475 -0.935 . . . . 7.57 108.475 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.24 -48.74 78.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.653 -1.158 . . . . 10.39 110.897 175.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.77 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.6 mt -59.38 -42.88 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 10.78 110.326 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.726 HD12 ' HB1' ' A' ' 95' ' ' ALA . 88.9 mt -63.74 -47.44 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.812 -0.631 . . . . 8.01 111.356 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -71.15 -21.39 62.19 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.298 -0.561 . . . . 10.38 110.763 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -75.9 -22.21 56.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.04 0.448 . . . . 12.35 110.371 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 29.5 mmt -72.75 -25.41 61.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.201 0.524 . . . . 10.33 110.072 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 4.55 3.96 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.539 -0.755 . . . . 9.53 112.069 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.599 ' HB2' HG22 ' A' ' 85' ' ' ILE . 28.0 m-85 -98.16 -177.51 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.766 0.317 . . . . 8.89 110.342 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.687 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 58.1 tt0 -94.45 142.34 27.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.561 -0.533 . . . . 10.16 109.561 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.0 ttm180 -57.89 -51.86 67.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.851 0.358 . . . . 11.98 111.241 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.59 -35.08 73.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 9.02 110.485 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.687 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.6 tt0 -66.63 -39.27 88.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.418 -0.81 . . . . 6.68 109.562 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.726 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.12 -40.55 97.93 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.285 -0.87 . . . . 5.22 110.498 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.596 HG13 HG11 ' A' ' 82' ' ' VAL . 1.1 mt -58.58 -52.43 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.163 -0.471 . . . . 6.39 110.438 176.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.7 tt0 -56.74 -45.94 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 8.36 111.103 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.91 -51.07 71.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.474 -0.785 . . . . 5.41 110.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 109' ' ' ALA . 82.2 mt -61.54 -35.62 78.27 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.641 -0.254 . . . . 5.77 111.609 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 90.8 mtt180 -54.03 -46.59 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.525 0.678 . . . . 7.71 110.153 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.64 67.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.764 -1.107 . . . . 8.88 111.615 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.697 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.5 p -86.19 3.98 40.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.871 0.693 . . . . 8.79 112.871 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.3 t30 64.72 46.8 2.96 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.997 -0.547 . . . . 10.09 110.514 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.609 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 82.4 m-20 67.15 16.58 10.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.388 -0.824 . . . . 7.8 111.437 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.9 t-20 -78.53 110.28 13.48 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.412 -0.588 . . . . 10.49 109.412 175.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.748 HD12 HG12 ' A' ' 81' ' ' ILE . 7.7 tt -55.33 -59.09 5.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.237 -0.892 . . . . 9.54 111.316 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.413 ' N ' HD23 ' A' ' 106' ' ' LEU . 16.6 mm-40 -53.35 -49.99 65.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.631 -1.168 . . . . 11.82 111.671 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.697 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 32.1 ttm180 -69.7 -28.76 66.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.443 -0.344 . . . . 12.41 111.017 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.699 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.02 -51.32 68.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.032 -0.729 . . . . 6.3 109.032 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.578 HD23 HG23 ' A' ' 85' ' ' ILE . 23.6 mt -59.16 -40.78 86.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.85 -1.068 . . . . 7.78 109.902 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.59 -50.43 71.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 9.04 110.178 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -60.68 -44.67 96.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.854 -1.066 . . . . 8.69 110.472 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.649 HD11 ' HA ' ' A' ' 95' ' ' ALA . 52.7 mt -70.45 -39.91 76.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.991 -1.004 . . . . 5.25 111.065 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -64.95 -28.33 69.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 6.92 111.196 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.8 t -83.38 5.84 22.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.859 -0.61 . . . . 8.33 110.044 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.572 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 52.3 m-70 -136.4 78.61 44.35 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.388 -0.824 . . . . 9.41 110.502 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -47.88 -70.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.858 3.039 . . . . 7.92 112.118 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.6 -51.48 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.942 -1.026 . . . . 11.42 109.484 172.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -117.73 9.76 13.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 15.58 110.609 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.572 ' OE2' ' HA ' ' A' ' 116' ' ' HIS . 12.5 mm-40 61.42 -170.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.646 -0.706 . . . . 11.4 110.387 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -92.41 143.12 26.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.295 -0.632 . . . . 12.26 109.295 169.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -109.83 151.94 26.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.489 -0.323 . . . . 15.51 110.4 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 p -50.18 117.18 2.21 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.031 0.832 . . . . 16.06 112.235 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.7 148.54 22.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.913 -0.585 . . . . 17.4 110.21 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -103.69 124.34 48.68 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.658 -0.701 . . . . 19.19 110.009 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.247 0.934 0 CA-C-N 116.294 -0.412 . . . . 20.33 110.921 -178.833 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.885 0.374 . . . . 7.16 110.713 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 82.2 mt -78.93 109.97 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.154 0.502 . . . . 5.69 110.592 -177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.2 85.89 1.9 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.449 -0.796 . . . . 4.6 110.716 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.529 ' HA ' HG12 ' A' ' 7' ' ' VAL . 38.3 mt-10 -72.7 -4.73 33.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.125 -0.489 . . . . 5.13 112.158 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -67.83 -31.55 71.47 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.965 -0.754 . . . . 4.17 108.965 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.75 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 16.9 m -64.89 -46.4 81.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 3.42 110.899 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.1 p -68.94 -40.91 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.144 -0.622 . . . . 3.24 110.53 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 71.0 mtp -63.96 -30.91 71.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.441 . . . . 5.17 111.576 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.75 ' HG2' ' O ' ' A' ' 6' ' ' SER . 10.4 pt20 -68.46 -38.77 81.4 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.435 -0.506 . . . . 5.38 109.672 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.858 ' HB3' HD12 ' A' ' 17' ' ' LEU . 16.4 mt -66.78 -43.74 83.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.648 0.737 . . . . 3.9 109.556 173.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.678 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.6 -33.93 74.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.347 -1.297 . . . . 4.46 112.202 -173.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.3 -36.16 27.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.98 -0.554 . . . . 6.27 111.183 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 18.2 ptp -90.55 0.71 57.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 5.2 112.292 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.67 -92.32 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.747 -1.216 . . . . 4.75 113.763 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 96.7 m-85 -136.52 162.4 56.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.439 -0.208 . . . . 5.09 110.439 -172.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 64.3 Cg_endo -68.05 77.24 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.154 2.569 . . . . 4.25 111.66 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.858 HD12 ' HB3' ' A' ' 10' ' ' LEU . 95.0 mt -85.16 63.84 8.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.967 -0.56 . . . . 3.29 112.428 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -55.96 -19.39 12.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.168 0.508 . . . . 5.48 110.057 169.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.497 ' HB1' ' CD2' ' A' ' 48' ' ' PHE . . . -57.68 -33.1 68.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.542 -0.754 . . . . 3.54 109.407 171.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 34.9 t -70.61 -46.34 63.55 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 115.027 -0.988 . . . . 3.27 109.525 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -53.18 -51.45 62.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.933 0.397 . . . . 6.1 111.044 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.91 -23.52 62.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 4.77 110.542 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -40.76 64.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.381 -0.372 . . . . 4.34 110.785 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 20' ' ' CYS . 77.2 t -56.65 -42.6 76.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 4.58 110.22 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -65.12 -43.04 93.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 7.48 110.514 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.4 -41.17 85.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 6.84 111.78 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.4 p -65.3 -22.34 66.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 5.71 111.436 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.83 25.02 13.85 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.847 -0.692 . . . . 5.75 111.601 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 60.72 47.21 8.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.333 0.587 . . . . 5.06 110.397 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.502 ' HB2' HG11 ' A' ' 34' ' ' VAL . 22.2 mmt -76.28 -23.33 54.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 6.28 112.483 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.15 176.37 14.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.17 -1.014 . . . . 4.17 112.95 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -63.95 -58.96 5.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.559 0.344 . . . . 3.73 111.69 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -55.13 -35.14 64.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.49 . . . . 5.46 111.387 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' A' ' 30' ' ' MET . 59.6 t -66.82 -46.64 84.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.052 -0.522 . . . . 4.88 111.184 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.36 -30.78 53.96 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.949 -0.3 . . . . 3.68 111.109 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 39' ' ' ILE . 65.8 t80 -58.48 -44.43 89.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.964 -0.754 . . . . 4.71 108.964 171.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.42 ' O ' HG13 ' A' ' 40' ' ' ILE . 7.4 t30 -63.73 -37.08 86.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.59 -0.732 . . . . 5.69 110.659 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -67.07 -33.85 76.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 5.87 110.418 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.788 HG12 HD13 ' A' ' 17' ' ' LEU . 3.2 tp -77.13 -38.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.466 -0.334 . . . . 3.69 111.171 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 43' ' ' MET . 2.7 pp -71.1 -28.0 31.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.715 -0.394 . . . . 5.04 110.918 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.9 -25.94 12.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.854 -0.338 . . . . 5.37 110.493 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -100.0 10.41 41.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.128 0.418 . . . . 5.35 112.128 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 14.1 ptp -62.4 -20.85 64.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.979 0.418 . . . . 5.73 110.149 174.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.29 -16.5 5.59 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.702 -0.681 . . . . 6.34 110.988 173.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.562 ' CB ' ' HB2' ' A' ' 48' ' ' PHE . 65.4 mm-40 -108.55 88.08 4.83 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.072 -0.513 . . . . 5.62 109.726 172.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.5 -45.43 41.14 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.387 2.724 . . . . 6.22 111.972 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.18 23.77 7.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.989 -1.46 . . . . 6.09 110.378 -170.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.562 ' HB2' ' CB ' ' A' ' 45' ' ' GLU . 6.9 t80 -77.36 -14.59 59.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.416 0.627 . . . . 5.89 109.399 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.33 -129.34 0.3 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.634 -0.712 . . . . 4.6 109.174 174.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.85 159.84 28.43 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.134 -0.691 . . . . 5.96 109.134 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -34.77 142.04 0.08 OUTLIER 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.856 3.038 . . . . 6.2 113.078 172.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.16 67.25 3.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.825 -0.625 . . . . 8.24 112.26 -169.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.5 p -99.51 132.03 45.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.088 -0.505 . . . . 7.27 109.832 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 20.9 ptp -86.06 115.84 63.42 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 121.018 0.437 . . . . 7.41 110.446 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.93 19.07 1.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.862 2.375 . . . . 5.89 112.909 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.91 81.45 0.37 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.094 -0.574 . . . . 6.63 112.241 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -78.69 24.48 0.29 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.06 0.393 . . . . 9.15 112.06 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 171.09 70.54 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.898 -0.668 . . . . 6.92 112.072 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.83 -153.8 34.96 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.69 -0.767 . . . . 7.34 112.569 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.38 -166.15 1.28 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.82 0.343 . . . . 7.8 110.79 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.81 29.5 5.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.996 0.369 . . . . 6.73 111.996 -173.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.7 t 61.13 59.05 2.08 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.913 -0.585 . . . . 7.03 111.758 172.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.6 125.34 29.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 6.23 110.545 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.81 140.04 9.82 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.033 -0.604 . . . . 7.09 112.014 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.29 112.53 17.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.716 0.293 . . . . 7.1 110.762 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -83.29 92.64 7.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.197 0.522 . . . . 7.6 110.62 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.17 125.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.907 -0.588 . . . . 8.01 109.932 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -84.28 -29.83 26.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.871 0.367 . . . . 8.06 110.874 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.04 -63.6 3.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.895 -0.669 . . . . 6.62 112.877 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 56.52 36.14 27.11 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.316 0.579 . . . . 6.12 109.867 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 m -56.17 125.81 23.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.859 -1.064 . . . . 7.65 112.197 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.06 -57.23 4.81 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.733 -0.667 . . . . 6.25 112.844 174.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 55.32 63.25 2.15 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.05 -0.722 . . . . 7.29 109.05 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.2 121.72 11.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.899 -1.046 . . . . 6.55 111.583 -174.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -108.19 30.5 6.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.178 -0.919 . . . . 7.51 108.667 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -73.32 142.1 81.33 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-N 114.431 -1.259 . . . . 7.14 109.762 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.569 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 83.7 Cg_exo -51.02 162.9 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.472 2.781 . . . . 5.41 112.822 176.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.7 ' HD2' HD13 ' A' ' 99' ' ' LEU . 38.0 Cg_endo -62.7 112.15 1.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.597 2.198 . . . . 7.14 111.526 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.9 pt-20 -58.97 -27.33 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.225 -0.898 . . . . 10.13 112.106 -174.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.57 ' HG2' ' N ' ' A' ' 81' ' ' ILE . 11.2 pm0 -70.21 -42.82 71.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.589 -0.893 . . . . 11.78 108.589 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 63.5 mt -70.82 -46.39 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.726 -1.125 . . . . 8.42 111.755 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 86' ' ' THR . 14.3 m -55.52 -38.0 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.54 -0.911 . . . . 7.57 108.54 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.36 -47.21 85.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.442 -1.254 . . . . 10.39 111.272 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 18.8 mt -60.0 -42.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 10.78 110.238 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.771 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.2 mt -65.16 -45.86 92.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 8.01 111.286 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.62 -21.23 61.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.367 -0.533 . . . . 10.38 110.799 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.6 t -74.28 -28.87 61.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.6 -0.518 . . . . 12.35 109.6 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.563 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.6 mmm -66.06 -27.61 68.22 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.315 0.578 . . . . 10.33 110.159 175.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.14 -5.22 4.63 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.548 -0.751 . . . . 9.53 112.14 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.619 ' HB2' HG22 ' A' ' 85' ' ' ILE . 31.5 m-85 -87.93 -175.45 5.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.722 0.296 . . . . 8.89 110.236 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 55.5 tt0 -98.02 145.35 26.6 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.839 -0.43 . . . . 10.16 109.839 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 7.0 ttm180 -55.73 -51.27 67.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.126 0.489 . . . . 11.98 110.431 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.47 -38.38 80.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.781 . . . . 9.02 111.027 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.632 ' HG3' HD13 ' A' ' 113' ' ' ILE . 4.3 tp-100 -59.94 -46.92 87.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.852 0.834 . . . . 6.68 109.35 174.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.771 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -58.38 -40.78 83.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.457 -1.247 . . . . 5.22 110.854 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.81 -52.11 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.034 -0.53 . . . . 6.39 110.617 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.577 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 58.8 tt0 -56.97 -47.01 81.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.794 -0.639 . . . . 8.36 110.866 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.75 -50.67 72.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.236 -0.893 . . . . 5.41 110.973 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.7 HD13 ' HD2' ' A' ' 78' ' ' PRO . 72.7 mt -61.8 -33.51 74.25 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.45 -0.341 . . . . 5.77 111.376 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 95.0 mtt180 -55.93 -47.2 77.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.405 0.621 . . . . 7.71 110.169 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.94 71.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.107 -0.951 . . . . 8.88 111.401 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.0 p -85.77 -0.68 55.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.849 0.685 . . . . 8.79 112.849 -174.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 66.76 48.18 1.41 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.15 0.58 . . . . 10.09 111.238 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.568 ' ND2' ' HD3' ' A' ' 78' ' ' PRO . 4.9 m-20 69.76 12.63 8.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.339 -0.846 . . . . 7.8 111.467 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 12.3 t-20 -77.43 109.51 11.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.139 -0.689 . . . . 10.49 109.139 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 81' ' ' ILE . 8.3 tt -56.46 -60.37 3.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.102 -0.954 . . . . 9.54 111.519 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.23 -45.68 72.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.979 -1.009 . . . . 11.82 111.542 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.705 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.4 ttm180 -70.92 -28.37 64.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.244 -0.434 . . . . 12.41 111.075 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.627 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.41 -51.32 68.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.382 -0.599 . . . . 6.3 109.382 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.58 HD23 HG23 ' A' ' 85' ' ' ILE . 18.1 mt -57.85 -38.6 75.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.374 -0.83 . . . . 7.78 109.662 174.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.56 -51.41 69.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.979 -1.01 . . . . 9.04 110.246 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -63.32 -45.58 90.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.759 -1.109 . . . . 8.69 110.177 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.632 HD13 ' HG3' ' A' ' 94' ' ' GLN . 54.9 mt -62.54 -34.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.13 -0.941 . . . . 5.25 110.414 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -69.39 -31.19 69.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 6.92 111.098 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.5 t -75.49 -0.19 19.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.412 0.625 . . . . 8.33 110.176 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -140.55 72.22 30.82 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.2 -0.909 . . . . 9.41 108.578 169.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -27.07 -65.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.952 1 C-N-CA 126.222 4.614 . . . . 7.92 114.474 -171.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -158.59 -41.87 0.06 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.834 -1.075 . . . . 11.42 108.427 173.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -151.23 46.89 0.83 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.106 -0.952 . . . . 15.58 109.633 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 64.34 -159.83 0.29 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.071 -0.968 . . . . 11.4 110.827 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.23 -172.89 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.578 0.228 . . . . 12.26 110.702 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.0 70.77 0.56 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.032 0.832 . . . . 15.51 110.878 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.2 p -125.13 145.28 50.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.251 -0.886 . . . . 16.06 109.908 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -91.3 25.42 2.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.309 0.576 . . . . 17.4 111.0 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.52 79.8 1.25 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.764 -0.653 . . . . 19.19 109.756 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.36 -0.829 . . . . 20.33 110.637 -178.645 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 110.056 -0.35 . . . . 7.16 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.7 mt 57.38 88.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 123.714 0.634 . . . . 5.69 110.414 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.28 91.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.527 -0.76 . . . . 4.6 111.174 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 21' ' ' ARG . 49.1 mt-10 -72.27 -5.71 37.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.875 -0.602 . . . . 5.13 111.579 176.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 2.0 m -59.11 -38.48 79.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.341 0.591 . . . . 4.17 109.565 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 24.1 m -64.63 -50.16 68.19 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.564 -0.744 . . . . 3.42 111.504 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -65.8 -41.81 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 120.849 -0.341 . . . . 3.24 111.153 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 88.3 mtp -61.21 -30.04 70.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.375 -0.375 . . . . 5.17 111.102 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 5' ' ' SER . 46.1 mt-30 -69.59 -34.67 74.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.69 -0.232 . . . . 5.38 111.053 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.702 HD13 HG21 ' A' ' 39' ' ' ILE . 14.3 mt -66.88 -47.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.838 0.827 . . . . 3.9 109.179 171.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.31 -45.83 91.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.022 -1.445 . . . . 4.46 112.403 -169.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 13' ' ' MET . 6.8 pt-20 -58.24 -36.26 72.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.301 0.572 . . . . 6.27 111.437 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.445 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 25.5 ptt? -99.36 7.47 45.52 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.401 -0.818 . . . . 5.2 112.063 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.29 103.21 0.2 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.624 -1.274 . . . . 4.75 114.521 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 78.6 m-85 71.66 138.27 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 113.47 0.915 . . . . 5.09 113.47 168.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.05 82.8 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.188 2.592 . . . . 4.25 111.364 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.702 HD13 HG12 ' A' ' 39' ' ' ILE . 85.7 mt -80.46 61.32 4.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.163 0.431 . . . . 3.29 112.163 -173.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -20.89 17.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.101 0.476 . . . . 5.48 110.626 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.55 -35.32 72.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.455 0.645 . . . . 3.54 109.909 171.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 33.5 t -73.92 -36.17 64.67 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.383 -0.826 . . . . 3.27 109.894 175.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 4' ' ' GLU . 1.3 tmm_? -57.09 -48.34 78.83 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.378 0.609 . . . . 6.1 109.477 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -74.43 -25.42 59.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.998 -0.546 . . . . 4.77 110.325 176.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.729 ' HA ' ' HD2' ' A' ' 26' ' ' PHE . . . -66.65 -38.52 87.06 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.11 0.481 . . . . 4.34 110.609 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 20' ' ' CYS . 71.8 t -59.8 -37.77 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.833 -0.621 . . . . 4.58 109.865 173.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 89.9 t80 -60.81 -41.36 95.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.17 -0.468 . . . . 7.48 110.54 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.729 ' HD2' ' HA ' ' A' ' 23' ' ' ALA . 53.6 m-85 -64.8 -46.25 82.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.617 0.246 . . . . 6.84 111.286 176.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 24' ' ' VAL . 33.7 p -70.62 -11.81 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 5.71 111.685 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.74 38.84 41.58 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 5.75 111.427 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.415 ' HA ' HG13 ' A' ' 24' ' ' VAL . 2.2 p-10 43.81 47.9 6.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.908 0.883 . . . . 5.06 111.966 -176.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.4 mtt -63.92 -64.48 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.498 -0.774 . . . . 6.28 110.66 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.84 179.99 45.78 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.815 -0.629 . . . . 4.17 111.665 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -65.22 -33.82 76.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.656 0.243 . . . . 3.73 111.656 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -53.74 -63.24 1.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.008 0.432 . . . . 5.46 111.837 -176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.23 -30.62 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 112.234 0.457 . . . . 4.88 112.234 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.85 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.667 -0.413 . . . . 3.68 111.988 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.559 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.7 t80 -58.72 -44.62 90.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.011 -0.737 . . . . 4.71 109.011 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -65.36 -34.64 78.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 5.69 111.031 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -66.23 -36.39 82.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.133 0.492 . . . . 5.87 110.506 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 10' ' ' LEU . 7.0 tp -76.98 -41.56 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.236 -0.438 . . . . 3.69 111.38 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.05 -26.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.864 0.364 . . . . 5.04 111.003 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 p -80.66 -31.82 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.864 -0.334 . . . . 5.37 110.783 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -100.44 14.59 30.68 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 122.051 -0.406 . . . . 5.35 111.892 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -64.08 -22.57 66.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.928 0.394 . . . . 5.73 111.399 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.0 -3.84 41.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.07 0.396 . . . . 6.34 112.07 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.844 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 21.9 mm-40 -66.01 123.28 84.64 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.97 -0.381 . . . . 5.62 109.97 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 13.2 Cg_endo -58.98 -36.34 96.98 Favored 'Trans proline' 0 N--CA 1.472 0.244 0 C-N-CA 123.1 2.533 . . . . 6.22 112.141 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -115.98 26.88 9.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.791 -1.095 . . . . 6.09 110.245 -171.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.844 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.5 p90 -60.33 -43.85 96.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.778 -0.646 . . . . 5.89 111.468 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -158.97 162.27 36.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.312 -0.996 . . . . 4.6 108.312 -175.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -100.81 90.54 1.55 Allowed Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 114.975 -1.011 . . . . 5.96 109.303 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 49' ' ' ALA . 97.1 Cg_endo -84.76 48.7 2.44 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.895 2.397 . . . . 6.2 112.809 -171.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -87.23 33.21 0.68 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.536 -0.756 . . . . 8.24 110.626 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.461 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 85.8 m -158.2 94.52 1.3 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.853 -0.612 . . . . 7.27 110.047 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 79.4 mtp -88.09 103.94 5.97 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.235 -0.438 . . . . 7.41 109.905 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.505 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 8.0 Cg_exo -72.65 -60.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.024 2.483 . . . . 5.89 112.691 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.33 -176.05 20.55 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.959 -0.639 . . . . 6.63 112.541 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -165.11 173.73 11.11 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.797 -0.446 . . . . 9.15 109.797 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.67 -136.34 7.55 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.581 -0.819 . . . . 6.92 112.544 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.72 -133.68 3.72 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.312 -0.47 . . . . 7.34 111.983 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -134.0 -44.75 0.79 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.216 -0.29 . . . . 7.8 110.216 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 49.94 53.24 13.14 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.639 0.587 . . . . 6.73 111.86 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.558 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 52.4 m 62.58 63.69 0.99 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.619 -0.719 . . . . 7.03 111.163 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.2 -42.41 31.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.138 0.494 . . . . 6.23 110.049 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.43 46.73 1.79 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.63 -0.795 . . . . 7.09 111.7 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 62' ' ' SER . . . -97.82 23.88 7.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 7.1 111.499 -175.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.1 m -151.33 139.69 20.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.12 0.486 . . . . 7.6 110.875 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.7 t -110.01 103.33 15.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.611 -0.722 . . . . 8.01 109.212 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -121.75 102.43 8.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.951 0.405 . . . . 8.06 110.502 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.57 18.57 5.15 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.877 -0.889 . . . . 6.62 110.877 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 73' ' ' LEU . . . -85.73 75.93 10.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.316 -0.442 . . . . 6.12 111.403 -175.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 p -66.82 -42.57 85.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.361 0.601 . . . . 7.65 110.042 175.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -143.81 78.15 0.27 Allowed Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.596 -1.002 . . . . 6.25 110.596 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.631 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 6.0 tt -74.24 -53.92 8.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.004 0.431 . . . . 7.29 110.513 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -98.35 119.39 36.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.073 -0.512 . . . . 6.55 110.235 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -130.17 33.85 4.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.448 0.642 . . . . 7.51 109.741 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -85.42 141.21 36.56 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.375 -0.83 . . . . 7.14 110.535 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.647 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 48.3 Cg_exo -61.87 164.48 16.34 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.062 2.508 . . . . 5.41 112.047 171.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.653 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 50.0 Cg_endo -66.37 112.92 2.48 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.95 2.433 . . . . 7.14 111.256 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.2 pt-20 -55.93 -29.56 60.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 10.13 110.77 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.3 tt0 -56.89 -51.0 70.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.265 0.555 . . . . 11.78 110.29 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.8 mt -75.67 -41.4 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.75 -0.659 . . . . 8.42 111.8 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.774 ' O ' HG22 ' A' ' 86' ' ' THR . 5.5 m -56.06 -38.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.601 -0.889 . . . . 7.57 108.601 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.11 -45.78 91.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.815 -1.084 . . . . 10.39 110.699 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.9 mt -62.5 -41.73 93.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 10.78 110.871 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.724 HD12 ' HB1' ' A' ' 95' ' ' ALA . 80.4 mt -65.97 -46.76 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.916 -0.584 . . . . 8.01 111.66 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.73 -21.2 63.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.042 -0.663 . . . . 10.38 110.518 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.5 t -73.03 -32.22 64.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.741 -0.466 . . . . 12.35 109.741 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.0 mmt -64.25 -26.26 68.42 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.214 0.531 . . . . 10.33 110.489 176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.64 6.21 4.7 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.71 . . . . 9.53 112.01 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.644 ' HB2' HG22 ' A' ' 85' ' ' ILE . 32.2 m-85 -99.07 -174.01 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.68 0.276 . . . . 8.89 110.297 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.811 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 34.2 mt-30 -91.05 149.55 21.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.47 -0.332 . . . . 10.16 110.468 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.4 ttm180 -61.99 -51.16 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.427 -0.583 . . . . 11.98 109.427 173.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.472 -0.785 . . . . 9.02 110.879 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.811 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 1.0 OUTLIER -63.6 -37.45 87.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.264 0.554 . . . . 6.68 109.728 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.724 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.72 -41.39 98.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.427 -0.806 . . . . 5.22 110.451 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.647 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.79 -52.15 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.127 -0.488 . . . . 6.39 110.277 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.639 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.6 tt0 -53.86 -47.11 71.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.837 -0.62 . . . . 8.36 111.162 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HB2' ' CG1' ' A' ' 113' ' ' ILE . . . -60.17 -52.09 66.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.01 -0.995 . . . . 5.41 110.91 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 109' ' ' ALA . 75.2 mt -62.93 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.438 -0.346 . . . . 5.77 111.542 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.639 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.8 mtt180 -54.64 -46.17 73.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.787 0.804 . . . . 7.71 109.66 175.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.69 -44.74 55.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.53 -1.213 . . . . 8.88 111.382 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.698 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 64.3 p -81.41 0.06 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.917 0.71 . . . . 8.79 112.917 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 61.58 62.94 1.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 10.09 110.257 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.5 p30 53.09 23.42 3.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.662 1.185 . . . . 7.8 112.662 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.553 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.1 t-20 -87.44 108.78 19.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.386 -0.598 . . . . 10.49 109.386 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.779 HD12 HG12 ' A' ' 81' ' ' ILE . 8.7 tt -53.94 -61.27 2.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.915 -1.039 . . . . 9.54 112.042 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.02 -45.79 75.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.811 -1.086 . . . . 11.82 111.655 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.698 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 9.0 ttm180 -69.66 -28.69 66.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.053 -0.521 . . . . 12.41 110.845 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.688 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.37 -50.92 68.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.103 -0.703 . . . . 6.3 109.103 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 85' ' ' ILE . 21.7 mt -58.58 -39.1 79.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.404 -0.816 . . . . 7.78 109.668 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 11.0 t70 -54.17 -54.54 38.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.982 -1.008 . . . . 9.04 109.942 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -62.68 -39.7 94.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.058 -1.428 . . . . 8.69 110.781 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.68 HD11 ' HA ' ' A' ' 95' ' ' ALA . 53.7 mt -71.37 -36.05 59.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.36 -0.836 . . . . 5.25 111.27 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -64.85 -33.39 75.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.48 0.657 . . . . 6.92 109.996 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.3 t -84.01 11.03 8.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.195 -0.911 . . . . 8.33 110.287 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -135.06 70.34 69.89 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.541 -0.754 . . . . 9.41 109.744 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.472 ' HD2' ' OE2' ' A' ' 120' ' ' GLU . 9.6 Cg_endo -49.29 -66.78 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 124.438 3.426 . . . . 7.92 113.431 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -171.1 -42.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.545 -0.752 . . . . 11.42 110.461 -176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -147.89 16.29 1.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.232 0.539 . . . . 15.58 109.921 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.472 ' OE2' ' HD2' ' A' ' 117' ' ' PRO . 46.6 mm-40 63.73 118.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.208 -0.905 . . . . 11.4 111.869 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.92 123.42 32.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.402 0.62 . . . . 12.26 110.865 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -137.43 -50.59 0.62 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.88 -0.6 . . . . 15.51 110.398 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.6 t -119.46 56.25 0.93 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.416 0.627 . . . . 16.06 109.987 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -111.54 -43.83 3.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.845 -0.616 . . . . 17.4 110.002 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -78.64 -38.53 39.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.857 -0.611 . . . . 19.19 109.364 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.421 -0.809 . . . . 20.33 110.591 179.577 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 121.277 0.561 . . . . 7.16 109.877 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.445 HG23 ' CG1' ' A' ' 24' ' ' VAL . 52.8 mt -138.82 135.3 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 115.47 -0.786 . . . . 5.69 109.253 178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.557 ' H ' HG11 ' A' ' 24' ' ' VAL . 10.0 m-20 -69.83 72.53 0.39 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.293 0.568 . . . . 4.6 109.605 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.577 ' HA ' HG12 ' A' ' 7' ' ' VAL . 43.7 mt-10 -71.14 -4.14 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.709 -0.678 . . . . 5.13 111.142 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.552 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 14.5 m -63.22 -30.96 72.0 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.251 -0.648 . . . . 4.17 109.251 169.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.659 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 48.2 t -66.96 -52.68 39.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.673 -0.694 . . . . 3.42 110.943 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 4' ' ' GLU . 5.1 p -63.67 -37.67 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.318 -0.401 . . . . 3.24 110.583 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 20.9 mmt -65.27 -29.0 69.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.0 -0.545 . . . . 5.17 111.516 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 5' ' ' SER . 71.3 mt-30 -66.37 -40.87 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.735 -0.386 . . . . 5.38 110.534 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.698 ' HB3' HD12 ' A' ' 17' ' ' LEU . 18.4 mt -68.67 -39.37 80.66 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.862 0.839 . . . . 3.9 109.533 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 8' ' ' MET . . . -61.88 -34.46 76.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.363 -1.29 . . . . 4.46 111.8 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 8' ' ' MET . 49.3 mt-10 -67.54 -18.91 65.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.34 . . . . 6.27 111.145 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.7 mtp -83.17 -1.16 52.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.168 0.508 . . . . 5.2 109.832 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.1 45.68 5.57 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.445 -0.798 . . . . 4.75 113.066 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -144.17 125.77 8.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.857 0.361 . . . . 5.09 110.64 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.59 66.12 4.69 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.354 2.703 . . . . 4.25 111.687 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.698 HD12 ' HB3' ' A' ' 10' ' ' LEU . 61.9 mt -89.65 64.6 6.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.691 0.758 . . . . 3.29 111.695 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -55.54 -21.81 18.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.02 -0.536 . . . . 5.48 109.714 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.603 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.92 -30.65 66.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.52 -0.764 . . . . 3.54 109.901 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HB2' HD12 ' A' ' 10' ' ' LEU . 17.5 t -72.16 -44.71 62.66 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.506 -0.77 . . . . 3.27 109.037 174.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -48.82 72.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.43 -0.804 . . . . 6.1 110.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 10.9 ptpt -75.76 -23.29 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.981 -0.288 . . . . 4.77 110.734 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.9 93.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.328 0.585 . . . . 4.34 110.067 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.557 HG11 ' H ' ' A' ' 3' ' ' ASP . 77.1 t -58.58 -40.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 4.58 110.009 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 87.3 t80 -60.73 -49.95 75.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.685 -0.689 . . . . 7.48 110.57 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -61.81 -43.36 99.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.646 -0.252 . . . . 6.84 111.597 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -66.82 -27.74 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.125 0.488 . . . . 5.71 111.094 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.77 36.29 6.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.791 -0.64 . . . . 5.75 112.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 59.29 64.48 1.35 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.947 0.403 . . . . 5.06 110.139 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.7 mmt -97.71 -32.72 11.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.044 -0.525 . . . . 6.28 111.922 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 171.12 18.59 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 119.72 -1.229 . . . . 4.17 113.035 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.659 ' HA ' ' HB2' ' A' ' 6' ' ' SER . . . -67.14 -54.52 20.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.229 0.455 . . . . 3.73 112.229 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.532 ' HA ' ' HB3' ' A' ' 36' ' ' PHE . 45.3 mt-10 -68.56 -24.23 64.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.837 0.351 . . . . 5.46 110.804 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.38 -46.67 89.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 4.88 110.318 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB3' ' OG ' ' A' ' 6' ' ' SER . . . -78.45 -27.38 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.49 -0.323 . . . . 3.68 111.09 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 81.1 t80 -57.89 -44.25 86.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.036 -0.727 . . . . 4.71 109.036 169.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.518 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.6 t30 -62.94 -40.86 98.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.462 -0.79 . . . . 5.69 110.285 175.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -65.16 -33.57 76.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.895 -0.593 . . . . 5.87 110.626 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 19' ' ' ALA . 3.9 tp -75.69 -37.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 3.69 111.111 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.1 -30.15 39.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.86 -0.336 . . . . 5.04 111.004 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.37 -21.47 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.796 -0.361 . . . . 5.37 110.76 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -101.8 1.32 37.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.902 0.382 . . . . 5.35 111.09 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.7 ptt? -62.87 -23.72 67.46 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.56 0.578 . . . . 5.73 112.56 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -71.04 -10.71 60.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.763 0.316 . . . . 6.34 111.78 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.829 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 6.6 mm-40 -77.42 127.4 82.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.437 -0.347 . . . . 5.62 110.666 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.22 -35.71 90.87 Favored 'Trans proline' 0 N--CA 1.473 0.306 0 C-N-CA 123.63 2.887 . . . . 6.22 113.014 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -115.7 25.64 10.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.113 -0.949 . . . . 6.09 110.392 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.829 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.0 p90 -63.3 -32.33 73.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.642 -0.708 . . . . 5.89 111.528 -176.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.52 -140.35 0.15 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.989 -0.745 . . . . 4.6 108.989 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -101.36 105.37 39.46 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.7 -0.482 . . . . 5.96 109.7 176.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.27 60.57 6.38 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 123.278 2.652 . . . . 6.2 112.129 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -128.98 96.3 4.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.628 -0.714 . . . . 8.24 110.227 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.9 t 36.24 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.403 1.081 . . . . 7.27 113.495 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 61.4 mtt -71.46 127.66 90.9 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.595 -0.729 . . . . 7.41 110.303 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 10.3 Cg_exo -71.79 -64.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.546 2.831 . . . . 5.89 113.159 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.26 166.16 39.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.914 -0.66 . . . . 6.63 112.014 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -84.5 28.42 0.65 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.096 0.474 . . . . 9.15 111.672 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.09 73.37 2.29 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.977 -0.63 . . . . 6.92 111.884 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.39 170.72 25.42 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.777 -0.725 . . . . 7.34 112.02 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.94 139.3 48.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.868 0.366 . . . . 7.8 110.818 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.89 120.66 25.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 6.73 109.763 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.2 p 47.02 58.23 4.98 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.681 0.613 . . . . 7.03 110.885 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.42 83.2 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 6.23 110.849 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.79 -118.26 2.69 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.71 -0.677 . . . . 7.09 111.443 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.11 155.05 17.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.415 -0.587 . . . . 7.1 109.415 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 t -82.55 72.1 9.62 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.592 -0.521 . . . . 7.6 109.592 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.4 t -95.19 124.46 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.6 -0.727 . . . . 8.01 110.442 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -93.47 -179.52 5.07 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.02 -0.536 . . . . 8.06 110.152 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.45 -164.82 14.22 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.319 -0.943 . . . . 6.62 112.543 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.42 -70.17 0.79 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.074 -0.343 . . . . 6.12 110.074 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m 58.25 63.34 1.76 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.9 -0.591 . . . . 7.65 110.483 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.5 39.06 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.411 -0.813 . . . . 6.25 111.251 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.18 20.02 15.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.065 0.459 . . . . 7.29 110.943 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -142.34 149.26 39.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.101 -0.5 . . . . 6.55 109.961 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -169.5 177.34 4.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.143 -1.058 . . . . 7.51 108.143 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -141.91 140.16 19.36 Favored Pre-proline 0 N--CA 1.438 -1.043 0 N-CA-C 109.545 -0.539 . . . . 7.14 109.545 173.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.0 Cg_exo -54.06 166.8 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.683 2.256 . . . . 5.41 111.666 170.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.689 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.8 Cg_endo -64.38 109.42 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.175 1.917 . . . . 7.14 110.407 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.675 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.1 pt-20 -58.13 -23.56 55.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.461 0.476 . . . . 10.13 110.274 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 3.6 tt0 -59.31 -53.04 62.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.616 -0.72 . . . . 11.78 110.108 171.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.1 mt -73.67 -42.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.74 -0.664 . . . . 8.42 111.648 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.781 ' O ' HG22 ' A' ' 86' ' ' THR . 5.8 m -55.14 -37.98 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.556 -0.905 . . . . 7.57 108.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.67 -47.97 82.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 10.39 111.055 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.8 mt -60.2 -41.33 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.863 -0.608 . . . . 10.78 110.309 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.734 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.8 mt -67.0 -45.16 87.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.747 -0.66 . . . . 8.01 111.657 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.14 -20.67 62.28 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.081 -0.648 . . . . 10.38 110.726 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.2 t -75.23 -27.14 59.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.121 0.486 . . . . 12.35 109.829 172.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 23.8 mmt -68.37 -23.05 64.63 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 10.33 110.703 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.09 -5.24 5.68 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.518 -0.765 . . . . 9.53 111.635 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.595 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.3 m-85 -90.8 -176.24 4.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.32 . . . . 8.89 110.614 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.8 tt0 -98.01 147.07 24.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.823 -0.436 . . . . 10.16 109.823 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.503 ' O ' HD12 ' A' ' 96' ' ' ILE . 10.2 ttm180 -56.66 -54.78 42.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 11.98 110.51 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.445 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 8.8 t30 -58.45 -36.74 74.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.853 -0.612 . . . . 9.02 111.016 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.0 tt0 -64.69 -38.39 90.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 6.68 109.626 176.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.734 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -66.06 -39.17 89.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.127 -0.942 . . . . 5.22 110.693 175.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.557 HG13 HG11 ' A' ' 82' ' ' VAL . 1.1 mp -59.41 -52.49 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 116.212 -0.449 . . . . 6.39 111.039 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 57.5 tt0 -58.91 -41.62 87.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.052 -0.522 . . . . 8.36 110.862 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.98 -53.35 58.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.346 -0.843 . . . . 5.41 110.417 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 109' ' ' ALA . 79.9 mt -61.46 -34.77 75.99 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.39 -0.368 . . . . 5.77 111.526 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 93.3 mtt180 -55.88 -46.35 78.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.544 0.688 . . . . 7.71 110.371 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.3 70.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.958 -1.019 . . . . 8.88 111.061 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.72 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 31.2 p -84.36 0.18 50.28 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.991 0.737 . . . . 8.79 112.991 -175.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 60.87 61.88 1.57 Allowed 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.021 0.528 . . . . 10.09 110.458 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.594 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 10.1 p30 51.67 25.5 2.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.589 1.156 . . . . 7.8 112.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 13.1 t-20 -86.1 109.62 18.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.946 -0.761 . . . . 10.49 108.946 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.724 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.4 tt -54.75 -59.73 4.32 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.094 -0.957 . . . . 9.54 111.436 -176.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.24 -48.38 74.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.637 -1.165 . . . . 11.82 111.737 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.72 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -67.98 -28.71 67.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.407 -0.36 . . . . 12.41 110.92 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.22 -50.41 71.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.353 -0.61 . . . . 6.3 109.353 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.508 HD23 HG23 ' A' ' 85' ' ' ILE . 17.0 mt -60.34 -39.22 86.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.266 -0.879 . . . . 7.78 109.665 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.93 -49.97 70.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.81 -1.086 . . . . 9.04 110.124 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -63.1 -49.85 72.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.375 -1.284 . . . . 8.69 110.489 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.694 HD11 ' HA ' ' A' ' 95' ' ' ALA . 44.2 mt -62.16 -32.33 54.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.931 -1.031 . . . . 5.25 111.394 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -61.95 -29.42 70.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.182 0.515 . . . . 6.92 110.997 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -82.99 -3.13 56.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.543 0.687 . . . . 8.33 109.841 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -141.82 62.68 15.02 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 9.41 110.246 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -36.5 -58.44 0.51 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 125.18 3.92 . . . . 7.92 113.308 -170.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 5.2 pt-20 -157.32 -57.06 0.08 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.866 -1.061 . . . . 11.42 108.835 173.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.445 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 33.1 t80 -158.76 12.29 0.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 15.58 110.562 176.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.08 -168.29 0.16 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.137 -0.483 . . . . 11.4 110.05 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -135.22 166.04 24.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.669 -0.493 . . . . 12.26 109.669 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.3 t70 51.75 76.13 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.07 0.857 . . . . 15.51 110.938 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.8 t -91.78 106.87 18.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.962 -0.563 . . . . 16.06 110.123 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -96.09 -28.78 14.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.013 -0.539 . . . . 17.4 110.436 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -88.64 -46.74 8.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.485 -0.325 . . . . 19.19 110.693 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 41.0 t . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.615 -0.707 . . . . 20.33 110.215 -178.109 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.079 0.466 . . . . 7.16 110.764 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.486 HG23 ' CG1' ' A' ' 24' ' ' VAL . 78.1 mt -98.27 130.32 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.646 -0.706 . . . . 5.69 110.923 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.34 74.74 1.87 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.174 0.512 . . . . 4.6 110.706 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.412 ' HA ' HG12 ' A' ' 7' ' ' VAL . 46.0 mt-10 -71.67 -5.45 33.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.401 0.62 . . . . 5.13 110.147 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 15.2 m -61.78 -34.28 75.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.612 -0.722 . . . . 4.17 109.301 167.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -59.78 -51.93 67.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 3.42 110.716 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 17' ' ' LEU . 3.8 p -66.58 -40.7 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.229 -0.441 . . . . 3.24 111.113 -177.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.6 mtp -63.45 -31.62 72.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.281 -0.418 . . . . 5.17 111.26 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 13' ' ' MET . 13.9 mm100 -60.28 -53.95 51.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 110.037 -0.357 . . . . 5.38 110.037 173.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.634 ' HB3' HD12 ' A' ' 17' ' ' LEU . 10.7 mt -57.2 -43.22 82.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.153 0.501 . . . . 3.9 109.841 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.88 -50.0 73.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.655 -1.157 . . . . 4.46 111.784 -172.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -60.17 -28.54 68.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.357 -0.383 . . . . 6.27 111.518 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.68 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 17.3 ptt? -112.91 31.1 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.891 0.33 . . . . 5.2 111.891 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.72 96.84 0.55 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.849 -1.167 . . . . 4.75 114.173 173.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 m-85 73.89 133.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 113.225 0.824 . . . . 5.09 113.225 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.31 83.77 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.93 2.42 . . . . 4.25 111.353 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.634 HD12 ' HB3' ' A' ' 10' ' ' LEU . 95.4 mt -82.33 66.98 8.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.781 -0.645 . . . . 3.29 112.137 -173.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 3.7 tt0 -56.38 -19.76 16.28 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.892 0.377 . . . . 5.48 111.001 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.64 -32.34 68.96 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.929 0.395 . . . . 3.54 109.983 172.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 49.5 t -72.02 -43.58 64.77 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.465 -0.789 . . . . 3.27 109.177 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 29.7 ttt180 -52.36 -52.75 51.72 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.868 -1.06 . . . . 6.1 110.049 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -72.71 -25.07 61.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.655 . . . . 4.77 110.834 177.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.46 78.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.62 0.248 . . . . 4.34 110.648 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' CYS . 93.4 t -56.83 -45.93 83.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.672 -0.492 . . . . 4.58 109.672 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -62.03 -46.47 89.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.506 -0.478 . . . . 7.48 110.713 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -64.25 -36.25 83.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 6.84 112.003 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.7 p -68.8 -21.05 64.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.205 0.526 . . . . 5.71 110.583 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.55 27.71 12.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.606 -0.725 . . . . 5.75 111.559 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 64.04 53.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.299 0.571 . . . . 5.06 110.327 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.542 ' HB3' HG21 ' A' ' 34' ' ' VAL . 20.4 mmt -82.08 -14.65 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 6.28 111.86 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.02 173.02 13.39 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.438 -0.887 . . . . 4.17 112.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.04 66.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.34 . . . . 3.73 111.053 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.97 -49.11 69.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.068 -0.515 . . . . 5.46 111.22 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 30' ' ' MET . 95.9 t -60.46 -38.71 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 4.88 111.343 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.17 54.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.079 -0.248 . . . . 3.68 111.662 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.656 ' O ' HG22 ' A' ' 39' ' ' ILE . 59.2 t80 -56.94 -44.78 82.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.904 -0.776 . . . . 4.71 108.904 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.493 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.4 m-20 -65.79 -39.95 91.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.395 -0.821 . . . . 5.69 110.536 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -64.36 -34.77 78.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 5.87 110.468 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 36' ' ' PHE . 7.2 tp -75.42 -40.73 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.201 -0.454 . . . . 3.69 111.475 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -69.71 -23.81 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.163 0.506 . . . . 5.04 110.606 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 37' ' ' ASN . 85.2 t -78.92 -42.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 5.37 110.824 171.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -101.12 19.21 17.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.391 0.515 . . . . 5.35 112.391 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.4 ptm -63.27 -21.11 66.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.2 0.524 . . . . 5.73 110.416 172.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 44' ' ' GLU . 8.2 pt-20 -66.23 -11.27 49.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.276 -0.874 . . . . 6.34 112.42 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.71 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 39.9 mm-40 -69.45 140.28 89.89 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.062 -0.347 . . . . 5.62 110.062 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.8 -49.16 5.66 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.965 2.443 . . . . 6.22 113.417 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -108.94 25.63 11.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.944 0.878 . . . . 6.09 110.361 -169.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.71 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 1.6 p90 -62.04 -25.81 67.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.399 -0.819 . . . . 5.89 112.08 -176.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.564 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -139.14 119.75 14.06 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.011 0.434 . . . . 4.6 110.285 -176.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 28.1 mt-10 -59.6 114.83 10.43 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.211 -0.904 . . . . 5.96 110.228 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 2.8 Cg_exo -75.8 71.92 5.32 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.083 2.522 . . . . 6.2 112.272 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.2 tp -127.73 67.72 1.32 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.886 -0.597 . . . . 8.24 110.685 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 m 66.12 113.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.736 -0.665 . . . . 7.27 112.044 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.47 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 17.1 ptm -86.38 129.43 53.4 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.235 -0.439 . . . . 7.41 110.538 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 13.2 Cg_exo -71.29 149.82 57.91 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.806 2.338 . . . . 5.89 111.539 175.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.88 115.02 2.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.027 -0.606 . . . . 6.63 111.991 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -70.21 128.17 35.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.668 0.27 . . . . 9.15 110.465 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.55 170.52 16.62 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.086 -0.578 . . . . 6.92 111.723 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.83 169.15 54.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.003 -0.618 . . . . 7.34 112.384 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.0 133.35 43.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.338 0.589 . . . . 7.8 111.327 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.64 27.22 3.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.573 -0.74 . . . . 6.73 110.648 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.8 t -125.55 144.09 50.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.017 -0.538 . . . . 7.03 110.263 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.61 87.64 6.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.105 -0.498 . . . . 6.23 109.76 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.5 -40.05 40.35 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.965 -0.636 . . . . 7.09 112.637 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.78 -56.21 0.83 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.906 -0.173 . . . . 7.1 111.256 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.2 t 54.68 50.67 15.37 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.198 0.523 . . . . 7.6 110.097 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.647 HG13 ' HD1' ' A' ' 68' ' ' PHE . 7.5 p -89.63 -32.0 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.969 -0.559 . . . . 8.01 110.008 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.647 ' HD1' HG13 ' A' ' 67' ' ' VAL . 9.8 m-85 -97.4 43.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.944 -0.571 . . . . 8.06 110.715 177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.53 153.27 21.5 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.718 -0.674 . . . . 6.62 111.478 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB1' HD22 ' A' ' 73' ' ' LEU . . . -93.63 -30.02 15.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.798 0.333 . . . . 6.12 110.345 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.6 t 63.1 -86.84 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.307 -0.86 . . . . 7.65 111.424 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -129.18 10.68 6.19 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.946 -0.645 . . . . 6.25 111.786 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.456 HD22 ' HB1' ' A' ' 70' ' ' ALA . 4.4 mm? 63.15 53.22 2.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.095 0.474 . . . . 7.29 111.288 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.57 76.05 7.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.592 0.71 . . . . 6.55 109.519 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -132.92 76.04 1.66 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.226 -0.897 . . . . 7.51 109.377 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -70.32 139.06 86.85 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.531 -0.914 . . . . 7.14 108.531 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 71.9 Cg_exo -52.67 159.2 5.07 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.756 2.304 . . . . 5.41 112.709 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.739 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 43.3 Cg_endo -65.29 113.28 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.874 2.383 . . . . 7.14 110.959 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.728 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.0 pt-20 -57.43 -28.8 63.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.955 -0.566 . . . . 10.13 110.309 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.3 tt0 -57.62 -50.57 72.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.908 -0.587 . . . . 11.78 109.924 174.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.766 ' HA ' HD12 ' A' ' 84' ' ' ILE . 68.7 mt -76.27 -42.72 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.845 -0.616 . . . . 8.42 112.036 -176.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 86' ' ' THR . 10.0 m -55.35 -38.28 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.463 -0.94 . . . . 7.57 108.463 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.35 -49.66 76.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.822 -1.081 . . . . 10.39 110.57 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.766 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.3 mt -59.78 -42.14 87.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.459 . . . . 10.78 110.737 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.771 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.6 mt -64.63 -47.0 90.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.076 -0.511 . . . . 8.01 111.424 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.03 -21.18 61.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.152 -0.619 . . . . 10.38 110.809 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -77.01 -17.66 58.68 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.809 0.338 . . . . 12.35 110.449 172.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 97.1 mmm -75.28 -25.45 57.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.286 0.565 . . . . 10.33 109.503 173.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.69 -1.77 5.2 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.252 -0.885 . . . . 9.53 112.012 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.624 ' HB2' HG22 ' A' ' 85' ' ' ILE . 32.0 m-85 -92.21 -174.09 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.748 0.309 . . . . 8.89 110.692 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.755 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 6.7 tt0 -97.18 143.28 28.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.916 -0.401 . . . . 10.16 109.916 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 96' ' ' ILE . 5.2 ttm180 -55.9 -54.85 39.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.981 0.42 . . . . 11.98 110.29 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.551 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 54.1 t30 -59.63 -35.82 75.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.641 . . . . 9.02 111.031 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.755 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.5 tt0 -64.96 -39.82 94.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.638 . . . . 6.68 109.533 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.771 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.83 -39.17 93.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.935 -1.03 . . . . 5.22 110.408 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER -59.45 -52.9 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 116.322 -0.399 . . . . 6.39 110.805 176.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.542 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 49.4 tt0 -56.35 -44.62 80.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.221 0.534 . . . . 8.36 110.82 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.04 -53.29 59.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.304 -0.862 . . . . 5.41 110.729 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.723 HD23 ' HB2' ' A' ' 109' ' ' ALA . 77.1 mt -62.01 -32.88 73.41 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 111.779 0.289 . . . . 5.77 111.779 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 75.3 mtp180 -57.37 -43.73 83.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.436 0.636 . . . . 7.71 110.262 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.1 60.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.19 -0.914 . . . . 8.88 111.077 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 33.7 p -84.47 -0.72 53.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.19 0.811 . . . . 8.79 113.19 -174.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 62.03 63.45 1.09 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.577 0.548 . . . . 10.09 110.621 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.8 p-10 50.04 27.64 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.221 1.008 . . . . 7.8 111.967 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 43.6 t-20 -88.96 107.32 18.96 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.827 -0.805 . . . . 10.49 108.827 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.737 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.0 tt -53.78 -60.34 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.093 -0.958 . . . . 9.54 111.393 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.422 ' N ' HD23 ' A' ' 106' ' ' LEU . 37.5 mm-40 -54.45 -49.66 69.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.86 -1.064 . . . . 11.82 111.926 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 26.3 ttm180 -66.9 -28.51 68.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.452 -0.34 . . . . 12.41 110.793 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.723 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.96 -51.28 67.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.679 -0.489 . . . . 6.3 109.679 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.577 HD23 HG23 ' A' ' 85' ' ' ILE . 16.4 mt -59.88 -39.21 84.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.461 -0.79 . . . . 7.78 109.52 175.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.81 -50.36 68.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.866 -1.061 . . . . 9.04 109.877 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -63.32 -49.06 75.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.333 -1.303 . . . . 8.69 110.482 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.647 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.3 mt -62.61 -37.08 78.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.944 -1.025 . . . . 5.25 111.23 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.38 -24.15 67.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 6.92 110.663 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.8 m -86.33 7.65 24.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.91 -0.586 . . . . 8.33 111.0 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -138.91 74.88 36.83 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.037 -0.529 . . . . 9.41 110.05 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -45.23 -59.93 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.571 3.514 . . . . 7.92 112.778 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.695 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 4.3 pt-20 -163.98 -56.44 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.685 -1.143 . . . . 11.42 108.133 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.695 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 91.4 t80 -128.31 -43.45 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.364 -1.289 . . . . 15.58 109.429 173.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 138.36 175.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 126.245 2.215 . . . . 11.4 109.149 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.27 147.35 52.57 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.492 -0.558 . . . . 12.26 109.492 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.65 -66.71 0.36 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.538 0.57 . . . . 15.51 112.538 -171.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.7 m -74.08 -15.18 61.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.579 -0.737 . . . . 16.06 112.893 -165.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -85.97 -41.86 14.52 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.54 -0.464 . . . . 17.4 110.881 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -78.37 -34.62 48.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.22 -0.446 . . . . 19.19 110.341 178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.245 -0.883 . . . . 20.33 110.734 179.396 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.413 HG12 ' HD1' ' A' ' 25' ' ' TYR . 4.3 mp . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 107.244 -1.391 . . . . 5.69 107.244 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.87 101.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.622 -1.172 . . . . 4.6 110.981 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.455 ' CD ' ' HE ' ' A' ' 21' ' ' ARG . 39.8 mt-10 -70.46 -2.12 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.372 -0.831 . . . . 5.13 111.008 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 1.2 m -57.62 -37.87 74.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.36 -0.608 . . . . 4.17 109.36 170.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -64.5 -49.03 72.93 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.701 -0.681 . . . . 3.42 111.372 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -66.59 -42.03 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 120.812 -0.355 . . . . 3.24 111.042 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 47.0 mtt -62.86 -34.83 78.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.266 -0.425 . . . . 5.17 111.145 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 5' ' ' SER . 51.0 mt-30 -59.14 -47.44 85.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.751 -0.38 . . . . 5.38 110.615 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.979 ' HB3' HD12 ' A' ' 17' ' ' LEU . 15.9 mt -60.31 -47.79 84.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.572 0.701 . . . . 3.9 109.989 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.17 -50.61 71.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.571 -1.195 . . . . 4.46 111.915 -174.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -69.53 1.27 4.2 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.528 0.566 . . . . 6.27 112.528 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 22.4 ptp -130.07 10.01 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.028 -0.269 . . . . 5.2 111.7 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.16 -94.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.528 -1.32 . . . . 4.75 113.611 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.8 m-85 -130.44 159.15 72.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.322 . . . . 5.09 110.129 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -69.66 80.79 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.984 2.456 . . . . 4.25 110.945 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.979 HD12 ' HB3' ' A' ' 10' ' ' LEU . 90.4 mt -81.67 66.72 7.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.7 -0.682 . . . . 3.29 111.849 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.74 -22.56 24.47 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.57 0.7 . . . . 5.48 110.125 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB1' ' HZ3' ' A' ' 38' ' ' TRP . . . -58.9 -33.25 70.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.453 -0.794 . . . . 3.54 110.042 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.573 ' HB2' HD12 ' A' ' 10' ' ' LEU . 44.3 t -73.16 -39.37 65.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.606 -0.725 . . . . 3.27 109.855 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.455 ' HE ' ' CD ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -50.02 -56.18 11.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.666 0.746 . . . . 6.1 109.803 177.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.605 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -71.69 -25.38 62.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.337 -0.847 . . . . 4.77 110.539 178.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -68.34 -43.24 77.91 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 116.396 -0.365 . . . . 4.34 110.976 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 20' ' ' CYS . 88.5 t -60.1 -43.09 92.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.965 0.412 . . . . 4.58 109.978 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.413 ' HD1' HG12 ' A' ' 2' ' ' ILE . 80.1 t80 -65.84 -39.1 90.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.039 -0.528 . . . . 7.48 110.864 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -71.62 -43.64 65.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 6.84 111.824 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -61.88 -27.64 68.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.107 0.48 . . . . 5.71 110.908 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.78 38.6 6.89 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 5.75 112.357 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 58.94 75.42 0.4 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.243 0.544 . . . . 5.06 110.077 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.487 ' HB3' HG21 ' A' ' 34' ' ' VAL . 26.3 mmt -112.88 -0.6 14.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.167 -0.47 . . . . 6.28 110.803 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.87 159.27 23.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.774 -0.727 . . . . 4.17 112.184 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.34 88.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 3.73 111.299 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 4.0 mp0 -58.35 -39.35 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.9 -0.591 . . . . 5.46 111.024 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' A' ' 30' ' ' MET . 75.1 t -71.54 -41.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 4.88 111.202 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.1 63.32 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 3.68 110.74 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.477 ' HD1' HD22 ' A' ' 10' ' ' LEU . 70.6 t80 -56.2 -43.09 78.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.99 -0.744 . . . . 4.71 108.99 170.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.524 ' HA ' HG13 ' A' ' 40' ' ' ILE . 26.2 t-20 -66.3 -37.84 86.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.857 . . . . 5.69 110.617 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.467 ' HE3' HD12 ' A' ' 39' ' ' ILE . 51.3 t90 -61.22 -35.52 77.44 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.433 0.635 . . . . 5.87 109.802 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.741 HG12 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -76.58 -43.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 3.69 111.696 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 37' ' ' ASN . 2.8 pp -70.33 -23.3 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.385 -0.526 . . . . 5.04 111.446 -174.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.29 -31.63 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 5.37 110.401 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -96.06 10.84 36.22 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.16 0.43 . . . . 5.35 112.16 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.3 ptt? . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 120.894 0.378 . . . . 5.73 111.051 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.7 0.286 . . . . 7.14 110.478 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.628 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 89.1 Cg_exo -49.85 167.05 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.732 2.954 . . . . 5.41 112.928 171.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.669 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 34.2 Cg_endo -61.47 112.45 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.481 2.121 . . . . 7.14 111.353 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.773 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.3 pt-20 -57.21 -27.59 62.13 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.882 -0.599 . . . . 10.13 110.63 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.8 tt0 -59.14 -51.99 67.64 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.21 0.528 . . . . 11.78 109.741 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 84' ' ' ILE . 80.4 mt -75.77 -42.37 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.671 -0.695 . . . . 8.42 112.024 -175.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.773 HG22 ' HA ' ' A' ' 79' ' ' GLU . 12.0 m -56.01 -38.45 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.594 -0.891 . . . . 7.57 108.594 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.31 -50.09 75.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.561 -1.2 . . . . 10.39 110.649 175.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 81' ' ' ILE . 23.2 mt -59.24 -42.22 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.965 -0.562 . . . . 10.78 110.613 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.738 HD12 ' HB1' ' A' ' 95' ' ' ALA . 84.9 mt -65.5 -46.01 91.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.833 -0.622 . . . . 8.01 111.467 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -71.31 -20.48 62.19 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.073 -0.651 . . . . 10.38 110.837 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -76.79 -21.13 55.58 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.412 . . . . 12.35 110.416 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 mmt -71.5 -22.45 61.79 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.464 0.65 . . . . 10.33 109.813 173.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.77 -3.3 8.04 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.196 -0.911 . . . . 9.53 111.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.599 ' HB2' HG22 ' A' ' 85' ' ' ILE . 31.9 m-85 -87.06 -179.07 6.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.792 0.33 . . . . 8.89 110.478 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 26.5 tt0 -90.58 141.54 28.67 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.589 -0.523 . . . . 10.16 109.589 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 11.7 ttm180 -56.48 -52.65 63.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.948 0.404 . . . . 11.98 110.354 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.78 -34.37 74.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.61 . . . . 9.02 110.938 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.2 tt0 -66.29 -39.2 89.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.57 -0.741 . . . . 6.68 109.359 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.738 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.32 -41.65 98.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.27 -0.877 . . . . 5.22 110.219 173.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.628 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.52 -52.09 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.872 -0.604 . . . . 6.39 110.419 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.573 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 59.6 tt0 -54.13 -47.94 71.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 8.36 110.742 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.89 -53.21 60.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.193 -0.912 . . . . 5.41 110.593 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 109' ' ' ALA . 73.6 mt -61.48 -30.73 70.79 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.593 -0.276 . . . . 5.77 111.36 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.573 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -56.49 -48.18 77.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 7.71 109.802 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.31 68.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.929 -1.032 . . . . 8.88 111.624 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 98' ' ' ALA . 23.6 p -81.59 -7.41 59.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.354 0.502 . . . . 8.79 112.354 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 65.18 63.27 0.67 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.601 0.715 . . . . 10.09 110.133 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.576 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.4 p-10 49.66 28.93 2.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.003 -1.453 . . . . 7.8 112.533 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -89.03 110.49 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.096 -0.705 . . . . 10.49 109.096 173.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.748 HD12 HG12 ' A' ' 81' ' ' ILE . 8.4 tt -56.31 -61.2 2.57 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.071 -0.968 . . . . 9.54 112.132 -175.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.431 ' N ' HD23 ' A' ' 106' ' ' LEU . 16.7 mm-40 -56.04 -46.89 78.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.378 -0.828 . . . . 11.82 111.115 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.639 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.3 ttm180 -66.36 -28.62 68.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.573 -0.285 . . . . 12.41 110.748 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.67 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.74 -50.66 68.2 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.332 -0.618 . . . . 6.3 109.332 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.54 HD23 HG23 ' A' ' 85' ' ' ILE . 18.3 mt -59.91 -39.0 83.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.183 -0.917 . . . . 7.78 109.635 175.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.81 -51.1 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 9.04 109.826 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -64.11 -42.67 96.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.507 -1.224 . . . . 8.69 110.862 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.665 HD13 ' HG2' ' A' ' 94' ' ' GLN . 47.6 mt -70.71 -40.66 77.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.361 -0.836 . . . . 5.25 111.584 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.6 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 6.92 111.802 -174.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.132 0.491 . . . . 5.69 109.876 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.92 82.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 4.6 110.364 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 8' ' ' MET . 43.8 mt-10 -72.63 -10.82 60.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.739 -0.664 . . . . 5.13 111.99 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.628 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 25.1 p -65.33 -32.6 74.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.732 -0.84 . . . . 4.17 108.732 175.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.689 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 43.6 m -59.87 -53.4 58.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.194 -0.912 . . . . 3.42 111.472 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -63.21 -37.84 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.734 -0.387 . . . . 3.24 110.435 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.486 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 64.3 mtt -62.69 -28.25 69.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 5.17 111.396 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 5' ' ' SER . 27.1 mt-30 -65.33 -46.74 79.06 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.91 -0.316 . . . . 5.38 110.478 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.695 HD11 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.21 -40.45 86.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.783 0.801 . . . . 3.9 109.375 176.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.47 -47.41 84.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.141 -1.391 . . . . 4.46 112.548 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.68 -27.87 69.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.267 0.469 . . . . 6.27 112.267 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 ptm -99.35 2.0 44.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.625 0.25 . . . . 5.2 111.268 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.96 -116.16 0.35 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.406 -0.902 . . . . 4.75 112.851 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.1 m-85 -101.65 154.32 37.35 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 5.09 110.719 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -71.47 85.65 0.88 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.785 2.323 . . . . 4.25 111.468 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 39' ' ' ILE . 2.6 mm? -78.46 68.67 4.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 3.29 112.089 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 12.9 tt0 -55.53 -25.38 37.16 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.912 -0.492 . . . . 5.48 110.918 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.7 -31.95 66.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 3.54 109.801 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.695 ' SG ' HD11 ' A' ' 10' ' ' LEU . 28.0 t -73.68 -39.88 64.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.481 -0.781 . . . . 3.27 109.769 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 18' ' ' GLU . 10.0 ttp180 -53.27 -53.37 51.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.085 0.469 . . . . 6.1 110.709 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 18' ' ' GLU . 8.7 ptpt -72.17 -22.83 61.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.226 -0.443 . . . . 4.77 110.721 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . . . -69.39 -41.28 76.66 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.237 -0.438 . . . . 4.34 110.75 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 20' ' ' CYS . 73.4 t -58.5 -42.17 83.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 4.58 110.159 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.11 -38.6 82.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.663 -0.415 . . . . 7.48 110.366 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.59 -37.64 82.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.388 -0.369 . . . . 6.84 111.427 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.5 p -71.55 -17.7 62.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 5.71 111.406 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.95 23.48 20.24 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.876 -0.678 . . . . 5.75 111.481 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.19 58.88 1.36 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.6 0.714 . . . . 5.06 110.263 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.429 ' HB3' HG21 ' A' ' 34' ' ' VAL . 87.4 mmm -88.23 -11.78 45.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.491 -0.777 . . . . 6.28 111.757 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.44 -173.67 17.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 4.17 113.298 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.689 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -58.84 -55.57 33.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.659 0.615 . . . . 3.73 112.659 -174.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.75 -44.78 92.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 5.46 112.149 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 30' ' ' MET . 86.9 t -65.25 -42.42 93.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.741 0.305 . . . . 4.88 111.096 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.16 50.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.596 -0.441 . . . . 3.68 111.172 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.519 ' O ' HG22 ' A' ' 39' ' ' ILE . 86.3 t80 -61.43 -40.63 95.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.978 -0.749 . . . . 4.71 108.978 171.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 40' ' ' ILE . 92.0 m-20 -60.69 -45.37 94.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.784 -0.644 . . . . 5.69 110.218 174.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 23' ' ' ALA . 42.9 t90 -60.84 -41.33 95.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.067 0.46 . . . . 5.87 110.114 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 36' ' ' PHE . 3.9 tp -73.07 -36.23 50.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.125 -0.489 . . . . 3.69 111.487 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.0 -21.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.108 0.48 . . . . 5.04 110.804 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 37' ' ' ASN . 95.3 t -74.88 -42.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.116 -0.493 . . . . 5.37 110.508 171.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -100.54 16.5 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.992 0.367 . . . . 5.35 111.992 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.0 ppp? . . . . . 0 C--N 1.327 -0.388 0 CA-C-O 121.154 0.502 . . . . 5.73 111.059 178.019 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 7.1 tt0 . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 109.522 -0.548 . . . . 7.14 109.522 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.586 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 86.8 Cg_exo -53.24 160.76 4.31 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.626 2.884 . . . . 5.41 113.579 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.722 ' HD2' HD13 ' A' ' 99' ' ' LEU . 46.5 Cg_endo -66.39 112.96 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.943 2.429 . . . . 7.14 111.157 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 82' ' ' VAL . 5.5 pt-20 -56.15 -27.35 53.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.67 -0.696 . . . . 10.13 111.079 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.7 tt0 -58.56 -53.07 62.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.195 0.521 . . . . 11.78 110.093 172.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.782 ' HA ' HD12 ' A' ' 84' ' ' ILE . 74.6 mt -74.66 -40.98 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.737 -0.665 . . . . 8.42 111.799 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.752 ' O ' HG22 ' A' ' 86' ' ' THR . 16.1 m -56.47 -37.85 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.719 -0.845 . . . . 7.57 108.719 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.3 -48.63 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.613 -1.176 . . . . 10.39 110.557 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.782 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.2 mt -60.63 -43.36 94.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 10.78 110.8 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.755 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.7 mt -63.53 -45.31 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.951 -0.568 . . . . 8.01 111.57 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 82' ' ' VAL . 2.1 t -72.5 -20.54 61.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.313 -0.555 . . . . 10.38 110.945 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.1 m -79.92 -16.95 54.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.798 0.333 . . . . 12.35 110.517 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.4 mmm -74.65 -25.29 59.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.302 0.572 . . . . 10.33 109.932 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.63 -2.27 4.89 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.977 -1.01 . . . . 9.53 111.762 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.596 ' HB2' HG22 ' A' ' 85' ' ' ILE . 30.7 m-85 -94.39 -173.8 3.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.666 0.27 . . . . 8.89 110.55 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 7.3 tt0 -101.03 145.54 28.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.66 -0.496 . . . . 10.16 109.66 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.447 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.5 ttm180 -58.11 -52.21 66.48 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.045 0.45 . . . . 11.98 110.61 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 48.3 t30 -58.41 -37.36 75.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.617 -0.719 . . . . 9.02 110.766 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 5.9 tt0 -65.71 -38.3 88.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.629 -0.714 . . . . 6.68 109.748 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.755 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.09 -37.96 89.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.215 -0.902 . . . . 5.22 110.755 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.597 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -58.61 -53.92 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 116.446 -0.343 . . . . 6.39 110.855 177.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 7.8 tt0 -57.4 -44.36 84.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.232 0.539 . . . . 8.36 110.866 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.32 -52.52 65.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.041 -0.981 . . . . 5.41 110.355 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.722 HD13 ' HD2' ' A' ' 78' ' ' PRO . 79.6 mt -61.69 -34.16 75.27 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.548 -0.296 . . . . 5.77 111.659 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 96' ' ' ILE . 59.1 mtp180 -58.47 -41.24 84.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.299 0.571 . . . . 7.71 110.643 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.4 -38.11 60.1 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.195 -0.911 . . . . 8.88 111.385 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 32.9 p -87.56 1.31 53.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.707 0.632 . . . . 8.79 112.707 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.19 65.21 1.23 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.67 -0.695 . . . . 10.09 110.575 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.5 p-10 50.01 28.33 2.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.13 -1.395 . . . . 7.8 112.562 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.5 t-20 -90.12 109.69 20.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.257 -0.646 . . . . 10.49 109.257 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.737 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.2 tt -52.44 -59.96 3.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.945 -1.025 . . . . 9.54 111.771 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -54.24 -52.44 61.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.706 -1.134 . . . . 11.82 111.794 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 17.7 ttm180 -66.47 -27.48 67.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.511 . . . . 12.41 110.96 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.63 -51.37 67.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.398 -0.593 . . . . 6.3 109.398 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.482 HD23 HG23 ' A' ' 85' ' ' ILE . 18.2 mt -59.82 -38.6 82.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.267 -0.879 . . . . 7.78 109.763 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 8.3 t70 -54.76 -51.15 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.869 -1.06 . . . . 9.04 110.155 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.36 -48.1 79.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.326 -1.306 . . . . 8.69 110.395 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 95' ' ' ALA . 41.1 mt -62.09 -41.16 90.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.231 -0.895 . . . . 5.25 110.974 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.6 t80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 6.92 111.106 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.462 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 86.3 mt . . . . . 0 N--CA 1.446 -0.632 0 N-CA-C 108.823 -0.806 . . . . 5.69 108.823 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.15 81.15 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.138 0.495 . . . . 4.6 111.34 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.581 ' HA ' HG12 ' A' ' 7' ' ' VAL . 35.8 mt-10 -70.83 -7.94 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.012 -0.54 . . . . 5.13 110.591 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 13.2 m -57.43 -34.83 69.34 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.27 -0.641 . . . . 4.17 109.27 170.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 3.3 m -66.13 -51.79 54.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.442 -0.799 . . . . 3.42 111.202 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -64.14 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 3.24 110.902 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 77.3 mtp -63.04 -32.66 74.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 5.17 111.052 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.625 ' O ' ' HG2' ' A' ' 13' ' ' MET . 14.9 mm100 -59.37 -48.82 80.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.061 -0.256 . . . . 5.38 110.454 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 39' ' ' ILE . 18.5 mt -64.63 -45.29 87.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.506 0.67 . . . . 3.9 110.184 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.79 -50.31 71.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.708 -1.133 . . . . 4.46 112.489 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.451 . . . . 6.27 111.565 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.625 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 24.2 ptt? -104.82 22.48 15.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.111 -0.495 . . . . 5.2 111.629 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.45 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.126 -1.035 . . . . 4.75 112.851 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 29.2 p90 -158.83 164.93 19.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.676 -0.861 . . . . 5.09 108.676 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 88.7 Cg_endo -71.52 83.94 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.562 2.175 . . . . 4.25 113.562 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.637 ' HG ' HG12 ' A' ' 39' ' ' ILE . 3.1 mm? -75.15 64.87 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.074 -0.25 . . . . 3.29 111.641 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.75 -19.38 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 121.387 -0.821 . . . . 5.48 109.681 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.594 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . . . -57.82 -32.7 67.84 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.577 -0.738 . . . . 3.54 110.029 170.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 35.1 t -72.09 -42.99 65.52 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.768 -1.105 . . . . 3.27 109.646 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -54.15 -46.67 72.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.161 0.505 . . . . 6.1 110.178 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 42.6 mtmt -70.52 -26.01 63.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 4.77 110.744 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.565 ' HB1' ' HD1' ' A' ' 38' ' ' TRP . . . -74.16 -44.89 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 4.34 110.928 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 20' ' ' CYS . 92.1 t -53.6 -47.68 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 4.58 109.954 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -56.08 -45.77 79.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.486 -0.779 . . . . 7.48 110.783 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -66.03 -40.3 90.92 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.405 -0.361 . . . . 6.84 111.593 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 30' ' ' MET . 74.8 p -67.47 -11.75 58.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.353 . . . . 5.71 111.51 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.62 26.18 47.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.921 -0.657 . . . . 5.75 111.722 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 76.7 m-20 60.84 60.57 1.84 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.181 0.515 . . . . 5.06 110.342 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 27' ' ' THR . 17.1 mmt -86.28 -34.25 20.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 6.28 112.152 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 170.4 17.74 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.929 -1.129 . . . . 4.17 112.795 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 6' ' ' SER . . . -62.62 -58.37 7.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.207 0.447 . . . . 3.73 112.207 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.58 -31.13 67.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.367 -0.379 . . . . 5.46 111.065 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.72 -45.28 92.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.068 -0.515 . . . . 4.88 110.662 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -27.02 50.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.92 -0.312 . . . . 3.68 111.258 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 66.6 t80 -56.6 -43.92 80.61 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.875 -0.787 . . . . 4.71 108.875 169.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.568 ' O ' HG13 ' A' ' 40' ' ' ILE . 41.6 t-20 -63.06 -43.74 97.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.066 -0.97 . . . . 5.69 110.28 177.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.565 ' HD1' ' HB1' ' A' ' 23' ' ' ALA . 13.1 t-105 -65.49 -30.24 70.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.809 -0.357 . . . . 5.87 111.029 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.637 HG12 ' HG ' ' A' ' 17' ' ' LEU . 3.1 tp -76.21 -37.65 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.997 -0.281 . . . . 3.69 110.912 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.49 -21.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.444 0.64 . . . . 5.04 110.378 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 37' ' ' ASN . 72.4 t -74.22 -51.01 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.594 -0.73 . . . . 5.37 109.997 169.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -85.42 14.38 5.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.193 0.442 . . . . 5.35 112.193 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 23.2 ptt? . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.358 -0.608 . . . . 5.73 109.358 169.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 C--O 1.235 0.335 0 CA-C-O 120.511 0.196 . . . . 7.14 110.719 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.573 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 88.4 Cg_exo -51.03 165.04 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.524 2.816 . . . . 5.41 112.823 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.669 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 41.9 Cg_endo -63.53 112.54 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.474 2.116 . . . . 7.14 110.999 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.753 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.5 pt-20 -55.84 -30.72 61.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.899 -0.592 . . . . 10.13 110.295 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.73 -51.48 67.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.562 -0.744 . . . . 11.78 110.139 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 75.1 mt -76.24 -42.7 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.924 -0.58 . . . . 8.42 111.98 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.779 ' O ' HG22 ' A' ' 86' ' ' THR . 12.6 m -55.76 -37.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.507 -0.923 . . . . 7.57 108.507 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.01 86.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.681 -1.145 . . . . 10.39 110.927 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.6 mt -60.58 -41.98 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.225 0.536 . . . . 10.78 110.501 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.75 HD12 ' HB1' ' A' ' 95' ' ' ALA . 89.6 mt -65.5 -47.4 86.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.703 -0.681 . . . . 8.01 111.527 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -70.19 -21.99 62.98 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.172 -0.611 . . . . 10.38 110.536 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 t -75.44 -19.95 59.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.976 0.417 . . . . 12.35 110.046 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.2 mmt -75.78 -24.55 56.0 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.323 0.582 . . . . 10.33 110.396 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.67 9.03 4.1 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.392 -0.822 . . . . 9.53 111.8 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.606 ' HB2' HG22 ' A' ' 85' ' ' ILE . 28.6 m-85 -101.05 -175.36 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.859 -0.423 . . . . 8.89 109.859 177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.587 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 51.5 tt0 -100.23 145.31 28.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.659 -0.497 . . . . 10.16 109.659 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.2 ttm180 -56.43 -52.29 65.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 11.98 110.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.469 ' HB3' ' NE2' ' A' ' 91' ' ' GLN . 28.3 t-20 -59.46 -35.96 75.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.792 -0.64 . . . . 9.02 111.085 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.618 ' HG2' HD13 ' A' ' 113' ' ' ILE . 7.7 tt0 -66.14 -38.65 88.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.699 . . . . 6.68 109.664 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.75 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.22 -39.51 94.13 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.231 -0.895 . . . . 5.22 110.412 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.573 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -59.26 -52.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.191 -0.459 . . . . 6.39 110.729 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.452 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 34.1 tt0 -56.61 -43.97 80.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.881 -0.6 . . . . 8.36 110.961 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.35 -53.89 52.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.409 -0.814 . . . . 5.41 110.846 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.728 HD23 ' HB2' ' A' ' 109' ' ' ALA . 84.3 mt -60.02 -34.2 73.04 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 111.474 0.176 . . . . 5.77 111.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.2 mtt180 -55.39 -46.47 76.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.528 0.68 . . . . 7.71 110.304 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.89 -42.48 69.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.125 -0.943 . . . . 8.88 111.422 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.687 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.3 p -82.93 -1.35 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.564 0.579 . . . . 8.79 112.564 -174.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m120 63.81 60.03 1.09 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.049 -0.523 . . . . 10.09 110.362 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 3.3 p-10 48.63 34.42 5.03 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.351 1.06 . . . . 7.8 111.933 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.6 t-20 -93.24 111.29 22.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.79 -0.818 . . . . 10.49 108.79 174.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.7 HD12 HG12 ' A' ' 81' ' ' ILE . 7.8 tt -56.24 -59.35 5.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.464 -0.789 . . . . 9.54 111.516 -175.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.413 ' N ' HD23 ' A' ' 106' ' ' LEU . 4.3 mt-10 -55.98 -50.06 71.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.711 -1.131 . . . . 11.82 111.344 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.687 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -66.03 -29.09 69.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.547 -0.751 . . . . 12.41 111.281 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.728 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.24 -50.13 72.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.308 -0.627 . . . . 6.3 109.308 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 85' ' ' ILE . 18.5 mt -61.31 -36.74 80.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.163 -0.926 . . . . 7.78 109.904 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 8.4 t70 -57.14 -52.88 63.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.263 -0.88 . . . . 9.04 109.627 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 63.8 t90 -60.59 -45.24 94.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.126 -1.397 . . . . 8.69 110.498 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.625 HD11 ' HA ' ' A' ' 95' ' ' ALA . 53.0 mt -67.71 -34.25 66.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.058 -0.974 . . . . 5.25 110.901 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.9 t80 . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 121.382 0.61 . . . . 6.92 110.165 177.548 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.45 -0.574 . . . . 5.69 109.45 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -75.0 76.94 2.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.435 0.636 . . . . 4.6 109.642 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.519 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.5 mt-10 -72.34 -10.48 59.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.809 -0.632 . . . . 5.13 112.022 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 54.3 p -62.05 -38.01 87.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.371 0.605 . . . . 4.17 109.489 176.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.684 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 50.3 m -60.67 -52.27 65.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.097 -0.956 . . . . 3.42 111.594 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.57 HG23 ' HB3' ' A' ' 20' ' ' CYS . 7.4 p -64.34 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.561 -0.456 . . . . 3.24 110.907 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 67.1 mtt -59.7 -31.88 70.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.519 -0.31 . . . . 5.17 111.22 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.591 ' O ' ' HG2' ' A' ' 13' ' ' MET . 15.3 mm100 -60.9 -56.88 15.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.593 -0.276 . . . . 5.38 110.48 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.81 HD11 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.9 -28.73 67.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.565 -0.454 . . . . 3.9 111.387 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.32 86.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.429 . . . . 4.46 110.996 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -79.45 -42.18 25.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 6.27 111.439 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.591 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 26.2 ptt? -92.14 32.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.782 0.325 . . . . 5.2 111.251 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.09 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.403 -0.903 . . . . 4.75 112.347 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.626 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 12.4 p90 -166.53 162.15 11.74 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.092 -0.707 . . . . 5.09 109.092 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 22.8 Cg_endo -55.1 91.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.687 2.924 . . . . 4.25 112.99 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.647 HD12 ' HB2' ' A' ' 10' ' ' LEU . 70.4 mt -96.81 57.32 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.891 -0.595 . . . . 3.29 111.745 -175.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -55.67 -23.89 30.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.161 0.505 . . . . 5.48 110.718 174.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.455 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . . . -57.75 -36.95 72.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.925 -0.58 . . . . 3.54 110.001 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.81 ' SG ' HD11 ' A' ' 10' ' ' LEU . 20.2 t -73.81 -31.75 63.4 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.421 -0.809 . . . . 3.27 110.449 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.38 -48.72 71.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.48 -0.933 . . . . 6.1 108.48 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 18.8 mttm -66.09 -42.32 89.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.026 . . . . 4.77 109.976 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -60.37 -40.81 92.16 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.643 -0.708 . . . . 4.34 111.918 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 20' ' ' CYS . 39.9 t -59.08 -45.76 92.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.153 -0.314 . . . . 4.58 110.153 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.46 -41.83 99.05 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.454 -0.498 . . . . 7.48 110.223 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.15 -41.59 85.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.82 -0.627 . . . . 6.84 112.085 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -65.46 -23.36 66.9 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.057 0.456 . . . . 5.71 110.835 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.37 29.65 8.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.6 -0.727 . . . . 5.75 111.73 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 59.39 49.44 8.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.217 0.532 . . . . 5.06 110.297 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.4 mmm -82.42 3.78 26.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 6.28 112.192 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.32 171.45 23.08 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.567 -0.825 . . . . 4.17 112.444 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.684 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -67.68 -45.22 75.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.665 -0.267 . . . . 3.73 111.679 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.97 -31.36 70.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.481 -0.327 . . . . 5.46 111.663 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.07 -44.65 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 4.88 110.56 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.0 60.72 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.613 -0.435 . . . . 3.68 110.49 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.454 ' O ' HG22 ' A' ' 39' ' ' ILE . 83.9 t80 -56.35 -42.55 77.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.958 -0.756 . . . . 4.71 108.958 171.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -61.75 -45.96 91.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 5.69 110.612 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -59.44 -43.03 93.22 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.532 0.682 . . . . 5.87 109.842 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 10' ' ' LEU . 3.0 tp -74.77 -36.3 39.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.486 -0.779 . . . . 3.69 111.861 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 43' ' ' MET . 2.8 pp -71.47 -21.34 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 5.04 111.54 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.59 -36.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.54 . . . . 5.37 110.19 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -99.52 7.6 45.21 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.416 0.524 . . . . 5.35 112.416 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 4.8 ppp? . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 121.211 0.529 . . . . 5.73 111.001 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 N--CA 1.449 -0.521 0 N-CA-C 110.141 -0.318 . . . . 7.14 110.141 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.621 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 76.7 Cg_exo -55.09 163.93 3.99 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.249 2.633 . . . . 5.41 112.044 171.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.685 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 36.6 Cg_endo -63.51 113.18 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.598 2.199 . . . . 7.14 111.464 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -58.16 -23.28 54.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.952 -0.567 . . . . 10.13 111.16 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 8.7 tt0 -61.61 -52.57 63.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.128 -0.487 . . . . 11.78 109.879 171.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.5 mt -75.18 -41.55 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.617 -0.72 . . . . 8.42 111.944 -175.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.79 HG22 ' HA ' ' A' ' 79' ' ' GLU . 13.7 m -56.56 -38.02 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.604 -0.887 . . . . 7.57 108.604 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.49 -49.88 75.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.903 -1.044 . . . . 10.39 110.576 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.0 mt -59.69 -43.07 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 10.78 110.808 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.743 HD12 ' HB1' ' A' ' 95' ' ' ALA . 90.5 mt -63.96 -47.76 89.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.92 -0.582 . . . . 8.01 111.84 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -70.08 -23.69 63.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.013 -0.675 . . . . 10.38 110.51 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.5 m -69.75 -31.2 69.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.701 0.286 . . . . 12.35 110.24 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 93.4 mmm -62.78 -29.07 70.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.206 0.526 . . . . 10.33 110.679 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.2 4.2 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.364 -0.835 . . . . 9.53 112.005 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.57 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.7 m-85 -91.5 -173.85 3.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.207 -0.294 . . . . 8.89 110.207 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.594 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 8.4 tt0 -101.49 147.16 26.7 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.699 -0.482 . . . . 10.16 109.699 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' HD12 ' A' ' 96' ' ' ILE . 20.7 ttm180 -57.74 -52.7 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 11.98 110.763 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -58.64 -36.74 74.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.776 -0.647 . . . . 9.02 110.786 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.653 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.8 tt0 -65.82 -38.94 90.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.546 -0.752 . . . . 6.68 109.63 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.743 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.88 -40.77 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.272 -0.876 . . . . 5.22 110.519 174.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.621 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -58.5 -52.2 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 116.002 -0.545 . . . . 6.39 110.656 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.646 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 27.3 tt0 -56.55 -44.78 81.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.046 -0.524 . . . . 8.36 111.08 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.95 -53.39 58.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.457 -0.792 . . . . 5.41 110.659 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 109' ' ' ALA . 76.1 mt -61.65 -32.28 72.44 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.609 -0.269 . . . . 5.77 111.392 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.646 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 88.7 mtt180 -54.86 -46.7 74.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.601 . . . . 7.71 109.752 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.69 62.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.928 -1.033 . . . . 8.88 111.903 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 27.8 p -85.2 1.04 49.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.627 0.603 . . . . 8.79 112.627 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.73 45.68 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.972 -0.558 . . . . 10.09 110.242 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 0.7 OUTLIER 69.93 16.56 7.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 7.8 111.072 176.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.4 t-20 -80.43 111.07 16.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.482 -0.562 . . . . 10.49 109.482 176.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.4 tt -55.02 -60.28 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.287 -0.87 . . . . 9.54 111.536 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 -52.74 52.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.681 -1.145 . . . . 11.82 110.913 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.692 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 12.2 ttm180 -65.14 -28.48 69.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.429 -0.805 . . . . 12.41 111.354 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.04 -50.56 70.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.394 -0.595 . . . . 6.3 109.394 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 85' ' ' ILE . 15.8 mt -59.75 -39.07 83.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 7.78 109.717 175.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.57 -50.06 73.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.007 -0.997 . . . . 9.04 109.956 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.57 -46.83 86.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.621 -1.172 . . . . 8.69 110.408 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.653 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.2 mt -63.61 -35.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.201 -0.908 . . . . 5.25 110.926 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 80.9 t80 . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 6.92 110.108 177.471 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mt . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 110.35 -0.241 . . . . 5.69 110.35 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.96 94.43 1.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 4.6 110.208 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.541 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.0 mt-10 -72.49 -2.33 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.95 -0.568 . . . . 5.13 112.136 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 4.4 m -59.99 -41.98 93.25 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.582 -0.525 . . . . 4.17 109.582 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 20.8 p -61.98 -52.11 65.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 3.42 111.832 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.6 p -62.02 -39.74 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 120.852 -0.339 . . . . 3.24 110.996 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.54 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 49.4 mtm -65.18 -26.75 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.449 -0.342 . . . . 5.17 111.445 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 5' ' ' SER . 76.6 mt-30 -69.09 -37.68 78.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.7 -0.4 . . . . 5.38 110.266 175.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.759 ' HB3' HD12 ' A' ' 17' ' ' LEU . 13.6 mt -68.89 -40.5 79.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.079 0.942 . . . . 3.9 109.133 172.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 8' ' ' MET . . . -62.8 -41.73 99.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.507 -1.224 . . . . 4.46 111.675 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 8' ' ' MET . 71.0 mm-40 -62.31 -29.93 70.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.606 0.595 . . . . 6.27 112.606 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.636 ' HG2' ' O ' ' A' ' 10' ' ' LEU . 22.0 ptp -81.84 -4.46 56.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.441 -0.504 . . . . 5.2 110.156 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.17 48.73 1.41 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.711 -0.677 . . . . 4.75 113.462 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 73.0 m-85 -143.12 125.37 8.7 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.859 0.361 . . . . 5.09 110.583 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.45 66.71 5.49 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.468 2.779 . . . . 4.25 111.762 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 10' ' ' LEU . 80.9 mt -94.2 57.66 2.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.649 0.737 . . . . 3.29 111.875 -172.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 13.9 tt0 -56.57 -22.32 32.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.179 0.514 . . . . 5.48 109.896 168.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -29.35 65.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.649 -0.705 . . . . 3.54 109.659 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.579 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.7 t -72.19 -44.61 62.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.758 . . . . 3.27 108.955 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.451 ' NH2' ' HG3' ' A' ' 18' ' ' GLU . 12.2 ttp180 -51.84 -42.33 62.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.878 -0.601 . . . . 6.1 110.232 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 42.8 mttt -71.47 -39.42 70.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.613 -0.721 . . . . 4.77 110.435 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.57 99.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.601 -0.727 . . . . 4.34 111.268 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 20' ' ' CYS . 88.6 t -59.15 -46.21 92.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.166 -0.47 . . . . 4.58 110.432 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -54.47 -48.2 72.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.256 -0.429 . . . . 7.48 110.921 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.96 -39.62 87.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.194 -0.457 . . . . 6.84 111.611 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 p -68.32 -15.08 63.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.081 0.467 . . . . 5.71 110.979 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.71 29.27 43.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.352 -0.699 . . . . 5.75 111.352 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.3 t30 60.67 73.91 0.47 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.349 0.595 . . . . 5.06 110.626 -175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.543 ' HB3' HG21 ' A' ' 34' ' ' VAL . 19.2 mmt -102.31 18.8 20.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.771 -0.65 . . . . 6.28 110.863 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.24 -178.65 50.71 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.574 -0.739 . . . . 4.17 113.059 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.4 -37.38 77.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.785 0.291 . . . . 3.73 111.785 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -54.62 -56.55 17.88 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.618 0.723 . . . . 5.46 110.395 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 30' ' ' MET . 92.9 t -65.42 -40.38 88.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.05 -0.977 . . . . 4.88 111.803 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.44 -35.1 58.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.313 0.486 . . . . 3.68 112.313 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.5 t80 -58.75 -41.91 87.61 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.879 -0.785 . . . . 4.71 108.879 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.528 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.2 m-80 -69.28 -38.43 78.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.671 -0.695 . . . . 5.69 110.862 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.5 -37.23 86.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.803 -0.443 . . . . 5.87 109.803 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.556 HG21 HD13 ' A' ' 10' ' ' LEU . 4.7 tp -72.57 -39.01 60.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.058 -0.519 . . . . 3.69 111.176 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -70.15 -21.67 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.371 0.605 . . . . 5.04 110.786 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 37' ' ' ASN . 70.6 t -74.45 -44.85 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.892 -0.595 . . . . 5.37 110.644 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -99.42 12.22 36.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.95 0.405 . . . . 5.35 111.223 -173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.453 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 27.1 ptt? . . . . . 0 N--CA 1.468 0.472 0 CA-C-N 116.318 -0.401 . . . . 5.73 111.785 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 120.606 0.241 . . . . 7.14 110.523 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.612 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 73.0 Cg_exo -54.15 167.34 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.497 2.798 . . . . 5.41 112.592 172.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.672 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.5 Cg_endo -63.33 112.11 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.35 2.033 . . . . 7.14 111.185 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.697 ' HA ' HG22 ' A' ' 82' ' ' VAL . 9.6 pt-20 -57.0 -26.69 60.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 10.13 110.855 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 6.2 tt0 -58.99 -51.25 70.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.945 -0.571 . . . . 11.78 110.46 173.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.798 ' HA ' HD12 ' A' ' 84' ' ' ILE . 70.1 mt -76.19 -41.43 37.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.921 -0.582 . . . . 8.42 111.642 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 86' ' ' THR . 11.3 m -55.55 -37.88 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.519 -0.919 . . . . 7.57 108.519 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.27 -48.54 79.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.637 -1.165 . . . . 10.39 110.871 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.3 mt -59.53 -42.16 87.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 10.78 110.624 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.729 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.1 mt -65.0 -44.9 95.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 8.01 111.434 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -73.48 -21.18 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.189 -0.604 . . . . 10.38 110.786 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.9 m -72.72 -26.55 61.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.063 0.458 . . . . 12.35 110.124 171.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.1 mmt -68.57 -26.9 65.62 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.963 -0.562 . . . . 10.33 110.462 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 -6.05 5.08 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.407 -0.815 . . . . 9.53 111.63 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.626 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.8 m-85 -87.7 -172.29 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.068 -0.345 . . . . 8.89 110.068 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 33.9 tt0 -103.63 146.92 27.86 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.931 -0.396 . . . . 10.16 109.931 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 16.0 ttm180 -57.0 -53.13 61.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.111 0.482 . . . . 11.98 110.19 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -59.07 -39.41 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 9.02 111.046 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 4.0 tt0 -63.91 -37.02 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.392 0.615 . . . . 6.68 109.758 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.729 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.99 -38.43 90.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.179 -0.919 . . . . 5.22 110.711 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -59.93 -52.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.053 -0.522 . . . . 6.39 110.636 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 60.5 tt0 -54.93 -46.03 74.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.769 -0.65 . . . . 8.36 110.855 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.89 -53.61 55.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.235 -0.893 . . . . 5.41 110.78 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.713 HD23 ' HB2' ' A' ' 109' ' ' ALA . 74.8 mt -61.38 -31.59 71.5 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.689 -0.232 . . . . 5.77 111.327 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.5 mtt180 -55.7 -50.29 70.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.393 0.616 . . . . 7.71 110.004 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.26 74.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.729 -1.123 . . . . 8.88 111.551 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 28.4 p -83.17 -5.7 59.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.694 0.627 . . . . 8.79 112.694 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 t30 64.78 65.72 0.61 Allowed 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.645 -0.707 . . . . 10.09 109.813 -175.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.551 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.4 p30 48.92 22.81 0.61 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.221 1.008 . . . . 7.8 112.428 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -81.68 109.45 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.726 -0.472 . . . . 10.49 109.726 173.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.0 tt -56.59 -59.84 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.176 0.922 . . . . 9.54 111.282 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.45 -48.3 71.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.9 -1.045 . . . . 11.82 111.268 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.693 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.1 ttm180 -69.5 -28.8 66.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 12.41 110.799 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.713 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.56 -51.24 68.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.219 -0.66 . . . . 6.3 109.219 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.625 HD23 HG23 ' A' ' 85' ' ' ILE . 21.4 mt -58.1 -40.12 80.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.845 -1.07 . . . . 7.78 109.605 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.33 -50.75 70.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.388 -0.824 . . . . 9.04 110.443 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -62.91 -44.44 96.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.491 -1.231 . . . . 8.69 110.375 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 95' ' ' ALA . 51.5 mt -65.71 -45.16 92.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.009 -0.996 . . . . 5.25 111.251 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.2 t80 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 6.92 110.976 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mt . . . . . 0 N--CA 1.444 -0.737 0 N-CA-C 108.141 -1.059 . . . . 5.69 108.141 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.7 88.11 0.35 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.377 0.608 . . . . 4.6 110.891 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.481 ' HA ' HG12 ' A' ' 7' ' ' VAL . 51.8 mt-10 -71.11 -8.18 51.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.282 -0.872 . . . . 5.13 110.59 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.635 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 18.8 m -57.7 -37.63 73.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.303 -0.628 . . . . 4.17 109.303 169.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 7.4 m -59.66 -51.85 68.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.794 -0.639 . . . . 3.42 110.937 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.568 HG11 ' HB2' ' A' ' 21' ' ' ARG . 4.4 p -67.45 -38.87 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 120.636 -0.426 . . . . 3.24 110.74 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.472 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 78.6 mtp -62.93 -27.01 69.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 5.17 111.324 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG3' ' O ' ' A' ' 5' ' ' SER . 29.3 mt-30 -62.65 -53.4 55.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.811 -0.44 . . . . 5.38 109.811 171.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.841 HD13 HG21 ' A' ' 39' ' ' ILE . 11.7 mt -58.51 -45.27 89.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.725 0.774 . . . . 3.9 109.653 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.8 -29.32 70.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.343 -1.299 . . . . 4.46 111.64 -175.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.14 -51.71 6.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.699 -0.682 . . . . 6.27 111.872 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.5 ptp -101.28 25.0 8.73 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 111.993 0.368 . . . . 5.2 111.993 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.94 -92.44 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.947 -1.12 . . . . 4.75 113.022 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 62.4 m-85 -136.95 151.09 71.54 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.892 -0.41 . . . . 5.09 109.892 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.56 74.44 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.802 2.335 . . . . 4.25 111.451 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.815 HD12 ' HB3' ' A' ' 10' ' ' LEU . 89.6 mt -89.45 62.6 6.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.772 -0.649 . . . . 3.29 112.175 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.551 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 7.6 tt0 -55.75 -24.54 35.86 Favored 'General case' 0 N--CA 1.458 -0.042 0 CA-C-O 120.939 0.399 . . . . 5.48 110.565 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.44 -31.17 65.65 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.124 -0.489 . . . . 3.54 110.255 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.6 t -73.5 -42.98 61.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.425 -0.807 . . . . 3.27 109.658 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HB2' HG11 ' A' ' 7' ' ' VAL . 24.5 ttt180 -52.02 -50.23 61.81 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.606 0.717 . . . . 6.1 110.082 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HE2' ' O ' ' A' ' 18' ' ' GLU . 25.8 mtmt -72.09 -23.5 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.085 -0.962 . . . . 4.77 110.623 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -73.6 -39.06 64.88 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.823 -0.626 . . . . 4.34 111.221 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' CYS . 97.7 t -58.97 -47.15 90.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.89 0.376 . . . . 4.58 110.11 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -58.64 -36.16 73.67 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.889 -0.596 . . . . 7.48 110.762 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.01 -45.78 39.52 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.506 -0.315 . . . . 6.84 111.674 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.4 p -62.21 -24.68 67.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.964 0.411 . . . . 5.71 111.162 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.14 29.41 20.13 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.803 -0.635 . . . . 5.75 112.039 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.7 t30 63.39 64.62 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.179 0.514 . . . . 5.06 110.497 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.611 ' HB3' HG21 ' A' ' 34' ' ' VAL . 87.2 mmm -91.77 -11.22 37.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.117 -0.492 . . . . 6.28 110.742 178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.23 162.05 11.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.791 -0.719 . . . . 4.17 112.387 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -55.77 -46.07 78.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.942 0.497 . . . . 3.73 111.54 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.22 -41.46 99.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 5.46 111.431 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.611 HG21 ' HB3' ' A' ' 30' ' ' MET . 98.8 t -62.58 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.475 -0.329 . . . . 4.88 111.256 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -28.89 54.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.629 -0.429 . . . . 3.68 111.24 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.605 ' O ' HG22 ' A' ' 39' ' ' ILE . 54.0 t80 -58.15 -43.24 87.25 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.043 -0.725 . . . . 4.71 109.043 170.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 40' ' ' ILE . 13.6 m120 -67.72 -40.65 84.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 5.69 110.952 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -59.86 -38.34 81.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.386 0.612 . . . . 5.87 109.932 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.841 HG21 HD13 ' A' ' 10' ' ' LEU . 4.3 tp -74.57 -37.57 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.862 -0.608 . . . . 3.69 111.699 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.8 pp -70.34 -23.35 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.406 -0.517 . . . . 5.04 110.899 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.9 t -79.43 -34.84 16.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 5.37 110.725 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -98.96 5.29 47.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.15 0.426 . . . . 5.35 112.15 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.587 0.232 . . . . 5.73 111.316 -177.934 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.956 -0.387 . . . . 7.14 109.956 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.605 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 58.7 Cg_exo -55.87 161.54 8.18 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.878 2.386 . . . . 5.41 112.264 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.695 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.0 Cg_endo -62.66 112.62 1.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 7.14 111.246 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.757 ' HA ' HG22 ' A' ' 82' ' ' VAL . 1.6 pm0 -57.11 -25.73 59.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.731 -0.668 . . . . 10.13 111.528 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 7.0 tt0 -60.15 -50.94 71.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.014 0.435 . . . . 11.78 109.839 172.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.796 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.2 mt -75.38 -42.17 43.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 8.42 111.737 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 86' ' ' THR . 11.2 m -56.12 -38.18 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.426 -0.953 . . . . 7.57 108.426 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.04 -48.96 79.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.802 -1.09 . . . . 10.39 110.674 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.0 mt -59.39 -41.65 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 10.78 110.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.742 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.2 mt -66.0 -45.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.904 -0.589 . . . . 8.01 111.479 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.84 -21.16 61.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.333 -0.547 . . . . 10.38 110.75 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -74.39 -26.99 60.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 12.35 110.166 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 95.1 mmm -66.74 -26.48 67.01 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.398 0.618 . . . . 10.33 110.233 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.51 -10.77 4.65 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.415 -0.811 . . . . 9.53 111.714 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.591 ' HB2' HG22 ' A' ' 85' ' ' ILE . 33.4 m-85 -83.02 -175.0 5.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.717 0.294 . . . . 8.89 110.323 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 51.1 tt0 -100.72 147.61 25.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.791 -0.448 . . . . 10.16 109.791 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.512 ' O ' HD12 ' A' ' 96' ' ' ILE . 7.9 ttm180 -55.72 -54.3 46.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.857 0.361 . . . . 11.98 110.503 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB3' ' NE2' ' A' ' 91' ' ' GLN . 55.7 t30 -58.46 -37.07 74.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.862 -0.608 . . . . 9.02 111.207 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.614 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.2 tt0 -65.49 -38.55 90.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 6.68 109.653 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.26 -37.88 89.07 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.25 -0.886 . . . . 5.22 110.625 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -60.9 -52.88 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.316 -0.402 . . . . 6.39 111.174 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.559 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 8.0 tt0 -56.09 -44.21 78.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.202 0.525 . . . . 8.36 110.713 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.31 -54.03 51.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.369 -0.832 . . . . 5.41 110.595 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.705 HD23 ' HB2' ' A' ' 109' ' ' ALA . 78.1 mt -61.18 -33.88 74.15 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.707 -0.224 . . . . 5.77 111.486 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.559 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 92.1 mtt180 -54.9 -46.83 74.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.484 0.659 . . . . 7.71 110.112 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.34 -38.05 68.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.87 -1.059 . . . . 8.88 111.467 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 23.7 p -85.6 1.5 48.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.81 0.67 . . . . 8.79 112.81 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m120 61.98 46.77 6.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.472 . . . . 10.09 111.123 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 9.4 m120 66.73 24.07 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.363 -0.835 . . . . 7.8 111.144 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 14.8 t-20 -86.46 113.9 22.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.892 -0.781 . . . . 10.49 108.892 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.726 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.1 tt -57.6 -59.05 5.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.904 -1.044 . . . . 9.54 111.268 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.61 -46.1 81.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.419 -1.264 . . . . 11.82 111.732 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.692 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.9 ttm180 -68.83 -28.83 67.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.445 -0.343 . . . . 12.41 110.625 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.705 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.64 -50.58 68.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.226 -0.657 . . . . 6.3 109.226 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.525 HD23 HG23 ' A' ' 85' ' ' ILE . 18.2 mt -60.29 -38.31 83.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.43 -0.804 . . . . 7.78 109.739 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 7.7 t70 -54.73 -51.61 65.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.033 -0.985 . . . . 9.04 110.107 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -63.87 -46.61 84.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.116 -1.402 . . . . 8.69 110.679 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.682 HD11 ' HA ' ' A' ' 95' ' ' ALA . 46.5 mt -64.57 -37.72 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.236 -0.893 . . . . 5.25 111.228 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 121.313 0.577 . . . . 6.92 110.432 179.233 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.572 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 78.3 mt . . . . . 0 N--CA 1.447 -0.599 0 CA-C-O 120.742 0.306 . . . . 5.69 111.15 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.68 82.25 1.56 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.299 0.571 . . . . 4.6 109.927 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.4 mt-10 -71.65 -3.11 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.647 -0.706 . . . . 5.13 111.107 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -56.71 -40.85 76.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 4.17 110.265 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.915 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 12.1 p -65.67 -52.47 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.736 -0.666 . . . . 3.42 111.751 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 21' ' ' ARG . 7.3 p -64.02 -38.73 83.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.913 -0.315 . . . . 3.24 111.274 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 64.7 mtt -62.5 -34.89 77.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.729 -0.214 . . . . 5.17 110.719 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 13' ' ' MET . 40.0 mt-30 -60.78 -40.25 91.91 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.79 -0.364 . . . . 5.38 110.76 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.737 ' HB3' HD12 ' A' ' 17' ' ' LEU . 11.2 mt -67.78 -49.0 64.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.878 0.847 . . . . 3.9 109.884 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.26 -50.55 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.99 -1.459 . . . . 4.46 113.111 -170.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 8' ' ' MET . 56.1 mm-40 -66.35 -24.1 66.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.164 0.431 . . . . 6.27 112.164 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 25.8 ptm -99.97 -3.85 31.36 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.652 -0.419 . . . . 5.2 111.79 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.6 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.674 -1.251 . . . . 4.75 113.588 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 33.0 m-85 -115.35 142.04 28.11 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 122.96 -0.141 . . . . 5.09 110.65 -172.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 76.73 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.983 2.455 . . . . 4.25 111.601 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.737 HD12 ' HB3' ' A' ' 10' ' ' LEU . 97.7 mt -79.8 66.76 5.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.49 -0.777 . . . . 3.29 111.846 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 21' ' ' ARG . 3.9 tt0 -56.68 -18.37 12.05 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.92 0.39 . . . . 5.48 110.892 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.418 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.51 -35.79 70.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.511 . . . . 3.54 109.83 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.625 ' O ' HG23 ' A' ' 24' ' ' VAL . 14.1 t -73.27 -41.98 63.02 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.335 -0.848 . . . . 3.27 109.287 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' HB2' HG21 ' A' ' 7' ' ' VAL . 25.2 ttt180 -52.01 -53.29 43.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.366 -0.834 . . . . 6.1 110.7 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HZ3' ' HB3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -71.55 -23.85 61.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 4.77 110.612 178.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HB1' ' CD1' ' A' ' 38' ' ' TRP . . . -69.69 -42.3 74.3 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.981 -0.554 . . . . 4.34 110.771 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 20' ' ' CYS . 86.1 t -55.43 -45.63 78.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.279 -0.418 . . . . 4.58 110.025 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -59.44 -49.91 75.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.02 -0.536 . . . . 7.48 110.499 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.76 -39.37 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.223 -0.444 . . . . 6.84 112.08 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.6 p -70.13 -15.1 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.101 0.477 . . . . 5.71 111.318 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.08 28.27 34.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.831 -0.7 . . . . 5.75 111.485 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 61.8 m-80 60.68 65.56 1.02 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.256 0.55 . . . . 5.06 110.816 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.402 ' HB3' HG21 ' A' ' 34' ' ' VAL . 91.4 mmm -95.94 34.59 1.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.797 -0.638 . . . . 6.28 111.225 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.14 -179.53 45.23 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.072 -0.585 . . . . 4.17 113.58 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.17 -39.23 78.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.288 . . . . 3.73 111.579 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -58.41 -52.72 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 5.46 111.663 -175.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 30' ' ' MET . 69.3 t -67.32 -38.1 80.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.256 -0.429 . . . . 4.88 111.798 -175.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -32.24 55.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.465 -0.494 . . . . 3.68 111.739 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.621 ' O ' HG22 ' A' ' 39' ' ' ILE . 75.7 t80 -61.64 -39.7 92.25 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.459 -0.941 . . . . 4.71 108.459 170.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.731 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.8 t30 -64.59 -39.08 93.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.421 -0.809 . . . . 5.69 110.792 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.415 ' CD1' ' HB1' ' A' ' 23' ' ' ALA . 24.2 t-105 -67.86 -30.81 70.28 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.565 -0.454 . . . . 5.87 110.363 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 36' ' ' PHE . 4.3 tp -77.45 -32.61 18.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 120.805 -0.358 . . . . 3.69 111.47 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.3 pp -68.36 -26.55 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.111 -0.636 . . . . 5.04 109.776 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 37' ' ' ASN . 96.2 t -70.43 -36.88 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.579 -0.737 . . . . 5.37 110.231 170.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -102.22 20.77 16.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.192 -0.458 . . . . 5.35 111.909 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.0 ptt? . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 5.73 110.871 174.473 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 109.399 -0.593 . . . . 7.14 109.399 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.593 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.5 Cg_exo -53.96 162.54 3.83 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 123.096 2.53 . . . . 5.41 112.412 175.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.672 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_endo -63.74 112.12 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.444 2.096 . . . . 7.14 111.089 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.7 pt-20 -56.42 -25.39 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.516 0.51 . . . . 10.13 110.556 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 2.3 tp10 -57.93 -55.0 40.58 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.486 -0.779 . . . . 11.78 110.163 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.796 ' HA ' HD12 ' A' ' 84' ' ' ILE . 82.6 mt -75.41 -40.64 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.774 -0.648 . . . . 8.42 112.094 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.765 ' O ' HG22 ' A' ' 86' ' ' THR . 9.0 m -56.32 -37.81 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 108.357 -0.979 . . . . 7.57 108.357 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.79 -48.83 80.03 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.885 -1.052 . . . . 10.39 110.599 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.8 mt -60.22 -43.54 93.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 10.78 110.827 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.72 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.4 mt -64.05 -45.52 96.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.034 -0.53 . . . . 8.01 111.708 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -72.13 -21.46 61.47 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.876 -0.729 . . . . 10.38 110.786 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.3 m -75.55 -22.04 57.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.041 0.448 . . . . 12.35 110.315 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.3 mmm -70.86 -26.63 63.34 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.275 0.56 . . . . 10.33 109.89 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.54 6.39 4.69 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.405 -0.816 . . . . 9.53 112.08 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 34.5 m-85 -99.24 -175.95 3.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.147 -0.316 . . . . 8.89 110.147 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.902 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 91.9 mt-30 -86.84 153.89 21.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.283 -0.266 . . . . 10.16 110.283 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 96' ' ' ILE . 14.2 ttm180 -65.45 -51.41 60.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.141 -0.688 . . . . 11.98 109.141 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.41 -39.65 88.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 9.02 110.886 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.902 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 8.3 tt0 -64.41 -36.64 84.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.139 0.495 . . . . 6.68 109.689 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.72 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -65.17 -40.23 94.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.458 -0.792 . . . . 5.22 110.466 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.593 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.46 -52.1 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.285 -0.416 . . . . 6.39 110.529 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.561 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 49.8 tt0 -58.24 -44.6 88.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.825 -0.625 . . . . 8.36 110.973 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.83 -53.1 61.84 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.54 -0.755 . . . . 5.41 110.441 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 109' ' ' ALA . 74.1 mt -60.64 -33.1 72.29 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 111.631 0.234 . . . . 5.77 111.631 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.561 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 73.2 mtt180 -55.29 -48.45 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.563 0.697 . . . . 7.71 110.21 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.76 -40.64 72.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.859 -1.064 . . . . 8.88 111.298 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 24.7 p -82.81 -0.04 46.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.547 0.573 . . . . 8.79 112.547 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.8 m120 58.82 63.22 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 10.09 110.161 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.1 p-10 49.14 32.85 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.498 1.119 . . . . 7.8 112.722 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 16.2 t-20 -93.78 113.87 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.033 -0.728 . . . . 10.49 109.033 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.712 HD12 HG12 ' A' ' 81' ' ' ILE . 8.2 tt -56.97 -60.6 3.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.99 -1.005 . . . . 9.54 111.594 -175.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.409 ' N ' HD23 ' A' ' 106' ' ' LEU . 7.2 mm-40 -57.41 -45.84 84.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.365 -0.834 . . . . 11.82 111.667 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.709 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 34.5 ttm180 -67.46 -28.8 68.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.416 -0.356 . . . . 12.41 110.754 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.32 -51.33 66.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.449 -0.574 . . . . 6.3 109.449 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.532 HD23 HG23 ' A' ' 85' ' ' ILE . 17.8 mt -59.01 -39.4 81.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.384 -0.825 . . . . 7.78 109.428 174.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.34 -46.21 83.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.029 -0.987 . . . . 9.04 110.461 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -67.8 -46.58 71.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.846 -1.07 . . . . 8.69 110.396 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.586 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.5 mt -60.78 -39.68 82.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 5.25 110.354 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.847 -0.615 . . . . 6.92 110.805 177.532 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.553 HG12 ' HB2' ' A' ' 25' ' ' TYR . 4.2 mp . . . . . 0 C--O 1.233 0.222 0 N-CA-C 109.731 -0.47 . . . . 5.69 109.731 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -63.58 97.6 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.224 0.535 . . . . 4.6 110.529 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.602 ' HA ' HG12 ' A' ' 7' ' ' VAL . 9.9 mt-10 -71.04 -5.41 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 5.13 111.9 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.3 t -55.94 -34.28 65.51 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.999 -0.741 . . . . 4.17 108.999 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.4 m -65.24 -52.76 52.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.671 -0.695 . . . . 3.42 111.049 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -69.03 -41.34 81.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.755 0.312 . . . . 3.24 111.308 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.641 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 57.7 mtt -59.54 -35.05 73.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.355 -0.384 . . . . 5.17 110.787 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -62.89 -42.52 99.8 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.029 0.206 . . . . 5.38 111.122 174.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.747 ' HB3' HD12 ' A' ' 17' ' ' LEU . 14.4 mt -63.26 -44.64 94.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.502 0.668 . . . . 3.9 109.685 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.1 -32.74 74.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.893 -1.049 . . . . 4.46 111.094 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.641 ' HG2' ' O ' ' A' ' 8' ' ' MET . 60.9 mm-40 -59.93 -31.18 69.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 6.27 110.281 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mtp -92.91 8.56 39.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.847 -0.615 . . . . 5.2 111.737 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.7 -102.74 0.23 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.798 -1.192 . . . . 4.75 114.228 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 93.5 m-85 -83.19 145.67 49.5 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 112.017 0.376 . . . . 5.09 112.017 -169.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.25 86.09 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.02 2.48 . . . . 4.25 110.98 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.785 HD13 HG12 ' A' ' 39' ' ' ILE . 92.2 mt -80.9 70.95 7.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.801 -0.636 . . . . 3.29 112.483 -170.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -24.37 38.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.256 0.551 . . . . 5.48 110.781 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.7 -30.97 67.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 3.54 110.022 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.562 ' O ' HG23 ' A' ' 24' ' ' VAL . 36.9 t -73.18 -43.51 61.29 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.402 -0.817 . . . . 3.27 109.643 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -49.73 -57.0 8.14 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.681 -0.69 . . . . 6.1 109.836 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 14.8 ptpt -66.24 -32.82 74.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.69 -0.686 . . . . 4.77 110.673 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.02 95.15 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.382 -0.372 . . . . 4.34 111.145 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 20' ' ' CYS . 79.1 t -57.01 -43.57 81.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.398 . . . . 4.58 110.172 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.553 ' HB2' HG12 ' A' ' 2' ' ' ILE . 54.4 t80 -67.93 -42.68 80.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.776 -0.77 . . . . 7.48 110.684 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.23 -40.31 97.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 6.84 111.744 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.7 p -65.8 -23.16 66.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.163 0.506 . . . . 5.71 110.79 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.52 26.83 8.39 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.768 -0.651 . . . . 5.75 111.566 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.5 t30 61.88 62.24 1.28 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.345 0.593 . . . . 5.06 109.68 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 97.2 mmm -101.57 21.65 13.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.867 -0.606 . . . . 6.28 112.103 -172.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.41 177.15 48.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.306 -0.95 . . . . 4.17 113.108 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.65 -44.26 70.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.758 0.281 . . . . 3.73 111.758 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.11 -43.5 91.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 5.46 111.847 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.8 t -68.87 -39.75 80.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.406 -0.361 . . . . 4.88 111.177 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.3 55.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.841 -0.343 . . . . 3.68 111.563 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.599 ' O ' HG22 ' A' ' 39' ' ' ILE . 78.3 t80 -58.08 -43.58 87.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.729 -0.841 . . . . 4.71 108.729 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.592 ' O ' HG13 ' A' ' 40' ' ' ILE . 47.4 t30 -64.06 -43.14 96.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.376 -0.829 . . . . 5.69 110.368 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -63.81 -33.93 76.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 5.87 110.719 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.785 HG12 HD13 ' A' ' 17' ' ' LEU . 6.4 tp -76.09 -38.74 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 3.69 111.218 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -70.05 -21.91 24.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.187 0.518 . . . . 5.04 110.504 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 37' ' ' ASN . 92.8 t -76.32 -48.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.819 -0.628 . . . . 5.37 110.241 170.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -83.3 2.64 35.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.098 -0.501 . . . . 5.35 111.349 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.6 ppp? . . . . . 0 C--N 1.326 -0.447 0 N-CA-C 111.931 0.345 . . . . 5.73 111.931 -176.943 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 24.8 tt0 . . . . . 0 N--CA 1.442 -0.827 0 CA-C-O 121.439 0.637 . . . . 7.14 111.452 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.676 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.7 Cg_exo -58.58 166.38 6.45 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.891 3.06 . . . . 5.41 112.879 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.678 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 44.6 Cg_endo -66.66 111.88 2.26 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.686 2.257 . . . . 7.14 111.143 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.6 pt-20 -52.25 -30.11 26.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 10.13 111.237 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 6.2 tt0 -58.66 -51.35 70.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.854 -0.612 . . . . 11.78 110.339 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.754 ' HA ' HD12 ' A' ' 84' ' ' ILE . 69.4 mt -75.13 -40.83 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.686 -0.688 . . . . 8.42 111.452 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.771 ' O ' HG22 ' A' ' 86' ' ' THR . 5.2 m -56.18 -38.29 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.626 -0.879 . . . . 7.57 108.626 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.07 -49.4 77.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.822 -1.081 . . . . 10.39 110.775 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.56 -40.11 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 10.78 110.729 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.732 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.3 mt -67.33 -46.74 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.874 -0.603 . . . . 8.01 111.64 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.99 -21.13 63.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.175 -0.61 . . . . 10.38 110.638 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -75.35 -25.47 57.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 12.35 110.619 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 21.9 mmt -69.15 -26.51 64.91 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.168 -0.469 . . . . 10.33 110.242 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.88 -2.83 4.87 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.714 -0.676 . . . . 9.53 111.817 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 35.2 m-85 -93.08 -173.98 3.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 8.89 110.468 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.596 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 4.7 tt0 -99.31 147.88 24.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.278 -0.419 . . . . 10.16 110.371 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.5 ttm180 -57.11 -54.65 44.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 11.98 110.731 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.97 -36.19 78.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.266 0.555 . . . . 9.02 110.915 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.646 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.7 tt0 -64.45 -38.81 92.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.725 . . . . 6.68 109.569 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.732 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.15 -40.34 95.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.278 -0.874 . . . . 5.22 110.703 173.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.676 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -59.64 -52.48 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.994 -0.548 . . . . 6.39 110.857 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.577 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.5 tt0 -52.97 -47.32 68.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.483 0.659 . . . . 8.36 110.709 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.65 -54.05 50.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.013 -0.994 . . . . 5.41 110.74 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 109' ' ' ALA . 68.1 mt -62.15 -30.99 71.43 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 111.54 0.2 . . . . 5.77 111.54 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 86.7 mtt180 -55.31 -46.97 76.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.365 0.602 . . . . 7.71 109.508 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.87 57.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.936 -1.029 . . . . 8.88 112.035 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 98' ' ' ALA . 29.2 p -83.19 -2.71 56.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.077 0.399 . . . . 8.79 112.077 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.96 41.44 2.08 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.06 0.85 . . . . 10.09 110.364 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.625 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 0.7 OUTLIER 72.23 18.7 4.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.456 -0.793 . . . . 7.8 110.962 178.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 17.6 t-20 -82.6 115.68 21.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.524 -0.547 . . . . 10.49 109.524 174.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.3 tt -58.16 -60.53 3.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.081 -0.963 . . . . 9.54 111.722 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.403 ' N ' HD23 ' A' ' 106' ' ' LEU . 51.1 mm-40 -53.68 -51.95 61.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.318 -0.856 . . . . 11.82 111.71 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.645 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.0 ttm180 -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.196 -0.456 . . . . 12.41 110.868 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.55 -50.61 68.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.302 -0.629 . . . . 6.3 109.302 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.573 HD23 HG23 ' A' ' 85' ' ' ILE . 15.7 mt -59.21 -38.28 79.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.07 -0.968 . . . . 7.78 109.434 175.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 15.1 t70 -56.95 -51.82 67.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.037 -0.983 . . . . 9.04 110.3 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.27 -47.51 84.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.278 -1.328 . . . . 8.69 110.663 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.663 HD11 ' HA ' ' A' ' 95' ' ' ALA . 47.9 mt -61.06 -41.9 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.12 -0.945 . . . . 5.25 110.804 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.4 t80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 6.92 110.546 179.733 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.442 HG22 ' HG3' ' A' ' 4' ' ' GLU . 54.7 mt . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.95 0.405 . . . . 5.69 111.343 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -83.33 82.64 8.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.238 0.542 . . . . 4.6 110.239 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 2' ' ' ILE . 36.1 mt-10 -71.64 -2.76 18.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 5.13 111.281 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.635 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 26.6 t -60.89 -35.91 77.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.717 -0.845 . . . . 4.17 108.717 168.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 6.7 m -58.48 -49.9 75.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.943 -0.571 . . . . 3.42 111.141 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 17' ' ' LEU . 2.7 p -64.26 -41.06 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.806 0.336 . . . . 3.24 110.832 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 81.1 mtp -63.71 -29.84 71.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.148 -0.478 . . . . 5.17 111.378 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 5' ' ' SER . 81.4 mm-40 -64.38 -44.44 91.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.996 -0.281 . . . . 5.38 110.504 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 20' ' ' CYS . 18.8 mt -68.09 -40.36 82.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.402 0.62 . . . . 3.9 109.756 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.64 -50.81 71.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.716 -1.129 . . . . 4.46 111.901 -175.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.99 -19.26 63.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.234 -0.439 . . . . 6.27 112.064 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptm -99.32 -4.6 31.38 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.57 -0.452 . . . . 5.2 111.321 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -98.4 0.12 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.189 -1.005 . . . . 4.75 113.206 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 99.0 m-85 -118.81 157.9 48.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.485 0.183 . . . . 5.09 111.047 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.65 82.46 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.594 2.196 . . . . 4.25 112.138 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 7' ' ' VAL . 4.4 mm? -73.86 69.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 3.29 111.618 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 5.6 tt0 -56.73 -24.14 47.56 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.277 -0.89 . . . . 5.48 109.981 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -29.68 66.33 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.062 -0.517 . . . . 3.54 109.856 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.688 ' HA ' HD11 ' A' ' 39' ' ' ILE . 49.9 t -69.37 -44.81 70.78 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.303 -0.629 . . . . 3.27 109.303 174.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.61 -49.76 67.12 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.013 -0.54 . . . . 6.1 109.911 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 26.5 mttm -62.16 -40.63 96.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.66 -0.7 . . . . 4.77 110.147 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.2 -43.19 92.38 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.364 -0.835 . . . . 4.34 111.714 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' CYS . 76.3 t -56.17 -47.18 81.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.743 0.306 . . . . 4.58 110.313 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.76 -36.7 83.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 7.48 110.492 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.1 -45.7 69.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 6.84 111.221 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -62.29 -27.14 68.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.194 0.521 . . . . 5.71 111.04 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.75 28.04 6.11 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.674 -0.694 . . . . 5.75 111.558 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 59.27 51.24 7.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.123 0.487 . . . . 5.06 109.923 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.462 ' HB3' HG21 ' A' ' 34' ' ' VAL . 80.9 mtp -81.39 -35.25 31.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 6.28 112.106 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.61 169.71 16.87 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.022 -1.085 . . . . 4.17 113.279 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.575 0.35 . . . . 3.73 111.706 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -67.66 -40.16 84.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 5.46 110.12 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 30' ' ' MET . 85.2 t -64.31 -41.49 92.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 4.88 110.782 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -32.89 58.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.441 -0.345 . . . . 3.68 111.109 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 40' ' ' ILE . 78.8 t80 -55.24 -44.41 75.46 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.156 -0.683 . . . . 4.71 109.156 172.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.686 ' O ' HG13 ' A' ' 40' ' ' ILE . 8.2 t30 -67.92 -35.78 79.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.519 -0.764 . . . . 5.69 110.609 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -65.46 -32.85 74.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.094 0.473 . . . . 5.87 109.872 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.688 HD11 ' HA ' ' A' ' 20' ' ' CYS . 1.4 mp -77.06 -37.76 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.864 -0.607 . . . . 3.69 112.099 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.4 pp -63.57 -30.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.637 0.732 . . . . 5.04 109.91 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' ASN . 60.2 t -69.57 -51.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.142 -0.935 . . . . 5.37 110.484 170.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -85.28 13.43 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.669 0.618 . . . . 5.35 112.669 -174.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.1 ptt? . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 5.73 111.07 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 110.147 -0.316 . . . . 7.14 110.147 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.3 Cg_exo -56.25 164.9 4.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.177 2.585 . . . . 5.41 112.115 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.658 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 39.8 Cg_endo -63.15 114.0 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.487 2.125 . . . . 7.14 111.186 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.726 ' HA ' HG22 ' A' ' 82' ' ' VAL . 15.1 pt-20 -58.2 -28.18 64.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 10.13 110.529 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 3.1 tt0 -57.34 -51.34 69.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.073 -0.512 . . . . 11.78 109.92 173.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.7 mt -76.59 -41.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 115.844 -0.616 . . . . 8.42 111.76 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.771 ' O ' HG22 ' A' ' 86' ' ' THR . 10.9 m -55.49 -38.27 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.549 -0.908 . . . . 7.57 108.549 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.38 -49.07 78.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.782 -1.099 . . . . 10.39 110.715 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.1 mt -59.54 -42.29 87.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 10.78 110.423 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.702 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.1 mt -64.83 -47.26 89.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.665 -0.698 . . . . 8.01 111.368 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -69.67 -21.2 63.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.98 -0.688 . . . . 10.38 110.874 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.1 m -76.52 -21.9 55.13 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.933 0.396 . . . . 12.35 110.645 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 94.2 mmm -71.33 -24.56 62.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.391 0.615 . . . . 10.33 110.167 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.93 0.48 5.59 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.108 -0.951 . . . . 9.53 111.529 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 34.3 m-85 -94.02 -173.67 3.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.827 0.346 . . . . 8.89 110.428 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.4 tt0 -100.08 146.47 26.74 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.85 -0.426 . . . . 10.16 109.85 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.516 ' O ' HD12 ' A' ' 96' ' ' ILE . 5.7 ttm180 -58.13 -53.62 56.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.119 0.485 . . . . 11.98 110.196 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -58.93 -37.45 76.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 9.02 111.145 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.8 tt0 -64.08 -40.43 96.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.65 -0.705 . . . . 6.68 109.586 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.702 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.76 -38.51 90.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.02 -0.991 . . . . 5.22 110.735 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.578 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mp -60.88 -52.72 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 116.267 -0.424 . . . . 6.39 110.849 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.2 tt0 -55.36 -44.58 76.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 8.36 110.811 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.08 -53.47 57.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.249 -0.887 . . . . 5.41 110.835 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.674 HD23 ' HB2' ' A' ' 109' ' ' ALA . 69.7 mt -62.59 -29.83 70.89 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.62 -0.264 . . . . 5.77 111.547 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -57.23 -50.83 71.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.424 0.63 . . . . 7.71 110.311 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.98 84.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.921 -1.036 . . . . 8.88 111.319 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 29.4 p -82.02 -7.35 59.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.684 0.624 . . . . 8.79 112.684 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.26 67.86 0.76 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.671 0.748 . . . . 10.09 110.289 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 8.5 p30 52.26 21.1 1.54 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.844 -1.526 . . . . 7.8 112.889 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.414 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 17.6 m-80 -82.33 110.35 17.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.495 -0.557 . . . . 10.49 109.495 174.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.733 HD12 HG12 ' A' ' 81' ' ' ILE . 8.2 tt -57.05 -60.74 3.14 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.973 -1.012 . . . . 9.54 111.732 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.414 ' N ' HD23 ' A' ' 106' ' ' LEU . 5.9 mm-40 -56.78 -45.66 82.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.325 -0.852 . . . . 11.82 111.428 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.646 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 29.1 ttm180 -67.21 -28.45 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.397 -0.365 . . . . 12.41 111.003 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.674 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.84 -50.65 68.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.252 -0.647 . . . . 6.3 109.252 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 HG23 ' A' ' 85' ' ' ILE . 17.9 mt -59.82 -37.34 78.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.218 -0.901 . . . . 7.78 109.637 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 10.8 t70 -54.18 -53.52 52.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.187 0.994 . . . . 9.04 110.004 172.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -61.36 -45.75 93.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.893 -1.503 . . . . 8.69 110.594 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.671 HD11 ' HA ' ' A' ' 95' ' ' ALA . 41.7 mt -66.98 -39.18 82.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.075 -0.966 . . . . 5.25 111.105 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.2 t80 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 6.92 110.624 -179.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.407 HG23 ' CG1' ' A' ' 24' ' ' VAL . 42.9 mt . . . . . 0 N--CA 1.434 -1.244 0 N-CA-C 109.898 -0.408 . . . . 5.69 109.898 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.76 84.33 0.65 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.379 0.609 . . . . 4.6 110.16 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.601 ' HA ' HG12 ' A' ' 7' ' ' VAL . 41.3 mt-10 -70.33 -5.5 28.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.424 -0.807 . . . . 5.13 110.063 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.442 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 4.3 m -57.86 -37.11 73.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.483 -0.78 . . . . 4.17 109.288 169.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.1 m -64.22 -52.48 58.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.817 -0.629 . . . . 3.42 111.236 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.624 HG11 ' HG2' ' A' ' 21' ' ' ARG . 4.8 p -64.61 -39.33 85.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.399 -0.364 . . . . 3.24 111.168 -177.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.481 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 23.7 mmt -66.46 -31.57 72.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.447 -0.342 . . . . 5.17 111.336 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 5' ' ' SER . 15.2 mm-40 -62.84 -39.3 93.95 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.253 -0.277 . . . . 5.38 110.253 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 39' ' ' ILE . 16.4 mt -70.86 -43.96 67.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.754 0.787 . . . . 3.9 109.833 173.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.61 -42.98 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.363 -1.29 . . . . 4.46 112.066 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.19 -9.85 54.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 6.27 112.198 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -72.14 -23.38 61.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 5.2 110.321 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 15' ' ' PHE . . . 124.62 48.16 0.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.841 -0.695 . . . . 4.75 113.023 176.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 60.0 t80 179.29 134.88 0.25 Allowed Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.49 . . . . 5.09 109.678 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.44 88.98 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.017 2.478 . . . . 4.25 112.241 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.72 57.66 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.317 -0.553 . . . . 3.29 110.829 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -56.34 -23.33 36.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.969 0.414 . . . . 5.48 111.009 174.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.647 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -59.81 -31.96 70.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.067 0.46 . . . . 3.54 110.281 172.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.569 ' HB3' HG23 ' A' ' 7' ' ' VAL . 37.9 t -73.81 -39.06 64.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.274 -0.875 . . . . 3.27 109.869 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.624 ' HG2' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -50.16 -52.13 37.87 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.73 0.776 . . . . 6.1 109.074 173.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 32.4 mttt -63.89 -44.72 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.551 -1.204 . . . . 4.77 110.218 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -56.57 -46.49 80.74 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.786 -0.643 . . . . 4.34 111.914 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 20' ' ' CYS . 98.5 t -59.37 -44.15 91.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 4.58 109.935 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.41 -43.48 98.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.964 -0.562 . . . . 7.48 110.973 175.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -69.41 -39.05 78.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.204 0.446 . . . . 6.84 112.204 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.4 p -67.3 -15.24 63.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.97 0.414 . . . . 5.71 111.268 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.7 23.12 47.73 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.652 -0.979 . . . . 5.75 110.652 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.98 72.56 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.633 -0.783 . . . . 5.06 110.496 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 34' ' ' VAL . 92.0 mmm -94.03 9.65 36.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.301 -0.863 . . . . 6.28 111.407 -177.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 172.26 36.75 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.474 -0.87 . . . . 4.17 112.874 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -57.87 -50.3 73.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.058 0.543 . . . . 3.73 112.355 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -53.97 -43.49 69.97 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.218 0.451 . . . . 5.46 112.218 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 30' ' ' MET . 92.1 t -72.96 -40.63 59.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 4.88 111.076 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.48 -30.79 60.01 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.417 -0.513 . . . . 3.68 111.661 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.567 ' O ' HG22 ' A' ' 39' ' ' ILE . 76.3 t80 -59.84 -42.64 94.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.621 -0.881 . . . . 4.71 108.621 171.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.542 ' O ' HG13 ' A' ' 40' ' ' ILE . 27.2 t-20 -67.56 -39.67 84.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.583 -0.735 . . . . 5.69 110.244 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -63.36 -31.96 73.26 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.016 0.436 . . . . 5.87 110.184 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.647 HD11 ' HB3' ' A' ' 19' ' ' ALA . 2.4 tp -76.79 -39.79 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.218 -0.446 . . . . 3.69 110.896 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.53 -16.19 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.387 0.613 . . . . 5.04 110.966 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 37' ' ' ASN . 75.1 t -79.17 -38.61 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.513 -0.767 . . . . 5.37 110.148 168.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -87.79 4.73 43.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.047 0.388 . . . . 5.35 112.047 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.57 0.224 . . . . 5.73 111.414 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.438 -1.039 0 N-CA-C 108.918 -0.771 . . . . 7.14 108.918 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 82.2 Cg_exo -51.47 162.27 1.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.953 2.435 . . . . 5.41 111.682 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.708 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 31.7 Cg_endo -60.94 110.37 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.512 2.141 . . . . 7.14 111.232 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -56.47 -26.86 55.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 10.13 111.389 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.2 tt0 -59.38 -51.56 69.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.263 -0.426 . . . . 11.78 110.069 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.783 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.5 mt -74.64 -42.2 48.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.101 -0.5 . . . . 8.42 111.981 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.76 ' O ' HG22 ' A' ' 86' ' ' THR . 8.4 m -56.02 -38.14 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.422 -0.955 . . . . 7.57 108.422 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.43 -48.74 79.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.753 -1.112 . . . . 10.39 110.758 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.783 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.42 -41.79 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.299 -0.41 . . . . 10.78 110.512 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.746 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.3 mt -65.29 -47.5 86.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.973 -0.558 . . . . 8.01 111.793 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.76 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.3 t -69.61 -21.67 63.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.316 -0.553 . . . . 10.38 110.966 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.0 m -71.49 -31.88 67.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.795 0.331 . . . . 12.35 110.44 171.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 98.3 mmm -64.94 -22.86 67.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.868 -0.605 . . . . 10.33 110.449 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.85 4.18 6.18 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.426 -0.806 . . . . 9.53 112.068 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.601 ' HB2' HG22 ' A' ' 85' ' ' ILE . 33.7 m-85 -96.32 -174.55 3.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.343 -0.243 . . . . 8.89 110.343 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -96.02 148.31 22.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.567 -0.531 . . . . 10.16 109.567 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.505 ' O ' HD12 ' A' ' 96' ' ' ILE . 12.5 ttm180 -58.8 -52.45 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.194 0.521 . . . . 11.98 110.069 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -61.6 -35.84 78.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 9.02 111.213 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.58 ' HG2' HD13 ' A' ' 113' ' ' ILE . 7.3 tt0 -65.9 -38.44 88.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.524 -0.762 . . . . 6.68 109.554 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.746 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.181 -0.918 . . . . 5.22 110.501 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.59 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.95 -52.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 CA-C-N 116.342 -0.39 . . . . 6.39 110.914 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.462 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.7 tt0 -57.95 -43.68 86.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.151 -0.477 . . . . 8.36 110.989 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.45 -50.4 73.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.668 -0.697 . . . . 5.41 110.844 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 109' ' ' ALA . 79.0 mt -63.08 -35.53 80.57 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.741 -0.208 . . . . 5.77 111.314 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.462 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.9 mtt180 -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.517 0.675 . . . . 7.71 110.277 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.93 72.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.736 -1.12 . . . . 8.88 111.6 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 63.0 p -86.69 2.66 47.79 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.116 0.784 . . . . 8.79 113.116 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 64.07 45.88 3.95 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.139 0.575 . . . . 10.09 111.395 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.579 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 77.2 m-20 68.08 21.12 8.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.405 -0.816 . . . . 7.8 111.509 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 4.5 m-20 -82.89 104.5 13.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.604 -0.517 . . . . 10.49 109.604 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.774 HD12 HG12 ' A' ' 81' ' ' ILE . 8.5 tt -47.7 -61.17 2.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.065 -0.971 . . . . 9.54 111.886 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.412 ' N ' HD23 ' A' ' 106' ' ' LEU . 6.4 mm-40 -56.64 -46.54 80.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.102 -0.953 . . . . 11.82 111.919 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.674 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.0 ttm180 -69.0 -28.97 67.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 12.41 110.537 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.746 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -61.4 -51.35 69.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.384 -0.599 . . . . 6.3 109.384 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.515 HD23 HG23 ' A' ' 85' ' ' ILE . 20.7 mt -59.26 -41.84 89.76 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.284 -0.871 . . . . 7.78 109.52 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.67 -49.52 70.42 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.599 0.714 . . . . 9.04 110.363 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -61.55 -48.56 80.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.442 -1.254 . . . . 8.69 110.253 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.58 HD13 ' HG2' ' A' ' 94' ' ' GLN . 44.0 mt -63.46 -40.38 88.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.296 -0.866 . . . . 5.25 110.596 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.465 0.298 0 C-N-CA 123.118 0.567 . . . . 6.92 111.165 175.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.613 HD11 ' HD1' ' A' ' 25' ' ' TYR . 1.9 mp . . . . . 0 N--CA 1.446 -0.669 0 N-CA-C 110.032 -0.358 . . . . 5.69 110.032 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.4 ' N ' HG11 ' A' ' 24' ' ' VAL . 21.9 m-20 -70.01 81.7 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 4.6 110.346 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.547 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.5 mt-10 -71.18 -11.82 61.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.059 -0.519 . . . . 5.13 111.0 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 9' ' ' GLN . 6.9 t -60.46 -28.4 68.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.018 -0.734 . . . . 4.17 109.018 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.66 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 1.9 m -69.34 -50.69 44.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.907 -0.588 . . . . 3.42 110.896 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 4' ' ' GLU . 2.1 p -63.36 -45.89 96.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.448 -0.501 . . . . 3.24 110.805 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.528 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 55.3 mtm -68.97 -26.64 65.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.056 -0.52 . . . . 5.17 111.848 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 6' ' ' SER . 4.4 pt20 -69.03 -34.66 75.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.454 -0.498 . . . . 5.38 109.82 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 6' ' ' SER . 20.4 mt -68.63 -43.42 76.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.613 0.721 . . . . 3.9 109.083 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.56 -37.43 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.629 -1.169 . . . . 4.46 111.503 -176.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 8' ' ' MET . 52.4 mt-10 -65.95 -23.72 66.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.386 0.513 . . . . 6.27 112.386 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 ptp -117.11 -3.86 11.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.296 0.48 . . . . 5.2 112.296 -173.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.25 -101.35 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.935 -1.126 . . . . 4.75 113.643 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.519 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 95.9 m-85 -124.67 165.47 24.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.056 -0.35 . . . . 5.09 110.056 -172.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 71.5 Cg_endo -72.09 82.92 1.24 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.473 2.115 . . . . 4.25 111.62 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 3.4 mm? -75.94 66.5 2.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 3.29 111.805 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -25.73 54.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.617 0.722 . . . . 5.48 109.481 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -31.26 68.08 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.235 -0.893 . . . . 3.54 110.39 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 18.2 t -73.26 -37.71 66.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.422 -0.808 . . . . 3.27 109.706 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.31 -52.58 35.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.852 0.834 . . . . 6.1 108.94 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -70.4 -34.15 72.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.785 -1.098 . . . . 4.77 111.385 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -61.6 -44.31 97.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.385 . . . . 4.34 111.599 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.492 ' CG1' HG23 ' A' ' 2' ' ' ILE . 94.1 t -64.69 -40.8 90.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 4.58 110.384 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.613 ' HD1' HD11 ' A' ' 2' ' ' ILE . 91.3 t80 -62.32 -41.21 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 7.48 110.422 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -68.95 -43.82 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 6.84 111.296 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.8 p -67.09 -17.17 64.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 5.71 111.359 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.85 49.61 5.59 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.707 -0.679 . . . . 5.75 111.907 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.07 45.41 4.57 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.532 0.733 . . . . 5.06 111.885 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.502 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.2 mmt -65.18 -63.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.544 -0.753 . . . . 6.28 111.223 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.87 166.72 38.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.728 -0.749 . . . . 4.17 111.693 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.647 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -65.31 -46.12 81.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.245 0.545 . . . . 3.73 110.982 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 36' ' ' PHE . 15.2 mm-40 -76.13 -27.67 57.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.585 -0.734 . . . . 5.46 110.253 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 30' ' ' MET . 99.1 t -58.27 -44.28 87.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.855 0.36 . . . . 4.88 110.481 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.64 -31.76 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 3.68 110.759 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 51.5 t80 -51.71 -46.2 63.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.304 -0.628 . . . . 4.71 109.304 170.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.52 -47.41 86.29 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.59 -0.732 . . . . 5.69 110.754 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.725 ' HE3' HD12 ' A' ' 39' ' ' ILE . 50.4 t90 -57.2 -36.88 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 5.87 110.237 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.725 HD12 ' HE3' ' A' ' 38' ' ' TRP . 1.2 mp -75.1 -46.64 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.642 -0.708 . . . . 3.69 112.082 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.41 -19.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.394 0.616 . . . . 5.04 111.003 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -80.03 -41.8 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.694 . . . . 5.37 110.807 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -102.89 20.69 16.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.307 0.484 . . . . 5.35 112.307 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 22.8 ptt? . . . . . 0 C--N 1.32 -0.678 0 CA-C-O 121.412 0.625 . . . . 5.73 109.579 171.332 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--O 1.235 0.307 0 N-CA-C 109.827 -0.434 . . . . 7.14 109.827 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.544 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.1 Cg_exo -53.88 164.53 2.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.95 2.433 . . . . 5.41 112.217 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.687 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 37.8 Cg_endo -63.54 111.16 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.651 2.234 . . . . 7.14 110.73 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.0 pt-20 -58.55 -26.15 63.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.814 -0.63 . . . . 10.13 110.781 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.4 tt0 -60.36 -50.2 74.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.183 0.516 . . . . 11.78 109.869 172.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.77 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.0 mt -74.72 -42.66 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.655 . . . . 8.42 111.769 -175.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.754 ' O ' HG22 ' A' ' 86' ' ' THR . 14.2 m -55.76 -37.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.475 -0.935 . . . . 7.57 108.475 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.24 -48.74 78.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.653 -1.158 . . . . 10.39 110.897 175.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.77 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.6 mt -59.38 -42.88 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 10.78 110.326 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.726 HD12 ' HB1' ' A' ' 95' ' ' ALA . 88.9 mt -63.74 -47.44 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.812 -0.631 . . . . 8.01 111.356 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -71.15 -21.39 62.19 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.298 -0.561 . . . . 10.38 110.763 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -75.9 -22.21 56.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.04 0.448 . . . . 12.35 110.371 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 29.5 mmt -72.75 -25.41 61.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.201 0.524 . . . . 10.33 110.072 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 4.55 3.96 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.539 -0.755 . . . . 9.53 112.069 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.599 ' HB2' HG22 ' A' ' 85' ' ' ILE . 28.0 m-85 -98.16 -177.51 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.766 0.317 . . . . 8.89 110.342 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.687 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 8.6 tt0 -94.45 142.34 27.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.561 -0.533 . . . . 10.16 109.561 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.0 ttm180 -57.89 -51.86 67.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.851 0.358 . . . . 11.98 111.241 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.59 -35.08 73.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 9.02 110.485 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.687 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.6 tt0 -66.63 -39.27 88.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.418 -0.81 . . . . 6.68 109.562 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.726 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.12 -40.55 97.93 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.285 -0.87 . . . . 5.22 110.498 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.596 HG13 HG11 ' A' ' 82' ' ' VAL . 1.1 mt -58.58 -52.43 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.163 -0.471 . . . . 6.39 110.438 176.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.7 tt0 -56.74 -45.94 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 8.36 111.103 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.91 -51.07 71.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.474 -0.785 . . . . 5.41 110.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 109' ' ' ALA . 82.2 mt -61.54 -35.62 78.27 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.641 -0.254 . . . . 5.77 111.609 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 90.8 mtt180 -54.03 -46.59 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.525 0.678 . . . . 7.71 110.153 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.64 67.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.764 -1.107 . . . . 8.88 111.615 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.697 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.5 p -86.19 3.98 40.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.871 0.693 . . . . 8.79 112.871 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 64.72 46.8 2.96 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.997 -0.547 . . . . 10.09 110.514 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.609 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 82.4 m-20 67.15 16.58 10.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.388 -0.824 . . . . 7.8 111.437 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.9 t-20 -78.53 110.28 13.48 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.412 -0.588 . . . . 10.49 109.412 175.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.748 HD12 HG12 ' A' ' 81' ' ' ILE . 7.7 tt -55.33 -59.09 5.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.237 -0.892 . . . . 9.54 111.316 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.413 ' N ' HD23 ' A' ' 106' ' ' LEU . 16.6 mm-40 -53.35 -49.99 65.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.631 -1.168 . . . . 11.82 111.671 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.697 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 32.1 ttm180 -69.7 -28.76 66.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.443 -0.344 . . . . 12.41 111.017 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.699 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.02 -51.32 68.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.032 -0.729 . . . . 6.3 109.032 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.578 HD23 HG23 ' A' ' 85' ' ' ILE . 23.6 mt -59.16 -40.78 86.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.85 -1.068 . . . . 7.78 109.902 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.59 -50.43 71.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 9.04 110.178 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -60.68 -44.67 96.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.854 -1.066 . . . . 8.69 110.472 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.649 HD11 ' HA ' ' A' ' 95' ' ' ALA . 52.7 mt -70.45 -39.91 76.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.991 -1.004 . . . . 5.25 111.065 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 6.92 111.196 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.567 HG12 HD21 ' A' ' 29' ' ' ASN . 82.2 mt . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 121.154 0.502 . . . . 5.69 110.592 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.2 85.89 1.9 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.449 -0.796 . . . . 4.6 110.716 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.529 ' HA ' HG12 ' A' ' 7' ' ' VAL . 38.3 mt-10 -72.7 -4.73 33.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.125 -0.489 . . . . 5.13 112.158 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -67.83 -31.55 71.47 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.965 -0.754 . . . . 4.17 108.965 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.75 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 16.9 m -64.89 -46.4 81.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 3.42 110.899 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.1 p -68.94 -40.91 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.144 -0.622 . . . . 3.24 110.53 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 71.0 mtp -63.96 -30.91 71.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.441 . . . . 5.17 111.576 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.75 ' HG2' ' O ' ' A' ' 6' ' ' SER . 10.4 pt20 -68.46 -38.77 81.4 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.435 -0.506 . . . . 5.38 109.672 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.858 ' HB3' HD12 ' A' ' 17' ' ' LEU . 16.4 mt -66.78 -43.74 83.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.648 0.737 . . . . 3.9 109.556 173.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.678 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.6 -33.93 74.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.347 -1.297 . . . . 4.46 112.202 -173.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.3 -36.16 27.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.98 -0.554 . . . . 6.27 111.183 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 18.2 ptp -90.55 0.71 57.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 5.2 112.292 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.67 -92.32 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.747 -1.216 . . . . 4.75 113.763 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 96.7 m-85 -136.52 162.4 56.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.439 -0.208 . . . . 5.09 110.439 -172.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 64.3 Cg_endo -68.05 77.24 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.154 2.569 . . . . 4.25 111.66 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.858 HD12 ' HB3' ' A' ' 10' ' ' LEU . 95.0 mt -85.16 63.84 8.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.967 -0.56 . . . . 3.29 112.428 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -55.96 -19.39 12.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.168 0.508 . . . . 5.48 110.057 169.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.68 -33.1 68.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.542 -0.754 . . . . 3.54 109.407 171.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 34.9 t -70.61 -46.34 63.55 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 115.027 -0.988 . . . . 3.27 109.525 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -53.18 -51.45 62.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.933 0.397 . . . . 6.1 111.044 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.91 -23.52 62.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 4.77 110.542 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -40.76 64.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.381 -0.372 . . . . 4.34 110.785 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 20' ' ' CYS . 77.2 t -56.65 -42.6 76.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 4.58 110.22 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -65.12 -43.04 93.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 7.48 110.514 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.4 -41.17 85.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 6.84 111.78 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.4 p -65.3 -22.34 66.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 5.71 111.436 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.83 25.02 13.85 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.847 -0.692 . . . . 5.75 111.601 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.567 HD21 HG12 ' A' ' 2' ' ' ILE . 11.7 m120 60.72 47.21 8.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.333 0.587 . . . . 5.06 110.397 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.502 ' HB2' HG11 ' A' ' 34' ' ' VAL . 22.2 mmt -76.28 -23.33 54.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 6.28 112.483 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.15 176.37 14.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.17 -1.014 . . . . 4.17 112.95 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -63.95 -58.96 5.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.559 0.344 . . . . 3.73 111.69 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -55.13 -35.14 64.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.49 . . . . 5.46 111.387 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' A' ' 30' ' ' MET . 59.6 t -66.82 -46.64 84.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.052 -0.522 . . . . 4.88 111.184 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.36 -30.78 53.96 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.949 -0.3 . . . . 3.68 111.109 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 39' ' ' ILE . 65.8 t80 -58.48 -44.43 89.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.964 -0.754 . . . . 4.71 108.964 171.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.42 ' O ' HG13 ' A' ' 40' ' ' ILE . 7.4 t30 -63.73 -37.08 86.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.59 -0.732 . . . . 5.69 110.659 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -67.07 -33.85 76.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 5.87 110.418 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.788 HG12 HD13 ' A' ' 17' ' ' LEU . 3.2 tp -77.13 -38.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.466 -0.334 . . . . 3.69 111.171 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 43' ' ' MET . 2.7 pp -71.1 -28.0 31.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.715 -0.394 . . . . 5.04 110.918 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.9 -25.94 12.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.854 -0.338 . . . . 5.37 110.493 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -100.0 10.41 41.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.128 0.418 . . . . 5.35 112.128 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 14.1 ptp . . . . . 0 N--CA 1.465 0.313 0 CA-C-O 120.979 0.418 . . . . 5.73 110.149 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 109.762 -0.458 . . . . 7.14 109.762 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.569 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 83.7 Cg_exo -51.02 162.9 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.472 2.781 . . . . 5.41 112.822 176.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.7 ' HD2' HD13 ' A' ' 99' ' ' LEU . 38.0 Cg_endo -62.7 112.15 1.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.597 2.198 . . . . 7.14 111.526 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.9 pt-20 -58.97 -27.33 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.225 -0.898 . . . . 10.13 112.106 -174.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.57 ' HG2' ' N ' ' A' ' 81' ' ' ILE . 11.2 pm0 -70.21 -42.82 71.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.589 -0.893 . . . . 11.78 108.589 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 63.5 mt -70.82 -46.39 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.726 -1.125 . . . . 8.42 111.755 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 86' ' ' THR . 14.3 m -55.52 -38.0 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.54 -0.911 . . . . 7.57 108.54 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.36 -47.21 85.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.442 -1.254 . . . . 10.39 111.272 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 18.8 mt -60.0 -42.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 10.78 110.238 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.771 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.2 mt -65.16 -45.86 92.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 8.01 111.286 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.62 -21.23 61.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.367 -0.533 . . . . 10.38 110.799 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.6 t -74.28 -28.87 61.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.6 -0.518 . . . . 12.35 109.6 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.563 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.6 mmm -66.06 -27.61 68.22 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.315 0.578 . . . . 10.33 110.159 175.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.14 -5.22 4.63 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.548 -0.751 . . . . 9.53 112.14 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.619 ' HB2' HG22 ' A' ' 85' ' ' ILE . 31.5 m-85 -87.93 -175.45 5.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.722 0.296 . . . . 8.89 110.236 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 8.7 tt0 -98.02 145.35 26.6 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.839 -0.43 . . . . 10.16 109.839 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 7.0 ttm180 -55.73 -51.27 67.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.126 0.489 . . . . 11.98 110.431 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.47 -38.38 80.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.781 . . . . 9.02 111.027 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.632 ' HG3' HD13 ' A' ' 113' ' ' ILE . 4.3 tp-100 -59.94 -46.92 87.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.852 0.834 . . . . 6.68 109.35 174.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.771 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -58.38 -40.78 83.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.457 -1.247 . . . . 5.22 110.854 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.81 -52.11 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.034 -0.53 . . . . 6.39 110.617 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.577 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 58.8 tt0 -56.97 -47.01 81.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.794 -0.639 . . . . 8.36 110.866 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.75 -50.67 72.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.236 -0.893 . . . . 5.41 110.973 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.7 HD13 ' HD2' ' A' ' 78' ' ' PRO . 72.7 mt -61.8 -33.51 74.25 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.45 -0.341 . . . . 5.77 111.376 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 95.0 mtt180 -55.93 -47.2 77.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.405 0.621 . . . . 7.71 110.169 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.94 71.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.107 -0.951 . . . . 8.88 111.401 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.0 p -85.77 -0.68 55.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.849 0.685 . . . . 8.79 112.849 -174.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.468 HD22 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER 66.76 48.18 1.41 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.15 0.58 . . . . 10.09 111.238 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.568 ' ND2' ' HD3' ' A' ' 78' ' ' PRO . 4.9 m-20 69.76 12.63 8.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.339 -0.846 . . . . 7.8 111.467 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 12.3 t-20 -77.43 109.51 11.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.139 -0.689 . . . . 10.49 109.139 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 81' ' ' ILE . 8.3 tt -56.46 -60.37 3.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.102 -0.954 . . . . 9.54 111.519 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.23 -45.68 72.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.979 -1.009 . . . . 11.82 111.542 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.705 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.4 ttm180 -70.92 -28.37 64.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.244 -0.434 . . . . 12.41 111.075 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.627 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.41 -51.32 68.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.382 -0.599 . . . . 6.3 109.382 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.58 HD23 HG23 ' A' ' 85' ' ' ILE . 18.1 mt -57.85 -38.6 75.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.374 -0.83 . . . . 7.78 109.662 174.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.56 -51.41 69.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.979 -1.01 . . . . 9.04 110.246 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -63.32 -45.58 90.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.759 -1.109 . . . . 8.69 110.177 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.632 HD13 ' HG3' ' A' ' 94' ' ' GLN . 54.9 mt -62.54 -34.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.13 -0.941 . . . . 5.25 110.414 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 6.92 111.098 177.879 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.7 mt . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 121.268 0.556 . . . . 5.69 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.28 91.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.527 -0.76 . . . . 4.6 111.174 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 21' ' ' ARG . 49.1 mt-10 -72.27 -5.71 37.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.875 -0.602 . . . . 5.13 111.579 176.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 2.0 m -59.11 -38.48 79.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.341 0.591 . . . . 4.17 109.565 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 24.1 m -64.63 -50.16 68.19 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.564 -0.744 . . . . 3.42 111.504 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -65.8 -41.81 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 120.849 -0.341 . . . . 3.24 111.153 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 88.3 mtp -61.21 -30.04 70.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.375 -0.375 . . . . 5.17 111.102 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 5' ' ' SER . 46.1 mt-30 -69.59 -34.67 74.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.69 -0.232 . . . . 5.38 111.053 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.702 HD13 HG21 ' A' ' 39' ' ' ILE . 14.3 mt -66.88 -47.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.838 0.827 . . . . 3.9 109.179 171.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.31 -45.83 91.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.022 -1.445 . . . . 4.46 112.403 -169.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 13' ' ' MET . 6.8 pt-20 -58.24 -36.26 72.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.301 0.572 . . . . 6.27 111.437 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.445 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 25.5 ptt? -99.36 7.47 45.52 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.401 -0.818 . . . . 5.2 112.063 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.29 103.21 0.2 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.624 -1.274 . . . . 4.75 114.521 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 78.6 m-85 71.66 138.27 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 113.47 0.915 . . . . 5.09 113.47 168.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.05 82.8 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.188 2.592 . . . . 4.25 111.364 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.702 HD13 HG12 ' A' ' 39' ' ' ILE . 85.7 mt -80.46 61.32 4.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.163 0.431 . . . . 3.29 112.163 -173.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -20.89 17.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.101 0.476 . . . . 5.48 110.626 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.55 -35.32 72.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.455 0.645 . . . . 3.54 109.909 171.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 33.5 t -73.92 -36.17 64.67 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.383 -0.826 . . . . 3.27 109.894 175.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 4' ' ' GLU . 1.3 tmm_? -57.09 -48.34 78.83 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.378 0.609 . . . . 6.1 109.477 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -74.43 -25.42 59.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.998 -0.546 . . . . 4.77 110.325 176.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.729 ' HA ' ' HD2' ' A' ' 26' ' ' PHE . . . -66.65 -38.52 87.06 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.11 0.481 . . . . 4.34 110.609 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 20' ' ' CYS . 71.8 t -59.8 -37.77 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.833 -0.621 . . . . 4.58 109.865 173.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 89.9 t80 -60.81 -41.36 95.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.17 -0.468 . . . . 7.48 110.54 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.729 ' HD2' ' HA ' ' A' ' 23' ' ' ALA . 53.6 m-85 -64.8 -46.25 82.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.617 0.246 . . . . 6.84 111.286 176.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 24' ' ' VAL . 33.7 p -70.62 -11.81 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 5.71 111.685 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.74 38.84 41.58 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 5.75 111.427 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.415 ' HA ' HG13 ' A' ' 24' ' ' VAL . 2.2 p-10 43.81 47.9 6.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.908 0.883 . . . . 5.06 111.966 -176.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.4 mtt -63.92 -64.48 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.498 -0.774 . . . . 6.28 110.66 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.84 179.99 45.78 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.815 -0.629 . . . . 4.17 111.665 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -65.22 -33.82 76.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.656 0.243 . . . . 3.73 111.656 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -53.74 -63.24 1.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.008 0.432 . . . . 5.46 111.837 -176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.23 -30.62 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 112.234 0.457 . . . . 4.88 112.234 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.85 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.667 -0.413 . . . . 3.68 111.988 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.559 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.7 t80 -58.72 -44.62 90.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.011 -0.737 . . . . 4.71 109.011 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -65.36 -34.64 78.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 5.69 111.031 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -66.23 -36.39 82.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.133 0.492 . . . . 5.87 110.506 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 10' ' ' LEU . 7.0 tp -76.98 -41.56 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.236 -0.438 . . . . 3.69 111.38 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.05 -26.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.864 0.364 . . . . 5.04 111.003 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 p -80.66 -31.82 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.864 -0.334 . . . . 5.37 110.783 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -100.44 14.59 30.68 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 122.051 -0.406 . . . . 5.35 111.892 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.8 ppp? . . . . . 0 C--N 1.325 -0.468 0 CA-C-O 120.928 0.394 . . . . 5.73 111.399 177.394 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 120.664 0.269 . . . . 7.14 110.535 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.647 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 48.3 Cg_exo -61.87 164.48 16.34 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.062 2.508 . . . . 5.41 112.047 171.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.653 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 50.0 Cg_endo -66.37 112.92 2.48 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.95 2.433 . . . . 7.14 111.256 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.2 pt-20 -55.93 -29.56 60.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 10.13 110.77 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.3 tt0 -56.89 -51.0 70.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.265 0.555 . . . . 11.78 110.29 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.8 mt -75.67 -41.4 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.75 -0.659 . . . . 8.42 111.8 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.774 ' O ' HG22 ' A' ' 86' ' ' THR . 5.5 m -56.06 -38.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.601 -0.889 . . . . 7.57 108.601 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.11 -45.78 91.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.815 -1.084 . . . . 10.39 110.699 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.9 mt -62.5 -41.73 93.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 10.78 110.871 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.724 HD12 ' HB1' ' A' ' 95' ' ' ALA . 80.4 mt -65.97 -46.76 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.916 -0.584 . . . . 8.01 111.66 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.73 -21.2 63.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.042 -0.663 . . . . 10.38 110.518 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.5 t -73.03 -32.22 64.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.741 -0.466 . . . . 12.35 109.741 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.0 mmt -64.25 -26.26 68.42 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.214 0.531 . . . . 10.33 110.489 176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.64 6.21 4.7 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.71 . . . . 9.53 112.01 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.644 ' HB2' HG22 ' A' ' 85' ' ' ILE . 32.2 m-85 -99.07 -174.01 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.68 0.276 . . . . 8.89 110.297 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.811 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 34.2 mt-30 -91.05 149.55 21.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.47 -0.332 . . . . 10.16 110.468 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.4 ttm180 -61.99 -51.16 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.427 -0.583 . . . . 11.98 109.427 173.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.472 -0.785 . . . . 9.02 110.879 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.811 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 1.0 OUTLIER -63.6 -37.45 87.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.264 0.554 . . . . 6.68 109.728 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.724 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.72 -41.39 98.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.427 -0.806 . . . . 5.22 110.451 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.647 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.79 -52.15 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.127 -0.488 . . . . 6.39 110.277 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.639 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.6 tt0 -53.86 -47.11 71.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.837 -0.62 . . . . 8.36 111.162 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HB2' ' CG1' ' A' ' 113' ' ' ILE . . . -60.17 -52.09 66.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.01 -0.995 . . . . 5.41 110.91 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 109' ' ' ALA . 75.2 mt -62.93 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.438 -0.346 . . . . 5.77 111.542 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.639 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.8 mtt180 -54.64 -46.17 73.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.787 0.804 . . . . 7.71 109.66 175.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.69 -44.74 55.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.53 -1.213 . . . . 8.88 111.382 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.698 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 64.3 p -81.41 0.06 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.917 0.71 . . . . 8.79 112.917 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 61.58 62.94 1.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 10.09 110.257 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.5 p30 53.09 23.42 3.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.662 1.185 . . . . 7.8 112.662 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.553 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.1 t-20 -87.44 108.78 19.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.386 -0.598 . . . . 10.49 109.386 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.779 HD12 HG12 ' A' ' 81' ' ' ILE . 8.7 tt -53.94 -61.27 2.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.915 -1.039 . . . . 9.54 112.042 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.02 -45.79 75.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.811 -1.086 . . . . 11.82 111.655 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.698 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 9.0 ttm180 -69.66 -28.69 66.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.053 -0.521 . . . . 12.41 110.845 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.688 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.37 -50.92 68.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.103 -0.703 . . . . 6.3 109.103 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 85' ' ' ILE . 21.7 mt -58.58 -39.1 79.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.404 -0.816 . . . . 7.78 109.668 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 11.0 t70 -54.17 -54.54 38.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.982 -1.008 . . . . 9.04 109.942 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -62.68 -39.7 94.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.058 -1.428 . . . . 8.69 110.781 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.68 HD11 ' HA ' ' A' ' 95' ' ' ALA . 53.7 mt -71.37 -36.05 59.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.36 -0.836 . . . . 5.25 111.27 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--N 1.327 -0.374 0 CA-C-O 121.48 0.657 . . . . 6.92 109.996 176.651 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.445 HG23 ' CG1' ' A' ' 24' ' ' VAL . 52.8 mt . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 109.253 -0.647 . . . . 5.69 109.253 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.557 ' H ' HG11 ' A' ' 24' ' ' VAL . 10.0 m-20 -69.83 72.53 0.39 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.293 0.568 . . . . 4.6 109.605 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.577 ' HA ' HG12 ' A' ' 7' ' ' VAL . 43.7 mt-10 -71.14 -4.14 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.709 -0.678 . . . . 5.13 111.142 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.552 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 14.5 m -63.22 -30.96 72.0 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.251 -0.648 . . . . 4.17 109.251 169.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.659 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 48.2 t -66.96 -52.68 39.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.673 -0.694 . . . . 3.42 110.943 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 4' ' ' GLU . 5.1 p -63.67 -37.67 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.318 -0.401 . . . . 3.24 110.583 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 20.9 mmt -65.27 -29.0 69.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.0 -0.545 . . . . 5.17 111.516 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 5' ' ' SER . 71.3 mt-30 -66.37 -40.87 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.735 -0.386 . . . . 5.38 110.534 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.698 ' HB3' HD12 ' A' ' 17' ' ' LEU . 18.4 mt -68.67 -39.37 80.66 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.862 0.839 . . . . 3.9 109.533 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 8' ' ' MET . . . -61.88 -34.46 76.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.363 -1.29 . . . . 4.46 111.8 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 8' ' ' MET . 49.3 mt-10 -67.54 -18.91 65.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.34 . . . . 6.27 111.145 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.7 mtp -83.17 -1.16 52.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.168 0.508 . . . . 5.2 109.832 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.1 45.68 5.57 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.445 -0.798 . . . . 4.75 113.066 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -144.17 125.77 8.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.857 0.361 . . . . 5.09 110.64 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.59 66.12 4.69 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.354 2.703 . . . . 4.25 111.687 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.698 HD12 ' HB3' ' A' ' 10' ' ' LEU . 61.9 mt -89.65 64.6 6.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.691 0.758 . . . . 3.29 111.695 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -55.54 -21.81 18.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.02 -0.536 . . . . 5.48 109.714 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.603 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.92 -30.65 66.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.52 -0.764 . . . . 3.54 109.901 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HB2' HD12 ' A' ' 10' ' ' LEU . 17.5 t -72.16 -44.71 62.66 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.506 -0.77 . . . . 3.27 109.037 174.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -48.82 72.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.43 -0.804 . . . . 6.1 110.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 10.9 ptpt -75.76 -23.29 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.981 -0.288 . . . . 4.77 110.734 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.9 93.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.328 0.585 . . . . 4.34 110.067 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.557 HG11 ' H ' ' A' ' 3' ' ' ASP . 77.1 t -58.58 -40.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 4.58 110.009 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 87.3 t80 -60.73 -49.95 75.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.685 -0.689 . . . . 7.48 110.57 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -61.81 -43.36 99.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.646 -0.252 . . . . 6.84 111.597 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -66.82 -27.74 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.125 0.488 . . . . 5.71 111.094 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.77 36.29 6.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.791 -0.64 . . . . 5.75 112.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.29 64.48 1.35 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.947 0.403 . . . . 5.06 110.139 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.7 mmt -97.71 -32.72 11.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.044 -0.525 . . . . 6.28 111.922 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 171.12 18.59 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 119.72 -1.229 . . . . 4.17 113.035 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.659 ' HA ' ' HB2' ' A' ' 6' ' ' SER . . . -67.14 -54.52 20.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.229 0.455 . . . . 3.73 112.229 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.532 ' HA ' ' HB3' ' A' ' 36' ' ' PHE . 45.3 mt-10 -68.56 -24.23 64.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.837 0.351 . . . . 5.46 110.804 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.38 -46.67 89.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 4.88 110.318 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB3' ' OG ' ' A' ' 6' ' ' SER . . . -78.45 -27.38 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.49 -0.323 . . . . 3.68 111.09 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 81.1 t80 -57.89 -44.25 86.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.036 -0.727 . . . . 4.71 109.036 169.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.518 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.6 t30 -62.94 -40.86 98.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.462 -0.79 . . . . 5.69 110.285 175.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -65.16 -33.57 76.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.895 -0.593 . . . . 5.87 110.626 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 19' ' ' ALA . 3.9 tp -75.69 -37.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 3.69 111.111 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.1 -30.15 39.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.86 -0.336 . . . . 5.04 111.004 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.37 -21.47 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.796 -0.361 . . . . 5.37 110.76 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -101.8 1.32 37.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.902 0.382 . . . . 5.35 111.09 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.7 ptt? . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 112.56 0.578 . . . . 5.73 112.56 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 109.545 -0.539 . . . . 7.14 109.545 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.0 Cg_exo -54.06 166.8 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.683 2.256 . . . . 5.41 111.666 170.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.689 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.8 Cg_endo -64.38 109.42 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.175 1.917 . . . . 7.14 110.407 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.675 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.1 pt-20 -58.13 -23.56 55.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.461 0.476 . . . . 10.13 110.274 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 3.6 tt0 -59.31 -53.04 62.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.616 -0.72 . . . . 11.78 110.108 171.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.1 mt -73.67 -42.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.74 -0.664 . . . . 8.42 111.648 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.781 ' O ' HG22 ' A' ' 86' ' ' THR . 5.8 m -55.14 -37.98 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.556 -0.905 . . . . 7.57 108.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.67 -47.97 82.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 10.39 111.055 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.8 mt -60.2 -41.33 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.863 -0.608 . . . . 10.78 110.309 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.734 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.8 mt -67.0 -45.16 87.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.747 -0.66 . . . . 8.01 111.657 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.14 -20.67 62.28 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.081 -0.648 . . . . 10.38 110.726 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.2 t -75.23 -27.14 59.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.121 0.486 . . . . 12.35 109.829 172.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 23.8 mmt -68.37 -23.05 64.63 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 10.33 110.703 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.09 -5.24 5.68 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.518 -0.765 . . . . 9.53 111.635 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.595 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.3 m-85 -90.8 -176.24 4.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.32 . . . . 8.89 110.614 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.8 tt0 -98.01 147.07 24.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.823 -0.436 . . . . 10.16 109.823 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.503 ' O ' HD12 ' A' ' 96' ' ' ILE . 10.2 ttm180 -56.66 -54.78 42.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 11.98 110.51 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.445 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 8.8 t30 -58.45 -36.74 74.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.853 -0.612 . . . . 9.02 111.016 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.0 tt0 -64.69 -38.39 90.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 6.68 109.626 176.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.734 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -66.06 -39.17 89.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.127 -0.942 . . . . 5.22 110.693 175.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.557 HG13 HG11 ' A' ' 82' ' ' VAL . 1.1 mp -59.41 -52.49 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 116.212 -0.449 . . . . 6.39 111.039 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 57.5 tt0 -58.91 -41.62 87.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.052 -0.522 . . . . 8.36 110.862 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.98 -53.35 58.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.346 -0.843 . . . . 5.41 110.417 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 109' ' ' ALA . 79.9 mt -61.46 -34.77 75.99 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.39 -0.368 . . . . 5.77 111.526 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 93.3 mtt180 -55.88 -46.35 78.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.544 0.688 . . . . 7.71 110.371 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.3 70.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.958 -1.019 . . . . 8.88 111.061 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.72 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 31.2 p -84.36 0.18 50.28 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.991 0.737 . . . . 8.79 112.991 -175.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.4 m120 60.87 61.88 1.57 Allowed 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.021 0.528 . . . . 10.09 110.458 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.594 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 10.1 p30 51.67 25.5 2.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.589 1.156 . . . . 7.8 112.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 13.1 t-20 -86.1 109.62 18.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.946 -0.761 . . . . 10.49 108.946 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.724 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.4 tt -54.75 -59.73 4.32 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.094 -0.957 . . . . 9.54 111.436 -176.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.24 -48.38 74.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.637 -1.165 . . . . 11.82 111.737 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.72 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -67.98 -28.71 67.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.407 -0.36 . . . . 12.41 110.92 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.22 -50.41 71.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.353 -0.61 . . . . 6.3 109.353 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.508 HD23 HG23 ' A' ' 85' ' ' ILE . 17.0 mt -60.34 -39.22 86.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.266 -0.879 . . . . 7.78 109.665 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.93 -49.97 70.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.81 -1.086 . . . . 9.04 110.124 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -63.1 -49.85 72.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.375 -1.284 . . . . 8.69 110.489 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.694 HD11 ' HA ' ' A' ' 95' ' ' ALA . 44.2 mt -62.16 -32.33 54.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.931 -1.031 . . . . 5.25 111.394 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.9 t80 . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 121.182 0.515 . . . . 6.92 110.997 178.78 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.486 HG23 ' CG1' ' A' ' 24' ' ' VAL . 78.1 mt . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 120.441 0.162 . . . . 5.69 110.923 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.34 74.74 1.87 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.174 0.512 . . . . 4.6 110.706 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.412 ' HA ' HG12 ' A' ' 7' ' ' VAL . 46.0 mt-10 -71.67 -5.45 33.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.401 0.62 . . . . 5.13 110.147 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 15.2 m -61.78 -34.28 75.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.612 -0.722 . . . . 4.17 109.301 167.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -59.78 -51.93 67.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 3.42 110.716 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 17' ' ' LEU . 3.8 p -66.58 -40.7 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.229 -0.441 . . . . 3.24 111.113 -177.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.6 mtp -63.45 -31.62 72.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.281 -0.418 . . . . 5.17 111.26 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 13' ' ' MET . 13.9 mm100 -60.28 -53.95 51.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 110.037 -0.357 . . . . 5.38 110.037 173.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.634 ' HB3' HD12 ' A' ' 17' ' ' LEU . 10.7 mt -57.2 -43.22 82.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.153 0.501 . . . . 3.9 109.841 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.88 -50.0 73.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.655 -1.157 . . . . 4.46 111.784 -172.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -60.17 -28.54 68.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.357 -0.383 . . . . 6.27 111.518 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.68 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 17.3 ptt? -112.91 31.1 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.891 0.33 . . . . 5.2 111.891 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.72 96.84 0.55 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.849 -1.167 . . . . 4.75 114.173 173.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 m-85 73.89 133.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 113.225 0.824 . . . . 5.09 113.225 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.31 83.77 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.93 2.42 . . . . 4.25 111.353 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.634 HD12 ' HB3' ' A' ' 10' ' ' LEU . 95.4 mt -82.33 66.98 8.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.781 -0.645 . . . . 3.29 112.137 -173.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 3.7 tt0 -56.38 -19.76 16.28 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.892 0.377 . . . . 5.48 111.001 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.64 -32.34 68.96 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.929 0.395 . . . . 3.54 109.983 172.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 49.5 t -72.02 -43.58 64.77 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.465 -0.789 . . . . 3.27 109.177 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 29.7 ttt180 -52.36 -52.75 51.72 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.868 -1.06 . . . . 6.1 110.049 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -72.71 -25.07 61.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.655 . . . . 4.77 110.834 177.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.46 78.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.62 0.248 . . . . 4.34 110.648 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' CYS . 93.4 t -56.83 -45.93 83.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.672 -0.492 . . . . 4.58 109.672 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -62.03 -46.47 89.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.506 -0.478 . . . . 7.48 110.713 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -64.25 -36.25 83.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 6.84 112.003 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.7 p -68.8 -21.05 64.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.205 0.526 . . . . 5.71 110.583 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.55 27.71 12.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.606 -0.725 . . . . 5.75 111.559 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 64.04 53.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.299 0.571 . . . . 5.06 110.327 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.542 ' HB3' HG21 ' A' ' 34' ' ' VAL . 20.4 mmt -82.08 -14.65 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 6.28 111.86 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.02 173.02 13.39 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.438 -0.887 . . . . 4.17 112.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.04 66.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.34 . . . . 3.73 111.053 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.97 -49.11 69.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.068 -0.515 . . . . 5.46 111.22 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 30' ' ' MET . 95.9 t -60.46 -38.71 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 4.88 111.343 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.17 54.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.079 -0.248 . . . . 3.68 111.662 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.656 ' O ' HG22 ' A' ' 39' ' ' ILE . 59.2 t80 -56.94 -44.78 82.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.904 -0.776 . . . . 4.71 108.904 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.493 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.4 m-20 -65.79 -39.95 91.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.395 -0.821 . . . . 5.69 110.536 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -64.36 -34.77 78.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 5.87 110.468 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 36' ' ' PHE . 7.2 tp -75.42 -40.73 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.201 -0.454 . . . . 3.69 111.475 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -69.71 -23.81 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.163 0.506 . . . . 5.04 110.606 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 37' ' ' ASN . 85.2 t -78.92 -42.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 5.37 110.824 171.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -101.12 19.21 17.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.391 0.515 . . . . 5.35 112.391 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.4 ptm . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.2 0.524 . . . . 5.73 110.416 172.592 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 108.531 -0.914 . . . . 7.14 108.531 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 71.9 Cg_exo -52.67 159.2 5.07 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.756 2.304 . . . . 5.41 112.709 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.739 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 43.3 Cg_endo -65.29 113.28 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.874 2.383 . . . . 7.14 110.959 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.728 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.0 pt-20 -57.43 -28.8 63.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.955 -0.566 . . . . 10.13 110.309 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.3 tt0 -57.62 -50.57 72.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.908 -0.587 . . . . 11.78 109.924 174.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.766 ' HA ' HD12 ' A' ' 84' ' ' ILE . 68.7 mt -76.27 -42.72 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.845 -0.616 . . . . 8.42 112.036 -176.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 86' ' ' THR . 10.0 m -55.35 -38.28 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.463 -0.94 . . . . 7.57 108.463 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.35 -49.66 76.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.822 -1.081 . . . . 10.39 110.57 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.766 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.3 mt -59.78 -42.14 87.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.459 . . . . 10.78 110.737 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.771 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.6 mt -64.63 -47.0 90.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.076 -0.511 . . . . 8.01 111.424 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.03 -21.18 61.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.152 -0.619 . . . . 10.38 110.809 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -77.01 -17.66 58.68 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.809 0.338 . . . . 12.35 110.449 172.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 97.1 mmm -75.28 -25.45 57.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.286 0.565 . . . . 10.33 109.503 173.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.69 -1.77 5.2 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.252 -0.885 . . . . 9.53 112.012 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.624 ' HB2' HG22 ' A' ' 85' ' ' ILE . 32.0 m-85 -92.21 -174.09 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.748 0.309 . . . . 8.89 110.692 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.755 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 6.7 tt0 -97.18 143.28 28.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.916 -0.401 . . . . 10.16 109.916 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 96' ' ' ILE . 5.2 ttm180 -55.9 -54.85 39.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.981 0.42 . . . . 11.98 110.29 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.551 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 54.1 t30 -59.63 -35.82 75.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.641 . . . . 9.02 111.031 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.755 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.5 tt0 -64.96 -39.82 94.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.638 . . . . 6.68 109.533 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.771 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.83 -39.17 93.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.935 -1.03 . . . . 5.22 110.408 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER -59.45 -52.9 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 116.322 -0.399 . . . . 6.39 110.805 176.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.542 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 7.5 tt0 -56.35 -44.62 80.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.221 0.534 . . . . 8.36 110.82 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.04 -53.29 59.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.304 -0.862 . . . . 5.41 110.729 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.723 HD23 ' HB2' ' A' ' 109' ' ' ALA . 77.1 mt -62.01 -32.88 73.41 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 111.779 0.289 . . . . 5.77 111.779 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 75.3 mtp180 -57.37 -43.73 83.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.436 0.636 . . . . 7.71 110.262 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.1 60.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.19 -0.914 . . . . 8.88 111.077 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 33.7 p -84.47 -0.72 53.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.19 0.811 . . . . 8.79 113.19 -174.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 62.03 63.45 1.09 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.577 0.548 . . . . 10.09 110.621 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.8 p-10 50.04 27.64 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.221 1.008 . . . . 7.8 111.967 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 43.6 t-20 -88.96 107.32 18.96 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.827 -0.805 . . . . 10.49 108.827 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.737 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.0 tt -53.78 -60.34 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.093 -0.958 . . . . 9.54 111.393 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.422 ' N ' HD23 ' A' ' 106' ' ' LEU . 37.5 mm-40 -54.45 -49.66 69.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.86 -1.064 . . . . 11.82 111.926 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 26.3 ttm180 -66.9 -28.51 68.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.452 -0.34 . . . . 12.41 110.793 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.723 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.96 -51.28 67.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.679 -0.489 . . . . 6.3 109.679 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.577 HD23 HG23 ' A' ' 85' ' ' ILE . 16.4 mt -59.88 -39.21 84.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.461 -0.79 . . . . 7.78 109.52 175.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.81 -50.36 68.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.866 -1.061 . . . . 9.04 109.877 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -63.32 -49.06 75.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.333 -1.303 . . . . 8.69 110.482 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.647 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.3 mt -62.61 -37.08 78.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.944 -1.025 . . . . 5.25 111.23 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 6.92 110.663 179.828 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 108.702 -0.851 . . . . 7.16 108.702 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.413 HG12 ' HD1' ' A' ' 25' ' ' TYR . 4.3 mp -95.96 75.14 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 107.244 -1.391 . . . . 5.69 107.244 166.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.87 101.05 0.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.622 -1.172 . . . . 4.6 110.981 -174.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' CD ' ' HE ' ' A' ' 21' ' ' ARG . 39.8 mt-10 -70.46 -2.12 12.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.372 -0.831 . . . . 5.13 111.008 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 1.2 m -57.62 -37.87 74.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.36 -0.608 . . . . 4.17 109.36 170.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -64.5 -49.03 72.93 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.701 -0.681 . . . . 3.42 111.372 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -66.59 -42.03 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 C-N-CA 120.812 -0.355 . . . . 3.24 111.042 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 47.0 mtt -62.86 -34.83 78.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.266 -0.425 . . . . 5.17 111.145 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 5' ' ' SER . 51.0 mt-30 -59.14 -47.44 85.3 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.751 -0.38 . . . . 5.38 110.615 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.979 ' HB3' HD12 ' A' ' 17' ' ' LEU . 15.9 mt -60.31 -47.79 84.53 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.572 0.701 . . . . 3.9 109.989 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.17 -50.61 71.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.571 -1.195 . . . . 4.46 111.915 -174.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -69.53 1.27 4.2 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.528 0.566 . . . . 6.27 112.528 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 22.4 ptp -130.07 10.01 5.36 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.028 -0.269 . . . . 5.2 111.7 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.16 -94.46 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.528 -1.32 . . . . 4.75 113.611 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.8 m-85 -130.44 159.15 72.1 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.129 -0.322 . . . . 5.09 110.129 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 53' ' ' THR . 59.7 Cg_endo -69.66 80.79 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.984 2.456 . . . . 4.25 110.945 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.979 HD12 ' HB3' ' A' ' 10' ' ' LEU . 90.4 mt -81.67 66.72 7.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.7 -0.682 . . . . 3.29 111.849 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -55.74 -22.56 24.47 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.57 0.7 . . . . 5.48 110.125 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB1' ' HZ3' ' A' ' 38' ' ' TRP . . . -58.9 -33.25 70.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.453 -0.794 . . . . 3.54 110.042 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.573 ' HB2' HD12 ' A' ' 10' ' ' LEU . 44.3 t -73.16 -39.37 65.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.606 -0.725 . . . . 3.27 109.855 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.455 ' HE ' ' CD ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -50.02 -56.18 11.75 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.666 0.746 . . . . 6.1 109.803 177.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.605 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -71.69 -25.38 62.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.337 -0.847 . . . . 4.77 110.539 178.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -68.34 -43.24 77.91 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 116.396 -0.365 . . . . 4.34 110.976 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 20' ' ' CYS . 88.5 t -60.1 -43.09 92.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.965 0.412 . . . . 4.58 109.978 177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.413 ' HD1' HG12 ' A' ' 2' ' ' ILE . 80.1 t80 -65.84 -39.1 90.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.039 -0.528 . . . . 7.48 110.864 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -71.62 -43.64 65.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 6.84 111.824 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -61.88 -27.64 68.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.107 0.48 . . . . 5.71 110.908 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.78 38.6 6.89 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.808 -0.633 . . . . 5.75 112.357 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 58.94 75.42 0.4 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.243 0.544 . . . . 5.06 110.077 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.487 ' HB3' HG21 ' A' ' 34' ' ' VAL . 26.3 mmt -112.88 -0.6 14.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.167 -0.47 . . . . 6.28 110.803 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.87 159.27 23.57 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.774 -0.727 . . . . 4.17 112.184 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.82 -39.34 88.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.757 0.313 . . . . 3.73 111.299 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 4.0 mp0 -58.35 -39.35 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.9 -0.591 . . . . 5.46 111.024 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' A' ' 30' ' ' MET . 75.1 t -71.54 -41.04 72.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 4.88 111.202 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.65 -31.1 63.32 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.463 -0.495 . . . . 3.68 110.74 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.477 ' HD1' HD22 ' A' ' 10' ' ' LEU . 70.6 t80 -56.2 -43.09 78.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.99 -0.744 . . . . 4.71 108.99 170.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.524 ' HA ' HG13 ' A' ' 40' ' ' ILE . 26.2 t-20 -66.3 -37.84 86.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.315 -0.857 . . . . 5.69 110.617 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.467 ' HE3' HD12 ' A' ' 39' ' ' ILE . 51.3 t90 -61.22 -35.52 77.44 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.433 0.635 . . . . 5.87 109.802 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.741 HG12 HD13 ' A' ' 17' ' ' LEU . 1.0 OUTLIER -76.58 -43.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 3.69 111.696 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 37' ' ' ASN . 2.8 pp -70.33 -23.3 24.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.385 -0.526 . . . . 5.04 111.446 -174.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.29 -31.63 13.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.795 -0.362 . . . . 5.37 110.401 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -96.06 10.84 36.22 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.16 0.43 . . . . 5.35 112.16 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.3 ptt? -61.18 -21.42 63.79 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.894 0.378 . . . . 5.73 111.051 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -62.43 -29.98 70.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.694 -0.685 . . . . 6.34 110.644 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.21 132.25 90.07 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.818 -0.628 . . . . 5.62 110.376 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.58 -49.12 0.62 Allowed 'Trans proline' 0 CA--C 1.527 0.133 0 C-N-CA 122.937 2.425 . . . . 6.22 113.509 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -115.58 24.56 11.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.3 0.572 . . . . 6.09 111.372 -167.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.556 ' HE2' HG13 ' A' ' 39' ' ' ILE . 1.6 p90 -71.2 -17.79 62.5 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.722 0.773 . . . . 5.89 109.747 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.552 ' CB ' HD23 ' A' ' 17' ' ' LEU . . . -156.18 127.75 7.23 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.531 -1.213 . . . . 4.6 108.334 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 50' ' ' GLU . 27.1 mt-10 -41.76 105.1 0.38 Allowed Pre-proline 0 C--N 1.323 -0.583 0 O-C-N 124.729 1.268 . . . . 5.96 112.007 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -88.8 17.11 1.71 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.011 2.474 . . . . 6.2 113.106 -174.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -128.64 32.98 4.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.765 -0.652 . . . . 8.24 109.784 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.546 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 9.2 m -145.03 96.5 2.86 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.39 -0.823 . . . . 7.27 110.08 -177.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 23.3 ptm -87.87 107.36 15.4 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.821 0.343 . . . . 7.41 111.057 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 53' ' ' THR . 7.0 Cg_exo -76.92 -28.84 5.8 Favored 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.358 2.705 . . . . 5.89 112.918 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 169.96 86.64 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.549 -1.31 . . . . 6.63 113.673 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -172.33 75.23 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.38 0.609 . . . . 9.15 109.49 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -102.69 -105.3 2.92 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.789 -0.72 . . . . 6.92 112.162 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.79 -70.52 2.26 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.994 -0.622 . . . . 7.34 112.238 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.13 -24.88 54.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.076 0.465 . . . . 7.8 110.761 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.56 -54.36 7.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.894 -0.593 . . . . 6.73 110.675 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 m -91.01 101.03 13.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.987 -0.551 . . . . 7.03 110.896 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.77 -61.26 0.43 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 6.23 110.308 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.43 -169.87 29.0 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.757 -0.735 . . . . 7.09 112.321 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.01 95.82 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.0 0.428 . . . . 7.1 110.252 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.8 p -85.12 75.93 10.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.515 0.674 . . . . 7.6 111.289 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 p -112.12 -13.89 11.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.811 -0.631 . . . . 8.01 110.86 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -105.76 9.14 33.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.864 0.364 . . . . 8.06 111.306 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.67 -134.61 38.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.003 -0.618 . . . . 6.62 111.917 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.509 ' H ' HD21 ' A' ' 73' ' ' LEU . . . -95.2 13.86 24.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.602 0.201 . . . . 6.12 111.313 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 45.8 t 65.37 102.86 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.859 -0.609 . . . . 7.65 111.562 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.92 69.7 1.32 Allowed Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.82 -0.705 . . . . 6.25 111.723 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.509 HD21 ' H ' ' A' ' 70' ' ' ALA . 4.4 mm? -71.55 103.57 3.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.584 0.23 . . . . 7.29 111.456 -174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.435 ' OD2' ' HB2' ' A' ' 76' ' ' GLN . 5.4 t70 70.2 162.35 0.23 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.485 -0.779 . . . . 6.55 111.017 176.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.4 28.0 7.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.667 -0.697 . . . . 7.51 110.853 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.435 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 9.0 tt0 -77.68 140.92 63.98 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.626 -0.715 . . . . 7.14 110.478 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.628 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 89.1 Cg_exo -49.85 167.05 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.732 2.954 . . . . 5.41 112.928 171.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.669 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 34.2 Cg_endo -61.47 112.45 1.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.481 2.121 . . . . 7.14 111.353 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.773 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.3 pt-20 -57.21 -27.59 62.13 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.882 -0.599 . . . . 10.13 110.63 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.8 tt0 -59.14 -51.99 67.64 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.21 0.528 . . . . 11.78 109.741 173.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 84' ' ' ILE . 80.4 mt -75.77 -42.37 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.671 -0.695 . . . . 8.42 112.024 -175.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.773 HG22 ' HA ' ' A' ' 79' ' ' GLU . 12.0 m -56.01 -38.45 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.594 -0.891 . . . . 7.57 108.594 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.31 -50.09 75.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.561 -1.2 . . . . 10.39 110.649 175.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 81' ' ' ILE . 23.2 mt -59.24 -42.22 86.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.965 -0.562 . . . . 10.78 110.613 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.738 HD12 ' HB1' ' A' ' 95' ' ' ALA . 84.9 mt -65.5 -46.01 91.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.833 -0.622 . . . . 8.01 111.467 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -71.31 -20.48 62.19 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.073 -0.651 . . . . 10.38 110.837 176.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -76.79 -21.13 55.58 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.412 . . . . 12.35 110.416 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 24.0 mmt -71.5 -22.45 61.79 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.464 0.65 . . . . 10.33 109.813 173.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.77 -3.3 8.04 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.196 -0.911 . . . . 9.53 111.714 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.599 ' HB2' HG22 ' A' ' 85' ' ' ILE . 31.9 m-85 -87.06 -179.07 6.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.792 0.33 . . . . 8.89 110.478 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 26.5 tt0 -90.58 141.54 28.67 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.589 -0.523 . . . . 10.16 109.589 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 11.7 ttm180 -56.48 -52.65 63.9 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.948 0.404 . . . . 11.98 110.354 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.78 -34.37 74.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.859 -0.61 . . . . 9.02 110.938 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.723 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.2 tt0 -66.29 -39.2 89.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.57 -0.741 . . . . 6.68 109.359 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.738 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.32 -41.65 98.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.27 -0.877 . . . . 5.22 110.219 173.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.628 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.52 -52.09 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 115.872 -0.604 . . . . 6.39 110.419 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.573 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 59.6 tt0 -54.13 -47.94 71.33 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 8.36 110.742 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.89 -53.21 60.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.193 -0.912 . . . . 5.41 110.593 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' A' ' 109' ' ' ALA . 73.6 mt -61.48 -30.73 70.79 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.593 -0.276 . . . . 5.77 111.36 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.573 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -56.49 -48.18 77.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.447 0.642 . . . . 7.71 109.802 174.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.83 -41.31 68.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.929 -1.032 . . . . 8.88 111.624 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 98' ' ' ALA . 23.6 p -81.59 -7.41 59.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.354 0.502 . . . . 8.79 112.354 -175.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 65.18 63.27 0.67 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.601 0.715 . . . . 10.09 110.133 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.576 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.4 p-10 49.66 28.93 2.83 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.003 -1.453 . . . . 7.8 112.533 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.426 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 1.0 OUTLIER -89.03 110.49 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.096 -0.705 . . . . 10.49 109.096 173.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.748 HD12 HG12 ' A' ' 81' ' ' ILE . 8.4 tt -56.31 -61.2 2.57 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.071 -0.968 . . . . 9.54 112.132 -175.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.431 ' N ' HD23 ' A' ' 106' ' ' LEU . 16.7 mm-40 -56.04 -46.89 78.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.378 -0.828 . . . . 11.82 111.115 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.639 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.3 ttm180 -66.36 -28.62 68.8 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.573 -0.285 . . . . 12.41 110.748 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.67 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.74 -50.66 68.2 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 109.332 -0.618 . . . . 6.3 109.332 177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.54 HD23 HG23 ' A' ' 85' ' ' ILE . 18.3 mt -59.91 -39.0 83.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.183 -0.917 . . . . 7.78 109.635 175.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.81 -51.1 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.108 -0.951 . . . . 9.04 109.826 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -64.11 -42.67 96.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.507 -1.224 . . . . 8.69 110.862 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.665 HD13 ' HG2' ' A' ' 94' ' ' GLN . 47.6 mt -70.71 -40.66 77.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.361 -0.836 . . . . 5.25 111.584 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -59.84 -31.98 70.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.488 . . . . 6.92 111.802 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 p -77.88 4.37 12.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.547 0.689 . . . . 8.33 111.197 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -122.92 78.51 50.17 Favored Pre-proline 0 C--N 1.312 -1.035 0 CA-C-N 114.949 -1.023 . . . . 9.41 109.81 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.3 -70.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.431 2.754 . . . . 7.92 111.721 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 6.5 pt-20 -168.9 -57.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.021 -0.99 . . . . 11.42 109.925 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.428 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 30.8 t80 -127.92 27.24 5.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.244 0.545 . . . . 15.58 109.995 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 60.75 99.46 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.305 -0.861 . . . . 11.4 111.53 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -92.31 173.24 7.91 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.554 -0.748 . . . . 12.26 111.981 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -134.64 13.93 3.71 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.9 -1.045 . . . . 15.51 108.997 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.4 t -88.8 32.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.141 -0.936 . . . . 16.06 110.666 -173.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.95 -69.77 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.906 -0.588 . . . . 17.4 110.368 176.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.3 t80 51.87 71.19 0.47 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.384 0.612 . . . . 19.19 110.885 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.212 -0.899 . . . . 20.33 109.946 179.396 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.079 -0.341 . . . . 7.16 110.079 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 38.9 mt 62.34 86.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 123.563 0.539 . . . . 5.69 109.876 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -67.92 82.88 0.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.341 -0.845 . . . . 4.6 110.364 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 8' ' ' MET . 43.8 mt-10 -72.63 -10.82 60.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.739 -0.664 . . . . 5.13 111.99 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.628 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 25.1 p -65.33 -32.6 74.33 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.732 -0.84 . . . . 4.17 108.732 175.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.689 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 43.6 m -59.87 -53.4 58.4 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.194 -0.912 . . . . 3.42 111.472 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -63.21 -37.84 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.734 -0.387 . . . . 3.24 110.435 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.486 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 64.3 mtt -62.69 -28.25 69.81 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.935 -0.575 . . . . 5.17 111.396 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 5' ' ' SER . 27.1 mt-30 -65.33 -46.74 79.06 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.91 -0.316 . . . . 5.38 110.478 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.695 HD11 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.21 -40.45 86.44 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.783 0.801 . . . . 3.9 109.375 176.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.645 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.47 -47.41 84.12 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.141 -1.391 . . . . 4.46 112.548 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -64.68 -27.87 69.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.267 0.469 . . . . 6.27 112.267 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 ptm -99.35 2.0 44.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.625 0.25 . . . . 5.2 111.268 -176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.96 -116.16 0.35 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.406 -0.902 . . . . 4.75 112.851 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.645 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 98.1 m-85 -101.65 154.32 37.35 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.747 0.308 . . . . 5.09 110.719 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.872 ' HG3' ' HB3' ' A' ' 52' ' ' LEU . 61.9 Cg_endo -71.47 85.65 0.88 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.785 2.323 . . . . 4.25 111.468 175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 39' ' ' ILE . 2.6 mm? -78.46 68.67 4.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.03 -0.532 . . . . 3.29 112.089 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 12.9 tt0 -55.53 -25.38 37.16 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 121.912 -0.492 . . . . 5.48 110.918 174.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.7 -31.95 66.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 3.54 109.801 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.695 ' SG ' HD11 ' A' ' 10' ' ' LEU . 28.0 t -73.68 -39.88 64.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.481 -0.781 . . . . 3.27 109.769 175.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 18' ' ' GLU . 10.0 ttp180 -53.27 -53.37 51.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.085 0.469 . . . . 6.1 110.709 176.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 18' ' ' GLU . 8.7 ptpt -72.17 -22.83 61.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.226 -0.443 . . . . 4.77 110.721 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB2' ' CE3' ' A' ' 38' ' ' TRP . . . -69.39 -41.28 76.66 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.237 -0.438 . . . . 4.34 110.75 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 20' ' ' CYS . 73.4 t -58.5 -42.17 83.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.093 -0.503 . . . . 4.58 110.159 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -68.11 -38.6 82.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.663 -0.415 . . . . 7.48 110.366 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.59 -37.64 82.88 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.388 -0.369 . . . . 6.84 111.427 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.5 p -71.55 -17.7 62.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.875 0.369 . . . . 5.71 111.406 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.95 23.48 20.24 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.876 -0.678 . . . . 5.75 111.481 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.6 t30 63.19 58.88 1.36 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.6 0.714 . . . . 5.06 110.263 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.429 ' HB3' HG21 ' A' ' 34' ' ' VAL . 87.4 mmm -88.23 -11.78 45.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.491 -0.777 . . . . 6.28 111.757 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.44 -173.67 17.28 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.298 -0.953 . . . . 4.17 113.298 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.689 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -58.84 -55.57 33.4 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.659 0.615 . . . . 3.73 112.659 -174.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.75 -44.78 92.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.223 -0.444 . . . . 5.46 112.149 -170.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 30' ' ' MET . 86.9 t -65.25 -42.42 93.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.741 0.305 . . . . 4.88 111.096 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.45 -25.16 50.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.596 -0.441 . . . . 3.68 111.172 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.519 ' O ' HG22 ' A' ' 39' ' ' ILE . 86.3 t80 -61.43 -40.63 95.13 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.978 -0.749 . . . . 4.71 108.978 171.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.533 ' O ' HG13 ' A' ' 40' ' ' ILE . 92.0 m-20 -60.69 -45.37 94.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.784 -0.644 . . . . 5.69 110.218 174.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 23' ' ' ALA . 42.9 t90 -60.84 -41.33 95.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.067 0.46 . . . . 5.87 110.114 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 36' ' ' PHE . 3.9 tp -73.07 -36.23 50.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 CA-C-N 116.125 -0.489 . . . . 3.69 111.487 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.0 -21.98 22.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.108 0.48 . . . . 5.04 110.804 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 37' ' ' ASN . 95.3 t -74.88 -42.59 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.116 -0.493 . . . . 5.37 110.508 171.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -100.54 16.5 24.51 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.992 0.367 . . . . 5.35 111.992 -176.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -61.15 -21.35 63.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.154 0.502 . . . . 5.73 111.059 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.15 -21.56 65.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.577 -0.738 . . . . 6.34 112.261 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 48' ' ' PHE . 18.7 mt-10 -85.99 111.52 38.78 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.31 0.576 . . . . 5.62 110.876 -174.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 25.6 Cg_endo -65.05 -52.19 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.721 2.947 . . . . 6.22 113.717 -176.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -98.45 -6.14 31.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.803 -0.635 . . . . 6.09 111.307 -168.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 45' ' ' GLU . 17.0 m-85 -69.57 -11.24 60.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.424 . . . . 5.89 111.07 176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -84.42 -120.06 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.467 -0.568 . . . . 4.6 109.467 171.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.52 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 21.3 mt-10 -137.5 143.58 41.54 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 110.07 -0.344 . . . . 5.96 110.07 172.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -71.45 69.53 2.65 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.749 2.299 . . . . 6.2 111.204 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.872 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 56.8 tp -138.37 108.57 6.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.368 -0.833 . . . . 8.24 110.307 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.7 m -43.57 120.33 1.93 Allowed 'General case' 0 C--O 1.236 0.392 0 O-C-N 124.025 0.828 . . . . 7.27 110.83 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.482 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 19.1 ptm -60.56 136.38 92.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 115.935 -0.575 . . . . 7.41 111.738 -172.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 7.2 Cg_exo -73.05 132.83 18.73 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.922 2.415 . . . . 5.89 111.189 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.85 89.1 1.42 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.867 -0.682 . . . . 6.63 112.046 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -66.81 100.43 0.71 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.963 -0.384 . . . . 9.15 109.963 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.39 36.94 4.97 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.862 -0.685 . . . . 6.92 111.539 -176.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.38 31.94 2.88 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.252 -0.499 . . . . 7.34 112.913 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.8 -33.76 17.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.212 0.529 . . . . 7.8 109.87 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.4 83.13 6.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.782 -0.645 . . . . 6.73 110.372 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 p -64.89 -39.42 93.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.839 -0.619 . . . . 7.03 111.209 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -116.54 33.08 5.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.275 -0.421 . . . . 6.23 110.753 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.01 -129.76 29.71 Favored Glycine 0 C--N 1.331 0.269 0 CA-C-N 115.935 -0.575 . . . . 7.09 112.618 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.23 -26.91 28.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 7.1 110.631 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m 64.88 33.06 10.33 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 114.714 -1.13 . . . . 7.6 112.018 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.87 94.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.829 0.823 . . . . 8.01 111.313 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -91.23 138.5 31.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.786 -0.643 . . . . 8.06 109.615 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.41 169.63 22.7 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.713 -0.756 . . . . 6.62 111.935 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.86 -14.45 44.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.671 0.272 . . . . 6.12 110.378 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 m 70.23 -65.79 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.117 -0.947 . . . . 7.65 111.546 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -145.58 126.48 2.57 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 121.103 -0.57 . . . . 6.25 111.677 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.51 6.77 48.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.289 0.566 . . . . 7.29 110.025 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -99.99 97.19 8.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.362 -0.836 . . . . 6.55 110.185 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -157.62 122.84 4.5 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.155 -0.683 . . . . 7.51 109.155 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 7.1 tt0 -79.85 136.08 55.06 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 109.522 -0.548 . . . . 7.14 109.522 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.586 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 86.8 Cg_exo -53.24 160.76 4.31 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.626 2.884 . . . . 5.41 113.579 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.722 ' HD2' HD13 ' A' ' 99' ' ' LEU . 46.5 Cg_endo -66.39 112.96 2.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.943 2.429 . . . . 7.14 111.157 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 82' ' ' VAL . 5.5 pt-20 -56.15 -27.35 53.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.67 -0.696 . . . . 10.13 111.079 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.7 tt0 -58.56 -53.07 62.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.195 0.521 . . . . 11.78 110.093 172.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.782 ' HA ' HD12 ' A' ' 84' ' ' ILE . 74.6 mt -74.66 -40.98 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.737 -0.665 . . . . 8.42 111.799 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.752 ' O ' HG22 ' A' ' 86' ' ' THR . 16.1 m -56.47 -37.85 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.719 -0.845 . . . . 7.57 108.719 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.3 -48.63 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.613 -1.176 . . . . 10.39 110.557 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.782 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.2 mt -60.63 -43.36 94.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.0 -0.545 . . . . 10.78 110.8 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.755 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.7 mt -63.53 -45.31 98.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.951 -0.568 . . . . 8.01 111.57 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 82' ' ' VAL . 2.1 t -72.5 -20.54 61.34 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.313 -0.555 . . . . 10.38 110.945 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.1 m -79.92 -16.95 54.27 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.798 0.333 . . . . 12.35 110.517 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.4 mmm -74.65 -25.29 59.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.302 0.572 . . . . 10.33 109.932 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.63 -2.27 4.89 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 114.977 -1.01 . . . . 9.53 111.762 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.596 ' HB2' HG22 ' A' ' 85' ' ' ILE . 30.7 m-85 -94.39 -173.8 3.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.666 0.27 . . . . 8.89 110.55 -179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 7.3 tt0 -101.03 145.54 28.58 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.66 -0.496 . . . . 10.16 109.66 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.447 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.5 ttm180 -58.11 -52.21 66.48 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 121.045 0.45 . . . . 11.98 110.61 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 48.3 t30 -58.41 -37.36 75.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.617 -0.719 . . . . 9.02 110.766 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.548 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 5.9 tt0 -65.71 -38.3 88.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.629 -0.714 . . . . 6.68 109.748 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.755 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.09 -37.96 89.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.215 -0.902 . . . . 5.22 110.755 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.597 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -58.61 -53.92 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 116.446 -0.343 . . . . 6.39 110.855 177.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 7.8 tt0 -57.4 -44.36 84.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.232 0.539 . . . . 8.36 110.866 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.32 -52.52 65.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.041 -0.981 . . . . 5.41 110.355 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.722 HD13 ' HD2' ' A' ' 78' ' ' PRO . 79.6 mt -61.69 -34.16 75.27 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 116.548 -0.296 . . . . 5.77 111.659 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 96' ' ' ILE . 59.1 mtp180 -58.47 -41.24 84.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.299 0.571 . . . . 7.71 110.643 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -75.4 -38.11 60.1 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.195 -0.911 . . . . 8.88 111.385 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 32.9 p -87.56 1.31 53.94 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.707 0.632 . . . . 8.79 112.707 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 67.1 t30 59.19 65.21 1.23 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.67 -0.695 . . . . 10.09 110.575 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.5 p-10 50.01 28.33 2.88 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.13 -1.395 . . . . 7.8 112.562 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.403 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.5 t-20 -90.12 109.69 20.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.257 -0.646 . . . . 10.49 109.257 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.737 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.2 tt -52.44 -59.96 3.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.945 -1.025 . . . . 9.54 111.771 -177.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -54.24 -52.44 61.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.706 -1.134 . . . . 11.82 111.794 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 17.7 ttm180 -66.47 -27.48 67.83 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.075 -0.511 . . . . 12.41 110.96 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.722 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.63 -51.37 67.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.398 -0.593 . . . . 6.3 109.398 176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.482 HD23 HG23 ' A' ' 85' ' ' ILE . 18.2 mt -59.82 -38.6 82.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.267 -0.879 . . . . 7.78 109.763 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 8.3 t70 -54.76 -51.15 66.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.869 -1.06 . . . . 9.04 110.155 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -63.36 -48.1 79.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.326 -1.306 . . . . 8.69 110.395 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.588 HD11 ' HA ' ' A' ' 95' ' ' ALA . 41.1 mt -62.09 -41.16 90.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.231 -0.895 . . . . 5.25 110.974 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.73 -26.55 68.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.175 -0.466 . . . . 6.92 111.106 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.2 m -75.37 -1.27 23.05 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 8.33 110.725 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -139.58 74.79 33.14 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.468 -0.938 . . . . 9.41 108.468 173.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.416 ' HG2' ' CA ' ' A' ' 120' ' ' GLU . 1.9 Cg_endo -38.38 -61.75 0.36 Allowed 'Trans proline' 0 C--N 1.354 0.833 1 C-N-CA 125.913 4.409 . . . . 7.92 114.361 -177.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 9.7 pt-20 -166.89 -51.0 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.331 -0.85 . . . . 11.42 108.915 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.462 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 37.2 t80 -140.68 37.43 1.82 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.624 -1.171 . . . . 15.58 108.001 174.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.416 ' CA ' ' HG2' ' A' ' 117' ' ' PRO . 29.1 mm-40 68.27 -178.96 0.22 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.398 -1.274 . . . . 11.4 110.032 -178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.35 164.25 16.61 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.898 -0.321 . . . . 12.26 111.587 -172.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.4 t70 73.3 132.62 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.257 -0.883 . . . . 15.51 113.113 171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.7 t -159.32 137.31 10.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.758 -1.11 . . . . 16.06 108.053 174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -150.15 150.05 31.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.059 0.457 . . . . 17.4 110.905 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -131.31 38.05 3.66 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.374 -0.83 . . . . 19.19 109.219 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 56.6 t . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.438 -0.801 . . . . 20.33 110.158 -175.168 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.714 -0.476 . . . . 7.16 109.714 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.462 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 86.3 mt -71.26 116.63 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.823 -0.806 . . . . 5.69 108.823 175.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.15 81.15 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.138 0.495 . . . . 4.6 111.34 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.581 ' HA ' HG12 ' A' ' 7' ' ' VAL . 35.8 mt-10 -70.83 -7.94 49.05 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.012 -0.54 . . . . 5.13 110.591 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 13.2 m -57.43 -34.83 69.34 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.27 -0.641 . . . . 4.17 109.27 170.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 32' ' ' ALA . 3.3 m -66.13 -51.79 54.64 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.442 -0.799 . . . . 3.42 111.202 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.581 HG12 ' HA ' ' A' ' 4' ' ' GLU . 4.0 p -64.14 -40.84 90.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 3.24 110.902 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 77.3 mtp -63.04 -32.66 74.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 5.17 111.052 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.625 ' O ' ' HG2' ' A' ' 13' ' ' MET . 14.9 mm100 -59.37 -48.82 80.18 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.061 -0.256 . . . . 5.38 110.454 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 39' ' ' ILE . 18.5 mt -64.63 -45.29 87.48 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.506 0.67 . . . . 3.9 110.184 177.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.79 -50.31 71.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.708 -1.133 . . . . 4.46 112.489 -173.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 57' ' ' TYR . 8.5 pt-20 -63.7 -35.59 81.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.207 -0.451 . . . . 6.27 111.565 -172.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.625 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 24.2 ptt? -104.82 22.48 15.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.111 -0.495 . . . . 5.2 111.629 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.45 -92.38 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.126 -1.035 . . . . 4.75 112.851 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.656 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 29.2 p90 -158.83 164.93 19.59 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.676 -0.861 . . . . 5.09 108.676 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 88.7 Cg_endo -71.52 83.94 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.562 2.175 . . . . 4.25 113.562 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.637 ' HG ' HG12 ' A' ' 39' ' ' ILE . 3.1 mm? -75.15 64.87 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.074 -0.25 . . . . 3.29 111.641 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -57.75 -19.38 27.34 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 121.387 -0.821 . . . . 5.48 109.681 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.594 ' HA ' ' HE3' ' A' ' 22' ' ' LYS . . . -57.82 -32.7 67.84 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.577 -0.738 . . . . 3.54 110.029 170.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 35.1 t -72.09 -42.99 65.52 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.768 -1.105 . . . . 3.27 109.646 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -54.15 -46.67 72.32 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.161 0.505 . . . . 6.1 110.178 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 42.6 mtmt -70.52 -26.01 63.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.589 -0.732 . . . . 4.77 110.744 177.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.565 ' HB1' ' HD1' ' A' ' 38' ' ' TRP . . . -74.16 -44.89 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 4.34 110.928 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 20' ' ' CYS . 92.1 t -53.6 -47.68 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 4.58 109.954 176.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -56.08 -45.77 79.26 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.486 -0.779 . . . . 7.48 110.783 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -66.03 -40.3 90.92 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.405 -0.361 . . . . 6.84 111.593 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 30' ' ' MET . 74.8 p -67.47 -11.75 58.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.84 0.353 . . . . 5.71 111.51 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.62 26.18 47.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.921 -0.657 . . . . 5.75 111.722 -177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 76.7 m-20 60.84 60.57 1.84 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.181 0.515 . . . . 5.06 110.342 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.411 ' HG2' ' O ' ' A' ' 27' ' ' THR . 17.1 mmt -86.28 -34.25 20.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.953 -0.567 . . . . 6.28 112.152 -177.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 170.4 17.74 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.929 -1.129 . . . . 4.17 112.795 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' A' ' 6' ' ' SER . . . -62.62 -58.37 7.78 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.207 0.447 . . . . 3.73 112.207 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.58 -31.13 67.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.367 -0.379 . . . . 5.46 111.065 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.72 -45.28 92.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.068 -0.515 . . . . 4.88 110.662 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -27.02 50.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.92 -0.312 . . . . 3.68 111.258 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 66.6 t80 -56.6 -43.92 80.61 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.875 -0.787 . . . . 4.71 108.875 169.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.568 ' O ' HG13 ' A' ' 40' ' ' ILE . 41.6 t-20 -63.06 -43.74 97.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.066 -0.97 . . . . 5.69 110.28 177.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.565 ' HD1' ' HB1' ' A' ' 23' ' ' ALA . 13.1 t-105 -65.49 -30.24 70.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.809 -0.357 . . . . 5.87 111.029 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.637 HG12 ' HG ' ' A' ' 17' ' ' LEU . 3.1 tp -76.21 -37.65 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.997 -0.281 . . . . 3.69 110.912 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.568 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.49 -21.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.444 0.64 . . . . 5.04 110.378 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 37' ' ' ASN . 72.4 t -74.22 -51.01 24.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.594 -0.73 . . . . 5.37 109.997 169.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 44' ' ' GLU . 2.0 m-70 -85.42 14.38 5.52 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.193 0.442 . . . . 5.35 112.193 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 23.2 ptt? -62.85 -20.29 64.95 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.358 -0.608 . . . . 5.73 109.358 169.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.581 ' HG3' ' HG2' ' A' ' 45' ' ' GLU . 9.6 pt-20 -49.36 -30.51 7.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.288 -0.869 . . . . 6.34 110.712 172.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.581 ' HG2' ' HG3' ' A' ' 44' ' ' GLU . 1.3 pt-20 -115.35 84.27 11.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 5.62 110.089 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 10.8 Cg_endo -55.09 -45.48 40.37 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 C-N-CA 123.897 3.064 . . . . 6.22 113.219 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -93.47 20.22 7.51 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.414 -1.266 . . . . 6.09 110.537 -168.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -76.36 -10.24 59.25 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.841 0.829 . . . . 5.89 108.882 172.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 16' ' ' PRO . . . -116.06 101.47 8.77 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.65 -1.159 . . . . 4.6 109.038 175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 2.2 mp0 -47.08 108.17 0.83 Allowed Pre-proline 0 C--N 1.321 -0.656 0 O-C-N 123.936 0.772 . . . . 5.96 111.43 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 3.7 Cg_exo -80.38 57.61 6.6 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.379 2.719 . . . . 6.2 112.605 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -96.98 31.56 2.36 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.096 -0.502 . . . . 8.24 110.86 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.54 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 6.7 m -159.22 107.0 1.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.368 -0.378 . . . . 7.27 110.203 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.9 ttm -88.6 102.44 3.91 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 110.253 -0.277 . . . . 7.41 110.253 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 53' ' ' THR . 6.1 Cg_exo -80.69 123.39 4.74 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.215 2.61 . . . . 5.89 112.273 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.94 65.34 3.75 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.734 -0.746 . . . . 6.63 111.847 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.512 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 40.3 p90 -74.2 135.57 42.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.955 0.407 . . . . 9.15 110.52 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.47 -155.06 20.93 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.189 -0.764 . . . . 6.92 111.189 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.63 -126.5 7.49 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.556 -0.831 . . . . 7.34 111.706 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 67.51 -72.19 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.297 0.639 . . . . 7.8 111.338 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.48 -62.5 1.23 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.528 -0.305 . . . . 6.73 110.478 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.3 m 50.06 55.38 9.53 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.423 0.63 . . . . 7.03 110.467 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 66' ' ' SER . . . -101.23 81.29 2.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.509 -0.769 . . . . 6.23 111.644 -174.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.31 -20.04 79.16 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.797 -0.921 . . . . 7.09 110.797 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.773 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -171.76 -48.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.178 -1.045 . . . . 7.1 108.178 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 18.9 m -106.5 169.83 8.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.738 -1.119 . . . . 7.6 108.736 170.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.4 m -89.86 135.95 24.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.621 0.248 . . . . 8.01 110.804 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.0 t80 58.15 60.29 2.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.641 -0.709 . . . . 8.06 110.669 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.84 -147.14 18.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.594 -0.812 . . . . 6.62 112.792 175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.39 34.17 4.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.28 0.562 . . . . 6.12 110.419 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.5 m -64.3 113.65 3.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.615 -0.72 . . . . 7.65 110.922 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.01 29.23 9.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 6.25 112.491 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.773 HD21 ' HB3' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -86.03 50.46 1.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.153 0.501 . . . . 7.29 111.242 -178.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -158.06 157.17 32.37 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.935 -0.575 . . . . 6.55 109.514 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -117.14 15.57 14.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.374 0.607 . . . . 7.51 110.379 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -62.78 143.56 96.86 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.778 -1.101 . . . . 7.14 110.719 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.573 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 88.4 Cg_exo -51.03 165.04 0.52 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.524 2.816 . . . . 5.41 112.823 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.669 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 41.9 Cg_endo -63.53 112.54 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.474 2.116 . . . . 7.14 110.999 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.753 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.5 pt-20 -55.84 -30.72 61.9 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.899 -0.592 . . . . 10.13 110.295 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -55.73 -51.48 67.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.562 -0.744 . . . . 11.78 110.139 174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 75.1 mt -76.24 -42.7 37.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.924 -0.58 . . . . 8.42 111.98 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.779 ' O ' HG22 ' A' ' 86' ' ' THR . 12.6 m -55.76 -37.9 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.507 -0.923 . . . . 7.57 108.507 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.01 86.28 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.681 -1.145 . . . . 10.39 110.927 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.6 mt -60.58 -41.98 89.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.225 0.536 . . . . 10.78 110.501 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.75 HD12 ' HB1' ' A' ' 95' ' ' ALA . 89.6 mt -65.5 -47.4 86.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.703 -0.681 . . . . 8.01 111.527 -178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.779 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -70.19 -21.99 62.98 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.172 -0.611 . . . . 10.38 110.536 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 t -75.44 -19.95 59.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.976 0.417 . . . . 12.35 110.046 174.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.2 mmt -75.78 -24.55 56.0 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.323 0.582 . . . . 10.33 110.396 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.67 9.03 4.1 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.392 -0.822 . . . . 9.53 111.8 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.606 ' HB2' HG22 ' A' ' 85' ' ' ILE . 28.6 m-85 -101.05 -175.36 2.85 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.859 -0.423 . . . . 8.89 109.859 177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.587 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 51.5 tt0 -100.23 145.31 28.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.659 -0.497 . . . . 10.16 109.659 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.2 ttm180 -56.43 -52.29 65.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.971 0.415 . . . . 11.98 110.82 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.469 ' HB3' ' NE2' ' A' ' 91' ' ' GLN . 28.3 t-20 -59.46 -35.96 75.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.792 -0.64 . . . . 9.02 111.085 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.618 ' HG2' HD13 ' A' ' 113' ' ' ILE . 7.7 tt0 -66.14 -38.65 88.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.699 . . . . 6.68 109.664 175.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.75 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.22 -39.51 94.13 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.231 -0.895 . . . . 5.22 110.412 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.573 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -59.26 -52.87 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.191 -0.459 . . . . 6.39 110.729 176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.452 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 34.1 tt0 -56.61 -43.97 80.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.881 -0.6 . . . . 8.36 110.961 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.35 -53.89 52.26 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.409 -0.814 . . . . 5.41 110.846 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.728 HD23 ' HB2' ' A' ' 109' ' ' ALA . 84.3 mt -60.02 -34.2 73.04 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 111.474 0.176 . . . . 5.77 111.474 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.2 mtt180 -55.39 -46.47 76.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.528 0.68 . . . . 7.71 110.304 175.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.89 -42.48 69.93 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.125 -0.943 . . . . 8.88 111.422 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.687 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.3 p -82.93 -1.35 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.564 0.579 . . . . 8.79 112.564 -174.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.5 m120 63.81 60.03 1.09 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.049 -0.523 . . . . 10.09 110.362 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 3.3 p-10 48.63 34.42 5.03 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.351 1.06 . . . . 7.8 111.933 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.6 t-20 -93.24 111.29 22.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.79 -0.818 . . . . 10.49 108.79 174.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.7 HD12 HG12 ' A' ' 81' ' ' ILE . 7.8 tt -56.24 -59.35 5.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.464 -0.789 . . . . 9.54 111.516 -175.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.413 ' N ' HD23 ' A' ' 106' ' ' LEU . 4.3 mt-10 -55.98 -50.06 71.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.711 -1.131 . . . . 11.82 111.344 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.687 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -66.03 -29.09 69.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.547 -0.751 . . . . 12.41 111.281 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.728 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.24 -50.13 72.98 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.308 -0.627 . . . . 6.3 109.308 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 85' ' ' ILE . 18.5 mt -61.31 -36.74 80.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.163 -0.926 . . . . 7.78 109.904 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 8.4 t70 -57.14 -52.88 63.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.263 -0.88 . . . . 9.04 109.627 173.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 63.8 t90 -60.59 -45.24 94.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.126 -1.397 . . . . 8.69 110.498 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.625 HD11 ' HA ' ' A' ' 95' ' ' ALA . 53.0 mt -67.71 -34.25 66.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.058 -0.974 . . . . 5.25 110.901 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -67.9 -30.37 69.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.382 0.61 . . . . 6.92 110.165 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.3 m -80.35 7.12 10.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.788 -0.642 . . . . 8.33 110.324 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -120.53 80.32 30.53 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 115.563 -0.744 . . . . 9.41 110.056 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.79 -60.85 0.68 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.915 2.41 . . . . 7.92 110.954 172.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -177.67 -39.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.496 -1.229 . . . . 11.42 110.251 171.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -131.93 2.48 4.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.638 0.732 . . . . 15.58 110.992 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 48.71 61.52 3.04 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.411 -1.268 . . . . 11.4 111.534 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -101.6 -178.49 3.74 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 113.957 -1.474 . . . . 12.26 109.135 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 t70 54.36 72.4 0.46 Allowed 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.743 0.652 . . . . 15.51 110.384 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 2.2 p -66.91 105.89 1.75 Allowed 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.954 -0.566 . . . . 16.06 111.366 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -47.15 -78.53 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.271 0.841 . . . . 17.4 113.271 -170.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -126.27 9.34 7.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.611 0.243 . . . . 19.19 111.461 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.839 -0.6 . . . . 20.33 110.489 179.902 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.173 0.511 . . . . 7.16 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.5 mt -114.94 133.17 61.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.803 -0.635 . . . . 5.69 109.45 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -75.0 76.94 2.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.435 0.636 . . . . 4.6 109.642 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.519 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.5 mt-10 -72.34 -10.48 59.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.809 -0.632 . . . . 5.13 112.022 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 54.3 p -62.05 -38.01 87.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.371 0.605 . . . . 4.17 109.489 176.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.684 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 50.3 m -60.67 -52.27 65.85 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.097 -0.956 . . . . 3.42 111.594 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.57 HG23 ' HB3' ' A' ' 20' ' ' CYS . 7.4 p -64.34 -40.0 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 120.561 -0.456 . . . . 3.24 110.907 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 67.1 mtt -59.7 -31.88 70.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.519 -0.31 . . . . 5.17 111.22 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.591 ' O ' ' HG2' ' A' ' 13' ' ' MET . 15.3 mm100 -60.9 -56.88 15.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.593 -0.276 . . . . 5.38 110.48 175.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.81 HD11 ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -67.9 -28.73 67.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.565 -0.454 . . . . 3.9 111.387 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.32 86.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.429 . . . . 4.46 110.996 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -79.45 -42.18 25.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 6.27 111.439 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.591 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 26.2 ptt? -92.14 32.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.782 0.325 . . . . 5.2 111.251 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.618 ' O ' ' HD2' ' A' ' 55' ' ' PRO . . . -172.09 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.403 -0.903 . . . . 4.75 112.347 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.626 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 12.4 p90 -166.53 162.15 11.74 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.092 -0.707 . . . . 5.09 109.092 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 15' ' ' PHE . 22.8 Cg_endo -55.1 91.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.687 2.924 . . . . 4.25 112.99 -175.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.647 HD12 ' HB2' ' A' ' 10' ' ' LEU . 70.4 mt -96.81 57.32 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.891 -0.595 . . . . 3.29 111.745 -175.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -55.67 -23.89 30.91 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.161 0.505 . . . . 5.48 110.718 174.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.455 ' HA ' ' HE2' ' A' ' 22' ' ' LYS . . . -57.75 -36.95 72.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.925 -0.58 . . . . 3.54 110.001 172.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.81 ' SG ' HD11 ' A' ' 10' ' ' LEU . 20.2 t -73.81 -31.75 63.4 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.421 -0.809 . . . . 3.27 110.449 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.38 -48.72 71.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.48 -0.933 . . . . 6.1 108.48 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 18.8 mttm -66.09 -42.32 89.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.944 -1.026 . . . . 4.77 109.976 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -60.37 -40.81 92.16 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.643 -0.708 . . . . 4.34 111.918 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 20' ' ' CYS . 39.9 t -59.08 -45.76 92.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 110.153 -0.314 . . . . 4.58 110.153 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -62.46 -41.83 99.05 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.454 -0.498 . . . . 7.48 110.223 174.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.15 -41.59 85.78 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.82 -0.627 . . . . 6.84 112.085 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.7 p -65.46 -23.36 66.9 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.057 0.456 . . . . 5.71 110.835 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.37 29.65 8.73 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.6 -0.727 . . . . 5.75 111.73 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 59.39 49.44 8.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.217 0.532 . . . . 5.06 110.297 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 81.4 mmm -82.42 3.78 26.73 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 6.28 112.192 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.32 171.45 23.08 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.567 -0.825 . . . . 4.17 112.444 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.684 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -67.68 -45.22 75.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.665 -0.267 . . . . 3.73 111.679 -175.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.97 -31.36 70.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.481 -0.327 . . . . 5.46 111.663 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.07 -44.65 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 4.88 110.56 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.59 -28.0 60.72 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.613 -0.435 . . . . 3.68 110.49 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.454 ' O ' HG22 ' A' ' 39' ' ' ILE . 83.9 t80 -56.35 -42.55 77.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.958 -0.756 . . . . 4.71 108.958 171.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -61.75 -45.96 91.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 5.69 110.612 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -59.44 -43.03 93.22 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.532 0.682 . . . . 5.87 109.842 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 10' ' ' LEU . 3.0 tp -74.77 -36.3 39.45 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.606 0 CA-C-N 115.486 -0.779 . . . . 3.69 111.861 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 43' ' ' MET . 2.8 pp -71.47 -21.34 21.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 5.04 111.54 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.1 t -76.59 -36.51 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.235 0.54 . . . . 5.37 110.19 170.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -99.52 7.6 45.21 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 112.416 0.524 . . . . 5.35 112.416 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 40' ' ' ILE . 4.8 ppp? -76.76 -22.38 53.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.211 0.529 . . . . 5.73 111.001 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.11 -21.74 64.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.254 -0.885 . . . . 6.34 111.035 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.827 ' HG3' ' HB2' ' A' ' 48' ' ' PHE . 3.9 pt-20 -90.05 119.75 69.3 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.541 0.686 . . . . 5.62 109.407 172.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.45 -47.26 22.68 Favored 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 124.149 3.232 . . . . 6.22 114.947 -165.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -105.19 24.52 11.92 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.146 0.974 . . . . 6.09 110.713 -167.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.827 ' HB2' ' HG3' ' A' ' 45' ' ' GLU . 35.5 t80 -76.75 -25.71 53.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.444 -0.798 . . . . 5.89 110.493 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 16' ' ' PRO . . . -93.21 -123.82 0.09 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.15 -0.477 . . . . 4.6 110.858 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 42.1 mt-10 -129.79 134.97 26.79 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 109.393 -0.595 . . . . 5.96 109.393 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 5.6 Cg_exo -78.71 65.99 8.65 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.944 2.429 . . . . 6.2 111.769 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.55 ' HG ' HG22 ' A' ' 53' ' ' THR . 51.2 tp -141.02 105.39 4.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.049 -0.523 . . . . 8.24 110.758 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.55 HG22 ' HG ' ' A' ' 52' ' ' LEU . 6.3 t 37.01 72.83 0.1 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 124.398 1.061 . . . . 7.27 113.229 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.477 ' HG3' ' HB2' ' A' ' 15' ' ' PHE . 4.2 mpp? -86.07 107.45 13.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 7.41 110.254 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 14' ' ' GLY . 6.1 Cg_exo -79.36 -54.9 0.04 OUTLIER 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.146 2.564 . . . . 5.89 112.941 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.54 -179.66 19.47 Favored Glycine 0 N--CA 1.452 -0.293 0 N-CA-C 111.29 -0.724 . . . . 6.63 111.29 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -109.92 -34.47 6.42 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.196 0.498 . . . . 9.15 112.217 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.89 -142.2 9.21 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 119.61 -1.281 . . . . 6.92 113.514 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 115.87 41.52 0.77 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.29 -0.724 . . . . 7.34 111.29 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.37 -164.53 1.3 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.451 0.167 . . . . 7.8 111.442 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 64.47 52.57 1.79 Allowed 'General case' 0 C--O 1.231 0.101 0 O-C-N 123.807 0.692 . . . . 6.73 111.546 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.1 t -94.54 119.09 32.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.788 -0.642 . . . . 7.03 110.214 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.13 140.54 48.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.248 -0.433 . . . . 6.23 110.307 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.4 95.71 0.4 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.547 -0.835 . . . . 7.09 112.879 -176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.63 152.57 22.3 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.543 -0.539 . . . . 7.1 109.543 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.562 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 11.3 t -161.31 -159.2 0.63 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.934 -0.306 . . . . 7.6 110.839 -177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.9 p -65.34 -23.16 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.208 0.448 . . . . 8.01 112.208 -175.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.562 ' CE2' ' HB3' ' A' ' 66' ' ' SER . 21.5 p90 -78.58 64.02 3.52 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.67 0.748 . . . . 8.06 111.958 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.03 -13.35 69.24 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.698 -0.683 . . . . 6.62 111.851 177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.793 ' HB1' HD23 ' A' ' 73' ' ' LEU . . . -120.97 154.29 36.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.228 -0.286 . . . . 6.12 110.228 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.6 p -80.95 57.67 3.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.159 0.504 . . . . 7.65 111.593 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.17 -56.3 4.85 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.033 -0.603 . . . . 6.25 112.345 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.793 HD23 ' HB1' ' A' ' 70' ' ' ALA . 1.8 mm? 65.5 32.53 9.37 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.858 0.463 . . . . 7.29 111.37 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -126.05 134.56 51.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.041 -0.725 . . . . 6.55 109.041 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -133.32 22.72 4.06 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.428 0.632 . . . . 7.51 110.272 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -93.78 135.84 24.54 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 115.315 -0.857 . . . . 7.14 110.141 -177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.621 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 76.7 Cg_exo -55.09 163.93 3.99 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.249 2.633 . . . . 5.41 112.044 171.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.685 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 36.6 Cg_endo -63.51 113.18 2.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.598 2.199 . . . . 7.14 111.464 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -58.16 -23.28 54.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.952 -0.567 . . . . 10.13 111.16 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 8.7 tt0 -61.61 -52.57 63.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.128 -0.487 . . . . 11.78 109.879 171.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.5 mt -75.18 -41.55 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.617 -0.72 . . . . 8.42 111.944 -175.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.79 HG22 ' HA ' ' A' ' 79' ' ' GLU . 13.7 m -56.56 -38.02 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.604 -0.887 . . . . 7.57 108.604 178.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.49 -49.88 75.78 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.903 -1.044 . . . . 10.39 110.576 175.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.0 mt -59.69 -43.07 90.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.038 -0.528 . . . . 10.78 110.808 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.743 HD12 ' HB1' ' A' ' 95' ' ' ALA . 90.5 mt -63.96 -47.76 89.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.92 -0.582 . . . . 8.01 111.84 -177.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -70.08 -23.69 63.11 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.013 -0.675 . . . . 10.38 110.51 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 57.5 m -69.75 -31.2 69.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.701 0.286 . . . . 12.35 110.24 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 93.4 mmm -62.78 -29.07 70.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.206 0.526 . . . . 10.33 110.679 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.2 4.2 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.364 -0.835 . . . . 9.53 112.005 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.57 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.7 m-85 -91.5 -173.85 3.71 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.207 -0.294 . . . . 8.89 110.207 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.594 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 8.4 tt0 -101.49 147.16 26.7 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.699 -0.482 . . . . 10.16 109.699 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.445 ' O ' HD12 ' A' ' 96' ' ' ILE . 20.7 ttm180 -57.74 -52.7 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.062 0.458 . . . . 11.98 110.763 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -58.64 -36.74 74.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.776 -0.647 . . . . 9.02 110.786 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.653 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.8 tt0 -65.82 -38.94 90.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.546 -0.752 . . . . 6.68 109.63 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.743 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.88 -40.77 97.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.272 -0.876 . . . . 5.22 110.519 174.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.621 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -58.5 -52.2 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 116.002 -0.545 . . . . 6.39 110.656 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.646 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 27.3 tt0 -56.55 -44.78 81.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.046 -0.524 . . . . 8.36 111.08 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.95 -53.39 58.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.457 -0.792 . . . . 5.41 110.659 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 109' ' ' ALA . 76.1 mt -61.65 -32.28 72.44 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-N 116.609 -0.269 . . . . 5.77 111.392 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.646 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 88.7 mtt180 -54.86 -46.7 74.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.361 0.601 . . . . 7.71 109.752 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.69 62.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.928 -1.033 . . . . 8.88 111.903 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 27.8 p -85.2 1.04 49.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.627 0.603 . . . . 8.79 112.627 -175.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.73 45.68 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.972 -0.558 . . . . 10.09 110.242 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 0.7 OUTLIER 69.93 16.56 7.65 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.443 -0.799 . . . . 7.8 111.072 176.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.4 t-20 -80.43 111.07 16.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.482 -0.562 . . . . 10.49 109.482 176.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.4 tt -55.02 -60.28 3.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.287 -0.87 . . . . 9.54 111.536 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.5 -52.74 52.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.681 -1.145 . . . . 11.82 110.913 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.692 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 12.2 ttm180 -65.14 -28.48 69.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.429 -0.805 . . . . 12.41 111.354 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.04 -50.56 70.14 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.394 -0.595 . . . . 6.3 109.394 178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 85' ' ' ILE . 15.8 mt -59.75 -39.07 83.56 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.233 -0.894 . . . . 7.78 109.717 175.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -56.57 -50.06 73.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.007 -0.997 . . . . 9.04 109.956 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -62.57 -46.83 86.55 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.621 -1.172 . . . . 8.69 110.408 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.653 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.2 mt -63.61 -35.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.201 -0.908 . . . . 5.25 110.926 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -68.01 -25.15 65.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.088 0.471 . . . . 6.92 110.108 177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.8 t -83.13 -2.47 55.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.454 0.645 . . . . 8.33 109.71 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -131.82 71.42 80.57 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.319 -0.855 . . . . 9.41 110.057 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -47.21 -51.47 9.39 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.995 3.13 . . . . 7.92 112.515 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.674 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 5.9 pt-20 -169.81 -60.94 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.761 -1.109 . . . . 11.42 108.932 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.674 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 29.2 t80 -152.56 28.46 0.55 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.858 -1.065 . . . . 15.58 108.387 176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 65.1 -154.45 0.28 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.048 -0.978 . . . . 11.4 110.329 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.86 -167.94 0.54 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.715 0.293 . . . . 12.26 110.583 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.79 101.49 0.82 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.124 0.488 . . . . 15.51 110.447 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.3 m -88.58 160.26 17.51 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.558 -0.746 . . . . 16.06 110.483 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.29 1.68 35.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 17.4 111.312 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -82.53 90.44 6.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.971 -0.559 . . . . 19.19 110.26 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.248 1.023 0 CA-C-N 115.805 -0.634 . . . . 20.33 110.294 179.535 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 1.5 p-10 . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.484 0.183 . . . . 7.16 111.344 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 37.4 mt -129.55 99.83 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 O-C-N 122.28 -0.262 . . . . 5.69 110.35 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.96 94.43 1.08 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.12 0.486 . . . . 4.6 110.208 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.541 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.0 mt-10 -72.49 -2.33 19.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.95 -0.568 . . . . 5.13 112.136 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 4.4 m -59.99 -41.98 93.25 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.582 -0.525 . . . . 4.17 109.582 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 20.8 p -61.98 -52.11 65.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.783 -0.644 . . . . 3.42 111.832 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.6 p -62.02 -39.74 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 C-N-CA 120.852 -0.339 . . . . 3.24 110.996 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.54 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 49.4 mtm -65.18 -26.75 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.449 -0.342 . . . . 5.17 111.445 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 5' ' ' SER . 76.6 mt-30 -69.09 -37.68 78.57 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.7 -0.4 . . . . 5.38 110.266 175.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.759 ' HB3' HD12 ' A' ' 17' ' ' LEU . 13.6 mt -68.89 -40.5 79.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 122.079 0.942 . . . . 3.9 109.133 172.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 8' ' ' MET . . . -62.8 -41.73 99.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.507 -1.224 . . . . 4.46 111.675 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 8' ' ' MET . 71.0 mm-40 -62.31 -29.93 70.79 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.606 0.595 . . . . 6.27 112.606 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.636 ' HG2' ' O ' ' A' ' 10' ' ' LEU . 22.0 ptp -81.84 -4.46 56.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.441 -0.504 . . . . 5.2 110.156 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.17 48.73 1.41 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.711 -0.677 . . . . 4.75 113.462 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 73.0 m-85 -143.12 125.37 8.7 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.859 0.361 . . . . 5.09 110.583 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.838 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . 89.6 Cg_endo -74.45 66.71 5.49 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 123.468 2.779 . . . . 4.25 111.762 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.759 HD12 ' HB3' ' A' ' 10' ' ' LEU . 80.9 mt -94.2 57.66 2.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.649 0.737 . . . . 3.29 111.875 -172.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 13.9 tt0 -56.57 -22.32 32.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.179 0.514 . . . . 5.48 109.896 168.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.497 ' HB2' ' HA ' ' A' ' 49' ' ' ALA . . . -57.91 -29.35 65.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.649 -0.705 . . . . 3.54 109.659 172.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.579 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.7 t -72.19 -44.61 62.74 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 108.955 -0.758 . . . . 3.27 108.955 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.451 ' NH2' ' HG3' ' A' ' 18' ' ' GLU . 12.2 ttp180 -51.84 -42.33 62.48 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.878 -0.601 . . . . 6.1 110.232 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 42.8 mttt -71.47 -39.42 70.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.613 -0.721 . . . . 4.77 110.435 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.57 99.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.601 -0.727 . . . . 4.34 111.268 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 20' ' ' CYS . 88.6 t -59.15 -46.21 92.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.166 -0.47 . . . . 4.58 110.432 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -54.47 -48.2 72.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.256 -0.429 . . . . 7.48 110.921 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.96 -39.62 87.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.194 -0.457 . . . . 6.84 111.611 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.9 p -68.32 -15.08 63.43 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.081 0.467 . . . . 5.71 110.979 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.71 29.27 43.75 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.352 -0.699 . . . . 5.75 111.352 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' ' 1' ' ' ASP . 51.3 t30 60.67 73.91 0.47 Allowed 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 121.349 0.595 . . . . 5.06 110.626 -175.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.543 ' HB3' HG21 ' A' ' 34' ' ' VAL . 19.2 mmt -102.31 18.8 20.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.771 -0.65 . . . . 6.28 110.863 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.24 -178.65 50.71 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.574 -0.739 . . . . 4.17 113.059 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.582 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.4 -37.38 77.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.785 0.291 . . . . 3.73 111.785 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -54.62 -56.55 17.88 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.618 0.723 . . . . 5.46 110.395 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 30' ' ' MET . 92.9 t -65.42 -40.38 88.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.05 -0.977 . . . . 4.88 111.803 -175.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.44 -35.1 58.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.313 0.486 . . . . 3.68 112.313 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.5 t80 -58.75 -41.91 87.61 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.879 -0.785 . . . . 4.71 108.879 173.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.528 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.2 m-80 -69.28 -38.43 78.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.671 -0.695 . . . . 5.69 110.862 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.5 -37.23 86.82 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.803 -0.443 . . . . 5.87 109.803 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.556 HG21 HD13 ' A' ' 10' ' ' LEU . 4.7 tp -72.57 -39.01 60.92 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 CA-C-N 116.058 -0.519 . . . . 3.69 111.176 -178.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -70.15 -21.67 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.371 0.605 . . . . 5.04 110.786 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 37' ' ' ASN . 70.6 t -74.45 -44.85 47.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.892 -0.595 . . . . 5.37 110.644 171.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -99.42 12.22 36.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.95 0.405 . . . . 5.35 111.223 -173.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.453 ' HB3' ' O ' ' A' ' 39' ' ' ILE . 27.1 ptt? -72.31 -20.9 61.42 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.318 -0.401 . . . . 5.73 111.785 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -69.63 2.56 3.12 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.854 0.359 . . . . 6.34 111.33 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.622 ' HB3' ' CD1' ' A' ' 48' ' ' PHE . 16.3 mm-40 -93.06 97.73 1.96 Allowed Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 108.548 -0.908 . . . . 5.62 108.548 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.41 -44.53 32.31 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.071 2.514 . . . . 6.22 113.219 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -115.05 13.03 16.82 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.816 0.817 . . . . 6.09 110.992 -169.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.622 ' CD1' ' HB3' ' A' ' 45' ' ' GLU . 22.7 m-85 -85.4 -11.54 54.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.987 -0.552 . . . . 5.89 111.113 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.497 ' HA ' ' HB2' ' A' ' 19' ' ' ALA . . . -81.87 -92.72 0.06 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.123 -0.489 . . . . 4.6 110.1 176.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.838 ' HB2' ' HB2' ' A' ' 16' ' ' PRO . 47.4 mt-10 -138.0 157.62 72.73 Favored Pre-proline 0 C--N 1.313 -1.005 0 N-CA-C 108.3 -1.0 . . . . 5.96 108.3 174.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.48 116.7 2.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.367 2.045 . . . . 6.2 110.851 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -44.97 97.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.168 0.803 . . . . 8.24 113.168 -168.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.7 m -144.03 61.69 1.36 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.263 -0.881 . . . . 7.27 108.92 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.497 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 24.5 ptt? -73.76 129.33 85.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 7.41 110.727 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 2.7 Cg_endo -81.93 -8.29 12.15 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.953 2.435 . . . . 5.89 112.251 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 69.01 -161.92 51.72 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.785 -0.643 . . . . 6.63 111.591 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -114.53 18.66 16.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.796 0.808 . . . . 9.15 109.381 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -104.39 91.58 0.8 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.342 -0.845 . . . . 6.92 111.069 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.69 142.43 15.96 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.71 -0.757 . . . . 7.34 112.507 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 65.39 -178.48 0.18 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.231 0.612 . . . . 7.8 111.997 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.11 148.29 18.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.611 -0.722 . . . . 6.73 109.951 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.9 p -76.16 111.58 11.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.13 0.49 . . . . 7.03 110.987 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -98.61 160.77 14.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.701 -0.681 . . . . 6.23 110.078 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.64 103.77 0.27 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.536 -0.84 . . . . 7.09 112.703 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.99 -163.71 1.08 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.248 -0.279 . . . . 7.1 110.248 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.0 m -63.51 111.62 2.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.042 0.449 . . . . 7.6 110.941 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 68' ' ' PHE . 15.5 m -102.7 48.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.143 -0.481 . . . . 8.01 110.972 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 92.6 t80 74.19 143.99 0.07 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.111 -0.949 . . . . 8.06 110.978 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.79 163.71 33.29 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.948 -0.644 . . . . 6.62 111.604 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.42 113.42 20.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.652 0.263 . . . . 6.12 110.669 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -83.02 45.31 1.0 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.289 -0.414 . . . . 7.65 111.481 -177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.34 79.39 0.18 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.755 -0.736 . . . . 6.25 112.204 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -90.47 11.88 20.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.98 0.419 . . . . 7.29 110.734 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -86.98 120.13 27.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.795 -0.639 . . . . 6.55 110.876 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -133.92 36.65 3.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.488 -0.778 . . . . 7.51 109.098 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -118.72 136.21 24.07 Favored Pre-proline 0 N--CA 1.446 -0.631 0 CA-C-N 115.539 -0.755 . . . . 7.14 110.523 -176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.612 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 73.0 Cg_exo -54.15 167.34 1.25 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.497 2.798 . . . . 5.41 112.592 172.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.672 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.5 Cg_endo -63.33 112.11 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.35 2.033 . . . . 7.14 111.185 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.697 ' HA ' HG22 ' A' ' 82' ' ' VAL . 9.6 pt-20 -57.0 -26.69 60.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 10.13 110.855 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 6.2 tt0 -58.99 -51.25 70.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.945 -0.571 . . . . 11.78 110.46 173.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.798 ' HA ' HD12 ' A' ' 84' ' ' ILE . 70.1 mt -76.19 -41.43 37.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.921 -0.582 . . . . 8.42 111.642 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 86' ' ' THR . 11.3 m -55.55 -37.88 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.519 -0.919 . . . . 7.57 108.519 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.27 -48.54 79.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.637 -1.165 . . . . 10.39 110.871 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.3 mt -59.53 -42.16 87.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 10.78 110.624 179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.729 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.1 mt -65.0 -44.9 95.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.86 -0.609 . . . . 8.01 111.434 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -73.48 -21.18 60.49 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.189 -0.604 . . . . 10.38 110.786 177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.9 m -72.72 -26.55 61.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.063 0.458 . . . . 12.35 110.124 171.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.1 mmt -68.57 -26.9 65.62 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.963 -0.562 . . . . 10.33 110.462 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.01 -6.05 5.08 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.407 -0.815 . . . . 9.53 111.63 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.626 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.8 m-85 -87.7 -172.29 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.068 -0.345 . . . . 8.89 110.068 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 33.9 tt0 -103.63 146.92 27.86 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.931 -0.396 . . . . 10.16 109.931 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 16.0 ttm180 -57.0 -53.13 61.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.111 0.482 . . . . 11.98 110.19 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -59.07 -39.41 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.603 -0.726 . . . . 9.02 111.046 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.52 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 4.0 tt0 -63.91 -37.02 85.86 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.392 0.615 . . . . 6.68 109.758 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.729 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.99 -38.43 90.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.179 -0.919 . . . . 5.22 110.711 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.612 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -59.93 -52.52 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 116.053 -0.522 . . . . 6.39 110.636 177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 60.5 tt0 -54.93 -46.03 74.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.769 -0.65 . . . . 8.36 110.855 178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.89 -53.61 55.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.235 -0.893 . . . . 5.41 110.78 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.713 HD23 ' HB2' ' A' ' 109' ' ' ALA . 74.8 mt -61.38 -31.59 71.5 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.689 -0.232 . . . . 5.77 111.327 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.5 mtt180 -55.7 -50.29 70.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.393 0.616 . . . . 7.71 110.004 175.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.23 -40.26 74.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.729 -1.123 . . . . 8.88 111.551 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.693 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 28.4 p -83.17 -5.7 59.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.694 0.627 . . . . 8.79 112.694 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 t30 64.78 65.72 0.61 Allowed 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.645 -0.707 . . . . 10.09 109.813 -175.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.551 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.4 p30 48.92 22.81 0.61 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.221 1.008 . . . . 7.8 112.428 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -81.68 109.45 16.11 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.726 -0.472 . . . . 10.49 109.726 173.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.0 tt -56.59 -59.84 4.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.176 0.922 . . . . 9.54 111.282 -177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.45 -48.3 71.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.9 -1.045 . . . . 11.82 111.268 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.693 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.1 ttm180 -69.5 -28.8 66.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.07 -0.514 . . . . 12.41 110.799 -178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.713 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.56 -51.24 68.16 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.219 -0.66 . . . . 6.3 109.219 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.625 HD23 HG23 ' A' ' 85' ' ' ILE . 21.4 mt -58.1 -40.12 80.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.845 -1.07 . . . . 7.78 109.605 175.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.33 -50.75 70.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.388 -0.824 . . . . 9.04 110.443 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 24.2 t-105 -62.91 -44.44 96.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.491 -1.231 . . . . 8.69 110.375 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 95' ' ' ALA . 51.5 mt -65.71 -45.16 92.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.009 -0.996 . . . . 5.25 111.251 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -59.02 -26.1 64.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.741 -0.663 . . . . 6.92 110.976 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 68.0 m -73.55 3.15 6.58 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.538 -0.756 . . . . 8.33 111.101 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -128.0 74.62 78.9 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 108.819 -0.808 . . . . 9.41 108.819 166.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.438 ' HD2' ' OE1' ' A' ' 120' ' ' GLU . 3.7 Cg_endo -38.65 -72.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 125.176 3.917 . . . . 7.92 113.526 -170.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -159.78 -42.31 0.05 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.311 -0.859 . . . . 11.42 110.103 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -136.13 14.2 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.565 -0.454 . . . . 15.58 111.771 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.438 ' OE1' ' HD2' ' A' ' 117' ' ' PRO . 6.0 mm-40 60.73 100.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.38 -0.827 . . . . 11.4 111.645 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.94 155.07 20.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.181 0.515 . . . . 12.26 111.825 -173.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -147.87 125.29 11.64 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.671 -0.863 . . . . 15.51 108.671 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.6 t -83.15 -59.54 2.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.096 -0.502 . . . . 16.06 110.68 -174.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.6 t70 54.36 76.24 0.25 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.471 0.653 . . . . 17.4 110.403 -177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -104.79 125.83 51.25 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.769 -0.651 . . . . 19.19 110.844 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 50.5 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.587 -0.72 . . . . 20.33 109.914 177.558 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.64 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 7.3 m-20 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.293 0.568 . . . . 7.16 109.643 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mt -137.67 82.62 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 108.141 -1.059 . . . . 5.69 108.141 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.7 88.11 0.35 Allowed 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.377 0.608 . . . . 4.6 110.891 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.481 ' HA ' HG12 ' A' ' 7' ' ' VAL . 51.8 mt-10 -71.11 -8.18 51.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.282 -0.872 . . . . 5.13 110.59 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.635 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 18.8 m -57.7 -37.63 73.83 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.303 -0.628 . . . . 4.17 109.303 169.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.442 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 7.4 m -59.66 -51.85 68.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.794 -0.639 . . . . 3.42 110.937 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.568 HG11 ' HB2' ' A' ' 21' ' ' ARG . 4.4 p -67.45 -38.87 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 120.636 -0.426 . . . . 3.24 110.74 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.472 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 78.6 mtp -62.93 -27.01 69.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.371 -0.377 . . . . 5.17 111.324 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG3' ' O ' ' A' ' 5' ' ' SER . 29.3 mt-30 -62.65 -53.4 55.09 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.811 -0.44 . . . . 5.38 109.811 171.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.841 HD13 HG21 ' A' ' 39' ' ' ILE . 11.7 mt -58.51 -45.27 89.14 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.725 0.774 . . . . 3.9 109.653 176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.635 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.8 -29.32 70.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.343 -1.299 . . . . 4.46 111.64 -175.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.14 -51.71 6.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.699 -0.682 . . . . 6.27 111.872 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 16.5 ptp -101.28 25.0 8.73 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 111.993 0.368 . . . . 5.2 111.993 -172.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.94 -92.44 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.947 -1.12 . . . . 4.75 113.022 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.635 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 62.4 m-85 -136.95 151.09 71.54 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.892 -0.41 . . . . 5.09 109.892 -173.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.56 74.44 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.802 2.335 . . . . 4.25 111.451 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.815 HD12 ' HB3' ' A' ' 10' ' ' LEU . 89.6 mt -89.45 62.6 6.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.772 -0.649 . . . . 3.29 112.175 -171.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.551 ' O ' ' HE2' ' A' ' 22' ' ' LYS . 7.6 tt0 -55.75 -24.54 35.86 Favored 'General case' 0 N--CA 1.458 -0.042 0 CA-C-O 120.939 0.399 . . . . 5.48 110.565 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.44 -31.17 65.65 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.124 -0.489 . . . . 3.54 110.255 174.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.6 t -73.5 -42.98 61.14 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.425 -0.807 . . . . 3.27 109.658 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HB2' HG11 ' A' ' 7' ' ' VAL . 24.5 ttt180 -52.02 -50.23 61.81 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-O 121.606 0.717 . . . . 6.1 110.082 175.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HE2' ' O ' ' A' ' 18' ' ' GLU . 25.8 mtmt -72.09 -23.5 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.085 -0.962 . . . . 4.77 110.623 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -73.6 -39.06 64.88 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.823 -0.626 . . . . 4.34 111.221 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' CYS . 97.7 t -58.97 -47.15 90.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.89 0.376 . . . . 4.58 110.11 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -58.64 -36.16 73.67 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.889 -0.596 . . . . 7.48 110.762 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -75.01 -45.78 39.52 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.506 -0.315 . . . . 6.84 111.674 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.4 p -62.21 -24.68 67.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.964 0.411 . . . . 5.71 111.162 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.14 29.41 20.13 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.803 -0.635 . . . . 5.75 112.039 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.64 ' HB2' ' O ' ' A' ' 1' ' ' ASP . 66.7 t30 63.39 64.62 0.81 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.179 0.514 . . . . 5.06 110.497 -178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.611 ' HB3' HG21 ' A' ' 34' ' ' VAL . 87.2 mmm -91.77 -11.22 37.31 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.117 -0.492 . . . . 6.28 110.742 178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.23 162.05 11.3 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.791 -0.719 . . . . 4.17 112.387 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -55.77 -46.07 78.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.942 0.497 . . . . 3.73 111.54 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.22 -41.46 99.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 5.46 111.431 -176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.611 HG21 ' HB3' ' A' ' 30' ' ' MET . 98.8 t -62.58 -43.97 98.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.475 -0.329 . . . . 4.88 111.256 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.13 -28.89 54.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.629 -0.429 . . . . 3.68 111.24 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.605 ' O ' HG22 ' A' ' 39' ' ' ILE . 54.0 t80 -58.15 -43.24 87.25 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.043 -0.725 . . . . 4.71 109.043 170.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 40' ' ' ILE . 13.6 m120 -67.72 -40.65 84.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 5.69 110.952 176.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -59.86 -38.34 81.88 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.386 0.612 . . . . 5.87 109.932 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.841 HG21 HD13 ' A' ' 10' ' ' LEU . 4.3 tp -74.57 -37.57 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.862 -0.608 . . . . 3.69 111.699 -176.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.8 pp -70.34 -23.35 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.406 -0.517 . . . . 5.04 110.899 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.9 t -79.43 -34.84 16.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 5.37 110.725 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -98.96 5.29 47.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.15 0.426 . . . . 5.35 112.15 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -69.91 -20.66 63.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.587 0.232 . . . . 5.73 111.316 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -56.19 -18.12 9.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.845 -0.616 . . . . 6.34 111.908 177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.533 ' HB2' ' HB2' ' A' ' 48' ' ' PHE . 65.3 mm-40 -84.34 109.11 17.19 Favored Pre-proline 0 N--CA 1.454 -0.249 0 CA-C-N 116.439 -0.346 . . . . 5.62 110.072 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 11.4 Cg_endo -56.36 -43.95 50.84 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 123.914 3.076 . . . . 6.22 113.196 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -97.66 -3.51 39.22 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.967 -1.015 . . . . 6.09 111.325 -167.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 45' ' ' GLU . 3.4 m-85 -80.27 -14.5 58.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.03 0.443 . . . . 5.89 110.385 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.43 80.67 2.25 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.645 -0.872 . . . . 4.6 108.645 167.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.19 133.48 80.87 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 114.431 -1.259 . . . . 5.96 111.67 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.55 76.53 1.44 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.231 2.621 . . . . 6.2 112.941 -174.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.1 tp -122.65 106.37 10.9 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 8.24 109.948 176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 p 53.91 81.72 0.09 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.337 0.655 . . . . 7.27 112.132 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.5 tpt -77.27 108.82 7.62 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.558 -0.746 . . . . 7.41 110.973 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -98.62 -163.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.75 2.967 . . . . 5.89 113.076 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.15 -44.62 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.768 -0.651 . . . . 6.63 112.153 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' HB3' ' HA ' ' A' ' 13' ' ' MET . 62.9 t80 54.94 81.8 0.1 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.358 0.599 . . . . 9.15 111.077 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.09 104.37 1.07 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.582 -0.818 . . . . 6.92 111.904 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -131.43 46.57 1.06 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.953 -0.641 . . . . 7.34 112.184 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 71.46 135.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.676 0.75 . . . . 7.8 112.27 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.94 -37.95 10.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.578 -0.737 . . . . 6.73 109.723 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.1 137.19 32.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.574 -0.739 . . . . 7.03 110.118 175.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.32 10.15 41.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.946 0.403 . . . . 6.23 111.585 -173.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.18 132.66 2.59 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.58 -0.819 . . . . 7.09 112.668 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.35 125.82 37.17 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.593 0.235 . . . . 7.1 110.479 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.1 m -148.7 141.55 24.67 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.792 -0.447 . . . . 7.6 109.792 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.5 136.36 56.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.911 0.386 . . . . 8.01 110.636 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -119.51 162.75 18.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.102 -0.499 . . . . 8.06 110.11 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.0 82.28 0.39 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 6.62 112.557 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.85 134.97 37.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.425 0.155 . . . . 6.12 110.73 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.2 m -72.18 82.51 1.0 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.584 0.707 . . . . 7.65 110.333 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.39 -44.3 0.45 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.332 -1.107 . . . . 6.25 110.332 -174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.13 -49.14 11.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.315 -0.995 . . . . 7.29 108.315 171.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.24 120.64 32.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.837 -1.074 . . . . 6.55 109.367 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -124.35 28.79 6.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.854 0.835 . . . . 7.51 109.609 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -72.53 136.07 81.12 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 114.816 -1.084 . . . . 7.14 109.956 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.605 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 58.7 Cg_exo -55.87 161.54 8.18 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.878 2.386 . . . . 5.41 112.264 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.695 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.0 Cg_endo -62.66 112.62 1.67 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.468 2.112 . . . . 7.14 111.246 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.757 ' HA ' HG22 ' A' ' 82' ' ' VAL . 1.6 pm0 -57.11 -25.73 59.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.731 -0.668 . . . . 10.13 111.528 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 7.0 tt0 -60.15 -50.94 71.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.014 0.435 . . . . 11.78 109.839 172.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.796 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.2 mt -75.38 -42.17 43.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.886 -0.597 . . . . 8.42 111.737 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 86' ' ' THR . 11.2 m -56.12 -38.18 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.426 -0.953 . . . . 7.57 108.426 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.04 -48.96 79.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.802 -1.09 . . . . 10.39 110.674 175.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.0 mt -59.39 -41.65 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.075 0.464 . . . . 10.78 110.598 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.742 HD12 ' HB1' ' A' ' 95' ' ' ALA . 87.2 mt -66.0 -45.7 90.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.904 -0.589 . . . . 8.01 111.479 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.84 -21.16 61.72 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.333 -0.547 . . . . 10.38 110.75 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.6 m -74.39 -26.99 60.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.856 0.36 . . . . 12.35 110.166 172.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 95.1 mmm -66.74 -26.48 67.01 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.398 0.618 . . . . 10.33 110.233 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.51 -10.77 4.65 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.415 -0.811 . . . . 9.53 111.714 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.591 ' HB2' HG22 ' A' ' 85' ' ' ILE . 33.4 m-85 -83.02 -175.0 5.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.717 0.294 . . . . 8.89 110.323 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 51.1 tt0 -100.72 147.61 25.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.791 -0.448 . . . . 10.16 109.791 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.512 ' O ' HD12 ' A' ' 96' ' ' ILE . 7.9 ttm180 -55.72 -54.3 46.03 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.857 0.361 . . . . 11.98 110.503 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB3' ' NE2' ' A' ' 91' ' ' GLN . 55.7 t30 -58.46 -37.07 74.71 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.862 -0.608 . . . . 9.02 111.207 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.614 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.2 tt0 -65.49 -38.55 90.08 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 6.68 109.653 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.26 -37.88 89.07 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.25 -0.886 . . . . 5.22 110.625 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -60.9 -52.88 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 116.316 -0.402 . . . . 6.39 111.174 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.559 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 8.0 tt0 -56.09 -44.21 78.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.202 0.525 . . . . 8.36 110.713 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.31 -54.03 51.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.369 -0.832 . . . . 5.41 110.595 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.705 HD23 ' HB2' ' A' ' 109' ' ' ALA . 78.1 mt -61.18 -33.88 74.15 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 116.707 -0.224 . . . . 5.77 111.486 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.559 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 92.1 mtt180 -54.9 -46.83 74.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.484 0.659 . . . . 7.71 110.112 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.34 -38.05 68.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.87 -1.059 . . . . 8.88 111.467 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.692 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 23.7 p -85.6 1.5 48.89 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.81 0.67 . . . . 8.79 112.81 -175.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.3 m120 61.98 46.77 6.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.09 0.472 . . . . 10.09 111.123 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 9.4 m120 66.73 24.07 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.363 -0.835 . . . . 7.8 111.144 177.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 14.8 t-20 -86.46 113.9 22.77 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.892 -0.781 . . . . 10.49 108.892 174.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.726 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.1 tt -57.6 -59.05 5.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.904 -1.044 . . . . 9.54 111.268 -175.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -56.61 -46.1 81.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.419 -1.264 . . . . 11.82 111.732 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.692 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 33.9 ttm180 -68.83 -28.83 67.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.445 -0.343 . . . . 12.41 110.625 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.705 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.64 -50.58 68.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.226 -0.657 . . . . 6.3 109.226 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.525 HD23 HG23 ' A' ' 85' ' ' ILE . 18.2 mt -60.29 -38.31 83.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.43 -0.804 . . . . 7.78 109.739 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.451 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 7.7 t70 -54.73 -51.61 65.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.033 -0.985 . . . . 9.04 110.107 173.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -63.87 -46.61 84.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.116 -1.402 . . . . 8.69 110.679 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.682 HD11 ' HA ' ' A' ' 95' ' ' ALA . 46.5 mt -64.57 -37.72 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.236 -0.893 . . . . 5.25 111.228 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -65.86 -26.42 67.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.313 0.577 . . . . 6.92 110.432 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.5 m -76.9 -2.51 33.95 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.319 -0.855 . . . . 8.33 109.963 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -135.72 67.11 64.69 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.573 -0.899 . . . . 9.41 108.573 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -38.44 -68.5 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.766 1 C-N-CA 125.303 4.002 . . . . 7.92 113.858 -169.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.81 ' HG3' ' HD1' ' A' ' 119' ' ' PHE . 7.2 pt-20 -167.85 -39.79 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.779 -1.1 . . . . 11.42 109.119 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.81 ' HD1' ' HG3' ' A' ' 118' ' ' GLU . 29.4 p90 -127.39 17.4 7.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.614 -0.721 . . . . 15.58 110.838 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 119' ' ' PHE . 10.7 mm-40 71.19 157.13 0.17 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.748 0.655 . . . . 11.4 111.761 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 44.0 -168.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.487 1.115 . . . . 12.26 113.245 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -142.37 131.93 23.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.917 -0.583 . . . . 15.51 109.504 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.3 m -121.38 -74.68 0.61 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.37 -0.377 . . . . 16.06 110.625 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -135.42 111.45 9.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 17.4 111.042 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -134.69 95.86 3.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 19.19 109.867 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.402 -0.809 . . . . 20.33 110.001 179.737 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 121.075 0.464 . . . . 7.16 110.616 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.572 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 78.3 mt -69.14 121.75 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 115.449 -0.796 . . . . 5.69 111.15 -175.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -73.68 82.25 1.56 Allowed 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.299 0.571 . . . . 4.6 109.927 176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' HA ' HG12 ' A' ' 7' ' ' VAL . 45.4 mt-10 -71.65 -3.11 19.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.647 -0.706 . . . . 5.13 111.107 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -56.71 -40.85 76.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.131 0.491 . . . . 4.17 110.265 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.915 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 12.1 p -65.67 -52.47 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.736 -0.666 . . . . 3.42 111.751 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.541 HG21 ' HB2' ' A' ' 21' ' ' ARG . 7.3 p -64.02 -38.73 83.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.913 -0.315 . . . . 3.24 111.274 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 64.7 mtt -62.5 -34.89 77.77 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.729 -0.214 . . . . 5.17 110.719 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.401 ' O ' ' HG2' ' A' ' 13' ' ' MET . 40.0 mt-30 -60.78 -40.25 91.91 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.79 -0.364 . . . . 5.38 110.76 175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.737 ' HB3' HD12 ' A' ' 17' ' ' LEU . 11.2 mt -67.78 -49.0 64.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.878 0.847 . . . . 3.9 109.884 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.26 -50.55 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.99 -1.459 . . . . 4.46 113.111 -170.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 8' ' ' MET . 56.1 mm-40 -66.35 -24.1 66.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.164 0.431 . . . . 6.27 112.164 -173.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 25.8 ptm -99.97 -3.85 31.36 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.652 -0.419 . . . . 5.2 111.79 -175.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.29 -92.6 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.674 -1.251 . . . . 4.75 113.588 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 33.0 m-85 -115.35 142.04 28.11 Favored Pre-proline 0 C--N 1.324 -0.522 0 O-C-N 122.96 -0.141 . . . . 5.09 110.65 -172.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.9 76.73 0.3 Allowed 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.983 2.455 . . . . 4.25 111.601 174.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.737 HD12 ' HB3' ' A' ' 10' ' ' LEU . 97.7 mt -79.8 66.76 5.37 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.49 -0.777 . . . . 3.29 111.846 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 21' ' ' ARG . 3.9 tt0 -56.68 -18.37 12.05 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 120.92 0.39 . . . . 5.48 110.892 174.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.899 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . . . -57.51 -35.79 70.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.172 0.511 . . . . 3.54 109.83 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.625 ' O ' HG23 ' A' ' 24' ' ' VAL . 14.1 t -73.27 -41.98 63.02 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.335 -0.848 . . . . 3.27 109.287 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' HB2' HG21 ' A' ' 7' ' ' VAL . 25.2 ttt180 -52.01 -53.29 43.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.366 -0.834 . . . . 6.1 110.7 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.404 ' HZ3' ' HB3' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -71.55 -23.85 61.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.821 -0.627 . . . . 4.77 110.612 178.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HB1' ' CD1' ' A' ' 38' ' ' TRP . . . -69.69 -42.3 74.3 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.981 -0.554 . . . . 4.34 110.771 175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 20' ' ' CYS . 86.1 t -55.43 -45.63 78.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.279 -0.418 . . . . 4.58 110.025 175.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -59.44 -49.91 75.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.02 -0.536 . . . . 7.48 110.499 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -61.76 -39.37 91.39 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.223 -0.444 . . . . 6.84 112.08 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.6 p -70.13 -15.1 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.101 0.477 . . . . 5.71 111.318 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.08 28.27 34.65 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.831 -0.7 . . . . 5.75 111.485 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 2' ' ' ILE . 61.8 m-80 60.68 65.56 1.02 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.256 0.55 . . . . 5.06 110.816 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.402 ' HB3' HG21 ' A' ' 34' ' ' VAL . 91.4 mmm -95.94 34.59 1.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.797 -0.638 . . . . 6.28 111.225 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.14 -179.53 45.23 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 121.072 -0.585 . . . . 4.17 113.58 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.915 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.17 -39.23 78.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.625 -0.288 . . . . 3.73 111.579 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -58.41 -52.72 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.194 -0.457 . . . . 5.46 111.663 -175.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 30' ' ' MET . 69.3 t -67.32 -38.1 80.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.256 -0.429 . . . . 4.88 111.798 -175.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -32.24 55.61 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.465 -0.494 . . . . 3.68 111.739 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.621 ' O ' HG22 ' A' ' 39' ' ' ILE . 75.7 t80 -61.64 -39.7 92.25 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.459 -0.941 . . . . 4.71 108.459 170.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.731 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.8 t30 -64.59 -39.08 93.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.421 -0.809 . . . . 5.69 110.792 174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.415 ' CD1' ' HB1' ' A' ' 23' ' ' ALA . 24.2 t-105 -67.86 -30.81 70.28 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.565 -0.454 . . . . 5.87 110.363 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 36' ' ' PHE . 4.3 tp -77.45 -32.61 18.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 120.805 -0.358 . . . . 3.69 111.47 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.3 pp -68.36 -26.55 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.111 -0.636 . . . . 5.04 109.776 175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 37' ' ' ASN . 96.2 t -70.43 -36.88 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.579 -0.737 . . . . 5.37 110.231 170.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.449 ' HB3' ' HG3' ' A' ' 45' ' ' GLU . 39.7 m-70 -102.22 20.77 16.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.192 -0.458 . . . . 5.35 111.909 -178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -59.22 -22.31 60.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.035 0.445 . . . . 5.73 110.871 174.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -80.37 14.95 1.76 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.592 -0.731 . . . . 6.34 111.911 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.729 ' HB3' ' HB2' ' A' ' 48' ' ' PHE . 4.5 mm-40 -107.65 93.81 10.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.526 -0.176 . . . . 5.62 110.526 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 11.1 Cg_endo -59.18 -52.0 5.67 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.874 2.383 . . . . 6.22 112.258 174.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -86.72 -14.45 42.43 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.08 -1.418 . . . . 6.09 112.039 -168.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.899 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . 23.7 m-85 -75.02 -9.49 58.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.164 0.507 . . . . 5.89 110.651 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.574 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -101.37 101.13 11.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.036 -1.098 . . . . 4.6 108.036 171.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 34.0 mm-40 -39.64 105.71 0.37 Allowed Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.495 1.122 . . . . 5.96 112.638 -176.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 5.9 Cg_exo -79.04 68.49 8.26 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.505 2.803 . . . . 6.2 112.322 -175.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.1 tp -134.5 105.12 6.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.561 -0.745 . . . . 8.24 109.772 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.0 m 66.58 84.09 0.16 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 7.27 110.455 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 93.9 mmm -70.47 113.44 18.26 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.024 -0.534 . . . . 7.41 109.878 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 74.5 Cg_endo -96.33 -168.3 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.227 2.618 . . . . 5.89 113.199 -173.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.75 166.62 39.78 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.97 -0.852 . . . . 6.63 110.97 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -82.42 133.0 35.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.065 0.433 . . . . 9.15 109.846 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.53 16.84 8.47 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.835 -0.698 . . . . 6.92 111.508 -176.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.5 86.98 0.92 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.575 -0.61 . . . . 7.34 111.575 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.47 -46.63 79.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.684 0.278 . . . . 7.8 111.375 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.95 -31.3 1.02 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.368 -0.378 . . . . 6.73 111.511 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.5 t -100.64 112.62 25.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.884 0.373 . . . . 7.03 110.88 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.45 -36.08 11.46 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.36 -0.607 . . . . 6.23 109.36 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -157.99 34.7 0.53 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.314 -0.857 . . . . 7.09 111.625 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.4 26.96 2.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.046 0.45 . . . . 7.1 111.268 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 p -89.43 -12.75 39.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.199 0.524 . . . . 7.6 110.407 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.0 t -89.33 86.51 2.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.883 -0.599 . . . . 8.01 110.778 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -137.85 115.23 11.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.237 0.541 . . . . 8.06 110.121 173.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.71 116.26 5.31 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.747 -0.661 . . . . 6.62 112.71 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.32 139.88 58.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.14 0.495 . . . . 6.12 110.4 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.1 m -66.52 -21.36 66.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.451 -0.795 . . . . 7.65 111.444 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.06 95.03 0.14 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 121.09 -0.576 . . . . 6.25 111.861 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.42 86.4 5.25 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.848 -0.797 . . . . 7.29 108.848 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.8 t70 58.7 80.51 0.18 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.577 0.704 . . . . 6.55 110.154 -173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -130.75 72.97 1.51 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.342 -0.845 . . . . 7.51 108.811 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -83.97 135.71 42.11 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.828 -0.624 . . . . 7.14 109.399 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.593 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.5 Cg_exo -53.96 162.54 3.83 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 123.096 2.53 . . . . 5.41 112.412 175.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.672 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_endo -63.74 112.12 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.444 2.096 . . . . 7.14 111.089 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.7 pt-20 -56.42 -25.39 50.16 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.516 0.51 . . . . 10.13 110.556 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 2.3 tp10 -57.93 -55.0 40.58 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.486 -0.779 . . . . 11.78 110.163 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.796 ' HA ' HD12 ' A' ' 84' ' ' ILE . 82.6 mt -75.41 -40.64 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.774 -0.648 . . . . 8.42 112.094 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.765 ' O ' HG22 ' A' ' 86' ' ' THR . 9.0 m -56.32 -37.81 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 108.357 -0.979 . . . . 7.57 108.357 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.79 -48.83 80.03 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.885 -1.052 . . . . 10.39 110.599 176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.796 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.8 mt -60.22 -43.54 93.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 10.78 110.827 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.72 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.4 mt -64.05 -45.52 96.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.034 -0.53 . . . . 8.01 111.708 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -72.13 -21.46 61.47 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.876 -0.729 . . . . 10.38 110.786 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.3 m -75.55 -22.04 57.39 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.041 0.448 . . . . 12.35 110.315 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.3 mmm -70.86 -26.63 63.34 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.275 0.56 . . . . 10.33 109.89 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.54 6.39 4.69 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.405 -0.816 . . . . 9.53 112.08 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 34.5 m-85 -99.24 -175.95 3.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.147 -0.316 . . . . 8.89 110.147 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.902 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 91.9 mt-30 -86.84 153.89 21.3 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.283 -0.266 . . . . 10.16 110.283 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 96' ' ' ILE . 14.2 ttm180 -65.45 -51.41 60.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.141 -0.688 . . . . 11.98 109.141 170.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -60.41 -39.65 88.16 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.336 -0.847 . . . . 9.02 110.886 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.902 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 8.3 tt0 -64.41 -36.64 84.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.139 0.495 . . . . 6.68 109.689 176.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.72 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -65.17 -40.23 94.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.458 -0.792 . . . . 5.22 110.466 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.593 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.46 -52.1 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 116.285 -0.416 . . . . 6.39 110.529 176.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.561 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 49.8 tt0 -58.24 -44.6 88.34 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.825 -0.625 . . . . 8.36 110.973 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.83 -53.1 61.84 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.54 -0.755 . . . . 5.41 110.441 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 109' ' ' ALA . 74.1 mt -60.64 -33.1 72.29 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 111.631 0.234 . . . . 5.77 111.631 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.561 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 73.2 mtt180 -55.29 -48.45 74.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.563 0.697 . . . . 7.71 110.21 175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.76 -40.64 72.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.859 -1.064 . . . . 8.88 111.298 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.709 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 24.7 p -82.81 -0.04 46.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.547 0.573 . . . . 8.79 112.547 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.8 m120 58.82 63.22 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.801 -0.636 . . . . 10.09 110.161 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.1 p-10 49.14 32.85 4.39 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.498 1.119 . . . . 7.8 112.722 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 16.2 t-20 -93.78 113.87 26.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.033 -0.728 . . . . 10.49 109.033 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.712 HD12 HG12 ' A' ' 81' ' ' ILE . 8.2 tt -56.97 -60.6 3.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.99 -1.005 . . . . 9.54 111.594 -175.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.409 ' N ' HD23 ' A' ' 106' ' ' LEU . 7.2 mm-40 -57.41 -45.84 84.13 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.365 -0.834 . . . . 11.82 111.667 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.709 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 34.5 ttm180 -67.46 -28.8 68.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.416 -0.356 . . . . 12.41 110.754 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.726 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.32 -51.33 66.44 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.449 -0.574 . . . . 6.3 109.449 177.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.532 HD23 HG23 ' A' ' 85' ' ' ILE . 17.8 mt -59.01 -39.4 81.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.384 -0.825 . . . . 7.78 109.428 174.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.34 -46.21 83.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.029 -0.987 . . . . 9.04 110.461 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -67.8 -46.58 71.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.846 -1.07 . . . . 8.69 110.396 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.586 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.5 mt -60.78 -39.68 82.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.281 -0.872 . . . . 5.25 110.354 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -70.18 -22.79 62.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.847 -0.615 . . . . 6.92 110.805 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.5 t -78.14 -5.94 53.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.112 -0.495 . . . . 8.33 110.045 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -140.95 71.96 28.47 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 9.41 110.812 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.528 ' HG2' ' HA ' ' A' ' 120' ' ' GLU . 8.3 Cg_endo -50.88 -62.84 0.34 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 123.674 2.916 . . . . 7.92 111.573 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.535 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 7.9 pt-20 -155.47 -54.51 0.09 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.601 -1.181 . . . . 11.42 109.327 173.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.535 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 36.4 t80 -133.87 13.37 4.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.379 -0.828 . . . . 15.58 109.097 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 117' ' ' PRO . 38.1 mt-10 65.2 176.75 0.2 Allowed 'General case' 0 C--O 1.232 0.136 0 CA-C-N 114.841 -1.072 . . . . 11.4 111.321 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -120.53 133.22 55.42 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.513 -0.551 . . . . 12.26 109.513 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -145.46 -53.18 0.27 Allowed 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.231 -0.588 . . . . 15.51 111.278 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 p 42.89 55.87 4.22 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.463 0.649 . . . . 16.06 110.62 -175.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -85.03 136.98 33.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.363 -0.835 . . . . 17.4 111.232 -174.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 t80 70.32 78.86 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.242 0.964 . . . . 19.19 110.765 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.252 1.185 0 CA-C-N 115.566 -0.743 . . . . 20.33 109.399 176.658 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.808 -0.812 . . . . 7.16 108.808 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.553 HG12 ' HB2' ' A' ' 25' ' ' TYR . 4.2 mp 45.41 74.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.731 -0.47 . . . . 5.69 109.731 -169.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -63.58 97.6 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.224 0.535 . . . . 4.6 110.529 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.602 ' HA ' HG12 ' A' ' 7' ' ' VAL . 9.9 mt-10 -71.04 -5.41 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.507 -0.77 . . . . 5.13 111.9 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.3 t -55.94 -34.28 65.51 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.999 -0.741 . . . . 4.17 108.999 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.532 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.4 m -65.24 -52.76 52.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.671 -0.695 . . . . 3.42 111.049 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -69.03 -41.34 81.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.755 0.312 . . . . 3.24 111.308 -177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.641 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 57.7 mtt -59.54 -35.05 73.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.355 -0.384 . . . . 5.17 110.787 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -62.89 -42.52 99.8 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 123.029 0.206 . . . . 5.38 111.122 174.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.747 ' HB3' HD12 ' A' ' 17' ' ' LEU . 14.4 mt -63.26 -44.64 94.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.502 0.668 . . . . 3.9 109.685 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -63.1 -32.74 74.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.893 -1.049 . . . . 4.46 111.094 -178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.641 ' HG2' ' O ' ' A' ' 8' ' ' MET . 60.9 mm-40 -59.93 -31.18 69.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 6.27 110.281 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.0 mtp -92.91 8.56 39.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.847 -0.615 . . . . 5.2 111.737 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 151.7 -102.74 0.23 Allowed Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 119.798 -1.192 . . . . 4.75 114.228 175.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 93.5 m-85 -83.19 145.67 49.5 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 112.017 0.376 . . . . 5.09 112.017 -169.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.25 86.09 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.02 2.48 . . . . 4.25 110.98 172.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.785 HD13 HG12 ' A' ' 39' ' ' ILE . 92.2 mt -80.9 70.95 7.81 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.801 -0.636 . . . . 3.29 112.483 -170.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -24.37 38.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.256 0.551 . . . . 5.48 110.781 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.7 -30.97 67.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.104 -0.498 . . . . 3.54 110.022 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.562 ' O ' HG23 ' A' ' 24' ' ' VAL . 36.9 t -73.18 -43.51 61.29 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.402 -0.817 . . . . 3.27 109.643 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -49.73 -57.0 8.14 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 115.681 -0.69 . . . . 6.1 109.836 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 19' ' ' ALA . 14.8 ptpt -66.24 -32.82 74.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.69 -0.686 . . . . 4.77 110.673 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.02 95.15 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.382 -0.372 . . . . 4.34 111.145 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 20' ' ' CYS . 79.1 t -57.01 -43.57 81.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.398 . . . . 4.58 110.172 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.553 ' HB2' HG12 ' A' ' 2' ' ' ILE . 54.4 t80 -67.93 -42.68 80.67 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 119.776 -0.77 . . . . 7.48 110.684 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.23 -40.31 97.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 6.84 111.744 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.7 p -65.8 -23.16 66.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.163 0.506 . . . . 5.71 110.79 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.52 26.83 8.39 Favored Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 115.768 -0.651 . . . . 5.75 111.566 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 40.5 t30 61.88 62.24 1.28 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.345 0.593 . . . . 5.06 109.68 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 97.2 mmm -101.57 21.65 13.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.867 -0.606 . . . . 6.28 112.103 -172.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.41 177.15 48.57 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.306 -0.95 . . . . 4.17 113.108 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -69.65 -44.26 70.92 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.758 0.281 . . . . 3.73 111.758 -176.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -59.11 -43.5 91.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.27 -0.423 . . . . 5.46 111.847 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.8 t -68.87 -39.75 80.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.406 -0.361 . . . . 4.88 111.177 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.99 -30.3 55.88 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.841 -0.343 . . . . 3.68 111.563 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.599 ' O ' HG22 ' A' ' 39' ' ' ILE . 78.3 t80 -58.08 -43.58 87.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.729 -0.841 . . . . 4.71 108.729 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.592 ' O ' HG13 ' A' ' 40' ' ' ILE . 47.4 t30 -64.06 -43.14 96.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.376 -0.829 . . . . 5.69 110.368 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -63.81 -33.93 76.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 5.87 110.719 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.785 HG12 HD13 ' A' ' 17' ' ' LEU . 6.4 tp -76.09 -38.74 35.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.395 -0.366 . . . . 3.69 111.218 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -70.05 -21.91 24.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.187 0.518 . . . . 5.04 110.504 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 37' ' ' ASN . 92.8 t -76.32 -48.98 26.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.819 -0.628 . . . . 5.37 110.241 170.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -83.3 2.64 35.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.098 -0.501 . . . . 5.35 111.349 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -68.95 -21.8 64.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.931 0.345 . . . . 5.73 111.931 -176.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.6 -11.4 58.05 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.042 0.386 . . . . 6.34 112.042 -175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.785 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 31.3 mm-40 -67.8 142.42 95.68 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 120.973 0.416 . . . . 5.62 110.31 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.82 -41.98 27.35 Favored 'Trans proline' 0 N--CA 1.47 0.133 0 C-N-CA 123.303 2.669 . . . . 6.22 112.675 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -116.15 27.24 9.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.719 0.771 . . . . 6.09 110.564 -171.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.785 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.8 p90 -56.77 -28.54 61.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.695 -0.684 . . . . 5.89 111.86 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.22 113.56 4.29 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.784 -0.45 . . . . 4.6 109.784 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 43.5 mt-10 -57.01 118.29 22.99 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 5.96 110.279 175.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 7.9 Cg_exo -72.38 73.31 2.77 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.106 2.537 . . . . 6.2 113.015 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.401 ' O ' ' HB ' ' A' ' 53' ' ' THR . 23.6 tp -81.23 82.07 7.22 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.15 -0.685 . . . . 8.24 109.15 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 88.1 m 70.39 99.46 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.572 -0.74 . . . . 7.27 110.371 -172.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.25 109.68 25.18 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.813 -0.63 . . . . 7.41 110.738 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 53' ' ' THR . 3.5 Cg_exo -82.23 138.82 10.2 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.158 2.572 . . . . 5.89 112.16 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.6 90.25 1.61 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.971 -0.633 . . . . 6.63 111.822 178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -79.46 66.96 5.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.499 0.666 . . . . 9.15 110.054 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.5 -60.84 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.41 -0.814 . . . . 6.92 111.415 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.6 -172.16 31.73 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.762 -0.733 . . . . 7.34 112.582 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -76.37 -65.73 0.89 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.537 -0.172 . . . . 7.8 110.537 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.92 54.65 8.74 Favored 'General case' 0 C--N 1.333 -0.143 0 O-C-N 123.699 0.624 . . . . 6.73 111.375 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 p -92.96 146.74 23.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.055 -0.521 . . . . 7.03 110.573 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -152.85 141.46 20.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.368 -0.378 . . . . 6.23 110.561 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.69 124.94 1.71 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.605 -0.598 . . . . 7.09 111.605 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 62.89 43.36 6.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.406 0.622 . . . . 7.1 110.488 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 t -89.33 159.39 17.39 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.414 -0.812 . . . . 7.6 110.178 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 t 60.5 68.24 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 121.651 0.739 . . . . 8.01 110.431 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -73.07 141.51 47.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.566 -0.743 . . . . 8.06 110.423 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.41 91.47 0.85 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.757 -0.735 . . . . 6.62 112.651 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.25 87.1 7.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.028 0.442 . . . . 6.12 110.107 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -83.93 -39.4 19.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.937 -0.574 . . . . 7.65 110.544 -178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -121.35 85.32 0.38 Allowed Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.543 -0.837 . . . . 6.25 112.325 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.83 -61.34 2.36 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.726 -0.472 . . . . 7.29 109.726 175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.2 t70 176.14 147.97 0.1 Allowed 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.596 -0.729 . . . . 6.55 109.869 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -91.15 74.41 6.26 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.204 -1.406 . . . . 7.51 107.204 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 24.8 tt0 -64.87 129.86 94.59 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 115.103 -0.953 . . . . 7.14 111.452 -168.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.676 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.7 Cg_exo -58.58 166.38 6.45 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 123.891 3.06 . . . . 5.41 112.879 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.678 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 44.6 Cg_endo -66.66 111.88 2.26 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.686 2.257 . . . . 7.14 111.143 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.6 pt-20 -52.25 -30.11 26.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 10.13 111.237 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 6.2 tt0 -58.66 -51.35 70.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.854 -0.612 . . . . 11.78 110.339 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.754 ' HA ' HD12 ' A' ' 84' ' ' ILE . 69.4 mt -75.13 -40.83 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 115.686 -0.688 . . . . 8.42 111.452 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.771 ' O ' HG22 ' A' ' 86' ' ' THR . 5.2 m -56.18 -38.29 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.626 -0.879 . . . . 7.57 108.626 177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.07 -49.4 77.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.822 -1.081 . . . . 10.39 110.775 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.56 -40.11 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.484 . . . . 10.78 110.729 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.732 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.3 mt -67.33 -46.74 83.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.874 -0.603 . . . . 8.01 111.64 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.99 -21.13 63.25 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.175 -0.61 . . . . 10.38 110.638 176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.0 m -75.35 -25.47 57.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.914 0.388 . . . . 12.35 110.619 172.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 21.9 mmt -69.15 -26.51 64.91 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.168 -0.469 . . . . 10.33 110.242 176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.88 -2.83 4.87 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.714 -0.676 . . . . 9.53 111.817 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 35.2 m-85 -93.08 -173.98 3.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 8.89 110.468 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.596 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 4.7 tt0 -99.31 147.88 24.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.278 -0.419 . . . . 10.16 110.371 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.474 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.5 ttm180 -57.11 -54.65 44.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.767 0.318 . . . . 11.98 110.731 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.97 -36.19 78.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.266 0.555 . . . . 9.02 110.915 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.646 ' HG2' HD13 ' A' ' 113' ' ' ILE . 8.7 tt0 -64.45 -38.81 92.31 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.604 -0.725 . . . . 6.68 109.569 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.732 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -64.15 -40.34 95.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.278 -0.874 . . . . 5.22 110.703 173.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.676 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mt -59.64 -52.48 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.994 -0.548 . . . . 6.39 110.857 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.577 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.5 tt0 -52.97 -47.32 68.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.483 0.659 . . . . 8.36 110.709 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.709 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.65 -54.05 50.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.013 -0.994 . . . . 5.41 110.74 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.754 HD23 ' HB2' ' A' ' 109' ' ' ALA . 68.1 mt -62.15 -30.99 71.43 Favored 'General case' 0 C--O 1.224 -0.272 0 N-CA-C 111.54 0.2 . . . . 5.77 111.54 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 86.7 mtt180 -55.31 -46.97 76.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.365 0.602 . . . . 7.71 109.508 175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.7 -35.87 57.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.936 -1.029 . . . . 8.88 112.035 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 98' ' ' ALA . 29.2 p -83.19 -2.71 56.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.077 0.399 . . . . 8.79 112.077 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.96 41.44 2.08 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 124.06 0.85 . . . . 10.09 110.364 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.625 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 0.7 OUTLIER 72.23 18.7 4.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.456 -0.793 . . . . 7.8 110.962 178.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 17.6 t-20 -82.6 115.68 21.67 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.524 -0.547 . . . . 10.49 109.524 174.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.728 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.3 tt -58.16 -60.53 3.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.081 -0.963 . . . . 9.54 111.722 -176.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.403 ' N ' HD23 ' A' ' 106' ' ' LEU . 51.1 mm-40 -53.68 -51.95 61.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.318 -0.856 . . . . 11.82 111.71 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.645 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.0 ttm180 -62.94 -28.69 70.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.196 -0.456 . . . . 12.41 110.868 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.754 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.55 -50.61 68.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.302 -0.629 . . . . 6.3 109.302 178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.573 HD23 HG23 ' A' ' 85' ' ' ILE . 15.7 mt -59.21 -38.28 79.55 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.07 -0.968 . . . . 7.78 109.434 175.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 15.1 t70 -56.95 -51.82 67.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.037 -0.983 . . . . 9.04 110.3 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.27 -47.51 84.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.278 -1.328 . . . . 8.69 110.663 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.663 HD11 ' HA ' ' A' ' 95' ' ' ALA . 47.9 mt -61.06 -41.9 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.12 -0.945 . . . . 5.25 110.804 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -67.52 -30.3 69.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.236 0.541 . . . . 6.92 110.546 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.1 m -85.44 0.68 51.53 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.684 -0.689 . . . . 8.33 110.656 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -142.39 72.41 21.34 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.927 -0.579 . . . . 9.41 110.932 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.72 ' HD2' ' HG3' ' A' ' 120' ' ' GLU . 6.2 Cg_endo -48.43 -40.4 36.45 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.736 2.957 . . . . 7.92 111.87 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.496 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 8.6 pt-20 -178.26 -53.58 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.748 -1.114 . . . . 11.42 108.873 175.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.496 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 36.3 t80 -146.97 12.58 1.1 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.372 -0.831 . . . . 15.58 109.6 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.72 ' HG3' ' HD2' ' A' ' 117' ' ' PRO . 3.4 mp0 56.92 -161.16 0.21 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.427 -1.26 . . . . 11.4 111.137 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 2.0 pm0 -81.33 156.35 25.55 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.375 -0.53 . . . . 12.26 110.08 174.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.51 106.93 18.61 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.819 -0.628 . . . . 15.51 110.43 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.7 p -65.87 158.78 27.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.225 -0.898 . . . . 16.06 111.682 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.88 120.03 11.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.968 -0.56 . . . . 17.4 110.635 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -89.3 -12.83 39.49 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.041 0.448 . . . . 19.19 109.872 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.417 -0.802 . . . . 20.33 110.016 177.79 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.225 -0.287 . . . . 7.16 110.225 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.442 HG22 ' HG3' ' A' ' 4' ' ' GLU . 54.7 mt -59.46 113.93 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 123.358 0.411 . . . . 5.69 111.343 -177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -83.33 82.64 8.19 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.238 0.542 . . . . 4.6 110.239 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' HG3' HG22 ' A' ' 2' ' ' ILE . 36.1 mt-10 -71.64 -2.76 18.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.556 -0.747 . . . . 5.13 111.281 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.635 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 26.6 t -60.89 -35.91 77.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.717 -0.845 . . . . 4.17 108.717 168.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 6.7 m -58.48 -49.9 75.68 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.943 -0.571 . . . . 3.42 111.141 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 17' ' ' LEU . 2.7 p -64.26 -41.06 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.806 0.336 . . . . 3.24 110.832 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 81.1 mtp -63.71 -29.84 71.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.148 -0.478 . . . . 5.17 111.378 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.635 ' HG2' ' O ' ' A' ' 5' ' ' SER . 81.4 mm-40 -64.38 -44.44 91.33 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.996 -0.281 . . . . 5.38 110.504 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.543 HD12 ' HB2' ' A' ' 20' ' ' CYS . 18.8 mt -68.09 -40.36 82.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.402 0.62 . . . . 3.9 109.756 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.64 -50.81 71.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.716 -1.129 . . . . 4.46 111.901 -175.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -69.99 -19.26 63.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.234 -0.439 . . . . 6.27 112.064 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.0 ptm -99.32 -4.6 31.38 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.57 -0.452 . . . . 5.2 111.321 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -167.54 -98.4 0.12 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.189 -1.005 . . . . 4.75 113.206 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 99.0 m-85 -118.81 157.9 48.98 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.485 0.183 . . . . 5.09 111.047 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 56.0 Cg_endo -71.65 82.46 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.594 2.196 . . . . 4.25 112.138 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 7' ' ' VAL . 4.4 mm? -73.86 69.6 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 3.29 111.618 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 5.6 tt0 -56.73 -24.14 47.56 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.277 -0.89 . . . . 5.48 109.981 171.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.44 -29.68 66.33 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 116.062 -0.517 . . . . 3.54 109.856 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.688 ' HA ' HD11 ' A' ' 39' ' ' ILE . 49.9 t -69.37 -44.81 70.78 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.303 -0.629 . . . . 3.27 109.303 174.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.61 -49.76 67.12 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 116.013 -0.54 . . . . 6.1 109.911 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 26.5 mttm -62.16 -40.63 96.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.66 -0.7 . . . . 4.77 110.147 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.2 -43.19 92.38 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.364 -0.835 . . . . 4.34 111.714 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 20' ' ' CYS . 76.3 t -56.17 -47.18 81.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.743 0.306 . . . . 4.58 110.313 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.76 -36.7 83.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 7.48 110.492 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -69.1 -45.7 69.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 6.84 111.221 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.4 p -62.29 -27.14 68.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.194 0.521 . . . . 5.71 111.04 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.75 28.04 6.11 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.674 -0.694 . . . . 5.75 111.558 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 59.27 51.24 7.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.123 0.487 . . . . 5.06 109.923 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.462 ' HB3' HG21 ' A' ' 34' ' ' VAL . 80.9 mtp -81.39 -35.25 31.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.796 -0.638 . . . . 6.28 112.106 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.61 169.71 16.87 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.022 -1.085 . . . . 4.17 113.279 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -62.99 -41.3 99.53 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.575 0.35 . . . . 3.73 111.706 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -67.66 -40.16 84.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 5.46 110.12 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 30' ' ' MET . 85.2 t -64.31 -41.49 92.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.358 -0.837 . . . . 4.88 110.782 -178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -32.89 58.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.441 -0.345 . . . . 3.68 111.109 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' O ' HG23 ' A' ' 40' ' ' ILE . 78.8 t80 -55.24 -44.41 75.46 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.156 -0.683 . . . . 4.71 109.156 172.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.686 ' O ' HG13 ' A' ' 40' ' ' ILE . 8.2 t30 -67.92 -35.78 79.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.519 -0.764 . . . . 5.69 110.609 177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -65.46 -32.85 74.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.094 0.473 . . . . 5.87 109.872 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.688 HD11 ' HA ' ' A' ' 20' ' ' CYS . 1.4 mp -77.06 -37.76 26.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.864 -0.607 . . . . 3.69 112.099 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.4 pp -63.57 -30.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.637 0.732 . . . . 5.04 109.91 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 37' ' ' ASN . 60.2 t -69.57 -51.83 37.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.142 -0.935 . . . . 5.37 110.484 170.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -85.28 13.43 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.669 0.618 . . . . 5.35 112.669 -174.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.1 ptt? -68.3 -22.1 64.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.805 0.336 . . . . 5.73 111.07 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -84.47 8.44 16.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 6.34 111.334 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 13.6 mm-40 -76.73 138.25 66.41 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.131 -0.486 . . . . 5.62 110.096 174.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.98 -34.99 99.36 Favored 'Trans proline' 0 CA--C 1.522 -0.124 0 C-N-CA 122.926 2.417 . . . . 6.22 112.129 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -115.81 24.49 11.46 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.766 -1.106 . . . . 6.09 110.389 -171.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.786 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 3.3 p90 -60.02 -38.17 81.92 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.201 0.524 . . . . 5.89 111.349 -176.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -131.23 97.71 4.35 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.657 -0.498 . . . . 4.6 109.657 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 47.8 mt-10 -60.01 126.03 82.48 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.572 -0.74 . . . . 5.96 110.634 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.528 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 8.2 Cg_exo -72.59 64.64 3.81 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.489 2.793 . . . . 6.2 113.251 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 tt -127.85 109.24 11.42 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.801 -0.814 . . . . 8.24 108.801 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.7 p 58.07 71.13 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 O-C-N 124.06 0.85 . . . . 7.27 111.082 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 65.0 mtm -87.29 119.37 70.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.27 -0.877 . . . . 7.41 110.451 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 22.5 Cg_exo -67.83 -55.07 0.29 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.205 2.604 . . . . 5.89 112.31 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.74 61.93 5.75 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 111.23 -0.748 . . . . 6.63 111.23 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -77.97 123.05 26.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.218 0.532 . . . . 9.15 111.797 -171.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.43 147.05 13.43 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.702 -0.959 . . . . 6.92 110.702 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.65 20.04 6.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.55 -0.834 . . . . 7.34 112.347 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 59.17 -84.59 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.334 0.654 . . . . 7.8 111.716 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -152.15 121.97 7.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.437 -0.347 . . . . 6.73 110.297 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.3 m -85.4 66.05 9.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.311 0.577 . . . . 7.03 109.691 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.62 97.28 6.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.658 -0.701 . . . . 6.23 111.334 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -89.31 121.91 6.26 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.879 -0.677 . . . . 7.09 111.594 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.38 151.49 30.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.767 0.317 . . . . 7.1 110.644 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.5 m -95.2 119.82 34.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.09 -0.504 . . . . 7.6 109.868 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.89 -10.27 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.058 -0.519 . . . . 8.01 112.18 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -117.29 140.06 50.04 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.186 -0.302 . . . . 8.06 110.186 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -145.65 -123.76 1.6 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 121.017 -0.611 . . . . 6.62 112.257 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.452 ' HB1' HD23 ' A' ' 73' ' ' LEU . . . -96.27 130.31 43.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.783 0.325 . . . . 6.12 110.856 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.9 p -83.4 33.07 0.45 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 7.65 111.737 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.77 -74.36 0.29 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.08 -0.581 . . . . 6.25 111.876 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.452 HD23 ' HB1' ' A' ' 70' ' ' ALA . 4.3 mm? 59.05 44.43 16.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.114 0.483 . . . . 7.29 110.807 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -147.47 111.12 4.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.784 -0.644 . . . . 6.55 109.726 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -160.58 65.78 0.32 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.66 0.743 . . . . 7.51 110.335 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -125.15 140.18 35.43 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.735 -0.666 . . . . 7.14 110.147 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.578 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.3 Cg_exo -56.25 164.9 4.69 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.177 2.585 . . . . 5.41 112.115 171.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.658 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 39.8 Cg_endo -63.15 114.0 2.28 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.487 2.125 . . . . 7.14 111.186 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.726 ' HA ' HG22 ' A' ' 82' ' ' VAL . 15.1 pt-20 -58.2 -28.18 64.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 10.13 110.529 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 3.1 tt0 -57.34 -51.34 69.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.073 -0.512 . . . . 11.78 109.92 173.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.7 mt -76.59 -41.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 115.844 -0.616 . . . . 8.42 111.76 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.771 ' O ' HG22 ' A' ' 86' ' ' THR . 10.9 m -55.49 -38.27 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 108.549 -0.908 . . . . 7.57 108.549 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.38 -49.07 78.4 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.782 -1.099 . . . . 10.39 110.715 175.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.1 mt -59.54 -42.29 87.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.996 -0.547 . . . . 10.78 110.423 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.702 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.1 mt -64.83 -47.26 89.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.665 -0.698 . . . . 8.01 111.368 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -69.67 -21.2 63.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 119.98 -0.688 . . . . 10.38 110.874 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.1 m -76.52 -21.9 55.13 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.933 0.396 . . . . 12.35 110.645 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 94.2 mmm -71.33 -24.56 62.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.391 0.615 . . . . 10.33 110.167 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.93 0.48 5.59 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.108 -0.951 . . . . 9.53 111.529 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.608 ' HB2' HG22 ' A' ' 85' ' ' ILE . 34.3 m-85 -94.02 -173.67 3.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.827 0.346 . . . . 8.89 110.428 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.4 tt0 -100.08 146.47 26.74 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.85 -0.426 . . . . 10.16 109.85 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.516 ' O ' HD12 ' A' ' 96' ' ' ILE . 5.7 ttm180 -58.13 -53.62 56.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.119 0.485 . . . . 11.98 110.196 178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -58.93 -37.45 76.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.575 -0.739 . . . . 9.02 111.145 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.8 tt0 -64.08 -40.43 96.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.65 -0.705 . . . . 6.68 109.586 175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.702 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.76 -38.51 90.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.02 -0.991 . . . . 5.22 110.735 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.578 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.2 mp -60.88 -52.72 58.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.175 0 CA-C-N 116.267 -0.424 . . . . 6.39 110.849 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.2 tt0 -55.36 -44.58 76.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.93 -0.577 . . . . 8.36 110.811 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.08 -53.47 57.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.249 -0.887 . . . . 5.41 110.835 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.674 HD23 ' HB2' ' A' ' 109' ' ' ALA . 69.7 mt -62.59 -29.83 70.89 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.62 -0.264 . . . . 5.77 111.547 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.3 mtt180 -57.23 -50.83 71.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.424 0.63 . . . . 7.71 110.311 175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.29 -41.98 84.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.921 -1.036 . . . . 8.88 111.319 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 29.4 p -82.02 -7.35 59.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.684 0.624 . . . . 8.79 112.684 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.26 67.86 0.76 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.671 0.748 . . . . 10.09 110.289 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 8.5 p30 52.26 21.1 1.54 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 113.844 -1.526 . . . . 7.8 112.889 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.414 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 17.6 m-80 -82.33 110.35 17.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.495 -0.557 . . . . 10.49 109.495 174.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.733 HD12 HG12 ' A' ' 81' ' ' ILE . 8.2 tt -57.05 -60.74 3.14 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 114.973 -1.012 . . . . 9.54 111.732 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.414 ' N ' HD23 ' A' ' 106' ' ' LEU . 5.9 mm-40 -56.78 -45.66 82.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.325 -0.852 . . . . 11.82 111.428 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.646 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 29.1 ttm180 -67.21 -28.45 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.397 -0.365 . . . . 12.41 111.003 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.674 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.84 -50.65 68.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.252 -0.647 . . . . 6.3 109.252 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.524 HD23 HG23 ' A' ' 85' ' ' ILE . 17.9 mt -59.82 -37.34 78.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.218 -0.901 . . . . 7.78 109.637 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 10.8 t70 -54.18 -53.52 52.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 122.187 0.994 . . . . 9.04 110.004 172.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -61.36 -45.75 93.09 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.893 -1.503 . . . . 8.69 110.594 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.671 HD11 ' HA ' ' A' ' 95' ' ' ALA . 41.7 mt -66.98 -39.18 82.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.075 -0.966 . . . . 5.25 111.105 -178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.506 ' O ' ' HD3' ' A' ' 117' ' ' PRO . 40.2 t80 -67.37 -20.7 65.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 6.92 110.624 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.7 t -67.15 -14.31 62.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.364 0.602 . . . . 8.33 109.814 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -125.49 67.35 57.27 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.167 -0.679 . . . . 9.41 109.167 171.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 114' ' ' PHE . 1.2 Cg_endo -39.17 -66.17 0.14 Allowed 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 125.272 3.981 . . . . 7.92 114.445 -170.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.475 ' HG2' ' HB2' ' A' ' 117' ' ' PRO . 3.5 pt-20 -167.39 -42.55 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.89 -1.05 . . . . 11.42 108.989 -173.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -146.53 30.37 1.01 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.742 -1.117 . . . . 15.58 108.422 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.417 ' CA ' ' HG2' ' A' ' 117' ' ' PRO . 57.8 mm-40 64.27 -162.75 0.27 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.839 -1.073 . . . . 11.4 109.528 -174.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 0.8 OUTLIER -87.91 116.8 26.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.322 0.582 . . . . 12.26 110.581 177.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -135.23 109.74 8.5 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.52 -0.763 . . . . 15.51 109.574 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -58.25 117.76 4.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.607 -0.724 . . . . 16.06 111.072 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -92.92 97.36 10.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.284 0.564 . . . . 17.4 109.641 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -79.07 96.49 5.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.84 -0.618 . . . . 19.19 110.543 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.666 -0.683 . . . . 20.33 109.625 177.464 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.703 0.763 . . . . 7.16 109.777 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.407 HG23 ' CG1' ' A' ' 24' ' ' VAL . 42.9 mt -129.48 112.4 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-N 115.025 -0.989 . . . . 5.69 109.898 -175.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -70.76 84.33 0.65 Allowed 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.379 0.609 . . . . 4.6 110.16 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.601 ' HA ' HG12 ' A' ' 7' ' ' VAL . 41.3 mt-10 -70.33 -5.5 28.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.424 -0.807 . . . . 5.13 110.063 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.442 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 4.3 m -57.86 -37.11 73.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.483 -0.78 . . . . 4.17 109.288 169.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 4.1 m -64.22 -52.48 58.6 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.817 -0.629 . . . . 3.42 111.236 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.624 HG11 ' HG2' ' A' ' 21' ' ' ARG . 4.8 p -64.61 -39.33 85.25 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 116.399 -0.364 . . . . 3.24 111.168 -177.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.481 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 23.7 mmt -66.46 -31.57 72.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.447 -0.342 . . . . 5.17 111.336 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 5' ' ' SER . 15.2 mm-40 -62.84 -39.3 93.95 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.253 -0.277 . . . . 5.38 110.253 174.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 39' ' ' ILE . 16.4 mt -70.86 -43.96 67.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.754 0.787 . . . . 3.9 109.833 173.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.61 -42.98 99.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.363 -1.29 . . . . 4.46 112.066 -172.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.19 -9.85 54.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.213 -0.449 . . . . 6.27 112.198 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -72.14 -23.38 61.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.052 0.453 . . . . 5.2 110.321 176.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 15' ' ' PHE . . . 124.62 48.16 0.22 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.841 -0.695 . . . . 4.75 113.023 176.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 60.0 t80 179.29 134.88 0.25 Allowed Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.678 -0.49 . . . . 5.09 109.678 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 89.2 Cg_endo -75.44 88.98 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.017 2.478 . . . . 4.25 112.241 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.72 57.66 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.317 -0.553 . . . . 3.29 110.829 177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 22' ' ' LYS . 0.4 OUTLIER -56.34 -23.33 36.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.969 0.414 . . . . 5.48 111.009 174.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.647 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -59.81 -31.96 70.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.067 0.46 . . . . 3.54 110.281 172.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.569 ' HB3' HG23 ' A' ' 7' ' ' VAL . 37.9 t -73.81 -39.06 64.37 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 115.274 -0.875 . . . . 3.27 109.869 177.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.624 ' HG2' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -50.16 -52.13 37.87 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.73 0.776 . . . . 6.1 109.074 173.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 18' ' ' GLU . 32.4 mttt -63.89 -44.72 92.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.551 -1.204 . . . . 4.77 110.218 175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -56.57 -46.49 80.74 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.786 -0.643 . . . . 4.34 111.914 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 20' ' ' CYS . 98.5 t -59.37 -44.15 91.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 4.58 109.935 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -62.41 -43.48 98.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.964 -0.562 . . . . 7.48 110.973 175.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -69.41 -39.05 78.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.204 0.446 . . . . 6.84 112.204 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.4 p -67.3 -15.24 63.58 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.97 0.414 . . . . 5.71 111.268 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.7 23.12 47.73 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.652 -0.979 . . . . 5.75 110.652 -173.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 t30 58.98 72.56 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.633 -0.783 . . . . 5.06 110.496 -175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.498 ' HB3' HG21 ' A' ' 34' ' ' VAL . 92.0 mmm -94.03 9.65 36.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.301 -0.863 . . . . 6.28 111.407 -177.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.33 172.26 36.75 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.474 -0.87 . . . . 4.17 112.874 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -57.87 -50.3 73.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.058 0.543 . . . . 3.73 112.355 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -53.97 -43.49 69.97 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.218 0.451 . . . . 5.46 112.218 -175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG21 ' HB3' ' A' ' 30' ' ' MET . 92.1 t -72.96 -40.63 59.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 4.88 111.076 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.48 -30.79 60.01 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.417 -0.513 . . . . 3.68 111.661 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.567 ' O ' HG22 ' A' ' 39' ' ' ILE . 76.3 t80 -59.84 -42.64 94.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.621 -0.881 . . . . 4.71 108.621 171.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.542 ' O ' HG13 ' A' ' 40' ' ' ILE . 27.2 t-20 -67.56 -39.67 84.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.583 -0.735 . . . . 5.69 110.244 176.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -63.36 -31.96 73.26 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.016 0.436 . . . . 5.87 110.184 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.647 HD11 ' HB3' ' A' ' 19' ' ' ALA . 2.4 tp -76.79 -39.79 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.218 -0.446 . . . . 3.69 110.896 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.53 -16.19 18.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.387 0.613 . . . . 5.04 110.966 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 37' ' ' ASN . 75.1 t -79.17 -38.61 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.513 -0.767 . . . . 5.37 110.148 168.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -87.79 4.73 43.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.047 0.388 . . . . 5.35 112.047 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -23.24 65.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.57 0.224 . . . . 5.73 111.414 177.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -95.22 13.98 23.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.057 0.456 . . . . 6.34 111.299 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.571 ' CB ' ' HB3' ' A' ' 48' ' ' PHE . 10.6 mm-40 -92.57 131.03 35.12 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.899 -0.592 . . . . 5.62 110.321 175.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -67.69 -40.51 9.85 Favored 'Trans proline' 0 CA--C 1.527 0.125 0 C-N-CA 122.979 2.453 . . . . 6.22 113.16 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -116.91 25.4 10.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.69 0.757 . . . . 6.09 111.386 -169.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.571 ' HB3' ' CB ' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -70.28 -36.82 74.64 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.659 -0.65 . . . . 5.89 111.6 -176.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.94 114.12 5.86 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 120.804 0.335 . . . . 4.6 110.321 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 52' ' ' LEU . 48.0 mt-10 -60.65 125.91 83.79 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.637 -0.71 . . . . 5.96 110.06 174.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 9.8 Cg_exo -73.01 38.52 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.103 2.535 . . . . 6.2 112.06 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 50' ' ' GLU . 37.1 tp -77.28 106.64 9.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.464 -0.789 . . . . 8.24 110.034 -177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 m 62.64 63.21 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.583 0.706 . . . . 7.27 110.149 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.514 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 ppp? -84.42 124.0 74.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.679 -0.691 . . . . 7.41 109.854 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.16 -174.31 2.07 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.583 2.189 . . . . 5.89 112.712 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.41 122.9 1.79 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.942 -0.647 . . . . 6.63 111.92 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -115.09 123.4 48.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.884 0.373 . . . . 9.15 110.737 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.92 166.24 32.4 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.06 -0.591 . . . . 6.92 111.664 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.9 3.56 81.03 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.791 -0.718 . . . . 7.34 111.454 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.61 160.55 29.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.758 0.313 . . . . 7.8 110.308 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.06 159.19 15.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.992 -0.549 . . . . 6.73 110.705 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.6 p -103.57 94.15 5.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 7.03 110.635 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.53 134.84 36.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 6.23 110.54 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.25 -100.11 0.88 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.801 -0.714 . . . . 7.09 112.215 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 57.74 77.48 0.28 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.145 0.498 . . . . 7.1 110.937 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.8 m -75.76 -43.42 46.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.825 -0.625 . . . . 7.6 111.124 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 m -110.77 151.78 12.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.911 -0.586 . . . . 8.01 111.748 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -120.19 148.23 43.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.956 -0.757 . . . . 8.06 108.956 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.87 77.36 0.34 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.169 -1.015 . . . . 6.62 113.148 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.14 -76.93 0.22 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.578 -0.527 . . . . 6.12 109.578 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m 60.08 -84.01 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.76 0.652 . . . . 7.65 112.76 176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.97 88.94 0.97 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.009 -0.615 . . . . 6.25 112.281 -176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.19 99.97 9.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.788 0.328 . . . . 7.29 110.436 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.35 141.85 35.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.169 -0.469 . . . . 6.55 110.035 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -146.6 134.97 21.88 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.159 -0.682 . . . . 7.51 109.159 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -101.53 134.5 20.2 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 108.918 -0.771 . . . . 7.14 108.918 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 82.2 Cg_exo -51.47 162.27 1.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.953 2.435 . . . . 5.41 111.682 173.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.708 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 31.7 Cg_endo -60.94 110.37 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.512 2.141 . . . . 7.14 111.232 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.755 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -56.47 -26.86 55.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.761 -0.654 . . . . 10.13 111.389 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.2 tt0 -59.38 -51.56 69.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.263 -0.426 . . . . 11.78 110.069 171.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.783 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.5 mt -74.64 -42.2 48.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.101 -0.5 . . . . 8.42 111.981 -176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.76 ' O ' HG22 ' A' ' 86' ' ' THR . 8.4 m -56.02 -38.14 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.422 -0.955 . . . . 7.57 108.422 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.43 -48.74 79.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.753 -1.112 . . . . 10.39 110.758 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.783 HD12 ' HA ' ' A' ' 81' ' ' ILE . 19.2 mt -59.42 -41.79 85.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.299 -0.41 . . . . 10.78 110.512 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.746 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.3 mt -65.29 -47.5 86.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.973 -0.558 . . . . 8.01 111.793 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.76 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.3 t -69.61 -21.67 63.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.316 -0.553 . . . . 10.38 110.966 177.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.0 m -71.49 -31.88 67.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.795 0.331 . . . . 12.35 110.44 171.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 98.3 mmm -64.94 -22.86 67.07 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.868 -0.605 . . . . 10.33 110.449 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 126.85 4.18 6.18 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.426 -0.806 . . . . 9.53 112.068 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.601 ' HB2' HG22 ' A' ' 85' ' ' ILE . 33.7 m-85 -96.32 -174.55 3.1 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.343 -0.243 . . . . 8.89 110.343 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -96.02 148.31 22.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.567 -0.531 . . . . 10.16 109.567 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.505 ' O ' HD12 ' A' ' 96' ' ' ILE . 12.5 ttm180 -58.8 -52.45 65.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.194 0.521 . . . . 11.98 110.069 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -61.6 -35.84 78.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.449 -0.796 . . . . 9.02 111.213 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.58 ' HG2' HD13 ' A' ' 113' ' ' ILE . 7.3 tt0 -65.9 -38.44 88.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.524 -0.762 . . . . 6.68 109.554 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.746 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.62 -40.05 95.91 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.181 -0.918 . . . . 5.22 110.501 174.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.59 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mp -58.95 -52.54 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 CA-C-N 116.342 -0.39 . . . . 6.39 110.914 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.462 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 7.7 tt0 -57.95 -43.68 86.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.151 -0.477 . . . . 8.36 110.989 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.45 -50.4 73.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.668 -0.697 . . . . 5.41 110.844 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 109' ' ' ALA . 79.0 mt -63.08 -35.53 80.57 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 116.741 -0.208 . . . . 5.77 111.314 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.462 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 87.9 mtt180 -53.78 -48.37 69.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.517 0.675 . . . . 7.71 110.277 175.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.93 72.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.736 -1.12 . . . . 8.88 111.6 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.674 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 63.0 p -86.69 2.66 47.79 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.116 0.784 . . . . 8.79 113.116 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 64.07 45.88 3.95 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.139 0.575 . . . . 10.09 111.395 -178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.579 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 77.2 m-20 68.08 21.12 8.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.405 -0.816 . . . . 7.8 111.509 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB2' ' HB ' ' A' ' 102' ' ' THR . 4.5 m-20 -82.89 104.5 13.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.604 -0.517 . . . . 10.49 109.604 175.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.774 HD12 HG12 ' A' ' 81' ' ' ILE . 8.5 tt -47.7 -61.17 2.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.065 -0.971 . . . . 9.54 111.886 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.412 ' N ' HD23 ' A' ' 106' ' ' LEU . 6.4 mm-40 -56.64 -46.54 80.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.102 -0.953 . . . . 11.82 111.919 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.674 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.0 ttm180 -69.0 -28.97 67.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.895 -0.322 . . . . 12.41 110.537 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.746 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -61.4 -51.35 69.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.384 -0.599 . . . . 6.3 109.384 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.515 HD23 HG23 ' A' ' 85' ' ' ILE . 20.7 mt -59.26 -41.84 89.76 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-N 115.284 -0.871 . . . . 7.78 109.52 175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.67 -49.52 70.42 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.599 0.714 . . . . 9.04 110.363 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -61.55 -48.56 80.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.442 -1.254 . . . . 8.69 110.253 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.58 HD13 ' HG2' ' A' ' 94' ' ' GLN . 44.0 mt -63.46 -40.38 88.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.296 -0.866 . . . . 5.25 110.596 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -61.93 -34.58 76.36 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.118 0.567 . . . . 6.92 111.165 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.9 m -82.47 11.97 5.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.313 -0.858 . . . . 8.33 110.741 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.58 ' HA ' ' OE1' ' A' ' 120' ' ' GLU . 82.0 t60 -132.7 71.95 78.02 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.276 -0.874 . . . . 9.41 109.565 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -49.52 -63.31 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 124.046 3.164 . . . . 7.92 112.503 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -179.22 -53.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.736 -1.12 . . . . 11.42 110.016 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -113.93 6.63 16.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.531 . . . . 15.58 110.543 -178.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.58 ' OE1' ' HA ' ' A' ' 116' ' ' HIS . 5.5 mm-40 56.92 -167.35 0.12 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.897 -1.047 . . . . 11.4 111.794 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.52 156.73 42.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.865 0.364 . . . . 12.26 110.196 170.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 125' ' ' PHE . 7.5 p-10 -119.87 38.59 3.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.445 0.641 . . . . 15.51 110.611 -178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.8 p -73.43 -20.12 60.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.627 -0.715 . . . . 16.06 110.842 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -160.74 138.63 9.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.75 -0.659 . . . . 17.4 110.429 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 122' ' ' ASP . 88.6 m-85 -117.03 -4.55 11.48 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.155 -0.475 . . . . 19.19 110.593 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 9.4 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.441 -0.79 . . . . 20.33 110.735 -176.417 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.076 0.465 . . . . 7.16 110.26 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.613 HD11 ' HD1' ' A' ' 25' ' ' TYR . 1.9 mp -66.03 121.86 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 115.725 -0.671 . . . . 5.69 110.032 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.4 ' N ' HG11 ' A' ' 24' ' ' VAL . 21.9 m-20 -70.01 81.7 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.061 -0.518 . . . . 4.6 110.346 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.547 ' HA ' HG12 ' A' ' 7' ' ' VAL . 44.5 mt-10 -71.18 -11.82 61.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.059 -0.519 . . . . 5.13 111.0 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 9' ' ' GLN . 6.9 t -60.46 -28.4 68.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.018 -0.734 . . . . 4.17 109.018 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.66 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 1.9 m -69.34 -50.69 44.04 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.907 -0.588 . . . . 3.42 110.896 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 4' ' ' GLU . 2.1 p -63.36 -45.89 96.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.448 -0.501 . . . . 3.24 110.805 -178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.528 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 55.3 mtm -68.97 -26.64 65.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.056 -0.52 . . . . 5.17 111.848 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.66 ' HG2' ' O ' ' A' ' 6' ' ' SER . 4.4 pt20 -69.03 -34.66 75.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.454 -0.498 . . . . 5.38 109.82 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 6' ' ' SER . 20.4 mt -68.63 -43.42 76.35 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.613 0.721 . . . . 3.9 109.083 173.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.56 -37.43 86.11 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.629 -1.169 . . . . 4.46 111.503 -176.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 8' ' ' MET . 52.4 mt-10 -65.95 -23.72 66.66 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.386 0.513 . . . . 6.27 112.386 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.5 ptp -117.11 -3.86 11.5 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.296 0.48 . . . . 5.2 112.296 -173.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -153.25 -101.35 0.2 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.935 -1.126 . . . . 4.75 113.643 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.519 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 95.9 m-85 -124.67 165.47 24.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 N-CA-C 110.056 -0.35 . . . . 5.09 110.056 -172.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 71.5 Cg_endo -72.09 82.92 1.24 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.473 2.115 . . . . 4.25 111.62 175.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 3.4 mm? -75.94 66.5 2.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 3.29 111.805 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -25.73 54.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.617 0.722 . . . . 5.48 109.481 169.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.7 -31.26 68.08 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.235 -0.893 . . . . 3.54 110.39 171.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . 18.2 t -73.26 -37.71 66.23 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.422 -0.808 . . . . 3.27 109.706 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.31 -52.58 35.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.852 0.834 . . . . 6.1 108.94 173.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -70.4 -34.15 72.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.785 -1.098 . . . . 4.77 111.385 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . . . -61.6 -44.31 97.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.352 -0.385 . . . . 4.34 111.599 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.492 ' CG1' HG23 ' A' ' 2' ' ' ILE . 94.1 t -64.69 -40.8 90.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 4.58 110.384 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.613 ' HD1' HD11 ' A' ' 2' ' ' ILE . 91.3 t80 -62.32 -41.21 98.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.921 -0.581 . . . . 7.48 110.422 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -68.95 -43.82 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 6.84 111.296 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.8 p -67.09 -17.17 64.76 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 5.71 111.359 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.85 49.61 5.59 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.707 -0.679 . . . . 5.75 111.907 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.7 p30 43.07 45.41 4.57 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.532 0.733 . . . . 5.06 111.885 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.502 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.2 mmt -65.18 -63.22 1.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.544 -0.753 . . . . 6.28 111.223 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -174.87 166.72 38.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.728 -0.749 . . . . 4.17 111.693 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.647 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -65.31 -46.12 81.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.245 0.545 . . . . 3.73 110.982 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 36' ' ' PHE . 15.2 mm-40 -76.13 -27.67 57.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.585 -0.734 . . . . 5.46 110.253 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 30' ' ' MET . 99.1 t -58.27 -44.28 87.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.855 0.36 . . . . 4.88 110.481 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.64 -31.76 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.381 -0.372 . . . . 3.68 110.759 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.421 ' HB3' ' HA ' ' A' ' 33' ' ' GLU . 51.5 t80 -51.71 -46.2 63.84 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.304 -0.628 . . . . 4.71 109.304 170.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.52 -47.41 86.29 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.59 -0.732 . . . . 5.69 110.754 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.725 ' HE3' HD12 ' A' ' 39' ' ' ILE . 50.4 t90 -57.2 -36.88 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.285 0.564 . . . . 5.87 110.237 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.725 HD12 ' HE3' ' A' ' 38' ' ' TRP . 1.2 mp -75.1 -46.64 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.642 -0.708 . . . . 3.69 112.082 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.41 -19.12 21.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.394 0.616 . . . . 5.04 111.003 -177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 76.1 t -80.03 -41.8 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.694 . . . . 5.37 110.807 170.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.473 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 88.2 m-70 -102.89 20.69 16.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.307 0.484 . . . . 5.35 112.307 -175.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -67.2 -21.28 65.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.412 0.625 . . . . 5.73 109.579 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -79.03 6.19 9.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.144 -0.934 . . . . 6.34 111.969 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 66.8 mm-40 -82.42 136.26 46.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.176 -0.676 . . . . 5.62 109.176 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.56 -41.96 13.76 Favored 'Trans proline' 0 N--CA 1.471 0.164 0 C-N-CA 123.112 2.541 . . . . 6.22 113.473 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -116.83 25.34 10.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.628 0.728 . . . . 6.09 110.602 -170.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.892 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 4.3 p90 -59.11 -35.74 73.96 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.644 -0.707 . . . . 5.89 112.063 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.2 117.12 4.12 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.193 -0.669 . . . . 4.6 109.193 -178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 35.6 mt-10 -62.36 114.12 10.87 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.907 -0.588 . . . . 5.96 110.099 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 19.1 Cg_endo -90.51 62.3 1.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.356 2.704 . . . . 6.2 113.369 -171.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 29.8 tp -124.07 36.42 4.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.767 0.794 . . . . 8.24 109.346 175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.1 t -169.3 50.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.016 -0.993 . . . . 7.27 109.924 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.6 ttp -76.97 118.61 73.05 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.519 -0.764 . . . . 7.41 110.65 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.471 ' HD3' ' HD3' ' A' ' 16' ' ' PRO . 94.3 Cg_endo -86.49 166.97 9.0 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.852 2.368 . . . . 5.89 112.181 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.27 115.82 4.29 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.499 -0.64 . . . . 6.63 111.499 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -68.58 141.37 55.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.041 0.448 . . . . 9.15 111.28 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.65 71.33 2.98 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.748 -0.66 . . . . 6.92 112.591 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -160.09 68.38 0.25 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.385 -0.686 . . . . 7.34 111.385 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.56 -60.91 1.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.787 0.327 . . . . 7.8 110.971 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.84 147.45 40.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.145 -0.48 . . . . 6.73 110.257 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 28.9 p -89.22 117.8 28.45 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 120.893 0.378 . . . . 7.03 111.071 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.44 70.17 0.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.012 -0.54 . . . . 6.23 110.064 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.09 -37.61 0.38 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.905 -0.664 . . . . 7.09 111.99 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.38 120.96 42.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.859 -0.423 . . . . 7.1 109.859 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 m -79.8 87.27 5.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.234 -0.439 . . . . 7.6 110.224 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.8 -59.66 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.94 -0.573 . . . . 8.01 109.639 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.6 t80 52.63 83.15 0.06 Allowed 'General case' 0 N--CA 1.463 0.218 0 O-C-N 124.039 0.837 . . . . 8.06 110.474 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.95 80.41 1.09 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.811 -0.709 . . . . 6.62 113.09 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.61 58.14 4.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.16 0.505 . . . . 6.12 110.398 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -70.02 -33.08 71.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.839 -0.619 . . . . 7.65 110.363 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -111.17 -65.64 0.52 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.074 -0.584 . . . . 6.25 111.856 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' HB3' ' H ' ' A' ' 74' ' ' ASP . 0.2 OUTLIER 56.87 -95.05 0.05 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.048 0.539 . . . . 7.29 111.123 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.428 ' H ' ' HB3' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -143.88 159.17 43.02 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 120.786 0.327 . . . . 6.55 110.175 -179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -140.54 34.04 1.84 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.746 0.784 . . . . 7.51 109.509 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -74.31 142.55 78.59 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.319 -0.855 . . . . 7.14 109.827 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.544 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 74.1 Cg_exo -53.88 164.53 2.38 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.95 2.433 . . . . 5.41 112.217 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.687 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 37.8 Cg_endo -63.54 111.16 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.651 2.234 . . . . 7.14 110.73 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.737 ' HA ' HG22 ' A' ' 82' ' ' VAL . 11.0 pt-20 -58.55 -26.15 63.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.814 -0.63 . . . . 10.13 110.781 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.4 tt0 -60.36 -50.2 74.55 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.183 0.516 . . . . 11.78 109.869 172.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.77 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.0 mt -74.72 -42.66 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.758 -0.655 . . . . 8.42 111.769 -175.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.754 ' O ' HG22 ' A' ' 86' ' ' THR . 14.2 m -55.76 -37.84 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.475 -0.935 . . . . 7.57 108.475 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.24 -48.74 78.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.653 -1.158 . . . . 10.39 110.897 175.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.77 HD12 ' HA ' ' A' ' 81' ' ' ILE . 22.6 mt -59.38 -42.88 88.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 10.78 110.326 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.726 HD12 ' HB1' ' A' ' 95' ' ' ALA . 88.9 mt -63.74 -47.44 91.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.812 -0.631 . . . . 8.01 111.356 -178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.754 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.8 t -71.15 -21.39 62.19 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.298 -0.561 . . . . 10.38 110.763 177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -75.9 -22.21 56.34 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.04 0.448 . . . . 12.35 110.371 173.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.562 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 29.5 mmt -72.75 -25.41 61.18 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.201 0.524 . . . . 10.33 110.072 175.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.41 4.55 3.96 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.539 -0.755 . . . . 9.53 112.069 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.599 ' HB2' HG22 ' A' ' 85' ' ' ILE . 28.0 m-85 -98.16 -177.51 3.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.766 0.317 . . . . 8.89 110.342 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.687 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 8.6 tt0 -94.45 142.34 27.54 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.561 -0.533 . . . . 10.16 109.561 176.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 18.0 ttm180 -57.89 -51.86 67.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.851 0.358 . . . . 11.98 111.241 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.59 -35.08 73.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.289 0.566 . . . . 9.02 110.485 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.687 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.6 tt0 -66.63 -39.27 88.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.418 -0.81 . . . . 6.68 109.562 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.726 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.12 -40.55 97.93 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.285 -0.87 . . . . 5.22 110.498 174.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.596 HG13 HG11 ' A' ' 82' ' ' VAL . 1.1 mt -58.58 -52.43 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.163 -0.471 . . . . 6.39 110.438 176.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.7 tt0 -56.74 -45.94 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 8.36 111.103 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.91 -51.07 71.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.474 -0.785 . . . . 5.41 110.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 109' ' ' ALA . 82.2 mt -61.54 -35.62 78.27 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 116.641 -0.254 . . . . 5.77 111.609 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 90.8 mtt180 -54.03 -46.59 71.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.525 0.678 . . . . 7.71 110.153 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.64 67.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.764 -1.107 . . . . 8.88 111.615 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.697 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.5 p -86.19 3.98 40.57 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.871 0.693 . . . . 8.79 112.871 -175.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 64.72 46.8 2.96 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.997 -0.547 . . . . 10.09 110.514 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.609 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 82.4 m-20 67.15 16.58 10.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.388 -0.824 . . . . 7.8 111.437 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 15.9 t-20 -78.53 110.28 13.48 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.412 -0.588 . . . . 10.49 109.412 175.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.748 HD12 HG12 ' A' ' 81' ' ' ILE . 7.7 tt -55.33 -59.09 5.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.237 -0.892 . . . . 9.54 111.316 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.413 ' N ' HD23 ' A' ' 106' ' ' LEU . 16.6 mm-40 -53.35 -49.99 65.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.631 -1.168 . . . . 11.82 111.671 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.697 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 32.1 ttm180 -69.7 -28.76 66.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.443 -0.344 . . . . 12.41 111.017 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.699 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.02 -51.32 68.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.032 -0.729 . . . . 6.3 109.032 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.578 HD23 HG23 ' A' ' 85' ' ' ILE . 23.6 mt -59.16 -40.78 86.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.85 -1.068 . . . . 7.78 109.902 175.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.59 -50.43 71.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.433 -0.803 . . . . 9.04 110.178 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -60.68 -44.67 96.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.854 -1.066 . . . . 8.69 110.472 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.649 HD11 ' HA ' ' A' ' 95' ' ' ALA . 52.7 mt -70.45 -39.91 76.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.991 -1.004 . . . . 5.25 111.065 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 0.6 OUTLIER -64.95 -28.33 69.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 6.92 111.196 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.8 t -83.38 5.84 22.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.859 -0.61 . . . . 8.33 110.044 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.572 ' HA ' ' OE2' ' A' ' 120' ' ' GLU . 52.3 m-70 -136.4 78.61 44.35 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.388 -0.824 . . . . 9.41 110.502 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -47.88 -70.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.858 3.039 . . . . 7.92 112.118 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.6 -51.48 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.942 -1.026 . . . . 11.42 109.484 172.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -117.73 9.76 13.12 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 15.58 110.609 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.572 ' OE2' ' HA ' ' A' ' 116' ' ' HIS . 12.5 mm-40 61.42 -170.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.646 -0.706 . . . . 11.4 110.387 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -92.41 143.12 26.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.295 -0.632 . . . . 12.26 109.295 169.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -109.83 151.94 26.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.489 -0.323 . . . . 15.51 110.4 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.7 p -50.18 117.18 2.21 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.031 0.832 . . . . 16.06 112.235 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.7 148.54 22.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.913 -0.585 . . . . 17.4 110.21 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -103.69 124.34 48.68 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.658 -0.701 . . . . 19.19 110.009 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.247 0.934 0 CA-C-N 116.294 -0.412 . . . . 20.33 110.921 -178.833 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.885 0.374 . . . . 7.16 110.713 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.567 HG12 HD21 ' A' ' 29' ' ' ASN . 82.2 mt -78.93 109.97 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.154 0.502 . . . . 5.69 110.592 -177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.2 85.89 1.9 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.449 -0.796 . . . . 4.6 110.716 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.529 ' HA ' HG12 ' A' ' 7' ' ' VAL . 38.3 mt-10 -72.7 -4.73 33.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.125 -0.489 . . . . 5.13 112.158 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -67.83 -31.55 71.47 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.965 -0.754 . . . . 4.17 108.965 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.75 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 16.9 m -64.89 -46.4 81.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.718 -0.674 . . . . 3.42 110.899 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.1 p -68.94 -40.91 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 120.144 -0.622 . . . . 3.24 110.53 178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 71.0 mtp -63.96 -30.91 71.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.231 -0.441 . . . . 5.17 111.576 178.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.75 ' HG2' ' O ' ' A' ' 6' ' ' SER . 10.4 pt20 -68.46 -38.77 81.4 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.435 -0.506 . . . . 5.38 109.672 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.858 ' HB3' HD12 ' A' ' 17' ' ' LEU . 16.4 mt -66.78 -43.74 83.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.648 0.737 . . . . 3.9 109.556 173.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.678 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.6 -33.93 74.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.347 -1.297 . . . . 4.46 112.202 -173.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -82.3 -36.16 27.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.98 -0.554 . . . . 6.27 111.183 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 18.2 ptp -90.55 0.71 57.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.765 -0.652 . . . . 5.2 112.292 -176.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -161.67 -92.32 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 119.747 -1.216 . . . . 4.75 113.763 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.678 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 96.7 m-85 -136.52 162.4 56.44 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 110.439 -0.208 . . . . 5.09 110.439 -172.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 15' ' ' PHE . 64.3 Cg_endo -68.05 77.24 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.154 2.569 . . . . 4.25 111.66 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.858 HD12 ' HB3' ' A' ' 10' ' ' LEU . 95.0 mt -85.16 63.84 8.33 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.967 -0.56 . . . . 3.29 112.428 -171.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -55.96 -19.39 12.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.168 0.508 . . . . 5.48 110.057 169.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.497 ' HB1' ' CD2' ' A' ' 48' ' ' PHE . . . -57.68 -33.1 68.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.542 -0.754 . . . . 3.54 109.407 171.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.567 ' O ' HG23 ' A' ' 24' ' ' VAL . 34.9 t -70.61 -46.34 63.55 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 115.027 -0.988 . . . . 3.27 109.525 173.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -53.18 -51.45 62.03 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.933 0.397 . . . . 6.1 111.044 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.91 -23.52 62.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 4.77 110.542 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.16 -40.76 64.58 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.381 -0.372 . . . . 4.34 110.785 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 20' ' ' CYS . 77.2 t -56.65 -42.6 76.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.258 -0.428 . . . . 4.58 110.22 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -65.12 -43.04 93.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 7.48 110.514 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -67.4 -41.17 85.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.31 -0.404 . . . . 6.84 111.78 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.4 p -65.3 -22.34 66.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.986 0.422 . . . . 5.71 111.436 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.83 25.02 13.85 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.847 -0.692 . . . . 5.75 111.601 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.567 HD21 HG12 ' A' ' 2' ' ' ILE . 11.7 m120 60.72 47.21 8.28 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.333 0.587 . . . . 5.06 110.397 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.502 ' HB2' HG11 ' A' ' 34' ' ' VAL . 22.2 mmt -76.28 -23.33 54.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 6.28 112.483 -172.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.15 176.37 14.48 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.17 -1.014 . . . . 4.17 112.95 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.441 ' HA ' ' OG ' ' A' ' 6' ' ' SER . . . -63.95 -58.96 5.16 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 122.559 0.344 . . . . 3.73 111.69 -176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -55.13 -35.14 64.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.123 -0.49 . . . . 5.46 111.387 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' A' ' 30' ' ' MET . 59.6 t -66.82 -46.64 84.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.052 -0.522 . . . . 4.88 111.184 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.36 -30.78 53.96 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.949 -0.3 . . . . 3.68 111.109 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.485 ' O ' HG22 ' A' ' 39' ' ' ILE . 65.8 t80 -58.48 -44.43 89.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.964 -0.754 . . . . 4.71 108.964 171.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.42 ' O ' HG13 ' A' ' 40' ' ' ILE . 7.4 t30 -63.73 -37.08 86.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.59 -0.732 . . . . 5.69 110.659 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -67.07 -33.85 76.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 5.87 110.418 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.788 HG12 HD13 ' A' ' 17' ' ' LEU . 3.2 tp -77.13 -38.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.466 -0.334 . . . . 3.69 111.171 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.438 ' O ' ' HG2' ' A' ' 43' ' ' MET . 2.7 pp -71.1 -28.0 31.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 120.715 -0.394 . . . . 5.04 110.918 -177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.6 p -79.9 -25.94 12.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.854 -0.338 . . . . 5.37 110.493 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -100.0 10.41 41.34 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.128 0.418 . . . . 5.35 112.128 178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 14.1 ptp -62.4 -20.85 64.87 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.979 0.418 . . . . 5.73 110.149 174.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.29 -16.5 5.59 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.702 -0.681 . . . . 6.34 110.988 173.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.562 ' CB ' ' HB2' ' A' ' 48' ' ' PHE . 65.4 mm-40 -108.55 88.08 4.83 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.072 -0.513 . . . . 5.62 109.726 172.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.5 -45.43 41.14 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.387 2.724 . . . . 6.22 111.972 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.18 23.77 7.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.989 -1.46 . . . . 6.09 110.378 -170.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.562 ' HB2' ' CB ' ' A' ' 45' ' ' GLU . 6.9 t80 -77.36 -14.59 59.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.416 0.627 . . . . 5.89 109.399 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.33 -129.34 0.3 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.634 -0.712 . . . . 4.6 109.174 174.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.85 159.84 28.43 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.134 -0.691 . . . . 5.96 109.134 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -34.77 142.04 0.08 OUTLIER 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.856 3.038 . . . . 6.2 113.078 172.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.16 67.25 3.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.825 -0.625 . . . . 8.24 112.26 -169.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.5 p -99.51 132.03 45.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.088 -0.505 . . . . 7.27 109.832 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 20.9 ptp -86.06 115.84 63.42 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 121.018 0.437 . . . . 7.41 110.446 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.93 19.07 1.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.862 2.375 . . . . 5.89 112.909 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 72.91 81.45 0.37 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 121.094 -0.574 . . . . 6.63 112.241 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -78.69 24.48 0.29 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.06 0.393 . . . . 9.15 112.06 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 171.09 70.54 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.898 -0.668 . . . . 6.92 112.072 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 80.83 -153.8 34.96 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.69 -0.767 . . . . 7.34 112.569 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.38 -166.15 1.28 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.82 0.343 . . . . 7.8 110.79 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.81 29.5 5.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.996 0.369 . . . . 6.73 111.996 -173.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.7 t 61.13 59.05 2.08 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.913 -0.585 . . . . 7.03 111.758 172.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.6 125.34 29.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.344 -0.389 . . . . 6.23 110.545 175.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.81 140.04 9.82 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.033 -0.604 . . . . 7.09 112.014 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.29 112.53 17.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.716 0.293 . . . . 7.1 110.762 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.4 t -83.29 92.64 7.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.197 0.522 . . . . 7.6 110.62 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.17 125.65 52.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.907 -0.588 . . . . 8.01 109.932 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -84.28 -29.83 26.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 120.871 0.367 . . . . 8.06 110.874 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.04 -63.6 3.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.895 -0.669 . . . . 6.62 112.877 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 56.52 36.14 27.11 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.316 0.579 . . . . 6.12 109.867 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 m -56.17 125.81 23.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.859 -1.064 . . . . 7.65 112.197 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.06 -57.23 4.81 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.733 -0.667 . . . . 6.25 112.844 174.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 55.32 63.25 2.15 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.05 -0.722 . . . . 7.29 109.05 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.2 121.72 11.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.899 -1.046 . . . . 6.55 111.583 -174.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -108.19 30.5 6.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.178 -0.919 . . . . 7.51 108.667 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -73.32 142.1 81.33 Favored Pre-proline 0 N--CA 1.445 -0.677 0 CA-C-N 114.431 -1.259 . . . . 7.14 109.762 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.569 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 83.7 Cg_exo -51.02 162.9 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.472 2.781 . . . . 5.41 112.822 176.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.7 ' HD2' HD13 ' A' ' 99' ' ' LEU . 38.0 Cg_endo -62.7 112.15 1.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.597 2.198 . . . . 7.14 111.526 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.9 pt-20 -58.97 -27.33 65.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.225 -0.898 . . . . 10.13 112.106 -174.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.57 ' HG2' ' N ' ' A' ' 81' ' ' ILE . 11.2 pm0 -70.21 -42.82 71.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.589 -0.893 . . . . 11.78 108.589 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 63.5 mt -70.82 -46.39 68.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.726 -1.125 . . . . 8.42 111.755 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.764 ' O ' HG22 ' A' ' 86' ' ' THR . 14.3 m -55.52 -38.0 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.54 -0.911 . . . . 7.57 108.54 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.36 -47.21 85.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 114.442 -1.254 . . . . 10.39 111.272 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 18.8 mt -60.0 -42.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 10.78 110.238 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.771 HD12 ' HB1' ' A' ' 95' ' ' ALA . 86.2 mt -65.16 -45.86 92.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.881 -0.6 . . . . 8.01 111.286 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.62 -21.23 61.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.367 -0.533 . . . . 10.38 110.799 177.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.6 t -74.28 -28.87 61.4 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.6 -0.518 . . . . 12.35 109.6 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.563 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 96.6 mmm -66.06 -27.61 68.22 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.315 0.578 . . . . 10.33 110.159 175.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.14 -5.22 4.63 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.548 -0.751 . . . . 9.53 112.14 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.619 ' HB2' HG22 ' A' ' 85' ' ' ILE . 31.5 m-85 -87.93 -175.45 5.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.722 0.296 . . . . 8.89 110.236 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 94' ' ' GLN . 8.7 tt0 -98.02 145.35 26.6 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.839 -0.43 . . . . 10.16 109.839 177.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 7.0 ttm180 -55.73 -51.27 67.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.126 0.489 . . . . 11.98 110.431 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -59.47 -38.38 80.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.483 -0.781 . . . . 9.02 111.027 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.632 ' HG3' HD13 ' A' ' 113' ' ' ILE . 4.3 tp-100 -59.94 -46.92 87.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.852 0.834 . . . . 6.68 109.35 174.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.771 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -58.38 -40.78 83.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.457 -1.247 . . . . 5.22 110.854 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.81 -52.11 64.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.034 -0.53 . . . . 6.39 110.617 176.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.577 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 58.8 tt0 -56.97 -47.01 81.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.794 -0.639 . . . . 8.36 110.866 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.75 -50.67 72.94 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.236 -0.893 . . . . 5.41 110.973 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.7 HD13 ' HD2' ' A' ' 78' ' ' PRO . 72.7 mt -61.8 -33.51 74.25 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.45 -0.341 . . . . 5.77 111.376 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.577 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 95.0 mtt180 -55.93 -47.2 77.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.405 0.621 . . . . 7.71 110.169 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.94 71.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.107 -0.951 . . . . 8.88 111.401 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.705 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 44.0 p -85.77 -0.68 55.92 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.849 0.685 . . . . 8.79 112.849 -174.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.468 HD22 ' N ' ' A' ' 103' ' ' ASN . 0.9 OUTLIER 66.76 48.18 1.41 Allowed 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.15 0.58 . . . . 10.09 111.238 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.568 ' ND2' ' HD3' ' A' ' 78' ' ' PRO . 4.9 m-20 69.76 12.63 8.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.339 -0.846 . . . . 7.8 111.467 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 12.3 t-20 -77.43 109.51 11.42 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.139 -0.689 . . . . 10.49 109.139 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.75 HD12 HG12 ' A' ' 81' ' ' ILE . 8.3 tt -56.46 -60.37 3.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.102 -0.954 . . . . 9.54 111.519 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.23 -45.68 72.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.979 -1.009 . . . . 11.82 111.542 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.705 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 27.4 ttm180 -70.92 -28.37 64.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.244 -0.434 . . . . 12.41 111.075 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.627 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.41 -51.32 68.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.382 -0.599 . . . . 6.3 109.382 176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.58 HD23 HG23 ' A' ' 85' ' ' ILE . 18.1 mt -57.85 -38.6 75.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.374 -0.83 . . . . 7.78 109.662 174.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -57.56 -51.41 69.61 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.979 -1.01 . . . . 9.04 110.246 175.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -63.32 -45.58 90.66 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.759 -1.109 . . . . 8.69 110.177 -178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.632 HD13 ' HG3' ' A' ' 94' ' ' GLN . 54.9 mt -62.54 -34.37 64.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.13 -0.941 . . . . 5.25 110.414 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -69.39 -31.19 69.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 6.92 111.098 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.5 t -75.49 -0.19 19.34 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.412 0.625 . . . . 8.33 110.176 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -140.55 72.22 30.82 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.2 -0.909 . . . . 9.41 108.578 169.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -27.07 -65.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.952 1 C-N-CA 126.222 4.614 . . . . 7.92 114.474 -171.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -158.59 -41.87 0.06 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.834 -1.075 . . . . 11.42 108.427 173.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -151.23 46.89 0.83 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.106 -0.952 . . . . 15.58 109.633 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 64.34 -159.83 0.29 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.071 -0.968 . . . . 11.4 110.827 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.23 -172.89 2.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.578 0.228 . . . . 12.26 110.702 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 62.0 70.77 0.56 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.032 0.832 . . . . 15.51 110.878 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 52.2 p -125.13 145.28 50.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.251 -0.886 . . . . 16.06 109.908 177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -91.3 25.42 2.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.309 0.576 . . . . 17.4 111.0 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -109.52 79.8 1.25 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.764 -0.653 . . . . 19.19 109.756 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.36 -0.829 . . . . 20.33 110.637 -178.645 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 110.056 -0.35 . . . . 7.16 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.7 mt 57.38 88.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 O-C-N 123.714 0.634 . . . . 5.69 110.414 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -65.28 91.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.527 -0.76 . . . . 4.6 111.174 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 21' ' ' ARG . 49.1 mt-10 -72.27 -5.71 37.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.875 -0.602 . . . . 5.13 111.579 176.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 2.0 m -59.11 -38.48 79.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.341 0.591 . . . . 4.17 109.565 175.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 32' ' ' ALA . 24.1 m -64.63 -50.16 68.19 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.564 -0.744 . . . . 3.42 111.504 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 4' ' ' GLU . 3.2 p -65.8 -41.81 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 C-N-CA 120.849 -0.341 . . . . 3.24 111.153 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 88.3 mtp -61.21 -30.04 70.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.375 -0.375 . . . . 5.17 111.102 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 5' ' ' SER . 46.1 mt-30 -69.59 -34.67 74.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.69 -0.232 . . . . 5.38 111.053 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.702 HD13 HG21 ' A' ' 39' ' ' ILE . 14.3 mt -66.88 -47.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.838 0.827 . . . . 3.9 109.179 171.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -62.31 -45.83 91.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.022 -1.445 . . . . 4.46 112.403 -169.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 13' ' ' MET . 6.8 pt-20 -58.24 -36.26 72.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.301 0.572 . . . . 6.27 111.437 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.445 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 25.5 ptt? -99.36 7.47 45.52 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.401 -0.818 . . . . 5.2 112.063 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.29 103.21 0.2 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 119.624 -1.274 . . . . 4.75 114.521 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 78.6 m-85 71.66 138.27 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.639 0 N-CA-C 113.47 0.915 . . . . 5.09 113.47 168.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.05 82.8 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.188 2.592 . . . . 4.25 111.364 176.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.702 HD13 HG12 ' A' ' 39' ' ' ILE . 85.7 mt -80.46 61.32 4.16 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.163 0.431 . . . . 3.29 112.163 -173.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.94 -20.89 17.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.101 0.476 . . . . 5.48 110.626 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.55 -35.32 72.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.455 0.645 . . . . 3.54 109.909 171.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 33.5 t -73.92 -36.17 64.67 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.383 -0.826 . . . . 3.27 109.894 175.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 4' ' ' GLU . 1.3 tmm_? -57.09 -48.34 78.83 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.378 0.609 . . . . 6.1 109.477 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 25' ' ' TYR . 0.2 OUTLIER -74.43 -25.42 59.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.998 -0.546 . . . . 4.77 110.325 176.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.729 ' HA ' ' HD2' ' A' ' 26' ' ' PHE . . . -66.65 -38.52 87.06 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.11 0.481 . . . . 4.34 110.609 174.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 20' ' ' CYS . 71.8 t -59.8 -37.77 73.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.833 -0.621 . . . . 4.58 109.865 173.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 89.9 t80 -60.81 -41.36 95.52 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.17 -0.468 . . . . 7.48 110.54 171.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.729 ' HD2' ' HA ' ' A' ' 23' ' ' ALA . 53.6 m-85 -64.8 -46.25 82.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.617 0.246 . . . . 6.84 111.286 176.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.451 ' OG1' ' HA ' ' A' ' 24' ' ' VAL . 33.7 p -70.62 -11.81 61.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 5.71 111.685 -177.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.74 38.84 41.58 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.867 -0.682 . . . . 5.75 111.427 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.415 ' HA ' HG13 ' A' ' 24' ' ' VAL . 2.2 p-10 43.81 47.9 6.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.908 0.883 . . . . 5.06 111.966 -176.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.4 mtt -63.92 -64.48 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.498 -0.774 . . . . 6.28 110.66 175.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.84 179.99 45.78 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.815 -0.629 . . . . 4.17 111.665 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 6' ' ' SER . . . -65.22 -33.82 76.91 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.656 0.243 . . . . 3.73 111.656 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -53.74 -63.24 1.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.008 0.432 . . . . 5.46 111.837 -176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 m -68.23 -30.62 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 112.234 0.457 . . . . 4.88 112.234 -175.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.85 47.25 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.667 -0.413 . . . . 3.68 111.988 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.559 ' O ' HG22 ' A' ' 39' ' ' ILE . 70.7 t80 -58.72 -44.62 90.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.011 -0.737 . . . . 4.71 109.011 173.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -65.36 -34.64 78.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.619 -0.719 . . . . 5.69 111.031 176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -66.23 -36.39 82.91 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.133 0.492 . . . . 5.87 110.506 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.702 HG21 HD13 ' A' ' 10' ' ' LEU . 7.0 tp -76.98 -41.56 31.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.236 -0.438 . . . . 3.69 111.38 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.05 -26.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.864 0.364 . . . . 5.04 111.003 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.0 p -80.66 -31.82 12.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.864 -0.334 . . . . 5.37 110.783 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -100.44 14.59 30.68 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 122.051 -0.406 . . . . 5.35 111.892 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -64.08 -22.57 66.99 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.928 0.394 . . . . 5.73 111.399 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.0 -3.84 41.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.07 0.396 . . . . 6.34 112.07 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.844 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 21.9 mm-40 -66.01 123.28 84.64 Favored Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 109.97 -0.381 . . . . 5.62 109.97 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 45' ' ' GLU . 13.2 Cg_endo -58.98 -36.34 96.98 Favored 'Trans proline' 0 N--CA 1.472 0.244 0 C-N-CA 123.1 2.533 . . . . 6.22 112.141 177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -115.98 26.88 9.64 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.791 -1.095 . . . . 6.09 110.245 -171.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.844 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.5 p90 -60.33 -43.85 96.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.778 -0.646 . . . . 5.89 111.468 -178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -158.97 162.27 36.78 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.312 -0.996 . . . . 4.6 108.312 -175.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -100.81 90.54 1.55 Allowed Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 114.975 -1.011 . . . . 5.96 109.303 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 49' ' ' ALA . 97.1 Cg_endo -84.76 48.7 2.44 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.895 2.397 . . . . 6.2 112.809 -171.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.9 mt -87.23 33.21 0.68 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.536 -0.756 . . . . 8.24 110.626 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.461 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 85.8 m -158.2 94.52 1.3 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.853 -0.612 . . . . 7.27 110.047 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 79.4 mtp -88.09 103.94 5.97 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 116.235 -0.438 . . . . 7.41 109.905 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.505 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 8.0 Cg_exo -72.65 -60.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.024 2.483 . . . . 5.89 112.691 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.33 -176.05 20.55 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.959 -0.639 . . . . 6.63 112.541 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -165.11 173.73 11.11 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.797 -0.446 . . . . 9.15 109.797 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.67 -136.34 7.55 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.581 -0.819 . . . . 6.92 112.544 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 156.72 -133.68 3.72 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.312 -0.47 . . . . 7.34 111.983 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -134.0 -44.75 0.79 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 110.216 -0.29 . . . . 7.8 110.216 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 49.94 53.24 13.14 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.639 0.587 . . . . 6.73 111.86 176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.558 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . 52.4 m 62.58 63.69 0.99 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.619 -0.719 . . . . 7.03 111.163 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.2 -42.41 31.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.138 0.494 . . . . 6.23 110.049 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.43 46.73 1.79 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.63 -0.795 . . . . 7.09 111.7 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 62' ' ' SER . . . -97.82 23.88 7.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 7.1 111.499 -175.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.1 m -151.33 139.69 20.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.12 0.486 . . . . 7.6 110.875 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.7 t -110.01 103.33 15.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.611 -0.722 . . . . 8.01 109.212 177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -121.75 102.43 8.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.951 0.405 . . . . 8.06 110.502 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -130.57 18.57 5.15 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.877 -0.889 . . . . 6.62 110.877 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 73' ' ' LEU . . . -85.73 75.93 10.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.316 -0.442 . . . . 6.12 111.403 -175.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.0 p -66.82 -42.57 85.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.361 0.601 . . . . 7.65 110.042 175.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -143.81 78.15 0.27 Allowed Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.596 -1.002 . . . . 6.25 110.596 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.631 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 6.0 tt -74.24 -53.92 8.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.004 0.431 . . . . 7.29 110.513 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -98.35 119.39 36.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.073 -0.512 . . . . 6.55 110.235 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -130.17 33.85 4.3 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.448 0.642 . . . . 7.51 109.741 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -85.42 141.21 36.56 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.375 -0.83 . . . . 7.14 110.535 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.647 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 48.3 Cg_exo -61.87 164.48 16.34 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.062 2.508 . . . . 5.41 112.047 171.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.653 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 50.0 Cg_endo -66.37 112.92 2.48 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.95 2.433 . . . . 7.14 111.256 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.648 ' HA ' HG22 ' A' ' 82' ' ' VAL . 10.2 pt-20 -55.93 -29.56 60.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.649 -0.705 . . . . 10.13 110.77 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 5.3 tt0 -56.89 -51.0 70.8 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.265 0.555 . . . . 11.78 110.29 174.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.779 ' HA ' HD12 ' A' ' 84' ' ' ILE . 71.8 mt -75.67 -41.4 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.75 -0.659 . . . . 8.42 111.8 -175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.774 ' O ' HG22 ' A' ' 86' ' ' THR . 5.5 m -56.06 -38.03 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.601 -0.889 . . . . 7.57 108.601 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -62.11 -45.78 91.96 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.815 -1.084 . . . . 10.39 110.699 176.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.9 mt -62.5 -41.73 93.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.885 -0.598 . . . . 10.78 110.871 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.724 HD12 ' HB1' ' A' ' 95' ' ' ALA . 80.4 mt -65.97 -46.76 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.916 -0.584 . . . . 8.01 111.66 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.2 t -69.73 -21.2 63.49 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.042 -0.663 . . . . 10.38 110.518 176.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.5 t -73.03 -32.22 64.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.741 -0.466 . . . . 12.35 109.741 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 25.0 mmt -64.25 -26.26 68.42 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.214 0.531 . . . . 10.33 110.489 176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.64 6.21 4.7 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.637 -0.71 . . . . 9.53 112.01 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.644 ' HB2' HG22 ' A' ' 85' ' ' ILE . 32.2 m-85 -99.07 -174.01 2.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.68 0.276 . . . . 8.89 110.297 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.811 ' HB2' ' HB3' ' A' ' 94' ' ' GLN . 34.2 mt-30 -91.05 149.55 21.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.47 -0.332 . . . . 10.16 110.468 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 96' ' ' ILE . 15.4 ttm180 -61.99 -51.16 69.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.427 -0.583 . . . . 11.98 109.427 173.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.472 -0.785 . . . . 9.02 110.879 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.811 ' HB3' ' HB2' ' A' ' 91' ' ' GLN . 1.0 OUTLIER -63.6 -37.45 87.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.264 0.554 . . . . 6.68 109.728 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.724 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -63.72 -41.39 98.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.427 -0.806 . . . . 5.22 110.451 175.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.647 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.1 mt -58.79 -52.15 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 116.127 -0.488 . . . . 6.39 110.277 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.639 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 51.6 tt0 -53.86 -47.11 71.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.837 -0.62 . . . . 8.36 111.162 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.443 ' HB2' ' CG1' ' A' ' 113' ' ' ILE . . . -60.17 -52.09 66.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.01 -0.995 . . . . 5.41 110.91 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 109' ' ' ALA . 75.2 mt -62.93 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.438 -0.346 . . . . 5.77 111.542 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.639 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 89.8 mtt180 -54.64 -46.17 73.9 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.787 0.804 . . . . 7.71 109.66 175.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.69 -44.74 55.74 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.53 -1.213 . . . . 8.88 111.382 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.698 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 64.3 p -81.41 0.06 39.2 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.917 0.71 . . . . 8.79 112.917 -174.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 61.58 62.94 1.23 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 10.09 110.257 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 11.5 p30 53.09 23.42 3.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.662 1.185 . . . . 7.8 112.662 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.553 ' OD1' ' HB2' ' A' ' 108' ' ' ARG . 2.1 t-20 -87.44 108.78 19.16 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.386 -0.598 . . . . 10.49 109.386 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.779 HD12 HG12 ' A' ' 81' ' ' ILE . 8.7 tt -53.94 -61.27 2.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.915 -1.039 . . . . 9.54 112.042 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.02 -45.79 75.17 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.811 -1.086 . . . . 11.82 111.655 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.698 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 9.0 ttm180 -69.66 -28.69 66.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.053 -0.521 . . . . 12.41 110.845 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.688 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -63.37 -50.92 68.0 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.103 -0.703 . . . . 6.3 109.103 176.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.506 HD23 HG23 ' A' ' 85' ' ' ILE . 21.7 mt -58.58 -39.1 79.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.404 -0.816 . . . . 7.78 109.668 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 108' ' ' ARG . 11.0 t70 -54.17 -54.54 38.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.982 -1.008 . . . . 9.04 109.942 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -62.68 -39.7 94.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.058 -1.428 . . . . 8.69 110.781 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.68 HD11 ' HA ' ' A' ' 95' ' ' ALA . 53.7 mt -71.37 -36.05 59.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.36 -0.836 . . . . 5.25 111.27 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -64.85 -33.39 75.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.48 0.657 . . . . 6.92 109.996 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.3 t -84.01 11.03 8.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.195 -0.911 . . . . 8.33 110.287 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -135.06 70.34 69.89 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.541 -0.754 . . . . 9.41 109.744 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.472 ' HD2' ' OE2' ' A' ' 120' ' ' GLU . 9.6 Cg_endo -49.29 -66.78 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 124.438 3.426 . . . . 7.92 113.431 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -171.1 -42.23 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.545 -0.752 . . . . 11.42 110.461 -176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -147.89 16.29 1.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.232 0.539 . . . . 15.58 109.921 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.472 ' OE2' ' HD2' ' A' ' 117' ' ' PRO . 46.6 mm-40 63.73 118.24 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.208 -0.905 . . . . 11.4 111.869 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.92 123.42 32.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.402 0.62 . . . . 12.26 110.865 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -137.43 -50.59 0.62 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.88 -0.6 . . . . 15.51 110.398 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.6 t -119.46 56.25 0.93 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.416 0.627 . . . . 16.06 109.987 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -111.54 -43.83 3.61 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.845 -0.616 . . . . 17.4 110.002 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -78.64 -38.53 39.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.857 -0.611 . . . . 19.19 109.364 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.421 -0.809 . . . . 20.33 110.591 179.577 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 121.277 0.561 . . . . 7.16 109.877 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.445 HG23 ' CG1' ' A' ' 24' ' ' VAL . 52.8 mt -138.82 135.3 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 115.47 -0.786 . . . . 5.69 109.253 178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.557 ' H ' HG11 ' A' ' 24' ' ' VAL . 10.0 m-20 -69.83 72.53 0.39 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.293 0.568 . . . . 4.6 109.605 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.577 ' HA ' HG12 ' A' ' 7' ' ' VAL . 43.7 mt-10 -71.14 -4.14 23.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.709 -0.678 . . . . 5.13 111.142 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.552 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 14.5 m -63.22 -30.96 72.0 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.251 -0.648 . . . . 4.17 109.251 169.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.659 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 48.2 t -66.96 -52.68 39.86 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.673 -0.694 . . . . 3.42 110.943 178.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 4' ' ' GLU . 5.1 p -63.67 -37.67 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.318 -0.401 . . . . 3.24 110.583 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.584 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 20.9 mmt -65.27 -29.0 69.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.0 -0.545 . . . . 5.17 111.516 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 5' ' ' SER . 71.3 mt-30 -66.37 -40.87 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.735 -0.386 . . . . 5.38 110.534 174.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.698 ' HB3' HD12 ' A' ' 17' ' ' LEU . 18.4 mt -68.67 -39.37 80.66 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.862 0.839 . . . . 3.9 109.533 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 8' ' ' MET . . . -61.88 -34.46 76.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.363 -1.29 . . . . 4.46 111.8 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 8' ' ' MET . 49.3 mt-10 -67.54 -18.91 65.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.813 0.34 . . . . 6.27 111.145 175.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.7 mtp -83.17 -1.16 52.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.168 0.508 . . . . 5.2 109.832 174.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.1 45.68 5.57 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.445 -0.798 . . . . 4.75 113.066 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -144.17 125.77 8.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.857 0.361 . . . . 5.09 110.64 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.59 66.12 4.69 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.354 2.703 . . . . 4.25 111.687 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.698 HD12 ' HB3' ' A' ' 10' ' ' LEU . 61.9 mt -89.65 64.6 6.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.691 0.758 . . . . 3.29 111.695 -173.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -55.54 -21.81 18.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.02 -0.536 . . . . 5.48 109.714 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.603 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -57.92 -30.65 66.09 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.52 -0.764 . . . . 3.54 109.901 173.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HB2' HD12 ' A' ' 10' ' ' LEU . 17.5 t -72.16 -44.71 62.66 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.506 -0.77 . . . . 3.27 109.037 174.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.77 -48.82 72.18 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.43 -0.804 . . . . 6.1 110.773 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 10.9 ptpt -75.76 -23.29 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.981 -0.288 . . . . 4.77 110.734 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.4 -41.9 93.17 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.328 0.585 . . . . 4.34 110.067 173.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.557 HG11 ' H ' ' A' ' 3' ' ' ASP . 77.1 t -58.58 -40.31 78.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.628 -0.715 . . . . 4.58 110.009 173.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 22' ' ' LYS . 87.3 t80 -60.73 -49.95 75.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.685 -0.689 . . . . 7.48 110.57 173.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -61.81 -43.36 99.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.646 -0.252 . . . . 6.84 111.597 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -66.82 -27.74 67.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.125 0.488 . . . . 5.71 111.094 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.77 36.29 6.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.791 -0.64 . . . . 5.75 112.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.29 64.48 1.35 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.947 0.403 . . . . 5.06 110.139 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.7 mmt -97.71 -32.72 11.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.044 -0.525 . . . . 6.28 111.922 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.69 171.12 18.59 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 119.72 -1.229 . . . . 4.17 113.035 178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.659 ' HA ' ' HB2' ' A' ' 6' ' ' SER . . . -67.14 -54.52 20.54 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.229 0.455 . . . . 3.73 112.229 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.532 ' HA ' ' HB3' ' A' ' 36' ' ' PHE . 45.3 mt-10 -68.56 -24.23 64.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.837 0.351 . . . . 5.46 110.804 -177.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.9 t -65.38 -46.67 89.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 4.88 110.318 174.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB3' ' OG ' ' A' ' 6' ' ' SER . . . -78.45 -27.38 46.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.49 -0.323 . . . . 3.68 111.09 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.549 ' O ' HG22 ' A' ' 39' ' ' ILE . 81.1 t80 -57.89 -44.25 86.62 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.036 -0.727 . . . . 4.71 109.036 169.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.518 ' O ' HG13 ' A' ' 40' ' ' ILE . 36.6 t30 -62.94 -40.86 98.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.462 -0.79 . . . . 5.69 110.285 175.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -65.16 -33.57 76.33 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.895 -0.593 . . . . 5.87 110.626 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 19' ' ' ALA . 3.9 tp -75.69 -37.89 36.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.693 -0.403 . . . . 3.69 111.111 -176.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.7 pp -71.1 -30.15 39.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.86 -0.336 . . . . 5.04 111.004 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -81.37 -21.47 10.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.796 -0.361 . . . . 5.37 110.76 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -101.8 1.32 37.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.902 0.382 . . . . 5.35 111.09 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 40' ' ' ILE . 25.7 ptt? -62.87 -23.72 67.46 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.56 0.578 . . . . 5.73 112.56 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -71.04 -10.71 60.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.763 0.316 . . . . 6.34 111.78 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.829 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 6.6 mm-40 -77.42 127.4 82.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.437 -0.347 . . . . 5.62 110.666 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -60.22 -35.71 90.87 Favored 'Trans proline' 0 N--CA 1.473 0.306 0 C-N-CA 123.63 2.887 . . . . 6.22 113.014 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -115.7 25.64 10.62 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.113 -0.949 . . . . 6.09 110.392 -170.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.829 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 2.0 p90 -63.3 -32.33 73.71 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.642 -0.708 . . . . 5.89 111.528 -176.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -137.52 -140.35 0.15 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.989 -0.745 . . . . 4.6 108.989 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -101.36 105.37 39.46 Favored Pre-proline 0 C--N 1.316 -0.884 0 N-CA-C 109.7 -0.482 . . . . 5.96 109.7 176.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.27 60.57 6.38 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 123.278 2.652 . . . . 6.2 112.129 -178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -128.98 96.3 4.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.628 -0.714 . . . . 8.24 110.227 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.9 t 36.24 93.67 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.403 1.081 . . . . 7.27 113.495 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.405 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 61.4 mtt -71.46 127.66 90.9 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.595 -0.729 . . . . 7.41 110.303 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 10.3 Cg_exo -71.79 -64.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.546 2.831 . . . . 5.89 113.159 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.26 166.16 39.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.914 -0.66 . . . . 6.63 112.014 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -84.5 28.42 0.65 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.096 0.474 . . . . 9.15 111.672 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.09 73.37 2.29 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.977 -0.63 . . . . 6.92 111.884 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.39 170.72 25.42 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.777 -0.725 . . . . 7.34 112.02 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.94 139.3 48.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.868 0.366 . . . . 7.8 110.818 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.89 120.66 25.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 6.73 109.763 176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.2 p 47.02 58.23 4.98 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.681 0.613 . . . . 7.03 110.885 -175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.42 83.2 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 6.23 110.849 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.79 -118.26 2.69 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.71 -0.677 . . . . 7.09 111.443 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.11 155.05 17.93 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.415 -0.587 . . . . 7.1 109.415 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 t -82.55 72.1 9.62 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.592 -0.521 . . . . 7.6 109.592 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.4 t -95.19 124.46 47.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.6 -0.727 . . . . 8.01 110.442 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -93.47 -179.52 5.07 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.02 -0.536 . . . . 8.06 110.152 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -157.45 -164.82 14.22 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.319 -0.943 . . . . 6.62 112.543 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.42 -70.17 0.79 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.074 -0.343 . . . . 6.12 110.074 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.4 m 58.25 63.34 1.76 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.9 -0.591 . . . . 7.65 110.483 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.5 39.06 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.411 -0.813 . . . . 6.25 111.251 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.18 20.02 15.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.065 0.459 . . . . 7.29 110.943 -176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -142.34 149.26 39.2 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.101 -0.5 . . . . 6.55 109.961 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -169.5 177.34 4.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.143 -1.058 . . . . 7.51 108.143 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -141.91 140.16 19.36 Favored Pre-proline 0 N--CA 1.438 -1.043 0 N-CA-C 109.545 -0.539 . . . . 7.14 109.545 173.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 77.0 Cg_exo -54.06 166.8 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.683 2.256 . . . . 5.41 111.666 170.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.689 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 40.8 Cg_endo -64.38 109.42 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.175 1.917 . . . . 7.14 110.407 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.675 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.1 pt-20 -58.13 -23.56 55.56 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.461 0.476 . . . . 10.13 110.274 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 3.6 tt0 -59.31 -53.04 62.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.616 -0.72 . . . . 11.78 110.108 171.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.773 ' HA ' HD12 ' A' ' 84' ' ' ILE . 73.1 mt -73.67 -42.39 54.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.74 -0.664 . . . . 8.42 111.648 -176.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.781 ' O ' HG22 ' A' ' 86' ' ' THR . 5.8 m -55.14 -37.98 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.556 -0.905 . . . . 7.57 108.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -61.67 -47.97 82.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.858 -1.065 . . . . 10.39 111.055 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 81' ' ' ILE . 20.8 mt -60.2 -41.33 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.863 -0.608 . . . . 10.78 110.309 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.734 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.8 mt -67.0 -45.16 87.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.747 -0.66 . . . . 8.01 111.657 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.4 t -71.14 -20.67 62.28 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.081 -0.648 . . . . 10.38 110.726 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.2 t -75.23 -27.14 59.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.121 0.486 . . . . 12.35 109.829 172.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 23.8 mmt -68.37 -23.05 64.63 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 10.33 110.703 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.09 -5.24 5.68 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.518 -0.765 . . . . 9.53 111.635 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.595 ' HB2' HG22 ' A' ' 85' ' ' ILE . 29.3 m-85 -90.8 -176.24 4.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.56 -0.32 . . . . 8.89 110.614 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 32.8 tt0 -98.01 147.07 24.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.823 -0.436 . . . . 10.16 109.823 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.503 ' O ' HD12 ' A' ' 96' ' ' ILE . 10.2 ttm180 -56.66 -54.78 42.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.101 0.477 . . . . 11.98 110.51 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.445 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 8.8 t30 -58.45 -36.74 74.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.853 -0.612 . . . . 9.02 111.016 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 9.0 tt0 -64.69 -38.39 90.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.578 -0.737 . . . . 6.68 109.626 176.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.734 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -66.06 -39.17 89.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.127 -0.942 . . . . 5.22 110.693 175.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.557 HG13 HG11 ' A' ' 82' ' ' VAL . 1.1 mp -59.41 -52.49 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-N 116.212 -0.449 . . . . 6.39 111.039 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 57.5 tt0 -58.91 -41.62 87.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.052 -0.522 . . . . 8.36 110.862 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.615 ' O ' HG23 ' A' ' 102' ' ' THR . . . -59.98 -53.35 58.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.346 -0.843 . . . . 5.41 110.417 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 109' ' ' ALA . 79.9 mt -61.46 -34.77 75.99 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.39 -0.368 . . . . 5.77 111.526 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 93.3 mtt180 -55.88 -46.35 78.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.544 0.688 . . . . 7.71 110.371 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.3 70.19 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.958 -1.019 . . . . 8.88 111.061 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.72 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 31.2 p -84.36 0.18 50.28 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.991 0.737 . . . . 8.79 112.991 -175.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.4 m120 60.87 61.88 1.57 Allowed 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.021 0.528 . . . . 10.09 110.458 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.594 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 10.1 p30 51.67 25.5 2.89 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.589 1.156 . . . . 7.8 112.339 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 108' ' ' ARG . 13.1 t-20 -86.1 109.62 18.98 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.946 -0.761 . . . . 10.49 108.946 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.724 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.4 tt -54.75 -59.73 4.32 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.094 -0.957 . . . . 9.54 111.436 -176.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -55.24 -48.38 74.03 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.637 -1.165 . . . . 11.82 111.737 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.72 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 31.6 ttm180 -67.98 -28.71 67.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.407 -0.36 . . . . 12.41 110.92 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.22 -50.41 71.87 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.353 -0.61 . . . . 6.3 109.353 177.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.508 HD23 HG23 ' A' ' 85' ' ' ILE . 17.0 mt -60.34 -39.22 86.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.266 -0.879 . . . . 7.78 109.665 175.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -54.93 -49.97 70.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.81 -1.086 . . . . 9.04 110.124 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -63.1 -49.85 72.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.375 -1.284 . . . . 8.69 110.489 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.694 HD11 ' HA ' ' A' ' 95' ' ' ALA . 44.2 mt -62.16 -32.33 54.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.931 -1.031 . . . . 5.25 111.394 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -61.95 -29.42 70.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.182 0.515 . . . . 6.92 110.997 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -82.99 -3.13 56.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.543 0.687 . . . . 8.33 109.841 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -141.82 62.68 15.02 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.731 -0.668 . . . . 9.41 110.246 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -36.5 -58.44 0.51 Allowed 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 125.18 3.92 . . . . 7.92 113.308 -170.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.445 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 5.2 pt-20 -157.32 -57.06 0.08 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.866 -1.061 . . . . 11.42 108.835 173.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.445 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 33.1 t80 -158.76 12.29 0.16 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.742 -0.663 . . . . 15.58 110.562 176.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.08 -168.29 0.16 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.137 -0.483 . . . . 11.4 110.05 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -135.22 166.04 24.03 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.669 -0.493 . . . . 12.26 109.669 173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.3 t70 51.75 76.13 0.18 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 124.07 0.857 . . . . 15.51 110.938 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.8 t -91.78 106.87 18.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.962 -0.563 . . . . 16.06 110.123 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -96.09 -28.78 14.44 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.013 -0.539 . . . . 17.4 110.436 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -88.64 -46.74 8.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.485 -0.325 . . . . 19.19 110.693 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 41.0 t . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.615 -0.707 . . . . 20.33 110.215 -178.109 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 121.079 0.466 . . . . 7.16 110.764 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.486 HG23 ' CG1' ' A' ' 24' ' ' VAL . 78.1 mt -98.27 130.32 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.646 -0.706 . . . . 5.69 110.923 -174.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.34 74.74 1.87 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.174 0.512 . . . . 4.6 110.706 174.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.412 ' HA ' HG12 ' A' ' 7' ' ' VAL . 46.0 mt-10 -71.67 -5.45 33.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.401 0.62 . . . . 5.13 110.147 176.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 15.2 m -61.78 -34.28 75.6 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.612 -0.722 . . . . 4.17 109.301 167.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t -59.78 -51.93 67.64 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 3.42 110.716 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 17' ' ' LEU . 3.8 p -66.58 -40.7 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 116.229 -0.441 . . . . 3.24 111.113 -177.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 65.6 mtp -63.45 -31.62 72.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.281 -0.418 . . . . 5.17 111.26 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 13' ' ' MET . 13.9 mm100 -60.28 -53.95 51.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 110.037 -0.357 . . . . 5.38 110.037 173.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.634 ' HB3' HD12 ' A' ' 17' ' ' LEU . 10.7 mt -57.2 -43.22 82.56 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.153 0.501 . . . . 3.9 109.841 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' PHE . . . -61.88 -50.0 73.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.655 -1.157 . . . . 4.46 111.784 -172.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -60.17 -28.54 68.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.357 -0.383 . . . . 6.27 111.518 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.68 ' HG2' ' O ' ' A' ' 9' ' ' GLN . 17.3 ptt? -112.91 31.1 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.891 0.33 . . . . 5.2 111.891 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.72 96.84 0.55 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 119.849 -1.167 . . . . 4.75 114.173 173.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 m-85 73.89 133.8 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 113.225 0.824 . . . . 5.09 113.225 169.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.31 83.77 0.47 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.93 2.42 . . . . 4.25 111.353 171.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.634 HD12 ' HB3' ' A' ' 10' ' ' LEU . 95.4 mt -82.33 66.98 8.18 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.781 -0.645 . . . . 3.29 112.137 -173.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 21' ' ' ARG . 3.7 tt0 -56.38 -19.76 16.28 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.892 0.377 . . . . 5.48 111.001 174.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 39' ' ' ILE . . . -58.64 -32.34 68.96 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 120.929 0.395 . . . . 3.54 109.983 172.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 49.5 t -72.02 -43.58 64.77 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.465 -0.789 . . . . 3.27 109.177 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 18' ' ' GLU . 29.7 ttt180 -52.36 -52.75 51.72 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.868 -1.06 . . . . 6.1 110.049 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.426 ' HB3' ' HZ3' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -72.71 -25.07 61.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.655 . . . . 4.77 110.834 177.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.43 -42.46 78.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 120.62 0.248 . . . . 4.34 110.648 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' CYS . 93.4 t -56.83 -45.93 83.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.672 -0.492 . . . . 4.58 109.672 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -62.03 -46.47 89.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 120.506 -0.478 . . . . 7.48 110.713 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -64.25 -36.25 83.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 6.84 112.003 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.7 p -68.8 -21.05 64.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.205 0.526 . . . . 5.71 110.583 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.55 27.71 12.58 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.606 -0.725 . . . . 5.75 111.559 -176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 64.04 53.63 1.82 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.299 0.571 . . . . 5.06 110.327 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.542 ' HB3' HG21 ' A' ' 34' ' ' VAL . 20.4 mmt -82.08 -14.65 55.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.805 -0.634 . . . . 6.28 111.86 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.02 173.02 13.39 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.438 -0.887 . . . . 4.17 112.663 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.04 66.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.34 . . . . 3.73 111.053 -178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -53.97 -49.11 69.51 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.068 -0.515 . . . . 5.46 111.22 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 30' ' ' MET . 95.9 t -60.46 -38.71 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.731 -0.668 . . . . 4.88 111.343 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.52 -34.17 54.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.079 -0.248 . . . . 3.68 111.662 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.656 ' O ' HG22 ' A' ' 39' ' ' ILE . 59.2 t80 -56.94 -44.78 82.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.904 -0.776 . . . . 4.71 108.904 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.493 ' O ' HG13 ' A' ' 40' ' ' ILE . 5.4 m-20 -65.79 -39.95 91.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.395 -0.821 . . . . 5.69 110.536 175.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -64.36 -34.77 78.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 5.87 110.468 -177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 36' ' ' PHE . 7.2 tp -75.42 -40.73 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.201 -0.454 . . . . 3.69 111.475 -176.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 37' ' ' ASN . 2.6 pp -69.71 -23.81 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.163 0.506 . . . . 5.04 110.606 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 37' ' ' ASN . 85.2 t -78.92 -42.05 24.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.078 -0.51 . . . . 5.37 110.824 171.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -101.12 19.21 17.95 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.391 0.515 . . . . 5.35 112.391 -172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.4 ptm -63.27 -21.11 66.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.2 0.524 . . . . 5.73 110.416 172.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 44' ' ' GLU . 8.2 pt-20 -66.23 -11.27 49.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.276 -0.874 . . . . 6.34 112.42 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.71 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 39.9 mm-40 -69.45 140.28 89.89 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.062 -0.347 . . . . 5.62 110.062 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.8 -49.16 5.66 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.965 2.443 . . . . 6.22 113.417 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -108.94 25.63 11.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.944 0.878 . . . . 6.09 110.361 -169.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.71 ' HB3' ' HB2' ' A' ' 45' ' ' GLU . 1.6 p90 -62.04 -25.81 67.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.399 -0.819 . . . . 5.89 112.08 -176.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.564 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -139.14 119.75 14.06 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.011 0.434 . . . . 4.6 110.285 -176.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 28.1 mt-10 -59.6 114.83 10.43 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.211 -0.904 . . . . 5.96 110.228 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 50' ' ' GLU . 2.8 Cg_exo -75.8 71.92 5.32 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.083 2.522 . . . . 6.2 112.272 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.2 tp -127.73 67.72 1.32 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.886 -0.597 . . . . 8.24 110.685 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.8 m 66.12 113.28 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.736 -0.665 . . . . 7.27 112.044 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.47 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 17.1 ptm -86.38 129.43 53.4 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.235 -0.439 . . . . 7.41 110.538 177.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 54' ' ' MET . 13.2 Cg_exo -71.29 149.82 57.91 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.806 2.338 . . . . 5.89 111.539 175.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.88 115.02 2.68 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.027 -0.606 . . . . 6.63 111.991 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -70.21 128.17 35.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.668 0.27 . . . . 9.15 110.465 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -124.55 170.52 16.62 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.086 -0.578 . . . . 6.92 111.723 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.83 169.15 54.95 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.003 -0.618 . . . . 7.34 112.384 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.0 133.35 43.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.338 0.589 . . . . 7.8 111.327 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.64 27.22 3.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.573 -0.74 . . . . 6.73 110.648 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.8 t -125.55 144.09 50.72 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.017 -0.538 . . . . 7.03 110.263 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.61 87.64 6.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.105 -0.498 . . . . 6.23 109.76 174.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.5 -40.05 40.35 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.965 -0.636 . . . . 7.09 112.637 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.78 -56.21 0.83 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.906 -0.173 . . . . 7.1 111.256 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.2 t 54.68 50.67 15.37 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.198 0.523 . . . . 7.6 110.097 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.647 HG13 ' HD1' ' A' ' 68' ' ' PHE . 7.5 p -89.63 -32.0 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.969 -0.559 . . . . 8.01 110.008 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.647 ' HD1' HG13 ' A' ' 67' ' ' VAL . 9.8 m-85 -97.4 43.37 1.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.944 -0.571 . . . . 8.06 110.715 177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.53 153.27 21.5 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.718 -0.674 . . . . 6.62 111.478 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB1' HD22 ' A' ' 73' ' ' LEU . . . -93.63 -30.02 15.16 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.798 0.333 . . . . 6.12 110.345 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.6 t 63.1 -86.84 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.307 -0.86 . . . . 7.65 111.424 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -129.18 10.68 6.19 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.946 -0.645 . . . . 6.25 111.786 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.456 HD22 ' HB1' ' A' ' 70' ' ' ALA . 4.4 mm? 63.15 53.22 2.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.095 0.474 . . . . 7.29 111.288 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.57 76.05 7.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.592 0.71 . . . . 6.55 109.519 177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -132.92 76.04 1.66 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.226 -0.897 . . . . 7.51 109.377 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -70.32 139.06 86.85 Favored Pre-proline 0 N--CA 1.443 -0.823 0 N-CA-C 108.531 -0.914 . . . . 7.14 108.531 176.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HG2' ' HA ' ' A' ' 96' ' ' ILE . 71.9 Cg_exo -52.67 159.2 5.07 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.756 2.304 . . . . 5.41 112.709 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.739 ' HG2' ' HB ' ' A' ' 81' ' ' ILE . 43.3 Cg_endo -65.29 113.28 2.38 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.874 2.383 . . . . 7.14 110.959 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.728 ' HA ' HG22 ' A' ' 82' ' ' VAL . 13.0 pt-20 -57.43 -28.8 63.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.955 -0.566 . . . . 10.13 110.309 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 4.3 tt0 -57.62 -50.57 72.72 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.908 -0.587 . . . . 11.78 109.924 174.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.766 ' HA ' HD12 ' A' ' 84' ' ' ILE . 68.7 mt -76.27 -42.72 37.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.845 -0.616 . . . . 8.42 112.036 -176.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.773 ' O ' HG22 ' A' ' 86' ' ' THR . 10.0 m -55.35 -38.28 47.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 108.463 -0.94 . . . . 7.57 108.463 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 80' ' ' GLU . . . -60.35 -49.66 76.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.822 -1.081 . . . . 10.39 110.57 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.766 HD12 ' HA ' ' A' ' 81' ' ' ILE . 21.3 mt -59.78 -42.14 87.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.189 -0.459 . . . . 10.78 110.737 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.771 HD12 ' HB1' ' A' ' 95' ' ' ALA . 85.6 mt -64.63 -47.0 90.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.076 -0.511 . . . . 8.01 111.424 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.773 HG22 ' O ' ' A' ' 82' ' ' VAL . 1.7 t -72.03 -21.18 61.58 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.152 -0.619 . . . . 10.38 110.809 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -77.01 -17.66 58.68 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.809 0.338 . . . . 12.35 110.449 172.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 84' ' ' ILE . 97.1 mmm -75.28 -25.45 57.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.286 0.565 . . . . 10.33 109.503 173.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.69 -1.77 5.2 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.252 -0.885 . . . . 9.53 112.012 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.624 ' HB2' HG22 ' A' ' 85' ' ' ILE . 32.0 m-85 -92.21 -174.09 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.748 0.309 . . . . 8.89 110.692 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.755 ' HB3' ' HB3' ' A' ' 94' ' ' GLN . 6.7 tt0 -97.18 143.28 28.14 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.916 -0.401 . . . . 10.16 109.916 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 96' ' ' ILE . 5.2 ttm180 -55.9 -54.85 39.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.981 0.42 . . . . 11.98 110.29 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.551 ' HB3' ' OE1' ' A' ' 91' ' ' GLN . 54.1 t30 -59.63 -35.82 75.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.791 -0.641 . . . . 9.02 111.031 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.755 ' HB3' ' HB3' ' A' ' 91' ' ' GLN . 8.5 tt0 -64.96 -39.82 94.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.439 0.638 . . . . 6.68 109.533 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.771 ' HB1' HD12 ' A' ' 85' ' ' ILE . . . -62.83 -39.17 93.5 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.935 -1.03 . . . . 5.22 110.408 174.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 77' ' ' PRO . 1.0 OUTLIER -59.45 -52.9 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 116.322 -0.399 . . . . 6.39 110.805 176.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.542 ' HA ' ' HD3' ' A' ' 100' ' ' ARG . 7.5 tt0 -56.35 -44.62 80.27 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.221 0.534 . . . . 8.36 110.82 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.601 ' O ' HG23 ' A' ' 102' ' ' THR . . . -60.04 -53.29 59.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.304 -0.862 . . . . 5.41 110.729 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.723 HD23 ' HB2' ' A' ' 109' ' ' ALA . 77.1 mt -62.01 -32.88 73.41 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 111.779 0.289 . . . . 5.77 111.779 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' A' ' 97' ' ' GLN . 75.3 mtp180 -57.37 -43.73 83.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.436 0.636 . . . . 7.71 110.262 176.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.87 -41.1 60.44 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.19 -0.914 . . . . 8.88 111.077 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.7 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 33.7 p -84.47 -0.72 53.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.19 0.811 . . . . 8.79 113.19 -174.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 62.03 63.45 1.09 Allowed 'General case' 0 C--O 1.231 0.095 0 O-C-N 123.577 0.548 . . . . 10.09 110.621 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HA ' ' HB3' ' A' ' 99' ' ' LEU . 2.8 p-10 50.04 27.64 2.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.221 1.008 . . . . 7.8 111.967 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.464 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 43.6 t-20 -88.96 107.32 18.96 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.827 -0.805 . . . . 10.49 108.827 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.737 ' HB2' HD13 ' A' ' 81' ' ' ILE . 8.0 tt -53.78 -60.34 3.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.093 -0.958 . . . . 9.54 111.393 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.422 ' N ' HD23 ' A' ' 106' ' ' LEU . 37.5 mm-40 -54.45 -49.66 69.51 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.86 -1.064 . . . . 11.82 111.926 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.7 ' HB3' ' HB ' ' A' ' 102' ' ' THR . 26.3 ttm180 -66.9 -28.51 68.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.452 -0.34 . . . . 12.41 110.793 -178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.723 ' HB2' HD23 ' A' ' 99' ' ' LEU . . . -62.96 -51.28 67.51 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.679 -0.489 . . . . 6.3 109.679 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.577 HD23 HG23 ' A' ' 85' ' ' ILE . 16.4 mt -59.88 -39.21 84.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.461 -0.79 . . . . 7.78 109.52 175.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -54.81 -50.36 68.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.866 -1.061 . . . . 9.04 109.877 174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -63.32 -49.06 75.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.333 -1.303 . . . . 8.69 110.482 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.647 HD13 ' HG2' ' A' ' 94' ' ' GLN . 46.3 mt -62.61 -37.08 78.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.944 -1.025 . . . . 5.25 111.23 -177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.38 -24.15 67.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.171 0.51 . . . . 6.92 110.663 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.8 m -86.33 7.65 24.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.91 -0.586 . . . . 8.33 111.0 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -138.91 74.88 36.83 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.037 -0.529 . . . . 9.41 110.05 176.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -45.23 -59.93 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.571 3.514 . . . . 7.92 112.778 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.695 ' HG3' ' H ' ' A' ' 119' ' ' PHE . 4.3 pt-20 -163.98 -56.44 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.685 -1.143 . . . . 11.42 108.133 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.695 ' H ' ' HG3' ' A' ' 118' ' ' GLU . 91.4 t80 -128.31 -43.45 1.45 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.364 -1.289 . . . . 15.58 109.429 173.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 138.36 175.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 O-C-N 126.245 2.215 . . . . 11.4 109.149 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.27 147.35 52.57 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.492 -0.558 . . . . 12.26 109.492 174.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -143.65 -66.71 0.36 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.538 0.57 . . . . 15.51 112.538 -171.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.7 m -74.08 -15.18 61.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.579 -0.737 . . . . 16.06 112.893 -165.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -85.97 -41.86 14.52 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.54 -0.464 . . . . 17.4 110.881 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -78.37 -34.62 48.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.22 -0.446 . . . . 19.19 110.341 178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.245 -0.883 . . . . 20.33 110.734 179.396 . . . . . . . . 0 0 . 1 stop_ save_